PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adamo, S; Michler, J; Zurbuchen, Y; Cervia, C; Taeschler, P; Raeber, ME; Sain, SB; Nilsson, J; Moor, AE; Boyman, O				Adamo, Sarah; Michler, Jan; Zurbuchen, Yves; Cervia, Carlo; Taeschler, Patrick; Raeber, Miro E.; Sain, Simona Baghai; Nilsson, Jakob; Moor, Andreas E.; Boyman, Onur			Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection	NATURE			English	Article							DIFFERENTIATION; PROLIFERATION; EFFECTOR; SUBSETS	Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and enhanced immune response upon re-infection with the same pathogen(1,2). Since the outbreak of the ongoing COVID-19 pandemic, a key question has focused on which SARS-CoV-2-specific T cells stimulated during acute infection give rise to long-lived memory T cells(3). Here, using spectral flow cytometry combined with cellular indexing of transcriptomes and T cell receptor sequencing, we longitudinally characterized individual SARS-CoV-2-specific CD8(+) T cells of patients with COVID-19 from acute infection to 1 year into recovery and found a distinct signatue identifying long-lived memory CD8(+) T cells. SARS-CoV-2-specific memory CD8(+3) T cells persisting 1 year after acute infection express CD45RA, IL-7 receptor-a and T cell factor 1, but they maintain low expression of CCR7, thus resembling CD45RA(+) effector memory T cells. Tracking individual clones of SARS-CoV-2-specific CD8(+) T cells, we reveal that an interferon signature marks clones that give rise to long-lived cells, whereas prolonged proliferation and mechanistic target of rapamycin signalling are associated with clonal disappearance from the blood. Collectively, we describe a transcriptional signature that marks long-lived, circulating human memory CD8(+) T cells following an acute viral infection.	[Adamo, Sarah; Zurbuchen, Yves; Cervia, Carlo; Taeschler, Patrick; Raeber, Miro E.; Nilsson, Jakob; Boyman, Onur] Univ Hosp Zurich, Dept Immunol, Zurich, Switzerland; [Michler, Jan; Sain, Simona Baghai; Moor, Andreas E.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Boyman, Onur] Univ Zurich, Fac Med, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Boyman, O (corresponding author), Univ Hosp Zurich, Dept Immunol, Zurich, Switzerland.; Boyman, O (corresponding author), Univ Zurich, Fac Med, Zurich, Switzerland.	onur.boyman@uzh.ch	Cervia, Carlo/GRR-2202-2022; Raeber, Miro E/J-7626-2012	Raeber, Miro E/0000-0003-2609-0246; Zurbuchen, Yves/0000-0001-5387-9950; Moor, Andreas/0000-0001-8715-8449; Cervia, Carlo/0000-0001-7120-8739; Boyman, Onur/0000-0001-8279-5545; Taeschler, Patrick/0000-0003-0522-7629; Adamo, Sarah/0000-0002-6161-3156	Swiss National Science Foundation [4078P0-198431, 310030-172978, 310030-200669]; Clinical Research Priority Program of the University of Zurich; Innovation grant of University Hospital Zurich; Pandemic Fund of University of Zurich; Botnar Research Centre for Child Health (COVID-19 FTC); Swiss Academy of Medical Sciences fellowships [323530-177975, 323530-191220, 323530-191230]; University of Zurich [FK-20-022]; Swiss Academy of Medical Sciences; G. & J. Bangerter-Rhyner Foundation [YTCR 08/20]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Clinical Research Priority Program of the University of Zurich; Innovation grant of University Hospital Zurich; Pandemic Fund of University of Zurich; Botnar Research Centre for Child Health (COVID-19 FTC); Swiss Academy of Medical Sciences fellowships; University of Zurich; Swiss Academy of Medical Sciences; G. & J. Bangerter-Rhyner Foundation	We thank S. Hasler for her assistance with patient recruitment and coordination; E. Baechli, A. Rudiger, M. Stussi-Helbling, L. C. Huber and D. J. Schaer for their support in patient recruitment; and the members of the Boyman laboratory for helpful discussions. Graphical representations were generated with BioRender.com. This work was funded by the Swiss National Science Foundation (4078P0-198431 to O.B. and J.N.; and 310030-172978 and 310030-200669 to O.B.), the Clinical Research Priority Program of the University of Zurich for CRPP CYTIMM-Z (to O.B.), an Innovation grant of University Hospital Zurich (to O.B.), the Pandemic Fund of University of Zurich (to O.B.), and the Botnar Research Centre for Child Health (COVID-19 FTC to A.E.M.). S.A., C.C. and Y.Z. received Swiss Academy of Medical Sciences fellowships (323530-177975, 323530-191220 and 323530-191230, respectively), S.A. received a Forschungskredit Candoc grant from the University of Zurich (FK-20-022) and M.E.R. received a Young Talents in Clinical Research Project Grant by the Swiss Academy of Medical Sciences and G. & J. Bangerter-Rhyner Foundation (YTCR 08/20).	Adamo S, 2021, ALLERGY, V76, P2866, DOI 10.1111/all.14866; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bonifacius A, 2021, IMMUNITY, V54, P340, DOI 10.1016/j.immuni.2021.01.008; Borcherding Nicholas, 2020, F1000Res, V9, P47, DOI 10.12688/f1000research.22139.1; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Buggert M, 2020, CELL, V183, P1946, DOI 10.1016/j.cell.2020.11.019; Cervia C, 2021, J ALLERGY CLIN IMMUN, V147, P545, DOI 10.1016/j.jaci.2020.10.040; Chemaitelly H, 2021, NAT MED, V27, P1614, DOI 10.1038/s41591-021-01446-y; Chevrier S, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2020.100166; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Escobar G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb9726; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Graham N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00479; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Heaton H, 2020, NAT METHODS, V17, P615, DOI 10.1038/s41592-020-0820-1; Hou H., 2021, J ALLERGY CLIN IMMUN, V148; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jalkanen P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24285-4; Jung JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24377-1; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Le Bert N, 2021, J EXP MED, V218, DOI 10.1084/jem.20202617; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Minervina AA, 2021, ELIFE, V10, DOI 10.7554/eLife.63502; Mold JE, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109174; Peng Y, 2020, NAT IMMUNOL, P1, DOI DOI 10.1038/s41590-020-0782-6; Raeber ME, 2018, IMMUNOL REV, V283, P176, DOI 10.1111/imr.12644; Saad-Roy CM, 2020, SCIENCE, V370, P811, DOI 10.1126/science.abd7343; Saini SK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7550; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Zuo JM, 2021, NAT IMMUNOL, V22, P620, DOI 10.1038/s41590-021-00902-8	42	22	22	6	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					148	+		10.1038/s41586-021-04280-x	http://dx.doi.org/10.1038/s41586-021-04280-x		DEC 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	34875673	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000741978300001
J	Dyer, O				Dyer, Owen			Poland's government plans mandatory registry of pregnancies and "family institute" with prosecutorial powers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2698; InterAmerican court of human rights, 2021, MAN OTH VS; Kochanowicz J., 2021, STATEMENT U CLIN HOS; Shepherd A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4253; Vollset SE, 2020, LANCET, V396, P1285, DOI 10.1016/S0140-6736(20)30677-2	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n3035	10.1136/bmj.n3035	http://dx.doi.org/10.1136/bmj.n3035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4DA	34876404				2022-12-28	WOS:000730815800014
J	Iacobucci, G				Iacobucci, Gareth			Government promises largest ever investment in treatment and recovery to tackle drug use	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Iacobucci, Gareth] BMJ, London, England		Iacobucci, G (corresponding author), BMJ, London, England.							HM Government, HARM HOP 10 YEAR DRU; Hurley R, BMJ-BRIT MED J, V374, P1758; Office of National Statistics, 2020, DEATHS REL DRUG POIS	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n3031	10.1136/bmj.n3031	http://dx.doi.org/10.1136/bmj.n3031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4DA	34876465				2022-12-28	WOS:000730815800010
J	Horton, R				Horton, Richard			Offline: Is democracy good for your health?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2060	2060						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863338	Bronze			2022-12-28	WOS:000726564200006
J	Mahase, E				Mahase, Elisabeth			Covid-19: Vaccine uptake during pregnancy has increased but deprived areas lag behind, data show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2862; UK Health Security Agency, COV 19 VACC SURV REP	2	0	0	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2932	10.1136/bmj.n2932	http://dx.doi.org/10.1136/bmj.n2932			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836884	Bronze			2022-12-28	WOS:000727787900013
J	Newton, K; Dixit, VM; Kayagaki, N				Newton, Kim; Dixit, Vishva M.; Kayagaki, Nobuhiko			Dying cells fan the flames of inflammation	SCIENCE			English	Review							CASPASE-8; APOPTOSIS; DEATH; MLKL; KINASE; FADD; NECROPTOSIS; HOMEOSTASIS; MUTATIONS; VARIANTS	Inflammatory processes that recruit leukocytes to injured or infected tissues are crucial for tissue repair and the elimination of pathogens. However, excessive or chronic inflammation promotes tissue damage and disease, as in arthritis, atherosclerosis, inflammatory bowel disease, and COVID-19. Intracellular constituents released from dying cells are among the stimuli that trigger proinflammatory gene expression programs in innate immune cells. We explore how programmed cell death mechanisms-apoptosis, necroptosis, and pyroptosis-may contribute to inflammatory disease. We discuss inhibition of cell death as a potential therapeutic strategy, focusing on the targets RIPK1 (receptor interacting serine/threonine kinase 1), NLRP3 (NLR family pyrin domain containing 3), and GSDMD (gasdermin D) as important mediators of lytic cell death. We also consider the potential benefits of limiting membrane rupture rather than cell death by targeting NINJ1.	[Newton, Kim; Dixit, Vishva M.; Kayagaki, Nobuhiko] Genentech Inc, Physiol Chem Dept, 1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech	Newton, K (corresponding author), Genentech Inc, Physiol Chem Dept, 1 DNA Way, San Francisco, CA 94080 USA.	knewton@gene.com; dixit@gene.com; kayagaki@gene.com	dixit, vishva/A-4496-2012	dixit, vishva/0000-0001-6983-0326	Genentech	Genentech(Roche HoldingGenentech)	K.N., V.M.D., and N.K. are funded by Genentech.	Ahn BJ, 2014, J BIOL CHEM, V289, P3328, DOI 10.1074/jbc.M113.498212; Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Caricchio R, 2021, JAMA-J AM MED ASSOC, V326, P230, DOI 10.1001/jama.2021.9508; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Cuchet-Lourenco D, 2018, SCIENCE, V361, P810, DOI 10.1126/science.aar2641; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Doerflinger M, 2020, IMMUNITY, V53, P533, DOI 10.1016/j.immuni.2020.07.004; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Fidler TP, 2021, NATURE, V592, P296, DOI 10.1038/s41586-021-03341-5; Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Gitlin AD, 2020, NATURE, V587, P275, DOI 10.1038/s41586-020-2796-5; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Hildebrand JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16819-z; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kayagaki N, 2019, SCIENCE, V366, P688, DOI 10.1126/science.aaw1177; Kristjansson RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10572; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Kyriazopoulou E, 2021, NAT MED, V27, P1752, DOI 10.1038/s41591-021-01499-z; Lalaoui N, 2020, NATURE, V577, P103, DOI 10.1038/s41586-019-1828-5; Lehle AS, 2019, GASTROENTEROLOGY, V156, P275, DOI 10.1053/j.gastro.2018.09.041; Li Y, 2019, P NATL ACAD SCI USA, V116, P970, DOI 10.1073/pnas.1813582116; Liu X, 2021, NAT REV DRUG DISCOV, V20, P384, DOI 10.1038/s41573-021-00154-z; Liu ZH, 2020, IMMUNITY, V53, P106, DOI 10.1016/j.immuni.2020.06.007; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Newton K, 2019, NATURE, V574, P428, DOI 10.1038/s41586-019-1548-x; Newton K, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036368; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Phulphagar K, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108826; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Schwarzer R, 2020, IMMUNITY, V52, P978, DOI 10.1016/j.immuni.2020.04.002; Sharma BR, 2021, NAT IMMUNOL, V22, P550, DOI 10.1038/s41590-021-00886-5; Svensson EC, 2018, CIRCULATION, V138; Tao PF, 2020, NATURE, V577, P109, DOI 10.1038/s41586-019-1830-y; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Tummers B, 2020, IMMUNITY, V52, P994, DOI 10.1016/j.immuni.2020.04.010; Tummers B, 2017, IMMUNOL REV, V277, P76, DOI 10.1111/imr.12541; Vora SM, 2021, NAT REV IMMUNOL, V21, P694, DOI 10.1038/s41577-021-00588-x; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Wang RC, 2020, NATURE, V580, P386, DOI 10.1038/s41586-020-2127-x; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Xia SY, 2021, NATURE, V593, P607, DOI 10.1038/s41586-021-03478-3; Zhang H, 2020, CELL HOST MICROBE, V27, P556, DOI 10.1016/j.chom.2020.02.004	53	28	28	24	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1076	+		10.1126/science.abi5934	http://dx.doi.org/10.1126/science.abi5934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822265				2022-12-28	WOS:000725668600037
J	Iacobucci, G				Iacobucci, Gareth			Jersey is set to allow assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2917	10.1136/bmj.n2917	http://dx.doi.org/10.1136/bmj.n2917			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824095				2022-12-28	WOS:000744251500013
J	Kamihara, J; Hamilton, KV; Pollard, JA; Clinton, CM; Madden, JA; Lin, J; Imamovic, A; Wall, CB; Wassner, AJ; Weil, BR; Heeney, MM; Vargas, SO; Kaelin, WG; Janeway, KA; Perini, RF; Zojwalla, NJ; Voss, SD; DuBois, SG				Kamihara, Junne; Hamilton, Kayla V.; Pollard, Jessica A.; Clinton, Catherine M.; Madden, Jill A.; Lin, Jasmine; Imamovic, Alma; Wall, Catherine B.; Wassner, Ari J.; Weil, Brent R.; Heeney, Matthew M.; Vargas, Sara O.; Kaelin, William G., Jr.; Janeway, Katherine A.; Perini, Rodolfo F.; Zojwalla, Naseem J.; Voss, Stephan D.; DuBois, Steven G.			Belzutifan, a Potent HIF2 alpha Inhibitor, in the Pacak-Zhuang Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARAGANGLIOMA; POLYCYTHEMIA; MUTATIONS; PHEOCHROMOCYTOMA	The integration of genomic testing into clinical care enables the use of individualized approaches to the management of rare diseases. We describe the use of belzutifan, a potent and selective small-molecule inhibitor of the protein hypoxia-inducible factor 2 alpha (HIF2 alpha), in a patient with polycythemia and multiple paragangliomas (the Pacak-Zhuang syndrome). The syndrome was caused in this patient by somatic mosaicism for an activating mutation in EPAS1. Treatment with belzutifan led to a rapid and sustained tumor response along with resolution of hypertension, headaches, and long-standing polycythemia. This case shows the application of a targeted therapy for the treatment of a patient with a rare tumor-predisposition syndrome. (Funded by the Morin Family Fund for Pediatric Cancer and Alex's Lemonade Stand Foundation.) Belzutifan in the Pacak-Zhuang Syndrome Pacak-Zhuang syndrome is an inherited tumor-predisposition disorder characterized by polycythemia and paragangliomas. A patient with this disorder had polycythemia, headache, hypertension, and norepinephrine-secreting paragangliomas. She had activating mutations in HIF2A. Use of belzutifan, a HIF2 alpha inhibitor, led to paraganglioma regression, normalized hemoglobin levels, and symptom resolution.	[Kamihara, Junne; Hamilton, Kayla V.; Pollard, Jessica A.; Clinton, Catherine M.; Imamovic, Alma; Wall, Catherine B.; Janeway, Katherine A.; DuBois, Steven G.] Harvard Med Sch, Dept Pediat Oncol, Boston, MA 02115 USA; [Kaelin, William G., Jr.] Harvard Med Sch, Dept Med Oncol, Boston, MA 02115 USA; [Kamihara, Junne; Pollard, Jessica A.; Heeney, Matthew M.; Janeway, Katherine A.; DuBois, Steven G.] Harvard Med Sch, Dana Farber Canc Inst, Div Hematol, Boston, MA 02115 USA; [Wassner, Ari J.] Harvard Med Sch, Dana Farber Canc Inst, Div Oncol, Boston, MA 02115 USA; [Weil, Brent R.] Harvard Med Sch, Dana Farber Canc Inst, Div Endocrinol, Boston, MA 02115 USA; [Weil, Brent R.] Harvard Med Sch, Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Vargas, Sara O.] Harvard Med Sch, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Voss, Stephan D.] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Madden, Jill A.; Lin, Jasmine] Manton Ctr Phan Dis Res, Boston, MA USA; [Madden, Jill A.; Lin, Jasmine] Manton Ctr Phan Dis Res, Div Genet & Gen, Boston Childrens Hosp, Boston, MA USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Perini, Rodolfo F.; Zojwalla, Naseem J.] Merck, Kenilworth, NJ USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Merck & Company	Kamihara, J (corresponding author), Harvard Med Sch, Dept Pediat Oncol, Boston, MA 02115 USA.	junne_kamihara@dfci.harvard.edu						[Anonymous], 2021, FDA APPR BELZ CANC A; [Anonymous], 2017, COMM TOX CRIT; Blackburn EH, 2011, CANCER PREV RES, V4, P787, DOI 10.1158/1940-6207.CAPR-11-0195; Brodeur GM, 2017, CLIN CANCER RES, V23, pE1, DOI 10.1158/1078-0432.CCR-17-0702; Buffet A, 2014, J CLIN ENDOCR METAB, V99, pE369, DOI 10.1210/jc.2013-2600; Choueiri TK, 2021, NAT MED, V27, P802, DOI 10.1038/s41591-021-01324-7; Crona J, 2017, ENDOCR REV, V38, P489, DOI 10.1210/er.2017-00062; Darr R, 2016, ENDOCR-RELAT CANCER, V23, P899, DOI 10.1530/ERC-16-0231; Dmitriev PM, 2020, JAMA OPHTHALMOL, V138, P148, DOI 10.1001/jamaophthalmol.2019.5244; DuBois SG, 2019, SCIENCE, V363, P1175, DOI 10.1126/science.aaw4153; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Lorenzo FR, 2013, J MOL MED, V91, P507, DOI 10.1007/s00109-012-0967-z; Pacak K, 2014, OPHTHALMOLOGY, V121, P2291, DOI 10.1016/j.ophtha.2014.06.019; Pacak K, 2013, J CLIN ONCOL, V31, P1690, DOI 10.1200/JCO.2012.47.1912; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rosenblum JS, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144368; Sholl LM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87062; Toyoda H, 2014, PEDIATRICS, V133, pE1787, DOI 10.1542/peds.2013-2419; Venot Q, 2018, NATURE, V558, P540, DOI 10.1038/s41586-018-0217-9; Welander J, 2014, ENDOCR-RELAT CANCER, V21, P495, DOI 10.1530/ERC-13-0384; Yang Chunzhang, 2015, Hum Genome Var, V2, P15053, DOI 10.1038/hgv.2015.53; Yang CZ, 2013, BLOOD, V121, P2563, DOI 10.1182/blood-2012-10-460972; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	24	15	15	5	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2059	2065		10.1056/NEJMoa2110051	http://dx.doi.org/10.1056/NEJMoa2110051			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC3KG	34818480	Bronze			2022-12-28	WOS:000721915400010
J	Meltzer, PS; Helman, LJ				Meltzer, Paul S.; Helman, Lee J.			New Horizons in the Treatment of Osteosarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PEDIATRIC-ONCOLOGY-GROUP; HIGH-GRADE OSTEOSARCOMA; PHASE-II; PREOPERATIVE CHEMOTHERAPY; METASTATIC OSTEOSARCOMA; ADJUVANT CHEMOTHERAPY; HISTOLOGIC RESPONSE; MURAMYL TRIPEPTIDE; OSTEOGENIC-SARCOMA; CANCER GENOME	Osteosarcoma Osteosarcoma, which is most common in people 10 to 30 years of age, is generally treated with resection and adjuvant chemotherapy. Detection of gene rearrangements, copy-number variations, and targeted disruption of tumor suppressors by whole-genome sequencing has not yet led to improved treatment.	[Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Helman, Lee J.] Osteo Sarcoma Inst, 100 Crescent Ct, Dallas, TX 75205 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Helman, LJ (corresponding author), Osteo Sarcoma Inst, 100 Crescent Ct, Dallas, TX 75205 USA.	lhelman@osinst.org		Meltzer, Paul/0000-0003-0963-1768				Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Behjati S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15936; Ben-Ami E, 2020, CANCERS, V12, DOI 10.3390/cancers12030757; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bielack SS, 2015, J CLIN ONCOL, V33, P2279, DOI 10.1200/JCO.2014.60.0734; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015; Davis LE, 2019, J CLIN ONCOL, V37, P1424, DOI 10.1200/JCO.18.02374; Disel U, 2020, ONCOLOGIST, V25, pE39, DOI 10.1634/theoncologist.2018-0528; Donehower LA, 2019, CELL REP, V28, P1370, DOI 10.1016/j.celrep.2019.07.001; Duffaud F, 2019, LANCET ONCOL, V20, P120, DOI 10.1016/S1470-2045(18)30742-3; Ebb D, 2012, J CLIN ONCOL, V30, P2545, DOI 10.1200/JCO.2011.37.4546; Ekhtiari S, 2020, LANCET ONCOL, V21, P1021, DOI 10.1016/S1470-2045(20)30171-6; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Feng WL, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920922055; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Fujiwara T, 2021, MOL CANCER THER, V20, P1388, DOI 10.1158/1535-7163.MCT-20-0591; Fujiwara T, 2021, CANCERS, V13, DOI 10.3390/cancers13051086; Gomez-Brouchet A, 2019, ORTHOP TRAUMATOL-SUR, V105, P773, DOI 10.1016/j.otsr.2018.12.015; Goorin AM, 2003, J CLIN ONCOL, V21, P1574, DOI 10.1200/JCO.2003.08.165; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; Guenther LM, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26896; Hong AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11987; Italiano A, 2020, LANCET ONCOL, V21, P446, DOI [10.1016/S1470-2045(19)30825-3, 10.1016/51470-2045(19)30825-3]; Jacobs JFM, 2007, INT J CANCER, V120, P67, DOI 10.1002/ijc.22118; Joseph CG, 2014, GENE CHROMOSOME CANC, V53, P15, DOI 10.1002/gcc.22114; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9940; Krishnadas DK, 2015, CANCER IMMUNOL IMMUN, V64, P1251, DOI 10.1007/s00262-015-1731-3; Lagmay JP, 2016, J CLIN ONCOL, V34, P3031, DOI 10.1200/JCO.2015.65.5381; Le Cesne A, 2019, EUR J CANCER, V119, P151, DOI 10.1016/j.ejca.2019.07.018; Lim G, 2005, GENE CHROMOSOME CANC, V42, P392, DOI 10.1002/gcc.20157; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Lu LC, 2020, ADV EXP MED BIOL, V1258, P37, DOI 10.1007/978-3-030-43085-6_3; Lu YC, 2017, J CLIN ONCOL, V35, P3322, DOI 10.1200/JCO.2017.74.5463; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARCOVE RC, 1970, J BONE JOINT SURG AM, VA 52, P411, DOI 10.2106/00004623-197052030-00001; Meyers P A, 1993, Cancer Treat Res, V62, P309; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Meyers PA, 2008, J CLIN ONCOL, V26, P633, DOI 10.1200/JCO.2008.14.0095; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Mirabello L, 2020, JAMA ONCOL, V6, P724, DOI 10.1001/jamaoncol.2020.0197; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Odes EJ, 2016, S AFR J SCI, V112, P100, DOI 10.17159/sajs.2016/20150471; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Purcell JW, 2018, CANCER RES, V78, P4059, DOI 10.1158/0008-5472.CAN-18-0327; ROSEN G, 1979, CANCER-AM CANCER SOC, V43, P2163, DOI 10.1002/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO;2-S; Roth M, 2014, CANCER-AM CANCER SOC, V120, P548, DOI 10.1002/cncr.28461; Sayles LC, 2019, CANCER DISCOV, V9, P46, DOI 10.1158/2159-8290.CD-17-1152; Selvarajah S, 2006, CHROMOSOMA, V115, P459, DOI 10.1007/s00412-006-0074-4; Slemmons KK, 2021, PEDIATR BLOOD CANCER, V68, DOI 10.1002/pbc.28771; Smeland S, 2019, EUR J CANCER, V109, P36, DOI 10.1016/j.ejca.2018.11.027; Sorenson L, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1629779; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tawbi HA, 2017, LANCET ONCOL, V18, P1493, DOI 10.1016/S1470-2045(17)30624-1; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vlachos A, 2012, BLOOD, V119, P3815, DOI 10.1182/blood-2011-08-375972; Vollger MR, 2020, ANN HUM GENET, V84, P125, DOI 10.1111/ahg.12364; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669; WIEMANN B, 1994, PHARMACOL THERAPEUT, V64, P529, DOI 10.1016/0163-7258(94)90023-X; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864	67	46	46	19	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2066	2076		10.1056/NEJMra2103423	http://dx.doi.org/10.1056/NEJMra2103423			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC3KG	34818481				2022-12-28	WOS:000721915400011
J	Mahase, E				Mahase, Elisabeth			Covid-19: What next for the Valneva vaccine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		European Centre for Disease Prevention and Control, COVID 19 VACC TRACK; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2551; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2474	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2839	10.1136/bmj.n2839	http://dx.doi.org/10.1136/bmj.n2839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE1ZI	34815232	Bronze			2022-12-28	WOS:000723193400001
J	Mahase, E				Mahase, Elisabeth			Health and Care Bill fails to tackle workforce problems and risks outsourcing to private providers, BMA warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2876	10.1136/bmj.n2876	http://dx.doi.org/10.1136/bmj.n2876			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815234				2022-12-28	WOS:000722577100004
J	Rubin, R				Rubin, Rita			Substance Use Disorders and COVID-19 Vaccine Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2000	2000						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812881	Bronze			2022-12-28	WOS:000724001500043
J	Lodge, FM; Moody, WE; Tosounidou, S; Chue, CD; Curtis, E; Neil, DAH; Bradlow, W				Lodge, Freya M.; Moody, William E.; Tosounidou, Sofia; Chue, Colin D.; Curtis, Elizabeth; Neil, Desley A. H.; Bradlow, William			Hydroxychloroquine-induced cardiomyopathy accelerated after gastric banding	LANCET			English	Editorial Material									[Lodge, Freya M.; Moody, William E.; Chue, Colin D.; Curtis, Elizabeth; Neil, Desley A. H.; Bradlow, William] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Tosounidou, Sofia] Birmingham City Hosp, Sandwell & West Birmingham NHS Trust, Birmingham, W Midlands, England; [Moody, William E.; Bradlow, William] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Lodge, FM (corresponding author), Aneurin Bevan Univ Hlth Board, Nevill Hall Hosp, Abergavenny NP7 7EG, England.	freyalodge@doctors.org.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1913	1913						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801107				2022-12-28	WOS:000720912600025
J	Robinson, JC				Robinson, James C.			Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Why Is Aducanumab Priced at $56,000 per Patient? Aducanumab's price can inform the drug-pricing policy debate because it responds to key features of the market environment for physician-administered drugs: Medicare's reimbursement formula, payment to physicians for infused drugs, and cost-sharing requirements.	[Robinson, James C.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.			Robinson, James/0000-0003-0056-3017				[Anonymous], 2021, AD ALZH DIS FIN POL; Chambers JD, 2019, HEALTH AFFAIR, V38, P1882, DOI 10.1377/hlthaff.2019.00201; Robinson JC, 2021, HEALTH AFFAIR, V40, P1395, DOI 10.1377/hlthaff.2021.00211; Robinson James C, 2019, Issue Brief (Commonw Fund), V2019, P1; Schulman KA, 2021, JAMA-J AM MED ASSOC, V326, P383, DOI 10.1001/jama.2021.11768	5	3	3	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2017	2019		10.1056/NEJMp2113679	http://dx.doi.org/10.1056/NEJMp2113679		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XC3KG	34797614				2022-12-28	WOS:000720682800001
J	Cusimano, MC; Chiu, M; Ferguson, SE; Moineddin, R; Aktar, S; Liu, N; Baxter, NN				Cusimano, Maria C.; Chiu, Maria; Ferguson, Sarah E.; Moineddin, Rahim; Aktar, Suriya; Liu, Ning; Baxter, Nancy N.			Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OVARIAN CONSERVATION; PROPHYLACTIC OOPHORECTOMY; LONG-TERM; INVERSE PROBABILITY; EPITHELIAL OVARIAN; SEXUAL FUNCTION; HYSTERECTOMY; MENOPAUSE; HEALTH; TIME	OBJECTIVES To determine if bilateral salpingo-oophorectomy, compared with ovarian conservation, is associated with all cause or cause specific death in women undergoing hysterectomy for non-malignant disease, and to determine how this association varies with age at surgery. DESIGN Population based cohort study. SETTING Ontario, Canada from 1 January 1996 to 31 December 2015, and follow-up to 31 December 2017. PARTICIPANTS 200 549 women (aged 30-70 years) undergoing non-malignant hysterectomy, stratified into premenopausal (<45 years), menopausal transition (45-49 years), early menopausal (50-54 years), and late menopausal (a55 years) groups according to age at surgery; median follow-up was 12 years (interquartile range 7-17). EXPOSURES Bilateral salpingo-oophorectomy versus ovarian conservation. MAIN OUTCOMES MEASURES The primary outcome was all cause death. Secondary outcomes were non-cancer and cancer death. Within each age group, overlap propensity score weighted survival models were used to examine the association between bilateral salpingo-oophorectomy and mortality outcomes, while adjusting for demographic characteristics, gynaecological conditions, and comorbidities. To account for comparisons in four age groups, P<0.0125 was considered statistically significant. RESULTS Bilateral salpingo-oophorectomy was performed in 19%, 41%, 69%, and 81% of women aged <45, 45-49, 50-54, and a55 years, respectively. The procedure was associated with increased rates of all cause death in women aged <45 years (hazard ratio 1.31, 95% confidence interval 1.18 to 1.45, P<0.001; number needed to harm 71 at 20 years) and 45-49 years (1.16, 1.04 to 1.30, P=0.007; 152 at 20 years), but not in women aged 50-54 years (0.83, 0.72 to 0.97, P=0.018) or a55 years (0.92, 0.82 to 1.03, P=0.16). Findings in women aged <50 years were driven largely by increased non-cancer death. In secondary analyses identifying a possible change in the association between bilateral salpingo-oophorectomy and all cause death with advancing age at surgery, the hazard ratio gradually decreased during the menopausal transition and remained around 1 at all ages thereafter. CONCLUSION In this observational study, bilateral salpingooophorectomy at non-malignant hysterectomy appeared to be associated with increased all cause mortality in women aged <50 years, but not in those aged a50 years. While caution is warranted when considering bilateral salpingo-oophorectomy in premenopausal women without indication, this strategy for ovarian cancer risk reduction does not appear to be detrimental to survival in postmenopausal women.	[Cusimano, Maria C.; Ferguson, Sarah E.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Cusimano, Maria C.; Chiu, Maria; Baxter, Nancy N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Chiu, Maria; Moineddin, Rahim; Aktar, Suriya; Liu, Ning; Baxter, Nancy N.] ICES, Toronto, ON, Canada; [Ferguson, Sarah E.] Sinai Hlth Syst, Princess Margaret Canc Ctr, Div Gynecol Oncol, Toronto, ON, Canada; [Moineddin, Rahim] Univ Toronto, Dalla Lana Sch Publ Hlth, Biostat Div, Toronto, ON, Canada; [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Baxter, Nancy N.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Melbourne	Baxter, NN (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Baxter, NN (corresponding author), ICES, Toronto, ON, Canada.; Baxter, NN (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	nancy.baxter@unimelb.edu.au	; Baxter, Nancy/E-7020-2015	Liu, Ning/0000-0001-9215-475X; Baxter, Nancy/0000-0003-4793-4620; Moineddin, Rahim/0000-0002-5506-084X	ICES - Ontario Ministry of Health and Long term Care; American College of Surgeons Resident Research Scholarship; Canadian Institutes of Health Research Vanier Canada Graduate Scholarship	ICES - Ontario Ministry of Health and Long term Care; American College of Surgeons Resident Research Scholarship; Canadian Institutes of Health Research Vanier Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long term Care. MCC is supported by the American College of Surgeons Resident Research Scholarship and the Canadian Institutes of Health Research Vanier Canada Graduate Scholarship. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement by ICES or the Ontario Ministry of Health and Long term Care is intended or should be inferred. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	AAGL, 2019, 5 THINGS PAT PROV SH; American Soc Reprod Med, 2008, FERTIL STERIL, V90, pS61, DOI 10.1016/j.fertnstert.2008.08.095; AUS, 2015, 5 THINGS PHYS PAT SH; Austin PC, 2017, STAT MED, V36, P4391, DOI 10.1002/sim.7501; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; Aziz A, 2005, MATURITAS, V51, P349, DOI 10.1016/j.maturitas.2004.08.018; Aziz A, 2005, ACTA OBSTET GYN SCAN, V84, P854, DOI 10.1111/j.0001-6349.2005.00658.x; Bansi-Matharu L, 2013, BJOG-INT J OBSTET GY, V120, P1500, DOI 10.1111/1471-0528.12319; Boerner T, 2021, J MINIM INVAS GYN, V28, P403, DOI 10.1016/j.jmig.2020.09.020; Chen X, 2013, ARCH GYNECOL OBSTET, V288, P1101, DOI 10.1007/s00404-013-2865-1; Cheung MC, 2017, J ONCOL PRACT, V13, pE602, DOI 10.1200/JOP.2016.019497; Chiu M, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0375-3; CIHI, 2013, HLTH IND 2013 DEF DA; Couzinet B, 2001, J CLIN ENDOCR METAB, V86, P5060, DOI 10.1210/jc.86.10.5060; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Cusimano MC, 2022, AM J OBSTET GYNECOL, V226, DOI 10.1016/j.ajog.2021.09.020; Cusimano MC, 2021, J OBSTET GYNECOLOGY, V224, P585; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Desai RJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5657; Evans EC, 2016, OBSTET GYNECOL, V128, P476, DOI 10.1097/AOG.0000000000001592; Falconer H, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju410; Fogle RH, 2007, J CLIN ENDOCR METAB, V92, P3040, DOI 10.1210/jc.2007-0581; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gierach GL, 2014, MENOPAUSE, V21, P592, DOI [10.1097/gme.0000000000000118, 10.1097/GME.0000000000000118]; HALL RE, 1994, CAN MED ASSOC J, V151, P1713; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Jacoby VL, 2011, ARCH INTERN MED, V171, P760, DOI 10.1001/archinternmed.2011.121; Juurlink D, 2006, CANADIAN I HLTH INFO; Kato I, 1998, J CLIN EPIDEMIOL, V51, P1271, DOI 10.1016/S0895-4356(98)00119-X; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P2149, DOI 10.2105/AJPH.94.12.2149; Lessard-Anderson CR, 2014, GYNECOL ONCOL, V135, P423, DOI 10.1016/j.ygyno.2014.10.005; Li F, 2019, AM J EPIDEMIOL, V188, P250, DOI 10.1093/aje/kwy201; Li L, 2012, MATURITAS, V73, P354, DOI 10.1016/j.maturitas.2012.09.008; Lipscomb LL, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3148-0; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Madsen C, 2015, ACTA OBSTET GYN SCAN, V94, P86, DOI 10.1111/aogs.12516; Mahal AS, 2017, MENOPAUSE, V24, P947, DOI 10.1097/GME.0000000000000875; MCKINLAY SM, 1992, AM J HUM BIOL, V4, P37, DOI 10.1002/ajhb.1310040107; Mikhail E, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.031; MOHLTC, 2016, QUAL BAS PROC CLIN H, P1; Mytton J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j372; NHS Digital, 2020, HOSP ADM DAT HYST EN; Parker WH, 2005, OBSTET GYNECOL, V106, P219, DOI 10.1097/01.AOG.0000167394.38215.56; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; RANZCOG Research Foundation, 2009, O G MAG, V11, P75; Read Michael D, 2010, Menopause Int, V16, P60, DOI 10.1258/mi.2010.010023; Reeves GK, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-45; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rivera CM, 2009, NEUROEPIDEMIOLOGY, V33, P32, DOI 10.1159/000211951; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Rocca WA, 2011, BRAIN RES, V1379, P188, DOI 10.1016/j.brainres.2010.10.031; Rodriguez MC, 2012, J OBSTET GYNAECOL, V32, P180, DOI 10.3109/01443615.2011.634035; Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42; Sozeri-Varma G, 2011, CLIMACTERIC, V14, P275, DOI 10.3109/13697137.2010.532251; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; The Johns Hopkins ACG<(R), 2011, CAS MIX SYST VERS 10; Thomas LE, 2020, JAMA-J AM MED ASSOC, V323, P2417, DOI 10.1001/jama.2020.7819; Thurston J, 2019, J OBSTET GYNAECOL CA, V41, P543, DOI 10.1016/j.jogc.2018.12.006; Tu JV, 2015, CIRCULATION, V132, P1549, DOI 10.1161/CIRCULATIONAHA.115.015345; Tu JV, 2015, CIRC-CARDIOVASC QUAL, V8, P204, DOI 10.1161/CIRCOUTCOMES.114.001416; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Tuesley KM, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.037; Wilson LF, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.10.002; Wright JD, 2013, OBSTET GYNECOL, V122, P233, DOI 10.1097/AOG.0b013e318299a6cf; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174; Zhou YJ, 2020, STAT METHODS MED RES, V29, P3721, DOI 10.1177/0962280220940334	74	10	10	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2021	375								e067528	10.1136/bmj-2021-067528	http://dx.doi.org/10.1136/bmj-2021-067528			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO9VU	34880044	hybrid, Green Published			2022-12-28	WOS:000730525000001
J	Lau, DCW; Erichsen, L; Francisco, AM; Satylganova, A; le Roux, CW; McGowan, B; Pedersen, SD; Pietilainen, KH; Rubino, D; Batterham, RL				Lau, David C. W.; Erichsen, Lars; Francisco, Ann Marie; Satylganova, Altynai; le Roux, Carel W.; McGowan, Barbara; Pedersen, Sue D.; Pietilainen, Kirsi H.; Rubino, Domenica; Batterham, Rachel L.			Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial	LANCET			English	Article							LIFE-STYLE INTERVENTION; ASSOCIATION; CHALLENGES; REDUCTION; AMYLIN; ADULTS; MG	Background Natural amylin is a pancreatic hormone that induces satiety. Cagrilintide is a long-acting amylin analogue under investigation for weight management. We assessed the dose-response relationship of cagrilintide regarding the effects on bodyweight, safety, and tolerability. Methods We conducted a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial at 57 sites including hospitals, specialist clinics, and primary care centres in ten countries (Canada, Denmark, Finland, Ireland, Japan, Poland, Serbia, South Africa, the UK, and the USA). Eligible participants were adults aged at least 18 years without diabetes, with a body-mass index of at least 30 kg/m(2) or at least 27 kg/m(2) with hypertension or dyslipidaemia. Participants were randomly assigned (6:1) to subcutaneous self-injections of once-weekly cagrilintide (0.3, 0.6,1.2, 2.4, or 4.5 mg), once-daily liraglutide 3.0 mg, or volume-matched placebo (for six placebo groups). The trial had a 26-week treatment period, including a dose-escalation period of up to 6 weeks, and a 6-week follow-up period without treatment. Participants and investigators were masked to the assigned study treatment with respect to active versus pooled placebo treatment, but not to different active treatments. The primary endpoint was the percentage change in bodyweight from baseline to week 26, assessed in all randomly assigned participants according to the trial product estimand (assuming all participants were adherent to treatment) and to the treatment policy estimand (regardless of adherence to treatment). Safety was assessed in all participants who received at least one dose of randomised treatment. This trial is registered with ClinicalTrials.gov , NCT03856047, and is closed to new participants. Findings Between March 1 and Aug 19, 2019, we randomly assigned 706 participants to cagrilintide 0.3-4.5 mg (100-102 per dose group), 99 to liraglutide 3.0 mg, and 101 to placebo. Permanent treatment discontinuation (n=73 [10%]) occurred similarly across treatment groups, mostly due to adverse events (n=30 [4%]). In total, 29 participants (4%) withdrew from the trial. According to the trial product estimand, mean percentage weight reductions from baseline were greater with all doses of cagrilintide (0.3-4.5 mg, 6.0%-10.8% [6.4-11.5 kg]) versus placebo (3.0% [3.3 kg]; estimated treatment difference range 3-0%-7.8%; p<0.001). Weight reductions were also greater with cagrilintide 4.5 mg versus liraglutide 3.0 mg (10.8% [11.5 kg] vs 9.0% [9.6 kg]; estimated treatment difference 1.8%, p=0.03). Similar weight loss reductions were observed with the treatment policy estimand. The most frequent adverse events were gastrointestinal disorders (eg, nausea, constipation, and diarrhoea) and administration-site reactions. More participants receiving cagrilintide 0.3-4.5 mg had gastrointestinal adverse events compared with placebo (41%-63% vs 32%), primarily nausea (20%-47% vs 18%). Interpretation Treatment with cagrilintide in people with overweight and obesity led to significant reductions in bodyweight and was well tolerated. The findings support the development of molecules with novel mechanisms of action for weight management. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Lau, David C. W.] Univ Calgary, Cumming Sch Med, Julia McFarlane Diabet Res, Calgary, AB T2N 4N1, Canada; [Lau, David C. W.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Erichsen, Lars; Francisco, Ann Marie; Satylganova, Altynai] Novo Nordisk AS, Soborg, Denmark; [le Roux, Carel W.] Univ Coll Dublin, Diabet Complicat Res Ctr, Dublin, Ireland; [McGowan, Barbara] Guys & St Thomas Hosp, Dept Endocrinol & Diabet, London, England; [Pedersen, Sue D.] Clin Calgary, C ENDO Diabet & Endocrinol, Calgary, AB, Canada; [Pietilainen, Kirsi H.] Univ Helsinki, Fac Med, Obes Res Unit, Res Program Clin & Mol, Helsinki, Finland; [Pietilainen, Kirsi H.] Helsinki Univ Hosp, Obes Ctr, Abdominal Ctr, Endocrinol, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland; [Rubino, Domenica] Washington Ctr Weight Management, Arlington, VA USA; [Batterham, Rachel L.] UCLH Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Batterham, Rachel L.] UCL, Dept Med, Obes Res Ctr, London, England	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Novo Nordisk; University College Dublin; Guy's & St Thomas' NHS Foundation Trust; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; University College London; University of London; University College London	Lau, DCW (corresponding author), Univ Calgary, Cumming Sch Med, Julia McFarlane Diabet Res, Calgary, AB T2N 4N1, Canada.; Lau, DCW (corresponding author), Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada.	dcwlau@ucalgary.ca		Batterham, Rachel/0000-0002-5477-8585	Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	This study was funded by Novo Nordisk A/S. We thank all participants, investigators, and trial staff who were involved in the trial; Marie Louise Muus Ghorbani (Novo Nordisk A/S, Bagsvaerd, Denmark) for her contribution to interpreting the safety data; Diana Marouco (Axis, a division of Spirit Medical Communications Group, Manchester, UK) for medical writing and editorial assistance funded by Novo Nordisk A/S; and the reviewer of this manuscript for suggesting the additional post-hoc analysis included in the manuscript.	Bessesen DH, 2018, LANCET DIABETES ENDO, V6, P237, DOI 10.1016/S2213-8587(17)30236-X; Boccia L, 2020, PEPTIDES, V132, DOI 10.1016/j.peptides.2020.170366; Boyle CN, 2018, MOL METAB, V8, P203, DOI 10.1016/j.molmet.2017.11.009; Dahl K, 2020, OB WEEK VIRT M NOV 2; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; Enebo LB, 2021, LANCET, V397, P1736, DOI 10.1016/S0140-6736(21)00845-X; European Medicines Agency, SAX 6 MG ML SOL INJ; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Garvey WT, 2016, ENDOCR PRACT, V22, P842, DOI 10.4158/EP161356.ESGL; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2019, ICH HARM GUID E9 R1; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kruse T, 2021, J MED CHEM, V64, P11183, DOI 10.1021/acs.jmedchem.1c00565; Kwok S, 2020, CLIN OBES, V10, DOI 10.1111/cob.12403; Neeland IJ, 2018, CIRCULATION, V137, P1391, DOI 10.1161/CIRCULATIONAHA.117.029617; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Raun K, 2020, OB WEEK VIRT M NOV 2; Rubino D, 2021, JAMA-J AM MED ASSOC, V325, P1414, DOI 10.1001/jama.2021.3224; Smith SR, 2008, DIABETES CARE, V31, P1816, DOI 10.2337/dc08-0029; US Food and Drug Administration, 2014, SAX LIR 3 0 MG PRESC; US Food & Drug Administration, 2014, SYML HIGHL PRESCR IN; Wadden TA, 2021, JAMA-J AM MED ASSOC, V325, P1403, DOI 10.1001/jama.2021.1831; Wharton S, 2021, INT J OBESITY, V45, P923, DOI 10.1038/s41366-020-00733-x; Wharton S, 2020, CAN MED ASSOC J, V192, pE875, DOI 10.1503/cmaj.191707; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Wookey PJ, 1998, MINER ELECTROL METAB, V24, P389, DOI 10.1159/000057400; Zakariassen HL, 2020, BASIC CLIN PHARMACOL, V127, P163, DOI 10.1111/bcpt.13427	30	19	19	3	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2021	398	10317					2160	2172		10.1016/S0140-6736(21)01751-7	http://dx.doi.org/10.1016/S0140-6736(21)01751-7		DEC 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN4HM	34798060	Green Submitted			2022-12-28	WOS:000729467800002
J	Dawwas, GK; Leonard, CE; Lewis, JD; Cuker, A				Dawwas, Ghadeer K.; Leonard, Charles E.; Lewis, James D.; Cuker, Adam			Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data	ANNALS OF INTERNAL MEDICINE			English	Article							ADMINISTRATIVE DATA; SURVIVAL; ICD-9-CM	Background: Apixaban and rivaroxaban are replacing vitamin K antagonists for the treatment of venous thromboembolism (VTE) in adults; however, head-to-head comparisons remain limited. Objective: To assess the effectiveness and safety of apixaban compared with rivaroxaban in patients with VTE. Design: Retrospective new-user cohort study. Setting: U.S.-based commercial health care insurance database from 1 January 2015 to 30 June 2020. Participants: Adults with VTE who were newly prescribed apixaban or rivaroxaban. Measurements: The primary effectiveness outcome was recurrent VTE, a composite of deep venous thrombosis and pulmonary embolism. The primary safety outcome was a composite of gastrointestinal and intracranial bleeding. Results: Of 49900 eligible patients with VTE, 18618 were new users of apixaban and 18618 were new users of rivaroxaban. Median follow-up was 102 days (25th, 75th percentiles: 30, 128 days) among apixaban and 105 days (25th, 75th percentiles: 30, 140 days) among rivaroxaban users. After propensity score matching, apixaban (vs. rivaroxaban) was associated with a lower rate for recurrent VTE (hazard ratio, 0.77 [95% CI, 0.69 to 0.87]) and bleeding (hazard ratio, 0.60 [CI, 0.53 to 0.69]). The absolute reduction in the probability of recurrent VTE with apixaban versus rivaroxaban was 0.006 (CI, 0.005 to 0.011) within 2 months and 0.011 (CI, 0.011 to 0.013) within 6 months of initiation. The absolute reduction in the probability of gastrointestinal and intracranial bleeding with apixaban versus rivaroxaban was 0.011 (CI, 0.010 to 0.011) within 2 months and 0.015 (CI, 0.013 to 0.015) within 6 months of initiation. Limitation: Short follow-up. Conclusion: In this population-based cohort study, patients with VTE who were new users of apixaban had lower rates for recurrent VTE and bleeding than new users of rivaroxaban.	[Dawwas, Ghadeer K.; Leonard, Charles E.; Lewis, James D.; Cuker, Adam] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Dawwas, GK (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, 423 Guardian Dr, Philadelphia, PA 19104 USA.	gkdawwas@pennmedicine.upenn.edu		Dawwas, Ghadeer/0000-0002-7982-7419				Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Aryal MR, 2019, BLOOD ADV, V3, P2381, DOI 10.1182/bloodadvances.2019000572; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Benedetto U, 2018, EUR J CARDIO-THORAC, V53, P1112, DOI 10.1093/ejcts/ezy167; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Cohen AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144856; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Dawwas GK, 2019, LANCET HAEMATOL, V6, pE20, DOI 10.1016/S2352-3026(18)30191-1; Fang MC, 2017, MED CARE, V55, pE137, DOI 10.1097/MLR.0000000000000524; Fitzmaurice DA, 2002, BMJ-BRIT MED J, V325, P828, DOI 10.1136/bmj.325.7368.828; Frost C, 2014, CLIN PHARMACOL-ADV A, V6, P179, DOI 10.2147/CPAA.S61131; Gregson J, 2019, JAMA CARDIOL, V4, P163, DOI 10.1001/jamacardio.2018.4537; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Huybrechts KF, 2019, CLIN PHARMACOL THER, V105, P979, DOI 10.1002/cpt.1256; Kearon C, 2016, J THROMB HAEMOST, V14, P1480, DOI 10.1111/jth.13336; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01647-2019; Mantha S, 2015, J THROMB THROMBOLYS, V39, P155, DOI 10.1007/s11239-014-1102-5; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Ortel TL, 2020, BLOOD ADV, V4, P4693, DOI 10.1182/bloodadvances.2020001830; Puhr HC, 2020, J THROMB THROMBOLYS, V49, P505, DOI 10.1007/s11239-019-01965-z; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Shehab N, 2019, PHARMACOEPIDEM DR S, V28, P951, DOI 10.1002/pds.4783; Sindet-Pedersen C, 2018, EUR HEART J-CARD PHA, V4, P220, DOI 10.1093/ehjcvp/pvy021; Tonelli M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0155-5; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; White RH, 2010, THROMB RES, V126, P61, DOI 10.1016/j.thromres.2010.03.009; Zhu JY, 2018, PHARMACOTHERAPY, V38, P907, DOI 10.1002/phar.2158	37	10	10	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					20	+		10.7326/M21-0717	http://dx.doi.org/10.7326/M21-0717		DEC 2021	17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34871048				2022-12-28	WOS:000729197300001
J	Grunau, B; Goldfarb, D; Asamoah-Boaheng, M; Golding, L; Kirkham, TL; Demers, PA; Lavoie, PM				Grunau, Brian; Goldfarb, DavidM.; Asamoah-Boaheng, Michael; Golding, Liam; Kirkham, Tracy L.; Demers, Paul A.; Lavoie, Pascal M.			Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Grunau, Brian] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Goldfarb, DavidM.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Asamoah-Boaheng, Michael] Mem Univ Newfoundland, Fac Med, St John, NF, Canada; [Golding, Liam] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada; [Kirkham, Tracy L.; Demers, Paul A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lavoie, Pascal M.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Memorial University Newfoundland; University of British Columbia; University of Toronto; University of British Columbia	Grunau, B (corresponding author), British Columbia Resuscitat Res Collaborat, 1190 Hornby St,Fourth Floor, Vancouver, BC V6Z 2K5, Canada.	brian.grunau@ubc.ca		Golding, Liam/0000-0002-8851-8052; Lavoie, Pascal/0000-0002-2205-0362; Goldfarb, David/0000-0003-0835-9504	government of Canada	government of Canada(CGIAR)	This study was supported by funding from the government of Canada, through the COVID-19 Immunity Task Force.	CDC, COVID 19; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Moghadas SM, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001211; Romero-Brufau S, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1087; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; WAHL M, 1988, INFECTION, V16, P229, DOI 10.1007/BF01650758	6	25	25	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					279	281		10.1001/jama.2021.21921	http://dx.doi.org/10.1001/jama.2021.21921		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	34860253	Green Published, Bronze			2022-12-28	WOS:000725722100001
J	Lynch, HF; Robertson, CT				Lynch, Holly Fernandez; Robertson, Christopher T.			Challenges in confirming drug effectiveness after early approval	SCIENCE			English	Editorial Material							ACCELERATED APPROVAL; US FOOD		[Lynch, Holly Fernandez] Univ Penn, Philadelphia, PA 19104 USA; [Robertson, Christopher T.] Boston Univ, Boston, MA 02215 USA	University of Pennsylvania; Boston University	Lynch, HF (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	lynchhf@pennmedicine.upenn.edu						Folkers K. M., 2020, WAKE FOREST J LAW PO, V11, P85; Gyawali B, 2021, JAMA INTERN MED, V181, P1275, DOI 10.1001/jamainternmed.2021.4604; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Herder M, 2019, MILBANK Q, V97, P820, DOI 10.1111/1468-0009.12413; Institute for Clinical and Economic Review, 2021, STRENGTH FDAS ACC AP; Kapczynski A, 2018, MINN LAW REV, V102, P2357; Lynch HF, 2020, J LAW MED ETHICS, V48, P365, DOI 10.1177/1073110520935352; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Powell K, 2021, JAMA ONCOL, V7, P1607, DOI 10.1001/jamaoncol.2021.3046; Skydel JJ, 2021, CLIN TRIALS, V18, P488, DOI 10.1177/17407745211005044; US Food and Drug Administration, 2014, GUID IND EXP PROGR S; Wallach JD, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.33601; Wallach JD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1344-3; Wallach JD, 2018, CLIN TRIALS, V15, P219, DOI 10.1177/1740774518770648; Wallach JD, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2031	15	3	3	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1205	1207		10.1126/science.abk3495	http://dx.doi.org/10.1126/science.abk3495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855490				2022-12-28	WOS:000728578700041
J	Msomi, N; Lessells, R; Mlisana, K; de Oliveira, T				Msomi, Nokukhanya; Lessells, Richard; Mlisana, Koleka; de Oliveira, Tulio			Africa: tackle HIV and COVID-19 together	NATURE			English	Editorial Material							SARS-COV-2		[Msomi, Nokukhanya] Univ KwaZulu Natal, Virol Dept, Durban, South Africa; [Msomi, Nokukhanya] Inkosi Albert Luthuli Cent Hosp, Natl Hlth Lab Serv, Durban, South Africa; [Lessells, Richard] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform, Durban, South Africa; [Mlisana, Koleka] Natl Hlth Lab Serv, Acad Affairs Res & Qual Assurance, Johannesburg, South Africa; [de Oliveira, Tulio] Stellenbosch Univ, Ctr Epidem Response & Innovat, Stellenbosch, South Africa; [de Oliveira, Tulio] KwaZulu Natal Res Innovat & Sequencing Platform, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; National Health Laboratory Service; Stellenbosch University	de Oliveira, T (corresponding author), Stellenbosch Univ, Ctr Epidem Response & Innovat, Stellenbosch, South Africa.; de Oliveira, T (corresponding author), KwaZulu Natal Res Innovat & Sequencing Platform, Durban, South Africa.	tulio@sun.ac.za		de Oliveira, Tulio/0000-0002-3027-5254				Autenrieth CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207005; Biccard BM, 2021, LANCET, V397, P1885, DOI 10.1016/S0140-6736(21)00441-4; Boulle A, 2021, CLIN INFECT DIS, V73, pE2005, DOI 10.1093/cid/ciaa1198; Burki TK, 2021, LANCET RESP MED, V9, pE121, DOI 10.1016/S2213-2600(21)00504-X; Corey L, 2021, NEW ENGL J MED, V385, P562, DOI 10.1056/NEJMsb2104756; Frater J, 2021, LANCET HIV, V8, pE474, DOI 10.1016/S2352-3018(21)00103-X; Global Fund The, 2021, RES REP 2021; Hall VG, 2021, NEW ENGL J MED, V385, P1244, DOI 10.1056/NEJMc2111462; Inzaule SC, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003666; Jassat W, 2021, LANCET HIV, V8, pE554, DOI 10.1016/S2352-3018(21)00151-X; Karim F, PREPRINT MEDRXIV, DOI [10.1101/2021.06.03.21258228(2021, DOI 10.1101/2021.06.03.21258228(2021]; Kerneis S, 2014, CLIN INFECT DIS, V58, P1130, DOI 10.1093/cid/cit937; Madhi SA, 2021, LANCET HIV, V8, pE568, DOI 10.1016/S2352-3018(21)00157-0; Salyer SJ, 2021, LANCET, V397, P1265, DOI 10.1016/S0140-6736(21)00632-2; Spinelli M. A., PREPRINT SSRN, DOI [10.2139/ssrn.3909785, DOI 10.2139/SSRN.3909785]; Wagner CE, 2021, SCIENCE, V373, P1488, DOI 10.1126/science.abj7364; WHO, 2021, STRAT ACH GLOB COV 1; Wilkinson Eduan, 2021, Science, V374, P423, DOI 10.1126/science.abj4336; World Health Organization (WHO), 2021, CLIN FEAT PROGN FACT	19	14	14	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					33	36		10.1038/d41586-021-03546-8	http://dx.doi.org/10.1038/d41586-021-03546-8			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XG8IW	34853449	Bronze			2022-12-28	WOS:000724992500012
J	Ofir, G; Herbst, E; Baroz, M; Cohen, D; Millman, A; Doron, S; Tal, N; Malheiro, DBA; Malitsky, S; Amitai, G; Sorek, R				Ofir, Gal; Herbst, Ehud; Baroz, Maya; Cohen, Daniel; Millman, Adi; Doron, Shany; Tal, Nitzan; Malheiro, Daniel B. A.; Malitsky, Sergey; Amitai, Gil; Sorek, Rotem			Antiviral activity of bacterial TIR domains via immune signalling molecules	NATURE			English	Article							NAD(+) CLEAVAGE ACTIVITY; RECEPTORS; PROTEINS; ENZYMES	The Toll/interleukin-1 receptor (TIR) domain is a canonical component of animal and plant immune systems(1,2). In plants, intracellular pathogen sensing by immune receptors triggers their TIR domains to generate a molecule that is a variant of cyclic ADP-ribose(3,4). This molecule is hypothesized to mediate plant cell death through a pathway that has yet to be resolved(5). TIR domains have also been shown to be involved in a bacterial anti-phage defence system called Thoeris(6), but the mechanism of Thoeris defence remained unknown. Here we show that phage infection triggers Thoeris TIR-domain proteins to produce an isomer of cyclic ADP-ribose. This molecular signal activates a second protein, ThsA, which then depletes the cell of the essential molecule nicotinamide adenine dinucleotide (NAD) and leads to abortive infection and cell death. We also show that, similar to eukaryotic innate immune systems, bacterial TIR-domain proteins determine the immunological specificity to the invading pathogen. Our results describe an antiviral signalling pathway in bacteria, and suggest that the generation of intracellular signalling molecules is an ancient immunological function of TIR domains that is conserved in both plant and bacterial immunity. The mechanism of Thoeris-a bacterial anti-phage defence system-is described in detail, revealing that bacterial TIR-domain proteins recognize infection and produce signalling molecules to execute cell death, akin to the roles of these proteins in plants.	[Ofir, Gal; Herbst, Ehud; Baroz, Maya; Cohen, Daniel; Millman, Adi; Doron, Shany; Tal, Nitzan; Amitai, Gil; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Malheiro, Daniel B. A.] MS Omics, Vedbaek, Denmark; [Malitsky, Sergey] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Amitai, G; Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.	gil.amitai@weizmann.ac.il; rotem.sorek@weizmann.ac.il		Ofir, Gal/0000-0002-8307-9388; Malitsky, Sergey/0000-0003-4619-7219; Millman, Adi/0000-0002-6844-7613; Doron, Shany/0000-0002-8392-6110				Balint-Kurti P, 2019, MOL PLANT PATHOL, V20, P1163, DOI 10.1111/mpp.12821; Bayless AM, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00539; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernheim A, 2021, NATURE, V589, P120, DOI 10.1038/s41586-020-2762-2; Burch-Smith Tessa M, 2007, Sci STKE, V2007, ppe46; Burroughs AM, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00365-20; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Cohen D, 2019, NATURE, V574, P691, DOI 10.1038/s41586-019-1605-5; Coronas-Serna JM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1007979; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Duxbury Z, 2020, P NATL ACAD SCI USA, V117, P18832, DOI 10.1073/pnas.2001185117; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Huang YH, 2020, CELL CALCIUM, V85, DOI 10.1016/j.ceca.2019.102111; Huang YH, 2019, ELIFE, V8, DOI 10.7554/eLife.50175; Ka D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16703-w; Lopatina A, 2020, ANNU REV VIROL, V7, P371, DOI 10.1146/annurev-virology-011620-040628; Mazzocco Amanda, 2009, V501, P81, DOI 10.1007/978-1-60327-164-6_9; Morehouse BR, 2020, NATURE, V586, P429, DOI 10.1038/s41586-020-2719-5; Myers OD, 2017, ANAL CHEM, V89, P8696, DOI 10.1021/acs.analchem.7b00947; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Sonn-Segev A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15642-w; Tzipilevich E, 2022, EMBO J, V41, DOI 10.15252/embj.2021109247; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Watanabe S, 2012, J BACTERIOL, V194, P7007, DOI 10.1128/JB.01798-12; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Ye QZ, 2020, MOL CELL, V77, P709, DOI 10.1016/j.molcel.2019.12.009; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	30	27	33	17	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					116	+		10.1038/s41586-021-04098-7	http://dx.doi.org/10.1038/s41586-021-04098-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34853457	Green Submitted			2022-12-28	WOS:000724992500028
J	Jolly, J				Jolly, Jallicia			The art of medicine A reproductive justice response to HIV/AIDS and COVID-19	LANCET			English	Editorial Material									[Jolly, Jallicia] Amherst Coll, Amer Studies & Black Studies, Amherst, MA 01002 USA	Amherst College	Jolly, J (corresponding author), Amherst Coll, Amer Studies & Black Studies, Amherst, MA 01002 USA.	jjolly@amherst.edu							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					1958	1959						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XD7PT	34838167	Green Published, Bronze			2022-12-28	WOS:000722897200014
J	Israel, A; Merzon, E; Schaffer, AA; Shenhar, Y; Green, I; Golan-Cohen, A; Ruppin, E; Magen, E; Vinker, S				Israel, Ariel; Merzon, Eugene; Schaffer, Alejandro A.; Shenhar, Yotam; Green, Ilan; Golan-Cohen, Avivit; Ruppin, Eytan; Magen, Eli; Vinker, Shlomo			Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To determine whether time elapsed since the second injection of the Pfizer-BioNTech BNT162b2 mRNA vaccine was significantly associated with the risk of covid-19 infection after vaccination in people who received two vaccine injections. DESIGN Test negative design study. SETTING Electronic health records of a large state mandated healthcare organisation, Israel. PARTICIPANTS Adults aged >= 18 years who had received a reverse transcription polymerase chain reaction (RT-PCR) test between 15 May 2021 and 17 September 2021, at least three weeks after their second vaccine injection, had not received a third vaccine injection, and had no history of covid-19 infection. MAIN OUTCOME MEASURES Positive result for the RT-PCR test. Individuals who tested positive for SARS-CoV-2 and controls were matched for week of testing, age category, and demographic group (ultra-orthodox Jews, individuals of Arab ancestry, and the general population). Conditional logistic regression was adjusted for age, sex, socioeconomic status, and comorbid conditions. RESULTS 83 057 adults received an RT-PCR test for SARS-CoV-2 during the study period and 9.6% had a positive result. Time elapsed since the vaccine injection was significantly longer in individuals who tested positive (P<0.001). Adjusted odds ratio for infection at time intervals >90 days since vaccination were significantly increased compared with the reference of <90 days: 2.37 (95% confidence interval 1.67 to 3.36) for 90119 days, 2.66 (1.94 to 3.66) for 120-149 days, 2.82 (2.07 to 3.84) for 150-179 days, and 2.82 (2.07 to 3.85) for >= 180 days (P<0.001 for each 30 day interval). CONCLUSIONS In this large population of adults tested for SARSCoV-2 by RT-PCR after two doses of mRNA BNT162b2 vaccine, a gradual increase in the risk of infection was seen for individuals who received their second vaccine dose after at least 90 days.	[Israel, Ariel; Merzon, Eugene; Shenhar, Yotam; Green, Ilan; Golan-Cohen, Avivit; Magen, Eli; Vinker, Shlomo] Leumit Hlth Serv, Tel Aviv, Israel; [Schaffer, Alejandro A.; Ruppin, Eytan] NCI, Canc Data Sci Lab, Bethesda, MD 20892 USA; [Merzon, Eugene] Ariel Univ, Adelson Sch Med, Ariel, Israel; [Green, Ilan; Golan-Cohen, Avivit; Vinker, Shlomo] Tel Aviv Univ, Sackler Fac Med, Dept Family Med, Tel Aviv, Israel; [Magen, Eli] Ben Gurion Univ Negev, Barzilai Univ Med Ctr, Clin Immunol & Allergy Div, Med Dept C, Ashqelon, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ariel University; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Barzilai Medical Center	Israel, A (corresponding author), Leumit Hlth Serv, Tel Aviv, Israel.	dr.ariel.israel@gmail.com	Israel, Ariel/AFL-8794-2022; Magen, Eli/N-7960-2014; Ruppin, Eytan/R-9698-2017	Magen, Eli/0000-0002-7713-423X; Vinker, Shlomo/0000-0001-9804-7103; Ruppin, Eytan/0000-0002-7862-3940; Merzon, Eugene/0000-0001-5469-0236; green, ilan/0000-0002-9435-7152; Schaffer, Alejandro/0000-0002-2147-8033	Leumit Health Services; Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research	Leumit Health Services; Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research	This research was internally funded by Leumit Health Services and was supported in part by the Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organisations imply endorsement by the US government.	Bajaj V, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.571416; Boyarsky BJ, 2021, TRANSPLANTATION, V105, pE270, DOI 10.1097/TP.0000000000003900; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Hamood R, 2016, ISR J HEALTH POLICY, V5, DOI 10.1186/s13584-016-0111-6; Israel A, 2022, VACCINES-BASEL, V10, DOI [10.3390/vaccines10010064, 10.1101/2021.08.19.21262111]; Israeli Ministry of Health, 2021, COV 19 DASHB; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kim JH, 2021, NAT MED, V27, P205, DOI 10.1038/s41591-021-01230-y; Lieber D, 2021, DELTA VARIANT OUTBRE; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Mallapaty S, 2021, NATURE, V590, P197, DOI 10.1038/d41586-021-00316-4; Parry H, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00528-x; Patel MM, 2020, JAMA-J AM MED ASSOC, V324, P1939, DOI 10.1001/jama.2020.19328; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Raz A, 2021, VACCINE, V39, P4027, DOI 10.1016/j.vaccine.2021.06.004; Rennert G, 2001, ISR MED ASSOC J, V3, P404; Rosen B, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00481-x; Rosen B, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00440-6; Schramm R, 2021, CLIN RES CARDIOL, V110, P1142, DOI 10.1007/s00392-021-01880-5; Sheehan MM, 2021, CLIN INFECT DIS, V15, DOI [10.1093/cid/ciab234, DOI 10.1093/cid/ciab234]; Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wheatley AK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21444-5; Yahav D, 2021, CLIN MICROBIOL INFEC, V27, P315, DOI 10.1016/j.cmi.2020.11.028	25	41	41	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								e067873	10.1136/bmj-2021-067873	http://dx.doi.org/10.1136/bmj-2021-067873			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE5JI	34819275	hybrid, Green Published			2022-12-28	WOS:000723423400006
J	Mair, FS; Montori, VM; May, CR				Mair, Frances S.; Montori, Victor M.; May, Carl R.			Digital transformation could increase the burden of treatment on patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mair, Frances S.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Montori, Victor M.] Patient Revolut Inc, Rochester, MN USA; [May, Carl R.] London Sch Hyg & Trop Med, London, England; [May, Carl R.] NIHR North London Appl Res Collaborat, London, England	University of Glasgow; Mayo Clinic; University of London; London School of Hygiene & Tropical Medicine	Mair, FS (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.							[Anonymous], TELEGRAPH; Department of Health, 2019, NHS LONG TERM PLAN; Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005	4	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2909	10.1136/bmj.n2909	http://dx.doi.org/10.1136/bmj.n2909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824093	Green Accepted, Bronze			2022-12-28	WOS:000744251500012
J	Dyer, C				Dyer, Clare			Leading oncologist who overtreated patients is found to have impaired fitness to practise	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2882	10.1136/bmj.n2882	http://dx.doi.org/10.1136/bmj.n2882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815238				2022-12-28	WOS:000722577100009
J	Cooke, GS; Nayagam, S				Cooke, Graham S.; Nayagam, Shevanthi			Liver disease: at the heart of public health challenges for Europe in the 21st century	LANCET			English	Editorial Material									[Cooke, Graham S.] Imperial Coll London, Dept Infect Dis, London, England; [Nayagam, Shevanthi] Imperial Coll London, Sect Hepatol & Gastroenterol, Dept Metab Digest & Reprod, London, England; [Nayagam, Shevanthi] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England; [Cooke, Graham S.; Nayagam, Shevanthi] Natl Inst Hlth Res Biomed Res Ctr Imperial Coll N, London W2 1NY, England	Imperial College London; Imperial College London; Imperial College London	Cooke, GS (corresponding author), Imperial Coll London, Dept Infect Dis, London, England.; Cooke, GS (corresponding author), Natl Inst Hlth Res Biomed Res Ctr Imperial Coll N, London W2 1NY, England.	g.cooke@imperial.ac.uk						Advisory Committee of People with AIDS, 1983, DENV PRINC STAT ADV; Gamkrelidze I, 2021, LIVER INT, V41, P456, DOI 10.1111/liv.14779; Im GY, 2019, J HEPATOL, V70, P328, DOI 10.1016/j.jhep.2018.11.007; Karlsen TH, 2022, LANCET, V399, P61, DOI 10.1016/S0140-6736(21)01701-3; NIAID, 2020, NIAID HIV LANG GUID; Obesity Action Coalition, 2021, PEOPL 1 LANG OB; Orlandi R, 2018, HEPATOL COMMUN, V2, P986, DOI 10.1002/hep4.1224	7	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					9	10		10.1016/S0140-6736(21)02728-8	http://dx.doi.org/10.1016/S0140-6736(21)02728-8		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YA3YW	34863361				2022-12-28	WOS:000738273800006
J	Ledford, H				Ledford, Heidi			What the Moderna-NIH COVID vaccine patent fight means for research	NATURE			English	News Item																		Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114	1	1	1	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					200	201		10.1038/d41586-021-03535-x	http://dx.doi.org/10.1038/d41586-021-03535-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL0PT	34853416				2022-12-28	WOS:000727856300010
J	Iwabuchi, Y				Iwabuchi, Yoshiharu			Directing carboxylic acid dehydrogenation	SCIENCE			English	Editorial Material									[Iwabuchi, Yoshiharu] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Iwabuchi, Y (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	iwabuchi@mail.pharm.tohoku.ac.jp						Chen G, 2016, SCIENCE, V353, P1023, DOI 10.1126/science.aaf4434; CRABTREE RH, 1985, CHEM REV, V85, P245, DOI 10.1021/cr00068a002; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Ross MO, 2017, J BIOL INORG CHEM, V22, P307, DOI 10.1007/s00775-016-1419-y; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Wang Z, 2021, SCIENCE, V374, P1281, DOI 10.1126/science.abl3939	6	1	1	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1199	1199		10.1126/science.abm4457	http://dx.doi.org/10.1126/science.abm4457			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855485				2022-12-28	WOS:000728578700037
J	Harter, P; Sehouli, J; Vergote, I; Ferron, G; Reuss, A; Meier, W; Greggi, S; Mosgard, BJ; Selle, F; Guyon, F; Pomel, C; Lecuru, F; Zang, R; Avail-Lundqvist, E; Kim, JW; Ponce, J; Raspagliesi, F; Kristensen, G; Classe, JM; Hillemanns, P; Jensen, P; Hasenburg, A; Ghaem-Maghami, S; Mirza, MR; Lund, B; Reinthaller, A; Santaballa, A; Olaitan, A; Hilpert, F; du Bois, A				Harter, P.; Sehouli, J.; Vergote, I; Ferron, G.; Reuss, A.; Meier, W.; Greggi, S.; Mosgard, B. J.; Selle, F.; Guyon, F.; Pomel, C.; Lecuru, F.; Zang, R.; Avail-Lundqvist, E.; Kim, J-W; Ponce, J.; Raspagliesi, F.; Kristensen, G.; Classe, J-M; Hillemanns, P.; Jensen, P.; Hasenburg, A.; Ghaem-Maghami, S.; Mirza, M. R.; Lund, B.; Reinthaller, A.; Santaballa, A.; Olaitan, A.; Hilpert, F.; du Bois, A.		DESKTOP III Investigators	Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPEN-LABEL; SECONDARY CYTOREDUCTION; EPITHELIAL OVARIAN; CHEMOTHERAPY; MULTICENTER; BEVACIZUMAB; RECURRENT; PACLITAXEL	BACKGROUND Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear. METHODS We randomly assigned patients with recurrent ovarian cancer who had a first relapse after a platinum-free interval (an interval during which no platinum-based chemotherapy was used) of 6 months or more to undergo secondary cytoreductive surgery and then receive platinum-based chemotherapy or to receive platinum-based chemotherapy alone. Patients were eligible if they presented with a positive Arbeitsgemeinschaft Gynakologische Onkologie (AGO) score, defined as an Eastern Cooperative Oncology Group performance-status score of 0 (on a 5-point scale, with higher scores indicating greater disability), ascites of less than 500 ml, and complete resection at initial surgery. A positive AGO score is used to identify patients in whom a complete resection might be achieved. The primary end point was overall survival. We also assessed quality of life and prognostic factors for survival. RESULTS A total of 407 patients underwent randomization: 206 were assigned to cytoreductive surgery and chemotherapy, and 201 to chemotherapy alone. A complete resection was achieved in 75.5% of the patients in the surgery group who underwent the procedure. The median overall survival was 53.7 months in the surgery group and 46.0 months in the no-surgery group (hazard ratio for death, 0.75; 95% confidence interval, 0.59 to 0.96; P=0.02). Patients with a complete resection had the most favorable outcome, with a median overall survival of 61.9 months. A benefit from surgery was seen in all analyses in subgroups according to prognostic factors. Quality-of-life measures through 1 year of follow-up did not differ between the two groups, and we observed no perioperative mortality within 30 days after surgery. CONCLUSIONS In women with recurrent ovarian cancer, cytoreductive surgery followed by chemotherapy resulted in longer overall survival than chemotherapy alone.	[Harter, P.; du Bois, A.] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Henricistr 92, D-45136 Essen, Germany; [Sehouli, J.] Charite, Dept Gynecol, Ctr Ontol Surg, Berlin, Germany; [Reuss, A.] Philipps Univ, Coordinating Ctr Clin Trials, Marburg, Germany; [Harter, P.] Philipps Univ, Dept Gynecol, Marburg, Germany; [Meier, W.] Heinrich Heine Univ, Dept Obstet & Gynecol, Dusseldorf, Germany; [Hillemanns, P.] Hannover Med Sch, Dept Gynecol & Obstet, Hannover, Germany; [Hasenburg, A.] Univ Med Ctr Mainz, Dept Gynecol & Obstet, Mainz, Germany; [Hilpert, F.] Jerusalem Hosp, Manunazentrum Hamburg, Hamburg, Germany; [Vergote, I] Univ Hosp Leuven, Leuven Canc Inst, Dept Gynecol Oncol, Leuven, Belgium; [Ferron, G.] Inst Univ Canc, Dept Surg Oncol, Inst Claudius Regaud, Toulouse, France; [Selle, F.] Grp Hosp Diaconesses Croix St Simon, Dept Med Oncol, Paris, France; [Lecuru, F.] Inst Curie, Oncol Gynecol, Paris, France; [Lecuru, F.] Univ Paris, Paris, France; [Guyon, F.] Comprehens Canc Ctr, Inst Bergonie, Dept Surg Oncol, Bordeaux, France; [Pomel, C.] Jean Perrin Canc Ctr, Dept Surg Oncol, Clermont Ferrand, France; [Classe, J-M] Univ Med, Inst Cancerol Ouest, Nantes, France; [Greggi, S.] Fdn IRCCS Pascale, Ist Nazl Tumori Napoli, Gynecol Oncol Unit, Naples, Italy; [Raspagliesi, F.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Mosgard, B. J.] Copenhagen Univ Hosp, Rigshosp, Gyne Oncol Dept Gynecol, Copenhagen, Denmark; [Mirza, M. R.] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Jensen, P.] Aarhus Univ Hosp, Dept Gynecol, Aarhus, Denmark; [Jensen, P.] Aarhus Univ, Inst Clin Med, Fac Hlth, Aarhus, Denmark; [Lund, B.] Aalborg Univ Hosp, Aalborg, Denmark; [Zang, R.] Fudan Univ, Dept Gynecol Oncol, Ovarian Canc Program, Zhongshan Hosp, Shanghai, Peoples R China; [Avail-Lundqvist, E.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Kim, J-W] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Ponce, J.] Univ Hosp Bellvitge, Barcelona, Spain; [Santaballa, A.] La Fe Univ Hosp, Gynecol Oncol Unit, Valencia, Spain; [Kristensen, G.] Oslo Univ Hosp, Dept Gynecol Oncol, Oslo, Norway; [Kristensen, G.] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway; [Ghaem-Maghami, S.] Imperial Coll London, Dept Surg & Canc, London, England; [Olaitan, A.] Univ Coll London Hosp, Dept Gynaecol Oncol, London, England; [Reinthaller, A.] Med Univ Vienna, Dept Gynecol & Gynecol Oncol, Vienna, Austria	Kliniken Essen-Mitte; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; Philipps University Marburg; Heinrich Heine University Dusseldorf; Hannover Medical School; Johannes Gutenberg University of Mainz; KU Leuven; University Hospital Leuven; UNICANCER; Institut Claudius Regaud; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Bergonie; UNICANCER; Centre Jean Perrin; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Fondazione IRCCS Istituto Nazionale Tumori Milan; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Fudan University; Karolinska Institutet; Seoul National University (SNU); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Oslo; University of Oslo; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Medical University of Vienna	Harter, P (corresponding author), Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Henricistr 92, D-45136 Essen, Germany.	p.harter@kem-med.com		Guyon, Frederic/0000-0002-2647-3004; Jensen, Pernille Tine/0000-0002-1637-6040; El-Ghobashy, Alaa/0000-0003-1167-7669; Ghaem-Maghami, Sadaf/0000-0002-7369-5080; Mosgaard, Berit/0000-0002-3043-6986				Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Clamp AR, 2019, LANCET, V394, P2084, DOI 10.1016/S0140-6736(19)32259-7; Coleman RL, 2019, NEW ENGL J MED, V381, P2403, DOI 10.1056/NEJMoa1909707; Coleman RL, 2019, NEW ENGL J MED, V381, P1929, DOI 10.1056/NEJMoa1902626; Coleman RL, 2017, LANCET ONCOL, V18, P779, DOI 10.1016/S1470-2045(17)30279-6; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; du Bois A, 2016, LANCET ONCOL, V17, P78, DOI 10.1016/S1470-2045(15)00366-6; du Bois A, 2015, INT J GYNECOL CANCER, V25, P1328, DOI 10.1097/IGC.0000000000000478; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Gonzalez-Martin A, 2019, NEW ENGL J MED, V381, P2391, DOI 10.1056/NEJMoa1910962; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hall M, 2019, ANN SURG ONCOL, V26, P2943, DOI 10.1245/s10434-019-07516-3; Harter P, 2005, CURR OPIN ONCOL, V17, P505, DOI 10.1097/01.cco.0000174166.06734.c7; Harter P, 2019, NEW ENGL J MED, V380, P822, DOI 10.1056/NEJMoa1808424; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Harter P, 2011, INT J GYNECOL CANCER, V21, P289, DOI 10.1097/IGC.0b013e31820aaafd; Klein DA, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.07.050; Moore K, 2018, NEW ENGL J MED, V379, P2495, DOI 10.1056/NEJMoa1810858; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Parmar MKB, 2003, LANCET, V361, P2099; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pfisterer J, 2020, LANCET ONCOL, V21, P699, DOI 10.1016/S1470-2045(20)30142-X; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; Poveda A, 2020, J CLIN ONCOL, V38; Ray-Coquard I, 2019, NEW ENGL J MED, V381, P2416, DOI 10.1056/NEJMoa1911361; Rosenberger WF, 2002, RANDOMIZATION CLIN T; Shi TY, 2021, LANCET ONCOL, V22, P439, DOI 10.1016/S1470-2045(21)00006-1	27	48	49	6	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2021	385	23					2123	2131		10.1056/NEJMoa2103294	http://dx.doi.org/10.1056/NEJMoa2103294			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE4VC	34874631	Green Published, Bronze			2022-12-28	WOS:000741124300008
J	Wei, YY; Sha, F; Zhao, Y; Jiang, QW; Hao, YT; Chen, F				Wei, Yongyue; Sha, Feng; Zhao, Yang; Jiang, Qingwu; Hao, Yuantao; Chen, Feng			Better modelling of infectious diseases: lessons from covid-19 in China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPIDEMIC		[Wei, Yongyue; Zhao, Yang; Chen, Feng] Nanjing Med Univ, China Int Cooperat Ctr Environm & Human Hlth, Sch Publ Hlth Ctr Global Hlth, Dept Biostat, Nanjing 211166, Peoples R China; [Sha, Feng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Peoples R China; [Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Peoples R China	Nanjing Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Fudan University; Sun Yat Sen University	Chen, F (corresponding author), Nanjing Med Univ, China Int Cooperat Ctr Environm & Human Hlth, Sch Publ Hlth Ctr Global Hlth, Dept Biostat, Nanjing 211166, Peoples R China.	fengchen@njmu.edu.cn	Wei, Yongyue/GYV-5660-2022	Wei, Yongyue/0000-0002-1132-1796; Sha, Feng/0000-0002-0966-5733	National Natural Science Foundation of China [82041024]; Bill & Melinda Gates Foundation [INV-006371]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The study was partially supported by the National Natural Science Foundation of China (82041024 to Feng Chen) and the Bill & Melinda Gates Foundation (INV-006371) .	[Anonymous], 2020, REPORT WHO CHINA JOI; Burki TK, 2021, LANCET RESP MED, V9, pE83, DOI 10.1016/S2213-2600(21)00328-3; Coronavirus Resource Center John Hopkins University and Medicine, 2021, SUMM VACC STAT; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Dietz K, 2002, MATH BIOSCI, V180, P1, DOI 10.1016/S0025-5564(02)00122-0; Guan JX, 2020, J BIOMED RES, V34, P422, DOI 10.7555/JBR.34.20200119; Hao XJ, 2020, NATURE, V584, P420, DOI 10.1038/s41586-020-2554-8; He ZY, 2021, LANCET, V397, P1075, DOI 10.1016/S0140-6736(21)00238-5; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Linka K, 2020, COMPUT METHOD BIOMEC, V23, P710, DOI 10.1080/10255842.2020.1759560; Peirlinck M, 2020, BIOMECH MODEL MECHAN, V19, P2179, DOI 10.1007/s10237-020-01332-5; Qingdao Health Commission, 2020, REC EP PREV CONTR SI; Siegenfeld AF, 2020, P NATL ACAD SCI USA, V117, P16092, DOI 10.1073/pnas.2011542117; Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Wei Y Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P470, DOI 10.3760/cma.j.cn112338-20200216-00106; Wei YY, 2020, ENGINEERING-PRC, V6, P1141, DOI 10.1016/j.eng.2020.04.008; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yang J, 2021, NAT HUM BEHAV, V5, P1009, DOI 10.1038/s41562-021-01155-z	20	4	4	9	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2365	10.1136/bmj.n2365	http://dx.doi.org/10.1136/bmj.n2365			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34852999	Green Published, hybrid			2022-12-28	WOS:000732779300010
J	Zhou, YBA; Jiang, HL; Wang, QY; Yang, MX; Chen, Y; Jiang, QW				Zhou, Yibiao; Jiang, Honglin; Wang, Quanyi; Yang, Meixia; Chen, Yue; Jiang, Qingwu			Use of contact tracing, isolation, and mass testing to control transmission of covid-19 in China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zhou, Yibiao; Jiang, Honglin; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Zhou, Yibiao; Jiang, Honglin; Jiang, Qingwu] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China; [Zhou, Yibiao; Jiang, Honglin; Jiang, Qingwu] Fudan Univ, Ctr Trop Dis Res, Shanghai, Peoples R China; [Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Beijing Res Ctr Prevent Med, Beijing, Peoples R China; [Yang, Meixia] Xuhui Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Chen, Yue] Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada	Fudan University; Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; University of Ottawa	Jiang, QW (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.; Jiang, QW (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.; Jiang, QW (corresponding author), Fudan Univ, Ctr Trop Dis Res, Shanghai, Peoples R China.	jiangqw@fudan.edu.cn		Jiang, Honglin/0000-0001-8815-0780; WANG, QUANYI/0000-0001-9552-2503; Jiang, Qingwu/0000-0001-8921-3317				Burki T, 2020, LANCET MICROBE, V1, pE317, DOI 10.1016/S2666-5247(20)30205-6; Cauchemez S, 2020, LANCET, V396, P1068, DOI 10.1016/S0140-6736(20)32034-1; Chinese National Health Commission, 2020, PROT PREV CONTR COVI; Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7; Garcia-Finana M, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1637; Hu Y, 2021, INVESTIGATION CORONA, DOI [10.19428/j.cnki.sjpm.2021.20873, DOI 10.19428/J.CNKI.SJPM.2021.20873]; Iacobucci G, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3482; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Lau LL, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01254-9; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Liang F, 2020, SOC MEDIA SOC, V6, DOI 10.1177/2056305120947657; National Health Commission of the People's Republic of China, COVID 19 EP NOT; Radulescu A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77628-4; Raffle AE, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3262; Shi Y, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00849-w; State Council of the People's Republic of China, 2021, CHIN STRENGTH NUCL A; State Council of the People's Republic of China, 2021, CHIN DAIL COVID 19 T; te Vrugt M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19024-0; Wang X, 2021, FACILITIES CENTRALIZ, DOI [10.1016/j.eng.2021.03.010, DOI 10.1016/J.ENG.2021.03.010]; WHO, 2020, DIAGN TEST SARS COV; Xie Q, 2020, Zhonghua Yi Xue Za Zhi, V100, P2532, DOI 10.3760/cma.j.cn112137-20200320-00860; Xing YH, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2032361	22	10	10	4	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2330	10.1136/bmj.n2330	http://dx.doi.org/10.1136/bmj.n2330			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853002	hybrid, Green Published			2022-12-28	WOS:000732779300020
J	Gilroy, A				Gilroy, Ali			Please tell me what the long term effects might be Ali Gilroy explains what it was like to be diagnosed with intrahepatic cholestasis of pregnancy, and how discovering the long term effects was unexpected	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												alig.gilroy@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2753	10.1136/bmj.n2753	http://dx.doi.org/10.1136/bmj.n2753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34852998	Bronze			2022-12-28	WOS:000726688600009
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Omicron-panic mongering or appropriate caution?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2941	10.1136/bmj.n2941	http://dx.doi.org/10.1136/bmj.n2941			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34845004	Bronze			2022-12-28	WOS:000740896100009
J	Sun, WF				Sun, Wenfei			Fat for heat	SCIENCE			English	Editorial Material							BROWN ADIPOSE-TISSUE		[Sun, Wenfei] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Sun, WF (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sunwe@stanford.edu	Sun, Wenfei/GWV-0960-2022; sun, wenfei/S-3513-2019	sun, wenfei/0000-0001-5762-6010				[Anonymous], 2021, LANCET GASTROENTEROL, V6, P677; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schwalie PC, 2018, NATURE, V559, P103, DOI 10.1038/s41586-018-0226-8; Sun WF, 2021, NAT METAB, V3, P751, DOI 10.1038/s42255-021-00417-4; Sun WF, 2020, NATURE, V587, P98, DOI 10.1038/s41586-020-2856-x; Sun WF, 2019, ADV SCI, V6, DOI 10.1002/advs.201900275; Sun WF, 2018, NAT MED, V24, P1372, DOI 10.1038/s41591-018-0102-y; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; World Health Organization, 2021, OBESITY; World-Health-Organization, 2021, OB OV	15	0	0	3	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1068	1068		10.1126/science.abm8138	http://dx.doi.org/10.1126/science.abm8138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822283				2022-12-28	WOS:000725668600033
J	O'Connell, J				O'Connell, James			Treatment of Diabetes - To Pump or Not to Pump	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPAIRED AWARENESS	Diabetes Technology - To Pump or Not to Pump This interactive feature about a person with type 1 diabetes mellitus and impaired awareness of hypoglycemia offers a case vignette accompanied by two essays supporting the use of a continuous glucose monitor paired with an insulin pump or a continuous glucose monitor with alerts.	[O'Connell, James] Hlth Serv Execut West, Dept Publ Hlth, Galway, Ireland		O'Connell, J (corresponding author), Hlth Serv Execut West, Dept Publ Hlth, Galway, Ireland.		O'Brien, Timothy/N-7112-2014	O'Brien, Timothy/0000-0001-9028-5481				Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, 2007, NEW ENGL J MED, V356, P1842; Farrell CM, 2021, THER ADV ENDOCRINOL, V12, DOI 10.1177/20420188211000248; Grunberger G, 2021, ENDOCR PRACT, V27, P505, DOI 10.1016/j.eprac.2021.04.008; Jacobson AM, 2021, LANCET DIABETES ENDO, V9, P436, DOI 10.1016/S2213-8587(21)00086-3; Lin R, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14528; Little SA, 2018, DIABETES CARE, V41, P1600, DOI 10.2337/dc17-2682; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; Pease A, 2020, DIABETES TECHNOL THE, V22, P411, DOI 10.1089/dia.2019.0417; Reddy M, 2018, DIABETIC MED, V35, P483, DOI 10.1111/dme.13561; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0; Vesco Anthony T, 2018, J Diabetes Sci Technol, V12, P792, DOI 10.1177/1932296818766381	12	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2092	2095		10.1056/NEJMclde2112076	http://dx.doi.org/10.1056/NEJMclde2112076			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC3KG	34818486				2022-12-28	WOS:000721915400016
J	Tang, H; Yuan, XH; Cheng, Y; Fei, HZ; Liu, FY; Liang, T; Zeng, ZD; Ishii, T; Wang, MS; Katsura, T; Sheng, HW; Gou, HY				Tang, Hu; Yuan, Xiaohong; Cheng, Yong; Fei, Hongzhan; Liu, Fuyang; Liang, Tao; Zeng, Zhidan; Ishii, Takayuki; Wang, Ming-Sheng; Katsura, Tomoo; Sheng, Howard; Gou, Huiyang			Synthesis of paracrystalline diamond	NATURE			English	Article							HIGH-PRESSURE; NANOTWINNED DIAMOND; CARBON; ORDER; SPECTROSCOPY; CHEMISTRY; MECHANISM; HARDNESS; C-60	Solids in nature can be generally classified into crystalline and non-crystalline states(1-7), depending on whether long-range lattice periodicity is present in the material. The differentiation of the two states, however, could face fundamental challenges if the degree of long-range order in crystals is significantly reduced. Here we report a paracrystalline state of diamond that is distinct from either crystalline or amorphous diamond(8-10). The paracrystalline diamond reported in this work, consisting of sub-nanometre-sized paracrystallites that possess a well-defined crystalline medium-range order up to a few atomic shells(4,5,11-13), was synthesized in high-pressure high-temperature conditions (for example, 30 GPa and 1,600 K) employing face-centred cubic C-60 as a precursor. The structural characteristics of the paracrystalline diamond were identified through a combination of X-ray diffraction, high-resolution transmission microscopy and advanced molecular dynamics simulation. The formation of paracrystalline diamond is a result of densely distributed nucleation sites developed in compressed C-60 as well as pronounced second-nearest-neighbour short-range order in amorphous diamond due to strong sp(3) bonding. The discovery of paracrystalline diamond adds an unusual diamond form to the enriched carbon family(14-16), which exhibits distinguishing physical properties and can be furthered exploited to develop new materials. Furthermore, this work reveals the missing link in the length scale between amorphous and crystalline states across the structural landscape, having profound implications for recognizing complex structures arising from amorphous materials. A study describes the synthesis, structural characterization and formation mechanism of a paracrystalline state of diamond, adding an unusual form of diamond to the family of carbon-based materials.	[Tang, Hu; Yuan, Xiaohong; Liu, Fuyang; Liang, Tao; Zeng, Zhidan; Ishii, Takayuki; Gou, Huiyang] Ctr High Pressure Sci & Technol Adv Res, Beijing, Peoples R China; [Cheng, Yong; Wang, Ming-Sheng] Xiamen Univ, Coll Mat, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China; [Fei, Hongzhan; Ishii, Takayuki; Katsura, Tomoo] Univ Bayreuth, Bayer Geoinst, Bayreuth, Germany; [Sheng, Howard] George Mason Univ, Dept Phys & Astron, Fairfax, VA USA; [Gou, Huiyang] Yanshan Univ, Coll Environm & Chem Engn, Qinhuangdao, Hebei, Peoples R China	Xiamen University; University of Bayreuth; George Mason University; Yanshan University	Gou, HY (corresponding author), Ctr High Pressure Sci & Technol Adv Res, Beijing, Peoples R China.; Sheng, HW (corresponding author), George Mason Univ, Dept Phys & Astron, Fairfax, VA USA.; Gou, HY (corresponding author), Yanshan Univ, Coll Environm & Chem Engn, Qinhuangdao, Hebei, Peoples R China.	hsheng@gmu.edu; huiyang.gou@hpstar.ac.cn	Ishii, Takayuki/AAQ-5482-2020; Wang, Ming-Sheng/E-5748-2010; Katsura, Tomoo/A-7483-2010; Fei, Hongzhan/E-7560-2017	Ishii, Takayuki/0000-0002-1494-2141; Katsura, Tomoo/0000-0001-7857-5101; Fei, Hongzhan/0000-0003-3143-7363; Yuan, Xiaohong/0000-0003-0901-6781; Tang, Hu/0000-0003-1571-8843; Zeng, Zhidan/0000-0003-4283-2393				Bewilogua K, 2014, SURF COAT TECH, V242, P214, DOI 10.1016/j.surfcoat.2014.01.031; Blank VD, 1996, PHYS LETT A, V220, P149, DOI 10.1016/0375-9601(96)00483-5; Chen LJ, 2002, MICROSC MICROANAL, V8, P268, DOI 10.1017/S1431927602020202; Daniels H, 2007, PHILOS MAG, V87, P4073, DOI 10.1080/14786430701394041; Dubrovinskaia N, 2005, DIAM RELAT MATER, V14, P16, DOI 10.1016/j.diamond.2004.06.017; ELLIOTT SR, 1991, NATURE, V354, P445, DOI 10.1038/354445a0; ELLIOTT SR, 1978, PHILOS MAG B, V37, P435, DOI 10.1080/01418637808225788; Faken D., 1994, Computational Materials Science, V2, P279, DOI 10.1016/0927-0256(94)90109-0; Ferrari AC, 2004, PHILOS T R SOC A, V362, P2477, DOI 10.1098/rsta.2004.1452; Georgakilas V, 2015, CHEM REV, V115, P4744, DOI 10.1021/cr500304f; Gibson JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.125504; HIRAI H, 1994, APPL PHYS LETT, V64, P1797, DOI 10.1063/1.111811; Hirata A, 2011, NAT MATER, V10, P28, DOI [10.1038/nmat2897, 10.1038/NMAT2897]; Huang Q, 2014, NATURE, V510, P250, DOI 10.1038/nature13381; Hujo W, 2011, J STAT PHYS, V145, P293, DOI 10.1007/s10955-011-0293-9; Hwang J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195505; Irifune T, 2003, NATURE, V421, P599, DOI 10.1038/421599b; Ishii T, 2019, ENGINEERING-PRC, V5, P434, DOI 10.1016/j.eng.2019.01.013; IWASA Y, 1994, SCIENCE, V264, P1570, DOI 10.1126/science.264.5165.1570; Lechner W, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2977970; Lee L.L., 2008, MOL THERMODYNAMICS E; Leocmach M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1974; Lin Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175504; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Merlen A, 2009, CARBON, V47, P1643, DOI 10.1016/j.carbon.2009.02.014; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; Nemeth P, 2020, NAT MATER, V19, P1126, DOI 10.1038/s41563-020-0759-8; Oganov AR, 2013, REV MINERAL GEOCHEM, V75, P47, DOI 10.2138/rmg.2013.75.3; Osswald S, 2006, J AM CHEM SOC, V128, P11635, DOI 10.1021/ja063303n; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pu JC, 2009, APPL SURF SCI, V256, P668, DOI 10.1016/j.apsusc.2009.08.042; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Sarac B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03744-5; Sheng HW, 2007, NAT MATER, V6, P192, DOI 10.1038/nmat1839; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Sumiya H, 2007, J MATER RES, V22, P2345, DOI 10.1557/JMR.2007.0295; Sundqvist B, 2021, PHYS REP, V909, P1, DOI 10.1016/j.physrep.2020.12.007; Tang H, 2018, CARBON, V129, P159, DOI 10.1016/j.carbon.2017.12.027; Tang H, 2016, CARBON, V108, P1, DOI 10.1016/j.carbon.2016.07.004; Teter DM, 1998, MRS BULL, V23, P22, DOI 10.1557/S0883769400031420; Treacy MMJ, 2012, SCIENCE, V335, P950, DOI 10.1126/science.1214780; Voyles PM, 2001, J APPL PHYS, V90, P4437, DOI 10.1063/1.1407319; Wang Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04648; Yamanaka S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076602; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; Zallen R., 1983, PHYS AMORPHOUS SOLID; Zeng ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00395-w; Zhang S., 2020, DISCOVERY CARBON BAS; Zhu SC, 2020, MATTER-US, V3, P864, DOI 10.1016/j.matt.2020.05.013	49	17	17	27	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					605	+		10.1038/s41586-021-04122-w	http://dx.doi.org/10.1038/s41586-021-04122-w			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819683	Green Submitted			2022-12-28	WOS:000722366200020
J	Mollerup, A; Henriksen, M; Larsen, SC; Bennetzen, AS; Simonsen, MK; Kofod, LM; Knudsen, JD; Nielsen, XC; Weis, N; Heitmann, BL				Mollerup, Annette; Henriksen, Marius; Larsen, Sofus Christian; Bennetzen, Anita Selmer; Simonsen, Mette Kildevaeld; Kofod, Linette Marie; Knudsen, Jenny Dahl; Nielsen, Xiaohui Chen; Weis, Nina; Heitmann, Berit Lilienthal			Effect of PEP flute self-care versus usual care in early covid-19: non-drug, open label, randomised controlled trial in a Danish community setting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITIVE EXPIRATORY PRESSURE	OBJECTIVE To determine whether positive expiratory pressure (PEP) by PEP flute self-care is effective in reducing respiratory symptoms among community dwelling adults with SARS-CoV-2 infection and early stage covid-19. DESIGN Non-drug, open label, randomised controlled trial. SETTING Capital Region and Region Zealand in Denmark from 6 October 2020 to 26 February 2021. PARTICIPANTS Community dwelling adults, able to perform self-care, with a new SARS-CoV-2 infection (verified by reverse transcription polymerase chain reaction tests) and symptoms of covid-19. INTERVENTION Participants were randomised to use PEP flute selfcare in addition to usual care or have usual care only. Randomisation was based on permuted random blocks in a 1:1 ratio, stratified for sex and age (<60 or >= 60 years). The PEP self-care group was instructed to use a PEP flute three times per day during the 30 day intervention. MAIN OUTCOME MEASURES Primary outcome was a change in symptom severity from baseline to day 30, as assessed by the self-reported COPD (chronic obstructive pulmonary disease) assessment test (CAT), which was adjusted for baseline values and stratification factors. Participants completed the CAT test questionnaire every day online. Secondary outcomes were selfreported urgent care visits due to covid-19, number of covid-19 related symptoms, and change in self-rated health, all within 30-days' follow-up. RESULTS 378 participants were assigned to the PEP flute selfcare intervention (n=190) or usual care only (n=188). In the PEP self-care group, the median number of days with PEP flute use was 21 days (interquartile range 13-25). For the intention-to-treat population, a group difference was observed in changes from baseline in CAT scores of -1.2 points (95% confidence interval -2.1 to -0.2; P=0.017) in favour of the PEP flute selfcare group. At day 30, the PEP flute self-care group also reported less chest tightness, less dyspnoea, more vigour, and higher level of daily activities, but these differences were small, and no consistent effects were seen on the secondary outcomes. No serious adverse events were reported. CONCLUSIONS In community dwelling adults with early covid-19, PEP flute self-care had a significant, yet marginal and uncertain clinical effect on respiratory symptom severity, as measured by CAT scores.	[Mollerup, Annette; Henriksen, Marius; Larsen, Sofus Christian; Bennetzen, Anita Selmer; Simonsen, Mette Kildevaeld; Heitmann, Berit Lilienthal] Copenhagen Univ Hosp Bispebjerg Frederiksberg, Parker Inst, Frederiksberg, Denmark; [Mollerup, Annette] Univ Coll Diakonissestiftelsen, Bachelor Sci Nursing Programme, Danish Deaconess Community, Frederiksberg, Denmark; [Simonsen, Mette Kildevaeld] Copenhagen Univ Hosp Bispebjerg Frederiksberg, Dept Neurol, Frederiksberg, Denmark; [Kofod, Linette Marie] Copenhagen Univ Hosp Hvidovre, Dept Physio & Occupat Therapy, Hvidovre, Denmark; [Kofod, Linette Marie] Copenhagen Univ Hosp Hvidovre, PMR C, Hvidovre, Denmark; [Knudsen, Jenny Dahl] Copenhagen Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Nielsen, Xiaohui Chen] Zealand Univ Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Weis, Nina] Copenhagen Univ Hosp Hvidovre, Dept Infect Dis, Hvidovre, Denmark; [Henriksen, Marius; Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Heitmann, Berit Lilienthal] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW, Australia; [Heitmann, Berit Lilienthal] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Sydney; University of Copenhagen	Mollerup, A (corresponding author), Copenhagen Univ Hosp Bispebjerg Frederiksberg, Parker Inst, Frederiksberg, Denmark.; Mollerup, A (corresponding author), Univ Coll Diakonissestiftelsen, Bachelor Sci Nursing Programme, Danish Deaconess Community, Frederiksberg, Denmark.	amol@ucdiakonissen.dk	Larsen, Sofus Christian/AAO-5894-2020; Mollerup, Annette/GQQ-6381-2022	Larsen, Sofus Christian/0000-0002-0838-9378; Kofod, Linette Marie/0000-0002-1184-9451; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Innovation Fund Denmark [0211-00023B]; Danish Nursing Council; Oak Foundation [OCAY-18-774]	Innovation Fund Denmark; Danish Nursing Council; Oak Foundation	The study was supported by Innovation Fund Denmark (grant 0211-00023B) and a grant (unnumbered) from the Danish Nursing Council. The Parker Institute, Bispebjerg-Frederiksberg hospital, is supported by a core grant from the Oak Foundation (grant OCAY-18-774). The funders had no role in the study design, conduct of the trial, data analysis and interpretation, writing of the manuscript, or the decision to publish the study.	Bo A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1095; Butler CC, 2021, LANCET, V397, P1063, DOI 10.1016/S0140-6736(21)00461-X; Clarke JM, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1239; Daynes E, 2021, THORAX, V76, P185, DOI 10.1136/thoraxjnl-2020-215916; Detry MA, 2016, JAMA-J AM MED ASSOC, V315, P407, DOI 10.1001/jama.2015.19394; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Ellis-Petersen H, 2021, GUARDIAN; GlaxoSmithKline, COPD ASS TEST CAT HE; Haase N, 2021, ACTA ANAESTH SCAND, V65, P68, DOI 10.1111/aas.13701; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones P, 2018, HEALTHCARE PROFESSIO, P1; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kofod LM, 2021, EUR CLIN RESPIR J, V8, DOI 10.1080/20018525.2021.1910191; Lenze EJ, 2020, JAMA-J AM MED ASSOC, V324, P2292, DOI 10.1001/jama.2020.22760; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Moller T, 2016, AM J HEMATOL, V91, P271, DOI 10.1002/ajh.24262; Mollerup A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050582; Ni YM, 2018, EXP THER MED, V16, P3241, DOI 10.3892/etm.2018.6552; Olsen MF, 2015, RESP MED, V109, P297, DOI 10.1016/j.rmed.2014.11.003; Osadnik CR, 2014, THORAX, V69, P137, DOI 10.1136/thoraxjnl-2013-203425; Osadnik CR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008328.pub2; Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Radovanovic D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041191; Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0; Smith JA, 2012, J PHYSIOL-LONDON, V590, P563, DOI 10.1113/jphysiol.2011.213157; Statens Serum Institut, COVIDMETER; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; The Lancet Infectious Diseases, LANCET INFEC DIS, V21, P1471, DOI [10.1016/S1473-3099(21)00633-2, DOI 10.1016/S1473-3099(21)00633-2]; Thomas S, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0369	29	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								e066952	10.1136/bmj-2021-066952	http://dx.doi.org/10.1136/bmj-2021-066952			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819329	hybrid			2022-12-28	WOS:000740893700014
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word .... Examining the efficiency paradox	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	jeffrey.aronson@phc.ox.ac.uk		Aronson, Jeffrey/0000-0003-1139-655X				Anandaciva S, 2021, KINGS FUND 0505; [Anonymous], 2021, BBC NEWS 0308; Aronson JK, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2712; Friedman J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22457-w; Fuggle P, 2016, J CHILD HEALTH CARE, V20, P195, DOI 10.1177/1367493514563856; Kimm SY, 2021, BMJ BEST PRACTICE; NHS England, 2021, BED AV OCC DAT OV; Proudfoot AG, 2021, INTENS CARE MED, DOI 10.1007/s00134-020-06334-6; Puchner R, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-016-1362-7; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2856	10.1136/bmj.n2856	http://dx.doi.org/10.1136/bmj.n2856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799413	Bronze			2022-12-28	WOS:000723212300018
J	Tholen, J; Razew, M; Weis, F; Galej, WP				Tholen, Jonas; Razew, Michal; Weis, Felix; Galej, Wojciech P.			Structural basis of branch site recognition by the human spliceosome	SCIENCE			English	Article							PRE-MESSENGER-RNA; U2 SNRNP PROTEINS; CRYO-EM STRUCTURE; ACTIVATED SPLICEOSOME; ATP REQUIREMENT; COMPLEX; MODEL; PRP5; SELECTION; POINT	Recognition of the intron branch site (BS) by the U2 small nuclear ribonucleoprotein (snRNP) is a critical event during spliceosome assembly. In mammals, BS sequences are poorly conserved, and unambiguous intron recognition cannot be achieved solely through a base-pairing mechanism. We isolated human 17S U2 snRNP and reconstituted in vitro its adenosine 5'-triphosphate (ATP)-dependent remodeling and binding to the pre-messenger RNA substrate. We determined a series of high-resolution (2.0 to 2.2 angstrom) structures providing snapshots of the BS selection process. The substrate-bound U2 snRNP shows that SF3B6 stabilizes the BS:U2 snRNA duplex, which could aid binding of introns with poor sequence complementarity. ATP-dependent remodeling uncoupled from substrate binding captures U2 snRNA in a conformation that competes with BS recognition, providing a selection mechanism based on branch helix stability.	[Tholen, Jonas; Razew, Michal; Galej, Wojciech P.] European Mol Biol Lab, 71 Ave Martyrs, F-38042 Grenoble, France; [Tholen, Jonas] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Weis, Felix] European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Galej, WP (corresponding author), European Mol Biol Lab, 71 Ave Martyrs, F-38042 Grenoble, France.	wgalei@embl.fr		Weis, Felix/0000-0002-8137-3532; Galej, Wojciech/0000-0001-8859-5229; Tholen, Jonas/0000-0002-0789-2692; Razew, Michal/0000-0003-1306-4743	European Research Council (ERC) under the European Union [950278]; EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND [847543]	European Research Council (ERC) under the European Union(European Research Council (ERC)); EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 950278, awarded to W.P.G.). M.R. was supported by a fellowship from the EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND (grant agreement no. 847543).	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Carrocci TJ, 2017, NUCLEIC ACIDS RES, V45, P4837, DOI 10.1093/nar/gkw1349; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cretu C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24741-1; Cretu C, 2018, MOL CELL, V70, P265, DOI 10.1016/j.molcel.2018.03.011; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Haselbach D, 2018, CELL, V172, P454, DOI 10.1016/j.cell.2018.01.010; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Irimia M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000148; KAO CY, 2021, NUCLEIC ACIDS RES, V49, P9965, DOI DOI 10.1093/NAR/GKAB695; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Koch B, 2018, NAT PROTOC, V13, P1465, DOI 10.1038/nprot.2018.042; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Liang WW, 2015, GENE DEV, V29, P81, DOI 10.1101/gad.253708.114; Loerch S, 2019, J BIOL CHEM, V294, P2892, DOI 10.1074/jbc.RA118.006764; MACMILLAN AM, 1994, GENE DEV, V8, P3008, DOI 10.1101/gad.8.24.3008; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newnham CM, 2001, RNA, V7, P1298, DOI 10.1017/S1355838201010561; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; ODay CL, 1996, J BIOL CHEM, V271, P33261, DOI 10.1074/jbc.271.52.33261; Perriman R, 2003, P NATL ACAD SCI USA, V100, P13857, DOI 10.1073/pnas.2036312100; Perriman R, 2010, MOL CELL, V38, P416, DOI 10.1016/j.molcel.2010.02.036; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Query CC, 1997, MOL CELL BIOL, V17, P2944, DOI 10.1128/MCB.17.5.2944; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sales-Lee J, 2021, CURR BIOL, V31, P4898, DOI 10.1016/j.cub.2021.09.004; Schellenberg MJ, 2011, RNA, V17, P155, DOI 10.1261/rna.2224411; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; Smith DJ, 2009, MOL CELL, V34, P333, DOI 10.1016/j.molcel.2009.03.012; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Taggart AJ, 2017, GENOME RES, V27, P639, DOI 10.1101/gr.202820.115; Talkish J, 2019, RNA, V25, P1020, DOI 10.1261/rna.070649.119; Tang Q, 2016, GENE DEV, V30, P2710, DOI 10.1101/gad.291872.116; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Weis F, 2020, ACTA CRYSTALLOGR D, V76, P724, DOI 10.1107/S2059798320008347; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Xu YZ, 2007, MOL CELL, V28, P838, DOI 10.1016/j.molcel.2007.09.022; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Zhan XC, 2018, CELL RES, V28, P1129, DOI 10.1038/s41422-018-0094-7; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang ZW, 2021, NATURE, V596, P296, DOI 10.1038/s41586-021-03789-5; Zhang ZW, 2020, NATURE, V583, P310, DOI 10.1038/s41586-020-2344-3; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081	69	3	3	6	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					50	+	eabm4245	10.1126/science.abm4245	http://dx.doi.org/10.1126/science.abm4245			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34822310				2022-12-28	WOS:000740261400038
J	Wallace, ZS; Rodriguez, K; Dau, J; Bloch, DB; Champion, SN				Wallace, Zachary S.; Rodriguez, Karen; Dau, Jonathan; Bloch, Donald B.; Champion, Samantha N.			Case 37-2021: A 60-Year-Old Man with Fevers, Fatigue, Arthralgias, a Mouth Ulcer, and a Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DERMATOMYOSITIS	A Man with Fevers, Fatigue, Arthralgias, a Mouth Ulcer, and a Rash A 60-year-old man presented with ongoing fevers and fatigue, a tongue ulcer, dry scaly nodules on the face and hands, and migratory arthralgias in the wrists, fingers, elbows, and shoulders. CT revealed dependent reticular opacities throughout the lower lobes of the lungs. Hypoxemia developed. A diagnostic test was performed.	[Wallace, Zachary S.; Dau, Jonathan; Bloch, Donald B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Rodriguez, Karen] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Champion, Samantha N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wallace, Zachary S.; Dau, Jonathan; Bloch, Donald B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Rodriguez, Karen] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Champion, Samantha N.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wallace, ZS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Wallace, ZS (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Brisse M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01586; Concha JSS, 2018, J AM ACAD DERMATOL, V78, P769, DOI 10.1016/j.jaad.2017.10.034; Dimachkie MM, 2014, NEUROL CLIN, V32, P629, DOI 10.1016/j.ncl.2014.04.001; Feist E, 2018, NAT REV RHEUMATOL, V14, P603, DOI 10.1038/s41584-018-0081-x; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Huang K, 2019, RHEUMATOL INT, V39, P1971, DOI 10.1007/s00296-019-04398-2; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kurasawa K, 2018, RHEUMATOLOGY, V57, P2114, DOI 10.1093/rheumatology/key188; Kurtzman DJB, 2018, J AM ACAD DERMATOL, V78, P776, DOI 10.1016/j.jaad.2017.12.010; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Marco JL, 2020, BEST PRACT RES CL RH, V34, DOI 10.1016/j.berh.2020.101503; Mariette X, 2018, NEW ENGL J MED, V378, P931, DOI 10.1056/NEJMcp1702514; Moghadam-Kia S, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0798-1; Narang NS, 2015, ARTHRIT CARE RES, V67, P667, DOI 10.1002/acr.22498; Riddell V, 2020, CURR OPIN RHEUMATOL, V32, P548, DOI 10.1097/BOR.0000000000000742; Tansley SL, 2020, RHEUMATOLOGY, V59, P2109, DOI 10.1093/rheumatology/keaa021; Tsuji H, 2020, ARTHRITIS RHEUMATOL, V72, P488, DOI 10.1002/art.41105; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Vattemi G, 2014, AUTOIMMUN HIGHLIGHTS, V5, P77, DOI 10.1007/s13317-014-0062-2; Watkinson RE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005253	20	1	1	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2282	2293		10.1056/NEJMcpc2107353	http://dx.doi.org/10.1056/NEJMcpc2107353			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XL4CS	34879452				2022-12-28	WOS:000728093600018
J	Voelker, R				Voelker, Rebecca			US, Canada, and UK Collaborate on New Guidance for Machine Learning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2121	2121		10.1001/jama.2021.21554	http://dx.doi.org/10.1001/jama.2021.21554			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874436				2022-12-28	WOS:000730077500009
J	Moberly, T				Moberly, Tom			Can I give Christmas gifts to colleagues?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2021	375								n2979	10.1136/bmj.n2979	http://dx.doi.org/10.1136/bmj.n2979			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4CS	34872912	Bronze			2022-12-28	WOS:000730815000003
J	Iacobucci, G				Iacobucci, Gareth			Elective care backlog could rise to 12 million patients by 2025, warns watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Audit Office, NHS BACKL WAIT TIM, P2021	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2977	10.1136/bmj.n2977	http://dx.doi.org/10.1136/bmj.n2977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853056				2022-12-28	WOS:000726688600008
J	Jung, AS; Haldane, V; Neill, R; Tan, MMJ; Abdalla, SM; Bartos, M; Shresha, P; Chua, AQ; Nordstrom, A; Legido-Quigley, H				Jung, Anne-Sophie; Haldane, Victoria; Neill, Rachel; Tan, Melisa Mei Jin; Abdalla, Salma M.; Bartos, Michael; Shresha, Pami; Chua, Alvin Qijia; Nordstrom, Anders; Legido-Quigley, Helena			From dichotomisation towards intersectionality in addressing covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN-RIGHTS; HEALTH		[Jung, Anne-Sophie] London Sch Hyg & Trop Med, London, England; [Haldane, Victoria] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Neill, Rachel; Legido-Quigley, Helena] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tan, Melisa Mei Jin; Shresha, Pami; Chua, Alvin Qijia; Legido-Quigley, Helena] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Bartos, Michael; Nordstrom, Anders; Legido-Quigley, Helena] Independent Panel Pandem Preparedness & Response, Geneva, Switzerland; [Abdalla, Salma M.] Boston Univ, Sch Publ Hlth, Boston, MA USA	University of London; London School of Hygiene & Tropical Medicine; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University	Jung, AS (corresponding author), London Sch Hyg & Trop Med, London, England.	Jung@lshtm.ac.uk	Chua, Alvin Qijia/GQH-3027-2022	Chua, Alvin Qijia/0000-0001-6920-1204; Jung, Anne-Sophie/0000-0001-7039-7830; Neill, Rachel/0000-0002-1110-5479	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response; open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	Birchall J., 2021, RESOURCE GUIDE COVID; Buyum AM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003394; Cho S, 2013, SIGNS, V38, P785, DOI 10.1086/669608; Davies SE, 2020, INT AFF, V96, P1227, DOI 10.1093/ia/iiaa135; Davis SLM, 2020, HEALTH HUM RIGHTS, V22, P1; De Foo C, 2021, LANCET, V398, P1547, DOI 10.1016/S0140-6736(21)02186-3; Escandon K, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06357-4; Ferreri E., 2020, DUKE TODAY CAMPUS ME; Global Health Observatory, 2020, CAT IND SERV COV DAT; Hurd Elizabeth Shakman, 2017, RELIG FREEDOM NEW GL; Leach M, 2021, WORLD DEV, V138, DOI 10.1016/j.worlddev.2020.105233; Mercy Corps, 2021, CLASH CONT IMP COVID; Ntumba HCK, 2019, LANCET, V394, P2242, DOI 10.1016/S0140-6736(19)32532-2; Prasad V, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002909; Razavi A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002477; Reliefweb, 2021, RIS CHALL COVID 19 G; Sekalala S, 2020, HEALTH HUM RIGHTS, V22, P7; Smithson M., 2020, CONVERSATION; Sugiyama S., 2020, THE JAPAN TIMES; Uganda Press Photo Award (UPPA), 2021, PROGR; Wenham C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001145	21	0	0	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067500	10.1136/bmj-2021-067500	http://dx.doi.org/10.1136/bmj-2021-067500			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840132	Green Published, hybrid			2022-12-28	WOS:000740896100018
J	Horton, R				Horton, Richard			Offline:The real meaning of decolonistation	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					1950	1950						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XD7PT	34838163	Bronze			2022-12-28	WOS:000722897200008
J	Ferreira, F				Ferreira, Fernanda			Memory Speaks	SCIENCE			English	Book Review																		National Science Board,National Science Foundation, SCI ENG IND 2020 STA	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1060	1060		10.1126/science.abm6530	http://dx.doi.org/10.1126/science.abm6530			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822273				2022-12-28	WOS:000725668600023
J	Issa, R; Krzanowski, J				Issa, Rita; Krzanowski, Jacob			Finding hope in COP26 COP26 didn't extinguish all hope, but given the urgency of this crisis, the conference fell short, write Rita Issa and Jacob Krzanowski	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Issa, Rita] UCL, Lancet Migrat, London, England; [Issa, Rita] NHS, London, England; [Krzanowski, Jacob] Royal Coll Psychiatrists, Sustainabil, London, England; [Krzanowski, Jacob] Ctr Sustainable Healthcare, Oxford, England	University of London; University College London	Issa, R (corresponding author), UCL, Lancet Migrat, London, England.; Issa, R (corresponding author), NHS, London, England.			Issa, Rita/0000-0002-0051-5595				Wise J, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2734	1	0	0	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2940	10.1136/bmj.n2940	http://dx.doi.org/10.1136/bmj.n2940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836891	Bronze			2022-12-28	WOS:000727787900019
J	Khachatryan, M; Papadopoulou, A; Ashkenazi, A; Hauenstein, F; Weinstein, LB; Hen, O; Piasetzky, E				Khachatryan, M.; Papadopoulou, A.; Ashkenazi, A.; Hauenstein, F.; Weinstein, L. B.; Hen, O.; Piasetzky, E.		CLAS Collaboration; e4v Collaboration	Electron-beam energy reconstruction for neutrino oscillation measurements	NATURE			English	Article								Neutrinos exist in one of three types or 'flavours'-electron, muon and tau neutrinos-and oscillate from one flavour to another when propagating through space. This phenomena is one of the few that cannot be described using the standard model of particle physics (reviewed in ref. (1)), and so its experimental study can provide new insight into the nature of our Universe (reviewed in ref. (2)). Neutrinos oscillate as a function of their propagation distance (L) divided by their energy (E). Therefore, experiments extract oscillation parameters by measuring their energy distribution at different locations. As accelerator-based oscillation experiments cannot directly measure E, the interpretation of these experiments relies heavily on phenomenological models of neutrino-nucleus interactions to infer E. Here we exploit the similarity of electron-nucleus and neutrino-nucleus interactions, and use electron scattering data with known beam energies to test energy reconstruction methods and interaction models. We find that even in simple interactions where no pions are detected, only a small fraction of events reconstruct to the correct incident energy. More importantly, widely used interaction models reproduce the reconstructed energy distribution only qualitatively and the quality of the reproduction varies strongly with beam energy. This shows both the need and the pathway to improve current models to meet the requirements of next-generation, high-precision experiments such as Hyper-Kamiokande (Japan)(3) and DUNE (USA)(4). Electron scattering measurements are shown to reproduce only qualitatively state-of-the-art lepton-nucleus energy reconstruction models, indicating that improvements to these particle-interaction models are required to ensure the accuracy of future high-precision neutrino oscillation experiments.	[Khachatryan, M.; Hauenstein, F.; Weinstein, L. B.] Old Domin Univ, Norfolk, VA USA; [Papadopoulou, A.; Ashkenazi, A.; Hauenstein, F.; Hen, O.] MIT, Cambridge, MA USA; [Piasetzky, E.] Tel Aviv Univ, Tel Aviv, Israel	Old Dominion University; Massachusetts Institute of Technology (MIT); Tel Aviv University	Ashkenazi, A (corresponding author), MIT, Cambridge, MA USA.	adishka@mit.edu	Gardiner, Steven/AAB-7294-2022; Ireland, David/E-8618-2010; Schumacher, Reinhard/K-6455-2013	Gardiner, Steven/0000-0002-8368-5898; ATAC, HAMZA/0000-0002-8945-5305; Pybus, Jackson/0000-0001-8951-2317; Hen, Or/0000-0002-4890-6544; Ireland, David/0000-0001-7713-7011; Ehrhart, Mathieu/0000-0002-8076-9690; Schmidt, Axel/0000-0002-1109-2954; Soto, Orlando/0000-0002-8613-0310; Wood, Michael/0000-0003-2906-1678; Tyler, Nicholas/0000-0002-2633-0230; Schumacher, Reinhard/0000-0002-3860-1827				Abe K, 2020, NATURE, V580, P339, DOI 10.1038/s41586-020-2177-0; Abe K, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.171802; Abe K, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.032003; Abratenko P, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.131801; Acciarri R, 2017, J INSTRUM, V12, DOI 10.1088/1748-0221/12/02/P02017; Aliaga L, 2014, NUCL INSTRUM METH A, V743, P130, DOI 10.1016/j.nima.2013.12.053; Alvarez-Ruso L, 2018, PROG PART NUCL PHYS, V100, P1, DOI 10.1016/j.ppnp.2018.01.006; Andreopoulos C, 2010, NUCL INSTRUM METH A, V614, P87, DOI 10.1016/j.nima.2009.12.009; Ankowski AM, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.091301; Ankowski AM, 2020, PHYS REV D, V102, DOI 10.1103/PhysRevD.102.053001; DUNE Collaboration, 2018, DUNE FAR DET INT DES, V1; FUKUGITA M, 1986, PHYS LETT B, V174, P45, DOI 10.1016/0370-2693(86)91126-3; Hyper-Kamiokande Proto-Collaboration, 2018, HYP KAM DES REP; Katori T, 2018, J PHYS G NUCL PARTIC, V45, DOI 10.1088/1361-6471/aa8bf7; Lu XG, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.015503; Maan K. K., 2016, P SCI 38 INT C HIGH, V282; Mecking BA, 2003, NUCL INSTRUM METH A, V503, P513, DOI 10.1016/S0168-9002(03)01001-5; MINERA Collaboration, 2017, PHYS REV LETT, V119; MINERA Collaboration, 2018, PHYS REV LETT, V121; MINERvA collaboration, 2016, PHYS REV D, V94; Mohapatra RN, 2007, REP PROG PHYS, V70, P1757, DOI 10.1088/0034-4885/70/11/R02; NOA Collaboration, 2018, PHYS REV D, V98; Rocco N, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.192501; T2K Collaboration, 2017, 18 INT WORKSH NEUTR, P2; Tanabashi M, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.030001; The DUNE Collaboration, 2016, LONG BASELINE NEUTRI, V2; The ICARUS-WA104 Collaboration The LAr1-ND Collaboration The MicroBooNE Collaboration & additional Fermilab contributors, PROP 3 DET SHORT BAS	31	7	7	7	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					565	+		10.1038/s41586-021-04046-5	http://dx.doi.org/10.1038/s41586-021-04046-5			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819691	Green Accepted, Green Submitted			2022-12-28	WOS:000722366200013
J	Reshetnyak, AV; Rossi, P; Myasnikov, AG; Sowaileh, M; Mohanty, J; Nourse, A; Miller, DJ; Lax, I; Schlessinger, J; Kalodimos, CG				Reshetnyak, Andrey V.; Rossi, Paolo; Myasnikov, Alexander G.; Sowaileh, Munia; Mohanty, Jyotidarsini; Nourse, Amanda; Miller, Darcie J.; Lax, Irit; Schlessinger, Joseph; Kalodimos, Charalampos G.			Mechanism for the activation of the anaplastic lymphoma kinase receptor	NATURE			English	Article							TYROSINE KINASE; PROTEIN STRUCTURES; ALK KINASE; CRYO-EM; MUTATIONS; LIGANDS; LTK; ULTRACENTRIFUGATION; REFINEMENT; SOFTWARE	Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) that regulates important functions in the central nervous system(1,2). The ALK gene is a hotspot for chromosomal translocation events that result in several fusion proteins that cause a variety of human malignancies(3). Somatic and germline gain-of-function mutations in ALK were identified in paediatric neuroblastoma(4-7). ALK is composed of an extracellular region (ECR), a single transmembrane helix and an intracellular tyrosine kinase domain(8,9). ALK is activated by the binding of ALKAL1 and ALKAL2 ligands(10-14) to its ECR, but the lack of structural information for the ALK-ECR or for ALKAL ligands has limited our understanding of ALK activation. Here we used cryo-electron microscopy, nuclear magnetic resonance and X-ray crystallography to determine the atomic details of human ALK dimerization and activation by ALKAL1 and ALKAL2. Our data reveal a mechanism of RTK activation that allows dimerization by either dimeric (ALKAL2) or monomeric (ALKAL1) ligands. This mechanism is underpinned by an unusual architecture of the receptor-ligand complex. The ALK-ECR undergoes a pronounced ligand-induced rearrangement and adopts an orientation parallel to the membrane surface. This orientation is further stabilized by an interaction between the ligand and the membrane. Our findings highlight the diversity in RTK oligomerization and activation mechanisms.	[Reshetnyak, Andrey V.; Rossi, Paolo; Myasnikov, Alexander G.; Sowaileh, Munia; Nourse, Amanda; Miller, Darcie J.; Kalodimos, Charalampos G.] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Mohanty, Jyotidarsini; Lax, Irit; Schlessinger, Joseph] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	St Jude Children's Research Hospital; Yale University	Kalodimos, CG (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Schlessinger, J (corresponding author), Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	joseph.schlessinger@yale.edu; babis.kalodimos@stjude.org		Nourse, Amanda/0000-0003-4595-5321; Myasnikov, Alexander/0000-0003-2607-7121	American Lebanese Syrian Associated Charities (ALSAC); NIH [R35 GM122462]	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC) and NIH grant R35 GM122462. Cryo-EM and NMR data were acquired at the St. Jude Cryo-EM Center and Biomolecular NMR Spectroscopy Center, respectively. X-ray data were collected at SERCAT ID and BM beamlines. We thank M. Rana and R. Kalathur for their help with protein expression and purification; M. Clay for assisting with NMR graphics; I. Chen for critical reading of the manuscript; E. Folta-Stogniew for discussions of SEC-MALS data; and Z. Luo for assisting with the preparation of figures and the animation.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; CRICK FHC, 1955, NATURE, V176, P780, DOI 10.1038/176780a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diwanji D, 2019, IUBMB LIFE, V71, P706, DOI 10.1002/iub.2060; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Fadeev A, 2018, P NATL ACAD SCI USA, V115, pE630, DOI 10.1073/pnas.1719137115; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Guan JK, 2015, ELIFE, V4, DOI 10.7554/eLife.09811; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kortt AA, 1999, ANAL BIOCHEM, V273, P133, DOI 10.1006/abio.1999.4183; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li TQ, 2021, NATURE, V600, P148, DOI 10.1038/s41586-021-04141-7; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mo ES, 2017, P NATL ACAD SCI USA, V114, P12027, DOI 10.1073/pnas.1710254114; Monneau YR, 2017, J BIOMOL NMR, V69, P215, DOI 10.1007/s10858-017-0149-y; Monneau YR, 2016, J BIOMOL NMR, V65, P99, DOI 10.1007/s10858-016-0041-1; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Murray PB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005916; Myers KV, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1022-2; Orthofer M, 2020, CELL, V181, P1246, DOI 10.1016/j.cell.2020.04.034; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Reshetnyak AV, 2018, P NATL ACAD SCI USA, V115, P8340, DOI 10.1073/pnas.1807881115; Reshetnyak AV, 2015, P NATL ACAD SCI USA, V112, P15862, DOI 10.1073/pnas.1520099112; Rossi P, 2019, METHOD ENZYMOL, V614, P107, DOI 10.1016/bs.mie.2018.08.036; Rossi P, 2016, J BIOMOL NMR, V66, P259, DOI 10.1007/s10858-016-0074-5; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Tejero R, 2013, J BIOMOL NMR, V56, P337, DOI 10.1007/s10858-013-9753-7; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Warkentin E, 2017, PROTEINS, V85, P2017, DOI 10.1002/prot.25355; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Xie T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101259; Zhang HB, 2014, P NATL ACAD SCI USA, V111, P15741, DOI 10.1073/pnas.1412009111; Zhao HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142915; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	61	3	3	5	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					153	+		10.1038/s41586-021-04140-8	http://dx.doi.org/10.1038/s41586-021-04140-8		NOV 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34819673	Green Accepted			2022-12-28	WOS:000722150800004
J	Tsogoeva, SB				Tsogoeva, Svetlana B.			A Noble Quest for Simplicity in the Chiral World	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tsogoeva, Svetlana B.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Erlangen, Germany	University of Erlangen Nuremberg	Tsogoeva, SB (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Erlangen, Germany.		Tsogoeva, Svetlana/B-8490-2012	Tsogoeva, Svetlana/0000-0003-4845-0951				Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Han B, 2021, CHEM SOC REV, V50, P1522, DOI 10.1039/d0cs00196a; Ishikawa H, 2009, ANGEW CHEM INT EDIT, V48, P1304, DOI 10.1002/anie.200804883; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Murphy JJ, 2016, NATURE, V532, P218, DOI 10.1038/nature17438	7	1	1	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2021	385	27					2579	2581		10.1056/NEJMcibr2116228	http://dx.doi.org/10.1056/NEJMcibr2116228		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XW2YE	34818476				2022-12-28	WOS:000721972000001
J	Abbasi, K; Dobson, J				Abbasi, Kamran; Dobson, Juliet			The world must act now to be prepared for future health emergencies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								An upcoming special session of the World Health Assembly, taking place from 29 November to 1 December 2021, will discuss the benefits of developing a new global agreement on pandemic preparedness and response. It offers a historic opportunity to protect current and future generations from health crises.											0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2879	10.1136/bmj.n2879	http://dx.doi.org/10.1136/bmj.n2879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815233	Bronze			2022-12-28	WOS:000722577100005
J	Davies, R				Davies, Rachael			Helen Milroy: pioneer in Indigenous and child mental health	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1866	1866						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801096				2022-12-28	WOS:000720912600014
J	Black, M				Black, Mary			The day a car bomb missed me	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2859	10.1136/bmj.n2859	http://dx.doi.org/10.1136/bmj.n2859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799352	Bronze			2022-12-28	WOS:000723212300004
J	Oh, HJ; Aguilar, R; Kesner, B; Lee, HG; Kriz, AJ; Chu, HP; Lee, JT				Oh, Hyun Jung; Aguilar, Rodrigo; Kesner, Barry; Lee, Hun-Goo; Kriz, Andrea J.; Chu, Hsueh-Ping; Lee, Jeannie T.			Jpx RNA regulates CTCF anchor site selection and formation of chromosome loops	CELL			English	Article							LONG NONCODING RNA; X-INACTIVATION; INSULATOR PROTEIN; SEQ EXPERIMENTS; BINDING-SITES; 3D GENOME; DNA; MAPS; TRANSCRIPTION; REGION	Chromosome loops shift dynamically during development, homeostasis, and disease. CCCTC-binding factor (CTCF) is known to anchor loops and construct 3D genomes, but how anchor sites are selected is not yet understood. Here, we unveil Jpx RNA as a determinant of anchor selectivity. Jpx RNA targets thousands of genomic sites, preferentially binding promoters of active genes. Depleting Jpx RNA causes ectopic CTCF binding, massive shifts in chromosome looping, and downregulation of >700 Jpx target genes. Without Jpx, thousands of lost loops are replaced by de novo loops anchored by ectopic CTCF sites. Although Jpx controls CTCF binding on a genome-wide basis, it acts selectively at the subset of developmentally sensitive CTCF sites. Specifically, Jpx targets low-affinity CTCF motifs and displaces CTCF protein through competitive inhibition. We conclude that Jpx acts as a CTCF release factor and shapes the 3D genome by regulating anchor site usage.	[Oh, Hyun Jung; Aguilar, Rodrigo; Kesner, Barry; Lee, Hun-Goo; Kriz, Andrea J.; Chu, Hsueh-Ping; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Oh, Hyun Jung; Aguilar, Rodrigo; Kesner, Barry; Lee, Hun-Goo; Kriz, Andrea J.; Chu, Hsueh-Ping; Lee, Jeannie T.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Aguilar, Rodrigo] Univ Andres Bello, Inst Biomed Sci ICB, Santiago, Chile; [Chu, Hsueh-Ping] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universidad Andres Bello; National Taiwan University	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Lee, JT (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu		Aguilar, Rodrigo/0000-0003-0410-5478; Chu, Hsueh-Ping Catherine/0000-0002-0281-0942; Kriz, Andrea/0000-0002-3395-4498	National Research Foundation of Korea (NRF); NIH [R37-GM58839]; Howard Hughes Medical Institute	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank R. Blum for help with bioinformatic analyses, Y. Jeon for experimental advice, and all lab members for support and stimulating discussions. This work was supported by the National Research Foundation of Korea (NRF) (to H.J.O.), NIH (R37-GM58839 to J.T.L.), and Howard Hughes Medical Institute (to J.T.L.).	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Ambrosini G, 2018, BIOINFORMATICS, V34, P2483, DOI 10.1093/bioinformatics/bty127; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BERKOWER I, 1973, J BIOL CHEM, V248, P5914; Carmona S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007378; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chillon I, 2015, METHOD ENZYMOL, V558, P3, DOI 10.1016/bs.mie.2015.01.008; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; da Rocha ST, 2017, NAT STRUCT MOL BIOL, V24, P197, DOI 10.1038/nsmb.3370; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Del Rosario BC, 2019, ELIFE, V8, DOI 10.7554/eLife.42341; Disteche CM, 2016, SEMIN CELL DEV BIOL, V56, P9, DOI 10.1016/j.semcdb.2016.04.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Greenwald WW, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1621-0; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hansen AS, 2019, MOL CELL, V76, P395, DOI 10.1016/j.molcel.2019.07.039; Hansen AS, 2018, NUCLEUS-PHILA, V9, P20, DOI 10.1080/19491034.2017.1389365; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holmgren C, 2001, CURR BIOL, V11, P1128, DOI 10.1016/S0960-9822(01)00314-1; Jegu T, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.17; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Karner H, 2020, J MOL BIOL, V432, P283, DOI 10.1016/j.jmb.2019.09.002; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Klenova EM, 2001, MOL CELL BIOL, V21, P2221, DOI 10.1128/MCB.21.6.2221-2234.2001; Kriz AJ, 2021, MOL CELL, V81, P1970, DOI 10.1016/j.molcel.2021.02.031; Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Li Y, 2020, NATURE, V578, P472, DOI 10.1038/s41586-019-1910-z; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Mirny LA, 2019, CURR OPIN CELL BIOL, V58, P142, DOI 10.1016/j.ceb.2019.05.001; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Naumova N, 2012, METHODS, V58, P192, DOI 10.1016/j.ymeth.2012.07.022; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Plasschaert RN, 2014, NUCLEIC ACIDS RES, V42, P774, DOI 10.1093/nar/gkt910; Pugacheva EM, 2020, P NATL ACAD SCI USA, V117, P2020, DOI 10.1073/pnas.1911708117; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Saldana-Meyer R, 2019, MOL CELL, V76, P412, DOI 10.1016/j.molcel.2019.08.015; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Bemmel JG, 2019, NAT GENET, V51, P1024, DOI 10.1038/s41588-019-0412-0; Wang CY, 2018, CELL, V174, P406, DOI 10.1016/j.cell.2018.05.007; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yang F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0618-0; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	97	10	10	6	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6157	+		10.1016/j.cell.2021.11.012	http://dx.doi.org/10.1016/j.cell.2021.11.012		DEC 2021	42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FF	34856126	Green Accepted, Bronze			2022-12-28	WOS:000730753900002
J	Freund, Y; Chauvin, A; Jimenez, S; Philippon, AL; Curac, S; Femy, F; Gorlicki, J; Chouihed, T; Goulet, H; Montassier, E; Dumont, M; Polo, LL; Le Borgne, P; Khellaf, M; Bouzid, D; Raynal, PA; Abdessaied, N; Laribi, S; Guenezan, J; Ganansia, O; Bloom, B; Miro, O; Cachanado, M; Simon, T				Freund, Yonathan; Chauvin, Anthony; Jimenez, Sonia; Philippon, Anne-Laure; Curac, Sonja; Femy, Florent; Gorlicki, Judith; Chouihed, Tahar; Goulet, Helene; Montassier, Emmanuel; Dumont, Margaux; Polo, Laura Lozano; Le Borgne, Pierrick; Khellaf, Mehdi; Bouzid, Donia; Raynal, Pierre-Alexis; Abdessaied, Nizar; Laribi, Said; Guenezan, Jeremy; Ganansia, Olivier; Bloom, Ben; Miro, Oscar; Cachanado, Marine; Simon, Tabassome			Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RULE-OUT CRITERIA; MULTICENTER; MANAGEMENT; NONINFERIORITY; PROBABILITY; CT	IMPORTANCE Uncontrolled studies suggest that pulmonary embolism (PE) can be safely ruled out using the YEARS rule, a diagnostic strategy that uses varying D-dimer thresholds. OBJECTIVE To prospectively validate the safety of a strategy that combines the YEARS rule with the pulmonary embolism rule-out criteria (PERC) rule and an age-adjusted D-dimer threshold. DESIGN, SETTINGS, AND PARTICIPANTS A cluster-randomized, crossover, noninferiority trial in 18 emergency departments (EDs) in France and Spain. Patients (N = 1414) who had a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE were included from October 2019 to June 2020, and followed up until October 2020. INTERVENTIONS Each center was randomized for the sequence of intervention periods. In the intervention period (726 patients), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years x 10 in patients >= 50 years). In the control period (688 patients), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold. MAIN OUTCOMES AND MEASURES The primary end point was venous thromboembolism (VTE) at 3 months. The noninferiority margin was set at 1.35%. There were 8 secondary end points, including chest imaging, ED length of stay, hospital admission. nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months. RESULTS Of the 1414 included patients (mean age, 55 years; 58% female), 1217 (86%) were analyzed in the per-protocol analysis. PE was diagnosed in the ED in 100 patients (7.1%). At 3 months, VTE was diagnosed in 1 patient in the intervention group (0.15% [95% CI, 0.0% to 0.86%]) vs 5 patients in the control group (0.80% [95% CI, 0.26% to 1.86%]) (adjusted difference, -0.64% [1-sided 97.5% CI, -infinity to 0.21%), within the noninferiority margin). Of the 6 analyzed secondary end points, only 2 showed a statistically significant difference in the intervention group compared with the control group: chest imaging (30.4% vs 40.0%; adjusted difference, -8.7% [95% CI, -13.8% to -3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, -1.6 hours [95% CI, -2.3 to -0.9]). CONCLUSIONS AND RELEVANCE Among ED patients with suspected PE, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients, compared with a conventional diagnostic strategy, did not result in an inferior rate of thromboembolic events.	[Freund, Yonathan; Philippon, Anne-Laure; Simon, Tabassome] Sorbonne Univ, Improving Emergency Care FHU, Paris, France; [Freund, Yonathan; Philippon, Anne-Laure; Dumont, Margaux] Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Chauvin, Anthony; Miro, Oscar] Hop Lariboisiere, AP HP, Emergency Dept, Paris, France; [Jimenez, Sonia] Univ Barcelona, Hosp Clin, Emergency Dept, IDIBAPS, Barcelona, Catalonia, Spain; [Curac, Sonja] Hop Beaujon, AP HP, Emergency Dept, Clichy, France; [Femy, Florent] Paris Univ, Emergency Dept, Hop Europeen Georges Pompidou, AP HP, Paris, France; [Femy, Florent] French Armed Forces Biomed Inst, Toxicol & Chem Risks Dept, Bretigny Sur Orges, France; [Gorlicki, Judith] Hop Avicenne, AP HP, Emergency Dept, INSERM U942 MASCOT, Bobigny, France; [Chouihed, Tahar] Univ Lorraine, Univ Hosp Nancy, Emergency Dept, UMR S 1116, Nancy, France; [Goulet, Helene] Hop Tenon, AP HP, Emergency Dept, Paris, France; [Montassier, Emmanuel] CHU Nantes, Emergency Dept, Nantes, France; [Polo, Laura Lozano] Univ Autonoma Barcelona, Emergency Dept, Hosp Santa Creu & St Pau, Barcelona, Catalonia, Spain; [Le Borgne, Pierrick] Hop Univ Strasbourg, Emergency Dept, Strasbourg, France; [Khellaf, Mehdi] CHU Henri Mondor, AP HP, INSERM, Emergency Dept,U955, Paris, France; [Bouzid, Donia] Univ Paris, IAME, INSERM, F-75006 Paris, France; [Bouzid, Donia] Bichat Claude Bernard Univ Hosp, AP HP, Emergency Dept, Paris, France; [Raynal, Pierre-Alexis] Hop St Antoine, AP HP, Emergency Dept, Paris, France; [Abdessaied, Nizar] Ctr Hosp St Denis, Emergency Dept, St Denis, Reunion, France; [Laribi, Said] Tours Univ, Tours Univ Hosp, Emergency Med Dept, Tours, France; [Guenezan, Jeremy] Univ Hosp Poitiers, Emergency Dept, Poitiers, France; [Ganansia, Olivier] Grp Hosp Paris St Joseph, Emergency Dept, Paris, France; [Bloom, Ben] Emergency Dept, Barts Hlth NHS Trust, London, England; [Cachanado, Marine; Simon, Tabassome] Sorbonne Univ, Dept Clin Pharmacol, St Antoine Hosp, AP HP, Paris, France; [Cachanado, Marine; Simon, Tabassome] Sorbonne Univ, Clin Res Platform Paris East URCEST CRC CRB, St Antoine Hosp, AP HP, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; CHU de Nancy; Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CHU Poitiers; Universite de Poitiers; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Barts Health NHS Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Freund, Y (corresponding author), Serv Accueil Urgences, 47-83 Bd Hop, F-75013 Paris, France.	yonathan.freund@aphp.fr	Lozano Polo, Laura/G-6067-2016; Polo, Laura Lozano/AAU-8497-2020; Bouzid, Donia/AAC-9054-2022	Lozano Polo, Laura/0000-0003-1787-0830; Polo, Laura Lozano/0000-0003-1787-0830; Bouzid, Donia/0000-0002-7538-3320	French Health Ministry (Programme Hospitalier de Recherche Clinique 2017); Assistance Publique-Hopitaux de Paris	French Health Ministry (Programme Hospitalier de Recherche Clinique 2017); Assistance Publique-Hopitaux de Paris	This research was funded by a grant from the French Health Ministry (Programme Hospitalier de Recherche Clinique 2017). The sponsor was the Assistance Publique-Hopitaux de Paris.	Alkhatip AAAMM, 2020, CRIT CARE MED, V48, P704, DOI 10.1097/CCM.0000000000004271; Bariteau A, 2018, ACAD EMERG MED, V25, P828, DOI 10.1111/acem.13399; Behringer W, 2021, EUR J EMERG MED, V28, P165, DOI 10.1097/MEJ.0000000000000830; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Donner A, 2004, BIOMETRICS, V60, P919, DOI 10.1111/j.0006-341X.2004.00247.x; Dronkers CEA, 2017, J THROMB HAEMOST, V15, P1040, DOI 10.1111/jth.13654; Freund Y, 2021, J THROMB HAEMOST, V19, P1832, DOI 10.1111/jth.15353; Freund Y, 2020, JAMA-J AM MED ASSOC, V324, P1948, DOI 10.1001/jama.2020.19378; Freund Y, 2018, JAMA INTERN MED, V178, P812, DOI 10.1001/jamainternmed.2018.0607; Freund Y, 2018, JAMA-J AM MED ASSOC, V319, P559, DOI 10.1001/jama.2017.21904; Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Mauri L, 2017, NEW ENGL J MED, V377, P1357, DOI 10.1056/NEJMra1510063; Penaloza A, 2017, LANCET HAEMATOL, V4, pE615, DOI 10.1016/S2352-3026(17)30210-7; Penaloza A, 2013, ANN EMERG MED, V62, P117, DOI 10.1016/j.annemergmed.2012.11.002; Pernod G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169268; Philippon AL, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04379-y; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Prins MH, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-13; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Raynal PA, 2019, EUR J EMERG MED, V26, P458, DOI 10.1097/MEJ.0000000000000625; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Stein PD, 2012, CLIN APPL THROMB-HEM, V18, P20, DOI 10.1177/1076029611422363; Tritschler T, 2020, J THROMB HAEMOST, V18, P1495, DOI 10.1111/jth.14769; van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1; van der Pol LM, 2018, J THROMB HAEMOST, V16, P725, DOI 10.1111/jth.13972; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178	30	16	19	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2141	2149		10.1001/jama.2021.20750	http://dx.doi.org/10.1001/jama.2021.20750			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874418	Bronze, Green Published			2022-12-28	WOS:000730077500017
J	McCartney, G; Douglas, M; Taulbut, M; Katikireddi, SV; McKee, M				McCartney, Gerry; Douglas, Margaret; Taulbut, Martin; Katikireddi, S. Vittal; McKee, Martin			Tackling population health challenges as we build back from the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ECONOMY; IMPACT		[McCartney, Gerry] Univ Glasgow, Coll Social Sci, Glasgow, Lanark, Scotland; [Douglas, Margaret] Univ Edinburgh, Coll Med & Vet Med, Usher Inst, Edinburgh, Midlothian, Scotland; [McCartney, Gerry; Douglas, Margaret; Taulbut, Martin; Katikireddi, S. Vittal] Publ Hlth Scotland, Glasgow, Lanark, Scotland; [Katikireddi, S. Vittal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England	University of Glasgow; University of Edinburgh; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; London School of Hygiene & Tropical Medicine	McCartney, G (corresponding author), Univ Glasgow, Coll Social Sci, Glasgow, Lanark, Scotland.; McCartney, G (corresponding author), Publ Hlth Scotland, Glasgow, Lanark, Scotland.	Gerard.McCartney@glasgow.ac.uk		Douglas, Margaret/0000-0003-1560-5451; Katikireddi, Srinivasa/0000-0001-6593-9092; McCartney, Gerry/0000-0001-6341-3521	NRS senior clinical fellowship [SCAF/15/02]; Medical Research Council [MC_UU_00022/2]; Scottish Government Chief Scientist Office [SPHSU17]	NRS senior clinical fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Government Chief Scientist Office	SVK acknowledges funding from a NRS senior clinical fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and Scottish Government Chief Scientist Office (SPHSU17).	[Anonymous], 2010, WHO ADELAIDE STATEME; [Anonymous], 2006, SECURING GOOD CARE O; [Anonymous], 2021, COVID 19 WID IMP HLT; Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Burnett D, 2020, PROTECTING HLTH WORK; Calvert J, FAILURES STATE INSID, P2021; Cameron EE., 2019, GLOBAL HLTH SECURITY; Chrysopoulou A, 2021, FAILURE DEMAND COUNT; Commission on Race and Ethnic Disparities, REPORT, P2021; Cooper K, 2021, CONSERVATIVE GOVERNM; Di Gessa G, MEDRXIV2021202104012, V2021; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Fenton L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029936; Glei DA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226732; Green F., 2018, WORK INTENSITY BRITA; Green L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189468; Hiam L, 2020, BRIT MED BULL, V133, P4, DOI 10.1093/bmb/ldz041; House of Commons Committee of Public Accounts, 2021, TEST TRAC UPD; Intergovernmental Panel on Climate Change, 2021, SYNTH REP 6 ASS REP; Islam N, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066768; Joyce R, 2013, OXFORD REV ECON POL, V29, P178, DOI 10.1093/oxrep/grt008; Katikireddi SV, 2021, J ROY COLL PHYS EDIN, V51, pS40, DOI 10.4997/JRCPE.2021.240; Marmot M., 2020, PANDEMIC SOCIOECONOM; McCartney Gerry, 2020, Public Health Pract (Oxf), V1, P100003, DOI 10.1016/j.puhip.2020.100003; McCartney G, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2019.305001; Mercer SW, 2021, LANCET, V397, P775, DOI 10.1016/S0140-6736(21)00317-2; Minton J, 2020, J EPIDEMIOL COMMUN H, V74, P741, DOI 10.1136/jech-2020-213870; ONS, INT COMP GDP COR COV, P2021; Parolin Z, 2021, POTENTIAL POVERTY RE; Rajan S, 2020, J LONG TERM CARE, P185, DOI [10.31389/jltc.53, DOI 10.31389/JLTC.53]; Scottish Government, 2011, CHRIST COMM FUT DEL; Sheikh A, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010370; Shipton D, 2021, J EPIDEMIOL COMMUN H, V75, P1129, DOI 10.1136/jech-2020-216070; Smith LE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n608; Suleman M., 2021, UNEQUAL PANDEMIC FAI; Teuton J, 2020, RAPID REV EVIDENCE S; UK Health and Social Care, 2021, SCI TECHN COMM COR L; Walsh D, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038135; Wellbeing Economy Alliance, 2021, WELLB EC GOV	40	12	12	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								e066232	10.1136/bmj-2021-066232	http://dx.doi.org/10.1136/bmj-2021-066232			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP4DA	34876411	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000730815800011
J	Cilloniz, C; Torres, A; Niederman, MS				Cilloniz, Catia; Torres, Antoni; Niederman, Michael S.			Management of pneumonia in critically ill patients	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES-SOCIETY; DRUG-RESISTANT PATHOGENS; COMBINATION ANTIBIOTIC-THERAPY; SUBGLOTTIC SECRETION DRAINAGE; CARE-UNIT ADMISSION; RECEIVING MECHANICAL VENTILATION; C-REACTIVE PROTEIN; INTENSIVE-CARE	Severe pneumonia is associated with high mortality (short and long term), as well as pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of adequate antimicrobial treatment for severe pneumonia are crucial in improving survival among critically ill patients. Identifying the underlying causative pathogen is also critical for antimicrobial stewardship. However, establishing an etiological diagnosis is challenging in most patients, especially in those with chronic underlying disease; those who received previous antibiotic treatment; and those treated with mechanical ventilation. Furthermore, as antimicrobial therapy must be empiric, national and international guidelines recommend initial antimicrobial treatment according to the location's epidemiology; for patients admitted to the intensive care unit, specific recommendations on disease management are available. Adherence to pneumonia guidelines is associated with better outcomes in severe pneumonia. Yet, the continuing and necessary research on severe pneumonia is expansive, inviting different perspectives on host immunological responses, assessment of illness severity, microbial causes, risk factors for multidrug resistant pathogens, diagnostic tests, and therapeutic options.	[Cilloniz, Catia; Torres, Antoni] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain; [Cilloniz, Catia; Torres, Antoni] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Cilloniz, Catia; Torres, Antoni] Univ Barcelona, Barcelona, Spain; [Cilloniz, Catia; Torres, Antoni] Biomed Res Networking Centers Resp Dis CIBERES, Barcelona, Spain; [Niederman, Michael S.] Weill Cornell Med Coll, Dept Pulm Crit Care Med, New York, NY 10065 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Cornell University	Niederman, MS (corresponding author), Weill Cornell Med Coll, Dept Pulm Crit Care Med, New York, NY 10065 USA.	msn9004@med.cornell.edu	Cillóniz, Catia/Y-1898-2018	cilloniz, catia/0000-0002-4646-9838				Aarts MAW, 2008, CRIT CARE MED, V36, P108, DOI 10.1097/01.CCM.0000297956.27474.9D; Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Abelenda-Alonso G, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa066; Aguilera ER, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00105; Akagi T, 2019, AM J MED SCI, V358, P33, DOI 10.1016/j.amjms.2019.04.005; Aldas I, 2020, ARCH BRONCONEUMOL, V56, P551, DOI 10.1016/j.arbres.2019.10.009; Aliberti S, 2014, CURR OPIN INFECT DIS, V27, P295, DOI [10.1097/QCO.0000000000000060, 10.1097/QCO.0000000000000055]; Aliberti S, 2013, THORAX, V68, P997, DOI 10.1136/thoraxjnl-2013-203384; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; Alimi Y, 2017, J CLIN VIROL, V95, P26, DOI 10.1016/j.jcv.2017.07.019; Almeida ST, 2021, J INFECT DIS, V223, P1590, DOI 10.1093/infdis/jiaa558; Lerma FA, 2014, MED INTENSIVA, V38, P226, DOI 10.1016/j.medin.2013.12.007; Alvarez-Lerma F, 2018, CRIT CARE MED, V46, P181, DOI 10.1097/CCM.0000000000002736; Anderson R, 2007, J ANTIMICROB CHEMOTH, V60, P1155, DOI 10.1093/jac/dkm338; Anderson R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041147; Annane D, 2018, NEW ENGL J MED, V378, P809, DOI 10.1056/NEJMoa1705716; [Anonymous], 2017, HEALTHCARE ASS INFEC; Antoni Torres CC, 2015, CLIN MANAGEMENT BACT, DOI [10.1007/978-3- 319-22062-8, DOI 10.1007/978-3-319-22062-8]; Arthur LE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004267.pub4; Baby N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02432-16, 10.1128/aac.02432-16]; Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Bassetti M, 2021, LANCET INFECT DIS, V21, P226, DOI 10.1016/S1473-3099(20)30796-9; Bassetti M, 2018, CURR OPIN CRIT CARE, V24, P385, DOI 10.1097/MCC.0000000000000534; Bassi GL, 2017, INTENS CARE MED, V43, P1572, DOI 10.1007/s00134-017-4858-1; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bein T, 2018, CURR OPIN CRIT CARE, V24, P35, DOI 10.1097/MCC.0000000000000476; Beno SM, 2020, J INFECT DIS, V222, P1882, DOI 10.1093/infdis/jiaa295; Bermejo-Martin JF, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110400; Bermejo-Martin JF, 2017, LANCET RESP MED, V5, pE35, DOI 10.1016/S2213-2600(17)30444-7; Bermejo-Martin JF, 2017, EBIOMEDICINE, V24, P231, DOI 10.1016/j.ebiom.2017.09.023; Bhalodi AA, 2019, J ANTIMICROB CHEMOTH, V74, P6, DOI 10.1093/jac/dky530; Black AD, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0002-1; Blackburn R, 2018, CLIN INFECT DIS, V67, P8, DOI 10.1093/cid/cix1144; Blot S, 2014, CRIT CARE MED, V42, P601, DOI 10.1097/01.ccm.0000435665.07446.50; Bonneau E, 2019, EJIFCC, V30, P114; Bouza E, 2008, CHEST, V134, P938, DOI 10.1378/chest.08-0103; Briel M, 2018, CLIN INFECT DIS, V66, P346, DOI 10.1093/cid/cix801; Brown AO, 2015, AM J RESP CRIT CARE, V191, P739, DOI 10.1164/rccm.201411-1951PP; Brown SM, 2009, CRIT CARE MED, V37, P3010, DOI 10.1097/CCM.0b013e3181b030d9; Buelow E, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0309-z; Burja S, 2018, BOSNIAN J BASIC MED, V18, P105, DOI 10.17305/bjbms.2017.2278; Burk M, 2016, EUR RESPIR REV, V25, P178, DOI 10.1183/16000617.0076-2015; Burns KEA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004127.pub3; Burrell A, 2018, NEW ENGL J MED, V378, P2138, DOI 10.1056/NEJMc1717178; Cao B, 2016, CRIT CARE MED, V44, pE318, DOI 10.1097/CCM.0000000000001616; Caroff DA, 2016, CRIT CARE MED, V44, P830, DOI 10.1097/CCM.0000000000001414; Cavallazzi R, 2020, CHEST, V158, P1008, DOI 10.1016/j.chest.2020.03.051; Cavallazzi R, 2018, CLIN CHEST MED, V39, P703, DOI 10.1016/j.ccm.2018.07.005; Ceccato A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060843; Cerceo E, 2016, MICROB DRUG RESIST, V22, P412, DOI 10.1089/mdr.2015.0220; Chalmers JD, 2008, AM J MED, V121, P219, DOI 10.1016/j.amjmed.2007.10.033; Chalmers JD, 2011, CLIN INFECT DIS, V53, P503, DOI 10.1093/cid/cir463; Chamot E, 2003, ANTIMICROB AGENTS CH, V47, P2756, DOI 10.1128/AAC.47.9.2756-2764.2003; Chastre J, 2016, INTENS CARE MED, V42, P1159, DOI 10.1007/s00134-016-4239-1; Chen JL, 2021, J MED MICROBIOL, V70, DOI 10.1099/jmm.0.001259; Chen YX, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1351-0; Chiewchalermsri C, 2020, J ASTHMA ALLERGY, V13, P127, DOI 10.2147/JAA.S207980; Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Cilloniz C, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00773-2020; Cilloniz C, 2019, CURR OPIN INFECT DIS, V32, P656, DOI 10.1097/QCO.0000000000000596; Cilloniz C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070961; Cilloniz C, 2019, J INFECT DIS, V220, P1166, DOI 10.1093/infdis/jiz257; Cilloniz C, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020049; Cilloniz C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02215-2017; Cilloniz C, 2016, EXPERT REV RESP MED, V10, P1211, DOI 10.1080/17476348.2016.1240037; Cilloniz C, 2016, RESPIROLOGY, V21, P65, DOI 10.1111/resp.12663; Cilloniz C, 2013, CHEST, V144, P999, DOI 10.1378/chest.13-0062; Ciofu O, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00913; Claessens YE, 2015, AM J RESP CRIT CARE, V192, P974, DOI 10.1164/rccm.201501-0017OC; Colombo SM, 2020, INTENS CARE MED, V46, P368, DOI 10.1007/s00134-019-05882-w; Corrales-Medina VF, 2015, AM HEART J, V170, P306, DOI 10.1016/j.ahj.2015.04.028; Corrales-Medina VF, 2013, LANCET, V381, P496, DOI 10.1016/S0140-6736(12)61266-5; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Danin PE, 2015, RESP CARE, V60, P21, DOI 10.4187/respcare.02722; De Gonzalo-Calvo D, 2021, TRANSL RES, V236, P147, DOI 10.1016/j.trsl.2021.05.004; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de la Torre MC, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000152; de la Torre MC, 2016, J CRIT CARE, V35, P115, DOI 10.1016/j.jcrc.2016.05.005; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Deschepper M, 2018, INTENS CARE MED, V44, P1017, DOI 10.1007/s00134-018-5171-3; Dezfulian C, 2005, AM J MED, V118, P11, DOI 10.1016/j.amjmed.2004.07.051; Ding CY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2566-7; Souza LCD, 2017, BRAZ ORAL RES, V31, DOI [10.1590/1807-3107bor-2017.vol31.0038, 10.1590/1807-3107BOR-2017.vol31.0038]; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Drewett GP, 2022, INFECT CONT HOSP EP, V43, P542, DOI 10.1017/ice.2021.28; Dudeck MA, 2015, AM J INFECT CONTROL, V43, P206, DOI 10.1016/j.ajic.2014.11.014; Esperatti M, 2013, CRIT CARE MED, V41, P2151, DOI 10.1097/CCM.0b013e31828a674a; Eurich DT, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j413; Ewig S, 2019, CLIN MICROBIOL INFEC, V25, P1173, DOI 10.1016/j.cmi.2019.02.022; Feldman C, 1999, EUR RESPIR J, V13, P546, DOI 10.1183/09031936.99.13354699; Feldman C, 2021, PNEUMONIA, V13, DOI 10.1186/s41479-021-00083-w; Fernandez-Barat L, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2523-5; Fernandez-Barat L, 2016, FUTURE MICROBIOL, V11, P1599, DOI 10.2217/fmb-2016-0040; Fernando SM, 2020, INTENS CARE MED, V46, P1170, DOI 10.1007/s00134-020-06036-z; Ferreira-Coimbra J, 2020, EUR J CLIN MICROBIOL, V39, P281, DOI 10.1007/s10096-019-03720-x; Flannery AH, 2020, CRIT CARE MED, V48, P912, DOI 10.1097/CCM.0000000000004326; Forel JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11312; Frank RC, 2019, NEW ENGL J MED, V380, DOI 10.1056/NEJMc1901647; Franquet T, 2018, J THORAC IMAG, V33, P282, DOI 10.1097/RTI.0000000000000347; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Frost SA, 2013, AUST CRIT CARE, V26, P180, DOI 10.1016/j.aucc.2013.03.003; Fukuyama H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-534; Garnacho-Montero J, 2007, CRIT CARE MED, V35, P1888, DOI 10.1097/01.CCM.0000275389.31974.22; Gilbert DN, 2017, INFECT DIS CLIN N AM, V31, P435, DOI 10.1016/j.idc.2017.05.003; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Giuliano KK, 2018, AM J INFECT CONTROL, V46, P322, DOI 10.1016/j.ajic.2017.09.005; Han J, 2020, CLIN MED, V20, pE47, DOI 10.7861/clinmed.Let.20.3.3; Hao JJ, 2016, INT J ANTIMICROB AG, V47, P28, DOI 10.1016/j.ijantimicag.2015.10.019; He HY, 2020, SEMIN RESP CRIT CARE, V41, P470, DOI 10.1055/s-0040-1709992; Herkel T, 2016, BIOMED PAP, V160, P448, DOI 10.5507/bp.2016.014; Heyland DK, 2008, CRIT CARE MED, V36, P737, DOI 10.1097/01.CCM.0B013E31816203D6; Hirata K, 2002, VET HUM TOXICOL, V44, P89; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hua Fang, 2016, Cochrane Database Syst Rev, V10, pCD008367; Huang XA, 2018, MEDICINE, V97, DOI [10.1097/md.0000000000011223, 10.1097/MD.0000000000011223]; Ibn Saied W, 2019, CRIT CARE MED, V47, P345, DOI 10.1097/CCM.0000000000003553; Iizuka Y, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1764-4; Ishida T, 2017, J INFECT CHEMOTHER, V23, P23, DOI 10.1016/j.jiac.2016.09.002; Ito A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54922-4; Ito A, 2017, J INFECT CHEMOTHER, V23, P142, DOI 10.1016/j.jiac.2016.11.006; Jaillette E, 2017, INTENS CARE MED, V43, P1562, DOI 10.1007/s00134-017-4736-x; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Julian-Jimenez A, 2017, MED CLIN-BARCELONA, V148, P501, DOI 10.1016/j.medcli.2017.02.024; Justel M, 2013, J CLIN VIROL, V58, P564, DOI 10.1016/j.jcv.2013.09.006; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Karhu J, 2014, CLIN INFECT DIS, V59, P62, DOI 10.1093/cid/ciu237; Kelly BJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0151-8; Keramat F, 2018, INT J GEN MED, V11, P217, DOI 10.2147/IJGM.S165190; Khan F, 2017, EXPERT REV CLIN PHAR, V10, P201, DOI 10.1080/17512433.2017.1268051; Kim MW, 2017, SCAND J CLIN LAB INV, V77, P486, DOI 10.1080/00365513.2017.1344298; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2017, SEMIN RESP CRIT CARE, V38, P381, DOI 10.1055/s-0037-1602584; Klompas M, 2016, JAMA INTERN MED, V176, P1277, DOI 10.1001/jamainternmed.2016.2427; Klompas M, 2015, AM J RESP CRIT CARE, V192, P1420, DOI 10.1164/rccm.201506-1161CI; Klompas M, 2014, JAMA INTERN MED, V174, P751, DOI 10.1001/jamainternmed.2014.359; Kobayashi D, 2018, INFECT DRUG RESIST, V11, P1703, DOI 10.2147/IDR.S165669; Kolditz M, 2016, INTENS CARE MED, V42, P2108, DOI 10.1007/s00134-016-4517-y; Kollef MH, 2019, LANCET INFECT DIS, V19, P1299, DOI 10.1016/S1473-3099(19)30403-7; Kollef MH, 2017, CHEST, V151, P1239, DOI 10.1016/j.chest.2016.11.026; Kontou P, 2009, AM J EMERG MED, V27, P968, DOI 10.1016/j.ajem.2008.07.037; Ekren PK, 2018, AM J RESP CRIT CARE, V197, P826, DOI 10.1164/rccm.201708-1717LE; Krein SL, 2017, CLIN INFECT DIS, V64, pS105, DOI 10.1093/cid/cix073; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kumar A, 2010, CRIT CARE MED, V38, P1651, DOI 10.1097/CCM.0b013e3181e96b91; Kuypers J, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01890-18; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Kyriazopoulou E, 2021, INFECT DIS THER, V10, P1437, DOI 10.1007/s40121-021-00459-x; La Combe B, 2018, INTENS CARE MED, V44, P531, DOI 10.1007/s00134-018-5061-8; Labeau SO, 2011, LANCET INFECT DIS, V11, P845, DOI 10.1016/S1473-3099(11)70127-X; Lan SH, 2020, J GLOB ANTIMICROB RE, V23, P94, DOI 10.1016/j.jgar.2020.08.005; Laporte L, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0430-6; Laursen CB., 2013, SCAND J TRAUMA RESUS, V21, pA21, DOI [DOI 10.1186/1757-7241-21-S2-A21, 10.1186/1757 -7241 -21 -S2 -A21]; Legramante JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187702; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P83, DOI 10.1016/j.accpm.2017.11.006; Liapikou A, 2009, CLIN INFECT DIS, V48, P377, DOI 10.1086/596307; Liu YT, 2017, FRONT MED-PRC, V11, P239, DOI 10.1007/s11684-017-0509-8; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3977, DOI 10.1128/AAC.00006-07; Long L, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005713; Luo QZ, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1943-y; Maertens B, 2018, CRIT CARE MED, V46, P316, DOI 10.1097/CCM.0000000000002889; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mao Z, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1527-7; Martin-Loeches I, 2010, INTENS CARE MED, V36, P612, DOI 10.1007/s00134-009-1730-y; Martin-Loeches I, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03219-4; Martinez JA, 2010, ANTIMICROB AGENTS CH, V54, P3590, DOI 10.1128/AAC.00115-10; Maruyama T, 2019, CLIN INFECT DIS, V68, P1080, DOI 10.1093/cid/ciy631; McCluskey SM, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw238; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Mendez R, 2018, AM J RESP CRIT CARE, V198, P370, DOI 10.1164/rccm.201709-1908OC; Menendez R, 2008, THORAX, V63, P447, DOI 10.1136/thx.2007.086785; Menendez R, 2019, CHEST, V156, P1080, DOI 10.1016/j.chest.2019.06.040; Metersky ML, 2016, JAMA-J AM MED ASSOC, V316, P2427, DOI 10.1001/jama.2016.16226; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Micek ST, 2016, CHEST, V150, P1008, DOI 10.1016/j.chest.2016.04.009; Micek ST, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0926-5; Micek ST, 2010, ANTIMICROB AGENTS CH, V54, P1742, DOI 10.1128/AAC.01365-09; Monro-Somerville T, 2017, CRIT CARE MED, V45, pE449, DOI 10.1097/CCM.0000000000002091; Moreno G, 2018, INTENS CARE MED, V44, P1470, DOI 10.1007/s00134-018-5332-4; Muller M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188913; Muscedere J, 2011, CRIT CARE MED, V39, P1985, DOI 10.1097/CCM.0b013e318218a4d9; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497; Musuuza JS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251170; Naghavi M, 2003, CIRCULATION, V107, P762, DOI 10.1161/01.CIR.0000048190.68071.2B; National Institutes of Health, INF COV 19 TREATM PR; Niederman MS, 2020, LANCET INFECT DIS, V20, P330, DOI 10.1016/S1473-3099(19)30574-2; Niederman MS, 2012, INTENS CARE MED, V38, P263, DOI 10.1007/s00134-011-2420-0; Odedra KM, 2014, POSTGRAD MED J, V90, P709, DOI 10.1136/postgradmedj-2013-132291; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Paonessa JR, 2019, CHEST, V155, P999, DOI 10.1016/j.chest.2019.02.007; Park SC, 2013, INT J TUBERC LUNG D, V17, P704, DOI 10.5588/ijtld.12.0723; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Philippart F, 2015, AM J RESP CRIT CARE, V191, P637, DOI 10.1164/rccm.201408-1398OC; Phua J, 2010, EUR RESPIR J, V36, P826, DOI 10.1183/09031936.00154209; Phua J, 2009, THORAX, V64, P598, DOI 10.1136/thx.2009.113795; Pileggi C, 2018, CRIT CARE MED, V46, P1167, DOI 10.1097/CCM.0000000000003136; Piralla A, 2017, J CLIN VIROL, V92, P48, DOI 10.1016/j.jcv.2017.05.004; Plantinga NL, 2018, CLIN MICROBIOL INFEC, V24, P505, DOI 10.1016/j.cmi.2017.08.019; Plantinga NL, 2016, INTENS CARE MED, V42, P620, DOI 10.1007/s00134-016-4217-7; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Postma DF, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3630-7; Pozuelo-Carrascosa DP, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0107-2019; Price R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2197; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Prina E, 2015, ANN AM THORAC SOC, V12, P153, DOI 10.1513/AnnalsATS.201407-305OC; Ranzani OT, 2017, AM J RESP CRIT CARE, V196, P1287, DOI [10.1164/rccm.201611-2262OC, 10.1164/rccm.201611-2262oc]; Renaud B, 2009, CRIT CARE MED, V37, P2867, DOI 10.1097/CCM.0b013e3181b02dbb; Restrepo MI, 2016, SEMIN RESP CRIT CARE, V37, P897, DOI 10.1055/s-0036-1593754; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Righy C, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0291-4; Rodrigo C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub2; Roquilly A, 2019, LANCET RESP MED, V7, P710, DOI 10.1016/S2213-2600(19)30140-7; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Saito M, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000024906; Sangla F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243762; Schuetz P, 2018, LANCET INFECT DIS, V18, P95, DOI [10.1016/s1473-3099(17)30592-3, 10.1016/S1473-3099(17)30592-3]; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Self WH, 2017, CLIN INFECT DIS, V65, P183, DOI 10.1093/cid/cix317; Sellers SA, 2017, INFLUENZA OTHER RESP, V11, P372, DOI 10.1111/irv.12470; Sharma A, 2019, J ALLERGY CLIN IMMUN, V144, P1214, DOI 10.1016/j.jaci.2019.06.025; Shenoy AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204032; Shi SJ, 2017, CLIN RESPIR J, V11, P352, DOI 10.1111/crj.12346; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shorr AF, 2008, ARCH INTERN MED, V168, P2205, DOI 10.1001/archinte.168.20.2205; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Siddiqui A.H., 2021, METHICILLIN RESISTAN; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sligl WI, 2014, CRIT CARE MED, V42, P420, DOI 10.1097/CCM.0b013e3182a66b9b; Sommerstein R, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0530-6; Soraluce A, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12010054; Spoorenberg SMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190575; Staub LJ, 2021, J INTENSIVE CARE MED, V36, P304, DOI 10.1177/0885066619894279; Stokker J, 2020, INTENS CARE MED, V46, P546, DOI 10.1007/s00134-019-05914-5; Su KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182252; Sweeney DA, 2019, CLIN MICROBIOL INFEC, V25, P1195, DOI 10.1016/j.cmi.2019.04.018; Tagami T, 2015, J INFECTION, V71, P158, DOI 10.1016/j.jinf.2015.04.003; Talbot GH, 2019, J INFECT DIS, V219, P1536, DOI 10.1093/infdis/jiy578; Tansarli GS, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.00635-18, 10.1128/AAC.00635-18]; Taubert M, 2016, ANTIMICROB AGENTS CH, V60, P5254, DOI 10.1128/AAC.00356-16; Thorarinsdottir HR, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03092-1; Titov Ivan, 2021, Clin Infect Dis, V73, pe4539, DOI 10.1093/cid/ciaa803; Tokioka F, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0307-7; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; Torres A, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz149; Torres A, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00259-0; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Torres A, 2016, EUR RESPIR J, V48, P1764, DOI 10.1183/13993003.01144-2016; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Tralhao A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020414; Valles J, 2016, MED INTENSIVA, V40, P238, DOI [10.1016/j.medin.2015.07.005, 10.1016/j.medine.2016.04.004]; Vardakas KZ, 2009, EUR RESPIR J, V34, P1148, DOI 10.1183/09031936.00041009; Vaschetto R, 2019, INTENS CARE MED, V45, P62, DOI 10.1007/s00134-018-5478-0; Vaughn VM, 2019, BMJ QUAL SAF, V28, P74, DOI 10.1136/bmjqs-2017-007573; Venkatesh B, 2018, NEW ENGL J MED, V378, P797, DOI 10.1056/NEJMoa1705835; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; Vincent JL, 2020, JAMA-J AM MED ASSOC, V323, P1478, DOI 10.1001/jama.2020.2717; Violi F, 2017, CLIN INFECT DIS, V64, P1486, DOI 10.1093/cid/cix164; Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812; Wang L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009946.pub2; Wang Z, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1085-z; Waterer Grant W, 2005, Curr Opin Infect Dis, V18, P157, DOI 10.1097/01.qco.0000160906.02308.3c; Watkins Richard R, 2019, F1000Res, V8, DOI 10.12688/f1000research.16517.2; Webb BJ, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00057-2019; Welte T, 2018, INTENS CARE MED, V44, P438, DOI 10.1007/s00134-018-5143-7; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wilden JJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115486; Wittekamp BH, 2018, JAMA-J AM MED ASSOC, V320, P2087, DOI 10.1001/jama.2018.13765; Woo TE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42862-y; Woodhead M, 2006, CRIT CARE, V10, DOI 10.1186/cc4927; Woolever Nathan L, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P550, DOI 10.1016/j.mayocpiqo.2020.05.002; Wu BG, 2018, CLIN CHEST MED, V39, P677, DOI 10.1016/j.ccm.2018.07.003; Wunderink RG, 2021, LANCET INFECT DIS, V21, P213, DOI 10.1016/S1473-3099(20)30731-3; Wunderink RG, 2018, INFECT DIS THER, V7, P439, DOI 10.1007/s40121-018-0214-1; Xie F, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06039-1; Zakharkina T, 2017, THORAX, V72, P803, DOI 10.1136/thoraxjnl-2016-209158; Zand F, 2017, J CRIT CARE, V40, P318, DOI 10.1016/j.jcrc.2017.02.029; Zhao TT, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub4; Zhou F, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02406-2018; Zhou HJ, 2020, EMERG MED INT, V2020, DOI 10.1155/2020/7979353; Zhou HJ, 2018, AM J EMERG MED, V36, P2155, DOI 10.1016/j.ajem.2018.03.050	286	4	4	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2021	375								e065871	10.1136/bmj-2021-065871	http://dx.doi.org/10.1136/bmj-2021-065871			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4CS	34872910	Bronze			2022-12-28	WOS:000730815000007
J	Lurie, P; Sharfstein, JM				Lurie, Peter; Sharfstein, Joshua M.			Product Approval and Public Health at the US Food and Drug Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lurie, Peter] Ctr Sci Publ Interest, Washington, DC USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St,W1033F, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St,W1033F, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu						[Anonymous], 2017, FDA REQ REM OP ER RI; Food and Drug Administration, BEN RISK ASS NEW DRU; Food and Drug Administration, 209 GFI FOOD DRUG AD; Gottlieb S, 2017, JAMA-J AM MED ASSOC, V318, P421, DOI 10.1001/jama.2017.9205; National Academies of Sciences Engineering and Medicine, 2017, PAIN MAN OP EP BAL S; Zettler PJ, 2018, FOOD DRUG LAW J, V73, P221	6	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2021	326	24					2469	2470		10.1001/jama.2021.22354	http://dx.doi.org/10.1001/jama.2021.22354		DEC 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC6FM	34870690				2022-12-28	WOS:000728824100001
J	Knudsen, J; Chokshi, DA				Knudsen, Janine; Chokshi, Dave A.			Covid-19 and the Safety Net - Moving from Straining to Sustaining	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Covid-19 and the Safety Net As we enter a new stage of pandemic response and recovery - in which we must address issues of racial health inequities, frontline health care infrastructure, and community preparedness - what constitutes adequate support for the U.S. health care safety net?	[Knudsen, Janine; Chokshi, Dave A.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Knudsen, Janine; Chokshi, Dave A.] NYU, Grossman Sch Med, New York, NY 10003 USA; [Knudsen, Janine] New York City Hlth & Hosp, New York, NY 11203 USA	New York City Department of Health & Mental Hygiene; New York University	Knudsen, J (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.; Knudsen, J (corresponding author), NYU, Grossman Sch Med, New York, NY 10003 USA.; Knudsen, J (corresponding author), New York City Hlth & Hosp, New York, NY 11203 USA.							Altman S, 2000, AM HLTH CARE SAFETY; Cerise FP., 2021, NEJM CATALYST INNOVA, V2, DOI [10.1056/CAT.20.0580, DOI 10.1056/CAT.20.0580]; Pollack HA, 2021, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20210401.95800/full/, DOI 10.1377/HBLOG20210401.95800/FULL]; Rosenbaum S, 2021, NEW ENGL J MED, V384, P2361, DOI 10.1056/NEJMp2107222; Toleos A., 2021, LOWN I 0711	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2209	2211		10.1056/NEJMp2114010	http://dx.doi.org/10.1056/NEJMp2114010		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XL4CS	34874629	Bronze			2022-12-28	WOS:000726232200001
J	Fernandes, B; Navin, MC; Reiss, DR; Omer, SB; Attwell, K				Fernandes, Breanna; Navin, Mark Christopher; Reiss, Dorit Rubinstein; Omer, Saad B.; Attwell, Katie			US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study assesses state-level legal interventions to promote or impede COVID-19 vaccine mandates in the US since the beginning of the pandemic.	[Fernandes, Breanna; Attwell, Katie] Univ Western Australia, Perth, WA, Australia; [Navin, Mark Christopher] Oakland Univ, Rochester, MI 48063 USA; [Reiss, Dorit Rubinstein] Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94143 USA; [Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT USA	University of Western Australia; Oakland University; University of California System; University of California San Francisco	Fernandes, B (corresponding author), Univ Western Australia, 35 Stirling Hwy, Crawley, WA 6009, Australia.	22981317@student.uwa.edu.au	Attwell, Kathryn Louise/D-4346-2018	Attwell, Kathryn Louise/0000-0002-0366-2160				[Anonymous], 2021, PATH OUT PANDEMIC PR; Delamater PL, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3301; Omer SB, 2019, NATURE, V571, P469, DOI 10.1038/d41586-019-02232-0; Omer SB, 2014, JAMA-J AM MED ASSOC, V311, P620, DOI 10.1001/jama.2013.282869; Stephenson Joan, 2021, JAMA Health Forum, V2, pe210874, DOI 10.1001/jamahealthforum.2021.0874	5	3	3	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					178	179		10.1001/jama.2021.22122	http://dx.doi.org/10.1001/jama.2021.22122		DEC 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	34854872	Bronze, Green Published			2022-12-28	WOS:000725722000001
J	Tang, JL; Li, LM				Tang, Jin-Ling; Li, Li-Ming			Importance of public health tools in emerging infectious diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tang, Jin-Ling] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Tang, Jin-Ling] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Li-Ming] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Peking University	Tang, JL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.; Tang, JL (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China.	jltang@cuhk.edu.hk						Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chou R, 2020, ANN INTERN MED, V173, P542, DOI 10.7326/M20-3213; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; El-Hayek G, 2017, JACC-CARDIOVASC INTE, V10, P462, DOI 10.1016/j.jcin.2016.12.002; Gaudino M, 2020, JAMA INTERN MED, V180, P1638, DOI 10.1001/jamainternmed.2020.4748; Guo W, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25568; Hatoun J, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-006460; Holloway K, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l640; Kuitunen I, 2020, PEDIATR INFECT DIS J, V39, pE423, DOI 10.1097/INF.0000000000002845; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lin CF, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.604089; Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1898; McKeown T., 1979, MED HIST, DOI DOI 10.1515/9781400854622; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Patel R, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22050; Ramirez PT, 2018, NEW ENGL J MED, V379, P1895, DOI 10.1056/NEJMoa1806395; Saquib N, 2015, INT J EPIDEMIOL, V44, P264, DOI 10.1093/ije/dyu140; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Wieseler B, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4340; World Health Organization, 2020, PRESS C WHO CHIN JOI; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhang RN, 2021, CHINA CDC WEEKLY, V3, P159, DOI 10.46234/ccdcw2021.020; Zhou SC, 2020, AM J ROENTGENOL, V214, P1287, DOI 10.2214/AJR.20.22975	25	5	5	8	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2374	10.1136/bmj.n2374	http://dx.doi.org/10.1136/bmj.n2374			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853003	Green Published, hybrid			2022-12-28	WOS:000732779300009
J	Dyer, C				Dyer, Clare			Covid-19: Government was "grossly negligent" in its handling of pandemic, says people's inquiry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		People's Covid Inquiry, 2021, MISC PUBL OFF WHY DI	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2955	10.1136/bmj.n2955	http://dx.doi.org/10.1136/bmj.n2955			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853055	Bronze			2022-12-28	WOS:000726688600004
J	Mahase, E				Mahase, Elisabeth			Covid-19: Poorly controlled asthma increases risk of hospital admission among children sixfold, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															UK Research and Innovation; Research and Innovation Industrial Strategy Challenge Fund; Health Data Research UK; Scottish government	UK Research and Innovation(UK Research & Innovation (UKRI)); Research and Innovation Industrial Strategy Challenge Fund; Health Data Research UK; Scottish government	The study was funded by UK Research and Innovation, the Research and Innovation Industrial Strategy Challenge Fund, Health Data Research UK, and the Scottish government.	Shi T, 2022, LANCET RESP MED, V10, P191, DOI 10.1016/S2213-2600(21)00491-4	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2529	10.1136/bmj.n2959	http://dx.doi.org/10.1136/bmj.n2959			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853067	Bronze			2022-12-28	WOS:000726688600005
J	Boos, WR; Pascale, S				Boos, William R.; Pascale, Salvatore			Mechanical forcing of the North American monsoon by orography	NATURE			English	Article							MARITIME TROPICAL AIR; HORIZONTAL RESOLUTION; STATIONARY WAVES; PRECIPITATION; MODEL; IMPACT; GULF; VARIABILITY; MAINTENANCE; HEMISPHERE	A band of intense rainfall extends more than 1,000 km along Mexico's west coast during Northern Hemisphere summer, constituting the core of the North American monsoon(1,2). As in other tropical monsoons, this rainfall maximum is commonly thought to be thermally forced by emission of heat from land and elevated terrain into the overlying atmosphere(3-5), but a clear understanding of the fundamental mechanism governing this monsoon is lacking. Here we show that the core North American monsoon is generated when Mexico's Sierra Madre mountains deflect the extratropical jet stream towards the Equator, mechanically forcing eastward, upslope flow that lifts warm and moist air to produce convective rainfall. These findings are based on analyses of dynamic and thermodynamic structures in observations, global climate model integrations and adiabatic stationary wave solutions. Land surface heat fluxes do precondition the atmosphere for convection, particularly in summer afternoons, but these heat fluxes alone are insufficient for producing the observed rainfall maximum. Our results indicate that the core North American monsoon should be understood as convectively enhanced orographic rainfall in a mechanically forced stationary wave, not as a classic, thermally forced tropical monsoon. This has implications for the response of the North American monsoon to past and future global climate change, making trends in jet stream interactions with orography of central importance. The core North American monsoon arises through topographic steering of the jet stream, and should be considered as convection-enhanced orographic rainfall produced by a mechanically forced stationary wave.	[Boos, William R.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA USA; [Boos, William R.] Lawrence Berkeley Natl Lab, Climate & Ecosyst Sci Div, Berkeley, CA USA; [Pascale, Salvatore] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Pascale, Salvatore] Bologna Business Sch, Ctr Sustainabil & Climate Change, Bologna, Italy	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Bologna	Boos, WR (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA USA.; Boos, WR (corresponding author), Lawrence Berkeley Natl Lab, Climate & Ecosyst Sci Div, Berkeley, CA USA.	billboos@alum.mit.edu	; Boos, William/C-6467-2014	Pascale, Salvatore/0000-0002-6762-3283; Boos, William/0000-0001-9076-3551				Adams DK, 1997, B AM METEOROL SOC, V78, P2197, DOI 10.1175/1520-0477(1997)078<2197:TNAM>2.0.CO;2; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], CRU TS400 CLIM RES U, DOI [10.5072/edf8febfdaad48abb2cbaf7d7-846a86, DOI 10.5072/EDF8FEBFDAAD48ABB2CBAF7D7-846A86]; Barlow M, 1998, J CLIMATE, V11, P2238, DOI 10.1175/1520-0442(1998)011<2238:EOTNAM>2.0.CO;2; Berbery EH, 2001, J CLIMATE, V14, P121, DOI 10.1175/1520-0442(2001)013<0121:MMAOTN>2.0.CO;2; BRENNER IS, 1974, MON WEATHER REV, V102, P375, DOI 10.1175/1520-0493(1974)102<0375:ASOMTA>2.0.CO;2; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; Bryson R.A., 1955, B AM METEOROL SOC, V36, P329, DOI [10.1175/1520-0477-36.7.329, DOI 10.1175/1520-0477-36.7.329]; Cabral-Cano E, 2018, SEISMOL RES LETT, V89, P373, DOI 10.1785/0220170190; Collier JC, 2007, J CLIMATE, V20, P1843, DOI 10.1175/JCLI4099.1; DOUGLAS MW, 1993, J CLIMATE, V6, P1665, DOI 10.1175/1520-0442(1993)006<1665:TMM>2.0.CO;2; Finch ZO, 2010, MON WEATHER REV, V138, P3540, DOI 10.1175/2010MWR3369.1; Geil KL, 2013, J CLIMATE, V26, P8787, DOI 10.1175/JCLI-D-13-00044.1; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1002/qj.49710644905; Global Modeling and Assimilation Office, MERRA 2 TAVGM 2D SLV, DOI [10.5067/AP1B0BA5PD2K, DOI 10.5067/AP1B0BA5PD2K]; HALES JE, 1972, MON WEATHER REV, V100, P298, DOI 10.1175/1520-0493(1972)100<0298:SOMTAN>2.3.CO;2; Harris I, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0453-3; Heald, 2010, TECHNICAL DESCRIPTIO; Held IM, 2002, J CLIMATE, V15, P2125, DOI 10.1175/1520-0442(2002)015<2125:NWSWTA>2.0.CO;2; Hersbach H., 2019, **DATA OBJECT**, DOI 10.24381/cds.f17050d7; Hersbach H, 2020, Q J ROY METEOR SOC, V146, P1999, DOI 10.1002/qj.3803; Higgins RW, 1999, J CLIMATE, V12, P653, DOI 10.1175/1520-0442(1999)012<0653:IVOTNA>2.0.CO;2; HOSKINS BJ, 1995, J ATMOS SCI, V52, P1329, DOI 10.1175/1520-0469(1995)052<1329:AMOTAS>2.0.CO;2; Hu SN, 2017, J ATMOS SCI, V74, P2949, DOI 10.1175/JAS-D-16-0312.1; Huffman G., 2019, GODDARD EARTH SCI DA, DOI [DOI 10.5067/GPM/IMERGDF/DAY/06, 10.5067/GPM/IMERGDF/DAY/06]; Johnson RH, 2007, J CLIMATE, V20, P1628, DOI 10.1175/JCLI4087.1; KRISHNAMURTI TN, 1971, J ATMOS SCI, V28, P1342, DOI 10.1175/1520-0469(1971)028<1342:TEWCDT>2.0.CO;2; Liang XZ, 2008, J CLIMATE, V21, P4424, DOI 10.1175/2008JCLI2174.1; Mechoso C. R., 2005, TROPICAL METEOROLOGY, V1266, P197, DOI [10.7916/D8ST803T, DOI 10.7916/D8ST803T]; Mo KC, 2005, J CLIMATE, V18, P3910, DOI 10.1175/JCLI3513.1; Neale R. B., 2012, NCAR TECHNICAL NOTES, P214, DOI [10.5065/D6N877R0, DOI 10.5065/D6N877R0]; Nesbitt SW, 2008, J HYDROMETEOROL, V9, P728, DOI 10.1175/2008JHM939.1; Nie J, 2010, J CLIMATE, V23, P4416, DOI 10.1175/2010JCLI3505.1; NOAA National Geophysical Data Center, ETOPO1 1 ARC MIN GLO; Pascale S, 2017, NAT CLIM CHANGE, V7, P806, DOI 10.1038/NCLIMATE3412; Pascale S, 2016, J CLIMATE, V29, P7911, DOI 10.1175/JCLI-D-16-0199.1; Perez-Ruiz ER, 2021, J GEOPHYS RES-BIOGEO, V126, DOI 10.1029/2020JG005809; Prive NC, 2007, J ATMOS SCI, V64, P1431, DOI 10.1175/JAS3917.1; Rodwell MJ, 1996, Q J ROY METEOR SOC, V122, P1385, DOI 10.1002/qj.49712253408; Rodwell MJ, 2001, J CLIMATE, V14, P3192, DOI 10.1175/1520-0442(2001)014<3192:SAASM>2.0.CO;2; Schmitz JT, 1996, J CLIMATE, V9, P1621, DOI 10.1175/1520-0442(1996)009<1621:WVTAWT>2.0.CO;2; Schneider U., 2011, GPCC FULL DATA REANA, DOI [10.5676/DWD_GPCC/FD_M_V7_050, DOI 10.5676/DWD_GPCC/FD_M_V7_050]; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Serra YL, 2016, B AM METEOROL SOC, V97, P2103, DOI 10.1175/BAMS-D-14-00250.1; Simpson IR, 2016, NAT CLIM CHANGE, V6, P65, DOI [10.1038/NCLIMATE2783, 10.1038/nclimate2783]; Simpson IR, 2015, J CLIMATE, V28, P1977, DOI 10.1175/JCLI-D-14-00298.1; Sobel AH, 2000, J CLIMATE, V13, P4378, DOI 10.1175/1520-0442(2000)013<4378:MTPIAS>2.0.CO;2; STENSRUD DJ, 1995, J CLIMATE, V8, P1775, DOI 10.1175/1520-0442(1995)008<1775:MCOTMM>2.0.CO;2; TANG MC, 1984, MON WEATHER REV, V112, P617, DOI 10.1175/1520-0493(1984)112<0617:PMOTNH>2.0.CO;2; Ting MF, 1998, J ATMOS SCI, V55, P3565, DOI 10.1175/1520-0469(1998)055<3565:SRTTHI>2.0.CO;2; Ting MF, 2006, J ATMOS SCI, V63, P1056, DOI 10.1175/JAS3664.1; TING MF, 1990, J ATMOS SCI, V47, P2546, DOI 10.1175/1520-0469(1990)047<2546:TSWRTA>2.0.CO;2; TING MF, 1994, J ATMOS SCI, V51, P3286, DOI 10.1175/1520-0469(1994)051<3286:MONSSW>2.0.CO;2; Turrent C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036299; Varuolo-Clarke AM, 2019, J CLIMATE, V32, P8355, DOI 10.1175/JCLI-D-18-0567.1; Vera C, 2006, J CLIMATE, V19, P4977, DOI 10.1175/JCLI3896.1; Wehner M, 2015, J CLIMATE, V28, P3905, DOI 10.1175/JCLI-D-14-00311.1; Wehner MF, 2018, EARTH SYST DYNAM, V9, P187, DOI 10.5194/esd-9-187-2018; WEXLER H, 1961, TELLUS, V13, P368, DOI 10.1111/j.2153-3490.1961.tb00098.x	61	3	3	4	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					611	+		10.1038/s41586-021-03978-2	http://dx.doi.org/10.1038/s41586-021-03978-2			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819681	Green Submitted			2022-12-28	WOS:000722366200021
J	Schnell, A; Huang, LL; Singer, M; Singaraju, A; Barilla, RM; Regan, BML; Bollhagen, A; Thakore, PI; Dionne, D; Delorey, TM; Pawlak, M; zu Horste, GM; Rozenblatt-Rosen, O; Irizarry, RA; Regev, A; Kuchroo, VK				Schnell, Alexandra; Huang, Linglin; Singer, Meromit; Singaraju, Anvita; Barilla, Rocky M.; Regan, Brianna M. L.; Bollhagen, Alina; Thakore, Pratiksha, I; Dionne, Danielle; Delorey, Toni M.; Pawlak, Mathias; zu Horste, Gerd Meyer; Rozenblatt-Rosen, Orit; Irizarry, Rafael A.; Regev, Aviv; Kuchroo, Vijay K.			Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity	CELL			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; T(H)17 CELLS; GUT MICROBIOTA; RNA-SEQ; INDUCTION; PLASTICITY; DRIVES; GENERATION; POPULATION; SIGNATURE	While intestinal Th17 cells are critical for maintaining tissue homeostasis, recent studies have implicated their roles in the development of extra-intestinal autoimmune diseases including multiple sclerosis. However, the mechanisms by which tissue Th17 cells mediate these dichotomous functions remain unknown. Here, we characterized the heterogeneity, plasticity, and migratory phenotypes of tissue Th17 cells in vivo by combined fate mapping with profiling of the transcriptomes and TCR clonotypes of over 84,000 Th17 cells at homeostasis and during CNS autoimmune inflammation. Inter- and intra-organ single-cell analyses revealed a homeostatic, stem-like TCF1(+) IL-17(+) SLAMF6(+) population that traffics to the intestine where it is maintained by the microbiota, providing a ready reservoir for the IL-23-driven generation of encephalitogenic GM-CSF+ IFN-gamma(+) CXCR6(+) T cells. Our study defines a direct in vivo relationship between IL-17(+) non-pathogenic and GM-CSF+ and IFN-gamma(+) pathogenic Th17 populations and provides a mechanism by which homeostatic intestinal Th17 cells direct extra-intestinal autoimmune disease.	[Schnell, Alexandra; Singaraju, Anvita; Barilla, Rocky M.; Regan, Brianna M. L.; Bollhagen, Alina; Pawlak, Mathias; zu Horste, Gerd Meyer; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Schnell, Alexandra; Singaraju, Anvita; Barilla, Rocky M.; Regan, Brianna M. L.; Bollhagen, Alina; Pawlak, Mathias; zu Horste, Gerd Meyer; Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Schnell, Alexandra; Singer, Meromit; Thakore, Pratiksha, I; Dionne, Danielle; Delorey, Toni M.; Pawlak, Mathias; Rozenblatt-Rosen, Orit; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Huang, Linglin; Singer, Meromit; Irizarry, Rafael A.] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02215 USA; [Huang, Linglin; Irizarry, Rafael A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Singer, Meromit] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA; [Bollhagen, Alina] DKFZ, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Singer, Meromit] Guardant Hlth, 505 Penobscot Dr, Redwood City, CA 94063 USA; [Thakore, Pratiksha, I; Rozenblatt-Rosen, Orit; Regev, Aviv] Genentech Inc, 1 DNA Way, San Francisco, CA 94025 USA; [zu Horste, Gerd Meyer] Univ Hosp Munster, Med Fac, Dept Neurol Inst Translat Neurol, D-48149 Munster, Germany	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Roche Holding; Genentech; University of Munster	Kuchroo, VK (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Regev, A; Kuchroo, VK (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94025 USA.	aviv.regev.sc@gmail.com; vkuchroo@evergrande.hms.harvard.edu	Thakore, Pratiksha I./HDM-5197-2022; Horste, Gerd Meyer zu/O-9549-2016; Rozenblatt-Rosen, Orit/HDN-4182-2022	Horste, Gerd Meyer zu/0000-0002-4341-4719; Delorey, Toni/0000-0001-6614-3803; Barilla, Rocky/0000-0002-8062-7246; Singaraju, Anvita/0000-0002-3109-6354; Schnell, Alexandra/0000-0003-3442-7750	National Institute of Health [R01NS045937, R01NS30843, R01AI144166, P01AI073748, P01AI039671, P01AI056299, P01 AI39671, R01HG005220]; Howard Hughes Medical Institute; Klarman Cell Observatory; German Academic Scholarship Foundation (Studienstiftung des Deutschen Volkes) PhD fellowship; Deutsche Forschungsgemeinschaft (DFG) [ME4050/1-1, ME4050/4-1]; National Multiple Sclerosis Society postdoctoral fellowship [FG20118-A-1]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; German Academic Scholarship Foundation (Studienstiftung des Deutschen Volkes) PhD fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Multiple Sclerosis Society postdoctoral fellowship(National Multiple Sclerosis Society)	We would like to thank all members of the Kuchroo laboratory for feedback. We thank Junrong Xia, Helene Stroh, Rajesh Kumar Krishnan, and Deneen Kozoriz for technical support and Leslie Gaffney for help with figures. Furthermore, we would like to thank Mary Collins for critical feedback on the manuscript and the Quintana laboratory for technical support for the photoconversion experiments. This work was supported by National Institute of Health grants (R01NS045937, R01NS30843, R01AI144166, P01AI073748, P01AI039671, and P01AI056299) to V.K.K. and by the Howard Hughes Medical Institute and Klarman Cell Observatory (A.R.). A.R. was an Investigator of the Howard Hughes Medical Institute when this study was conducted. A. Schnell is supported by a German Academic Scholarship Foundation (Studienstiftung des Deutschen Volkes) PhD fellowship. This manuscript was supported in part by a grant from the National Institute of Health grant P01 AI39671 (to V.K.K. and M.S.). G.M.z.H. was supported by the Deutsche Forschungsgemeinschaft (DFG; grants ME4050/1-1 and ME4050/4-1) and a National Multiple Sclerosis Society postdoctoral fellowship (grant FG20118-A-1). R.A.I. was supported by National Institute of Health grant R01HG005220.	Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Bradley CP, 2017, CELL HOST MICROBE, V22, P697, DOI 10.1016/j.chom.2017.10.007; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cosorich I, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700492; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Delaney C, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20199005; Downs-Canner S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14649; Escobar G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb9726; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Gaublomme JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10756-2; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hemmers S, 2019, J EXP MED, V216, P2466, DOI 10.1084/jem.20190993; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang H, 2020, NAT BIOTECHNOL, V38, P1194, DOI 10.1038/s41587-020-0505-4; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Hwang SS, 2020, SCIENCE, V367, P1255, DOI 10.1126/science.aax0194; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kim D., 2016, **DATA OBJECT**, DOI 10.5281/zenodo.211733; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Krebs CF, 2016, IMMUNITY, V45, P1078, DOI 10.1016/j.immuni.2016.10.020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGinley AM, 2020, IMMUNITY, V52, P342, DOI 10.1016/j.immuni.2020.01.002; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miyauchi E, 2020, NATURE, V585, P102, DOI 10.1038/s41586-020-2634-9; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pratama A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190428; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rasouli J, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba9953; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenblum MD, 2015, J CLIN INVEST, V125, P2228, DOI 10.1172/JCI78088; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schafflick D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14118-w; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schnell A, 2020, CELL RES, V30, P285, DOI 10.1038/s41422-020-0277-x; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Soneson C, 2018, NAT METHODS, V15, P255, DOI [10.1038/nmeth.4612, 10.1038/NMETH.4612]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tom MR, 2016, INFLAMM BOWEL DIS, V22, P1596, DOI 10.1097/MIB.0000000000000848; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Wagner A, 2021, CELL, V184, P4168, DOI 10.1016/j.cell.2021.05.045; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhang HY, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108433; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	98	24	24	27	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2021	184	26					6281	+		10.1016/j.cell.2021.11.018	http://dx.doi.org/10.1016/j.cell.2021.11.018		DEC 2021	42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YN0WG	34875227				2022-12-28	WOS:000746987200002
J	Hayashi, Y				Hayashi, Yoshimasa			Tokyo Nutrition for Growth Summit 2021: an opportunity to accelerate the efforts towards achieving the SDGs	LANCET			English	Editorial Material							CONSEQUENCES		[Hayashi, Yoshimasa] Govt Japan, Minist Foreign Affairs Japan, Minister Foreign Affairs, Tokyo 1008919, Japan		Hayashi, Y (corresponding author), Govt Japan, Minist Foreign Affairs Japan, Minister Foreign Affairs, Tokyo 1008919, Japan.	satoshi.ezoe@mofa.go.jp						Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Food and Agriculture Organization, 2020, The state of food security and nutrition in the world 2020: transforming food systems for affordable healthy diets, DOI 10.4060/ca9692en; Grosso G, 2020, EUR J PUBLIC HEALTH, V30, P19, DOI 10.1093/eurpub/ckaa034; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Independent Group of Scientists appointed by the Secretary-General, 2019, GLOBAL SUSTAINABLE D; Ministry of Health Labour and Welfare of Japan, 2021, NUTR POL JAP LEAV NO; Osendarp S, 2021, NAT FOOD, V2, P476, DOI 10.1038/s43016-021-00319-4; Tsuboyama-Kasaoka N, 2014, ASIA PAC J CLIN NUTR, V23, P505, DOI 10.6133/apjcn.2014.23.4.23; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization,, 2015, OB OV	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2021	398	10317					2128	2130		10.1016/S0140-6736(21)02748-3	http://dx.doi.org/10.1016/S0140-6736(21)02748-3		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XN4HM	34863370				2022-12-28	WOS:000729467800020
J	Kumbhare, D				Kumbhare, Dinesh			In rotator cuff disorder, progressive exercise vs. physiotherapy advice, with or without corticosteroid injection, did not differ at 12 mo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kumbhare, Dinesh] Univ Toronto, Toronto, ON, Canada	University of Toronto	Kumbhare, D (corresponding author), Univ Toronto, Toronto, ON, Canada.							Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Page MJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012224	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC137	JC137		10.7326/ACPJ202112210-137	http://dx.doi.org/10.7326/ACPJ202112210-137		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871052				2022-12-28	WOS:000729198100001
J	Dyer, C				Dyer, Clare			Show jumper wins case against mother's GP for "wrongful conception" that resulted in her disability	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, EWHC 3234; Dyer C, BMJ-BRIT MED J, V2021, P375	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n2999	10.1136/bmj.n2999	http://dx.doi.org/10.1136/bmj.n2999			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862168				2022-12-28	WOS:000729712200015
J	Berlin, I; Berlin, N; Malecot, M; Breton, M; Jusot, F; Goldzahl, L				Berlin, Ivan; Berlin, Noemi; Malecot, Marie; Breton, Martine; Jusot, Florence; Goldzahl, Leontine			Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VOUCHER-BASED INCENTIVES; CONTINGENCY MANAGEMENT; CIGARETTE-SMOKING; ABSTINENCE	OBJECTIVE To evaluate the efficacy of financial incentives dependent on continuous smoking abstinence on smoking cessation and birth outcomes among pregnant smokers. DESIGN Single blind, randomised controlled trial. SETTING Financial Incentive for Smoking Cessation in Pregnancy (FISCP) trial in 18 maternity wards in France. PARTICIPANTS 460 pregnant smokers aged at least 18 years who smoked <= 5 cigarettes/day or <= 3 roll-your-own cigarettes/day and had a pregnancy gestation of <18 weeks were randomised to a financial incentives group (n=231) or a control group (n=229). INTERVENTIONS Participants in the financial incentives group received a voucher equivalent to euro 20 (17; pound $23), and further progressively increasing vouchers at each study visit if they remained abstinent. Participants in the control group received no financial incentive for abstinence. All participants received a euro 20 show-up fee at each of six visits. MAIN OUTCOME MEASURES The main outcome measure was continuous smoking abstinence from the first post-quit date visit to visit 6, before delivery. Secondary outcomes in the mothers were point prevalence abstinence, time to smoking relapse, withdrawal symptoms, blood pressure, and alcohol and cannabis use in past 30 days. Secondary outcomes in the babies were gestational age at birth, birth characteristics (birth weight, length, head circumference, Apgar score), and a poor neonatal outcome-a composite measure of transfer to the neonatal unit, congenital malformation, convulsions, or perinatal death. RESULTS Mean age was 29 years. In the financial incentives and control groups, respectively, 137 (59%) and 148 (65%) were employed, 163 (71%) and 171 (75%) were in a relationship, and 41 (18%) and 31 (13%) were married. The participants had smoked a median of 60 cigarettes in the past seven days. The continuous abstinence rate was significantly higher in the financial incentives group (16%, 38/231) than control group (7%, 17/229): odds ratio 2.45 (95% confidence interval 1.34 to 4.49), P=0.004). The point prevalence abstinence rate was higher (4.61, 1.41 to 15.01, P=0.011), the median time to relapse was longer (visit 5 (interquartile range 3-6) and visit 4 (3-6), P<0.001)), and craving for tobacco was lower (beta=-1.81, 95% confidence interval -3.55 to -0.08, P=0.04) in the financial incentives group than control group. Financial incentives were associated with a 7% reduction in the risk of a poor neonatal outcome: 4 babies (2%) in the financial incentives group and 18 babies (9%) in the control group: mean difference 14 (95% confidence interval 5 to 23), P=0.003. Post hoc analyses suggested that more babies in the financial incentives group had birth weights >= 2500 g than in the control group: unadjusted odds ratio 1.95 (95% confidence interval 0.99 to 3.85), P=0.055; sex adjusted odds ratio 2.05 (1.03 to 4.10), P=0.041; and sex and prematurity adjusted odds ratio 2.06 (0.90 to 4.71), P=0.086. As these are post hoc analyses, the results should be interpreted with caution. CONCLUSIONS Financial incentives to reward smoking abstinence compared with no financial incentives were associated with an increased abstinence rate in pregnant smokers. Financial incentives dependent on smoking abstinence could be implemented as a safe and effective intervention to help pregnant smokers quit smoking. TRIAL REGISTRATION ClinicalTrials.gov NCT02606227.	[Berlin, Ivan] Sorbonne Univ, Hop Pitie Salpetriere, Dept Pharmacol, F-75013 Paris, France; [Berlin, Noemi] Univ Paris Nanterre, CNRS, EconomiX, Nanterre, France; [Malecot, Marie] Ctr Hosp St Joseph St Luc, Unite Addictol, Lyon, France; [Breton, Martine] CHU Morvan, Brest, France; [Jusot, Florence] PSL Res Univ, Univ Paris Dauphine, LEDa, Paris, France; [Goldzahl, Leontine] EDHEC Business Sch, Roubaix, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHU Brest; Universite de Bretagne Occidentale; UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire dEconomie de Dauphine LEDa; Universite Catholique de Lille; EDHEC Business School	Berlin, I (corresponding author), Sorbonne Univ, Hop Pitie Salpetriere, Dept Pharmacol, F-75013 Paris, France.	berlin.ivan@gmail.com		Berlin, Ivan/0000-0002-5928-5616	French National Cancer Institute (INCa) Recherche en Prevention Primaire [2014-100]	French National Cancer Institute (INCa) Recherche en Prevention Primaire	This research was funded by the French National Cancer Institute (INCa) Recherche en Prevention Primaire (grant No 2014-100). Logistic support was provided by Assistance Publique-Hopitaux de Paris, Direction a la Recherche Clinique et Innovation, Paris, France. The present paper represents the opinions of the authors and does not necessarily reflect the position of their employers. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/and declare: no support from the French National Cancer Institute (INCa); no support from any organisation for the submitted work with the exception of LG who was supported by the study's grant and by a grant from the health chair-a joint initiative between Paris Sciences et Lettres (PSL), Universite Paris-Dauphine, l'Ecole nationale de la statistique et de l'administration economique (ENSAE), Mutuelle generale de l'Education nationale (MGEN), Universite Paris-Dauphine, and ISTYA Collectives under the aegis of the Fondation du Risque as a postdoctoral fellow. All authors declare no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 2012, BORN TOO SOON GLOBAL; Berlin I, 2010, NICOTINE TOB RES, V12, P500, DOI 10.1093/ntr/ntq039; Berlin N, 2018, EUR J HEALTH ECON, V19, P697, DOI 10.1007/s10198-017-0914-6; Berlin N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011669; Claire R, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078.pub3; Conference de consensus, 2005, PROF SAGE FEMME, P19; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Grange G, 2020, J GYNECOL OBSTET HUM, V49, DOI 10.1016/j.jogoh.2020.101847; Heil SH, 2008, ADDICTION, V103, P1009, DOI 10.1111/j.1360-0443.2008.02237.x; Higgins ST, 2004, NICOTINE TOB RES, V6, P1015, DOI 10.1080/14622200412331324910; Higgins ST, 2014, PREV MED, V68, P51, DOI 10.1016/j.ypmed.2014.03.024; Higgins ST, 2012, PREV MED, V55, pS33, DOI 10.1016/j.ypmed.2011.12.016; Higgins ST, 2010, ADDICTION, V105, P2023, DOI 10.1111/j.1360-0443.2010.03073.x; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Krist AH, 2021, JAMA-J AM MED ASSOC, V325, P265, DOI 10.1001/jama.2020.25019; National Centre for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONS SMOK; Notley C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub6; Ondersma SJ, 2012, NICOTINE TOB RES, V14, P351, DOI 10.1093/ntr/ntr221; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; Taylor L, 2021, ADDICTION, V116, P239, DOI 10.1111/add.15185; US Centres for Disease Control and Prevention U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Valent AM, 2020, OBSTET GYNECOL, V135, pE221, DOI 10.1097/AOG.0000000000003822; Weise A., 2012, GLOBAL NUTR TARGETS, P1	25	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								065217	10.1136/bmj-2021-065217	http://dx.doi.org/10.1136/bmj-2021-065217			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853024	Green Published, hybrid			2022-12-28	WOS:000726688600010
J	Haldane, V; Jung, AS; De Foo, C; Bonk, M; Jamieson, M; Wu, SS; Verma, M; Abdalla, SM; Singh, S; Nordstrom, A; Legido-Quigley, H				Haldane, Victoria; Jung, Anne-Sophie; De Foo, Chuan; Bonk, Mathias; Jamieson, Margaret; Wu, Shishi; Verma, Monica; Abdalla, Salma M.; Singh, Sudhvir; Nordstrom, Anders; Legido-Quigley, Helena			Strengthening the basics: public health responses to prevent the next pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Haldane, Victoria; Jamieson, Margaret] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jung, Anne-Sophie; Legido-Quigley, Helena] London Sch Hyg & Trop Med, London, England; [De Foo, Chuan; Verma, Monica; Legido-Quigley, Helena] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wu, Shishi] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Abdalla, Salma M.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Singh, Sudhvir] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	University of Toronto; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; Boston University; University of Auckland	Haldane, V (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	v.haldane@mail.utoronto.ca	Foo, Chuan De/AAJ-9844-2021	Foo, Chuan De/0000-0001-7254-4881; Singh, Sudhvir/0000-0002-9915-6755; Jung, Anne-Sophie/0000-0001-7039-7830	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response. Open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ	Abbasi K, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4425; Abdalla SM, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-067487; Addiss DG, 2019, HEALTH HUM RIGHTS, V21, P19; Ali ST, 2020, SCIENCE, V369, P1106, DOI 10.1126/science.abc9004; Allen-Scott LK, 2014, INT J PUBLIC HEALTH, V59, P3, DOI 10.1007/s00038-013-0526-6; Bell E, 2017, EMERG INFECT DIS, V23, pS33, DOI 10.3201/eid2313.170949; Chiriboga D, 2020, LANCET, V395, P1690, DOI 10.1016/S0140-6736(20)31145-4; De Foo C, 2021, LANCET, V398, P1547, DOI 10.1016/S0140-6736(21)02186-3; Enria D, 2021, B WORLD HEALTH ORGAN, V99, P610, DOI 10.2471/BLT.21.287054; Fisher DA, 2020, LANCET, V396, P598, DOI 10.1016/S0140-6736(20)31760-8; Gasser U, 2020, LANCET DIGIT HEALTH, V2, pE425, DOI 10.1016/S2589-7500(20)30137-0; Gilmore B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003188; Gugglberger L, 2018, HEALTH PROMOT INT, V33, P557, DOI 10.1093/heapro/day060; Gupta V, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020416; Harman S, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006504; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Knight GM, 2021, WELLCOME OPEN RES, V5, P239; Manabe YC, 2020, JAMA-J AM MED ASSOC, V324, P2153, DOI 10.1001/jama.2020.21694; Matthews Q, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00891-4; McMahon DE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008412; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Robishaw J, 2021, LANCET MICROBE, V2, pE481, DOI 10.1016/S2666-5247(21)00121-X; Talisuna A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001312; The Pan-European Commission on Health and Sustainable Development, 2021, DRAW LIGHT PAND NEW; Williams SG, 2020, HEALTH SECUR, V18, pS113, DOI 10.1089/hs.2019.0119; Wong BL, 2021, HUM RESOUR HEALTH, V19, DOI 10.1186/s12960-021-00627-7; World Health Organization, 2021, CONS STRENGTH LEG FR; World Health Organization, 2021, CONT TOUR; World Health Organization, 2020, COMMUNITY ENGAGEMENT; World Health Organization (WHO), 2016, INT HLTH REG 2005; Wynn Aaron, 2012, Am J Public Health, V102, pe9, DOI 10.2105/AJPH.2012.300957; Yamey G, 2017, LANCET GLOB HEALTH, V5, pE742, DOI 10.1016/S2214-109X(17)30203-6	32	4	4	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067510	10.1136/bmj-2021-067510	http://dx.doi.org/10.1136/bmj-2021-067510			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840134	Green Published, hybrid			2022-12-28	WOS:000740896100021
J	Broadman, HG; Guile, BR; Delpy, DT; Pisano, AP				Broadman, Harry G.; Guile, Bruce R.; Delpy, David T.; Pisano, Albert P.			Capitalizing on the G7 Research Compact Rules for S&T collaboration should be integrated with trade and investment agreements	SCIENCE			English	Editorial Material									[Broadman, Harry G.] Berkeley Res Grp LLC, Washington, DC 20036 USA; [Broadman, Harry G.] Johns Hopkins Univ, Sch Adv Int Studies, Washington, DC 20036 USA; [Guile, Bruce R.] BRG Inst, Global Innovat & Natl Interests Working Grp, Emeryville, CA USA; [Delpy, David T.] UCL, Med Photon, London, England; [Pisano, Albert P.] Univ Calif San Diego, Jacobs Sch Engn, San Diego, CA 92103 USA	Johns Hopkins University; University of London; University College London; University of California System; University of California San Diego	Broadman, HG (corresponding author), Berkeley Res Grp LLC, Washington, DC 20036 USA.; Broadman, HG (corresponding author), Johns Hopkins Univ, Sch Adv Int Studies, Washington, DC 20036 USA.	hbroadman@thinkbrg.com						Blumenthal M, 2020, DIGITAL EPIDEMIOLOGY; Broadman H. G., 2021, FDI INTELLIGENCE FEB; Broadman H. G., 2020, 4 BERK RES GROUP I; Guile B., 2021, ISSUES SCI TECHNOL, V37; Pisano A., 2020, 2 BERK RES GROUP I W; Tyson L.D., 2021, ISSUES SCI TECHNOL, V37	6	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1056	1058		10.1126/science.abm4781	http://dx.doi.org/10.1126/science.abm4781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822301				2022-12-28	WOS:000725668600022
J	Tobon, S				Tobon, Santiago			Community policing in the developing world Community policing did not improve trust or reduce crime	SCIENCE			English	Editorial Material									[Tobon, Santiago] Univ EAFIT, Dept Econ, Medellin, Antioquia, Colombia	Universidad EAFIT	Tobon, S (corresponding author), Univ EAFIT, Dept Econ, Medellin, Antioquia, Colombia.	stobonz@eafit.edu.co						Andrews M., 2017, BUILDING STATE CAPAB, P29, DOI [10.1093/acprof:oso/9780198747482.003.0003, DOI 10.1093/ACPROF:OSO/9780198747482.003.0003]; Blair G., 2021, SCIENCE, V374; Blattman C., 2021, J EUR EC ASS, V19, P2022; Blattman C., 2021, GANG RULE UNDERSTAND; Braga AA, 2019, CAMPBELL SYST REV, V15, DOI 10.1002/cl2.1046; Gill C, 2014, J EXP CRIMINOL, V10, P399, DOI 10.1007/s11292-014-9210-y; Lessing B, 2021, PERSPECT POLIT, V19, P854, DOI 10.1017/S1537592720001243; Lum C., 2017, EVIDENCE BASED POLIC; Magaloni B, 2020, AM POLIT SCI REV, V114, P1013, DOI 10.1017/S0003055420000520; Magaloni B, 2020, AM POLIT SCI REV, V114, P552, DOI 10.1017/S0003055419000856; Weisburd D, 2006, CAMB STUD CRIMINOL, P1, DOI 10.2277/ 0521544831	11	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1046	1047		10.1126/science.abm4112	http://dx.doi.org/10.1126/science.abm4112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822278				2022-12-28	WOS:000725668600016
J	Murphy, WJ; Longo, DL				Murphy, William J.; Longo, Dan L.			A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murphy, William J.; Longo, Dan L.] Univ Calif Davis, Dept Internal Med, Div Hematol & Oncol, Sacramento, CA 95817 USA; [Murphy, William J.; Longo, Dan L.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Murphy, WJ (corresponding author), Univ Calif Davis, Dept Internal Med, Div Hematol & Oncol, Sacramento, CA 95817 USA.; Murphy, WJ (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95616 USA.							Barizien N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93546-5; CLEVELAND WL, 1983, NATURE, V305, P56, DOI 10.1038/305056a0; Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Panariello F, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.582345; PAQUE RE, 1991, J VIROL, V65, P16, DOI 10.1128/JVI.65.1.16-22.1991; PLOTZ PH, 1983, LANCET, V2, P824; Samavati L, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00317; Talotta R, 2021, CYTOKINE GROWTH F R, V60, P52, DOI 10.1016/j.cytogfr.2021.05.001; XUE W, 1991, VET MICROBIOL, V29, P201, DOI 10.1016/0378-1135(91)90128-3; Zhao YC, 2021, CELL RES, V31, P818, DOI 10.1038/s41422-021-00495-9	11	31	32	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					394	396		10.1056/NEJMcibr2113694	http://dx.doi.org/10.1056/NEJMcibr2113694		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	34818473	Bronze			2022-12-28	WOS:000721972200001
J	Rubin, R				Rubin, Rita			New Clinical Trial Grants for Rare Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2003	2003		10.1001/jama.2021.20256	http://dx.doi.org/10.1001/jama.2021.20256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812885				2022-12-28	WOS:000724001500051
J	Li, Z; Wang, Z; Chekshin, N; Qian, SQ; Qiao, JX; Cheng, PT; Yeung, KS; Ewing, WR; Yu, JQ				Li, Zhen; Wang, Zhen; Chekshin, Nikita; Qian, Shaoqun; Qiao, Jennifer X.; Cheng, Peter T.; Yeung, Kap-Sun; Ewing, William R.; Yu, Jin-Quan			A tautomeric ligand enables directed C-H hydroxylation with molecular oxygen	SCIENCE			English	Article							GAUSSIAN-TYPE BASIS; DIMETHYLPLATINUM(II) COMPLEXES; CATALYTIC-OXIDATION; ORBITAL METHODS; BOND FORMATION; ALCOHOLS; FUNCTIONALIZATION; THERMOCHEMISTRY; ACTIVATION; ARYLATION	Hydroxylation of aryl carbon-hydrogen bonds with transition metal catalysts has proven challenging when oxygen is used as the oxidant. Here, we report a palladium complex bearing a bidentate pyridine/ pyridone ligand that efficiently catalyzes this reaction at ring positions adjacent to carboxylic acids. Infrared, x-ray, and computational analysis support a possible role of ligand tautomerization from monoanionic (L,X) to neutral (L,L) coordination in the catalytic cycle of aerobic carbon-hydrogen hydroxylation reaction. The conventional site selectivity dictated by heterocycles is overturned by this catalyst, thus allowing late-stage modification of compounds of pharmaceutical interest at previously inaccessible sites.	[Li, Zhen; Wang, Zhen; Chekshin, Nikita; Qian, Shaoqun; Yu, Jin-Quan] Scripps Res Inst, La Jolla, CA 92037 USA; [Qiao, Jennifer X.; Cheng, Peter T.; Ewing, William R.] Bristol Myers Squibb, Discovery Chem, Princeton, NJ 08543 USA; [Yeung, Kap-Sun] Bristol Myers Squibb Res & Dev, Cambridge, MA 02142 USA	Scripps Research Institute; Bristol-Myers Squibb; Bristol-Myers Squibb	Yu, JQ (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	yu200@scripps.edu		Ewing, William/0000-0002-9434-8053; Cheng, Peter/0000-0002-6289-8341; Wang, Zhen/0000-0001-8125-8019; Li, Zhen/0000-0002-0815-9839; Chekshin, Nikita/0000-0002-9687-3310	Scripps Research Institute; NIH (National Institute of General Medical Sciences) [R01GM102265]; Bristol-Myers Squibb	Scripps Research Institute; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was supported by The Scripps Research Institute, the NIH (National Institute of General Medical Sciences grant R01GM102265) and Bristol-Myers Squibb.	ALSTERS PL, 1990, RECL TRAV CHIM PAY B, V109, P487; ANDRAE D, 1990, THEOR CHIM ACTA, V77, P123, DOI 10.1007/BF01114537; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Boisvert L, 2009, J AM CHEM SOC, V131, P15802, DOI 10.1021/ja9061932; Chakrabarty S, 2020, CHEM SOC REV, V49, P8137, DOI 10.1039/d0cs00440e; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Di Marco VB, 2002, EUR J INORG CHEM, P2648; Dick AR, 2004, J AM CHEM SOC, V126, P2300, DOI 10.1021/ja031543m; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; DOLG M, 1987, J CHEM PHYS, V86, P866, DOI 10.1063/1.452288; Ferreira EM, 2001, J AM CHEM SOC, V123, P7725, DOI 10.1021/ja015791z; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P7420, DOI 10.1002/anie.200502767; GONZALEZ C, 1991, J CHEM PHYS, V95, P5853, DOI 10.1063/1.461606; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2012, CHEM-EUR J, V18, P9955, DOI 10.1002/chem.201200497; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; GRINSTAFF MW, 1994, SCIENCE, V264, P1311, DOI 10.1126/science.8191283; GROVES JT, 1989, J AM CHEM SOC, V111, P8537, DOI 10.1021/ja00204a047; Guo L, 2018, ACCOUNTS CHEM RES, V51, P1185, DOI 10.1021/acs.accounts.8b00023; HANSSON S, 1990, J ORG CHEM, V55, P975, DOI 10.1021/jo00290a031; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783; Hratchian HP, 2004, J CHEM PHYS, V120, P9918, DOI 10.1063/1.1724823; Jensen DR, 2001, J AM CHEM SOC, V123, P7475, DOI 10.1021/ja015827n; LAU TC, 1988, J CHEM SOC CHEM COMM, P1406, DOI 10.1039/c39880001406; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Legault C., 2009, CYLVIEW 1 0 B; LINDSEY AS, 1957, CHEM REV, V57, P583, DOI 10.1021/cr50016a001; Liu CW, 2018, ANGEW CHEM INT EDIT, V57, P16721, DOI 10.1002/anie.201810145; Liu YJ, 2014, NATURE, V515, P389, DOI 10.1038/nature13885; Luchini G., 2020, F1000RESEARCH, V9, P291, DOI DOI 10.12688/F1000RESEARCH.22758.1; Mack JBC, 2019, J AM CHEM SOC, V141, P972, DOI 10.1021/jacs.8b10950; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; O'Reilly E, 2011, CHEM COMMUN, V47, P2490, DOI 10.1039/c0cc03165h; Piera J, 2008, ANGEW CHEM INT EDIT, V47, P3506, DOI 10.1002/anie.200700604; Qu FR, 2014, CHEM COMMUN, V50, P3036, DOI 10.1039/c3cc49387c; Rostovtsev VV, 1998, ORGANOMETALLICS, V17, P4530, DOI 10.1021/om980541l; Rostovtsev VV, 2002, INORG CHEM, V41, P3608, DOI 10.1021/ic0112903; Salamanca V, 2018, J AM CHEM SOC, V140, P17851, DOI 10.1021/jacs.8b10680; Salazar CA, 2020, SCIENCE, V370, P1454, DOI 10.1126/science.abd1085; Stahl SS, 2004, ANGEW CHEM INT EDIT, V43, P3400, DOI 10.1002/anie.200300630; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Taktak S, 2005, CHEM COMMUN, P5301, DOI 10.1039/b508004e; Tang FZ, 2012, ORGANOMETALLICS, V31, P6690, DOI 10.1021/om300752w; ten Brink GJ, 2000, SCIENCE, V287, P1636; Wang DY, 2013, ORGANOMETALLICS, V32, P4882, DOI 10.1021/om400618n; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Wang P, 2017, NATURE, V551, P489, DOI 10.1038/nature24632; Yoneyama T, 1996, J MOL CATAL A-CHEM, V108, P35, DOI 10.1016/1381-1169(95)00289-8; Zhang YH, 2009, J AM CHEM SOC, V131, P14654, DOI 10.1021/ja907198n; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	56	35	35	28	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2021	372	6549					1452	+		10.1126/science.abg2362	http://dx.doi.org/10.1126/science.abg2362			201	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY4KW	34840353	Green Accepted			2022-12-28	WOS:000665860000050
J	Reynolds, CJ; Gibbons, JM; Pade, C; Lin, KM; Sandoval, DM; Pieper, F; Butler, DK; Liu, SY; Otter, AD; Joy, G; Menacho, K; Fontana, M; Smit, A; Kele, B; Cutino-Moguel, T; Maini, MK; Noursadeghi, M; Brooks, T; Semper, A; Manisty, C; Treibel, TA; Moon, JC; McKnight, A; Altmann, DM; Boyton, RJ				Reynolds, Catherine J.; Gibbons, Joseph M.; Pade, Corinna; Lin, Kai-Min; Sandoval, Diana Munoz; Pieper, Franziska; Butler, David K.; Liu, Siyi; Otter, Ashley D.; Joy, George; Menacho, Katia; Fontana, Marianna; Smit, Angelique; Kele, Beatrix; Cutino-Moguel, Teresa; Maini, Mala K.; Noursadeghi, Mahdad; Brooks, Tim; Semper, Amanda; Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.; McKnight, Aine; Altmann, Daniel M.; Boyton, Rosemary J.		COVIDsortium Immune Correlates Net; COVIDsortium Investigators	Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants	SCIENCE			English	Article							T-CELL IMMUNITY	The impact of the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting strain on downstream immunity to heterologous variants of concern (VOCs) is unknown. Studying a longitudinal healthcare worker cohort, we found that after three antigen exposures (infection plus two vaccine doses), S1 antibody, memory B cells, and heterologous neutralization of B.1.351, P.1, and B.1.617.2 plateaued, whereas B.1.1.7 neutralization and spike T cell responses increased. Serology using the Wuhan Hu-1 spike receptor binding domain poorly predicted neutralizing immunity against VOCs. Neutralization potency against VOCs changed with heterologous virus encounter and number of antigen exposures. Neutralization potency fell differentially depending on targeted VOCs over the 5 months from the second vaccine dose. Heterologous combinations of spike encountered during infection and vaccination shape subsequent cross-protection against VOC, with implications for future-proof next-generation vaccines.	[Reynolds, Catherine J.; Lin, Kai-Min; Sandoval, Diana Munoz; Pieper, Franziska; Butler, David K.; Liu, Siyi; Boyton, Rosemary J.] Imperial Coll London, Dept Infect Dis, London, England; [Gibbons, Joseph M.; Pade, Corinna; McKnight, Aine] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Otter, Ashley D.; Brooks, Tim; Semper, Amanda] UK Hlth Secur Agcy, Porton Down, England; [Joy, George; Menacho, Katia; Kele, Beatrix; Cutino-Moguel, Teresa; Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England; [Fontana, Marianna; Smit, Angelique] Royal Free London NHS Fdn Trust, London, England; [Maini, Mala K.; Noursadeghi, Mahdad] UCL, Div Infect & Immun, London, England; [Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.] UCL, Inst Cardiovasc Sci, London, England; [Altmann, Daniel M.] Imperial Coll London, Dept Immunol & Inflammat, London, England; [Boyton, Rosemary J.] Guys & St Thomas NHS Fdn Trust, Lung Div, Royal Brompton & Harefield Hosp, London, England	Imperial College London; University of London; Queen Mary University London; Barts Health NHS Trust; University of London; Queen Mary University London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; University of London; University College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital	Boyton, RJ (corresponding author), Imperial Coll London, Dept Infect Dis, London, England.; Boyton, RJ (corresponding author), Guys & St Thomas NHS Fdn Trust, Lung Div, Royal Brompton & Harefield Hosp, London, England.	r.boyton@imperial.ac.uk	Moon, James/AAA-9905-2020; Lin, Kai-Min/GQQ-7027-2022; Gibbons, Joseph M/ABD-7726-2021; Lin, Kai-Min/R-5480-2017	Moon, James/0000-0001-8071-1491; Gibbons, Joseph M/0000-0002-7238-2381; Munoz Sandoval, Diana/0000-0001-8350-3989; Di Genova, Cecilia/0000-0002-2121-0715; McKnight, Aine/0000-0002-8113-817X; Manisty, Charlotte/0000-0003-0245-7090; Liu, Siyi/0000-0003-0206-9661; Joy, George/0000-0003-1467-5490; Pade, Corinna/0000-0003-0626-2346; Reynolds, Catherine/0000-0002-1371-653X; Treibel, Thomas/0000-0003-1560-7414; Otter, Ashley/0000-0002-8317-9194; Butler, David/0000-0003-1882-8159; Lin, Kai-Min/0000-0003-2109-1530	Medical Research Council (MRC) [MR/S019553/1, MR/R02622X/1, MR/V036939/1, MR/W020610/1]; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC): ITMAT, Cystic Fibrosis Trust SRC [2019SRC015]; NIHR EME Fast Track [NIHR134607]; NIHR Long Covid [COVLT2-0027]; Innovate UK [SBRI 10008614]; Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) European Training Network [860325]; MRC [MR/W020610/1]; Rosetrees Trust; John Black Charitable Foundation; Medical College of St Bartholomew's Hospital Trust; Goldman Sachs; K. C. Griffin; Guy Foundation; GW Pharmaceuticals; Kusuma Trust; Jagclif Charitable Trust; UCLH Charity; Barts Health NHS Trust; Royal Free NHS Foundation Trust; University College London; Queen Mary University of London; UKRI/NIHR UK-CIC; Wellcome Trust [214191/Z/18/Z, 207511/Z/17/Z]; CRUK Immunology [26603]; University College London Hospitals (UCLH); Barts NIHR Biomedical Research Centres and through the British Heart Foundation (BHF) [AA/18/6/34223]; BHF Intermediate Research Fellowship [FS/19/35/34374]; NIHR Biomedical Research Funding	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC): ITMAT, Cystic Fibrosis Trust SRC; NIHR EME Fast Track; NIHR Long Covid; Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) European Training Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); John Black Charitable Foundation; Medical College of St Bartholomew's Hospital Trust; Goldman Sachs; K. C. Griffin; Guy Foundation; GW Pharmaceuticals; Kusuma Trust; Jagclif Charitable Trust; UCLH Charity; Barts Health NHS Trust; Royal Free NHS Foundation Trust; University College London(General Electric); Queen Mary University of London; UKRI/NIHR UK-CIC; Wellcome Trust(Wellcome TrustEuropean Commission); CRUK Immunology; University College London Hospitals (UCLH); Barts NIHR Biomedical Research Centres and through the British Heart Foundation (BHF); BHF Intermediate Research Fellowship; NIHR Biomedical Research Funding	R.J.B. and D.M.A. are supported by the Medical Research Council (MRC) (grants MR/S019553/1, MR/R02622X/1, MR/V036939/1, and MR/W020610/1), the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC): ITMAT, Cystic Fibrosis Trust SRC (grant 2019SRC015), NIHR EME Fast Track (grant NIHR134607), NIHR Long Covid (grant COVLT2-0027), Innovate UK (grant SBRI 10008614), and Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) European Training Network (grant 860325). A.M. is supported by the MRC (grant MR/W020610/1), NIHR EME Fast Track (grant NIHR134607), Rosetrees Trust, The John Black Charitable Foundation, and Medical College of St Bartholomew's Hospital Trust. The COVIDsortium is supported by funding donated by individuals, charitable Trusts, and corporations including Goldman Sachs, K. C. Griffin, The Guy Foundation, GW Pharmaceuticals, Kusuma Trust, and Jagclif Charitable Trust, and enabled by Barts Charity with support from UCLH Charity. Wider support is acknowledged on the COVIDsortium website. Institutional support from Barts Health NHS Trust and Royal Free NHS Foundation Trust facilitated study processes, in partnership with University College London and Queen Mary University of London. MKM is supported by UKRI/NIHR UK-CIC, Wellcome Trust Investigator Award (214191/Z/18/Z) and CRUK Immunology grant (26603). J.C.M., C.M., and T.A.T. are directly and indirectly supported by the University College London Hospitals (UCLH) and Barts NIHR Biomedical Research Centres and through the British Heart Foundation (BHF) (accelerator award AA/18/6/34223). T.T. is funded by a BHF Intermediate Research Fellowship (FS/19/35/34374). MN is supported by the Wellcome Trust (grant 207511/Z/17/Z) and by NIHR Biomedical Research Funding to UCL and UCLH. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Altmann DM, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100286; Altmann DM, 2021, SCIENCE, V371, P1103, DOI 10.1126/science.abg7404; Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Aydillo T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23977-1; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Collier DA, 2021, NATURE, V596, P417, DOI 10.1038/s41586-021-03739-1; Del Bello A., 2021, AM J TRANSPLANT AJT, V16775; Del Bello A, 2022, AM J TRANSPLANT, V22, P322, DOI 10.1111/ajt.16775; Ebinger JE, 2021, NAT MED, V27, P981, DOI 10.1038/s41591-021-01325-6; Faulkner N, 2021, ELIFE, V10, DOI 10.7554/eLife.69317; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; GISAID, TRACK VAR; GISAID, 2021, 10985872 HUM SEQ COL; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Gupta RK, 2021, LANCET MICROBE, V2, pE495, DOI 10.1016/S2666-5247(21)00146-4; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Kamar N, 2021, NEW ENGL J MED, V385, P661, DOI 10.1056/NEJMc2108861; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Lu L, 2021, EBIOMEDICINE, V71, DOI 10.1016/j.ebiom.2021.103544; Manisty C, 2021, LANCET, V397, P1057, DOI 10.1016/S0140-6736(21)00501-8; Manisty C, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103259; Martin DP, 2021, CELL, V184, P5189, DOI 10.1016/j.cell.2021.09.003; Martin Darren P, 2021, medRxiv, DOI 10.1101/2021.02.23.21252268; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Moyo-Gwete T, 2021, NEW ENGL J MED, V384, P2161, DOI 10.1056/NEJMc2104192; Muecksch F, 2021, IMMUNITY, V54, P1853, DOI 10.1016/j.immuni.2021.07.008; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Quigley KJ, 2015, AM J RESP CRIT CARE, V191, P1250, DOI 10.1164/rccm.201411-1995OC; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Reynolds C, 2015, J IMMUNOL, V194, P4814, DOI 10.4049/jimmunol.1402862; Reynolds CJ, 2021, SCIENCE, V372, P1418, DOI 10.1126/science.abh1282; Reynolds CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abf3698; Snyder Thomas M, 2020, medRxiv, DOI 10.1101/2020.07.31.20165647; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Treibel TA, 2020, LANCET, V395, P1608, DOI 10.1016/S0140-6736(20)31100-4; VanBlargan LA, 2021, IMMUNITY, V54, P2399, DOI 10.1016/j.immuni.2021.08.016; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wellcome Sanger Institute, 2021, COVID 19 GEN SURV; Wheatley AK, 2021, TRENDS IMMUNOL, V42, P956, DOI 10.1016/j.it.2021.09.001; Zhang A, 2019, J IMMUNOL, V202, P335, DOI 10.4049/jimmunol.1801149; Zou J, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00313-8	46	27	27	5	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					183	+		10.1126/science.abm0811	http://dx.doi.org/10.1126/science.abm0811			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	34855510	Green Accepted, Green Published			2022-12-28	WOS:000742401600031
J	Sharma, A; Zhang, XK; Dejnirattisai, W; Dai, XH; Gong, DY; Wongwiwat, W; Duquerroy, S; Rouvinski, A; Vaney, MC; Guardado-Calvo, P; Haouz, A; England, P; Sun, R; Zhou, ZH; Mongkolsapaya, J; Screaton, GR; Rey, FA				Sharma, Arvind; Zhang, Xiaokang; Dejnirattisai, Wanwisa; Dai, Xinghong; Gong, Danyang; Wongwiwat, Wiyada; Duquerroy, Stephane; Rouvinski, Alexander; Vaney, Marie-Christine; Guardado-Calvo, Pablo; Haouz, Ahmed; England, Patrick; Sun, Ren; Zhou, Z. Hong; Mongkolsapaya, Juthathip; Screaton, Gavin R.; Rey, Felix A.			The epitope arrangement on flavivirus particles contributes to Mab C10's extraordinary neutralization breadth across Zika and dengue viruses	CELL			English	Article							ANTIBODY; PROTEIN; DETERMINANTS; RECOGNITION; SEQUENCE; SYSTEM; POTENT; TYPE-2	The human monoclonal antibody C10 exhibits extraordinary cross-reactivity, potently neutralizing Zika virus (ZIKV) and the four serotypes of dengue virus (DENV1-DENV4). Here we describe a comparative structure function analysis of C10 bound to the envelope (E) protein dimers of the five viruses it neutralizes. We demonstrate that the C10 Fab has high affinity for ZIKV and DENV1 but not for DENV2, DENV3, and DENV4. We further show that the C10 interaction with the latter viruses requires an E protein conformational landscape that limits binding to only one of the three independent epitopes per virion. This limited affinity is nevertheless counterbalanced by the particle's icosahedral organization, which allows two different dimers to be reached by both Fab arms of a C10 immunoglobulin. The epitopes' geometric distribution thus confers C10 its exceptional neutralization breadth. Our results highlight the importance not only of paratope/epitope complementarity but also the topological distribution for epitope-focused vaccine design.	[Sharma, Arvind; Zhang, Xiaokang; Duquerroy, Stephane; Rouvinski, Alexander; Vaney, Marie-Christine; Guardado-Calvo, Pablo; Rey, Felix A.] Univ Paris, Inst Pasteur, Unite Virol Struct, CNRS UMR3569, F-75015 Paris, France; [Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Dai, Xinghong; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Dai, Xinghong; Gong, Danyang; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Sun, Ren; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Haouz, Ahmed; England, Patrick] Univ Paris, Ctr Technol Resources & Res, Inst Pasteur, CNRS UMR 3528, F-75015 Paris, France; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dengue Hemorrhag Fever Res Unit,Off Res & Dev, Bangkok, Thailand; [Screaton, Gavin R.] Univ Oxford, Div Med Sci, Oxford, England; [Duquerroy, Stephane] Univ Paris Saclay, Fac Sci, F-91405 Orsay, France; [Zhang, Xiaokang] Chinese Acad Sci, Shenzhen Hong Kong Inst Brain Sci Shenzhen Fundam, Shenzhen Inst Adv Technol,Interdisciplinary Ctr B, Brain Cognit & Brain Dis Inst,Fac Life & Hlth Sci, Shenzhen 518055, Guangdong, Peoples R China; [Dai, Xinghong] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Gong, Danyang] Amgen Inc, Amgen Res, Dept Therapeut Discovery, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA; [Rouvinski, Alexander] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Mahidol University; University of Oxford; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Case Western Reserve University; Amgen; Hebrew University of Jerusalem	Rey, FA (corresponding author), Univ Paris, Inst Pasteur, Unite Virol Struct, CNRS UMR3569, F-75015 Paris, France.; Screaton, GR (corresponding author), Univ Oxford, Div Med Sci, Oxford, England.	gavin.screaton@medsci.ox.ac.uk; felix.rey@pasteur.fr	Sharma, Arvind/ABG-2614-2021; Zhou, Z Hong/HDN-0747-2022; Zhang, Xiaokang/AHE-3776-2022; Guardado-Calvo, Pablo/O-5145-2019	Sharma, Arvind/0000-0002-7029-9867; Zhang, Xiaokang/0000-0001-5073-2582; Guardado-Calvo, Pablo/0000-0001-7292-5270; ENGLAND, Patrick/0000-0001-6410-5918; Screaton, Gavin/0000-0002-3549-4309	Wellcome Trust [UNS22082]; National Institute for Health Research Biomedical Research Centre Funding Scheme; National Institutes of Health [DE028583, AI094386, DE025567]; NSF [DBI-1338135, DMR-1548924]; Well-come Trust [095541/A/11/Z]; Institut Pasteur; CNRS;  [1S10RR23057];  [1S10OD018111];  [1U24GM116792]	Wellcome Trust(Wellcome Trust); National Institute for Health Research Biomedical Research Centre Funding Scheme(National Institute for Health Research (NIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Well-come Trust(Wellcome Trust); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ; ; 	This project was supported by a Wellcome Trust collaborative grant (UNS22082 to G.R.S., J.M., and F.A.R.) , by the National Institute for Health Research Biomedical Research Centre Funding Scheme (to G.R.S.) , and bygrants from the National Institutes of Health (DE028583, AI094386, and DE025567 to Z.H.Z. and R.S.) . We thank Fabrice Agou and the staff of the Che-mogenomic and Biological Screening Platform for access to the MALS equip-ment as well as the staff of the Crytallography core facility at the Institut Pas-teur for robot-driven crystallization screens. We acknowledge the use of synchrotron beam lines PX1 and PX2 at SOLEIL (St Aubin, France) , ID29 and ID23-1 at ESRF (Grenoble, France) and X06SA at SLS (Villigen, Switzerland) , and we thank their staff for assistance. We also acknowledge the use of the resources at the Electron Imaging Center for Nanomachines, supported in part by 1S10RR23057, 1S10OD018111, 1U24GM116792 and NSF DBI-1338135 and DMR-1548924 at UCLA. G.R.S. is supported as a Well-come Trust Senior Investigator (095541/A/11/Z) . F.A.R. is supported by Institut Pasteur and the CNRS.	Anez G, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01583-15; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439; Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; dos Santos CND, 2000, VIROLOGY, V274, P292, DOI 10.1006/viro.2000.0457; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100; GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2020, VACCINE, V38, P5572, DOI 10.1016/j.vaccine.2020.06.079; Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014; Hardy JM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22773-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031; Kivioja T, 2000, J STRUCT BIOL, V131, P126, DOI 10.1006/jsbi.2000.4279; Kroschewski H, 2009, J GEN VIROL, V90, P2457, DOI 10.1099/vir.0.011486-0; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lim XX, 2021, CELL, V184, P6067, DOI 10.1016/j.cell.2021.11.009; Liu YT, 2017, J GEN VIROL, V98, P2837, DOI 10.1099/jgv.0.000903; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y; Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157	59	8	8	8	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6052	+		10.1016/j.cell.2021.11.010	http://dx.doi.org/10.1016/j.cell.2021.11.010		DEC 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FJ	34852239	Green Published, hybrid			2022-12-28	WOS:000730754300008
J	Kanner, L; Glatt, AE				Kanner, Lawrence; Glatt, Aaron E.			Patients with COVID-19 had increased risk for acute MI and ischemic stroke at 14 d vs. matched controls	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kanner, Lawrence] Mt Sinai South Nassau, Oceanside, NY 11570 USA; Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Kanner, L (corresponding author), Mt Sinai South Nassau, Oceanside, NY 11570 USA.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC142	JC142		10.7326/ACPJ202112210-142	http://dx.doi.org/10.7326/ACPJ202112210-142		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871047				2022-12-28	WOS:000729195400001
J	Du, B; Wang, CT; Singer, M				Du, Bin; Wang, Chunting; Singer, Mervyn			Learning for the next pandemic: the Wuhan experience of managing critically ill people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Du, Bin] Peking Union Med Coll Hosp, Med Intens Care Unit, State Key Lab Rare Complex & Crit Dis, Beijing 100730, Peoples R China; [Wang, Chunting] Shandong First Med Univ, Dept Crit Care Med, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Singer, Mervyn] UCL, Div Med, Bloomsbury Inst Intens Care Med, London, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; University of London; University College London	Du, B (corresponding author), Peking Union Med Coll Hosp, Med Intens Care Unit, State Key Lab Rare Complex & Crit Dis, Beijing 100730, Peoples R China.	dubin98@gmail.com			Ministry of Science and Technology of the People's Republic of China [2021YFC0863100]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported, in part, by funds from Ministry of Science and Technology of the People's Republic of China (2021YFC0863100).	Burki T, 2020, LANCET INFECT DIS, V20, P292, DOI 10.1016/S1473-3099(20)30076-1; Cao B, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2008043; Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575	9	3	3	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								e066090	10.1136/bmj-2021-066090	http://dx.doi.org/10.1136/bmj-2021-066090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34852995	Green Published, hybrid			2022-12-28	WOS:000732779300024
J	Gao, WJ; Lv, J; Pang, YJ; Li, LM				Gao, Wenjing; Lv, Jun; Pang, Yuanjie; Li, Liming			Role of asymptomatic and pre-symptomatic infections in covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHINA; MUNICIPALITY		[Gao, Wenjing; Lv, Jun; Pang, Yuanjie; Li, Liming] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Lv, Jun; Li, Liming] Peking Univ, Ctr Publ Hlth & Epidem Preparedness & Response, Beijing, Peoples R China	Peking University; Peking University	Li, LM (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.; Li, LM (corresponding author), Peking Univ, Ctr Publ Hlth & Epidem Preparedness & Response, Beijing, Peoples R China.	lmlee@bjmu.edu.cn		Pang, Yuanjie/0000-0002-4826-8861	National Natural Science Foundation of China [82041027]; Peking University [PKU2020PKYZX002]; China Medical Board [20-366]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University); China Medical Board	We thankJinlingTang for comments on an earlier draft of the manuscript. This analysis is supported by the National Natural Science Foundation of China (82041027) , Peking University (PKU2020PKYZX002) ,and the China Medical Board (20-366) . We thank Xuanming Hong, Zhiyu Wu, and Yutong Wang for their data extracting.	Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Chen C, 2021, INT J INFECT DIS, V104, P458, DOI 10.1016/j.ijid.2021.01.017; Chen HY, 2021, CHINA CDC WEEKLY, V3, P1, DOI 10.46234/ccdcw2020.270; Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595; He JJ, 2021, J MED VIROL, V93, P820, DOI 10.1002/jmv.26326; He ZY, 2021, LANCET, V397, P1075, DOI 10.1016/S0140-6736(21)00238-5; JOHANSSON MA, 2021, JAMA NETW OPEN, V4, DOI [10.1001/jamanetworkopen.2020.35057, DOI 10.1001/JAMANETWORKOPEN.2020.35057]; Li ZJ, 2021, LANCET REG HEALTH-W, V8, DOI 10.1016/j.lanwpc.2021.100094; Li ZJ, 2020, LANCET, V396, P63, DOI 10.1016/S0140-6736(20)31278-2; Mayorga L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09843-7; Muller M, 2020, PHYS BIOL, V17, DOI 10.1088/1478-3975/aba6d0; Nogrady B, 2020, NATURE, V587, P534, DOI 10.1038/d41586-020-03141-3; Pollock AM, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4851; Sun TZ, 2020, J MED VIROL, V92, P1995, DOI 10.1002/jmv.25939; Syangtan G, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.587374; WHO, 2020, 73 WHO; Wu ZY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00679-2; Ye S, 2021, CHINA CDC WEEKLY, V3, P409, DOI 10.46234/ccdcw2021.109; Zhang WZ, 2021, CHINA CDC WEEKLY, V3, P214, DOI 10.46234/ccdcw2020.062	21	12	12	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2342	10.1136/bmj.n2342	http://dx.doi.org/10.1136/bmj.n2342			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34852994	hybrid, Green Published			2022-12-28	WOS:000732779300022
J	Anishchenko, I; Pellock, SJ; Chidyausiku, TM; Ramelot, TA; Ovchinnikov, S; Hao, JZ; Bafna, K; Norn, C; Kang, A; Bera, AK; DiMaio, F; Carter, L; Chow, CM; Montelione, GT; Baker, D				Anishchenko, Ivan; Pellock, Samuel J.; Chidyausiku, Tamuka M.; Ramelot, Theresa A.; Ovchinnikov, Sergey; Hao, Jingzhou; Bafna, Khushboo; Norn, Christoffer; Kang, Alex; Bera, Asim K.; DiMaio, Frank; Carter, Lauren; Chow, Cameron M.; Montelione, Gaetano T.; Baker, David			De novo protein design by deep network hallucination	NATURE			English	Article							NMR STRUCTURE; SOFTWARE SUITE; PREDICTION; ALIGNMENT; ALGORITHM; FEATURES; SYSTEM	There has been considerable recent progress in protein structure prediction using deep neural networks to predict inter-residue distances from amino acid sequences(1-3). Here we investigate whether the information captured by such networks is sufficiently rich to generate new folded proteins with sequences unrelated to those of the naturally occurring proteins used in training the models. We generate random amino acid sequences, and input them into the trRosetta structure prediction network to predict starting residue-residue distance maps, which, as expected, are quite featureless. We then carry out Monte Carlo sampling in amino acid sequence space, optimizing the contrast (Kullback-Leibler divergence) between the inter-residue distance distributions predicted by the network and background distributions averaged over all proteins. Optimization from different random starting points resulted in novel proteins spanning a wide range of sequences and predicted structures. We obtained synthetic genes encoding 129 of the network-'hallucinated' sequences, and expressed and purified the proteins in Escherichia coli; 27 of the proteins yielded monodisperse species with circular dichroism spectra consistent with the hallucinated structures. We determined the three-dimensional structures of three of the hallucinated proteins, two by X-ray crystallography and one by NMR, and these closely matched the hallucinated models. Thus, deep networks trained to predict native protein structures from their sequences can be inverted to design new proteins, and such networks and methods should contribute alongside traditional physics-based models to the de novo design of proteins with new functions.	[Anishchenko, Ivan; Pellock, Samuel J.; Chidyausiku, Tamuka M.; Norn, Christoffer; Kang, Alex; Bera, Asim K.; DiMaio, Frank; Carter, Lauren; Chow, Cameron M.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Anishchenko, Ivan; Pellock, Samuel J.; Chidyausiku, Tamuka M.; Norn, Christoffer; Kang, Alex; Bera, Asim K.; DiMaio, Frank; Carter, Lauren; Chow, Cameron M.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Ramelot, Theresa A.; Hao, Jingzhou; Bafna, Khushboo; Montelione, Gaetano T.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY USA; [Ramelot, Theresa A.; Hao, Jingzhou; Bafna, Khushboo; Montelione, Gaetano T.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Sci, Troy, NY USA; [Ovchinnikov, Sergey] Harvard Univ, John Harvard Distinguished Sci Fellowship Program, Cambridge, MA 02138 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Harvard University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@uw.edu	Bafna, Khushboo/AGK-9642-2022	Norn, Christoffer/0000-0002-1450-4651; Ovchinnikov, Sergey/0000-0003-2774-2744; Bafna, Khushboo/0000-0002-1893-1175	NSF [DBI 1937533, MCB 2032259]; NIH [DP5OD026389, R01 GM120574, R35GM141818, P30GM124165, S10OD021527]; Open Philanthropy; Eric and Wendy Schmidt by the Schmidt Futures program; Audacious project; Washington Research Foundation; Novo Nordisk Foundation [NNF17OC0030446]; Howard Hughes Medical Institute; STF at the University of Washington; Rosetta@Home volunteers in ab initio structure prediction calculations; DOE [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Philanthropy; Eric and Wendy Schmidt by the Schmidt Futures program; Audacious project; Washington Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Howard Hughes Medical Institute(Howard Hughes Medical Institute); STF at the University of Washington; Rosetta@Home volunteers in ab initio structure prediction calculations; DOE(United States Department of Energy (DOE))	We thank R. Xiao, G. Liu and A. Wu (Nexomics Biosciences), for assistance in initial NMR protein production; J. Aramini for assistance with NMR data collection for initial HSQC screening; R. Ballard and X. Li for mass spectrometry assistance; and R. Divine and R. Kibler for AKTA scripting. This work was funded by grants from the NSF (DBI 1937533 to D.B. and I.A., and MCB 2032259 to S.O.), the NIH (DP5OD026389 to S.O.), Open Philanthropy (C.C. and A.B.), Eric and Wendy Schmidt by recommendation of the Schmidt Futures program (F.D. and L.C.), and the Audacious project (A.K.), the Washington Research Foundation (S.J.P.), Novo Nordisk Foundation Grant NNF17OC0030446 (C.N.). This work was also supported in part by NIH grants R01 GM120574 (G.T.M.) and R35GM141818 (G.T.M.), and the Howard Hughes Medical Institute (D.B. and T.M.C.). We also acknowledge computing resources provided by the Hyak supercomputer system funded by the STF at the University of Washington, and Rosetta@Home volunteers in ab initio structure prediction calculations, and thank staff at Northeastern Collaborative Access Team at Advanced Photon Source for the beamline, supported by NIH grants P30GM124165 and S10OD021527, and DOE contract DE-AC02-06CH11357. We acknowledge the NMR Core Facility resources at Renssealaer Polytechnic Institute and thank S. McCallum for providing valuable support.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anand N., 2022, PROTEIN SEQUENCE DES, V13, P1, DOI [DOI 10.1101/2020.01.06.895466, 10.1101/2020.01.06.895466]; [Anonymous], 2021, PYMOL MOL GRAPHICS S; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Biswas S, 2021, NAT METHODS, V18, P389, DOI 10.1038/s41592-021-01100-y; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costello Z., ARXIV 2019 190300458, V2019; Davidsen K, 2019, ELIFE, V8, DOI 10.7554/eLife.46935; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Dou JY, 2018, NATURE, V561, P485, DOI 10.1038/s41586-018-0509-0; Eguchi RR., 2020, BIORXIV, V2020, DOI [10.1101/2020.08.07.242347, DOI 10.1101/2020.08.07.242347]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favier A, 2019, J BIOMOL NMR, V73, P199, DOI 10.1007/s10858-019-00249-1; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hawkins-Hooker A, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008736; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huang PS., 2019, ICLR; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karimi M, 2020, J CHEM INF MODEL, V60, P5667, DOI 10.1021/acs.jcim.0c00593; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lee W, 2019, J BIOMOL NMR, V73, P213, DOI 10.1007/s10858-019-00255-3; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Madani A., 2004, PROGEN LANGUAGE MODE, V2020, DOI [10.1101/ 2020.03.07.982272, DOI 10.1101/2020.03.07.982272]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Norn C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017228118; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Repecka D, 2021, NAT MACH INTELL, V3, P324, DOI 10.1038/s42256-021-00310-5; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; Sadiq S.K., 2021, BIORXIV, DOI [10.1101/2021.10.11.463937, DOI 10.1101/2021.10.11.463937]; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Senior AW, 2019, PROTEINS, V87, P1141, DOI 10.1002/prot.25834; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Strokach A, 2020, CELL SYST, V11, P402, DOI 10.1016/j.cels.2020.08.016; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Tischer D., 2020, DESIGN PROTEINS PRES, DOI [10.1101/2020.11.29.402743, DOI 10.1101/2020.11.29.402743]; Wang J., DEEP LEARNING METHOD, DOI [10.1101/2021.11.10.468128(2021, DOI 10.1101/2021.11.10.468128(2021]; Wang JX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24760-x; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Ying JF, 2017, J BIOMOL NMR, V68, P101, DOI 10.1007/s10858-016-0072-7; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	60	54	54	30	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 16	2021	600	7889					547	+		10.1038/s41586-021-04184-w	http://dx.doi.org/10.1038/s41586-021-04184-w		DEC 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XP3FN	34853475	Green Accepted, Green Submitted			2022-12-28	WOS:000724666000005
J	Shepherd, A				Shepherd, Alison			Camels in Kenya provide a mobile clinic like no other	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2947	10.1136/bmj.n2947	http://dx.doi.org/10.1136/bmj.n2947			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH5YO	34848496				2022-12-28	WOS:000725509900008
J	Vallentin, MF; Granfeldt, A; Meilandt, C; Povlsen, AL; Sindberg, B; Holmberg, MJ; Iversen, BN; Maerkedahl, R; Mortensen, LR; Nyboe, R; Vandborg, MP; Tarpgaard, M; Runge, C; Christiansen, CF; Dissing, TH; Terkelsen, CJ; Christensen, S; Kirkegaard, H; Andersen, LW				Vallentin, Mikael Fink; Granfeldt, Asger; Meilandt, Carsten; Povlsen, Amalie Ling; Sindberg, Birthe; Holmberg, Mathias J.; Iversen, Bo Nees; Maerkedahl, Rikke; Mortensen, Lone Riis; Nyboe, Rasmus; Vandborg, Mads Partridge; Tarpgaard, Maren; Runge, Charlotte; Christiansen, Christian Fynbo; Dissing, Thomas H.; Terkelsen, Christian Juhl; Christensen, Steffen; Kirkegaard, Hans; Andersen, Lars W.			Effect of Intravenous or Intraosseous Calcium vs Saline on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESUSCITATION COUNCIL GUIDELINES; ASSOCIATION; CHLORIDE; TIME	IMPORTANCE It is unclear whether administration of calcium has a beneficial effect in patients with cardiac arrest. OBJECTIVE To determine whether administration of calcium during out-of-hospital cardiac arrest improves return of spontaneous circulation in adults. DESIGN, SETTING, AND PARTICIPANTS This double-blind, placebo-controlled randomized clinical trial included 397 adult patients with out-of-hospital cardiac arrest and was conducted in the Central Denmark Region between January 20, 2020, and April 15, 2021. The last 90-day follow-up was on July 15, 2021. INTERVENTIONS The intervention consisted of up to 2 intravenous or intraosseous doses with 5 mmol of calcium chloride (n = 197) or saline (n = 200). The first dose was administered immediately after the first dose of epinephrine. MAIN OUTCOMES AND MEASURES The primary outcome was sustained return of spontaneous circulation. The secondary outcomes included survival and a favorable neurological outcome (modified Rankin Scale score of 0-3) at 30 days and 90 days. RESULTS Based on a planned interim analysis of 383 patients, the steering committee stopped the trial early due to concerns about harm in the calcium group. Of 397 adult patients randomized, 391 were included in the analyses (193 in the calcium group and 198 in the saline group; mean age, 68 [SD, 14] years; 114 [29%] were female). There was no loss to follow-up. There were 37 patients (19%) in the calcium group who had sustained return of spontaneous circulation compared with 53 patients (27%) in the saline group (risk ratio, 0.72 [95% CI, 0.49 to 1.03]; risk difference, -7.6% [95% CI, -16% to 0.8%]; P = .09). At 30 days, 10 patients (5.2%) in the calcium group and 18 patients (9.1%) in the saline group were alive (risk ratio, 0.57 [95% CI, 0.27 to 1.18]; risk difference, -3.9% [95% CI, -9.4% to 1.3%]; P = .17). A favorable neurological outcome at 30 days was observed in 7 patients (3.6%) in the calcium group and in 15 patients (7.6%) in the saline group (risk ratio, 0.48 [95% CI, 0.20 to 1.12]; risk difference, -4.0% [95% CI, -8.9% to 0.7%]; P = .12). Among the patients with calcium values measured who had return of spontaneous circulation, 26 (74%) in the calcium group and 1 (2%) in the saline group had hypercalcemia. CONCLUSIONS AND RELEVANCE Among adults with out-of-hospital cardiac arrest, treatment with intravenous or intraosseous calcium compared with saline did not significantly improve sustained return of spontaneous circulation. These results do not support the administration of calcium during out-of-hospital cardiac arrest in adults.	[Vallentin, Mikael Fink; Meilandt, Carsten; Povlsen, Amalie Ling; Iversen, Bo Nees; Maerkedahl, Rikke; Mortensen, Lone Riis; Nyboe, Rasmus; Vandborg, Mads Partridge; Tarpgaard, Maren; Runge, Charlotte; Dissing, Thomas H.; Kirkegaard, Hans; Andersen, Lars W.] Cent Denmark Reg, Prehosp Emergency Med Serv, Aarhus, Denmark; [Granfeldt, Asger; Iversen, Bo Nees; Dissing, Thomas H.; Christensen, Steffen; Andersen, Lars W.] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care, Aarhus, Denmark; [Sindberg, Birthe; Holmberg, Mathias J.; Kirkegaard, Hans; Andersen, Lars W.] Aarhus Univ, Dept Clin Med, Res Ctr Emergency Med, Aarhus, Denmark; [Sindberg, Birthe; Holmberg, Mathias J.; Kirkegaard, Hans; Andersen, Lars W.] Aarhus Univ Hosp, Emergency Dept, Aarhus, Denmark; [Holmberg, Mathias J.] Viborg Reg Hosp, Dept Cardiol, Viborg, Denmark; [Maerkedahl, Rikke; Terkelsen, Christian Juhl] Herning Reg Hosp, Dept Anesthesiol & Intens Care, Herning, Denmark; [Mortensen, Lone Riis] Randers Reg Hosp, Dept Anesthesiol & Intens Care, Randers, Denmark; [Nyboe, Rasmus] Horsens Reg Hosp, Dept Anesthesiol & Intens Care, Horsens, Denmark; [Vandborg, Mads Partridge] Viborg Reg Hosp, Dept Anesthesiol & Intens Care, Viborg, Denmark; [Runge, Charlotte] Silkeborg Reg Hosp, Elect Surg Ctr, Silkeborg, Denmark; [Christensen, Steffen] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Terkelsen, Christian Juhl] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Silkeborg Central Hospital; Aarhus University; Aarhus University	Andersen, LW (corresponding author), Cent Denmark Reg, Prehospital Emergency Med Serv, Olof Palmes 34, DK-8200 Aarhus, Denmark.	lwandersen@clin.au.dk	Holmberg, Mathias/GWQ-7813-2022; Christiansen, Christian/B-5870-2014	Holmberg, Mathias Johan/0000-0001-5816-337X; Andersen, Lars Wiuff/0000-0001-5752-8082; Povlsen, Amalie Ling/0000-0001-6044-8841; Runge, Charlotte/0000-0001-9480-2490; Meilandt, Carsten/0000-0002-7026-0807; Christiansen, Christian/0000-0002-0727-953X	Novo Nordic Foundation [DKK 2 942 996]; Aarhus University [DKK 180 000]; Health Research Foundation of Central Denmark Region [DKK 782 449]; Fonden til Laegevidenskabens Fremme [DKK 55 000]	Novo Nordic Foundation(Novo Nordisk Foundation); Aarhus University; Health Research Foundation of Central Denmark Region; Fonden til Laegevidenskabens Fremme	Funding for the trial was provided by the Novo Nordic Foundation (DKK 2 942 996), Aarhus University (DKK 180 000), the Health Research Foundation of Central Denmark Region (DKK 782 449), and Fonden til Laegevidenskabens Fremme (DKK 55 000).	Ali MU, 2018, RESUSCITATION, V132, P63, DOI 10.1016/j.resuscitation.2018.08.025; ALLEN DG, 1993, ADV EXP MED BIOL, V346, P19; Andersen LW, 2018, RESUSCITATION, V125, P79, DOI 10.1016/j.resuscitation.2018.02.006; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Cerella Claudia, 2010, Int J Cell Biol, V2010, P546163, DOI 10.1155/2010/546163; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Gando S, 1988, J Anesth, V2, P154, DOI 10.1007/s0054080020154; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Holmberg MJ, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005580; Holmberg MJ, 2019, RESUSCITATION, V139, P106, DOI 10.1016/j.resuscitation.2019.04.008; Jankowski S, 1995, J Intensive Care Med, V10, P91; Jensen CE, 2021, APPL HEALTH ECON HEA, V19, P579, DOI 10.1007/s40258-021-00639-3; Kahan BC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-20; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; Kette F, 2013, EUR J EMERG MED, V20, P72, DOI 10.1097/MEJ.0b013e328358e336; Lindqwister AL, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00340-0; Lindskou TA, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0676-5; Lomivorotov VV, 2020, J CARDIOTHOR VASC AN, V34, P235, DOI 10.1053/j.jvca.2019.06.016; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Moskowitz A, 2019, CRIT CARE MED, V47, P194, DOI 10.1097/CCM.0000000000003506; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Piper HM, 2003, ANN THORAC SURG, V75, pS644, DOI 10.1016/S0003-4975(02)04686-6; Ringgren KB, 2018, RAPPORT DANSK HJERTE; Ross CE, 2021, RESUSCITATION, V158, P243, DOI 10.1016/j.resuscitation.2020.09.040; Soar J, 2021, RESUSCITATION, V161, P115, DOI 10.1016/j.resuscitation.2021.02.010; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; STIELL IG, 1995, ACAD EMERG MED, V2, P264, DOI 10.1111/j.1553-2712.1995.tb03220.x; STUEVEN HA, 1985, ANN EMERG MED, V14, P630, DOI 10.1016/S0196-0644(85)80875-1; STUEVEN HA, 1985, ANN EMERG MED, V14, P626, DOI 10.1016/S0196-0644(85)80874-X; URBAN P, 1988, ANN INTERN MED, V109, P110, DOI 10.7326/0003-4819-109-2-110; van Walraven C, 1998, ANN EMERG MED, V32, P544, DOI 10.1016/S0196-0644(98)70031-9; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Youngquist ST, 2010, RESUSCITATION, V81, P117, DOI 10.1016/j.resuscitation.2009.10.002; Zampieri FG, 2021, AM J RESP CRIT CARE, V203, P543, DOI 10.1164/rccm.202006-2381CP	36	10	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2021	326	22					2268	2276		10.1001/jama.2021.20929	http://dx.doi.org/10.1001/jama.2021.20929		NOV 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XQ5NW	34847226	Green Published			2022-12-28	WOS:000725790700001
J	Shang, YC; Liu, ZD; Dong, JJ; Yao, MG; Yang, ZX; Li, QJ; Zhai, CG; Shen, FR; Hou, XY; Wang, L; Zhang, NQ; Zhang, W; Fu, R; Ji, JF; Zhang, XM; Lin, H; Fei, YW; Sundqvist, B; Wang, WH; Liu, BB				Shang, Yuchen; Liu, Zhaodong; Dong, Jiajun; Yao, Mingguang; Yang, Zhenxing; Li, Quanjun; Zhai, Chunguang; Shen, Fangren; Hou, Xuyuan; Wang, Lin; Zhang, Nianqiang; Zhang, Wei; Fu, Rong; Ji, Jianfeng; Zhang, Xingmin; Lin, He; Fei, Yingwei; Sundqvist, Bertil; Wang, Weihua; Liu, Bingbing			Ultrahard bulk amorphous carbon from collapsed fullerene	NATURE			English	Article							HIGH-PRESSURE; DIAMOND; SUPERHARD; C-60; PHASE; FULLERITES	Preparing amorphous phases of carbon with mostly sp(3) bonding in bulk is challenging, but macroscopic samples that are nearly pure sp(3) are synthesized here by heating fullerenes at high pressure. Amorphous materials inherit short- and medium-range order from the corresponding crystal and thus preserve some of its properties while still exhibiting novel properties(1,2). Due to its important applications in technology, amorphous carbon with sp(2) or mixed sp(2)-sp(3) hybridization has been explored and prepared(3,4), but synthesis of bulk amorphous carbon with sp(3) concentration close to 100% remains a challenge. Such materials inherit the short-/medium-range order of diamond and should also inherit its superior properties(5). Here, we successfully synthesized millimetre-sized samples-with volumes 10(3)-10(4) times as large as produced in earlier studies-of transparent, nearly pure sp(3) amorphous carbon by heating fullerenes at pressures close to the cage collapse boundary. The material synthesized consists of many randomly oriented clusters with diamond-like short-/medium-range order and possesses the highest hardness (101.9 +/- 2.3 GPa), elastic modulus (1,182 +/- 40 GPa) and thermal conductivity (26.0 +/- 1.3 W m(-1) K-1) observed in any known amorphous material. It also exhibits optical bandgaps tunable from 1.85 eV to 2.79 eV. These discoveries contribute to our knowledge about advanced amorphous materials and the synthesis of bulk amorphous materials by high-pressure and high-temperature techniques and may enable new applications for amorphous solids.	[Shang, Yuchen; Liu, Zhaodong; Dong, Jiajun; Yao, Mingguang; Yang, Zhenxing; Li, Quanjun; Zhai, Chunguang; Shen, Fangren; Hou, Xuyuan; Sundqvist, Bertil; Liu, Bingbing] Jilin Univ, Coll Phys, State Key Lab Superhard Mat, Changchun, Peoples R China; [Liu, Zhaodong; Liu, Bingbing] Jilin Univ, Synerget Extreme Condit User Facil, Changchun, Peoples R China; [Wang, Lin; Fei, Yingwei] Carnegie Inst Sci, Earth & Planets Lab, Washington, DC USA; [Wang, Lin] Univ Bayreuth, Bayer Geoinst, Bayreuth, Germany; [Zhang, Nianqiang] Harbin Inst Technol, Key Lab Struct Dynam Behav & Control Minist E, Harbin, Peoples R China; [Zhang, Wei] Jilin Univ, Sch Mat Sci & Engn, Elect Microscopy Ctr & Int Ctr Future Sci, Key Lab Automobile Mat MOE, Changchun, Peoples R China; [Fu, Rong] Shanghai Univ, Sch Mat Sci & Engn, State Key Lab Adv Special Steel, Shanghai, Peoples R China; [Ji, Jianfeng; Zhang, Xingmin; Lin, He] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China; [Sundqvist, Bertil] Umea Univ, Dept Phys, Umea, Sweden; [Wang, Weihua] Chinese Acad Sci, Inst Phys, Beijing, Peoples R China	Jilin University; Jilin University; Carnegie Institution for Science; University of Bayreuth; Harbin Institute of Technology; Jilin University; Shanghai University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Umea University; Chinese Academy of Sciences; Institute of Physics, CAS	Yao, MG; Liu, BB (corresponding author), Jilin Univ, Coll Phys, State Key Lab Superhard Mat, Changchun, Peoples R China.; Liu, BB (corresponding author), Jilin Univ, Synerget Extreme Condit User Facil, Changchun, Peoples R China.	yaomg@jlu.edu.cn; liubb@jlu.edu.cn	zhang, xu/GYE-3558-2022; liu, bb/GXA-2527-2022; zhang, wei/A-7910-2010; Zhang, xiaoyu/GXA-3206-2022; Yao, Mingguang/AHC-9325-2022	zhang, wei/0000-0002-6414-7015; Zhai, Chunguang/0000-0002-6707-0359				Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Ben Ghorbal G, 2017, J EUR CERAM SOC, V37, P2531, DOI 10.1016/j.jeurceramsoc.2017.02.014; BLANK VD, 1995, PHYS LETT A, V205, P208, DOI 10.1016/0375-9601(95)00564-J; Blank VD, 1998, CARBON, V36, P665, DOI 10.1016/S0008-6223(98)00065-7; Blase X, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.215505; Brazhkin VV, 2012, J SUPERHARD MATER+, V34, P400, DOI 10.3103/S1063457612060135; BRULEY J, 1995, J MICROSC-OXFORD, V180, P22, DOI 10.1111/j.1365-2818.1995.tb03653.x; Bundy FP, 1996, CARBON, V34, P141, DOI 10.1016/0008-6223(96)00170-4; Cadot GBJ, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa70fe; CHOY CL, 1991, J APPL PHYS, V70, P4919, DOI 10.1063/1.349037; Chupas PJ, 2003, J APPL CRYSTALLOGR, V36, P1342, DOI 10.1107/S0021889803017564; DITMARS DA, 1985, INT J THERMOPHYS, V6, P499, DOI 10.1007/BF00508893; Gaskell PH, 1996, PHYS REV LETT, V76, P66, DOI 10.1103/PhysRevLett.76.66; Harris PJF, 2004, PHILOS MAG, V84, P3159, DOI 10.1080/14786430410001720363; Hashemi A, 2020, J APPL PHYS, V127, DOI 10.1063/1.5124821; HIRAI H, 1994, APPL PHYS LETT, V64, P1797, DOI 10.1063/1.111811; Hirai H, 1999, PHYS REV B, V60, P6357, DOI 10.1103/PhysRevB.60.6357; Hu M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603213; Ishii T, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941716; Ishii T, 2019, NAT GEOSCI, V12, P869, DOI 10.1038/s41561-019-0452-1; LiBassi A, 2000, DIAM RELAT MATER, V9, P771, DOI 10.1016/S0925-9635(99)00233-2; Liu X, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.035901; Liu ZD, 2017, J GEOPHYS RES-SOL EA, V122, P7775, DOI 10.1002/2017JB014579; McMillan PF, 2005, J SOLID STATE CHEM, V178, P937, DOI 10.1016/j.jssc.2004.12.040; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; Prescher C, 2015, HIGH PRESSURE RES, V35, P223, DOI 10.1080/08957959.2015.1059835; Ramamurty U, 2014, CRYSTENGCOMM, V16, P12, DOI 10.1039/c3ce41266k; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Shang YC, 2020, CHINESE PHYS LETT, V37, DOI 10.1088/0256-307X/37/8/080701; Shi Y, 2019, J NON-CRYST SOLIDS, V516, P71, DOI 10.1016/j.jnoncrysol.2019.03.037; Su YF, 2016, MICROSC MICROANAL, V22, P666, DOI 10.1017/S1431927616000805; Sundqvist B, 1999, ADV PHYS, V48, P1, DOI 10.1080/000187399243464; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Thompson JW., 2004, J APPL CRYSTALLOGR, V37, P678, DOI 10.1107/S0021889804011744; To T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16382-7; Treacy MMJ, 2012, SCIENCE, V335, P950, DOI 10.1126/science.1214780; Wang L, 2012, SCIENCE, V337, P825, DOI 10.1126/science.1220522; Wang WH, 2012, PROG MATER SCI, V57, P487, DOI 10.1016/j.pmatsci.2011.07.001; Yao MG, 2015, ADV MATER, V27, P3962, DOI 10.1002/adma.201500188; YOO CS, 1992, CHEM PHYS LETT, V198, P379, DOI 10.1016/0009-2614(92)85068-L; Yue YH, 2020, NATURE, V582, P370, DOI 10.1038/s41586-020-2361-2; Zeng ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00395-w; Zhu J, 2017, NANOSC MICROSC THERM, V21, P177, DOI 10.1080/15567265.2017.1313343	43	32	32	67	234	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					599	+		10.1038/s41586-021-03882-9	http://dx.doi.org/10.1038/s41586-021-03882-9			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819685				2022-12-28	WOS:000722366200019
J	Jaffe, S				Jaffe, Susan			Legal challenges threaten Biden's COVID-19 vaccine rule	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1863	1864						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801094	Bronze, Green Published			2022-12-28	WOS:000720912600012
J	Lee, KK				Lee, Kelly K.			How a broadly neutralizing antibody grapples with antigenic and conformational diversity in dengue virus	CELL			English	Editorial Material								In this issue of Cell, two studies apply powerful structural approaches to probe the modes of interaction be-tween a broadly neutralizing antibody and a conserved epitope found on four dengue virus serotypes and Zika virus. These findings offer new insights into how a broadly neutralizing antibody surmounts antigenic and conformational variation.	[Lee, Kelly K.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Lee, KK (corresponding author), Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.	kklee@uw.edu			NIH [R01-GM099989, R01-AI140868]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K.K.L. is supported by NIH grants R01-GM099989 and R01-AI140868.		0	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6015	6016		10.1016/j.cell.2021.11.020	http://dx.doi.org/10.1016/j.cell.2021.11.020		DEC 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FJ	34856127	Bronze			2022-12-28	WOS:000730754300003
J	Sherman, SV; Turner, M				Khanna, Sagar; Turner, Michael			Ectopic Tooth in the Nose	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Khanna, Sagar; Turner, Michael] Mt Sinai Hlth Syst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sherman, SV (corresponding author), Mt Sinai Hlth Syst, New York, NY 10029 USA.	docsagarkhanna@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2021	385	23							e82	10.1056/NEJMicm2112363	http://dx.doi.org/10.1056/NEJMicm2112363			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YE4VC	34874633				2022-12-28	WOS:000741124300003
J	Beaufort, L; Bolton, CT; Sarr, AC; Sucheras-Marx, B; Rosenthal, Y; Donnadieu, Y; Barbarin, N; Bova, S; Cornuault, P; Gally, Y; Gray, E; Mazur, JC; Tetard, M				Beaufort, Luc; Bolton, Clara T.; Sarr, Anta-Clarisse; Sucheras-Marx, Baptiste; Rosenthal, Yair; Donnadieu, Yannick; Barbarin, Nicolas; Bova, Samantha; Cornuault, Pauline; Gally, Yves; Gray, Emmeline; Mazur, Jean-Charles; Tetard, Martin			Cyclic evolution of phytoplankton forced by changes in tropical seasonality	NATURE			English	Article							PACIFIC WARM POOL; CALCAREOUS NANNOPLANKTON EVOLUTION; EARTH SYSTEM MODEL; GEPHYROCAPSA COCCOLITHS; INDIAN MONSOON; OCEAN; CARBON; PLEISTOCENE; VARIABILITY; QUATERNARY	Although the role of Earth's orbital variations in driving global climate cycles has long been recognized, their effect on evolution is hitherto unknown. The fossil remains of coccolithophores, a key calcifying phytoplankton group, enable a detailed assessment of the effect of cyclic orbital-scale climate changes on evolution because of their abundance in marine sediments and the preservation of their morphological adaptation to the changing environment(1,2). Evolutionary genetic analyses have linked broad changes in Pleistocene fossil coccolith morphology to species radiation events(3). Here, using high-resolution coccolith data, we show that during the last 2.8 million years the morphological evolution of coccolithophores was forced by Earth's orbital eccentricity with rhythms of around 100,000 years and 405,000 years-a distinct spectral signature to that of coeval global climate cycles(4). Simulations with an Earth System Model(5) coupled with an ocean biogeochemical model(6) show a strong eccentricity modulation of the seasonal cycle, which we suggest directly affects the diversity of ecological niches that occur over the annual cycle in the tropical ocean. Reduced seasonality in surface ocean conditions favours species with mid-size coccoliths, increasing coccolith carbonate export and burial; whereas enhanced seasonality favours a larger range of coccolith sizes and reduced carbonate export. We posit that eccentricity pacing of phytoplankton evolution contributed to the strong 405,000-year cyclicity that is seen in global carbon cycle records.	[Beaufort, Luc; Bolton, Clara T.; Sarr, Anta-Clarisse; Sucheras-Marx, Baptiste; Donnadieu, Yannick; Barbarin, Nicolas; Cornuault, Pauline; Gally, Yves; Gray, Emmeline; Mazur, Jean-Charles; Tetard, Martin] Aix Marseille Univ, CEREGE, INRAE, CNRS,IRD, Aix En Provence, France; [Rosenthal, Yair; Bova, Samantha] Rutgers State Univ, Dept Marine & Coastal Sci & Earth & Planetary Sci, New Brunswick, NJ USA; [Barbarin, Nicolas] TOTAL SA, Pau, France; [Bova, Samantha] San Diego State Univ, Dept Geol Sci, San Diego, CA 92182 USA; [Cornuault, Pauline] Univ Bremen, MARUM, Bremen, Germany; [Gray, Emmeline] Open Univ, Milton Keynes, Bucks, England	Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Rutgers State University New Brunswick; Total SA; California State University System; San Diego State University; University of Bremen; Open University - UK	Beaufort, L; Bolton, CT (corresponding author), Aix Marseille Univ, CEREGE, INRAE, CNRS,IRD, Aix En Provence, France.	beaufort@cerege.fr; bolton@cerege.fr	Beaufort, Luc/ABG-2289-2021; Sarr, Anta-Clarisse/GLV-4287-2022; donnadieu, yannick/G-7546-2016; Sucheras-Marx, Baptiste/C-8152-2012	Beaufort, Luc/0000-0001-6055-9373; Bova, Samantha/0000-0002-5064-8775; donnadieu, yannick/0000-0002-7315-2684; Sarr, Anta-Clarisse/0000-0002-9495-5355; Sucheras-Marx, Baptiste/0000-0002-8107-8242; Rosenthal, yair/0000-0002-7546-6011; Bolton, Clara/0000-0002-3078-1253; Gray, Emmeline/0000-0002-1664-4930	French ANR project CALHIS; French ANR project iMonsoon; French ANR project AMOR; INSU project CALVE; FRB project COCCACE; IODP France	French ANR project CALHIS(French National Research Agency (ANR)); French ANR project iMonsoon(French National Research Agency (ANR)); French ANR project AMOR(French National Research Agency (ANR)); INSU project CALVE; FRB project COCCACE; IODP France	This paper is a contribution of the Climate research group at CEREGE. This research uses samples provided by the IODP. We thank the scientists, technical staff and crews of IODP expeditions 353 and 363 and IMAGES expeditions 3 and 13; A. Fruy and S. Sergi for sample preparation assistance; and the CEA-CCRT for providing access to the HPC resources of TGCC under the allocation 2019-A0070102212 made by GENCI. We acknowledge French ANR projects CALHIS (L.B.), iMonsoon (C.T.B.) and AMOR (Y.D.), and INSU project CALVE (C.T.B.) and FRB project COCCACE (L.B.) , which provided funding for this work. IODP France provided post-cruise funding to L.B. and C.T.B.	ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Aumont O, 2015, GEOSCI MODEL DEV, V8, P2465, DOI 10.5194/gmd-8-2465-2015; Barbarin N., 2014, THESIS AIX MARSEILLE; Beaufort L, 2004, MAR MICROPALEONTOL, V51, P57, DOI 10.1016/j.marmicro.2003.09.003; Beaufort L, 1997, SCIENCE, V278, P1451, DOI 10.1126/science.278.5342.1451; Beaufort L, 2005, MICROPALEONTOLOGY, V51, P289, DOI 10.2113/gsmicropal.51.4.289; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; BEAUFORT L, 1991, MICROPALEONTOLOGY, V37, P415, DOI 10.2307/1485914; Beaufort L, 1999, RECONSTRUCTING OCEAN HISTORY, P245; Beaufort L, 2014, NAT PROTOC, V9, P633, DOI 10.1038/nprot.2014.028; Beaufort L, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001493; Bendif E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12169-7; BLACKMAN RB, 1958, AT&T TECH J, V37, P185, DOI 10.1002/j.1538-7305.1958.tb03874.x; Bollmann J, 1997, MAR MICROPALEONTOL, V29, P319, DOI 10.1016/S0377-8398(96)00028-X; Bollmann J, 1998, PALEOCEANOGRAPHY, V13, P517, DOI 10.1029/98PA00610; Bolton CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10284; Bosmans JHC, 2018, QUATERNARY SCI REV, V188, P121, DOI 10.1016/j.quascirev.2018.03.025; Bown PR, 2005, MICROPALEONTOLOGY, V51, P299, DOI 10.2113/gsmicropal.51.4.299; Braconnot P, 2003, MAR GEOL, V201, P23, DOI 10.1016/S0025-3227(03)00206-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broecker W, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001731; Carcaillet JT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017550; Chen MT, 1998, TERR ATMOS OCEAN SCI, V9, P129; Chepstow-Lusty A., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V108, P121, DOI 10.2973/odp.proc.sr.108.122.1989; Clemens, 2015, 353 INT OC DISC PROG; Clemens SC, 2016, P OCEAN DRILLING PRO, P353, DOI 10.14379/iodp.proc.353.2016; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Dollfus D, 1999, NEURAL NETWORKS, V12, P553, DOI 10.1016/S0893-6080(99)00011-8; Dollfus D., 1997, THESIS AIX MARSEILLE; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Erb MP, 2015, J CLIMATE, V28, P9258, DOI 10.1175/JCLI-D-15-0242.1; Fichefet T, 1997, J GEOPHYS RES-OCEANS, V102, P12609, DOI 10.1029/97JC00480; Filatov DA, 2019, MOL BIOL EVOL, V36, P4, DOI 10.1093/molbev/msy195; GARTNER S, 1988, MAR MICROPALEONTOL, V13, P23, DOI 10.1016/0377-8398(88)90011-4; Gebregiorgis D, 2020, GEOCHEM GEOPHY GEOSY, V21, DOI 10.1029/2019GC008414; Gebregiorgis D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07076-2; Gibbs S, 2004, MAR MICROPALEONTOL, V51, P39, DOI 10.1016/j.marmicro.2003.09.002; Henderiks J, 2004, MAR MICROPALEONTOL, V50, P161, DOI 10.1016/S0377-8398(03)00070-7; Henderiks J, 2008, MAR MICROPALEONTOL, V67, P143, DOI 10.1016/j.marmicro.2008.01.005; Herbert TD, 1997, P NATL ACAD SCI USA, V94, P8362, DOI 10.1073/pnas.94.16.8362; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; Hourdin F, 2013, CLIM DYNAM, V40, P2193, DOI 10.1007/s00382-012-1343-y; Krinner G., 2005, BIOGEOSCIENCES DISCU, V2, P1243, DOI [10.5194/bgd-2-1243-2005, DOI 10.5194/BGD-2-1243-2005]; Laepple T, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001674; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Li MS, 2019, COMPUT GEOSCI-UK, V127, P12, DOI 10.1016/j.cageo.2019.02.011; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Longhurst, 1998, ECOLOGICAL GEOGRAPHY, V1; Lyle M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000777; Ma WT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047680; Madec G., 2008, OCEAN DYNAMICS COMPO; Madec G., 2017, ZENODO, DOI [10.5281/ZENODO.3248739, DOI 10.5281/ZENODO.3248739]; Mayorga E, 2010, ENVIRON MODELL SOFTW, V25, P837, DOI 10.1016/j.envsoft.2010.01.007; McGrath SM, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2020GL092249; OKADA H, 1979, MAR BIOL, V54, P319, DOI 10.1007/BF00395438; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Party S. S., 2005, MD148 PECTEN; Perch-Nielsen, 1989, PLANKTON STRATIGRAPH, V1; Prescott CL, 2019, GLOBAL PLANET CHANGE, V173, P33, DOI 10.1016/j.gloplacha.2018.12.002; PUJOS A, 1993, OCEANOL ACTA, V16, P349; Raffi I, 2006, QUATERNARY SCI REV, V25, P3113, DOI 10.1016/j.quascirev.2006.07.007; Regoli F, 2015, PALEOCEANOGRAPHY, V30, P439, DOI 10.1002/2014PA002696; Rickaby REM, 2007, EARTH PLANET SC LETT, V253, P83, DOI 10.1016/j.epsl.2006.10.016; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Righetti D, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6253; Rosenthal, 2018, PROC INT OCEAN DISCO, V363, DOI 10.14379/iodp.proc.363.106.2018; RUDDIMAN WF, 1988, PHILOS T ROY SOC B, V318, P411, DOI 10.1098/rstb.1988.0017; RUDDIMAN WF, 1986, EARTH PLANET SC LETT, V80, P117, DOI 10.1016/0012-821X(86)90024-5; Sepulchre P, 2020, GEOSCI MODEL DEV, V13, P3011, DOI 10.5194/gmd-13-3011-2020; Sexton PF, 2012, EARTH PLANET SC LETT, V321, P81, DOI 10.1016/j.epsl.2011.12.043; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Si WM, 2019, NAT GEOSCI, V12, P833, DOI 10.1038/s41561-019-0450-3; Sucheras-Marx B, 2019, BIOGEOSCIENCES, V16, P2501, DOI 10.5194/bg-16-2501-2019; Sucheras-Marx B, 2014, GLOBAL PLANET CHANGE, V123, P97, DOI 10.1016/j.gloplacha.2014.10.015; Tachikawa K, 2011, QUATERNARY SCI REV, V30, P3716, DOI 10.1016/j.quascirev.2011.09.016; THIERSTEIN HR, 1977, GEOLOGY, V5, P400, DOI 10.1130/0091-7613(1977)5<400:GSOLQC>2.0.CO;2; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Valcke S, 2012, GEOSCI MODEL DEV, V5, P1589, DOI 10.5194/gmd-5-1589-2012; Wang PX, 2010, EARTH PLANET SC LETT, V290, P319, DOI 10.1016/j.epsl.2009.12.028; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1; Zeebe RE, 2017, PALEOCEANOGRAPHY, V32, P440, DOI 10.1002/2016PA003054	82	9	11	13	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891					79	+		10.1038/s41586-021-04195-7	http://dx.doi.org/10.1038/s41586-021-04195-7		DEC 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD5HH	34853471	Green Submitted			2022-12-28	WOS:000724666000004
J	Cermakova, K; Demeulemeester, J; Lux, V; Nedomova, M; Goldman, SR; Smith, EA; Srb, P; Hexnerova, R; Fabry, M; Madlikova, M; Horejsi, M; De Rijck, J; Debyser, Z; Adelman, K; Hodges, HC; Veverka, V				Cermakova, Katerina; Demeulemeester, Jonas; Lux, Vanda; Nedomova, Monika; Goldman, Seth R.; Smith, Eric A.; Srb, Pavel; Hexnerova, Rozalie; Fabry, Milan; Madlikova, Marcela; Horejsi, Magdalena; De Rijck, Jan; Debyser, Zeger; Adelman, Karen; Hodges, H. Courtney; Veverka, Vaclav			A ubiquitous disordered protein interaction module orchestrates transcription elongation	SCIENCE			English	Article							MEDIATOR SUBUNIT MED26; N-TERMINAL DOMAIN; STRUCTURAL-CHARACTERIZATION; COMPLEX; REVEALS; ASSIGNMENT; DISCOVERY; ELONGIN; DYNAMICS; PLATFORM	During eukaryotic transcription elongation, RNA polymerase II (RNAP2) is regulated by a chorus of factors. Here, we identified a common binary interaction module consisting of TFIIS N-terminal domains (TNDs) and natively unstructured TND-interacting motifs (TIMs). This module was conserved among the elongation machinery and linked complexes including transcription factor TFIIS, Mediator, super elongation complex, elongin, IWS1, SPT6, PP1-PNUTS phosphatase, H3K36me3 readers, and other factors. Using nuclear magnetic resonance, live-cell microscopy, and mass spectrometry, we revealed the structural basis for these interactions and found that TND-TIM sequences were necessary and sufficient to induce strong and specific colocalization in the crowded nuclear environment. Disruption of a single TIM in IWS1 induced robust changes in gene expression and RNAP2 elongation dynamics, which underscores the functional importance of TND-TIM surfaces for transcription elongation.	[Cermakova, Katerina; Smith, Eric A.; Hodges, H. Courtney] Baylor Coll Med, Ctr Precis Environm Hlth, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cermakova, Katerina; Smith, Eric A.; Hodges, H. Courtney] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Cermakova, Katerina; Lux, Vanda; Nedomova, Monika; Srb, Pavel; Hexnerova, Rozalie; Madlikova, Marcela; Veverka, Vaclav] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Demeulemeester, Jonas; De Rijck, Jan; Debyser, Zeger] Katholieke Univ Leuven, Mol Virol & Gene Therapy, Leuven, Flanders, Belgium; [Goldman, Seth R.; Adelman, Karen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Fabry, Milan; Horejsi, Magdalena] Czech Acad Sci, Inst Mol Genet, Prague, Czech Republic; [Hodges, H. Courtney] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Hodges, H. Courtney] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Veverka, Vaclav] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Demeulemeester, Jonas] Francis Crick Inst, London, England	Baylor College of Medicine; Baylor College of Medicine; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; KU Leuven; Harvard University; Harvard Medical School; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Texas System; UTMD Anderson Cancer Center; Rice University; Charles University Prague; Francis Crick Institute	Hodges, HC (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Hodges, HC (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.; Veverka, V (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.; Hodges, HC (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA.; Hodges, HC (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Veverka, V (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	chodges@tem.edu; vevertra@uochb.cas.cz	Veverka, Vaclav/G-9174-2014; Demeulemeester, Jonas/J-6130-2014; Nedomová, Monika/H-1418-2014; Fabry, Milan/G-3602-2014; Srb, Pavel/C-5202-2014	Veverka, Vaclav/0000-0003-3782-5279; Demeulemeester, Jonas/0000-0002-2660-2478; Nedomová, Monika/0000-0002-7327-9917; Srb, Pavel/0000-0002-4562-578X; Smith, Eric/0000-0002-8147-6179; Goldman, Seth/0000-0001-5096-3778; Lux, Vanda/0000-0002-0184-8076	GACR [GA19-14360S]; Ministry of Education of the Czech Republic [LO1304]; European Regional Development Fund OP RDE, Chemical Biology for Drugging Undruggable Targets (ChemBioDrug) [CZ.02.1.01/0.0/0.0/16_019/0000729]; National Institutes of Health [R35GM137996]; Cancer Prevention and Research Institute of Texas [RR170036]; Gabrielle's Angel Foundation Medical Research Award; V Foundation [V2018-003]; Mark Foundation for Cancer Research [20-024-ASP]; FWO [G099018]; KU Leuven Research Fund	GACR(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund OP RDE, Chemical Biology for Drugging Undruggable Targets (ChemBioDrug); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Gabrielle's Angel Foundation Medical Research Award; V Foundation; Mark Foundation for Cancer Research; FWO(FWO); KU Leuven Research Fund(KU Leuven)	This work was supported by GACR grant GA19-14360S (V.V.); Ministry of Education of the Czech Republic grant LO1304 (V.V.); European Regional Development Fund OP RDE, Chemical Biology for Drugging Undruggable Targets (ChemBioDrug) grant CZ.02.1.01/0.0/0.0/16_019/0000729 (V.V.); National Institutes of Health grant R35GM137996 (H.C.H.); Cancer Prevention and Research Institute of Texas grant RR170036 (H.C.H.); Gabrielle's Angel Foundation Medical Research Award (H.C.H.); V Foundation grant V2018-003 (H.C.H.); Mark Foundation for Cancer Research grant 20-024-ASP (H.C.H.); FWO postdoctoral funding (J.D.); FWO grant G099018 (Z.D.); and the KU Leuven Research Fund (Z.D.).	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Adelman lab, 2021, ZENODO; [Anonymous], 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5519928; [Anonymous], **DATA OBJECT**, DOI 10.5281/zenodo.5519915; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cermakova K, 2018, MOLECULES, V23, DOI 10.3390/molecules23081958; Cermakova K, 2014, CANCER RES, V74, P5139, DOI 10.1158/0008-5472.CAN-13-3602; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cortazar MA, 2019, MOL CELL, V76, P896, DOI 10.1016/j.molcel.2019.09.031; Davey NE, 2012, NUCLEIC ACIDS RES, V40, P10628, DOI 10.1093/nar/gks854; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Diebold ML, 2010, EMBO J, V29, P3979, DOI 10.1038/emboj.2010.272; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dronamraju R, 2018, CELL REP, V25, P3476, DOI 10.1016/j.celrep.2018.11.089; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hodges H. C., HODGESLAB WORKFLOWS; Hodges H. C., 2021, ZENODO; Hodges HC, 2018, NAT STRUCT MOL BIOL, V25, P61, DOI 10.1038/s41594-017-0007-3; Izumi K, 2015, NAT GENET, V47, P338, DOI 10.1038/ng.3229; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Krystkowiak I, 2017, NUCLEIC ACIDS RES, V45, pW464, DOI 10.1093/nar/gkx238; Langerova H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122547; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lens Z, 2017, J MOL BIOL, V429, P3043, DOI 10.1016/j.jmb.2017.09.001; LeRoy G, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay3068; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu Y, 2020, NATURE, V577, P426, DOI 10.1038/s41586-019-1820-0; Lopez-Delisle L, 2021, BIOINFORMATICS, V37, P422, DOI 10.1093/bioinformatics/btaa692; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Martin B., ZENODO; Martin B., 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5519915; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; McDonald SM, 2010, MOL CELL, V40, P725, DOI 10.1016/j.molcel.2010.11.014; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Miller TE, 2017, NATURE, V547, P355, DOI 10.1038/nature23000; Park JW, 2013, METHODS MOL BIOL, V1038, P171, DOI 10.1007/978-1-62703-514-9_10; Peruzzini R, 2016, BIOMOL NMR ASSIGN, V10, P233, DOI 10.1007/s12104-016-9673-z; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Reim NI, 2020, NUCLEIC ACIDS RES, V48, P10241, DOI 10.1093/nar/gkaa745; Reimer KA, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.018; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sharma S, 2018, P NATL ACAD SCI USA, V115, pE7053, DOI 10.1073/pnas.1803909115; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Takahashi T, 2011, J URBAN ECON, V69, P92, DOI 10.1016/j.jue.2010.08.003; Tesina P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8968; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Yuva-Aydemir Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13477-8; Zenodo, 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5511049	82	6	6	8	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1113	+		10.1126/science.abe2913	http://dx.doi.org/10.1126/science.abe2913			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822292	Green Accepted			2022-12-28	WOS:000725668600044
J	Le Roy, C; Amadori, D; Charberet, S; Windt, J; Muijres, FT; Llaurens, V; Debat, V				Le Roy, Camille; Amadori, Dario; Charberet, Samuel; Windt, Jaap; Muijres, Florian T.; Llaurens, Violaine; Debat, Vincent			Adaptive evolution of flight in Morpho butterflies	SCIENCE			English	Article							PERFORMANCE; SHAPE	The diversity of flying animals suggests that countless combinations of flight morphologies and behaviors have evolved with specific lifestyles, thereby exploiting diverse aerodynamic mechanisms. How morphology, flight behavior, and aerodynamic properties together diversify with contrasting ecology remains to be elucidated. We studied the adaptive codivergence in wing shape, flight behavior, and aerodynamic efficiency among Morpho butterflies living in different forest strata by combining highspeed videography in the field with morphometric analyses and aerodynamic modeling. By comparing canopy and understory species, we show that adaptation to an open canopy environment resulted in increased glide efficiency. Moreover, this enhanced glide efficiency was achieved by different canopy species through distinct combinations of flight behavior, wing shape, and aerodynamic mechanisms, highlighting the multiple pathways of adaptive evolution.	[Le Roy, Camille; Charberet, Samuel; Llaurens, Violaine; Debat, Vincent] Univ Antilles, Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, Museum Natl Hist Nat,CNRS,EPHE, CP50, F-75005 Paris, France; [Le Roy, Camille] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Le Roy, Camille; Muijres, Florian T.] Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; [Amadori, Dario; Windt, Jaap] Maritime Res Inst Netherlands, NL-6708 PM Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Wageningen University & Research; Maritime Research Institute Netherlands (MARIN)	Le Roy, C (corresponding author), Univ Antilles, Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, Museum Natl Hist Nat,CNRS,EPHE, CP50, F-75005 Paris, France.; Le Roy, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.; Le Roy, C (corresponding author), Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	camille.leroy@wur.nl	Debat, Vincent/H-9610-2019; Muijres, Florian/N-6483-2015	Debat, Vincent/0000-0003-0040-1181; Llaurens, Violaine/0000-0003-1962-7391; Muijres, Florian/0000-0002-5668-0653; Le Roy, Camille/0000-0003-0421-296X	Agence National de la Recherche [ANR-10-LABX-0003-BCDiv, ANR-11-IDEX-0004-02]; Emergence program of the Paris city council; Universite de Paris; Ecole Doctorale FIRE - Program Bettencourt	Agence National de la Recherche(French National Research Agency (ANR)); Emergence program of the Paris city council; Universite de Paris; Ecole Doctorale FIRE - Program Bettencourt	This work was supported by grants from the Agence National de la Recherche under the LabEx ANR-10-LABX-0003-BCDiv, in the program "Investissements d'avenir" ANR-11-IDEX-0004-02 (to C.L.R.), the Emergence program of the Paris city council (to V.L.), and Universite de Paris and the Ecole Doctorale FIRE -Program Bettencourt (to C.L.R.).	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094335; Amadori D., 2019, P 22 NUM TOW TANK S; Blandin Patrick, 2013, Tropical Lepidoptera Research, V23, P62; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Cespedes A, 2015, J ANIM ECOL, V84, P808, DOI 10.1111/1365-2656.12325; Chazot N, 2021, J EVOLUTION BIOL, V34, P1592, DOI 10.1111/jeb.13921; Chazot N, 2016, EVOLUTION, V70, P181, DOI 10.1111/evo.12842; Daniel TL, 2002, INTEGR COMP BIOL, V42, P1044, DOI 10.1093/icb/42.5.1044; DeVries PJ, 2010, J ANIM ECOL, V79, P1077, DOI 10.1111/j.1365-2656.2010.01710.x; Eca L, 2016, J COMPUT PHYS, V310, P418, DOI 10.1016/j.jcp.2016.01.002; Eca L, 2014, J COMPUT PHYS, V262, P104, DOI 10.1016/j.jcp.2014.01.006; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Gibo D.L., 1986, P172; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Le Roy C, DRYAD, DOI [10.5061/dryad.cz8w9gj44, DOI 10.5061/DRYAD.CZ8W9GJ44]; Le Roy C., 2021, DRYAD; Menter F. R., 2003, TURBUL HEAT MASS TRA, V4, P625; Muijres FT, 2012, J THEOR BIOL, V306, P120, DOI 10.1016/j.jtbi.2012.04.014; Muijres FT, 2011, EXP FLUIDS, V51, P511, DOI 10.1007/s00348-011-1067-5; Murali G, 2018, ANIM BEHAV, V142, P207, DOI 10.1016/j.anbehav.2018.06.017; Norberg UML, 2002, J MORPHOL, V252, P52, DOI 10.1002/jmor.10013; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Spedding GR, 2008, J EXP BIOL, V211, P215, DOI 10.1242/jeb.007823; Sponberg S, 2015, SCIENCE, V348, P1245, DOI 10.1126/science.aaa3042; Theriault DH, 2014, J EXP BIOL, V217, P1843, DOI 10.1242/jeb.100529	28	2	2	7	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1158	+		10.1126/science.abh2620	http://dx.doi.org/10.1126/science.abh2620			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822295	Green Submitted			2022-12-28	WOS:000725668600052
J	Asteria, L; Zahn, HP; Kosch, MN; Sengstock, K; Weitenberg, C				Asteria, Luca; Zahn, Henrik P.; Kosch, Marcel N.; Sengstock, Klaus; Weitenberg, Christof			Quantum gas magnifier for sub-lattice-resolved imaging of 3D quantum systems	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; CRITICAL-TEMPERATURE; SINGLE; ATOMS	Imaging is central to gaining microscopic insight into physical systems, and new microscopy methods have always led to the discovery of new phenomena and a deeper understanding of them. Ultracold atoms in optical lattices provide a quantum simulation platform, featuring a variety of advanced detection tools including direct optical imaging while pinning the atoms in the lattice(1,2). However, this approach suffers from the diffraction limit, high optical density and small depth of focus, limiting it to two-dimensional (2D) systems. Here we introduce an imaging approach where matter wave optics magnifies the density distribution before optical imaging, allowing 2D sub-lattice-spacing resolution in three-dimensional (3D) systems. By combining the site-resolved imaging with magnetic resonance techniques for local addressing of individual lattice sites, we demonstrate full accessibility to 2D local information and manipulation in 3D systems. We employ the high-resolution images for precision thermodynamics of Bose-Einstein condensates in optical lattices as well as studies of thermalization dynamics driven by thermal hopping. The sub-lattice resolution is demonstrated via quench dynamics within the lattice sites. The method opens the path for spatially resolved studies of new quantum many-body regimes, including exotic lattice geometries or sub-wavelength lattices(3-6), and paves the way for single-atom-resolved imaging of atomic species, where efficient laser cooling or deep optical traps are not available, but which substantially enrich the toolbox of quantum simulation of many-body systems. Existing techniques for high-resolution imaging of trapped quantum gases are limited to two-dimensional systems, but the approach described here works in three dimensions by magnifying the quantum gas with matter wave optics.	[Asteria, Luca; Zahn, Henrik P.; Kosch, Marcel N.; Sengstock, Klaus; Weitenberg, Christof] Univ Hamburg, Inst Laserphys, Hamburg, Germany; [Sengstock, Klaus; Weitenberg, Christof] Hamburg Ctr Ultrafast Imaging, Hamburg, Germany; [Sengstock, Klaus] Univ Hamburg, Zentrum Opt Quantentechnol, Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg	Sengstock, K (corresponding author), Univ Hamburg, Inst Laserphys, Hamburg, Germany.; Sengstock, K (corresponding author), Hamburg Ctr Ultrafast Imaging, Hamburg, Germany.; Sengstock, K (corresponding author), Univ Hamburg, Zentrum Opt Quantentechnol, Hamburg, Germany.	klaus.sengstock@physnet.uni-hamburg.de						Anderson B, 2003, CONTEMP PHYS, V44, P473, DOI 10.1080/00107510310001608863; Anderson RP, 2020, PHYS REV RES, V2, DOI [10.1103/PhysRevResearch.2.013149, 10.1103/physrevresearch.2.013149]; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Becker C, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065025; Bergschneider A, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.063613; Bongs K, 2004, REP PROG PHYS, V67, P907, DOI 10.1088/0034-4885/67/6/R03; Bucker R, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103039; Cayla H, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.061609; Choi JY, 2016, SCIENCE, V352, P1547, DOI 10.1126/science.aaf8834; Ensher JR, 1996, PHYS REV LETT, V77, P4984, DOI 10.1103/PhysRevLett.77.4984; Flaschner N, 2016, SCIENCE, V352, P1091, DOI 10.1126/science.aad4568; Gerbier F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.155303; Gericke T, 2008, NAT PHYS, V4, P949, DOI 10.1038/nphys1102; Giorgini S, 1996, PHYS REV A, V54, pR4633, DOI 10.1103/PhysRevA.54.R4633; Irsigler B, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.010406; Karski M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065027; Ketterle W, 1996, PHYS REV A, V54, P656, DOI 10.1103/PhysRevA.54.656; LAWALL J, 1995, PHYS REV LETT, V75, P4194, DOI 10.1103/PhysRevLett.75.4194; McDonald M, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021001; McKay D, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063605; Murthy PA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043611; Murthy P. A., 2019, DIRECT IMAGING ORDER; Nascimbene S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.140401; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Pethick CJ, 2008, BOSE-EINSTEIN CONDENSATION IN DILUTE GASES, P1; PETSAS KI, 1994, PHYS REV A, V50, P5173, DOI 10.1103/PhysRevA.50.5173; Pitaevskii L., 2016, BOSE EINSTEIN CONDEN, DOI DOI 10.1093/ACPROF:OSO/9780198758884.001.0001; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; Ritt G, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063622; Santra B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15601; Schmaljohann H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040402; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Shvarchuck I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270404; Smith RP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.250403; Soltan-Panahi P, 2011, NAT PHYS, V7, P434, DOI [10.1038/nphys1916, 10.1038/NPHYS1916]; Subhankar S, 2019, PHYS REV X, V9, DOI [10.1103/PhysRevX.9.021002, 10.1103/physrevx.9.021002]; Trotzky S, 2010, NAT PHYS, V6, P998, DOI 10.1038/NPHYS1799; Tung S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230408; van Amerongen AH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.090402; Veit C, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.011036; Wang Y, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.083601; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wigley PB, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.013612; Windpassinger P, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/8/086401; Wurtz P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.080404; Yamamoto R, 2020, NEW J PHYS, V22, DOI 10.1088/1367-2630/abcdc8; Yang J, 2021, PRX QUANTUM, V2, DOI 10.1103/PRXQuanttun.2.020344	48	6	6	10	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					571	+		10.1038/s41586-021-04011-2	http://dx.doi.org/10.1038/s41586-021-04011-2			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819679	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000722366200014
J	Hamilton, F; West, C				Hamilton, Fabian; West, Catherine			Predatory marriage: Doctors can help to spot and prevent this exploitation Doctors can play a vital role in helping older patients who are at risk of being exploited via predatory marriage	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2906	10.1136/bmj.n2906	http://dx.doi.org/10.1136/bmj.n2906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE5JI	34819320	Bronze			2022-12-28	WOS:000723423400002
J	Mastenbroek, S; de Wert, G; Adashi, EY				Mastenbroek, Sebastiaan; de Wert, Guido; Adashi, Eli Y.			The Imperative of Responsible Innovation in Reproductive Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IN-VITRO FERTILIZATION; ADVANCED MATERNAL AGE; PREIMPLANTATION GENETIC DIAGNOSIS; HUMAN EMBRYOS; CHROMOSOMAL MOSAICISM; BLASTOCYST TRANSFER; SITU HYBRIDIZATION; IMPLANTATION; ANEUPLOIDIES; PREGNANCIES		[Mastenbroek, Sebastiaan] Univ Amsterdam, Amsterdam UMC, Amsterdam Re Prod & Dev Res Inst, Ctr Reprod Med, Amsterdam, Netherlands; [de Wert, Guido] Maastricht Univ, Dept Hlth Eth & Soc, Res Sch GROW, Maastricht, Netherlands; [Adashi, Eli Y.] Brown Univ, Dept Med Sci, Providence, RI 02912 USA	University of Amsterdam; Maastricht University; Brown University	Mastenbroek, S (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Re Prod & Dev Res Inst, Ctr Reprod Med, Amsterdam, Netherlands.			Mastenbroek, Sebastiaan/0000-0002-7550-2924; Adashi, Eli/0000-0001-7730-1192				[Anonymous], 2021, ILLUMINA; [Anonymous], 2020, 2018 ASS REPR TECHN; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Cornelisse S, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005291.pub3; DELHANTY JDA, 1993, HUM MOL GENET, V2, P1183, DOI 10.1093/hmg/2.8.1183; Dondorp W, 2011, HUM REPROD, V26, P1604, DOI 10.1093/humrep/der112; Foong P, 2021, BIONEWS; Forman EJ, 2013, FERTIL STERIL, V100, P100, DOI 10.1016/j.fertnstert.2013.02.056; Gleicher N, 2020, REPROD BIOL ENDOCRIN, V18, DOI 10.1186/s12958-020-00616-w; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Griesinger G, 2016, HUM REPROD, V31, P249, DOI 10.1093/humrep/dev322; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Lawrenz B, 2019, HUM REPROD, V34, P998, DOI 10.1093/humrep/dez055; Mastenbroek S, 2011, HUM REPROD UPDATE, V17, P454, DOI 10.1093/humupd/dmr003; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Munne S, 2007, NEW ENGL J MED, V357, P1769; Munne S, 2020, HUM REPROD, V35, P70, DOI 10.1093/humrep/dez242; Patrizio P, 2019, J ASSIST REPROD GEN, V36, P1599, DOI 10.1007/s10815-019-01510-0; Paulson RJ, 2019, FERTIL STERIL, V112, P1013, DOI 10.1016/j.fertnstert.2019.11.002; Penzias A, 2020, FERTIL STERIL, V114, P246, DOI 10.1016/j.fertnstert.2020.05.014; Popovic M, 2018, HUM REPROD, V33, P1342, DOI 10.1093/humrep/dey106; Quinn MM, 2018, J ASSIST REPROD GEN, V35, P2155, DOI 10.1007/s10815-018-1337-8; Rubio C, 2017, FERTIL STERIL, V107, P1122, DOI 10.1016/j.fertnstert.2017.03.011; Rubio C, 2013, FERTIL STERIL, V99, P1400, DOI 10.1016/j.fertnstert.2012.11.041; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Scott RT, 2012, FERTIL STERIL, V97, P870, DOI 10.1016/j.fertnstert.2012.01.104; Sermon K, 2016, MOL HUM REPROD, V22, P545, DOI 10.1093/molehr/gaw034; Shaia K, 2020, J ASSIST REPROD GEN, V37, P1117, DOI 10.1007/s10815-020-01746-1; Singla S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16796-3; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; van de Wiel L, 2020, REPROD BIOMED ONLINE, V41, P801, DOI 10.1016/j.rbmo.2020.07.021; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; van Loendersloot L, 2014, REPROD BIOMED ONLINE, V29, P222, DOI 10.1016/j.rbmo.2014.04.016; VERLINSKY Y, 1995, HUM REPROD, V10, P1923, DOI 10.1093/oxfordjournals.humrep.a136207; Wise J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l226; Yan JH, 2021, NEW ENGL J MED, V385, P2047, DOI 10.1056/NEJMoa2103613; Yang M, 2021, NAT CELL BIOL, V23, P314, DOI 10.1038/s41556-021-00660-7; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Zegers-Hochschild F, 2017, HUM REPROD, V32, P1786, DOI 10.1093/humrep/dex234	39	16	16	3	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2096	2100		10.1056/NEJMsb2101718	http://dx.doi.org/10.1056/NEJMsb2101718			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XC3KG	34818487				2022-12-28	WOS:000721915400017
J	Wise, J				Wise, Jacqui			Adverts for cosmetic surgery targeting teenagers to be banned from next year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Advertising Standards Authority, 2016, GUID MARK SURG NONS; Advertising Standards Authority, 2020, CONS PLAC SCHED ADS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2911	10.1136/bmj.n2911	http://dx.doi.org/10.1136/bmj.n2911			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824094				2022-12-28	WOS:000744251500001
J	Mulcahy, E				Mulcahy, Elaine			A strategy for NHS Scotland focused on reducing emissions and enhancing wellbeing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mulcahy, Elaine] UK Hlth Alliance Climate Change, London, England		Mulcahy, E (corresponding author), UK Hlth Alliance Climate Change, London, England.							NHS Scotland, NHS SCOTLAND CLIMATE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2905	10.1136/bmj.n2905	http://dx.doi.org/10.1136/bmj.n2905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819307	Bronze			2022-12-28	WOS:000740893700013
J	Tanne, JH				Tanne, Janice Hopkins			Opioids: US court finds major pharmacy chains guilty of contributing to crisis	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2865; Dyer O, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1867; Dyer O, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2235	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2893	10.1136/bmj.n2893	http://dx.doi.org/10.1136/bmj.n2893			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819305				2022-12-28	WOS:000740893700009
J	Roston, D				Roston, Diane			Taking Down the Shingle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a psychiatrist reflects on the lasting effects of her practice after it closes, understanding that its memory will be preserved by her patients.	[Roston, Diane] West Cent Behav Hlth, 85 Mechan St,Ste 2, Lebanon, NH 03766 USA		Roston, D (corresponding author), West Cent Behav Hlth, 85 Mechan St,Ste 2, Lebanon, NH 03766 USA.	dr@dianerostonmd.com						Kane CK, RECENT CHANGES PHYS; Yalom I., 2003, GIFT THERAPY OPEN LE	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2011	2011		10.1001/jama.2021.20106	http://dx.doi.org/10.1001/jama.2021.20106			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812860				2022-12-28	WOS:000724001500018
J	Woloshin, S; Kramer, B				Woloshin, Steven; Kramer, Barnett			Overdiagnosis: it's official	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Woloshin, Steven] Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Ctr Med & Media, Dartmouth, NS, Canada; [Woloshin, Steven; Kramer, Barnett] Lisa Schwartz Fdn Truth Med, Dartmouth, NS, Canada		Woloshin, S (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Ctr Med & Media, Dartmouth, NS, Canada.; Woloshin, S (corresponding author), Lisa Schwartz Fdn Truth Med, Dartmouth, NS, Canada.							[Anonymous], PREVENTING OVERDIAGN; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; NIH National Library of Medicine, WELC MED SUBJ HEAD; NIH National Library of Medicine, MED SUBJ HEAD PREF; Podolsky S., HIST OVERDIAGNOSIS L; Tybaert S., 2020, NLM TECH B, Ve3a	6	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2854	10.1136/bmj.n2854	http://dx.doi.org/10.1136/bmj.n2854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799371	Bronze			2022-12-28	WOS:000723212300019
J	Spyropoulos, AC; Bonaca, MP				Spyropoulos, Alex C.; Bonaca, Marc P.			Studying the coagulopathy of COVID-19	LANCET			English	Editorial Material							ANTICOAGULATION		[Spyropoulos, Alex C.] Feinstein Inst Med Res, Inst Hlth Syst Sci, Manhasset, NY 11030 USA; [Spyropoulos, Alex C.] Donald & Barbara Zucker Sch Med Hofstra & Northwe, Hempstead, NY 11549 USA; [Spyropoulos, Alex C.] Lenox Hill Hosp, Dept Med, Anticoagulat & Clin Thrombosis Serv, Northwell Hlth, New York, NY 10075 USA; [Spyropoulos, Alex C.] IM Sechenov First Moscow State Med Univ, Dept Obstet & Gynecol, Moscow, Russia; [Bonaca, Marc P.] Univ Colorado, Div Cardiol, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Bonaca, Marc P.] CPC Clin Res, Aurora, CO USA	Northwell Health; Northwell Health; Sechenov First Moscow State Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus	Spyropoulos, AC (corresponding author), Feinstein Inst Med Res, Inst Hlth Syst Sci, Manhasset, NY 11030 USA.; Spyropoulos, AC (corresponding author), Donald & Barbara Zucker Sch Med Hofstra & Northwe, Hempstead, NY 11549 USA.; Spyropoulos, AC (corresponding author), Lenox Hill Hosp, Dept Med, Anticoagulat & Clin Thrombosis Serv, Northwell Hlth, New York, NY 10075 USA.; Spyropoulos, AC (corresponding author), IM Sechenov First Moscow State Med Univ, Dept Obstet & Gynecol, Moscow, Russia.	aspyropoul@northwell.edu						Berger JS, 2021, LANCET, V397, P2226, DOI 10.1016/S0140-6736(21)01291-5; Bikdeli B, 2020, THROMB HAEMOSTASIS, V120, P1004, DOI 10.1055/s-0040-1713152; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4; O'Brien J, 2000, LANCET, V355, P1295; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Spyropoulos AC, 2021, JAMA INTERN MED, V181, P1612, DOI 10.1001/jamainternmed.2021.6203; Spyropoulos AC, 2020, CIRCULATION, V142, P129, DOI 10.1161/CIRCULATIONAHA.120.048020; Tritschler T, 2020, J THROMB HAEMOST, V18, P2958, DOI 10.1111/jth.15094; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Zarychanski R., 2021, THERAPEUTIC ANTICOAG, DOI 10.1101/2021.03.10.21252749	12	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					118	119		10.1016/S0140-6736(21)01906-1	http://dx.doi.org/10.1016/S0140-6736(21)01906-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34800425	Green Published, Bronze			2022-12-28	WOS:000740652500003
J	Shah, M; Dorman, SE				Shah, Maunank; Dorman, Susan E.			Latent Tuberculosis Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISONIAZID PREVENTIVE THERAPY; WEEKLY RIFAPENTINE; RELEASE ASSAYS; UNITED-STATES; FOLLOW-UP; ADULTS; DIAGNOSIS; RIFAMPIN; PROPHYLAXIS; COMPLETION	Latent Tuberculosis Infection Persons with risk factors for Mycobacterium tuberculosis exposure or for progression to tuberculosis disease should be tested for M. tuberculosis infection, preferably with an interferon-gamma release assay. After tuberculosis disease is ruled out, those at increased risk for progression should be treated, preferably with a rifamycin-based regimen. Key Clinical Points Latent Tuberculosis Infection Prevention of progression from latent tuberculosis infection (LTBI) to tuberculosis disease is an important individual and public health goal. Adults and children should be screened for risk factors for Mycobacterium tuberculosis exposure and for risk factors for progression to tuberculosis disease. Persons who screen positive should be tested for M. tuberculosis infection, preferably with the use of an interferon-gamma release assay. Persons who test positive for M. tuberculosis infection should be assessed for tuberculosis disease. Persons with LTBI who are at increased risk for progression to tuberculosis disease generally should be treated for LTBI and followed until treatment is completed. Preferred LTBI treatment regimens include 3 months of once-weekly rifapentine plus isoniazid, 4 months of once-daily rifampin, or 3 months of once-daily isoniazid plus rifampin. Isoniazid administered once daily for 6 or 9 months is an alternative. Risk factors for hepatotoxic effects and drug-drug interactions should be considered when the LTBI treatment regimen is selected.	[Shah, Maunank] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Shah, Maunank] Baltimore City Dept Hlth, Baltimore, MD USA; [Dorman, Susan E.] Med Univ South Carolina, 135 Rutledge Ave,Rm 1207, Charleston, SC 29425 USA; [Dorman, Susan E.] South Carolina Dept Hlth & Environm Control, Columbia, SC USA	Johns Hopkins University; Medical University of South Carolina	Dorman, SE (corresponding author), Med Univ South Carolina, 135 Rutledge Ave,Rm 1207, Charleston, SC 29425 USA.	dorman@musc.edu						Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2021, GLOBAL TUBERCULOSIS; [Anonymous], 2020, TREATM REG LAT TB IN; Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Banaei Niaz, 2016, J Clin Microbiol, V54, P845, DOI 10.1128/JCM.02803-15; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Belknap R, 2017, ANN INTERN MED, V167, P689, DOI [10.7326/M17-1150, 10.7326/m17-1150]; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Campbell JR, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m549; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Cohen A, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00655-2019; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Deutsch-Feldman M, 2021, MMWR-MORBID MORTAL W, V70, P409, DOI 10.15585/mmwr.mm7012a1; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Drain PK, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00021-18; Ena J, 2005, CLIN INFECT DIS, V40, P670, DOI 10.1086/427802; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Gupta A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002882; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; HSU KHK, 1984, JAMA-J AM MED ASSOC, V251, P1283, DOI 10.1001/jama.251.10.1283; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Ledesma JR, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06141-4; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Menzies D, 2018, NEW ENGL J MED, V379, P440, DOI 10.1056/NEJMoa1714283; National Society of Tuberculosis Clinicians and National Tuberculosis Controllers Association, 2021, TEST TREATM LAT TUB; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Ronald LA, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.02048-2019; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Scriba TJ, 2021, LANCET INFECT DIS, V21, P354, DOI 10.1016/S1473-3099(20)30914-2; Sotgiu G, 2019, J INFECTION, V79, P444, DOI 10.1016/j.jinf.2019.08.018; Sterling TR, 2020, MMWR RECOMM REP, V69; Sterling TR, 2016, AIDS, V30, P1607, DOI 10.1097/QAD.0000000000001098; Sterling TR, 2015, CLIN INFECT DIS, V61, P527, DOI 10.1093/cid/civ323; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Swindells S, 2019, NEW ENGL J MED, V380, P1001, DOI 10.1056/NEJMoa1806808; Tait DR, 2019, NEW ENGL J MED, V381, P2429, DOI 10.1056/NEJMoa1909953; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; WHO consolidated guidelines on tuberculosis, 2020, MOD 1 PREV TUB PREV	49	9	10	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2271	2280		10.1056/NEJMcp2108501	http://dx.doi.org/10.1056/NEJMcp2108501			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XL4CS	34879450				2022-12-28	WOS:000728093600016
J	Crovetto, F; Crispi, F; Casas, R; Martin-Asuero, A; Borras, R; Vieta, E; Estruch, R; Gratacos, E				Crovetto, Francesca; Crispi, Fatima; Casas, Rosa; Martin-Asuero, Andres; Borras, Roger; Vieta, Eduard; Estruch, Ramon; Gratacos, Eduard		IMPACT BCN Trial Investigators	Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction on Prevention of Small-for-Gestational Age Birth Weights in Newborns Born to At-Risk Pregnant Individuals The IMPACT BCN Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FETAL-GROWTH RESTRICTION; PREDICTION; OUTCOMES; TERM	IMPORTANCE Being born small for gestational age (SGA) is a leading cause of perinatal morbidity and mortality with no effective prevention or therapy. Maternal suboptimal nutrition and high stress levels have been associated with poor fetal growth and adverse pregnancy outcomes. OBJECTIVE To investigate whether structured interventions based on a Mediterranean diet or mindfulness-based stress reduction (stress reduction) in high-risk pregnancies can reduce the percentage of newborns who were born SGA and other adverse pregnancy outcomes. DESIGN, SETTING, AND PARTICIPANTS Parallel-group randomized clinical trial conducted at a university hospital in Barcelona, Spain, including 1221 individuals with singleton pregnancies (19-23 weeks' gestation) at high risk for SGA. Enrollment took place from February 1, 2017, to October 10, 2019, with follow-up until delivery (final follow-up on March 1, 2020). INTERVENTIONS Participants in the Mediterranean diet group (n = 407) received 2 hours monthly of individual and group educational sessions and free provision of extra-virgin olive oil and walnuts. Individuals in the stress reduction group (n = 407) underwent an 8-week stress reduction program adapted for pregnancy, consisting of weekly 2.5-hour sessions and 1 full-day session. Individuals in the usual care group (n = 407) received pregnancy care per institutional protocols. MAIN OUTCOMES AND MEASURES The primary end point was the percentage of newborns who were SGA at delivery, defined as birth weight below the 10th percentile. The secondary end point was a composite adverse perinatal outcome (at least 1 of the following: preterm birth, preeclampsia, perinatal mortality, severe SGA, neonatal acidosis, low Apgar score, or presence of any major neonatal morbidity). RESULTS Among the 1221 randomized individuals (median [IQR] age, 37 [34-40] years), 1184 (97%) completed the trial (392 individuals assigned to the Mediterranean diet group, 391 to the stress reduction group, and 401 to the usual care group). SGA occurred in 88 newborns (21.9%) in the control group, 55 (14.0%) in the Mediterranean diet group (odds ratio [OR], 0.58 [95% CI, 0.40-0.84]; risk difference [RD], -7.9 [95% CI, -13.6 to -2.6]; P = .004), and 61 (15.6%) in the stress reduction group (OR, 0.66 [95% CI, 0.46-0.94]; RD, -6.3 [95% CI, -11.8 to -0.9]; P = .02). The composite adverse perinatal outcome occurred in 105 newborns (26.2%) in the control group, 73 (18.6%) in the Mediterranean diet group (OR, 0.64 [95% CI, 0.46-0.90]; RD, -7.6 [95% CI, -13.4 to -1.8]; P = .01), and 76 (19.5%) in the stress reduction group (OR, 0.68 [95% CI, 0.49-0.95]; RD, -6.8 [95% CI, -12.6 to -0.3]; P = .02). CONCLUSIONS AND RELEVANCE In this randomized trial conducted at a single institution in Spain, treating pregnant individuals at high risk for SGA with a structured Mediterranean diet or with mindfulness-based stress reduction, compared with usual care, significantly reduced the percentage of newborns with birth weight below the 10th percentile. Due to important study limitations, these findings should be considered preliminary and require replication, as well as assessment in additional patient populations, before concluding that these treatments should be recommended to patients.	[Crovetto, Francesca; Crispi, Fatima; Gratacos, Eduard] Hosp Clin Barcelona, BCNatal Fetal Med Res Ctr, Barcelona, Spain; [Crovetto, Francesca; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp St Joan de Deu, Barcelona, Spain; [Crovetto, Francesca; Crispi, Fatima; Gratacos, Eduard] Ctr Biomed Res Rare Dis CIBER ER, Madrid, Spain; [Casas, Rosa; Estruch, Ramon] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Casas, Rosa; Estruch, Ramon] Univ Barcelona, Dept Internal Med Hosp Clin, IDIBAPS, Barcelona, Spain; [Martin-Asuero, Andres] Inst EsMindfulness, Barcelona, Spain; [Borras, Roger] Univ Autonoma Barcelona, Hosp Clin, Cardiovasc Inst, IDIBAPS, Barcelona, Spain; [Borras, Roger; Vieta, Eduard] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Vieta, Eduard] Univ Barcelona, Hosp Clin, Neurosci Inst, IDIBAPS,Dept Psychiat & Psychol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gratacos, E (corresponding author), Univ Barcelona, BCNatal Hosp St Joan de Diu, Sabino de Arana 1, Barcelona 08036, Spain.; Gratacos, E (corresponding author), Univ Barcelona, Hosp Clin, Sabino de Arana 1, Barcelona 08036, Spain.	egratacos@ub.edu	COLLADO, MARIA CARMEN/H-4924-2012; Casas, Rosa/ABD-1915-2020; Vieta, Eduard/I-6330-2013	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Casas, Rosa/0000-0002-0211-9166; Nakaki, Ayako/0000-0002-4395-3878; Gratacos, Eduard/0000-0002-7405-7224; Vellve, Kilian/0000-0002-2376-7664; Vieta, Eduard/0000-0002-0548-0053; Domenech, Monica/0000-0001-5447-6686	"La Caixa" Foundation [LCF/PR/GN18/10310003]; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR under grant 2017 SGR [1531]; Centro de Investigaciones Biomedicas en Red sobre Enfermedades Raras (CIBERER); "La Caixa" Foundation, Doctoral INPhINIT Retaining fellowship [LCF/BQ/DR19/11740018]	"La Caixa" Foundation(La Caixa Foundation); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR under grant 2017 SGR; Centro de Investigaciones Biomedicas en Red sobre Enfermedades Raras (CIBERER); "La Caixa" Foundation, Doctoral INPhINIT Retaining fellowship	The project was partially funded by a grant from "La Caixa" Foundation (LCF/PR/GN18/10310003); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR under grant 2017 SGR No. 1531. Dr Crovetto has received support from Centro de Investigaciones Biomedicas en Red sobre Enfermedades Raras (CIBERER). Dr Nakaki has received support from a fellowship from "La Caixa" Foundation, Doctoral INPhINIT Retaining fellowship (LCF/BQ/DR19/11740018).	Al Wattar BH, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002857; American College of Obstetricians and Gynecologists' Committee on Practice BulletinsObstetrics and the Society forMaternal-FetalMedicin, 2019, Obstet Gynecol, V133, pe97, DOI 10.1097/AOG.0000000000003070; [Anonymous], INVESTIGATION MANAGE; Assaf-Balut C, 2019, ANN NUTR METAB, V74, P69, DOI 10.1159/000495793; Assaf-Balut C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185873; Bakalis S, 2015, ULTRASOUND OBST GYN, V45, P409, DOI 10.1002/uog.14822; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577; Bussieres EL, 2015, DEV REV, V36, P179, DOI 10.1016/j.dr.2015.04.001; Crispi F, 2018, AM J OBSTET GYNECOL, V218, pS869, DOI 10.1016/j.ajog.2017.12.012; Crovetto F, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05309-2; Dhillon A, 2017, MINDFULNESS, V8, P1421, DOI 10.1007/s12671-017-0726-x; Dossett ML, 2020, NEW ENGL J MED, V382, P1390, DOI 10.1056/NEJMp1917461; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Galante J, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003481; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Guo PP, 2021, J ADV NURS, V77, P125, DOI 10.1111/jan.14588; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Juton C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051629; Katanoda K, 2017, J EPIDEMIOL, V27, P428, DOI 10.1016/j.je.2016.08.016; Khoury J, 2005, AM J OBSTET GYNECOL, V193, P1292, DOI 10.1016/j.ajog.2005.05.016; Koncz A, 2021, HEALTH PSYCHOL REV, V15, P56, DOI 10.1080/17437199.2020.1760727; Lindsay KL, 2017, ANN NUTR METAB, V70, P191, DOI 10.1159/000457136; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; Middleton P, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub3; Miranda J, 2017, ULTRASOUND OBST GYN, V50, P353, DOI 10.1002/uog.17317; Pilliod RA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.039; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Raghavan R, 2019, AM J CLIN NUTR, V109, p729S, DOI 10.1093/ajcn/nqy353; Ros E, 2014, ADV NUTR, V5, p330S, DOI 10.3945/an.113.005389; Ross S, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-31; Sacchi C, 2020, JAMA PEDIATR, V174, P772, DOI 10.1001/jamapediatrics.2020.1097; Schwingshackl L, 2020, BRIT J PHARMACOL, V177, P1241, DOI 10.1111/bph.14778; Traylor CS, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100229; Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668	38	15	14	11	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2150	2160		10.1001/jama.2021.20178	http://dx.doi.org/10.1001/jama.2021.20178			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XO3GR	34874420	Green Published, Bronze			2022-12-28	WOS:000730077500018
J	Robinson, A				Robinson, Ann			Ann Robinson's research reviews-3 December 2021	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Bennell KL, 2021, JAMA-J AM MED ASSOC, V326, P2021, DOI 10.1001/jama.2021.19415; Clemency BM, 2022, JAMA INTERN MED, V182, P42, DOI 10.1001/jamainternmed.2021.6759; Deardorff WJ, 2022, JAMA INTERN MED, V182, P33, DOI 10.1001/jamainternmed.2021.6745; Horby PW, 2022, LANCET, V399, P143, DOI 10.1016/S0140-6736(21)01825-0; Neuman MD, 2021, NEW ENGL J MED, V385, P2025, DOI 10.1056/NEJMoa2113514	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3006	10.1136/bmj.n3006	http://dx.doi.org/10.1136/bmj.n3006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862206	Bronze			2022-12-28	WOS:000729712200018
J	Chen, QL; Rodewald, L; Lai, SJ; Gao, GF				Chen, Qiulan; Rodewald, Lance; Lai, Shengjie; Gao, George F.			Rapid and sustained containment of covid-19 is achievable and worthwhile: implications for pandemic response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chen, Qiulan] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Rodewald, Lance; Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Lai, Shengjie] Univ Southampton, Sch Geog & Environm Sci, Worldpop, Southampton, Hants, England; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Southampton; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaofu@chinacdc.cn		Lai, Shengjie/0000-0001-9781-8148; Rodewald, Lance/0000-0003-2593-542X	Chinese National Science and Technology Major Project [2018ZX10101002-003-002]; Emergency Response Mechanism Operation Program, Chinese Centre for Disease Control and Prevention [131031001000015001]; Public Health System Construction Project, Chinese Centre for Disease Control and Prevention [131031001000190045]; National Natural Science Foundation of China [81773498]; Bill and Melinda Gates Foundation [INV-024911]	Chinese National Science and Technology Major Project; Emergency Response Mechanism Operation Program, Chinese Centre for Disease Control and Prevention; Public Health System Construction Project, Chinese Centre for Disease Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	QC is supported by Chinese National Science and Technology Major Project (No 2018ZX10101002-003-002) , the Emergency Response Mechanism Operation Program, Chinese Centre for Disease Control and Prevention (131031001000015001) , and the Public Health System Construction Project, Chinese Centre for Disease Control and Prevention (131031001000190045) . SL is supported by the National Natural Science Foundation of China (81773498) and the Bill and Melinda Gates Foundation (INV-024911) .	Bai L, 2021, CHINA CDC WEEKLY, V3, P30, DOI 10.46234/ccdcw2021.008; Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907; Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025; Jiang TX, 2020, CHINA CDC WEEKLY, V2, P268; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011; Li F, 2021, LANCET INFECT DIS, V21, P617, DOI [10.1016/S1473-3099(20)30981-6Hubei430030, 10.1016/S1473-3099(20)30981-6]; Li ZJ, 2021, NAT MED, V27, P740, DOI 10.1038/s41591-021-01308-7; Li ZJ, 2021, LANCET REG HEALTH-W, V8, DOI 10.1016/j.lanwpc.2021.100094; Li ZJ, 2020, LANCET, V396, P63, DOI 10.1016/S0140-6736(20)31278-2; Liu FF, 2021, CHINA CDC WEEKLY, V3, P527, DOI 10.46234/ccdcw2021.138; Liu JM, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n415; National Health Commission of the People's Republic of China, 2021, EP SIT COR PNEUM MAR; Pang XH, 2020, NATL SCI REV, V7, P1861, DOI 10.1093/nsr/nwaa264; State CouncilInformationOffice., 2020, FIGHT COVID 19 CHIN, DOI [10.28655/n.cnki.nrmrb.2020.005185, DOI 10.28655/N.CNKI.NRMRB.2020.005185]; Stenseth NC, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.694705; The Joint Prevention and Control Mechanism of the State Council, 2020, GUID OP NORM COVID 1; The Joint Prevention and Control Mechanism of the State Council, 2020, NAT GUID PREV CONTR; The Joint Prevention and Control Mechanism of the State Council, 2020, PREC REF GUID COMM P; The Joint Prevention and Control Mechanism of the State Council, 2020, FURTH NOT COVID 19 P; The State Council Information Office of the People's Republic of China, 2020, PCR TEST JOINT PREV; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; WHO, 2021, UNHCR ETH; World Health Organization, REP WHO CHIN JOINT M; Zhou L, 2021, CLIN INFECT DIS, V72, P332, DOI 10.1093/cid/ciaa725	25	9	9	7	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								e066169	10.1136/BMJ-2021-066169	http://dx.doi.org/10.1136/BMJ-2021-066169			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34852997	hybrid, Green Published			2022-12-28	WOS:000732779300016
J	Taylor, L				Taylor, Luke			World Health Organization to begin negotiating international pandemic treaty	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WHO, WORLD TOG EST INT NE	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2991	10.1136/bmj.n2991	http://dx.doi.org/10.1136/bmj.n2991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857541	Bronze			2022-12-28	WOS:000732779300023
J	Singh, S; Bartos, M; Abdalla, S; Legido-Quigley, H; Nordstrom, A; Sirleaf, EJ; Clark, H				Singh, Sudhvir; Bartos, Michael; Abdalla, Salma; Legido-Quigley, Helena; Nordstrom, Anders; Sirleaf, Ellen Johnson; Clark, Helen			Resetting international systems for pandemic preparedness and response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Singh, Sudhvir] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Bartos, Michael] Australian Natl Univ, Sch Sociol, Canberra, ACT, Australia; [Abdalla, Salma] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Legido-Quigley, Helena] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	University of Auckland; Australian National University; Boston University; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine	Bartos, M (corresponding author), Australian Natl Univ, Sch Sociol, Canberra, ACT, Australia.	michael.bartos@anu.edu.au		Singh, Sudhvir/0000-0002-9915-6755	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response. Open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	Baum F, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n91; Duff JH, 2021, LANCET PUBLIC HEALTH, V6, pE428, DOI 10.1016/S2468-2667(21)00070-0; G20 High Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response, 2021, G20 HIGH LEVEL INDEP; G7, 2021, CARB BAY G7 COMM OUR; Global Health Security Index; A World At Risk, 2019, WORLD RISK ANN REP G; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Highlevel Panel on the Global Response to Health Crises, 2016, PROT HUM FUT HLTH CR; Radin E, 2021, FINANCING PANDEMIC P; Sirleaf EJ, 2021, LANCET, V398, P101, DOI 10.1016/S0140-6736(21)01095-3; Spicer N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00592-1; The Independent Panel for Pandemic Preparedness & Response, 2021, COVID 19 MAK IT LAST; The state of governance and coordination for health emergency preparedness and response, 2020, STATE GOVERNANCE COO; WHO, EM COMM REG OUTBR NO; WHO, 2021, WHAA749 WHO; World Health Organization, 3 M WORK GROUP SUST; World Health Organization, RES WHA 73 1 COVID 1	16	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067518	10.1136/bmj-2021-067518	http://dx.doi.org/10.1136/bmj-2021-067518			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840131	Green Published, hybrid			2022-12-28	WOS:000740896100023
J	Jonasch, E; Donskov, F; Iliopoulos, O; Rathmell, WK; Narayan, VK; Maughan, BL; Oudard, S; Else, T; Maranchie, JK; Welsh, SJ; Thamake, S; Park, EK; Perini, RF; Linehan, WM; Srinivasan, R				Jonasch, Eric; Donskov, Frede; Iliopoulos, Othon; Rathmell, W. Kimryn; Narayan, Vivek K.; Maughan, Benjamin L.; Oudard, Stephane; Else, Tobias; Maranchie, Jodi K.; Welsh, Sarah J.; Thamake, Sanjay; Park, Eric K.; Perini, Rodolfo F.; Linehan, W. Marston; Srinivasan, Ramaprasad		MK Investigators	Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTAGONIST; TRIAL; VHL	Background Patients with von Hippel-Lindau (VHL) disease have a high incidence of renal cell carcinoma owing to VHL gene inactivation and constitutive activation of the transcription factor hypoxia-inducible factor 2 alpha (HIF-2 alpha). Methods In this phase 2, open-label, single-group trial, we investigated the efficacy and safety of the HIF-2 alpha inhibitor belzutifan (MK-6482, previously called PT2977), administered orally at a dose of 120 mg daily, in patients with renal cell carcinoma associated with VHL disease. The primary end point was objective response (complete or partial response) as measured according to the Response Evaluation Criteria in Solid Tumors, version 1.1, by an independent central radiology review committee. We also assessed responses to belzutifan in patients with non-renal cell carcinoma neoplasms and the safety of belzutifan. Results After a median follow-up of 21.8 months (range, 20.2 to 30.1), the percentage of patients with renal cell carcinoma who had an objective response was 49% (95% confidence interval, 36 to 62). Responses were also observed in patients with pancreatic lesions (47 of 61 patients [77%]) and central nervous system hemangioblastomas (15 of 50 patients [30%]). Among the 16 eyes that could be evaluated in 12 patients with retinal hemangioblastomas at baseline, all (100%) were graded as showing improvement. The most common adverse events were anemia (in 90% of the patients) and fatigue (in 66%). Seven patients discontinued treatment: four patients voluntarily discontinued, one discontinued owing to a treatment-related adverse event (grade 1 dizziness), one discontinued because of disease progression as assessed by the investigator, and one patient died (of acute toxic effects of fentanyl). Conclusions Belzutifan was associated with predominantly grade 1 and 2 adverse events and showed activity in patients with renal cell carcinomas and non-renal cell carcinoma neoplasms associated with VHL disease. (Funded by Merck Sharp and Dohme and others; MK-6482-004 ClinicalTrials.gov number, .) HIF-2 alpha Inhibition in von Hippel-Lindau Disease The cause of von Hippel-Lindau disease is excess activity of the HIF-2 alpha pathway. A total of 61 patients with renal cell carcinoma and other proliferative manifestations of the hypoxia-induced signaling pathway received belzutifan, which inhibits the HIF-2 alpha pathway. Nearly half the patients with renal cell carcinoma had a response to treatment, and 98% had disease control.	[Jonasch, Eric] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Donskov, Frede] Aarhus Univ Hosp, Aarhus, Denmark; [Iliopoulos, Othon] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Iliopoulos, Othon] Harvard Med Sch, Boston, MA 02115 USA; [Rathmell, W. Kimryn] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Narayan, Vivek K.] Univ Penn, Philadelphia, PA 19104 USA; [Maughan, Benjamin L.] Univ Utah, Salt Lake City, UT USA; [Oudard, Stephane] Univ Paris, Hop Europeen Georges Pompidou, Paris, France; [Else, Tobias] Univ Michigan, Ann Arbor, MI 48109 USA; [Maranchie, Jodi K.] Univ Pittsburgh, Pittsburgh, PA USA; [Welsh, Sarah J.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Thamake, Sanjay; Park, Eric K.; Perini, Rodolfo F.] Merck, Kenilworth, NJ USA; [Linehan, W. Marston; Srinivasan, Ramaprasad] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Srinivasan, Ramaprasad] NCI, Ctr Canc Res, Mol Canc Sect, Bldg 10,10 Ctr Dr, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; Aarhus University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vanderbilt University; University of Pennsylvania; Utah System of Higher Education; University of Utah; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cambridge; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Srinivasan, R (corresponding author), NCI, Ctr Canc Res, Mol Canc Sect, Bldg 10,10 Ctr Dr, Bethesda, MD 20892 USA.	ramasrin@mail.nih.gov		Donskov, Frede/0000-0002-8449-863X; OUDARD, Stephane/0000-0003-0893-285X				Binderup MLM, 2017, EUR J HUM GENET, V25, P301, DOI 10.1038/ejhg.2016.173; Binderup MLM, 2017, J MED GENET, V54, P11, DOI 10.1136/jmedgenet-2016-104058; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Choueiri TK, 2021, NAT MED, V27, P802, DOI 10.1038/s41591-021-01324-7; Choueiri TK, 2020, NAT MED, V26, P1519, DOI 10.1038/s41591-020-1093-z; Couch V, 2000, MAYO CLIN PROC, V75, P265; Courtney KD, 2020, CLIN CANCER RES, V26, P793, DOI 10.1158/1078-0432.CCR-19-1459; Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627; Haase VH, 2009, CURR PHARM DESIGN, V15, P3895, DOI 10.2174/138161209789649394; Jonasch E, 2011, ANN ONCOL, V22, P2661, DOI 10.1093/annonc/mdr011; Jonasch E, 2018, LANCET ONCOL, V19, P1351, DOI 10.1016/S1470-2045(18)30487-X; Kim E, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00016; Maher ER, 2011, EUR J HUM GENET, V19, P617, DOI 10.1038/ejhg.2010.175; Melendez-Rodriguez F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00214; National Comprehensive Cancer Network, 2021, KIDN CANC VERS 4 CLI; Oudard S, 2016, ONCOTARGET, V7, P85306, DOI 10.18632/oncotarget.13301; Pilie Patrick, 2018, Oncotarget, V9, P23390, DOI 10.18632/oncotarget.25171; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Schmid S, 2014, ONCOL RES TREAT, V37, P761, DOI 10.1159/000369362; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637	22	91	91	8	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2036	2046		10.1056/NEJMoa2103425	http://dx.doi.org/10.1056/NEJMoa2103425			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC3KG	34818478	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000721915400008
J	Sherman, SV; Petruzzi, M; della Vella, F				Sherman, Stephanie V.; Petruzzi, Massimo; della Vella, Fedora			Pyostomatitis Vegetans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Petruzzi, Massimo; della Vella, Fedora] Univ Bari Aldo Moro, Bari, Italy	Universita degli Studi di Bari Aldo Moro	della Vella, F (corresponding author), Univ Bari Aldo Moro, Bari, Italy.	dellavellaf@gmail.com	Petruzzi, Massimo/O-6040-2016						0	0	0	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22							e77	10.1056/NEJMicm2108327	http://dx.doi.org/10.1056/NEJMicm2108327			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XC3KG	34818482				2022-12-28	WOS:000721915400001
J	Mulderrig, L; Garaycoechea, JI; Tuong, ZK; Millington, CL; Dingler, FA; Ferdinand, JR; Gaul, L; Tadross, JA; Arends, MJ; O'Rahilly, S; Crossan, GP; Clatworthy, MR; Patel, KJ				Mulderrig, Lee; Garaycoechea, Juan I.; Tuong, Zewen K.; Millington, Christopher L.; Dingler, Felix A.; Ferdinand, John R.; Gaul, Liam; Tadross, John A.; Arends, Mark J.; O'Rahilly, Stephen; Crossan, Gerry P.; Clatworthy, Menna R.; Patel, Ketan J.			Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; COCKAYNE-SYNDROME; COUPLED REPAIR; MICE; FORMALDEHYDE; CANCER; UBIQUITYLATION; INITIATION; CLEARANCE; DEFICIENT	Endogenous DNA damage can perturb transcription, triggering a multifaceted cellular response that repairs the damage, degrades RNA polymerase II and shuts down global transcription(1-4). This response is absent in the human disease Cockayne syndrome, which is caused by loss of the Cockayne syndrome A (CSA) or CSB proteins(5-7). However, the source of endogenous DNA damage and how this leads to the prominent degenerative features of this disease remain unknown. Here we find that endogenous formaldehyde impedes transcription, with marked physiological consequences. Mice deficient in formaldehyde clearance (Adh5(-/-)) and CSB (Csb(m/m); Csb is also known as Ercc6) develop cachexia and neurodegeneration, and succumb to kidney failure, features that resemble human Cockayne syndrome. Using single-cell RNA sequencing, we find that formaldehyde-driven transcriptional stress stimulates the expression of the anorexiogenic peptide GDF15 by a subset of kidney proximal tubule cells. Blocking this response with an anti-GDF15 antibody alleviates cachexia in Adh5(-/-)Csb(m/m) mice. Therefore, CSB provides protection to the kidney and brain against DNA damage caused by endogenous formaldehyde, while also suppressing an anorexic endocrine signal. The activation of this signal might contribute to the cachexia observed in Cockayne syndrome as well as chemotherapy-induced anorectic weight loss. A plausible evolutionary purpose for such a response is to ensure aversion to genotoxins in food.	[Mulderrig, Lee; Millington, Christopher L.; Dingler, Felix A.; Patel, Ketan J.] Univ Oxford, MRC Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford, England; [Mulderrig, Lee; Crossan, Gerry P.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge, England; [Garaycoechea, Juan I.] Hubrecht Inst, Utrecht, Netherlands; [Tuong, Zewen K.; Ferdinand, John R.; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, Cambridge, England; [Tuong, Zewen K.; Clatworthy, Menna R.] Wellcome Sanger Inst, Cellular Genet, Wellcome Genome Campus, Hinxton, England; [Gaul, Liam] Francis Crick Inst, London, England; [Tadross, John A.; O'Rahilly, Stephen] Univ Cambridge, Wellcome Trust Med Res Council Inst Metab Sci, MRC Metab Dis Unit, Cambridge, England; [Tadross, John A.] Univ Cambridge, Dept Pathol, Cambridge, England; [Arends, Mark J.] Univ Edinburgh, Div Pathol, Canc Res UK Edinburgh Ctr, IGMM, Edinburgh, Midlothian, Scotland; [Clatworthy, Menna R.] Univ Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge, England; [Clatworthy, Menna R.] NIHR Cambridge Biomed Res Ctr, Cambridge, England	University of Oxford; MRC Laboratory Molecular Biology; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Cambridge; Wellcome Trust Sanger Institute; Francis Crick Institute; University of Cambridge; University of Cambridge; University of Edinburgh; University of Cambridge; University of Cambridge	Patel, KJ (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford, England.; Patel, KJ (corresponding author), MRC Lab Mol Biol, Cambridge, England.	ketan.patel@imm.ox.ac.uk	Tadross, John/E-7513-2012; Tuong, Zewen Kelvin/E-4419-2017	Tadross, John/0000-0002-8424-1252; Arends, Mark/0000-0002-6826-8770; Gaul, Liam/0000-0002-3159-8127; Ferdinand, John Robert/0000-0003-0936-0128; Tuong, Zewen Kelvin/0000-0002-6735-6808	MRC, CRUK [C42693/A23273, FC0001166]; Wellcome Trust [106202/Z/14/Z, FC001166]; European Union Research and Innovation programme Horizon 2020 [730879]; Hubrecht Institute; NIHR Research Professorship [RP-2017-08-ST2-002]; NIHR Cambridge Blood and Transplant Research Unit Organ Donation; MRC HCA [MR/S035842/1]; UK Medical Research Council [FC001166]; Medical Research Council [MRC.MC.UU.12012.1]; Wellcome Senior Investigator Award [214274/Z/18/Z]; NIHR Cambridge Biomedical Research Centre; NIHR Clinical Lectureship [CL-2019-14-504]; CRUK [C42693/A23273, FC0001166]	MRC, CRUK; Wellcome Trust(Wellcome Trust); European Union Research and Innovation programme Horizon 2020; Hubrecht Institute; NIHR Research Professorship; NIHR Cambridge Blood and Transplant Research Unit Organ Donation; MRC HCA; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Senior Investigator Award; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Clinical Lectureship; CRUK(Cancer Research UK)	We thank members of the K.J.P., G.P.C. and J.I.G. laboratories for critical reading of the manuscript. We thank J. Svejstrup and A. Tufegdzic Vidakovic for the pGEX-Dsk2 plasmid, E. Friedberg, G. T. van der Horst and J. Hoeijmakers for sharing the Xpc<SUP>-/-</SUP>, Xpa<SUP>-/-</SUP> and Csb<SUP>m/m</SUP> mice and S. Wells, M. Stewart and H. Cater for work done at MRC Harwell. We thank Pfizer for the GDF15 monoclonal antibody. K.J.P. is supported by MRC, CRUK (C42693/A23273), Wellcome Trust (106202/Z/14/Z) and European Union Research and Innovation programme Horizon 2020 (Grant Agreement Number 730879). L.M., F.A.D. and G.P.C. were supported by CRUK (C42693/A23273). J.I.G. is supported by the Hubrecht Institute. C.L.M. is supported by the Wellcome Trust (106202/Z/14/Z). M.R.C. is funded by an NIHR Research Professorship (RP-2017-08-ST2-002). J.R.F. is funded by NIHR Cambridge Blood and Transplant Research Unit Organ Donation. Z.K.T. and M.R.C. are funded by MRC HCA grant MR/S035842/1. L.G. is funded from CRUK (FC0001166), the UK Medical Research Council (FC001166) and the Wellcome Trust (FC001166). S.O. is supported by the Medical Research Council MRC.MC.UU.12012.1, a Wellcome Senior Investigator Award 214274/Z/18/Z and the NIHR Cambridge Biomedical Research Centre. J.A.T. is supported by an NIHR Clinical Lectureship (CL-2019-14-504).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breen DM, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.023; Brooks CR, 2015, EMBO J, V34, P2441, DOI 10.15252/embj.201489838; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheng G, 2003, CHEM RES TOXICOL, V16, P145, DOI 10.1021/tx025614r; Cheo DL, 1997, MUTAT RES-FUND MOL M, V374, P1, DOI 10.1016/S0027-5107(97)00046-8; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Dingler FA, 2020, MOL CELL, V80, P996, DOI 10.1016/j.molcel.2020.10.012; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Feng D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52961-5; Freitas MCS, 2011, TRANSPLANTATION, V92, P131, DOI 10.1097/TP.0b013e318220586e; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Gregersen LH, 2018, TRENDS BIOCHEM SCI, V43, P327, DOI 10.1016/j.tibs.2018.02.010; Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kubota M, 2015, PEDIATR INT, V57, P339, DOI 10.1111/ped.12635; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lans H, 2019, NAT REV MOL CELL BIO, V20, P766, DOI 10.1038/s41580-019-0169-4; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Liu J, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94716; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Mulderrig L, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008555; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Niedernhofer Laura J, 2011, Mech Ageing Dev, V132, P340, DOI 10.1016/j.mad.2011.06.004; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pontel LB, 2015, MOL CELL, V60, P177, DOI 10.1016/j.molcel.2015.08.020; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Ranes M, 2016, NUCLEIC ACIDS RES, V44, P5246, DOI 10.1093/nar/gkw216; Stern-Delfils A, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.01.002; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; van der Horst GTJ, 2002, DNA REPAIR, V1, P143, DOI 10.1016/S1568-7864(01)00010-6; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329; Vidakovic AT, 2020, CELL, V180, P1245, DOI 10.1016/j.cell.2020.02.009; Vidakovic AT, 2019, METHODS, V159, P146, DOI 10.1016/j.ymeth.2019.02.005; Watson HJ, 2019, NAT GENET, V51, P1207, DOI 10.1038/s41588-019-0439-2; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Wilson BT, 2016, GENET MED, V18, P483, DOI 10.1038/gim.2015.110; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; Young Matthew D, 2020, Gigascience, V9, DOI 10.1093/gigascience/giaa151; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699	54	13	13	7	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					158	+		10.1038/s41586-021-04133-7	http://dx.doi.org/10.1038/s41586-021-04133-7		NOV 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34819667	Green Submitted			2022-12-28	WOS:000722150800003
J	Bennell, KL; Paterson, KL; Metcalf, BR; Duong, V; Eyles, J; Kasza, J; Wang, YY; Cicuttini, F; Buchbinder, R; Forbes, A; Harris, A; Yu, SP; Connell, D; Linklater, J; Wang, BH; Oo, WM; Hunter, DJ				Bennell, Kim L.; Paterson, Kade L.; Metcalf, Ben R.; Duong, Vicky; Eyles, Jillian; Kasza, Jessica; Wang, Yuanyuan; Cicuttini, Flavia; Buchbinder, Rachelle; Forbes, Andrew; Harris, Anthony; Yu, Shirley P.; Connell, David; Linklater, James; Wang, Bing Hui; Oo, Win Min; Hunter, David J.			Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis The RESTORE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Question Does intra-articular injection of platelet-rich plasma (PRP), compared with placebo saline injection, improve symptoms and joint structure in patients with knee osteoarthritis? Findings In this randomized clinical trial that included 288 adults aged 50 years or older with mild to moderate radiographic knee osteoarthritis, treatment with PRP vs placebo injection resulted in a mean change in knee pain scores of -2.1 vs -1.8 on an 11-point scale (range, 0-10) and a mean change in medial tibial cartilage volume of -1.4% vs -1.2% at 12 months. Neither comparison was statistically significant. Meaning Among adults with mild to moderate knee osteoarthritis, treatment with PRP vs saline injection did not significantly improve knee pain or slow disease progression. Importance Most clinical guidelines do not recommend platelet-rich plasma (PRP) for knee osteoarthritis (OA) because of lack of high-quality evidence on efficacy for symptoms and joint structure, but the guidelines emphasize the need for rigorous studies. Despite this, use of PRP in knee OA is increasing. Objective To evaluate the effects of intra-articular PRP injections on symptoms and joint structure in patients with symptomatic mild to moderate radiographic medial knee OA. Design, Setting, and Participants This randomized, 2-group, placebo-controlled, participant-, injector-, and assessor-blinded clinical trial enrolled community-based participants (n = 288) aged 50 years or older with symptomatic medial knee OA (Kellgren and Lawrence grade 2 or 3) in Sydney and Melbourne, Australia, from August 24, 2017, to July 5, 2019. The 12-month follow-up was completed on July 22, 2020. Interventions Interventions involved 3 intra-articular injections at weekly intervals of either leukocyte-poor PRP using a commercially available product (n = 144 participants) or saline placebo (n = 144 participants). Main Outcomes and Measures The 2 primary outcomes were 12-month change in overall average knee pain scores (11-point scale; range, 0-10, with higher scores indicating worse pain; minimum clinically important difference of 1.8) and percentage change in medial tibial cartilage volume as assessed by magnetic resonance imaging (MRI). Thirty-one secondary outcomes (25 symptom related and 6 MRI assessed; minimum clinically important difference not known) evaluated pain, function, quality of life, global change, and joint structures at 2-month and/or 12-month follow-up. Results Among 288 patients who were randomized (mean age, 61.9 [SD, 6.5] years; 169 [59%] women), 269 (93%) completed the trial. In both groups, 140 participants (97%) received all 3 injections. After 12 months, treatment with PRP vs placebo injection resulted in a mean change in knee pain scores of -2.1 vs -1.8 points, respectively (difference, -0.4 [95% CI, -0.9 to 0.2] points; P = .17). The mean change in medial tibial cartilage volume was -1.4% vs -1.2%, respectively (difference, -0.2% [95% CI, -1.9% to 1.5%]; P = .81). Of 31 prespecified secondary outcomes, 29 showed no significant between-group differences. Conclusions and Relevance Among patients with symptomatic mild to moderate radiographic knee OA, intra-articular injection of PRP, compared with injection of saline placebo, did not result in a significant difference in symptoms or joint structure at 12 months. These findings do not support use of PRP for the management of knee OA. This randomized trial assesses the effect of injections of platelet-rich plasma vs saline placebo on 12-month changes in knee pain scores and medial tibial cartilage volume among patients with symptomatic mild to moderate knee osteoarthritis.	[Bennell, Kim L.; Paterson, Kade L.; Metcalf, Ben R.] Univ Melbourne, Fac Med Dent & Hlth Sci, Ctr Hlth Exercise & Sports Med, Sch Hlth Sci,Dept Physiotherapy, Melbourne, Vic, Australia; [Duong, Vicky; Eyles, Jillian; Yu, Shirley P.; Oo, Win Min; Hunter, David J.] Univ Sydney, Royal North Shore Hosp, Inst Bone & Joint Res, Kolling Inst,Rheumatol Dept, Sydney, NSW, Australia; [Kasza, Jessica; Wang, Yuanyuan; Cicuttini, Flavia; Forbes, Andrew] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Cicuttini, Flavia] Alfred Hosp, Rheumatol Dept, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Harris, Anthony] Monash Univ, Ctr Hlth Econ, Melbourne, Vic, Australia; [Connell, David] Imaging Olymp Pk, Melbourne, Vic, Australia; [Linklater, James] Castlereagh Imaging, Sydney, NSW, Australia; [Wang, Bing Hui] Monash Univ, Monash Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Wang, Bing Hui] Baker Heart & Diabet Inst, Biomarker Discovery Lab, Melbourne, Vic, Australia; [Oo, Win Min] Univ Med Mandalay, Dept Phys Med & Rehabil, Mandalay, Myanmar	University of Melbourne; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Monash University; Florey Institute of Neuroscience & Mental Health; Cabrini Health; Monash University; Monash University; Monash University	Bennell, KL (corresponding author), Univ Melbourne, Dept Physiotherapy, Ctr Hlth Exercise Arid Sports Med, 161 Barry St, Carlton, Vic 3010, Australia.	k.bennell@unimelb.edu.au	Oo, Win Min/D-9508-2015; Duong, Vicky/K-2012-2019; Paterson, Kade/G-4715-2012	Duong, Vicky/0000-0002-4450-8194; Oo, Win Min/0000-0002-4065-7395; Paterson, Kade/0000-0002-0323-6129				Ahmad HS, 2018, INT J RHEUM DIS, V21, P960, DOI 10.1111/1756-185X.13315; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; [Anonymous], 2015, REGENBCT TUBE PERFOR; Bannuru RR, 2019, OSTEOARTHR CARTILAGE, V27, P1578, DOI 10.1016/j.joca.2019.06.011; Belk JW, 2021, AM J SPORT MED, V49, P249, DOI 10.1177/0363546520909397; BELLAMY N, 1992, J RHEUMATOL, V19, P444; Bennell KL, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0652-x; Bennell KL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2912; Buendia-Lopez D, 2018, J ORTHOP TRAUMATOL, V19, DOI 10.1186/s10195-018-0501-3; Carpenter JA, 2013, STUD WORLD CHR SER, P1; Cicuttini FM, 2004, ANN RHEUM DIS, V63, P1124, DOI 10.1136/ard.2004.021253; Elik H, 2020, J BACK MUSCULOSKELET, V33, P127, DOI 10.3233/BMR-181374; Fice MP, 2019, ARTHROSCOPY, V35, P961, DOI 10.1016/j.arthro.2018.10.125; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P409, DOI 10.1016/j.joca.2007.12.015; Hay SI, 2017, LANCET, V389, pE1; Hohmann E, 2020, EUR J ORTHOP SURG TR, V30, P955, DOI 10.1007/s00590-020-02623-4; Hong M, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/2191926; Hunter DJ, 2015, OSTEOARTHR CARTILAGE, V23, P698, DOI 10.1016/j.joca.2015.03.012; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P990, DOI 10.1016/j.joca.2011.05.004; James KE, 1996, STAT MED, V15, P1421; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; Kon E, 2020, EXPERT OPIN BIOL TH, V20, P1447, DOI 10.1080/14712598.2020.1798925; McAlindon TE, 2015, OSTEOARTHR CARTILAGE, V23, P747, DOI 10.1016/j.joca.2015.03.005; Murray IR, 2017, J BONE JOINT SURG AM, V99, P809, DOI 10.2106/JBJS.16.00793; Patel S, 2013, AM J SPORT MED, V41, P356, DOI 10.1177/0363546512471299; Paterson KL, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2205-5; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; Shen LX, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0521-3; ten Klooster PM, 2006, PAIN, V121, P151, DOI 10.1016/j.pain.2005.12.021; Werner BC, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967119900811	33	43	43	16	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2021	2030		10.1001/jama.2021.19415	http://dx.doi.org/10.1001/jama.2021.19415			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812863	Bronze, Green Published			2022-12-28	WOS:000724001500022
J	Iacobucci, G				Iacobucci, Gareth			Sepsis guidance may change as result of deaths of two women from herpes infection after giving birth	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Melley J, 2021, BBC NEWS; Royal College of Obstetricians and Gynaecologists, 2012, SEPS FOLL PREGN BACT	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2881	10.1136/bmj.n2881	http://dx.doi.org/10.1136/bmj.n2881			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815235				2022-12-28	WOS:000722577100003
J	Kuehn, BM				Kuehn, Bridget M.			Unhygienic Practices Lead to Routine Vaccination-Linked Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2002	2002		10.1001/jama.2021.20171	http://dx.doi.org/10.1001/jama.2021.20171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812856				2022-12-28	WOS:000724001500049
J	Iacobucci, G				Iacobucci, Gareth			Covid-19 and pregnancy: vaccine hesitancy and how to overcome it	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, PUBLIC HLTH SCOTLAND; Gurol-Urganci I, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.05.016; Intensive Care National Audit and Research Centre, 2021, ICNARC REP COV 19 CR; Knight M, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3305; National Perinatal Epidemiology Unit University of Oxford, 2021, MBRRACE UK MOTH BAB; UK Health Security Agency, 2021, WEEKL NAT INFL COVID; UK Obstetric Surveillance System, 2021, KEY INF COVID 19 PRE; UK Obstetric Surveillance System, 2021, COV 19 VACC PREGN 24; Vousden N., 2021, PLoS ONE, V16, DOI 10.1371/journal.pone.0251123; Vousden N., 2021, IMPACT SARS COV 2 VA, DOI [10.1101/2021.07.22.21261000, DOI 10.1101/2021.07.22.21261000]	10	19	19	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2021	375								n2862	10.1136/bmj.n2862	http://dx.doi.org/10.1136/bmj.n2862			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3LL	34810161	Bronze			2022-12-28	WOS:000730089900007
J	Burki, T				Burki, Talha			mRNA discoveries earn the 2021 Prince Mahidol Award	LANCET			English	Editorial Material																			0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1865	1865						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801095	Green Published, Bronze			2022-12-28	WOS:000720912600013
J	Incze, MA; Kelley, AT; Singer, PM				Incze, Michael A.; Kelley, A. Taylor; Singer, Phillip M.			Heterogeneous State Cannabis Policies Potential Implications for Patients and Health Care Professionals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses how the varied and fragmented policies and sources of information about cannabis use in the US can lead to confusion among patients and clinicians.	[Incze, Michael A.; Kelley, A. Taylor] Univ Utah, Sch Med, Program Addict Res Clin Care Knowledge & Advocacy, Div Epidemiol,Dept Internal Med, Salt Lake City, UT USA; [Kelley, A. Taylor] VA Salt Lake City Hlth Care Syst, Vulnerable Vet Innovat Patient Aligned Care Team, Initiat Informat Decis Enhancement & Analyt Sci I, Salt Lake City, UT USA; [Singer, Phillip M.] Univ Utah, Dept Polit Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Incze, MA (corresponding author), Univ Utah, Div Gen Internal Med, 30 N 1900 E,Room 5R218, Salt Lake City, UT 84132 USA.	michael.incze@hsc.utah.edu						[Anonymous], DEA CONT PRIOR EFF E; Boatwright KD, 2020, J PHARM PRACT, V33, P457, DOI 10.1177/0897190018818907; Han BJH, 2020, JAMA INTERN MED, V180, P609, DOI 10.1001/jamainternmed.2019.7517; Natl Acad Sci Engn Med, 2017, HEALTH EFFECTS OF CANNABIS AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR RESEARCH, P1, DOI 10.17226/24625; Philpot LM, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0906-y; Rehman Y, 2021, AIMS NEUROSCI, V8, P414, DOI 10.3934/Neuroscience.2021022; Schauer GL, 2016, AM J PREV MED, V50, P1, DOI 10.1016/j.amepre.2015.05.027; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Substance Abuse and Mental Health Services Administration, 2021, PEP195068 HHS; Williams AR, 2020, ANN INTERN MED, V173, pITC65, DOI 10.7326/AITC202011030	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2021	326	23					2363	2364		10.1001/jama.2021.21182	http://dx.doi.org/10.1001/jama.2021.21182		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC5RI	34797377				2022-12-28	WOS:000720515700002
J	Olatunbosun-Alakija, A				Olatunbosun-Alakija, Ayoade			Unless we address the inequity in global health, then the world will not be prepared for the next pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Olatunbosun-Alakija, Ayoade] African Union, Africa Vaccine Delivery Alliance, Durban, South Africa		Olatunbosun-Alakija, A (corresponding author), African Union, Africa Vaccine Delivery Alliance, Durban, South Africa.							GPMB, WORLDS APART	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2848	10.1136/bmj.n2848	http://dx.doi.org/10.1136/bmj.n2848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799360	Green Published, hybrid			2022-12-28	WOS:000723212300002
J	Patton, GC; Neufeld, LM; Dogra, S; Frongillo, EA; Hargreaves, D; He, SS; Mates, E; Menon, P; Naguib, M; Norris, SA				Patton, George C.; Neufeld, Lynnette M.; Dogra, Surabhi; Frongillo, Edward A.; Hargreaves, Dougal; He, Shanshan; Mates, Emily; Menon, Purnima; Naguib, Mariam; Norris, Shane A.			Nourishing our future: the Lancet Series on adolescent nutrition	LANCET			English	Editorial Material							CHILDREN		[Patton, George C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Patton, George C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Neufeld, Lynnette M.] Global Alliance Improved Nutr GAIN, Geneva, Switzerland; [Dogra, Surabhi] Youth Network Lancet Standing Commiss Adolescent, Noida, India; [He, Shanshan] Youth Network Lancet Standing Commiss Adolescent, Beijing, Peoples R China; [Frongillo, Edward A.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Hargreaves, Dougal] Imperial Coll London, Mohn Ctr Childrens Hlth & Wellbeing, London, England; [Mates, Emily] Emergency Nutr Network, Oxford, England; [Menon, Purnima] Int Food Policy Res Inst, New Delhi, India; [Naguib, Mariam] McGill Univ, Dept Gen Pediat, Montreal, PQ, Canada; [Norris, Shane A.] Univ Southampton, Sch Human Dev & Hlth, Global Hlth Res Inst, Southampton, Hants, England	University of Melbourne; Murdoch Children's Research Institute; University of South Carolina System; University of South Carolina Columbia; Imperial College London; CGIAR; International Food Policy Research Institute (IFPRI); McGill University; University of Southampton	Patton, GC (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.; Patton, GC (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	george.patton@rch.org.au	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Mates, Emily/0000-0002-0042-3017; Dogra, Surabhi/0000-0003-4136-2115				[Anonymous], 2011, LANCET, V378, P741, DOI 10.1016/S0140-6736(11)61356-1; [Anonymous], 2021, CHILDR ALL POL; Azzopardi PS, 2019, LANCET, V393, P1101, DOI 10.1016/S0140-6736(18)32427-9; Branca F, 2020, LANCET, V395, P8, DOI 10.1016/S0140-6736(19)32690-X; Clark H, 2020, LANCET, V395, P605, DOI 10.1016/S0140-6736(19)32540-1; Dalglish SL, 2021, LANCET, V397, P1605, DOI 10.1016/S0140-6736(21)00718-2; Depauw E, 2019, ECON HIST REV, V72, P925, DOI 10.1111/ehr.12745; Hargreaves D, 2022, LANCET, V399, P198, DOI 10.1016/S0140-6736(21)01593-2; Horton R, 2019, LANCET, V393, P2286, DOI 10.1016/S0140-6736(19)31328-5; Hunt D, 2021, PUBLIC HEALTH NUTR, V24, P3124, DOI 10.1017/S1368980020003353; Li ZH, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1072; Neufeld LM, 2022, LANCET, V399, P185, DOI 10.1016/S0140-6736(21)01687-1; Norris SA, 2022, LANCET, V399, P172, DOI 10.1016/S0140-6736(21)01590-7; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; SPRING, 2018, AD NUTR CALL ACT BET; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; World Health Organization, 2017, GLOB TARG 2025 IMPR; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P	19	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					123	125		10.1016/S0140-6736(21)02140-1	http://dx.doi.org/10.1016/S0140-6736(21)02140-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34856189				2022-12-28	WOS:000740652500006
J	Vasan, A; Harris, A; Kangovi, S; Mahoney, KB				Vasan, Aditi; Harris, Ashlee; Kangovi, Shreya; Mahoney, Kevin B.			Getting Proximate - Flipping the Mentorship Paradigm to Promote Health Equity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vasan, Aditi; Harris, Ashlee; Kangovi, Shreya; Mahoney, Kevin B.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Vasan, A (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.			Vasan, Aditi/0000-0001-8992-5672				American College of Health Care Executives, 2020, INCR SUST RAC ETHN D; Gonzalez Cristina M, 2018, Acad Med, V93, pS74, DOI 10.1097/ACM.0000000000002386; Hansen H, 2018, JAMA PSYCHIAT, V75, P117, DOI 10.1001/jamapsychiatry.2017.3894; National Center for Health Statistics, 2020, NATL VITAL STAT SYST; Wilkerson I., 2020, NEW YORK TIMES MAGAZ	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24								10.1056/NEJMpv2116137	http://dx.doi.org/10.1056/NEJMpv2116137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XL4CS	34879455	Bronze			2022-12-28	WOS:000728093600005
J	Wise, J				Wise, Jacqui			GP leaders warn over the rollout of cholesterol lowering inclisiran in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, RCGP BMA UPDATE INFO; Byrne P, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2462; National Institute for Health and Care Excellence, 2021, INCL TREAT PRIM HYP; Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2143	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2021	375								n3025	10.1136/bmj.n3025	http://dx.doi.org/10.1136/bmj.n3025			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4CS	34872911				2022-12-28	WOS:000730815000002
J	Charon, R				Charon, Rita			Knowing, seeing, and telling in medicine	LANCET			English	Editorial Material									[Charon, Rita] Columbia Vagelos Coll Phys & Surg, Dept Med Humanities & Eth, New York, NY 10032 USA		Charon, R (corresponding author), Columbia Vagelos Coll Phys & Surg, Dept Med Humanities & Eth, New York, NY 10032 USA.	rac5@cumc.columbia.edu			National Center for Advancing Translational Sciences, US National Institutes of Health [UL1TR001873]	National Center for Advancing Translational Sciences, US National Institutes of Health	This publication was supported by the National Center for Advancing Translational Sciences, US National Institutes of Health, through grant number UL1TR001873. The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH.		0	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2068	2070						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863343				2022-12-28	WOS:000726564200012
J	Abrahams, C				Abrahams, Caroline			Healthcare professionals have a vital role to play in safeguarding older people from abuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Abrahams, Caroline] Age UK, London, England		Abrahams, C (corresponding author), Age UK, London, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2866	10.1136/bmj.n2866	http://dx.doi.org/10.1136/bmj.n2866			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XE5JI	34819322	Bronze			2022-12-28	WOS:000723423400005
J	Feng, YQ; Li, CL; Stewart, JA; Barbulescu, P; Desivo, NS; alvarez-Quilon, A; Pezo, RC; Perera, MLW; Chan, KE; Tong, AHY; Mohamad-Ramshan, R; Berru, M; Nakib, D; Li, GV; Kardar, GA; Carlyle, JR; Moffat, J; Durocher, D; Di Noia, JM; Bhagwat, AS; Martin, A				Feng, Yuqing; Li, Conglei; Stewart, Jessica A.; Barbulescu, Philip; Desivo, Noe Seija; alvarez-Quilon, Alejandro; Pezo, Rossanna C.; Perera, Madusha L. W.; Chan, Katherine; Tong, Amy Hin Yan; Mohamad-Ramshan, Rukshana; Berru, Maribel; Nakib, Diana; Li, Gavin; Kardar, Gholam Ali; Carlyle, James R.; Moffat, Jason; Durocher, Daniel; Di Noia, Javier M.; Bhagwat, Ashok S.; Martin, Alberto			FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation	NATURE			English	Article							CLASS SWITCH RECOMBINATION; IMMUNOGLOBULIN GENE CONVERSION; CYTIDINE DEAMINASE AID; DNA-POLYMERASE-ETA; SOMATIC HYPERMUTATION; B-CELLS; URACIL; EXCISION; MSH2; DEFICIENT	Activation-induced cytidine deaminase (AID) catalyses the deamination of deoxycytidines to deoxyuracils within immunoglobulin genes to induce somatic hypermutation and class-switch recombination(1,2). AID-generated deoxyuracils are recognized and processed by subverted base-excision and mismatch repair pathways that ensure a mutagenic outcome in B cells(3-6). However, why these DNA repair pathways do not accurately repair AID-induced lesions remains unknown. Here, using a genome-wide CRISPR screen, we show that FAM72A is a major determinant for the error-prone processing of deoxyuracils. Fam72a-deficient CH12F3-2 B cells and primary B cells from Fam72a(-/-) mice exhibit reduced class-switch recombination and somatic hypermutation frequencies at immunoglobulin and Bcl6 genes, and reduced genome-wide deoxyuracils. The somatic hypermutation spectrum in B cells from Fam72a(-/-) mice is opposite to that observed in mice deficient in uracil DNA glycosylase 2 (UNG2)(7), which suggests that UNG2 is hyperactive in FAM72A-deficient cells. Indeed, FAM72A binds to UNG2, resulting in reduced levels of UNG2 protein in the G1 phase of the cell cycle, coinciding with peak AID activity. FAM72A therefore causes U.G mispairs to persist into S phase, leading to error-prone processing by mismatch repair. By disabling the DNA repair pathways that normally efficiently remove deoxyuracils from DNA, FAM72A enables AID to exert its full effects on antibody maturation. This work has implications in cancer, as the overexpression of FAM72A that is observed in many cancers(8) could promote mutagenesis.	[Feng, Yuqing; Li, Conglei; Barbulescu, Philip; Berru, Maribel; Nakib, Diana; Li, Gavin; Carlyle, James R.; Martin, Alberto] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Stewart, Jessica A.; Perera, Madusha L. W.; Mohamad-Ramshan, Rukshana; Bhagwat, Ashok S.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Desivo, Noe Seija; Di Noia, Javier M.] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Desivo, Noe Seija; Di Noia, Javier M.] Univ Montreal, Dept Med, Mol Biol Programs, Montreal, PQ, Canada; [alvarez-Quilon, Alejandro; Moffat, Jason; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [alvarez-Quilon, Alejandro; Durocher, Daniel] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Pezo, Rossanna C.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Pezo, Rossanna C.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chan, Katherine; Tong, Amy Hin Yan; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Kardar, Gholam Ali] Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; [Moffat, Jason] Univ Toronto, Inst Biomed Engn, Toronto, ON, Canada; [Bhagwat, Ashok S.] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI USA; [Li, Conglei] Chinese Univ Hong Kong, Sch Med, Shenzhen, Peoples R China	University of Toronto; Wayne State University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences; University of Toronto; Wayne State University; Chinese University of Hong Kong, Shenzhen	Martin, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	alberto.martin@utoronto.ca	Bhagwat, Ashok/AAU-4186-2021; Durocher, Daniel/A-7733-2010; Bhagwat, Ashok/ABA-3861-2020; Di Noia, Javier Marcelo/D-2285-2012; Moffat, Jason/AAC-1110-2020	Bhagwat, Ashok/0000-0003-1188-0579; Durocher, Daniel/0000-0003-3863-8635; Di Noia, Javier Marcelo/0000-0003-2896-0321; Moffat, Jason/0000-0002-5663-8586; Alvarez-Quilon, Alejandro/0000-0001-9330-6823	Canadian Institutes of Health Research Postdoctoral Fellowship; FRQ-S (Fonds de recherche Sante Quebec); Wayne State University; Thomas C. Rumble fellowship; Fonds de recherche de Quebec-Sante; CIHR [PJT-155944, CBT-438323, FDN143343, PJT-153307, PJT-156330]; National Institutes of Health [1R21AI144708]	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); FRQ-S (Fonds de recherche Sante Quebec); Wayne State University; Thomas C. Rumble fellowship; Fonds de recherche de Quebec-Sante; CIHR(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Poussier and M. Shulman for critical review of the manuscript. Y.F., C.L. and A.A.-Q. are recipients of the Canadian Institutes of Health Research Postdoctoral Fellowship. N.S.D. is the recipient of a doctoral award from the FRQ-S (Fonds de recherche Sante Quebec). J.A.S. was supported by a competitive graduate research assistantship from the Wayne State University and R.M.-R. was supported by a Thomas C. Rumble fellowship. J.M.D.N. is a Merit scholar from the Fonds de recherche de Quebec-Sante and is supported by CIHR (PJT-155944). J.M. is supported from a CIHR project grant (CBT-438323) and holds a Canada Research Chair in Functional Genomics. D.D. is a Canada Research Chair (Tier I) and work in the D.D. laboratory was supported by a grant from the CIHR (FDN143343). A.S.B. was supported by a National Institutes of Health grant (1R21AI144708) and Bridge Funding grant from Wayne State University. A.M. is supported by grants from the CIHR (PJT-153307 and PJT-156330).	Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Aregger M, 2019, METHODS MOL BIOL, V1869, P169, DOI 10.1007/978-1-4939-8805-1_15; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Boulianne B, 2013, J IMMUNOL, V191, P4521, DOI 10.4049/jimmunol.1300769; Campo VA, 2013, NUCLEIC ACIDS RES, V41, P3032, DOI 10.1093/nar/gks1470; Cappelli E, 2001, CARCINOGENESIS, V22, P387, DOI 10.1093/carcin/22.3.387; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2006, EMBO J, V25, P585, DOI 10.1038/sj.emboj.7600939; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; Feng YQ, 2020, TRENDS IMMUNOL, V41, P586, DOI 10.1016/j.it.2020.04.009; Frieder D, 2009, MOL CELL BIOL, V29, P5148, DOI 10.1128/MCB.00647-09; Guo CG, 2008, CANCER RES, V68, P6118, DOI 10.1158/0008-5472.CAN-08-1259; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; Krusong K, 2006, J BIOL CHEM, V281, P4983, DOI 10.1074/jbc.M509137200; Lawson KA, 2020, NATURE, V586, P120, DOI 10.1038/s41586-020-2746-2; Li CL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1027; Li CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03455-x; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Perez-Duran P, 2012, J EXP MED, V209, P1379, DOI 10.1084/jem.20112253; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramachandran S, 2016, CELL REP, V15, P1554, DOI 10.1016/j.celrep.2016.04.041; Sarno A, 2019, NUCLEIC ACIDS RES, V47, P4569, DOI 10.1093/nar/gkz145; Siriwardena SU, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00238-18; So CC, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00488-18; Thientosapol ES, 2017, NUCLEIC ACIDS RES, V45, P3146, DOI 10.1093/nar/gkw1300; Wang Q, 2017, J EXP MED, V214, P49, DOI 10.1084/jem.20161649; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	38	12	12	4	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					324	+		10.1038/s41586-021-04144-4	http://dx.doi.org/10.1038/s41586-021-04144-4		NOV 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34819670	Green Accepted			2022-12-28	WOS:000722150800002
J	Izumi, H; Matsumoto, S; Liu, J; Tanaka, K; Mori, S; Hayashi, K; Kumagai, S; Shibata, Y; Hayashida, T; Watanabe, K; Fukuhara, T; Ikeda, T; Yoh, K; Kato, T; Nishino, K; Nakamura, A; Nakachi, I; Kuyama, S; Furuya, N; Sakakibara-Konishi, J; Okamoto, I; Taima, K; Ebi, N; Daga, H; Yamasaki, A; Kodani, M; Udagawa, H; Kirita, K; Zenke, Y; Nosaki, K; Sugiyama, E; Sakai, T; Nakai, T; Ishii, G; Niho, S; Ohtsu, A; Kobayashi, SS; Goto, K				Izumi, Hiroki; Matsumoto, Shingo; Liu, Jie; Tanaka, Kosuke; Mori, Shunta; Hayashi, Kumiko; Kumagai, Shogo; Shibata, Yuji; Hayashida, Takuma; Watanabe, Kana; Fukuhara, Tatsuro; Ikeda, Takaya; Yoh, Kiyotaka; Kato, Terufumi; Nishino, Kazumi; Nakamura, Atsushi; Nakachi, Ichiro; Kuyama, Shoichi; Furuya, Naoki; Sakakibara-Konishi, Jun; Okamoto, Isamu; Taima, Kageaki; Ebi, Noriyuki; Daga, Haruko; Yamasaki, Akira; Kodani, Masahiro; Udagawa, Hibiki; Kirita, Keisuke; Zenke, Yoshitaka; Nosaki, Kaname; Sugiyama, Eri; Sakai, Tetsuya; Nakai, Tokiko; Ishii, Genichiro; Niho, Seiji; Ohtsu, Atsushi; Kobayashi, Susumu S.; Goto, Koichi			The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer	NATURE			English	Article							OVERCOMES RESISTANCE; EXPRESSION; INHIBITOR; CLIP-170; GENE; RET	Lung cancer is one of the most aggressive tumour types. Targeted therapies stratified by oncogenic drivers have substantially improved therapeutic outcomes in patients with non-small-cell lung cancer (NSCLC)(1). However, such oncogenic drivers are not found in 25-40% of cases of lung adenocarcinoma, the most common histological subtype of NSCLC2. Here we identify a novel fusion transcript of CLIP1 and LTK using whole-transcriptome sequencing in a multi-institutional genome screening platform (LC-SCRUM-Asia, UMIN000036871). The CLIP1-LTK fusion was present in 0.4% of NSCLCs and was mutually exclusive with other known oncogenic drivers. We show that kinase activity of the CLIP1-LTK fusion protein is constitutively activated and has transformation potential. Treatment of Ba/F3 cells expressing CLIP1-LTK with lorlatinib, an ALK inhibitor, inhibited CLIP1-LTK kinase activity, suppressed proliferation and induced apoptosis. One patient with NSCLC harbouring the CLIP1-LTK fusion showed a good clinical response to lorlatinib treatment. To our knowledge, this is the first description of LTK alterations with oncogenic activity in cancers. These results identify the CLIP1-LTK fusion as a target in NSCLC that could be treated with lorlatinib.	[Izumi, Hiroki; Matsumoto, Shingo; Mori, Shunta; Shibata, Yuji; Ikeda, Takaya; Yoh, Kiyotaka; Udagawa, Hibiki; Kirita, Keisuke; Zenke, Yoshitaka; Nosaki, Kaname; Sugiyama, Eri; Sakai, Tetsuya; Niho, Seiji; Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; [Liu, Jie; Tanaka, Kosuke; Hayashida, Takuma; Udagawa, Hibiki; Kobayashi, Susumu S.] Natl Canc Ctr, Div Translat Genom, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Hayashi, Kumiko] LSI Medience Corp Cent Lab, Itabashi Ku, Tokyo, Japan; [Kumagai, Shogo] Natl Canc Ctr, Div Canc Immunol, Res Inst, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Hayashida, Takuma; Kobayashi, Susumu S.] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Watanabe, Kana; Fukuhara, Tatsuro] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi, Japan; [Kato, Terufumi] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan; [Nishino, Kazumi] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan; [Nakamura, Atsushi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Nakachi, Ichiro] Saiseikai Utsunomiya Hosp, Div Pulm, Dept Internal Med, Utsunomiya, Tochigi, Japan; [Kuyama, Shoichi] Natl Hosp Org Iwakuni Clin Ctr, Dept Resp Med, Iwakuni, Japan; [Furuya, Naoki] St Marianna Univ, Dept Internal Med, Div Resp Med, Sch Med, Kawasaki, Kanagawa, Japan; [Sakakibara-Konishi, Jun] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido, Japan; [Okamoto, Isamu] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka, Japan; [Taima, Kageaki] Hirosaki Univ, Dept Resp Med, Grad Sch Med, Hirosaki, Aomori, Japan; [Ebi, Noriyuki] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan; [Daga, Haruko] Osaka City Gen Hosp, Dept Med Oncol, Osaka, Japan; [Yamasaki, Akira; Kodani, Masahiro] Tottori Univ, Dept Multidisciplinary Internal Med, Div Resp Med & Rheumatol, Fac Med, Yonago, Tottori, Japan; [Nakai, Tokiko; Ishii, Genichiro] Natl Canc Ctr, Dept Pathol & Clin Labs, Kashiwa, Chiba, Japan; [Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Kobayashi, Susumu S.] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; Miyagi Cancer Center; Kanagawa Prefectural Cancer Center; Sendai Kousei Hospital; Saint Marianna University; Hokkaido University; Kyushu University; Hirosaki University; Osaka City General Hospital; Tottori University; National Cancer Center - Japan; National Cancer Center - Japan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Goto, K (corresponding author), Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan.; Kobayashi, SS (corresponding author), Natl Canc Ctr, Div Translat Genom, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan.; Kobayashi, SS (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.; Kobayashi, SS (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	sukobaya@east.ncc.go.jp; kgoto@east.ncc.go.jp	Furuya, Naoki/AAP-6618-2020	Furuya, Naoki/0000-0001-7162-5946; Izumi, Hiroki/0000-0002-9566-4859	Princess Takamatsu Cancer Research Fund [18-250]; JSPS KAKENHI [JP20K17215, JP16K21746, JP21K15541]; National Cancer Center Research and Development Fund [31-A-5, 31-A-6, 28-A-6]; AMED [JP21ck0106289, JP21ck0106294, JP21ck0106483, JP21ck0106568, JP20ck0106411, JP20ck0106449, JP20ck0106450, JP20ak0101050, JP18Ik0201056, JP18kk0205004, JP17Ack0106148, JP17Ack0106147, JP16ck0106041]; Amgen; Astellas; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai; Daiichi sankyo; Eisai; Janssen; Kyowa kirin; Merck; Medical & Biological Laboratories; MSD; Novartis; Ono; Pfizer; Sumitomo Dainippon; Taiho; Takeda; Merus	Princess Takamatsu Cancer Research Fund; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); AMED; Amgen(Amgen); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Chugai; Daiichi sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kyowa kirin; Merck(Merck & Company); Medical & Biological Laboratories; MSD; Novartis(Novartis); Ono; Pfizer(Pfizer); Sumitomo Dainippon; Taiho; Takeda(Takeda Pharmaceutical Company Ltd); Merus	We thank Y. Murata and PREMIA for administrative assistance with managing clinical samples, molecular screening and the clinico-genomic database in LC-SCRUM-Asia; and T. Y. Morita for assistance with flow cytometry analyses. This work was supported by the Princess Takamatsu Cancer Research Fund 18-250 (S.S.K.), JSPS KAKENHI Grant Number JP20K17215 (H.I.), JP16K21746 (S.S.K.) and JP21K15541 (K. Tanaka.), the National Cancer Center Research and Development Fund 31-A-5 (A.O.), 31-A-6 (S.S.K) and 28-A-6 (K.G.), and AMED Grant Number JP21ck0106289 (K.G.), JP21ck0106294 (K.Y.), JP21ck0106483 (K. Nosaki), JP21ck0106568 (K.G.), JP20ck0106411 (S. Matsumoto), JP20ck0106449 (I.O.), JP20ck0106450 (S.N.), JP20ak0101050 (K. Tsuchihara), JP18Ik0201056 (A.O.), JP18kk0205004 (H. Nakagama), JP17Ack0106148 (K.G.), JP17Ack0106147 (S. Yano), and JP16ck0106041 (K.G.). Molecular screening in LC-SCRUM-Asia was supported by Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Daiichi sankyo, Eisai, Janssen, Kyowa kirin, Merck, Medical & Biological Laboratories, MSD, Novartis, Ono, Pfizer, Sumitomo Dainippon, Taiho and Takeda. WTS was supported by Merus.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bruno R, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080521; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Drilon A, 2016, LANCET ONCOL, V17, P1653, DOI 10.1016/S1470-2045(16)30562-9; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Gainor JF, 2016, CANCER DISCOV, V6, P1118, DOI 10.1158/2159-8290.CD-16-0596; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Haas BJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1842-9; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Konig D, 2021, CANCERS, V13, DOI 10.3390/cancers13040804; Kohno T, 2015, TRANSL LUNG CANCER R, V4, P156, DOI 10.3978/j.issn.2218-6751.2014.11.11; Kuroda N, 2020, MODERN PATHOL, V33, P2564, DOI 10.1038/s41379-020-0578-0; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pinsolle J, 2019, CLIN LUNG CANCER, V20, pE535, DOI 10.1016/j.cllc.2019.05.001; Roll JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031733; Saito M, 2016, CANCER SCI, V107, P713, DOI 10.1111/cas.12941; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; VARMUS HE, 1984, ANNU REV GENET, V18, P553; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Yamada S, 2008, NEUROREPORT, V19, P1733, DOI 10.1097/WNR.0b013e3283186bf8; Yasuda H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007205; Yeh I, 2015, AM J SURG PATHOL, V39, P581, DOI 10.1097/PAS.0000000000000387; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zou HY, 2015, CANCER CELL, V28, P70, DOI 10.1016/j.ccell.2015.05.010	30	9	10	10	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					319	+		10.1038/s41586-021-04135-5	http://dx.doi.org/10.1038/s41586-021-04135-5		NOV 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34819663	Green Accepted			2022-12-28	WOS:000722150800001
J	Qin, Y; Huttlin, EL; Winsnes, CF; Gosztyla, ML; Wacheul, L; Kelly, MR; Blue, SM; Zheng, F; Chen, M; Schaffer, LV; Licon, K; Backstrom, A; Vaites, LP; Lee, JJ; Ouyang, W; Liu, SN; Zhang, T; Silva, E; Park, J; Pitea, A; Kreisberg, JF; Gygi, SP; Ma, JZ; Harper, JW; Yeo, GW; Lafontaine, DLJ; Lundberg, E; Ideker, T				Qin, Yue; Huttlin, Edward L.; Winsnes, Casper F.; Gosztyla, Maya L.; Wacheul, Ludivine; Kelly, Marcus R.; Blue, Steven M.; Zheng, Fan; Chen, Michael; Schaffer, Leah, V; Licon, Katherine; Backstrom, Anna; Vaites, Laura Pontano; Lee, John J.; Ouyang, Wei; Liu, Sophie N.; Zhang, Tian; Silva, Erica; Park, Jisoo; Pitea, Adriana; Kreisberg, Jason F.; Gygi, Steven P.; Ma, Jianzhu; Harper, J. Wade; Yeo, Gene W.; Lafontaine, Denis L. J.; Lundberg, Emma; Ideker, Trey			A multi-scale map of cell structure fusing protein images and interactions	NATURE			English	Article							PRE-RIBOSOMAL-RNA; BINDING; NETWORKS; SNRNP	The cell is a multi-scale structure with modular organization across at least four orders of magnitude(1). Two central approaches for mapping this structure-protein fluorescent imaging and protein biophysical association-each generate extensive datasets, but of distinct qualities and resolutions that are typically treated separately(2,3). Here we integrate immunofluorescence images in the Human Protein Atlas(4) with affinity purifications in BioPlex(5) to create a unified hierarchical map of human cell architecture. Integration is achieved by configuring each approach as a general measure of protein distance, then calibrating the two measures using machine learning. The map, known as the multi-scale integrated cell (MuSIC 1.0), resolves 69 subcellular systems, of which approximately half are to our knowledge undocumented. Accordingly, we perform 134 additional affinity purifications and validate subunit associations for the majority of systems. The map reveals a pre-ribosomal RNA processing assembly and accessory factors, which we show govern rRNA maturation, and functional roles for SRRM1 and FAM120C in chromatin and RPS3A in splicing. By integration across scales, MuSIC increases the resolution of imaging while giving protein interactions a spatial dimension, paving the way to incorporate diverse types of data in proteome-wide cell maps.	[Qin, Yue; Kelly, Marcus R.; Zheng, Fan; Chen, Michael; Schaffer, Leah, V; Licon, Katherine; Lee, John J.; Liu, Sophie N.; Silva, Erica; Park, Jisoo; Pitea, Adriana; Kreisberg, Jason F.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Qin, Yue; Yeo, Gene W.; Ideker, Trey] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Huttlin, Edward L.; Vaites, Laura Pontano; Zhang, Tian; Gygi, Steven P.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Winsnes, Casper F.; Backstrom, Anna; Ouyang, Wei; Lundberg, Emma] KTH Royal Inst Technol, Sch Engn Sci Chem Biotechnol & Hlth, Sci Life Lab, Stockholm, Sweden; [Gosztyla, Maya L.; Blue, Steven M.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Gosztyla, Maya L.; Blue, Steven M.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Gosztyla, Maya L.; Blue, Steven M.; Yeo, Gene W.; Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Wacheul, Ludivine; Lafontaine, Denis L. J.] Univ Libre Bruxelles ULB, RNA Mol Biol, Fonds Rech Sci FRS FNRS, Gosselies, Belgium; [Ma, Jianzhu] Peking Univ, Inst Artificial Intelligence, Beijing, Peoples R China; [Lundberg, Emma] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lundberg, Emma] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Ideker, Trey] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Royal Institute of Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Fonds de la Recherche Scientifique - FNRS; Peking University; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Ideker, T (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.; Lundberg, E (corresponding author), KTH Royal Inst Technol, Sch Engn Sci Chem Biotechnol & Hlth, Sci Life Lab, Stockholm, Sweden.; Ideker, T (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.; Lundberg, E (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Lundberg, E (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Ideker, T (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.; Ideker, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	emma.lundberg@scilifelab.se; tideker@ucsd.edu	Qin, Yue/GWV-0264-2022; Zheng, Fan/ABF-6176-2020; Gosztyla, Maya/GLV-4865-2022	Zheng, Fan/0000-0002-4403-112X; Gosztyla, Maya/0000-0003-4758-4800; Lee, John/0000-0002-7967-3384; Liu, Sophie/0000-0001-7934-8605; Kaller Lundberg, Emma/0000-0001-7034-0850; Blue, Steven/0000-0003-0279-6690; Ideker, Trey/0000-0002-1708-8454; Qin, Yue/0000-0002-0496-7134; Yeo, Eugene/0000-0002-0799-6037; Huttlin, Edward/0000-0002-1822-1173; Kreisberg, Jason/0000-0002-3616-079X; Ludivine, Wacheul/0000-0002-0443-8865	National Institutes of Health (NIH) [U54 CA209891, U01 MH115747, P41 GM103504, R01 HG009979, F99 CA264422, U24 HG006673, U41 HG009889, R01s HL137223, HG004659, R50 CA243885]; Erling-Persson family foundation; Knut and Alice Wallenberg Foundation [2016.0204]; Swedish Research Council [2017-05327]; Belgian Fonds de la Recherche Scientifique (F.R.S./FNRS); Universite Libre de Bruxelles (ULB); European Joint Programme on Rare Diseases ('RiboEurope'); European Joint Programme on Rare Diseases ('DBAcure'); Region Wallonne (SPW EER) ('RIBOcancer'); Internationale Brachet Stiftung; Epitran COST action [CA16120]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erling-Persson family foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Belgian Fonds de la Recherche Scientifique (F.R.S./FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles (ULB); European Joint Programme on Rare Diseases ('RiboEurope'); European Joint Programme on Rare Diseases ('DBAcure'); Region Wallonne (SPW EER) ('RIBOcancer'); Internationale Brachet Stiftung; Epitran COST action(European Cooperation in Science and Technology (COST))	We thank C. Ng, A. Palmer, Q. Zhang, Y. Quan, members of the laboratories of T.I. and E.L., the Human Protein Atlas and J. Swedlow for discussion and comments; M. Dow for helping us to improve the MuSIC GitHub repository and test the MuSIC pipeline; and the Cell Profiling facility and C. Stadler at the Science for Life Laboratory for help with in situ fractionation. This work was supported by the National Institutes of Health (NIH) under grants U54 CA209891, U01 MH115747, P41 GM103504 and R01 HG009979 to T.I., F99 CA264422 to Y.Q., U24 HG006673 to E.L.H., S.P.G. and J.W.H., U41 HG009889 and R01s HL137223 and HG004659 to G.W.Y. and R50 CA243885 to J.F.K.; by a gift from Google Ventures to J.W.H. and S.P.G.; by the Erling-Persson family foundation, Knut and Alice Wallenberg Foundation (2016.0204) and the Swedish Research Council (2017-05327) to E.L.; and by the Belgian Fonds de la Recherche Scientifique (F.R.S./FNRS), the Universite Libre de Bruxelles (ULB), the European Joint Programme on Rare Diseases (`RiboEurope' and `DBAcure'), the Region Wallonne (SPW EER) (`RIBOcancer'), the Internationale Brachet Stiftung and the Epitran COST action (CA16120) to D.L.J.L.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Blencowe BJ, 2000, RNA, V6, P111, DOI 10.1017/S1355838200991982; Charenton C, 2019, SCIENCE, V364, P362, DOI 10.1126/science.aax3289; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Eppens NA, 2002, NUCLEIC ACIDS RES, V30, P4222, DOI 10.1093/nar/gkf538; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Fortunato S, 2016, PHYS REP, V659, P1, DOI 10.1016/j.physrep.2016.09.002; Go CD, 2021, NATURE, V595, P120, DOI 10.1038/s41586-021-03592-2; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Grover A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P855, DOI 10.1145/2939672.2939754; Harold FM, 2005, MICROBIOL MOL BIOL R, V69, P544, DOI 10.1128/MMBR.69.4.544-564.2005; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huttlin EL, 2021, CELL, V184, P3022, DOI 10.1016/j.cell.2021.04.011; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mori H, 2016, METHODS MOL BIOL, V1458, P1, DOI 10.1007/978-1-4939-3801-8_1; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Ouyang W, 2019, NAT METHODS, V16, P1254, DOI 10.1038/s41592-019-0658-6; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Schaffer LV, 2021, CELL SYST, V12, P622, DOI 10.1016/j.cels.2021.05.012; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Van Nostrand EL, 2017, METHODS MOL BIOL, V1648, P177, DOI 10.1007/978-1-4939-7204-3_14; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Williams SG, 2011, BIOPHYS CHEM, V159, P82, DOI 10.1016/j.bpc.2011.05.010; Yoshikatsu Y, 2015, BIOCHEM BIOPH RES CO, V464, P780, DOI 10.1016/j.bbrc.2015.07.032	32	15	15	14	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 16	2021	600	7889					536	+		10.1038/s41586-021-04115-9	http://dx.doi.org/10.1038/s41586-021-04115-9		NOV 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XP3FN	34819669	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000722128900003
J	Heitmann, JS; Bilich, T; Tandler, C; Nelde, A; Maringer, Y; Marconato, M; Reusch, J; Jager, S; Denk, M; Richter, M; Anton, L; Weber, LM; Roerden, M; Bauer, J; Rieth, J; Wacker, M; Horber, S; Peter, A; Meisner, C; Fischer, I; Loffler, MW; Karbach, J; Jager, E; Klein, R; Rammensee, HG; Salih, HR; Walz, JS				Heitmann, Jonas S.; Bilich, Tatjana; Tandler, Claudia; Nelde, Annika; Maringer, Yacine; Marconato, Maddalena; Reusch, Julia; Jaeger, Simon; Denk, Monika; Richter, Marion; Anton, Leonard; Weber, Lisa Marie; Roerden, Malte; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Hoerber, Sebastian; Peter, Andreas; Meisner, Christoph; Fischer, Imma; Loeffler, Markus W.; Karbach, Julia; Jaeger, Elke; Klein, Reinhild; Rammensee, Hans-Georg; Salih, Helmut R.; Walz, Juliane S.			A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity	NATURE			English	Article							RESPONSES; HELP	T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins(1,2), combined with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, aiming to induce profound SARS-CoV-2 T cell immunity to combat COVID-19. Here we conducted a phase I open-label trial, recruiting 36 participants aged 18-80 years, who received a single subcutaneous CoVac-1 vaccination. The primary end point was safety analysed until day 56. Immunogenicity in terms of CoVac-1-induced T cell response was analysed as the main secondary end point until day 28 and in the follow-up until month 3. No serious adverse events and no grade 4 adverse events were observed. Expected local granuloma formation was observed in all study participants, whereas systemic reactogenicity was absent or mild. SARS-CoV-2-specific T cell responses targeting multiple vaccine peptides were induced in all study participants, mediated by multifunctional T helper 1 CD4(+) and CD8(+) T cells. CoVac-1-induced IFN gamma T cell responses persisted in the follow-up analyses and surpassed those detected after SARS-CoV-2 infection as well as after vaccination with approved vaccines. Furthermore, vaccine-induced T cell responses were unaffected by current SARS-CoV-2 variants of concern. Together, CoVac-1 showed a favourable safety profile and induced broad, potent and variant of concern-independent T cell responses, supporting the presently ongoing evaluation in a phase II trial for patients with B cell or antibody deficiency.	[Heitmann, Jonas S.; Bilich, Tatjana; Tandler, Claudia; Nelde, Annika; Maringer, Yacine; Marconato, Maddalena; Reusch, Julia; Jaeger, Simon; Anton, Leonard; Weber, Lisa Marie; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Salih, Helmut R.; Walz, Juliane S.] Univ Hosp Tubingen, Dept Internal Med, Clin Collaborat Unit Translat Immunol, German Canc Consortium DKTK, Tubingen, Germany; [Heitmann, Jonas S.; Bilich, Tatjana; Tandler, Claudia; Nelde, Annika; Maringer, Yacine; Roerden, Malte; Bauer, Jens; Wacker, Marcel; Loeffler, Markus W.; Rammensee, Hans-Georg; Salih, Helmut R.; Walz, Juliane S.] Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany; [Bilich, Tatjana; Tandler, Claudia; Nelde, Annika; Maringer, Yacine; Denk, Monika; Richter, Marion; Roerden, Malte; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Loeffler, Markus W.; Rammensee, Hans-Georg; Walz, Juliane S.] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany; [Jaeger, Simon; Walz, Juliane S.] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Jaeger, Simon; Loeffler, Markus W.] Univ Hosp Tubingen, Dept Clin Pharmacol, Tubingen, Germany; [Roerden, Malte; Klein, Reinhild] Univ Hosp Tubingen, Dept Hematol Oncol Clin Immunol & Rheumatol, Tubingen, Germany; [Hoerber, Sebastian; Peter, Andreas] Univ Hosp Tubingen, Inst Clin Chem & Pathobiochem, Dept Diagnost Lab Med, Tubingen, Germany; [Meisner, Christoph; Fischer, Imma] Univ Hosp Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Meisner, Christoph] Robert Bosch Krankenhaus, Robert Bosch Soc Med Res, Stuttgart, Germany; [Loeffler, Markus W.; Rammensee, Hans-Georg] German Canc Consortium DKTK, Tubingen, Germany; [Loeffler, Markus W.; Rammensee, Hans-Georg] German Canc Res Ctr, Partner Site Tubingen, Tubingen, Germany; [Loeffler, Markus W.] Univ Hosp Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [Karbach, Julia; Jaeger, Elke] Krankenhaus NW Frankfurt, Dept Oncol & Hematol, Frankfurt, Germany; [Walz, Juliane S.] Robert Bosch Ctr Tumor Dis RBCT, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Krankenhaus Nordwest	Walz, JS (corresponding author), Univ Hosp Tubingen, Dept Internal Med, Clin Collaborat Unit Translat Immunol, German Canc Consortium DKTK, Tubingen, Germany.; Walz, JS (corresponding author), Univ Tubingen, Cluster Excellence iFIT EXC2180 Image Guided & Fu, Tubingen, Germany.; Walz, JS (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany.; Walz, JS (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.; Walz, JS (corresponding author), Robert Bosch Ctr Tumor Dis RBCT, Stuttgart, Germany.	juliane.walz@med.uni-tuebingen.de	Löffler, Markus/K-2239-2014; Bilich, Tatjana/ABH-2314-2020	Löffler, Markus/0000-0003-2513-1317; Bilich, Tatjana/0000-0002-8107-0419; Weber, Lisa M./0000-0001-9514-5218; Maringer, Yacine/0000-0002-2197-8740; Nelde, Annika/0000-0001-8504-8481	'Zentrum fur Klinische Studien' at the University Hospital Tubingen; Ministry of Science, Research and the Arts Baden-Wurttemberg, Germany [TU17]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ:01KI20130]; Robert Bosch Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [WA 4608/1-2]; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC2180390900677]; German Cancer Consortium (DKTK); Wilhelm Sander Stiftung [2016.177.2]; Jose Carreras Leukamie-Stiftung [DJCLS 05 R/2017]; Fortune Program of the University of Tubingen [2451-0-0]; Ernst-Jung-Preis; 'Wirkstoffpeptid Labor', Department of Immunology, Tubingen; University Hospital Tubingen; Institute for Clinical Epidemiology and Applied Biometry	'Zentrum fur Klinische Studien' at the University Hospital Tubingen; Ministry of Science, Research and the Arts Baden-Wurttemberg, Germany; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Robert Bosch Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG)); German Cancer Consortium (DKTK); Wilhelm Sander Stiftung; Jose Carreras Leukamie-Stiftung; Fortune Program of the University of Tubingen; Ernst-Jung-Preis; 'Wirkstoffpeptid Labor', Department of Immunology, Tubingen; University Hospital Tubingen; Institute for Clinical Epidemiology and Applied Biometry	We thank all of the participants of this trial and the members of the data safety monitoring board (P. Brossart, Bonn; H. Schild, Mainz; C. Wendtner, Munich); the technical and clinical staff of the CCU Translational Immunology, Department of Internal Medicine, University Hospital Tubingen; the team of the 'Wirkstoffpeptid Labor', Department of Immunology, Tubingen; the pharmacy of the University Hospital Tubingen; the data management team at the Institute for Clinical Epidemiology and Applied Biometry; the `Zentrum fur Klinische Studien' (particularly M. Walker) at the University Hospital Tubingen for support and coordination; and EMC Microcollections GmbH for provision of XS15. This work was supported by the Ministry of Science, Research and the Arts Baden-Wurttemberg, Germany (Sonderfordermassnahme COVID-19, TU17), Bundesministerium fur Bildung und Forschung (BMBF, FKZ:01KI20130), the Robert Bosch Stiftung, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, grant WA 4608/1-2), the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy (grant EXC2180390900677), the German Cancer Consortium (DKTK), the Wilhelm Sander Stiftung (grant 2016.177.2), the Jose Carreras Leukamie-Stiftung (grant DJCLS 05 R/2017), the Fortune Program of the University of Tubingen (Fortune number 2451-0-0) and the Ernst-Jung-Preis awarded to H.-G.R.	Andreano E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103154118; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Atsmon J, 2012, J CLIN IMMUNOL, V32, P595, DOI 10.1007/s10875-011-9632-5; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bilich T, 2021, CANCER DISCOV, V11, P1982, DOI 10.1158/2159-8290.CD-21-0191; Bilich T, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf7517; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Emary KRW, 2021, LANCET, V397, P1351, DOI 10.1016/S0140-6736(21)00628-0; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Feyerabend S, 2009, PROSTATE, V69, P917, DOI 10.1002/pros.20941; Gallais F, 2021, EMERG INFECT DIS, V27, P113, DOI 10.3201/eid2701.203611; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Herishanu Y, 2021, BLOOD, V137, P3165, DOI 10.1182/blood.2021011568; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Kemball CC, 2007, J IMMUNOL, V179, P1113, DOI 10.4049/jimmunol.179.2.1113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kran AMB, 2004, AIDS, V18, P1875, DOI 10.1097/00002030-200409240-00003; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lee LYW., 2020, LANCET, V395, P1919, DOI [10.1016/S0140-6736(20)31173-9, DOI 10.1016/S0140-6736(20)31173-9]; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Monin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Noguchi M, 2003, PROSTATE, V57, P80, DOI 10.1002/pros.10276; Platten M, 2021, NATURE, V592, P463, DOI 10.1038/s41586-021-03363-z; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Rammensee HG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050428; Rammensee HG, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0796-5; Rini BI, 2016, LANCET ONCOL, V17, P1599, DOI 10.1016/S1470-2045(16)30408-9; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.1101/2020.08.11.20171843, 10.21203/rs.3.rs-57112/v1]; Sato Y, 2003, CANCER SCI, V94, P802, DOI 10.1111/j.1349-7006.2003.tb01522.x; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; TSUJI M, 1990, J EXP MED, V172, P1353, DOI 10.1084/jem.172.5.1353; van Doorn E, 2016, HUM VACC IMMUNOTHER, V12, P159, DOI 10.1080/21645515.2015.1071455; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	51	51	52	12	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					617	+		10.1038/s41586-021-04232-5	http://dx.doi.org/10.1038/s41586-021-04232-5		NOV 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34814158	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000744417800001
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... wine, chocolate, and coffee	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, GUARDIAN 1119; Luscher TF., EUR HEART J, V42, P4520	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2021	375								n2868	10.1136/bmj.n2868	http://dx.doi.org/10.1136/bmj.n2868			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3LL	34810158				2022-12-28	WOS:000730089900005
J	Abaluck, J; Kwong, LH; Styczynski, A; Haque, A; Kabir, MA; Bates-Jefferys, E; Crawford, E; Benjamin-Chung, J; Raihan, S; Rahman, S; Benhachmi, S; Bintee, NZ; Winch, PJ; Hossain, M; Reza, HM; Jaber, AA; Momen, SG; Rahman, A; Banti, FL; Huq, TS; Luby, SP; Mobarak, AM				Abaluck, Jason; Kwong, Laura H.; Styczynski, Ashley; Haque, Ashraful; Kabir, Md Alamgir; Bates-Jefferys, Ellen; Crawford, Emily; Benjamin-Chung, Jade; Raihan, Shabib; Rahman, Shadman; Benhachmi, Salim; Bintee, Neeti Zaman; Winch, Peter J.; Hossain, Maqsud; Reza, Hasan Mahmud; Jaber, Abdullah All; Momen, Shawkee Gulshan; Rahman, Aura; Banti, Faika Laz; Huq, Tahrima Saiha; Luby, Stephen P.; Mobarak, Ahmed Mushfiq			Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh	SCIENCE			English	Review							HEALTH-CARE WORKERS; SOCIAL NORMS; BEHAVIOR; POLICIES; IMAGE	We conducted a cluster-randomized trial to measure the effect of community-level mask distribution and promotion on symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in rural Bangladesh from November 2020 to April 2021 (N = 600 villages, N = 342,183 adults). We crossrandomized mask type (cloth versus surgical) and promotion strategies at the village and household level. Proper mask-wearing increased from 13.3% in the control group to 42.3% in the intervention arm (adjusted percentage point difference = 0.29; 95% confidence interval = [0.26, 0.31]). The intervention reduced symptomatic seroprevalence (adjusted prevalence ratio = 0.91 [0.82, 1.00]), especially among adults >= 60 years old in villages where surgical masks were distributed (adjusted prevalence ratio = 0.65 [0.45, 0.85]). Mask distribution with promotion was a scalable and effective method to reduce symptomatic SARS-CoV-2 infections.	[Abaluck, Jason; Crawford, Emily; Mobarak, Ahmed Mushfiq] Yale Univ, Yale Sch Management, New Haven, CT 06520 USA; [Kwong, Laura H.; Luby, Stephen P.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Kwong, Laura H.] Univ Calif Berkeley, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Styczynski, Ashley; Luby, Stephen P.] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Haque, Ashraful; Kabir, Md Alamgir; Raihan, Shabib; Rahman, Shadman; Bintee, Neeti Zaman] Innovat Poverty Act Bangladesh, Dhaka, Bangladesh; [Bates-Jefferys, Ellen] Innovat Poverty Act, Evanston, IL USA; [Benjamin-Chung, Jade] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA 94305 USA; [Benhachmi, Salim] Yale Univ, Yale Res Initiat Innovat & Scale, New Haven, CT USA; [Winch, Peter J.] Johns Hopkins Bloomberg Sch Publ Hlth, Social & Behav Intervent Program, Baltimore, MD USA; [Hossain, Maqsud; Jaber, Abdullah All; Momen, Shawkee Gulshan; Rahman, Aura; Banti, Faika Laz; Huq, Tahrima Saiha] North South Univ, NGRI, Dhaka, Bangladesh; [Reza, Hasan Mahmud] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Mobarak, Ahmed Mushfiq] Deakin Univ, Dept Econ, Melbourne, Vic, Australia	Yale University; Stanford University; University of California System; University of California Berkeley; Stanford University; Stanford University; Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; North South University (NSU); North South University (NSU); Deakin University	Abaluck, J; Mobarak, AM (corresponding author), Yale Univ, Yale Sch Management, New Haven, CT 06520 USA.; Mobarak, AM (corresponding author), Deakin Univ, Dept Econ, Melbourne, Vic, Australia.	jason.abaluck@yale.edu; ahmed.mobarak@yale.edu	Reza, Hasan Mahmud/AFL-0151-2022	Reza, Hasan Mahmud/0000-0003-3287-942X; Haque, Ashraful/0000-0002-0764-359X; Abaluck, Jason/0000-0002-0932-9369; Kwong, Laura H./0000-0002-9776-9355; Styczynski, Ashley/0000-0002-4682-8087; Raihan, Shabib/0000-0002-4125-1207	GiveWell.org [GR-000000272]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [K01AI141616]	GiveWell.org; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was financially supported by a grant from GiveWell.org to IPA (grant GR-000000272). J.B.-C. was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant K01AI141616).	Abaluck J., 2021, Zenodo, DOI 10.5281/zenodo.5703876; Abaluck J, 2020, WHITEBOARD 1201; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; [Anonymous], [No title captured], DOI 10.5281/zenodo.5703876; [Anonymous], 2006, NORMS WILD DIAGNOSE; Arce JSS, 2021, NAT MED, V27, P1385, DOI 10.1038/s41591-021-01454-y; Ariely D, 2009, AM ECON REV, V99, P544, DOI 10.1257/aer.99.1.544; Ashraf N, 2020, AM ECON REV, V110, P1355, DOI 10.1257/aer.20180326; Ashraf N, 2014, J PUBLIC ECON, V120, P1, DOI 10.1016/j.jpubeco.2014.06.014; Bates M.A., 2012, FIELD ACTIONS SCI FA, V4, P30; Beaman L, 2021, AM ECON REV, V111, P1918, DOI 10.1257/aer.20200295; Bhattacharjee S., 2021, BUSINESS STANDARD IN; Bhuiyan T. R., 2021, 21260611 MEDRXIV, DOI [10.1101/ 2021.07.16.21260611, DOI 10.1101/2021.07.16.21260611]; Biswas D, 2019, AM J TROP MED HYG, V101, P1446, DOI 10.4269/ajtmh.19-0376; Brophy JM, 2020, BMJ OPINION; Brosseau L. M., 2020, COMMENTARY MASKS FOR; Bryan G, 2010, ANNU REV ECON, V2, P671, DOI 10.1146/annurev.economics.102308.124324; Bundgaard H, 2021, ANN INTERN MED, V174, P335, DOI 10.7326/M20-6817; Bursztyn L, 2017, ANNU REV ECON, V9, P131, DOI 10.1146/annurev-economics-063016-103625; CDC, 2021, SCI BRIEF COMM US CL; Cheng YF, 2021, SCIENCE, V372, P1439, DOI 10.1126/science.abg6296; Chernozhukov V, 2021, J ECONOMETRICS, V220, P23, DOI 10.1016/j.jeconom.2020.09.003; Chetty R, 2014, J ECON PERSPECT, V28, P169, DOI 10.1257/jep.28.3.169; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cohen A, 2007, AM ECON REV, V97, P745, DOI 10.1257/aer.97.3.745; Duncan S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258191; Environment and Social Development Organization (ESDO), 2020, COVID 19 PAND PUSH S; Fadare OO, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140279; Gaure S., 2011, MEMORANDUM 142010; GiveWell, 2021, 2021 GIVEWELL COST E; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Guimaraes P, 2010, STATA J, V10, P628, DOI 10.1177/1536867X1101000406; Guiteras R., 2019, DEMAND ESTIMATION ST; Guiteras R, 2015, SCIENCE, V348, P903, DOI 10.1126/science.aaa0491; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hollands GJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012573.pub3; Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Jakubowski A., 21250487 MEDRXIV, V2021, DOI [10.1101/2021.01.27.21250487, DOI 10.1101/2021.01.27.21250487]; Jang ES, 2020, INFECT CHEMOTHER, V52, P583, DOI 10.3947/ic.2020.52.4.583; Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057; Jordan J., 2020, DONT GET IT DONT SPR, DOI DOI 10.31234/OSF.IO/YUQ7X; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; Karing A., 2021, SOCIAL SIGNALING CHI; Karlan D, 2016, MANAGE SCI, V62, P3393, DOI 10.1287/mnsc.2015.2296; Kasting ML, 2016, HUM VACC IMMUNOTHER, V12, P1435, DOI 10.1080/21645515.2016.1141158; Kremer M, 2007, Q J ECON, V122, P1007, DOI 10.1162/qjec.122.3.1007; Kwong LH, 2021, ACS NANO, V15, P5904, DOI 10.1021/acsnano.0c10146; Leffler CT, 2020, AM J TROP MED HYG, V103, P2400, DOI 10.4269/ajtmh.20-1015; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Luoto J, 2014, J DEV ECON, V110, P13, DOI 10.1016/j.jdeveco.2014.02.010; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Maclntyre CR, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h694; Management Information System (MIS) Directorate General of Health Services (DGHS), 2021, COVID 19 DYN DASHB B; Manchanda P, 2008, MARKET SCI, V27, P961, DOI 10.1287/mksc.1070.0354; McGuinness SL, 2018, TROP MED INT HEALTH, V23, P816, DOI 10.1111/tmi.13080; Miller G, 2015, MARKET SCI, V34, P480, DOI 10.1287/mksc.2014.0845; Mullard Asher, 2020, Nature, DOI 10.1038/d41586-020-03370-6; Murhekar MV, 2021, INT J INFECT DIS, V108, P145, DOI 10.1016/j.ijid.2021.05.040; Naikoba S, 2001, J HOSP INFECT, V47, P173, DOI 10.1053/jhin.2000.0882; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Oster E, 2012, J EUR ECON ASSOC, V10, P1263, DOI 10.1111/j.1542-4774.2012.01090.x; Pan J, 2021, AEROSOL SCI TECH, V55, P718, DOI 10.1080/02786826.2021.1890687; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Riaz S, 2021, ARAB NEW PAKIST 0630; Rutterford C, 2015, INT J EPIDEMIOL, V44, P1051, DOI 10.1093/ije/dyv113; Seo HJ, 2019, J HOSP INFECT, V102, P394, DOI 10.1016/j.jhin.2019.03.013; Steensgaard IM, 2017, ENVIRON POLLUT, V224, P289, DOI 10.1016/j.envpol.2017.02.007; Subramanian a, 2021, 3 NEW ESTIMATES INDI; Tithila K. K, 2021, DHAKA TRIBUNE B 0715; van Eck PS, 2011, J PROD INNOVAT MANAG, V28, P187, DOI 10.1111/j.1540-5885.2011.00791.x; Viscusi WK, 2017, J BENEFIT-COST ANAL, V8, P226, DOI 10.1017/bca.2017.12; World Health Organization, 2020, WHO COVID 19 CASE DE; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; Yan YP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82574-w; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	77	43	43	15	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					160	+		10.1126/science.abi9069	http://dx.doi.org/10.1126/science.abi9069			89	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	34855513	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000742401600026
J	Munro, APS; Janani, L; Cornelius, V; Aley, PK; Babbage, G; Baxter, D; Bula, M; Cathie, K; Chatterjee, K; Dodd, K; Enever, Y; Gokani, K; Goodman, AL; Green, CA; Harndahl, L; Haughney, J; Hicks, A; van der Klaauw, AA; Kwok, J; Lambe, T; Libri, V; Llewelyn, MJ; McGregor, AC; Minassian, AM; Moore, P; Mughal, M; Mujadidi, YF; Murira, J; Osanlou, O; Osanlou, R; Owens, DR; Pacurar, M; Palfreeman, A; Pan, D; Rampling, T; Regan, K; Saich, S; Salkeld, J; Saralaya, D; Sharma, S; Sheridan, R; Sturdy, A; Thomson, EC; Todd, S; Twelves, C; Read, RC; Charlton, S; Hallis, B; Ramsay, M; Andrews, N; Nguyen-Van-Tam, JS; Snape, MD; Liu, XX; Faust, SN				Munro, Alasdair P. S.; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K.; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L.; Green, Christopher A.; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A.; Kwok, Jonathan; Lambe, Teresa; Libri, Vincenzo; Llewelyn, Martin J.; McGregor, Alastair C.; Minassian, Angela M.; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F.; Murira, Jennifer; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R.; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Salkeld, Jo; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Thomson, Emma C.; Todd, Shirley; Twelves, Chris; Read, Robert C.; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Nguyen-Van-Tam, Jonathan S.; Snape, Matthew D.; Liu, Xinxue; Faust, Saul N.		COV-BOOST Study Grp	Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial	LANCET			English	Article								Background Few data exist on the comparative safety and immunogenicity of different COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection of booster vaccines, we investigated the reactogenicity and immunogenicity of seven different COVID-19 vaccines as a third dose after two doses of ChAdOx1 nCov-19 (Oxford-AstraZeneca; hereafter referred to as ChAd) or BNT162b2 (Pfizer-BioNtech, hearafter referred to as BNT). Methods COV-BOOST is a multicentre, randomised, controlled, phase 2 trial of third dose booster vaccination against COVID-19. Participants were aged older than 30 years, and were at least 70 days post two doses of ChAd or at least 84 days post two doses of BNT primary COVID-19 immunisation course, with no history of laboratory-confirmed SARS-CoV-2 infection. 18 sites were split into three groups (A, B, and C). Within each site group (A, B, or C), participants were randomly assigned to an experimental vaccine or control. Group A received NVX-CoV2373 (Novavax; hereafter referred to as NVX), a half dose of NVX, ChAd, or quadrivalent meningococcal conjugate vaccine (MenACWY) control (1:1:1:1). Group B received BNT, VLA2001 (Valneva; hereafter referred to as VLA), a half dose of VLA, Ad26. COV2.S (Janssen; hereafter referred to as Ad26) or MenACWY (1:1:1:1:1). Group C received mRNA1273 (Moderna; hereafter referred to as m1273), CVnCov (CureVac; hereafter referred to as CVn), a half dose of BNT, or MenACWY (1:1:1:1). Participants and all investigatory staff were blinded to treatment allocation. Coprimary outcomes were safety and reactogenicity and immunogenicity of anti-spike IgG measured by ELISA. The primary analysis for immunogenicity was on a modified intention-to-treat basis; safety and reactogenicity were assessed in the intention-to-treat population. Secondary outcomes included assessment of viral neutralisation and cellular responses. This trial is registered with ISRCTN, number 73765130. Findings Between June 1 and June 30, 2021, 3498 people were screened. 2878 participants met eligibility criteria and received COVID-19 vaccine or control. The median ages of ChAd/ChAd-primed participants were 53 years (IQR 44-61) in the younger age group and 76 years (73-78) in the older age group. In the BNT/BNT-primed participants, the median ages were 51 years (41-59) in the younger age group and 78 years (75-82) in the older age group. In the ChAd/ChAD-primed group, 676 (46.7%) participants were female and 1380 (95.4%) were White, and in the BNT/BNT-primed group 770 (53.6%) participants were female and 1321 (91.9%) were White. Three vaccines showed overall increased reactogenicity: m1273 after ChAd/ChAd or BNT/BNT; and ChAd and Ad26 after BNT/BNT. For ChAd/ChAd-primed individuals, spike IgG geometric mean ratios (GMRs) between study vaccines and controls ranged from 1.8 (99% CI 1.5-2.3) in the half VLA group to 32.3 (24.8-42.0) in the m1273 group. GMRs for wildtype cellular responses compared with controls ranged from 1.1 (95% CI 0.7-1.6) for ChAd to 3.6 (2.4-5.5) for m1273. For BNT/BNT-primed individuals, spike IgG GMRs ranged from 1.3 (99% CI 1.0-1.5) in the half VLA group to 11.5 (9.4-14.1) in the m1273 group. GMRs for wild-type cellular responses compared with controls ranged from 1.0 (95% CI 0.7-1.6) for half VLA to 4.7 (3.1-7.1) for m1273. The results were similar between those aged 30-69 years and those aged 70 years and older. Fatigue and pain were the most common solicited local and systemic adverse events, experienced more in people aged 30-69 years than those aged 70 years or older. Serious adverse events were uncommon, similar in active vaccine and control groups. In total, there were 24 serious adverse events: five in the control group (two in control group A, three in control group B, and zero in control group C), two in Ad26, five in VLA, one in VLA-half, one in BNT, two in BNT-half, two in ChAd, one in CVn, two in NVX, two in NVX-half, and one in m1273. Interpretation All study vaccines boosted antibody and neutralising responses after ChAd/ChAd initial course and all except one after BNT/BNT, with no safety concerns. Substantial differences in humoral and cellular responses, and vaccine availability will influence policy choices for booster vaccination. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Munro, Alasdair P. S.; Babbage, Gavin; Cathie, Katrina; Owens, Daniel R.; Pacurar, Mihaela; Saich, Stephen; Read, Robert C.; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Clin Res Facil, Southampton SO16 6YD, Hants, England; [Munro, Alasdair P. S.; Babbage, Gavin; Cathie, Katrina; Owens, Daniel R.; Pacurar, Mihaela; Saich, Stephen; Read, Robert C.; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Biomed Res Ctr, Southampton, Hants, England; [Munro, Alasdair P. S.; Cathie, Katrina; Owens, Daniel R.; Pacurar, Mihaela; Read, Robert C.; Faust, Saul N.] Univ Southampton, Fac Med, Southampton, Hants, England; [Munro, Alasdair P. S.; Cathie, Katrina; Owens, Daniel R.; Pacurar, Mihaela; Read, Robert C.; Faust, Saul N.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Janani, Leila; Cornelius, Victoria] Imperial Coll London, Imperial Clin Trials Unit, London, England; [Aley, Parvinder K.; Lambe, Teresa; Minassian, Angela M.; Mujadidi, Yama F.; Snape, Matthew D.; Liu, Xinxue] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England; [Kwok, Jonathan] Univ Oxford, Canc Res UK Oxford Ctr, Oxford, England; [Minassian, Angela M.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Aley, Parvinder K.; Lambe, Teresa; Snape, Matthew D.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Baxter, David; Mughal, Mehmood] Stockport NHS Fdn Trust, Stockport, Lancs, England; [Bula, Marcin; Dodd, Kate] NIHR Liverpool & Broadgreen Clin Res Facil, Liverpool, Merseyside, England; [Chatterjee, Krishna] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Clin Res Facil, Cambridge, England; [Enever, Yvanne] PHARMExcel, Welwyn Garden City, Herts, England; [Gokani, Karishma; Green, Christopher A.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Wellcome Clin Res Facil, Birmingham, W Midlands, England; [Goodman, Anna L.; Salkeld, Jo] Guys & St Thomas NHS Fdn Trust, Dept Infect, London, England; [Goodman, Anna L.] UCL, MRC Clin Trials Unit, London, England; [Harndahl, Linda; Hicks, Alexander] Portsmouth Hosp Univ NHS Trust, Portsmouth, Hants, England; [Haughney, John; Thomson, Emma C.] NHS Greater Glasgow & Clyde, Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [van der Klaauw, Agatha A.] Univ Cambridge, Wellcome MRC Inst Metab Sci, Dept Clin Biochem, Cambridge, England; [Libri, Vincenzo; Rampling, Tommy] Univ Coll London Hosp NHS Fdn Trust, NIHR UCLH Clin Res Facil, London, England; [Libri, Vincenzo; Rampling, Tommy] Univ Coll London Hosp NHS Fdn Trust, NIHR UCLH Biomed Res Ctr, London, England; [Llewelyn, Martin J.; Sharma, Sunil] Univ Hosp Sussex NHS Fdn Trust, Brighton, E Sussex, England; [McGregor, Alastair C.; Sturdy, Ann] London Northwest Univ Healthcare, Dept Infect Dis & Trop Med, London, England; [Moore, Patrick] Adam Practice, Poole, Dorset, England; [Murira, Jennifer; Twelves, Chris] Leeds Teaching Hosp Trust, NIHR Leeds Clin Res Facil, Leeds, W Yorkshire, England; [Murira, Jennifer; Twelves, Chris] Univ Leeds, Leeds, W Yorkshire, England; [Osanlou, Orod] Betsi Cadwaladr Univ Hlth Board, North Wales Clin Res Facil, Bangor, Gwynedd, Wales; [Osanlou, Orod] Bangor Univ, Bangor, Gwynedd, Wales; [Osanlou, Rostam] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Palfreeman, Adrian; Pan, Daniel] Univ Leicester, Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Regan, Karen; Saralaya, Dinesh] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Regan, Karen; Saralaya, Dinesh] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Sheridan, Ray; Todd, Shirley] Royal Devon & Exeter Hosp NHS Fdn Trust, Exeter, Devon, England; [Thomson, Emma C.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [Charlton, Sue; Hallis, Bassam] UK Hlth Secur Agcy, Porton Down, England; [Ramsay, Mary; Andrews, Nick] UK Hlth Secur Agcy, London, England; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Sch Med, Nottingham, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; Imperial College London; University of Oxford; University of Oxford; University of Oxford; Jenner Institute; University of Oxford; University of Cambridge; University of Birmingham; Guy's & St Thomas' NHS Foundation Trust; Medical Research Council Clinical Trials Unit; University of London; University College London; Queen Elizabeth University Hospital (QEUH); University of Cambridge; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Leeds; University of Leeds; Bangor University; University of Liverpool; University Hospitals of Leicester NHS Trust; University of Leicester; University of Glasgow; University of Nottingham	Faust, SN (corresponding author), Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Clin Res Facil, Southampton SO16 6YD, Hants, England.	s.faust@soton.ac.uk	Munro, Alasdair/S-4817-2019; Pan, Daniel/GYI-8783-2022; Llewelyn, Martin/A-7194-2011; Lambe, Teresa/E-5733-2016; Thomson, Emma C/M-8690-2017; Faust, Saul/J-9779-2014	Munro, Alasdair/0000-0002-4317-0742; Llewelyn, Martin/0000-0002-6811-1124; Lambe, Teresa/0000-0001-7711-897X; Thomson, Emma C/0000-0003-1482-0889; Goodman, Anna/0000-0003-0643-9017; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Pan, Daniel/0000-0002-1268-2243; Farooq Mujadidi, Yama/0000-0002-2342-8531; Faust, Saul/0000-0003-3410-7642; Moore, Patrick/0000-0001-8279-6724; Mazzella, Andrea/0000-0003-1560-7465; Aslam, Suhail/0000-0003-4205-814X; Macdonald, Jonathan/0000-0003-0249-107X; Janani, Leila/0000-0003-3829-6364; LADIKOU, ELENI/0000-0003-3021-3851; Naker, Kush/0000-0003-1853-9330; Holliday, Kyra/0000-0003-1429-9288; Perkins, Jonathan/0000-0002-7448-471X; Ustianowski, Andrew/0000-0002-6134-7855; Leung, Stephanie/0000-0002-8880-2977; Cornelius, Victoria/0000-0002-0080-1065; Welham, Benjamin/0000-0001-9683-252X; Cathie, Katrina/0000-0001-5074-0769; Green, Christopher/0000-0002-1984-4014; Salkeld, Jo/0000-0002-7868-7071; Read, Robert/0000-0002-4297-6728; Allen, Lauren/0000-0003-1846-8181; Owens, Daniel/0000-0002-8110-4252	UK Government through the National Institute for Health Research (NIHR); University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Southampton Clinical Research Facility and Biomedical Research Centre; NIHR Clinical Research Network; NIHR; Wellcome Trust [210755/Z/18/Z]; Vaccine Taskforce	UK Government through the National Institute for Health Research (NIHR); University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Southampton Clinical Research Facility and Biomedical Research Centre; NIHR Clinical Research Network; NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Vaccine Taskforce	The study is funded by the UK Government through the National Institute for Health Research (NIHR) and the Vaccine Taskforce. The study sponsor is University Hospital Southampton NHS Foundation Trust, Southampton, UK. ChAd, BNT, and m1273 used in this study were supplied by the UK Health Security Agency (previously Public Health England). NVX, VLA, Ad26, and CVn were supplied by the manufacturers, without charge. The research is supported by the NIHR Southampton Clinical Research Facility and Biomedical Research Centre, the NIHR Clinical Research Network, and the NIHR funded National Immunisation Schedule Evaluation Consortium. SNF and MDS are NIHR Senior Investigators. KC is a Wellcome Trust Investigator (210755/Z/18/Z) and NIHR Senior Investigator Emeritus. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The investigators would like to thank the UK Medicines and Healthcare products Regulatory Agency (MHRA) and Heath Research Authority (HRA) for their extraordinary efforts in rapidly reviewing submissions, for their attention to detail and input into trial design. Specific thanks go to Kirsty Wydenbach, Lisa Campbell, David Jones, Graham McNaughton, Marie-Christine Bielsky, and David Brown at the MHRA; to David Carpenter and Mike Proven and all volunteer officers and members of the South Central, Berkshire Research Ethics Committee; and to Kevin Ahmed and all HRA staff who supported the trial. The investigators express their gratitude for the contribution of all trial participants, the UK Vaccine Taskforce (Jacinda Kemps, Kate Hilyard, and Kate Taylor) and the invaluable advice of the trial committees. Andrew Ustianowski, Chris Rogers, and Andrew Riordan served as the independent members of the data monitoring and safety committee. Robert Read is the chair of the trial steering committee.	Advisory Committee on Immunisation Practices, 2021, BOOST DOS JANSS COVI; Atmar Robert L, 2021, medRxiv, DOI 10.1101/2021.10.10.21264827; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Choi A, 2021, NAT MED, V27, P2025, DOI 10.1038/s41591-021-01527-y; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; CureVac, 2021, CUREVAC SHIFT FOC CO; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Flaxman A, 2021, LANCET, V398, P981, DOI 10.1016/S0140-6736(21)01699-8; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Hulme WJ, 2021, COMP EFFECTIVENESS C; Li J, 2021, HETEROLOGOUS PRIME B, DOI [10.1101/2021.09.03.21263062, DOI 10.1101/2021.09.03.21263062]; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Nordstrom P, 2021, LANCET REG HEALTH-EU, V11, DOI 10.1016/j.lanepe.2021.100249; Our World Data, COR COVID 19 VACC 20; Parry H., 2021, PERFORMANCE VACCINAT, p2021.05.15.21257017, DOI [10.1101/2021.05.15.21257017, DOI 10.1101/2021.04.12.21255308]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pouwels KB, 2021, NAT MED, V27, P2127, DOI 10.1038/s41591-021-01548-7; Quebec National Institute of Public Health, 2021, EFF 2 DOS VACC COVID; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Shaw RH, 2021, LANCET, V397, P2043, DOI [10.1016/S0140-6736(21)01158-2, 10.1016/S0140-6736(21)01115-6]; Singanayagam A, 2022, LANCET INFECT DIS, V22, P183, DOI 10.1016/S1473-3099(21)00648-4; Stuart ASV, LANCET; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; US Food and Drug Administration, 2021, MOD COVID 19 VACC; World Health Organization, 2021, INT STAT BOOST DOS C	35	217	220	8	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2021	398	10318					2258	2276						19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XQ3YW	34863358	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000731484500019
J	Baksh, SC; Finley, LWS				Baksh, Sanjeethan C.; Finley, Lydia W. S.			Short-circuiting respiration	SCIENCE			English	Editorial Material									[Baksh, Sanjeethan C.; Finley, Lydia W. S.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Finley, LWS (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	finleyl@mskcc.org						Baksh SC, 2021, TRENDS CELL BIOL, V31, P24, DOI 10.1016/j.tcb.2020.09.010; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; Mao C, 2021, NATURE, V593, P586, DOI 10.1038/s41586-021-03539-7; Martinez-Reyes I, 2020, NATURE, V585, P288, DOI 10.1038/s41586-020-2475-6; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Rossmann MP, 2021, SCIENCE, V372, P716, DOI 10.1126/science.aaz2740; Spinelli JB, 2021, SCIENCE, V374, P1227, DOI 10.1126/science.abi7495; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882	10	0	0	4	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1196	1197		10.1126/science.abm8098	http://dx.doi.org/10.1126/science.abm8098			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855498				2022-12-28	WOS:000728578700035
J	Li, YY; Liu, HX; Xia, W; Wong, GWK; Xu, SQ				Li, Yuan-Yuan; Liu, Hong-Xiu; Xia, Wei; Wong, Gary W. K.; Xu, Shun-Qing			Cold chain logistics: a possible mode of SARS-CoV-2 transmission?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHINA		[Li, Yuan-Yuan; Liu, Hong-Xiu; Xia, Wei; Xu, Shun-Qing] Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ & Environm Protect, Key Lab Environm & Hlth,Tongji Med Coll, Wuhan, Peoples R China; [Xia, Wei; Wong, Gary W. K.] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, State Key Lab Environm Hlth Incubat, Wuhan, Peoples R China; Chinese Univ Hong Kong, Dept Paediat, Fac Med, Hong Kong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese University of Hong Kong	Xu, SQ (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ & Environm Protect, Key Lab Environm & Hlth,Tongji Med Coll, Wuhan, Peoples R China.	xust@hust.edu.cn	li, yuanyuan/GZA-4435-2022; Wong, Gary WK/AAY-9207-2020	Wong, Gary WK/0000-0001-5939-812X; Xu, Shunqing/0000-0002-7771-3821	National Natural Science Foundation of China [42077398]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (42077398) .	[Anonymous], CHINA DAILY 0103, V2021; [Anonymous], 2020, VOICE OF CHINA 1127; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Colaneri M, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.05.009; Fang FH, 2020, CHINA CDC WEEKLY, V2, P910, DOI 10.46234/ccdcw2020.246; Huang SY, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00104-21; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Li X, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146040; Liu Peipei, 2020, Biosaf Health, V2, P199, DOI 10.1016/j.bsheal.2020.11.003; Ma HL, 2021, CHINA CDC WEEKLY, V3, P441, DOI 10.46234/ccdcw2021.114; Pang XH, 2020, NATL SCI REV, V7, P1861, DOI 10.1093/nsr/nwaa264; Pastorino B, 2020, EMERG INFECT DIS, V26, P2256, DOI 10.3201/eid2609.201788; Song Y, 2020, CHINA CDC WEEKLY, V2, P884, DOI 10.46234/ccdcw2020.241; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; WHO-Worl Health Organization, 2020, CRIT REL COVID 19 PA	15	3	3	19	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								e066129	10.1136/bmj-2021-066129	http://dx.doi.org/10.1136/bmj-2021-066129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853016	hybrid, Green Published			2022-12-28	WOS:000732779300008
J	Stahl-Timmins, W				Stahl-Timmins, Will			The eyes have it: getting the gist of covid-19 transmission	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								A new interactive graphic, published by The BMJ, is designed to help people to decide how best to protect themselves and others from covid-19. Will Stahl-Timmins explains why data visualisation can help us understand complex problems, and what inspired him and his co-authors to create this graphic										Alberto Cairo., 2016, TRUTHFUL ART; Rutter H, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-065312; Ware C, 2008, MORG KAUF SER INTER, P1	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2978	10.1136/bmj.n2978	http://dx.doi.org/10.1136/bmj.n2978			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853081	Bronze			2022-12-28	WOS:000732779300003
J	Wang, YH; Zheng, SS; Yang, WM; Zhou, RY; He, QF; Radjenovic, P; Dong, JC; Li, SN; Zheng, JX; Yang, ZL; Attard, G; Pan, F; Tian, ZQ; Li, JF				Wang, Yao-Hui; Zheng, Shisheng; Yang, Wei-Min; Zhou, Ru-Yu; He, Quan-Feng; Radjenovic, Petar; Dong, Jin-Chao; Li, Shunning; Zheng, Jiaxin; Yang, Zhi-Lin; Attard, Gary; Pan, Feng; Tian, Zhong-Qun; Li, Jian-Feng			In situ Raman spectroscopy reveals the structure and dissociation of interfacial water	NATURE			English	Article							HYDROGEN EVOLUTION REACTION; SURFACES; MOLECULES; METALS; SHELL	Understanding the structure and dynamic process of water at the solid-liquid interface is an extremely important topic in surface science, energy science and catalysis(1-3). As model catalysts, atomically flat single-crystal electrodes exhibit well-defined surface and electric field properties, and therefore may be used to elucidate the relationship between structure and electrocatalytic activity at the atomic level(4,5). Hence, studying interfacial water behaviour on single-crystal surfaces provides a framework for understanding electrocatalysis(6,7). However, interfacial water is notoriously difficult to probe owing to interference from bulk water and the complexity of interfacial environments(8). Here, we use electrochemical, in situ Raman spectroscopic and computational techniques to investigate the interfacial water on atomically flat Pd single-crystal surfaces. Direct spectral evidence reveals that interfacial water consists of hydrogen-bonded and hydrated Na+ ion water. At hydrogen evolution reaction (HER) potentials, dynamic changes in the structure of interfacial water were observed from a random distribution to an ordered structure due to bias potential and Na+ ion cooperation. Structurally ordered interfacial water facilitated high-efficiency electron transfer across the interface, resulting in higher HER rates. The electrolytes and electrode surface effects on interfacial water were also probed and found to affect water structure. Therefore, through local cation tuning strategies, we anticipate that these results may be generalized to enable ordered interfacial water to improve electrocatalytic reaction rates. Interfacial water consists of hydrogen-bonded water and Na center dot H2O, its structure changes at hydrogen evolution reaction (HER) potentials, and when structurally ordered it aids interfacial electron transfer, resulting in higher HER rates.	[Wang, Yao-Hui; Yang, Wei-Min; Zhou, Ru-Yu; He, Quan-Feng; Radjenovic, Petar; Dong, Jin-Chao; Yang, Zhi-Lin; Tian, Zhong-Qun; Li, Jian-Feng] Xiamen Univ, MOE Key Lab Spectrochem Anal & Instrumentat,Coll, State Key Lab Phys Chem Solid Surfaces,Coll Energ, Coll Phys Sci & Technol,Coll Chem & Chem Engn,ICh, Xiamen, Fujian, Peoples R China; [Zheng, Shisheng; Li, Shunning; Zheng, Jiaxin; Pan, Feng] Peking Univ, Shenzhen Grad Sch, Sch Adv Mat, Shenzhen, Guangdong, Peoples R China; [Attard, Gary] Univ Liverpool, Dept Phys, Liverpool, Merseyside, England; [Tian, Zhong-Qun; Li, Jian-Feng] Innovat Lab Sci & Technol Energy Mat Fujian Provi, Xiamen, Fujian, Peoples R China; [Li, Jian-Feng] China Jiliang Univ, Coll Opt & Elect Technol, Hangzhou, Zhejiang, Peoples R China	Xiamen University; Peking University; University Town of Shenzhen; University of Liverpool; China Jiliang University	Li, JF (corresponding author), Xiamen Univ, MOE Key Lab Spectrochem Anal & Instrumentat,Coll, State Key Lab Phys Chem Solid Surfaces,Coll Energ, Coll Phys Sci & Technol,Coll Chem & Chem Engn,ICh, Xiamen, Fujian, Peoples R China.; Pan, F (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Adv Mat, Shenzhen, Guangdong, Peoples R China.; Li, JF (corresponding author), Innovat Lab Sci & Technol Energy Mat Fujian Provi, Xiamen, Fujian, Peoples R China.; Li, JF (corresponding author), China Jiliang Univ, Coll Opt & Elect Technol, Hangzhou, Zhejiang, Peoples R China.	panfeng@pkusz.edu.cn; li@xmu.edu.cn	Yang, Wei/HIA-0360-2022; Yang, Wei/GWV-4107-2022; Li, Shunning/ABB-4187-2021	Li, Shunning/0000-0002-5381-6025				Ataka K, 1996, J PHYS CHEM-US, V100, P10664, DOI 10.1021/jp953636z; Chen HC, 2014, ACS NANO, V8, P2704, DOI 10.1021/nn406403c; Chen YX, 1998, J RAMAN SPECTROSC, V29, P749, DOI 10.1002/(SICI)1097-4555(199808)29:8<749::AID-JRS285>3.3.CO;2-U; Davis JG, 2012, NATURE, V491, P582, DOI 10.1038/nature11570; Dong JC, 2019, NAT ENERGY, V4, P60, DOI 10.1038/s41560-018-0292-z; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Guha A, 2020, J MATER CHEM A, V8, P15795, DOI 10.1039/c9ta12926j; Guha A, 2018, ACS APPL ENERG MATER, V1, P7116, DOI 10.1021/acsaem.8b01546; Guo J, 2014, NAT MATER, V13, P184, DOI [10.1038/nmat3848, 10.1038/NMAT3848]; Hammer B, 1999, PHYS REV B, V59, P7413, DOI 10.1103/PhysRevB.59.7413; Kendrick E, 2007, NAT MATER, V6, P871, DOI 10.1038/nmat2039; Kibler LA, 2006, CHEMPHYSCHEM, V7, P985, DOI 10.1002/cphc.200500646; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lambert DK, 1996, ELECTROCHIM ACTA, V41, P623, DOI 10.1016/0013-4686(95)00349-5; Ledezma-Yanez I, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.31; Li JF, 2010, NATURE, V464, P392, DOI 10.1038/nature08907; Li JF, 2010, PHYS CHEM CHEM PHYS, V12, P2493, DOI 10.1039/b919266b; Liu WT, 2014, P NATL ACAD SCI USA, V111, P1293, DOI 10.1073/pnas.1317290111; Mesa CA, 2020, NAT CHEM, V12, P82, DOI 10.1038/s41557-019-0347-1; Mubeen S, 2013, NAT NANOTECHNOL, V8, P247, DOI 10.1038/nnano.2013.18; Sakong S, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4948638; Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514; Seh ZW, 2017, SCIENCE, V355, DOI 10.1126/science.aad4998; SENIOR WA, 1965, NATURE, V205, P170, DOI 10.1038/205170a0; Strmcnik D, 2010, NAT CHEM, V2, P880, DOI [10.1038/nchem.771, 10.1038/NCHEM.771]; Subbaraman R, 2012, NAT MATER, V11, P550, DOI [10.1038/NMAT3313, 10.1038/nmat3313]; Subbaraman R, 2011, SCIENCE, V334, P1256, DOI 10.1126/science.1211934; TONEY MF, 1994, NATURE, V368, P444, DOI 10.1038/368444a0; Tong YJ, 2017, ANGEW CHEM INT EDIT, V56, P4211, DOI 10.1002/anie.201612183; Tonigold K, 2012, J COMPUT CHEM, V33, P695, DOI 10.1002/jcc.22900; Velasco-Velez JJ, 2014, SCIENCE, V346, P831, DOI 10.1126/science.1259437; Vidal-Iglesias FJ, 2010, ANGEW CHEM INT EDIT, V49, P6998, DOI 10.1002/anie.201002501; Wang XS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12773-7; Yamakata A, 2009, J AM CHEM SOC, V131, P6892, DOI 10.1021/ja8100374	34	94	94	199	504	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					81	+		10.1038/s41586-021-04068-z	http://dx.doi.org/10.1038/s41586-021-04068-z			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34853456				2022-12-28	WOS:000724992500022
J	Zhang, J; Peng, B; Kim, S; Monifi, F; Jiang, XF; Li, YH; Yu, P; Liu, LQ; Liu, YX; Alu, A; Yang, L				Zhang, Jing; Peng, Bo; Kim, Seunghwi; Monifi, Faraz; Jiang, Xuefeng; Li, Yihang; Yu, Peng; Liu, Lianqing; Liu, Yu-xi; Alu, Andrea; Yang, Lan			Optomechanical dissipative solitons	NATURE			English	Article							FREQUENCY COMB GENERATION; CAVITY SOLITONS; OSCILLATOR; MODE; WAVE	Nonlinear wave-matter interactions may give rise to solitons, phenomena that feature inherent stability in wave propagation and unusual spectral characteristics. Solitons have been created in a variety of physical systems and have had important roles in a broad range of applications, including communications, spectroscopy and metrology(1-4). In recent years, the realization of dissipative Kerr optical solitons in microcavities has led to the generation of frequency combs in a chip-scale platform(5-10). Within a cavity, photons can interact with mechanical modes. Cavity optomechanics has found applications for frequency conversion, such as microwave-to-optical or radio-frequency-to-optical(11-13), of interest for communications and interfacing quantum systems operating at different frequencies. Here we report the observation of mechanical micro-solitons excited by optical fields in an optomechanical microresonator, expanding soliton generation in optical resonators to a different spectral window. The optical field circulating along the circumference of a whispering gallery mode resonator triggers a mechanical nonlinearity through optomechanical coupling, which in turn induces a time-varying periodic modulation on the propagating mechanical mode, leading to a tailored modal dispersion. Stable localized mechanical wave packets-mechanical solitons-can be realized when the mechanical loss is compensated by phonon gain and the optomechanical nonlinearity is balanced by the tailored modal dispersion. The realization of mechanical micro-solitons driven by light opens up new avenues for optomechanical technologies(14) and may find applications in acoustic sensing, information processing, energy storage, communications and surface acoustic wave technology. Stable, dissipative optomechanical solitons are realized using optical fields in a whispering gallery mode resonator by balancing the optomechanical nonlinearities with a tailored modal dispersion.	[Zhang, Jing; Peng, Bo; Monifi, Faraz; Jiang, Xuefeng; Li, Yihang; Yang, Lan] Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63110 USA; [Zhang, Jing] Tsinghua Univ, Dept Automat, Beijing, Peoples R China; [Kim, Seunghwi; Alu, Andrea] CUNY, Photon Initiat Adv Sci Res Ctr, New York, NY USA; [Yu, Peng; Liu, Lianqing] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang, Peoples R China; [Liu, Yu-xi] Tsinghua Univ, Inst Microelect, Beijing, Peoples R China; [Alu, Andrea] CUNY, Grad Ctr, Phys Program, New York, NY USA	Washington University (WUSTL); Tsinghua University; City University of New York (CUNY) System; Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Tsinghua University; City University of New York (CUNY) System	Yang, L (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63110 USA.	yang@seas.wustl.edu	yang, lan/GRJ-3120-2022; Kim, Seunghwi/GMY-6844-2022; Liu, Yu-xi/A-6385-2009	Liu, Yu-xi/0000-0002-3961-2691; Liu, Lianqing/0000-0002-2271-5870				Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.061102; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Barland S, 2017, ADV PHYS-X, V2, P496, DOI 10.1080/23746149.2017.1321501; Barland S, 2002, NATURE, V419, P699, DOI 10.1038/nature01049; BOYD JP, 1984, J MATH PHYS, V25, P3390, DOI 10.1063/1.526109; Brasch V, 2016, SCIENCE, V351, P357, DOI 10.1126/science.aad4811; Butsch A, 2014, OPTICA, V1, P158, DOI 10.1364/OPTICA.1.000158; Cao LS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.075505; Carmon T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.223902; Carmon T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167203; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Czaplewski DA, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.244302; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Fiore V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133601; Forsch M, 2020, NAT PHYS, V16, P69, DOI 10.1038/s41567-019-0673-7; Gan JH, 2016, OPT LETT, V41, P2676, DOI 10.1364/OL.41.002676; Ganesan A, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.033903; Grelu P, 2012, NAT PHOTONICS, V6, P84, DOI [10.1038/nphoton.2011.345, 10.1038/NPHOTON.2011.345]; Grudinin IS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.083901; Hao HY, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.064302; Haus HA, 1996, REV MOD PHYS, V68, P423, DOI 10.1103/RevModPhys.68.423; Hereman W., 2009, ENCY COMPLEXITY APPL, P8112, DOI DOI 10.1007/978-0-387-30440-3_480; Herr T, 2014, NAT PHOTONICS, V8, P145, DOI [10.1038/NPHOTON.2013.343, 10.1038/nphoton.2013.343]; Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264; Jang JK, 2013, NAT PHOTONICS, V7, P657, DOI [10.1038/nphoton.2013.157, 10.1038/NPHOTON.2013.157]; Jing H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053604; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Kippenberg TJ, 2018, SCIENCE, V361, DOI 10.1126/science.aan8083; Korteweg DJ., 1895, PHILOS MAG, V39, P422, DOI DOI 10.1080/14786449508620739; Leo F, 2010, NAT PHOTONICS, V4, P471, DOI [10.1038/nphoton.2010.120, 10.1038/NPHOTON.2010.120]; Li Q, 2017, OPTICA, V4, P193, DOI 10.1364/OPTICA.4.000193; Lugiato L, 2015, NONLINEAR OPTICAL SYSTEMS, P1, DOI 10.1017/CBO9781107477254; Miri MA, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aab5c6; Monifi F, 2016, NAT PHOTONICS, V10, P399, DOI [10.1038/nphoton.2016.73, 10.1038/NPHOTON.2016.73]; NAYANOV VI, 1986, JETP LETT+, V44, P314; Rueda A, 2019, NATURE, V568, P378, DOI 10.1038/s41586-019-1110-x; Savchenkov AA, 2011, OPT LETT, V36, P3338, DOI 10.1364/OL.36.003338; Savchenkov AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.093902; Shao LB, 2019, OPTICA, V6, P1498, DOI 10.1364/OPTICA.6.001498; Stern B, 2018, NATURE, V562, P401, DOI 10.1038/s41586-018-0598-9; Suh MG, 2016, SCIENCE, V354, P600, DOI 10.1126/science.aah6516; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Xiong H, 2018, LASER PHOTONICS REV, V12, DOI 10.1002/lpor.201700305; Xiong H, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.153901; Yamazaki R, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.053839; Yi X, 2015, OPTICA, V2, P1078, DOI 10.1364/OPTICA.2.001078; Zhang J, 2018, NAT PHOTONICS, V12, P479, DOI 10.1038/s41566-018-0213-5; Zhang M, 2019, NATURE, V568, P373, DOI 10.1038/s41586-019-1008-7	48	14	14	12	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					75	+		10.1038/s41586-021-04012-1	http://dx.doi.org/10.1038/s41586-021-04012-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34853455				2022-12-28	WOS:000724992500021
J	Lynch-Kelly, K				Lynch-Kelly, Katharine			Subscribe to thrive: paid subscriptions to online medical education materials should be included with tuition fees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lynch-Kelly, Katharine] Kings Coll London, GKT Sch Med Educ, London, England	University of London; King's College London	Lynch-Kelly, K (corresponding author), Kings Coll London, GKT Sch Med Educ, London, England.	katharine.lynch-kelly@kcl.ac.uk		Lynch-Kelly, Katharine/0000-0003-1920-3986				[Anonymous], 2016, FULL FACT; [Anonymous], Medical student finance.; Ball J., 2021, GUARDIAN 0321; Carrell S., 2016, GUARDIAN 0122; Dost S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042378; Rughani G., 2013, BMJ-BRIT MED J, V346, pF3500, DOI [10.1136/sbmj.f3500, DOI 10.1136/SBMJ.F3500, 10.1136/ sbmj. f3500]; Smith C, 2020, BMA 0730; Walsh JL, 2018, POSTGRAD MED J, V94, P97, DOI 10.1136/postgradmedj-2017-135018; Wong A, 2018, BMC BLOG NETWOR 0608; Wynter L, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1462-9	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2970	10.1136/bmj.n2970	http://dx.doi.org/10.1136/bmj.n2970			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853004	Bronze			2022-12-28	WOS:000726688600007
J	Zarocostas, J				Zarocostas, John			Countries prepare or pandemic treaty decision	LANCET			English	Editorial Material																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					1951	1951						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XD7PT	34838164				2022-12-28	WOS:000722897200009
J	Blair, G; Weinstein, JM; Christia, F; Arias, E; Badran, E; Blair, RA; Cheema, A; Farooqui, A; Fetzer, T; Grossman, G; Haim, D; Hameed, Z; Hanson, R; Hasanain, A; Kronick, D; Morse, BS; Muggah, R; Nadeem, F; Tsai, LL; Nanes, M; Slough, T; Ravanilla, N; Shapiro, JN; Silva, B; Souza, PCL; Wilke, AM				Blair, Graeme; Weinstein, Jeremy M.; Christia, Fotini; Arias, Eric; Badran, Emile; Blair, Robert A.; Cheema, Ali; Farooqui, Ahsan; Fetzer, Thiemo; Grossman, Guy; Haim, Dotan; Hameed, Zulfiqar; Hanson, Rebecca; Hasanain, Ali; Kronick, Dorothy; Morse, Benjamin S.; Muggah, Robert; Nadeem, Fatiq; Tsai, Lily L.; Nanes, Matthew; Slough, Tara; Ravanilla, Nico; Shapiro, Jacob N.; Silva, Barbara; Souza, Pedro C. L.; Wilke, Anna M.			Community policing does not build citizen trust in police or reduce crime in the Global South	SCIENCE			English	Article							LEGITIMACY; DISORDER; VIOLENCE	Is it possible to reduce crime without exacerbating adversarial relationships between police and citizens? Community policing is a celebrated reform with that aim, which is now adopted on six continents. However, the evidence base is limited, studying reform components in isolation in a limited set of countries, and remaining largely silent on citizen-police trust. We designed six field experiments with Global South police agencies to study locally designed models of community policing using coordinated measures of crime and the attitudes and behaviors of citizens and police. In a preregistered meta-analysis, we found that these interventions led to mixed implementation, largely failed to improve citizen-police relations, and did not reduce crime. Societies may need to implement structural changes first for incremental police reforms such as community policing to succeed.	[Blair, Graeme] Univ Calif Los Angeles, Dept Polit Sci, Los Angeles, CA 90095 USA; [Weinstein, Jeremy M.] Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA; [Christia, Fotini; Tsai, Lily L.] MIT, Dept Polit Sci, Cambridge, MA 02139 USA; [Arias, Eric] World Bank Grp, Equitable Growth Finance & Inst Practice Grp, Bouchard 547,Piso 29, RA-1106 Buenos Aires, DF, Argentina; [Badran, Emile; Muggah, Robert; Silva, Barbara] Igarape Inst, BR-22281 Rio De Janeiro, Brazil; [Blair, Robert A.] Brown Univ, Dept Polit Sci, Providence, RI 02912 USA; [Blair, Robert A.] Brown Univ, Watson Inst Int & Publ Affairs, Providence, RI 02912 USA; [Cheema, Ali; Hasanain, Ali] Lahore Univ Management Sci, Dept Econ, Lahore 54792, Pakistan; [Farooqui, Ahsan] Inst Dev & Econ Alternat, Lahore 54000, Pakistan; [Fetzer, Thiemo; Souza, Pedro C. L.] Queen Mary Univ London, Sch Econ & Finance, London E1 4NS, England; [Grossman, Guy; Kronick, Dorothy] Univ Penn, Dept Polit Sci, Philadelphia, PA 19104 USA; [Haim, Dotan] Florida State Univ, Dept Polit Sci, Tallahassee, FL 32306 USA; [Hameed, Zulfiqar] Govt Punjab, Punjab Police, Lahore 54000, Pakistan; [Hanson, Rebecca] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL 32611 USA; [Hanson, Rebecca] Univ Florida, Dept Sociol Criminol & Law, Gainesville, FL 32611 USA; [Morse, Benjamin S.] Social Impact, Arlington, VA 22201 USA; [Nadeem, Fatiq] Univ Calif Santa Barbara, Bren Sch, Santa Barbara, CA 93117 USA; [Nanes, Matthew] St Louis Univ, Dept Polit Sci, St Louis, MO 63103 USA; [Slough, Tara] NYU, Wilf Family Dept Polit, New York, NY 10003 USA; [Ravanilla, Nico] Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA; [Shapiro, Jacob N.] Princeton Univ, Dept Polit, Princeton, NJ 08544 USA; [Wilke, Anna M.] Columbia Univ, Dept Polit Sci, New York, NY 10027 USA	University of California System; University of California Los Angeles; Stanford University; Massachusetts Institute of Technology (MIT); Brown University; Brown University; Lahore University of Management Sciences; University of London; Queen Mary University London; University of Pennsylvania; State University System of Florida; Florida State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Santa Barbara; Saint Louis University; New York University; University of California System; University of California San Diego; Princeton University; Columbia University	Blair, G (corresponding author), Univ Calif Los Angeles, Dept Polit Sci, Los Angeles, CA 90095 USA.	graeme.blair@ucla.edu	Grossman, Guy/AAF-3940-2019; Souza, Pedro/GZH-1275-2022	Grossman, Guy/0000-0002-6980-6390; Christia, Fotini/0000-0003-1076-9879; Farooqui, Ahsan/0000-0003-2902-4703	UK Foreign, Commonwealth AMP; Development Office [205133]; Fidelity Charitable Gift Fund [5896]; Jameel Poverty Action Lab Crime and Violence Initiative [PKGR-0895]; University of California-San Diego Policy Design and Evaluation Lab; Oxford Policy Management [A0014-21585]; University of California-Berkeley Economic Development and Institutions program; Corporacion Andina de Fomento	UK Foreign, Commonwealth AMP; Development Office; Fidelity Charitable Gift Fund; Jameel Poverty Action Lab Crime and Violence Initiative; University of California-San Diego Policy Design and Evaluation Lab; Oxford Policy Management; University of California-Berkeley Economic Development and Institutions program; Corporacion Andina de Fomento	Funding for the Brazil, Colombia, Liberia, Pakistan, and Uganda sites and overall study coordination and the meta-analysis was provided by the UK Foreign, Commonwealth & Development Office (205133). Funding for the Philippines study was provided by a grant from the Fidelity Charitable Gift Fund (5896). Individual studies received supplementary funding or in-kind support from various sources. The Pakistan study was supported by the Jameel Poverty Action Lab Crime and Violence Initiative (PKGR-0895); Philippines from the University of California-San Diego Policy Design and Evaluation Lab; Uganda from Oxford Policy Management (A0014-21585); and Colombia from the University of California-Berkeley Economic Development and Institutions program and Corporacion Andina de Fomento.	Akerlof George, 1994, GANG BEHAV LAW ENFOR; Alpert G., 2013, BUILDING BRIDGES POL; Amnesty International, 1994, POL VIOL COL MYTH RE; [Anonymous], 2017, WHEN POLICE KILL; Arizona State University Center for Problem-Oriented Policing, 2018, KEY EL PROBL OR POL; Banerjee A, 2021, AM ECON J-ECON POLIC, V13, P36, DOI 10.1257/pol.20190664; Beetham D., 1991, LEGITIMATION POWER; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair G., 2021, COMMUNITY POLICING D, DOI [10.17605/OSF.IO/2JUYZ, DOI 10.17605/0SF.I0/2JUYZ]; Blair G, 2019, AM POLIT SCI REV, V113, P838, DOI [10.1017/s0003055419000194, 10.1017/S0003055419000194]; Blair R. A., 2021, MILITARY POLICING EX; Blair R. A., 2021, REBEL GOVERNANCE FIE; Blair RA, 2019, AM POLIT SCI REV, V113, P641, DOI 10.1017/S0003055419000121; Blattman C., 2017, PLACE BASED INTERVEN; Blattman C., 2021, 28458 NAT BUR EC RES, P2021; Borenstein M., 2009, INTRO METAANALYSIS; Braga AA, 2019, J EXP CRIMINOL, V15, P289, DOI 10.1007/s11292-019-09372-3; Brierley S, 2020, AM J POLIT SCI, V64, P209, DOI 10.1111/ajps.12495; Bulla P., 2012, EVALUACION IMPACTO P; Campbell DT, 1967, EXPT QUASIEXPERIMENT; Collazos D., 2019, HOT SPOTS POLICING H; Collins R., 2007, GEORGETOWN J POVERTY, VXIV, P419; Cooper J., 2016, RANDOMIZED IMPACT EV; Das D.K., 1998, POLICING, V21, P353, DOI DOI 10.1108/13639519810220352; de Mesquita Neto P., 2004, CALLES MAS SEGURAS E; de Mesquita Neto P., 2003, CRIME VIOLENCE LATIN, P179; Directorate for Police Community Relations, 2021, US; Directorate for Police Community Relations, 2021, US; Directorate for Police Community Relations, 2012, POL COMM REL MAN REV; Dunning T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2612; Dunning Thad, 2016, ANNU REV POLIT SCI, V19, pS1, DOI DOI 10.1146/ANNUREV-P0LISCI-072516-014127; European Crime Prevention Network, 2018, COMM OR POL EUR UN T; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Garcia Juan, 2013, POLICE REFORM TRAINI; Geller W. A., 1959, POLICE VIOLENCE UNDE; Gerber A.S., 2012, FIELD EXPT DESIGN AN; Gonzalez Y, 2019, WORLD POLIT, V71, P44, DOI 10.1017/S004388711800014X; Greene J. R., 1988, COMMUNITY POLICING R; Greene JR, 2014, POLIC-J POLICY PRACT, V8, P379, DOI 10.1093/police/pau043; Hassan M, 2017, AM J POLIT SCI, V61, P382, DOI 10.1111/ajps.12279; Howell K. B., 2009, NYU REV L SOC CHANGE, V33, P271; International Association of Chiefs of Police, 2015, IACP NAT POL SUMM CO; International Association of Chiefs of Police (IACP), 2015, IACP NAT POL SUMM CO; Karim S, 2020, AM POLIT SCI REV, V114, P536, DOI 10.1017/S0003055419000716; Kelling G., 1974, KANSAS CITY PREVENTI; Kerrison EM, 2019, POLICE PRACT RES, V20, P567, DOI 10.1080/15614263.2019.1657627; Khosa T., 2015, POLICE POLITICS PEOP; Krishnasamy M., 2004, COMMUNITY POLICING C, pxvii; Llorente M. V., 2006, PUBLIC SECURITY POLI, P111; Magaloni B, 2020, AM POLIT SCI REV, V114, P552, DOI 10.1017/S0003055419000856; Marshall G., 1965, POLICE GOVT STATUS A, V216; Masud M. O., 2002, RES SUMMARY 17 COPRO; McCaffrey Daniel, 2003, QUALITY CONTROL APPL, V48, P677; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muggah R., 2016, MAKING CITIES SAFER; Muggah R., 2016, MAKING CITIES SAFER; Mummolo J, 2018, P NATL ACAD SCI USA, V115, P9181, DOI 10.1073/pnas.1805161115; Narag RE, 2013, Community Policing in Indigenous Communities, P201; Pettersson T., 2017, J PEACE RES, V55; Policia Nacional de Colombia, 2010, ESTR I SEG CIUD PLAN; Policia Nacional de Colombia, 2010, ESTR I SEG CIUD PLAN; President's Task Force on 21st Century Policing, 2015, FIN REP PRES TASK FO; Pustejovsky JE, 2018, J BUS ECON STAT, V36, P672, DOI 10.1080/07350015.2016.1247004; Ratcliffe JH, 2011, CRIMINOLOGY, V49, P795, DOI 10.1111/j.1745-9125.2011.00240.x; Reaves B. A., 2015, 2013 PERSONNEL POLIC; Reaves Brian A., 2015, LOCAL POLICE DEP 201; Reith C., 1956, NEW STUDY POLICE HIS; Vasquez JCR, 2012, POLIC SOC, V22, P43, DOI 10.1080/10439463.2011.597855; Saeed B., 2015, HDB COMMUNITY POLICI; Schwartz A. I., 1977, CINCINNATI TEAM POLI; Sherman L., 1998, PREVENTING CRIME WHA; Skogan Wesley G, 1997, COMMUNITY POLICING C; Slough T., 2019, INT METH C TALK 8 NO; Sunshine J, 2003, LAW SOC REV, V37, P513, DOI 10.1111/1540-5893.3703002; Trojanowicz R.C., 1985, IMPACT FOOT PATROL B; Tyler T.R., 2002, TRUST LAW ENCOURAGIN; Tyler TR, 2011, EUR J CRIMINOL, V8, P254, DOI 10.1177/1477370811411462; United Nations Police, 2018, POL MAN COMM OR POL; United States Government Accountability Office, 2012, FOR POL ASS DEF ROL; Visser M., 2015, AIDS UGANDA COUNTRY; Visser M., 2015, EVALUATION IRISH AID; Waddington PA., 1999, POLICING CITIZENS AU; Walsh DPJ, 2011, CRIME LAW SOCIAL CH, V55, P61, DOI 10.1007/s10611-011-9269-6; Weisburd D, 2004, ANN AM ACAD POLIT SS, V593, P42, DOI 10.1177/0002716203262548; Weisburd D, 2010, CRIMINOL PUBLIC POL, V9, P139, DOI 10.1111/j.1745-9133.2010.00617.x; Westmarland L, 2001, BRIT J CRIMINOL, V41, P523, DOI 10.1093/bjc/41.3.523	86	12	12	9	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1098	+	eabd3446	10.1126/science.abd3446	http://dx.doi.org/10.1126/science.abd3446			146	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822276	Green Submitted			2022-12-28	WOS:000725668600041
J	Seo, J; De, C; Ha, H; Lee, JE; Park, S; Park, J; Skourski, Y; Choi, ES; Kim, B; Cho, GY; Yeom, HW; Cheong, SW; Kim, JH; Yang, BJ; Kim, K; Kim, JS				Seo, Junho; De, Chandan; Ha, Hyunsoo; Lee, Ji Eun; Park, Sungyu; Park, Joonbum; Skourski, Yurii; Choi, Eun Sang; Kim, Bongjae; Cho, Gil Young; Yeom, Han Woong; Cheong, Sang-Wook; Kim, Jae Hoon; Yang, Bohm-Jung; Kim, Kyoo; Kim, Jun Sung			Colossal angular magnetoresistance in ferrimagnetic nodal-line semiconductors	NATURE			English	Article							ANISOTROPIC MAGNETORESISTANCE; STATE	Efficient magnetic control of electronic conduction is at the heart of spintronic functionality for memory and logic applications(1,2). Magnets with topological band crossings serve as a good material platform for such control, because their topological band degeneracy can be readily tuned by spin configurations, dramatically modulating electronic conduction(3-10). Here we propose that the topological nodal-line degeneracy of spin-polarized bands in magnetic semiconductors induces an extremely large angular response of magnetotransport. Taking a layered ferrimagnet, Mn3Si2Te6, and its derived compounds as a model system, we show that the topological band degeneracy, driven by chiral molecular orbital states, is lifted depending on spin orientation, which leads to a metal-insulator transition in the same ferrimagnetic phase. The resulting variation of angular magnetoresistance with rotating magnetization exceeds a trillion per cent per radian, which we call colossal angular magnetoresistance. Our findings demonstrate that magnetic nodal-line semiconductors are a promising platform for realizing extremely sensitive spin- and orbital-dependent functionalities. A study reports a colossal angular magnetoresistance in the topological magnet Mn3Si2Te6, resulting from a metal-to-insulator transition caused by controlled lifting of a topological band degeneracy, and discusses the key parameters involved.	[Seo, Junho; De, Chandan; Park, Sungyu; Cho, Gil Young; Yeom, Han Woong; Kim, Jun Sung] Inst Basic Sci IBS, Ctr Artificial Low Dimens Elect Syst, Pohang, South Korea; [Seo, Junho; Cho, Gil Young; Yeom, Han Woong; Kim, Jun Sung] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, South Korea; [De, Chandan; Cheong, Sang-Wook] Pohang Accelerator Lab, Lab Pohang Emergent Mat, Pohang, South Korea; [Ha, Hyunsoo; Yang, Bohm-Jung] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Lee, Ji Eun; Kim, Jae Hoon] Yonsei Univ, Dept Phys, Seoul, South Korea; [Park, Joonbum; Skourski, Yurii] Hochfeld Magnetlabor Dresden HLD EMFL, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Choi, Eun Sang] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL USA; [Kim, Bongjae] Kunsan Natl Univ, Dept Phys, Kunsan, South Korea; [Cho, Gil Young] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Cheong, Sang-Wook] Rutgers State Univ, Rutgers Ctr Emergent Mat & Dept Phys Astron, Piscataway, NJ USA; [Yang, Bohm-Jung] Inst Basic Sci IBS, Ctr Correlated Elect Syst, Seoul, South Korea; [Yang, Bohm-Jung] Seoul Natl Univ, Ctr Theoret Phys CTP, Seoul, South Korea; [Kim, Kyoo] Korea Atom Energy Res Inst KAERI, Daejeon, South Korea	Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Yonsei University; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); State University System of Florida; Florida State University; Kunsan National University; Asia Pacific Center for Theoretical Physics; Rutgers State University New Brunswick; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Korea Atomic Energy Research Institute (KAERI)	Kim, JS (corresponding author), Inst Basic Sci IBS, Ctr Artificial Low Dimens Elect Syst, Pohang, South Korea.; Kim, JS (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, South Korea.; Yang, BJ (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.; Kim, JH (corresponding author), Yonsei Univ, Dept Phys, Seoul, South Korea.; Yang, BJ (corresponding author), Inst Basic Sci IBS, Ctr Correlated Elect Syst, Seoul, South Korea.; Yang, BJ (corresponding author), Seoul Natl Univ, Ctr Theoret Phys CTP, Seoul, South Korea.; Kim, K (corresponding author), Korea Atom Energy Res Inst KAERI, Daejeon, South Korea.	super@yonsei.ac.kr; bjyang@snu.ac.kr; kyoo@kaeri.re.kr; js.kim@postech.ac.kr	Park, Joonbum/L-2508-2015; Cho, Gil Young/AFI-8512-2022; Kim, Jun Sung/G-8861-2012; Cho, Gil Young/AAF-4136-2022	Park, Joonbum/0000-0003-2290-0352; Kim, Jun Sung/0000-0002-1413-7265; De, Chandan/0000-0003-1759-1137; Skourski, Yurii/0000-0002-4100-6420; Lee, Ji Eun/0000-0001-8947-826X; Kim, Bongjae/0000-0002-3841-2989				Armitage NP, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.015001; Chang CZ, 2015, NAT MATER, V14, P473, DOI [10.1038/nmat4204, 10.1038/NMAT4204]; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Checkelsky JG, 2014, NAT PHYS, V10, P731, DOI [10.1038/NPHYS3053, 10.1038/nphys3053]; Deng YJ, 2020, SCIENCE, V367, P895, DOI 10.1126/science.aax8156; Ding LC, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.041061; Dura OJ, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.045202; Eckstein JN, 1996, APPL PHYS LETT, V69, P1312, DOI 10.1063/1.117402; Endo T., 1999, J MAGN SOC JPN, V23, P1129; Fert A, 2008, REV MOD PHYS, V80, P1517, DOI 10.1103/RevModPhys.80.1517; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hauser AJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789505; Jungwirth T, 2006, REV MOD PHYS, V78, P809, DOI 10.1103/RevModPhys.78.809; Kanamori J, 2001, J PHYS SOC JPN, V70, P1433, DOI 10.1143/JPSJ.70.1433; Kim K, 2018, NAT MATER, V17, P794, DOI 10.1038/s41563-018-0132-3; Koepernik K, 1999, PHYS REV B, V59, P1743, DOI 10.1103/PhysRevB.59.1743; Kokado S, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024705; Kumar N, 2021, CHEM REV, V121, P2780, DOI 10.1021/acs.chemrev.0c00732; Li PG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17174-9; Li RW, 2009, P NATL ACAD SCI USA, V106, P14224, DOI 10.1073/pnas.0907618106; Li ZG, 2017, SEMICOND SCI TECH, V32, DOI 10.1088/1361-6641/aa5390; Liu EK, 2018, NAT PHYS, V14, P1125, DOI 10.1038/s41567-018-0234-5; Lu CL, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894465; Manna K, 2018, NAT REV MATER, V3, P244, DOI 10.1038/s41578-018-0036-5; Manyala N, 2000, NATURE, V404, P581, DOI 10.1038/35007030; May AF, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.174440; Mostofi AA, 2014, COMPUT PHYS COMMUN, V185, P2309, DOI 10.1016/j.cpc.2014.05.003; Nagaosa N, 2020, NAT REV MATER, V5, P621, DOI 10.1038/s41578-020-0208-y; Narang P, 2021, NAT MATER, V20, P293, DOI 10.1038/s41563-020-00820-4; Okamura Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18470-0; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; RIMET R, 1981, J MAGN MAGN MATER, V25, P7, DOI 10.1016/0304-8853(81)90141-4; Sakai A, 2020, NATURE, V581, P53, DOI 10.1038/s41586-020-2230-z; Sakai A, 2018, NAT PHYS, V14, P1119, DOI 10.1038/s41567-018-0225-6; Sharma SK, 2007, SOLID STATE ELECTRON, V51, P1124, DOI 10.1016/j.sse.2007.06.007; Soh JR, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.174406; Suzuki T, 2019, SCIENCE, V365, P377, DOI 10.1126/science.aat0348; Tsirkin SS, 2021, NPJ COMPUT MATER, V7, DOI 10.1038/s41524-021-00498-5; Tsujii N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat5935; VINCENT H, 1986, J SOLID STATE CHEM, V63, P349, DOI 10.1016/0022-4596(86)90190-8; Wang HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10299-6; Wang J, 2017, NAT MATER, V16, P1062, DOI 10.1038/nmat5012; Wang ZC, 2021, ADV MATER, V33, DOI 10.1002/adma.202005755; Xu LC, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.180404; Yang H., OBSERVATION UNUSUAL; Yasuda K, 2017, SCIENCE, V358, P1311, DOI 10.1126/science.aan5991; Yasuda K, 2020, NAT NANOTECHNOL, V15, P831, DOI 10.1038/s41565-020-0733-2; Ye LD, 2018, NATURE, V555, P638, DOI 10.1038/nature25987; Yildiz A, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.111203; Yin JY, 2020, PHYS REV MATER, V4, DOI 10.1103/PhysRevMaterials.4.013405; Yu P., 2005, FUNDAMENTALS SEMICON; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	54	8	7	53	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					576	+		10.1038/s41586-021-04028-7	http://dx.doi.org/10.1038/s41586-021-04028-7			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819684				2022-12-28	WOS:000722366200015
J	Heald, JB; Lengyel, M; Wolpert, DM				Heald, James B.; Lengyel, Mate; Wolpert, Daniel M.			Contextual inference underlies the learning of sensorimotor repertoires	NATURE			English	Article							ADAPTATION; MEMORY; MODEL; DYNAMICS; ERRORS	Humans spend a lifetime learning, storing and refining a repertoire of motor memories. For example, through experience, we become proficient at manipulating a large range of objects with distinct dynamical properties. However, it is unknown what principle underlies how our continuous stream of sensorimotor experience is segmented into separate memories and how we adapt and use this growing repertoire. Here we develop a theory of motor learning based on the key principle that memory creation, updating and expression are all controlled by a single computation-contextual inference. Our theory reveals that adaptation can arise both by creating and updating memories (proper learning) and by changing how existing memories are differentially expressed (apparent learning). This insight enables us to account for key features of motor learning that had no unified explanation: spontaneous recovery(1), savings(2), anterograde interference(3), how environmental consistency affects learning rate(4,5) and the distinction between explicit and implicit learning(6). Critically, our theory also predicts new phenomena-evoked recovery and context-dependent single-trial learning-which we confirm experimentally. These results suggest that contextual inference, rather than classical single-context mechanisms(1,4,7-9), is the key principle underlying how a diverse set of experiences is reflected in our motor behaviour.	[Heald, James B.; Wolpert, Daniel M.] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA; [Heald, James B.; Lengyel, Mate; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge, England; [Heald, James B.; Wolpert, Daniel M.] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Lengyel, Mate] Cent European Univ, Dept Cognit Sci, Ctr Cognit Computat, Budapest, Hungary	Columbia University; University of Cambridge; Columbia University; Central European University	Heald, JB (corresponding author), Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA.; Heald, JB (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge, England.; Heald, JB (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	jamesbheald@gmail.com		Heald, James/0000-0002-7293-7914; Lengyel, Mate/0000-0001-7266-0049	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [726090]; Wellcome Trust [212262/Z/18/Z, 097803/Z/11/Z]; Royal Society (Noreen Murray Professorship in Neurobiology); National Institutes of Health [R01NS117699, U19NS104649]; Engineering and Physical Sciences Research Council	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Wellcome Trust(Wellcome Trust); Royal Society (Noreen Murray Professorship in Neurobiology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. N. Ingram for technical support and G. Hennequin for discussions. This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 726090 to M.L.), the Wellcome Trust (Investigator Awards 212262/Z/18/Z to M.L. and 097803/Z/11/Z to D.M.W.), the Royal Society (Noreen Murray Professorship in Neurobiology to D.M.W), the National Institutes of Health (R01NS117699 and U19NS104649 to D.M.W.) and Engineering and Physical Sciences Research Council (studentship to J.B.H).	Acerbi L, 2017, ADV NEURAL INF PROCE, V30, P1834; [Anonymous], 2015, REP; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Carvalho CM, 2010, STAT SCI, V25, P88, DOI 10.1214/10-STS325; Castro LNG, 2014, CURR BIOL, V24, P1050, DOI 10.1016/j.cub.2014.03.049; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Coltman SK, 2019, J NEUROPHYSIOL, V121, P1575, DOI 10.1152/jn.00794.2018; Donchin O, 2003, J NEUROSCI, V23, P9032; Fox E.B., 2008, P 25 INT C MACHINE L, P312; Gershman SJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003939; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Heald JB, 2018, NAT HUM BEHAV, V2, P300, DOI 10.1038/s41562-018-0324-5; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; Houlsby NMT, 2013, CURR BIOL, V23, P2169, DOI 10.1016/j.cub.2013.09.012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Hulst T., CEREBELLAR DEGENERAT, DOI [10.1101/2020.07.03.185959(2021, DOI 10.1101/2020.07.03.185959(2021]; Jeffreys H., 1939, THEORY PROBABILITY, V1; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Kitago T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00307; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Li JN, 2008, NEUROIMAGE, V41, P398, DOI 10.1016/j.neuroimage.2008.01.068; Lopes H. F., 2011, BAYESIAN STAT, V9; McDougle SD, 2016, TRENDS COGN SCI, V20, P535, DOI 10.1016/j.tics.2016.05.002; McDougle SD, 2016, P NATL ACAD SCI USA, V113, P6797, DOI 10.1073/pnas.1523669113; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; Miyamoto YR, 2020, NAT NEUROSCI, V23, P443, DOI 10.1038/s41593-020-0600-3; Oh Y, 2019, J NEUROSCI, V39, P9237, DOI 10.1523/JNEUROSCI.3250-18.2019; Pekny SE, 2011, J NEUROSCI, V31, P13829, DOI 10.1523/JNEUROSCI.1704-11.2011; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Sanders H, 2020, ELIFE, V9, DOI 10.7554/eLife.51140; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sing GC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000893; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Taylor JA, 2011, J NEUROPHYSIOL, V106, P3157, DOI 10.1152/jn.01008.2010; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	42	16	16	5	87	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 16	2021	600	7889					489	+		10.1038/s41586-021-04129-3	http://dx.doi.org/10.1038/s41586-021-04129-3		NOV 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XP3FN	34819674	Green Submitted, Green Accepted			2022-12-28	WOS:000722150800006
J	Schousboe, JT; Sprague, BL; Abraham, L; O'Meara, ES; Onega, T; Advani, S; Henderson, LM; Wernli, KJ; Zhang, DY; Miglioretti, DL; Braithwaite, D; Kerlikowske, K				Schousboe, John T.; Sprague, Brian L.; Abraham, Linn; O'Meara, Ellen S.; Onega, Tracy; Advani, Shailesh; Henderson, Louise M.; Wernli, Karen J.; Zhang, Dongyu; Miglioretti, Diana L.; Braithwaite, Dejana; Kerlikowske, Karla			Cost-Effectiveness of Screening Mammography Beyond Age 75 Years	ANNALS OF INTERNAL MEDICINE			English	Article; Early Access							CARCINOMA IN-SITU; BREAST-CANCER; COMORBID CONDITIONS; WOMEN; SURVEILLANCE; BENEFITS; MODEL; OVERDIAGNOSIS; OUTCOMES; PROGRAM	Background: The cost-effectiveness of screening mammog-raphy beyond age 75 years remains unclear. Objective: To estimate benefits, harms, and cost-effective-ness of extending mammography to age 80, 85, or 90 years according to comorbidity burden. Design: Markov microsimulation model. Data Sources: SEER (Surveillance, Epidemiology, and End Results) program and Breast Cancer Surveillance Consortium. Target Population: U.S. women aged 65 to 90 years in groups defined by Charlson comorbidity score (CCS). Time Horizon: Lifetime. Perspective: National health payer. Intervention: Screening mammography to age 75, 80, 85, or 90 years. Outcome Measures: Breast cancer death, survival, and costs. Results of Base-Case Analysis: Extending biennial mam-mography from age 75 to 80 years averted 1.7, 1.4, and 1.0 breast cancer deaths and increased days of life gained by 5.8, 4.2, and 2.7 days per 1000 women for comorbidity scores of 0, 1, and 2, respectively. Annual mammography beyond age 75 years was not cost-effective, but extending biennial mammography to age 80 years was ($54000, $65000, and $85000 per quality-adjusted life-year [QALY] gained for women with CCSs of 0, 1, and >= 2, respectively). Overdiagnosis cases were double the number of deaths averted from breast cancer. Results of Sensitivity Analysis: Costs per QALY gained were sensitive to changes in invasive cancer incidence and shift of breast cancer stage with screening mammography. Limitation: No randomized controlled trials of screening mam-mography beyond age 75 years are available to provide model parameter inputs. Conclusion: Although annual mammography is not cost-effective, biennial screening mammography to age 80 years is; however, the absolute number of deaths averted is small, especially for women with comorbidities. Women consider-ing screening beyond age 75 years should weigh the poten-tial harms of overdiagnosis versus the potential benefit of averting death from breast cancer. Primary Funding Source: National Cancer Institute and National Institutes of Health.	[Schousboe, John T.] Univ Minnesota, Pk Nicollet Clin, Minneapolis, MN USA; [Schousboe, John T.] Univ Minnesota, HealthPartners Inst, Minneapolis, MN USA; [Schousboe, John T.] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN USA; [Sprague, Brian L.] Univ Vermont, Dept Surg, Burlington, VT USA; [Sprague, Brian L.] Univ Vermont, Dept Radiol, Burlington, VT USA; [Abraham, Linn; O'Meara, Ellen S.; Wernli, Karen J.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Onega, Tracy] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Onega, Tracy] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Advani, Shailesh] Georgetown Univ, Sch Med, Dept Oncol, Washington, DC USA; [Advani, Shailesh] Terasaki Inst Biomed Innovat, Los Angeles, CA USA; [Henderson, Louise M.] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Zhang, Dongyu] Univ Florida, Canc Control & Populat Sci Program, Dept Epidemiol, Gainesville, FL USA; [Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA USA; [Miglioretti, Diana L.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Braithwaite, Dejana] Univ Florida, Canc Control & Populat Sci Program, Dept Epidemiol, Gainesville, FL USA; [Braithwaite, Dejana] Univ Florida, Inst Aging, Gainesville, FL USA; [Kerlikowske, Karla] Univ Calif San Fransisco, Dept Med, San Francisco, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Biostat, San Francisco, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Vet Affairs VA, Div Gen Internal Med, San Francisco, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; University of Vermont; Kaiser Permanente; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; University of California System; University of California Davis; Kaiser Permanente; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schousboe, JT (corresponding author), 3800 Pk Nicollet Blvd,St Louis Pk, St Louis Pk, MN 55416 USA.	john.schousboe@parknicollet.com	Zhang, Dongyu/M-7310-2019	Onega, Tracy/0000-0002-1633-3040; Schousboe, John/0000-0002-9329-0750; Miglioretti, Diana/0000-0002-5547-1833; Zhang, Dongyu/0000-0002-7845-4630	National Cancer Institute [P01 CA154292, U54CA163303, R01CA149365, R01 CA207361]; BCSC; Patient-Centered Outcomes Research Institute [PCS-1504-30370]; Agency for Healthcare Research and Quality [R01 HS018366-01A1]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCSC; Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By National Cancer Institute grant R01 CA207361. Data collection was additionally supported by the BCSC with funding from the National Cancer Institute (grants P01 CA154292, U54CA163303, and R01CA149365), the Patient-Centered Outcomes Research Institute (grant PCS-1504-30370), and the Agency for Healthcare Research and Quality (grant R01 HS018366-01A1). Cancer data collection from BCSC was supported in part by several state public health departments and cancer registries (www.bcsc-research.org/about/work-acknowledgement).	Arias Elizabeth, 2018, Natl Vital Stat Rep, V67, P1; Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Centers for Medicare & Medicaid Services, OV MED PHYS FEE SCHE; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Demb J, 2020, JNCI-J NATL CANCER I, V112, P599, DOI 10.1093/jnci/djz172; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Expert Panel on Breast Imaging:, 2017, J Am Coll Radiol, V14, pS383, DOI 10.1016/j.jacr.2017.08.044; Garcia-Albeniz X, 2020, ANN INTERN MED, V172, P381, DOI 10.7326/M18-1199; Hendrick RE, 2018, RADIOLOGY, V287, P391, DOI 10.1148/radiol.2017171622; Janssen EM, 2019, MED DECIS MAKING, V39, P621, DOI 10.1177/0272989X19853516; Jewett PI, 2018, ANN EPIDEMIOL, V28, P65, DOI 10.1016/j.annepidem.2017.11.012; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lee CS, 2018, AM J ROENTGENOL, V210, P256, DOI 10.2214/AJR.17.18705; Lee KT, 2018, CLIN GERIATR MED, V34, P11, DOI 10.1016/j.cger.2017.09.002; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Lehman CD, 2017, RADIOLOGY, V283, P49, DOI 10.1148/radiol.2016161174; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Lowry KP, 2020, JNCI-J NATL CANCER I, V112, P582, DOI 10.1093/jnci/djz184; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Narayan A, 2017, BREAST CANCER RES TR, V164, P719, DOI 10.1007/s10549-017-4286-5; National Cancer Institute, BREAST CANC RISK ASS; National Cancer Institute Surveillance, EP END RES PROGR SEE; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Qaseem A, 2019, ANN INTERN MED, V170, P547, DOI 10.7326/M18-2147; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9	38	4	4	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.												10.7326/M20-8076	http://dx.doi.org/10.7326/M20-8076		NOV 2021	18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN0IO	34807717	Green Accepted			2022-12-28	WOS:000729198900001
J	Sherman, SV				Sherman, Stephanie V.			Tinea Capitis Due to Microsporum canis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Tinea Capitis Due to Microsporum canis A 6-year-old boy presented with a rash on his scalp and hair loss. Areas of bright green fluorescence were seen on Wood's lamp examination. Infection with Microsporum canis was identified on molecular testing.						Wang, Tingting/0000-0001-8812-2579					0	1	1	8	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2077	2077		10.1056/NEJMicm2108047	http://dx.doi.org/10.1056/NEJMicm2108047		NOV 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XC3KG	34797615				2022-12-28	WOS:000720683000001
J	Liu, XM; Farahi, G; Chiu, CL; Papic, Z; Watanabe, K; Taniguchi, T; Zaletel, MP; Yazdani, A				Liu, Xiaomeng; Farahi, Gelareh; Chiu, Cheng-Li; Papic, Zlatko; Watanabe, Kenji; Taniguchi, Takashi; Zaletel, Michael P.; Yazdani, Ali			Visualizing broken symmetry and topological defects in a quantum Hall ferromagnet	SCIENCE			English	Article							GRAPHENE; SPECTROSCOPY; QUANTIZATION; SKYRMIONS; STATES	The interaction between electrons in graphene under high magnetic fields drives the formation of a rich set of quantum Hall ferromagnetic (QHFM) phases with broken spin or valley symmetry. Visualizing atomic-scale electronic wave functions with scanning tunneling spectroscopy (STS), we resolved microscopic signatures of valley ordering in QHFM phases and spectral features of fractional quantum Hall phases of graphene. At charge neutrality, we observed a field-tuned continuous quantum phase transition from a valley-polarized state to an intervalley coherent state, with a Kekule distortion of its electronic density. Mapping the valley texture extracted from STS measurements of the Kekule phase, we could visualize valley skyrmion excitations localized near charged defects. Our techniques can be applied to examine valley-ordered phases and their topological excitations in a wide range of materials.	[Liu, Xiaomeng; Farahi, Gelareh; Chiu, Cheng-Li; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Liu, Xiaomeng; Farahi, Gelareh; Chiu, Cheng-Li; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Papic, Zlatko] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Zaletel, Michael P.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Princeton University; Princeton University; University of Leeds; National Institute for Materials Science; National Institute for Materials Science; University of California System; University of California Berkeley	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.; Yazdani, A (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	yazdani@princeton.edu	; Watanabe, Kenji/H-2825-2011	Liu, Xiaomeng/0000-0002-0039-7090; Yazdani, Ali/0000-0003-4996-8904; Watanabe, Kenji/0000-0003-3701-8119	Gordon and Betty Moore Foundation EPiQS initiative grant [GBMF9469]; NSF-MRSEC through the Princeton Center for Complex Materials [NSF-DMR-2011750]; DOE-BES grant [DE-FG02-07ER46419]; Princeton Catalysis Initiative; Elemental Strategy Initiative, Japan [JPMXP0112101001]; JSPS KAKENHI grant [JP20H00354]; JST [CREST JPMJCR15F3]; Army Research Office through the MURI program [W911NF-17-1-0323]; NSF [PHY-1607611]; Trinity College; ICAM; Gordon and Betty Moore Foundation [GBMF9616];  [NSF-DMR-1904442];  [ONR-N00014-21-1-2592]	Gordon and Betty Moore Foundation EPiQS initiative grant; NSF-MRSEC through the Princeton Center for Complex Materials(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); DOE-BES grant(United States Department of Energy (DOE)); Princeton Catalysis Initiative; Elemental Strategy Initiative, Japan; JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST(Japan Science & Technology Agency (JST)); Army Research Office through the MURI program; NSF(National Science Foundation (NSF)); Trinity College; ICAM; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); ; 	Supported by NSF-DMR-1904442 and ONR-N00014-21-1-2592; Gordon and Betty Moore Foundation EPiQS initiative grant GBMF9469; NSF-MRSEC through the Princeton Center for Complex Materials NSF-DMR-2011750; DOE-BES grant DE-FG02-07ER46419; the Princeton Catalysis Initiative; the Elemental Strategy Initiative, Japan, grant JPMXP0112101001, JSPS KAKENHI grant JP20H00354, and CREST JPMJCR15F3), JST (K.W. and T.T.); and the Army Research Office through the MURI program (grant W911NF-17-1-0323) (M.P.Z.). A.Y. acknowledges the hospitality of the Aspen Center for Physics, which is supported by NSF grant PHY-1607611, and Trinity College, where his stay was supported by a QuantEmX grant from ICAM and the Gordon and Betty Moore Foundation through grant GBMF9616.	Atteia J, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.035403; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chae JS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116802; Chatterjee S, 2020, ARXIV201001144; Chatterjee S., 2020, ARXIV201001144CONDMA; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; Coissard A., 2021, ARXIV211002811; Coissard A., 2021, ARXIV211002811CONDMA; Das A., 2021, ARXIV210907515; Das A., ARXIV210907515CONDMA; Das I, 2021, NAT PHYS, V17, P710, DOI 10.1038/s41567-021-01186-3; Dial OE, 2007, NATURE, V448, P176, DOI 10.1038/nature05982; Dial OE, 2010, NATURE, V464, P566, DOI 10.1038/nature08941; DOLGOPOLOV VT, 1992, PHYS REV B, V46, P12560, DOI 10.1103/PhysRevB.46.12560; EISENSTEIN JP, 1992, PHYS REV LETT, V69, P3804, DOI 10.1103/PhysRevLett.69.3804; Ezawa Z. F., 2008, QUANTUM HALL EFFECTS, V2nd; Feldman BE, 2016, SCIENCE, V354, P316, DOI 10.1126/science.aag1715; Ghahari F, 2017, SCIENCE, V356, P845, DOI 10.1126/science.aal0212; Gutierrez C, 2018, SCIENCE, V361, P789, DOI 10.1126/science.aar2014; HALDANE FDM, 1983, PHYS REV LETT, V51, P605, DOI 10.1103/PhysRevLett.51.605; Halperin B. I., 2020, FRACTIONAL QUANTUM H, DOI DOI 10.1142/1175; Haussmann R, 1996, PHYS REV LETT, V76, P979, DOI 10.1103/PhysRevLett.76.979; HE S, 1993, PHYS REV LETT, V71, P777, DOI 10.1103/PhysRevLett.71.777; Hou CY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.075427; Jung SY, 2011, NAT PHYS, V7, P245, DOI 10.1038/NPHYS1866; Kim S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22886-7; Li GH, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3605664; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Lian YL, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.245428; Liu X., 2021, HARVARD DATAVERSE, DOI [10.7910/DVN/JZWE2C. 1, DOI 10.7910/DVN/JZWE2C.1]; Liu XM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23031-0; Luican A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.041405; Luican-Mayer A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.036804; MacDonald AH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.206801; Miller DL, 2010, NAT PHYS, V6, P811, DOI 10.1038/NPHYS1736; Miller DL, 2009, SCIENCE, V324, P924, DOI 10.1126/science.1171810; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Nomura K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.216801; Nuckolls KP, 2020, NATURE, V588, P610, DOI 10.1038/s41586-020-3028-8; Papic Z, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011037; Park JM, 2021, NATURE, V592, P43, DOI 10.1038/s41586-021-03366-w; Randeria MT, 2018, NAT PHYS, V14, P796, DOI 10.1038/s41567-018-0148-2; Song YJ, 2010, NATURE, V467, P185, DOI 10.1038/nature09330; Walkup D, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.035428; Weisse A, 2006, REV MOD PHYS, V78, P275, DOI 10.1103/RevModPhys.78.275; Wu S, 2021, NAT MATER, V20, P488, DOI 10.1038/s41563-020-00911-2; Yang FY, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.156802; Zhou H, 2020, NAT PHYS, V16, P154, DOI 10.1038/s41567-019-0729-8; Zhou H., 2021, ARXIV210201061CONDMA; Zhou H., 2021, ARXIV210201061; Zibrov AA, 2018, NAT PHYS, V14, P930, DOI 10.1038/s41567-018-0190-0	62	17	16	29	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					321	+		10.1126/science.abm3770	http://dx.doi.org/10.1126/science.abm3770			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	34855512	Green Submitted, Green Accepted			2022-12-28	WOS:000745036100034
J	Simbayi, LC; Moyo, S; van Heerden, A; Zuma, K; Zungu, N; Marinda, E; Jooste, SE; Cloete, A; Mabaso, M; van Rooyen, H				Simbayi, Leickness C.; Moyo, Sizulu; van Heerden, Alastair; Zuma, Khangelani; Zungu, Nompumelelo; Marinda, Edmore; Jooste, Sean Edwin; Cloete, Allanise; Mabaso, Musawenkosi; van Rooyen, Heidi			Global HIV efforts need to focus on key populations in LMICs Comment	LANCET			English	Editorial Material							IMPACT		[Simbayi, Leickness C.; Moyo, Sizulu; Jooste, Sean Edwin; Cloete, Allanise; van Rooyen, Heidi] Human Sci Res Council, ZA-8000 Cape Town, South Africa; [Zuma, Khangelani; Zungu, Nompumelelo; Marinda, Edmore] Human Sci Res Council, Pretoria, South Africa; [Mabaso, Musawenkosi] Human Sci Res Council, Durban, South Africa; [van Heerden, Alastair] Human Sci Res Council, Pietermaritzburg, South Africa	Human Sciences Research Council-South Africa; Human Sciences Research Council-South Africa; Human Sciences Research Council-South Africa	Simbayi, LC (corresponding author), Human Sci Res Council, ZA-8000 Cape Town, South Africa.	isimbayi@hsrc.ac.za	Van Heerden, Alastair/AAY-6262-2020	Van Heerden, Alastair/0000-0003-2530-6885; Zuma, Khangelani/0000-0003-4492-5083				Dorward J, 2021, LANCET HIV, V8, pe158, DOI 10.1016/S2352-3018(20)30359-3; Govender K, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00504; Iversen J, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25632; Katz IT, 2021, AIDS BEHAV, V25, P1129, DOI 10.1007/s10461-020-03063-1; Baena-Diez JM, 2020, J PUBLIC HEALTH-UK, V42, P698, DOI 10.1093/pubmed/fdaa136; Shahmanesh M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11399-z; Simbayi L, 2019, S AFRICAN NATL HIV P; Taggart T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4387; UNAIDS, 2020, PREV PAND PUTT PEOPL; UNAIDS, 2021, GLOB AIDS UPD CONFR; UNAIDS, 2020, COVID 19 HIV 1 MOM 2; UNAIDS, 2020, SEIZ MOM TACKL ENTR; USAID, COVID 19 CONT TRAC T; WHO, 2017, HIV AIDS FRAM ACT AF; WHO, WHO COR COVID 19 DAS, P2021; WHO Regional Office for Africa, 2021, LESS 10 AFR COUNTR H	16	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2021	398	10318					2213	2215		10.1016/S0140-6736(21)02692-1	http://dx.doi.org/10.1016/S0140-6736(21)02692-1		DEC 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XQ3YW	34856188	Green Published, Bronze			2022-12-28	WOS:000731484500005
J	Bacharier, LB; Maspero, JF; Katelaris, CH; Fiocchi, AG; Gagnon, R; de Mir, I; Jain, N; Sher, LD; Mao, X; Liu, D; Zhang, Y; Khan, AH; Kapoor, U; Khokhar, FA; Rowe, PJ; Deniz, Y; Ruddy, M; Laws, E; Patel, N; Weinreich, DM; Yancopoulos, GD; Amin, N; Mannent, LP; Lederer, DJ; Hardin, M				Bacharier, Leonard B.; Maspero, Jorge F.; Katelaris, Constance H.; Fiocchi, Alessandro G.; Gagnon, Remi; de Mir, Ines; Jain, Neal; Sher, Lawrence D.; Mao, X.; Liu, D.; Zhang, Yi; Khan, Asif H.; Kapoor, Upender; Khokhar, Faisal A.; Rowe, Paul J.; Deniz, Yamo; Ruddy, Marcella; Laws, Elizabeth; Patel, Naimish; Weinreich, David M.; Yancopoulos, George D.; Amin, Nikhil; Mannent, Leda P.; Lederer, David J.; Hardin, Megan		Liberty Asthma VOYAGE Investiga	Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD ASTHMA; ADULTS	BACKGROUND Children with moderate-to-severe asthma continue to have disease complications despite the receipt of standard-of-care therapy. The monoclonal antibody dupilumab has been approved for the treatment of adults and adolescents with asthma as well as with other type 2 inflammatory diseases. METHODS In this 52-week phase 3, randomized, double-blind, placebo-controlled trial, we assigned 408 children between the ages of 6 and 11 years who had uncontrolled moderate-to-severe asthma to receive a subcutaneous injection of dupilumab (at a dose of 100 mg for those weighing <= 30 kg and 200 mg for those weighing >30 kg) or matched placebo every 2 weeks. All the children continued to receive a stable dose of standard background therapy. The primary end point was the annualized rate of severe asthma exacerbations. Secondary end points included the change from baseline in the percentage of predicted prebronchodilator forced expiratory volume in 1 second (ppFEV(1)) at week 12 and in the score on the Asthma Control Questionnaire 7 Interviewer-Administered (ACQ-7-IA) at week 24. End points were evaluated in the two primary efficacy populations who had either a type 2 inflammatory asthma phenotype (>= 150 blood eosinophils per cubic millimeter or a fraction of exhaled nitric oxide of >= 20 ppb at baseline) or a blood eosinophil count of at least 300 cells per cubic millimeter at baseline. RESULTS In patients with the type 2 inflammatory phenotype, the annualized rate of severe asthma exacerbations was 0.31 (95% confidence interval [CI], 0.22 to 0.42) with dupilumab and 0.75 (95% CI, 0.54 to 1.03) with placebo (relative risk reduction in the dupilumab group, 59.3%; 95% CI, 39.5 to 72.6; P<0.001). The mean (+/- SE) change from baseline in the ppFEV(1) was 10.5 +/- 1.0 percentage points with dupilumab and 5.3 +/- 1.4 percentage points with placebo (mean difference, 5.2 percentage points; 95% CI, 2.1 to 8.3; P<0.001). Dupilumab also resulted in significantly better asthma control than placebo (P<0.001). Similar results were observed in the patients with an eosinophil count of at least 300 cells per cubic millimeter at baseline. The incidence of serious adverse events was similar in the two groups. CONCLUSIONS Among children with uncontrolled moderate-to-severe asthma, those who received add-on dupilumab had fewer asthma exacerbations and better lung function and asthma control than those who received placebo.	[Bacharier, Leonard B.] Vanderbilt, Monroe Carell Jr Childrens Hosp, Nashville, TN USA; [Maspero, Jorge F.] Fdn CIDEA, Buenos Aires, DF, Argentina; [Katelaris, Constance H.] Campbelltown Hosp, Campbelltown, NSW, Australia; [Katelaris, Constance H.] Western Sydney Univ, Sydney, NSW, Australia; [Fiocchi, Alessandro G.] Bambino Gesu Childrens Hosp IRCCS, Rome, Italy; [Gagnon, Remi] Clin Specialisee Allergie Capitale, Quebec City, PQ, Canada; [de Mir, Ines] Hosp Valle De Hebron, Barcelona, Spain; [Jain, Neal] Arizona Allergy & Immunol Res, Gilbert, AZ USA; [Sher, Lawrence D.] Peninsula Res Associates, Rolling Hills Estates, CA USA; [Mao, X.; Kapoor, Upender; Rowe, Paul J.; Laws, Elizabeth] Sanofi, Bridgewater, NJ USA; [Liu, D.] Sanofi, Beijing, Peoples R China; [Zhang, Yi; Khokhar, Faisal A.; Deniz, Yamo; Ruddy, Marcella; Weinreich, David M.; Yancopoulos, George D.; Amin, Nikhil; Lederer, David J.] Regeneron Pharmaceut, Tarrytown, NY USA; [Khan, Asif H.; Mannent, Leda P.] Sanofi, Chilly Mazarin, France; [Patel, Naimish; Hardin, Megan] Sanofi Genzyme, Cambridge, MA USA	Vanderbilt University; Western Sydney University; IRCCS Bambino Gesu; Hospital Universitari Vall d'Hebron; Sanofi-Aventis; Sanofi-Aventis; Regeneron; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Genzyme Corporation	Bacharier, LB (corresponding author), Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Div Allergy Immunol & Pulm Med, 2200 Childrens Way,Doctors Off Tower 11205, Nashville, TN 37232 USA.	leonard.bacharier@vumc.org	Khan, Asif H/GRJ-1775-2022; Scott, Chris/I-4442-2019	Khan, Asif H/0000-0001-9158-0116; Scott, Chris/0000-0003-3874-1704; Fiocchi, Alessandro/0000-0002-2549-0523	Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	Supported by Sanofi and Regeneron Pharmaceuticals.	Barthel SR, 2008, J LEUKOCYTE BIOL, V83, P1, DOI 10.1189/jlb.0607344; Bellin MH, 2015, J PEDIATR HEALTH CAR, V29, P536, DOI 10.1016/j.pedhc.2015.04.018; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Centers for Disease Control and Prevention, VIT SIGNS; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fleming L, 2015, EUR RESPIR J, V46, P1322, DOI 10.1183/13993003.00780-2015; Gandhi NA, 2017, EXPERT REV CLIN IMMU, V13, P425, DOI 10.1080/1744666X.2017.1298443; GINA, 2021, STRAT ASTHM MAN PREV; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Hayden LP, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0890-0; Le Floc'h A, 2020, ALLERGY, V75, P1188, DOI 10.1111/all.14151; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; McGeachie MJ, 2017, CURR OPIN ALLERGY CL, V17, P104, DOI 10.1097/ACI.0000000000000348; Murphy JFA., 2018, IR MED J, V93, P135; Nunes Carlos, 2017, Asthma Res Pract, V3, P1, DOI 10.1186/s40733-016-0029-3; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Ramratnam SK, 2017, J ALLER CL IMM-PRACT, V5, P889, DOI 10.1016/j.jaip.2017.04.031; Tagiyeva N, 2016, AM J RESP CRIT CARE, V193, P23, DOI 10.1164/rccm.201505-0870OC; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Tozawa H, 2011, MOL CELL BIOL, V31, P2196, DOI 10.1128/MCB.01430-10; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5	23	25	25	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2230	2240		10.1056/NEJMoa2106567	http://dx.doi.org/10.1056/NEJMoa2106567			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XL4CS	34879449	Green Published, Bronze			2022-12-28	WOS:000728093600012
J	Good, CR; Aznar, MA; Kuramitsu, S; Samareh, P; Agarwal, S; Donahue, G; Ishiyama, K; Wellhausen, N; Rennels, AK; Ma, YJ; Tian, LF; Guedan, S; Alexander, KA; Zhang, Z; Rommel, PC; Singh, N; Glastad, KM; Richardson, MW; Watanabe, K; Tanyi, JL; O'Hara, MH; Ruella, M; Lacey, SF; Moon, EK; Schuster, SJ; Albelda, SM; Lanier, LL; Young, RM; Berger, SL; June, CH				Good, Charly R.; Aznar, M. Angela; Kuramitsu, Shunichiro; Samareh, Parisa; Agarwal, Sangya; Donahue, Greg; Ishiyama, Kenichi; Wellhausen, Nils; Rennels, Austin K.; Ma, Yujie; Tian, Lifeng; Guedan, Sonia; Alexander, Katherine A.; Zhang, Zhen; Rommel, Philipp C.; Singh, Nathan; Glastad, Karl M.; Richardson, Max W.; Watanabe, Keisuke; Tanyi, Janos L.; O'Hara, Mark H.; Ruella, Marco; Lacey, Simon F.; Moon, Edmund K.; Schuster, Stephen J.; Albelda, Steven M.; Lanier, Lewis L.; Young, Regina M.; Berger, Shelley L.; June, Carl H.			An NK-like CAR T cell transition in CAR T cell dysfunction	CELL			English	Article							READ ALIGNMENT; RNA-SEQ; EXHAUSTION; ANTIGEN; TARGET; REGULATORS; INFECTION; CHROMATIN; LIMITS; ID3	Chimeric antigen receptor (CAR) T cell therapy has achieved remarkable success in hematological malignancies but remains ineffective in solid tumors, due in part to CAR T cell exhaustion in the solid tumor micro environment. To study dysfunction of mesothelin-redirected CAR T cells in pancreatic cancer, we establish a robust model of continuous antigen exposure that recapitulates hallmark features of T cell exhaustion and discover, both in vitro and in CAR T cell patients, that CAR dysregulation is associated with a CD8+ T-toNK-like T cell transition. Furthermore, we identify a gene signature defining CAR and TCR dysregulation and transcription factors, including SOX4 and ID3 as key regulators of CAR T cell exhaustion. Our findings shed light on the plasticity of human CAR T cells and demonstrate that genetic downmodulation of ID3 and SOX4 expression can improve the efficacy of CART cell therapy in solid tumors by preventing or delaying CAR T cell dysfunction.	[Good, Charly R.; Samareh, Parisa; Donahue, Greg; Alexander, Katherine A.; Zhang, Zhen; Glastad, Karl M.; Berger, Shelley L.] Penn Inst Epigenet, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Aznar, M. Angela; Kuramitsu, Shunichiro; Agarwal, Sangya; Wellhausen, Nils; Rennels, Austin K.; Ma, Yujie; Tian, Lifeng; Guedan, Sonia; Rommel, Philipp C.; Singh, Nathan; Watanabe, Keisuke; Ruella, Marco; Lacey, Simon F.; Moon, Edmund K.; Albelda, Steven M.; Young, Regina M.; June, Carl H.] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ishiyama, Kenichi; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Ishiyama, Kenichi; Lanier, Lewis L.] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA; [Agarwal, Sangya; Tian, Lifeng; Lacey, Simon F.; June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tian, Lifeng; Ruella, Marco; Lacey, Simon F.; June, Carl H.] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Richardson, Max W.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Richardson, Max W.; Tanyi, Janos L.; O'Hara, Mark H.; Ruella, Marco; Moon, Edmund K.; Albelda, Steven M.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Tanyi, Janos L.] Univ Penn, Div Gynecol Oncol, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Moon, Edmund K.; Albelda, Steven M.] Univ Penn, Div Pulm Allergy & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ruella, Marco; Schuster, Stephen J.] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Berger, SL (corresponding author), Penn Inst Epigenet, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Young, RM; June, CH (corresponding author), Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	ryoung@upenn.edu; bergers@pennmedicine.upenn.edu; cjune@upenn.edu	ma, yujie/GYA-3957-2022; Agarwal, Sangya/GNP-5646-2022; Guedan, Sonia/O-9645-2018; Rommel, Philipp C/AAP-1813-2020; Ruella, Marco/GQP-8473-2022	Guedan, Sonia/0000-0002-9605-0760; Rommel, Philipp C/0000-0002-9790-4086; Agarwal, Sangya/0000-0003-4272-515X; Wellhausen, Nils/0000-0001-8955-7582; ISHIYAMA, KENICHI/0000-0002-9377-2098	SU2C-Lustgarten Foundation Translational Cancer Research Team Grant [SU2-CAACR-DT21-17, SU2C-RT6162]; NIH [P01CA214278, CA078831, CA232466]; American Cancer Society; Parker Institute for Can-cer Immunotherapy; National Institutes of Health/National Cancer Institute [5T32CA009140]; NIH DRC Center [P30 DK063720, S10 1S10OD018040-01]	SU2C-Lustgarten Foundation Translational Cancer Research Team Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Parker Institute for Can-cer Immunotherapy; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH DRC Center	Research supported by a SU2C-Lustgarten Foundation Translational Cancer Research Team Grant, grant numbers SU2-CAACR-DT21-17 and SU2C-RT6162. S.L.B. is supported by NIH grant CA078831. C.R.G. is supported by NIH grant CA232466 and the American Cancer Society - Rob Kugler - Post-doctoral Fellowship. R.M.Y. and C.H.J. are supported by NIH grant P01CA214278. C.H.J. and L.L.L. are supported by the Parker Institute for Can-cer Immunotherapy. P.C.R. is supported by the National Institutes of Health/National Cancer Institute grant 5T32CA009140. We acknowledge the Parnas-sus Flow Cytometry Core, in part supported by the NIH DRC Center grants P30 DK063720 and S10 1S10OD018040-01, for use of the CyTOF instrument. The authors wish to thank E. John Wherry and Austin L. Good for their valuable feedback on this manuscript.	Abd Hamid M, 2019, CANCER IMMUNOL RES, V7, P1293, DOI 10.1158/2326-6066.CIR-18-0885; Agarwal S, 2021, JOVE-J VIS EXP, DOI 10.3791/62299; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Balin SJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7668; Barbarin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00316; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Boroughs AC, 2020, MOL THER, V28, P2577, DOI 10.1016/j.ymthe.2020.07.023; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chan TE, 2017, CELL SYST, V5, P251, DOI 10.1016/j.cels.2017.08.014; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guo J, 2020, CANCER CELL, V37, P627, DOI 10.1016/j.ccell.2020.04.009; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Gurusamy D, 2020, CANCER CELL, V37, P818, DOI 10.1016/j.ccell.2020.05.004; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kurioka A, 2018, IMMUNOLOGY, V154, P547, DOI 10.1111/imm.12925; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leong JW, 2017, CLIN IMMUNOL, V177, P60, DOI 10.1016/j.clim.2016.03.003; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WT, 2020, IMMUNITY, V53, P456, DOI 10.1016/j.immuni.2020.07.011; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Lu YC, 2019, CANCER IMMUNOL RES, V7, P1824, DOI 10.1158/2326-6066.CIR-19-0299; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Malhotra N, 2018, J EXP MED, V215, P2887, DOI 10.1084/jem.20172021; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mathewson ND, 2021, CELL, V184, P1281, DOI 10.1016/j.cell.2021.01.022; McMahon CW, 2002, J IMMUNOL, V169, P1444, DOI 10.4049/jimmunol.169.3.1444; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Milner JJ, 2020, IMMUNITY, V52, P808, DOI 10.1016/j.immuni.2020.04.007; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Moon EK, 2016, CLIN CANCER RES, V22, P436, DOI 10.1158/1078-0432.CCR-15-1070; Moon EK, 2014, CLIN CANCER RES, V20, P4262, DOI 10.1158/1078-0432.CCR-13-2627; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Poorebrahim M, 2021, ONCOGENE, V40, P421, DOI 10.1038/s41388-020-01501-x; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Roth TL, 2020, CELL, V181, P728, DOI 10.1016/j.cell.2020.03.039; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sato K, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1639-x; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Seyda M, 2016, TRENDS IMMUNOL, V37, P546, DOI 10.1016/j.it.2016.06.004; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Stromnes IM, 2015, CANCER CELL, V28, P638, DOI 10.1016/j.ccell.2015.09.022; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; van Montfoort N, 2018, CELL, V175, P1744, DOI 10.1016/j.cell.2018.10.028; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	78	33	37	24	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6081	+		10.1016/j.cell.2021.11.016	http://dx.doi.org/10.1016/j.cell.2021.11.016		DEC 2021	47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YJ0DU	34861191	Green Accepted, Bronze			2022-12-28	WOS:000744210600002
J	Markaki, Y; Chong, JG; Wang, YY; Jacobson, EC; Luong, C; Tan, SYX; Jachowicz, JW; Strehle, M; Maestrini, D; Banerjee, AK; Mistry, BA; Dror, I; Dossin, F; Schoneberg, J; Heard, E; Guttman, M; Chou, T; Plath, K				Markaki, Yolanda; Chong, Johnny Gan; Wang, Yuying; Jacobson, Elsie C.; Luong, Christy; Tan, Shawn Y. X.; Jachowicz, Joanna W.; Strehle, Mackenzie; Maestrini, Davide; Banerjee, Abhik K.; Mistry, Bhaven A.; Dror, Iris; Dossin, Francois; Schoeneberg, Johannes; Heard, Edith; Guttman, Mitchell; Chou, Tom; Plath, Kathrin			Xist nucleates local protein gradients to propagate silencing across the X chromosome	CELL			English	Article							STRUCTURED ILLUMINATION MICROSCOPY; INACTIVE X; MESSENGER-RNA; CHROMATIN; SEPARATION; MOUSE; IDENTIFICATION; LOCALIZATION; PCGF3/5-PRC1; METHYLATION	The lncRNA Xist forms -50 diffraction-limited foci to transcriptionally silence one X chromosome. How this small number of RNA foci and interacting proteins regulate a much larger number of X-linked genes is unknown. We show that Xist foci are locally confined, contain -2 RNA molecules, and nucleate supramolecular complexes (SMACs) that include many copies of the critical silencing protein SPEN. Aggregation and exchange of SMAC proteins generate local protein gradients that regulate broad, proximal chromatin regions. Partitioning of numerous SPEN molecules into SMACs is mediated by their intrinsically disordered regions and essential for transcriptional repression. Polycomb deposition via SMACs induces chromatin compaction and the increase in SMACs density around genes, which propagates silencing across the X chromosome. Our findings introduce a mechanism for functional nuclear compartmentalization whereby crowding of transcriptional and architectural regulators enables the silencing of many target genes by few RNA molecules.	[Markaki, Yolanda; Chong, Johnny Gan; Wang, Yuying; Jacobson, Elsie C.; Luong, Christy; Tan, Shawn Y. X.; Dror, Iris; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Jachowicz, Joanna W.; Strehle, Mackenzie; Banerjee, Abhik K.; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Maestrini, Davide; Mistry, Bhaven A.; Chou, Tom] Univ Calif Los Angeles, Dept Computat Med, Los Angeles, CA 90095 USA; [Mistry, Bhaven A.] Claremont McKenna Coll, Claremont, CA 91711 USA; [Dossin, Francois; Heard, Edith] European Mol Biol Lab, Directors Unit, D-69117 Heidelberg, Germany; [Schoeneberg, Johannes] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Schoeneberg, Johannes] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology; University of California System; University of California Los Angeles; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; European Molecular Biology Laboratory (EMBL); University of California System; University of California San Diego; University of California System; University of California San Diego	Markaki, Y; Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Chou, T (corresponding author), Univ Calif Los Angeles, Dept Computat Med, Los Angeles, CA 90095 USA.	gmarkaki@mednet.ucla.edu; tomchou@ucla.edu; kplath@mednet.ucla.edu	Strehle, Mackenzie/GNP-8006-2022	Strehle, Mackenzie/0000-0003-1410-8701; Markaki, Yolanda/0000-0001-6013-2417; Dossin, Francois/0000-0002-4085-1446; , Abhik/0000-0002-9797-0104; Jacobson, Elsie/0000-0002-6094-5490; Luong, Christy/0000-0003-2841-9930; Wang, Yuying/0000-0002-2548-5863; Jachowicz, Joanna/0000-0002-1599-682X; Gan Chong, Johnny/0000-0001-8925-6368	Department of Biological Chemistry; NIH [R01GM115233, P30EY000331, 1R01MH109166, R21HD094172, R03HD095086, F30HL136080]; Keck Foundation; HHMI Faculty Scholar grant; NSF [DMS1814364]; BSCRC at UCLA; DGSOM at UCLA	Department of Biological Chemistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); HHMI Faculty Scholar grant; NSF(National Science Foundation (NSF)); BSCRC at UCLA; DGSOM at UCLA	We thank David Baker for sharing the ct-60 gene and Yi-Yun Ho, Tsotne Chitiashvili, Amy Pandya-Jones, and Mario Blanco for help with the study. We thank Lars Dreier, Douglas Black, Emilie Marcus, and Plath lab members for critical discussions. We thank the DGSOM at UCLA, David Williams, and the Department of Biological Chemistry for support. The imaging was supported by the NIH (R01GM115233 and P30EY000331); Y.M. by NIH (R03HD095086); K.P. by an Innovation Award from the BSCRC at UCLA, NIH (R01GM115233, 1R01MH109166, R21HD094172), the Keck Foundation, and a HHMI Faculty Scholar grant; D. M. and T.C. by the NSF (DMS1814364) and NIH (R01HL146552); and A.B. by NIH (F30HL136080).	Almeida M, 2017, SCIENCE, V356, P1081, DOI 10.1126/science.aal2512; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berg BA, 2008, COMPUT PHYS COMMUN, V179, P443, DOI 10.1016/j.cpc.2008.03.010; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bousard A, 2019, EMBO REP, V20, DOI 10.15252/embr.201948019; Boyle S, 2020, GENE DEV, V34, P931, DOI 10.1101/gad.336487.120; Brackley CA, 2020, BRIEF FUNCT GENOMICS, V19, P111, DOI 10.1093/bfgp/elz032; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; Brockdorff N, 2020, GENE DEV, V34, P733, DOI 10.1101/gad.337196.120; Brockdorff N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2017.0021; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Cerase A, 2019, NAT STRUCT MOL BIOL, V26, P331, DOI 10.1038/s41594-019-0223-0; Cerase A, 2014, P NATL ACAD SCI USA, V111, P2235, DOI 10.1073/pnas.1312951111; Chang JC, 2015, BIOPHYS J, V109, P966, DOI 10.1016/j.bpj.2015.07.028; Chang JC, 2014, J STAT PHYS, V157, P582, DOI 10.1007/s10955-014-1059-y; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Colognori D, 2019, MOL CELL, V74, P101, DOI 10.1016/j.molcel.2019.01.015; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Darrow EM, 2016, P NATL ACAD SCI USA, V113, pE4504, DOI 10.1073/pnas.1609643113; Sousa LBDE, 2019, GENOME RES, V29, P1087, DOI 10.1101/gr.245027.118; Demmerle J, 2017, NAT PROTOC, V12, P988, DOI 10.1038/nprot.2017.019; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dossin F, 2020, NATURE, V578, P455, DOI 10.1038/s41586-020-1974-9; Dundr Miroslav, 2003, Curr Protoc Cell Biol, VChapter 13, DOI 10.1002/0471143030.cb1305s18; Eliscovich C, 2013, J BIOL CHEM, V288, P20361, DOI 10.1074/jbc.R113.452094; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Finn EH, 2017, METHODS, V123, P47, DOI 10.1016/j.ymeth.2017.01.007; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frank L, 2020, J MOL BIOL, V432, P4270, DOI 10.1016/j.jmb.2020.04.015; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Galupa R, 2018, ANNU REV GENET, V52, P535, DOI 10.1146/annurev-genet-120116-024611; Giorgetti L, 2016, NATURE, V535, P575, DOI 10.1038/nature18589; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Gu B, 2018, NAT BIOTECHNOL, V36, P632, DOI 10.1038/nbt.4166; Gu ZG, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4625-x; Guttman, 2021, XIST SPATIALLY AMPLI; Guttman M, 2020, BIORXIV, DOI [10.1101/2020.08.25.267435, DOI 10.1101/2020.08.25.267435]; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Hayashi K, 2013, NAT PROTOC, V8, P1513, DOI 10.1038/nprot.2013.090; Hendrich BD, 1997, NUCLEIC ACIDS RES, V25, P2661, DOI 10.1093/nar/25.13.2661; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Illingworth RS, 2019, CURR OPIN GENET DEV, V55, P82, DOI 10.1016/j.gde.2019.06.006; Jansz N, 2018, CELL REP, V25, P1912, DOI 10.1016/j.celrep.2018.10.044; Jegu T, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.17; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kang MC, 2010, BIOPHYS J, V99, P2737, DOI 10.1016/j.bpj.2010.09.013; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Kraus F, 2017, NAT PROTOC, V12, P1011, DOI 10.1038/nprot.2017.020; Kuznetsova IM, 2014, INT J MOL SCI, V15, P23090, DOI 10.3390/ijms151223090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1597-8; Loda A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008333; Markaki Yolanda, 2013, Methods Mol Biol, V950, P43, DOI 10.1007/978-1-62703-137-0_4; Markaki Y, 2012, BIOESSAYS, V34, P412, DOI 10.1002/bies.201100176; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Minkovsky A, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-12; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nesterova TB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11171-3; Ng K, 2011, MOL BIOL CELL, V22, P2634, DOI 10.1091/mbc.E11-02-0146; Nozaki T, 2017, MOL CELL, V67, P282, DOI 10.1016/j.molcel.2017.06.018; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Pacini G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23643-6; Pandya-Jones A, 2020, NATURE, V587, P145, DOI 10.1038/s41586-020-2703-0; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Pintacuda G, 2017, MOL CELL, V68, P955, DOI 10.1016/j.molcel.2017.11.013; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ridings-Figueroa R, 2017, GENE DEV, V31, P876, DOI 10.1101/gad.295907.117; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; RStudio Team, 2020, RSTUDIO INT DEV R; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schertzer MD, 2019, MOL CELL, V75, P523, DOI 10.1016/j.molcel.2019.05.028; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Sladitschek HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124958; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Sunwoo H, 2017, P NATL ACAD SCI USA, V114, P10654, DOI 10.1073/pnas.1711206114; Sunwoo H, 2015, P NATL ACAD SCI USA, V112, pE4216, DOI 10.1073/pnas.1503690112; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Teller K, 2011, NUCLEUS-PHILA, V2, P465, DOI 10.4161/nucl.2.5.17862; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Van der Auwera G.A., 2020, GENOMICS CLOUD USING; Van Rossum G., 2009, PYTHON 3 REFERENCE M, DOI DOI 10.5555/1593511; van Zon R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3366523; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang CY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10755-3; Wang CY, 2018, CELL, V174, P406, DOI 10.1016/j.cell.2018.05.007; Waskom M. L., 2021, J OPEN SOURCE SOFTW, V6, P3021, DOI [DOI 10.21105/JOSS.03021, 10.5281/ZENODO.592845]; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xie LQ, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.20209653; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yue MH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006890; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; ZIMMERMAN SB, 1983, P NATL ACAD SCI-BIOL, V80, P5852, DOI 10.1073/pnas.80.19.5852; Zylicz JJ, 2019, CELL, V176, P182, DOI 10.1016/j.cell.2018.11.041	123	20	20	16	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6174	+		10.1016/j.cell.2021.10.022	http://dx.doi.org/10.1016/j.cell.2021.10.022		DEC 2021	52	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FF	34813726	Green Accepted, Bronze			2022-12-28	WOS:000730753900003
J	Bar-On, YM; Goldberg, Y; Mandel, M; Bodenheimer, O; Freedman, L; Alroy-Preis, S; Ash, N; Huppert, A; Milo, R				Bar-On, Yinon M.; Goldberg, Yair; Mandel, Micha; Bodenheimer, Omri; Freedman, Laurence; Alroy-Preis, Sharon; Ash, Nachman; Huppert, Amit; Milo, Ron			Protection against Covid-19 by BNT162b2 Booster across Age Groups	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE; IMPACT	BACKGROUND After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer-BioNTech) to persons 60 years of age or older, the booster campaign in Israel was gradually expanded to persons in younger age groups who had received a second dose at least 5 months earlier. METHODS We extracted data for the period from July 30 to October 10, 2021, from the Israel Ministry of Health database regarding 4,696,865 persons 16 years of age or older who had received two doses of BNT162b2 at least 5 months earlier. In the primary analysis, we compared the rates of confirmed coronavirus disease 2019 (Covid-19), severe illness, and death among those who had received a booster dose at least 12 days earlier (booster group) with the rates among those who had not received a booster (nonbooster group). In a secondary analysis, we compared the rates in the booster group with the rates among those who had received a booster 3 to 7 days earlier (early postbooster group). We used Poisson regression models to estimate rate ratios after adjusting for possible confounding factors. RESULTS The rate of confirmed infection was lower in the booster group than in the nonbooster group by a factor of approximately 10 (range across five age groups, 9.0 to 17.2) and was lower in the booster group than in the early postbooster group by a factor of 4.9 to 10.8. The adjusted rate difference ranged from 57.0 to 89.5 infections per 100,000 person-days in the primary analysis and from 34.4 to 38.3 in the secondary analysis. The rates of severe illness in the primary and secondary analyses were lower in the booster group by a factor of 17.9 (95% confidence interval [CI], 15.1 to 21.2) and 6.5 (95% CI, 5.1 to 8.2), respectively, among those 60 years of age or older and by a factor of 21.7 (95% CI, 10.6 to 44.2) and 3.7 (95% CI, 1.3 to 10.2) among those 40 to 59 years of age. The adjusted rate difference in the primary and secondary analyses was 5.4 and 1.9 cases of severe illness per 100,000 person-days among those 60 years of age or older and 0.6 and 0.1 among those 40 to 59 years of age. Among those 60 years of age or older, mortality was lower by a factor of 14.7 (95% CI, 10.0 to 21.4) in the primary analysis and 4.9 (95% CI, 3.1 to 7.9) in the secondary analysis. The adjusted rate difference in the primary and secondary analyses was 2.1 and 0.8 deaths per 100,000 person-days. CONCLUSIONS Across the age groups studied, rates of confirmed Covid-19 and severe illness were substantially lower among participants who received a booster dose of the BNT162b2 vaccine than among those who did not.	[Bar-On, Yinon M.; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Goldberg, Yair] Technion Israel Inst Technol, Haifa, Israel; [Mandel, Micha] Hebrew Univ Jerusalem, Dept Stat & Data Sci, Jerusalem, Israel; [Bodenheimer, Omri; Alroy-Preis, Sharon; Ash, Nachman] Israel Minist Hlth, Jerusalem, Israel; [Freedman, Laurence; Huppert, Amit] Gertner Inst Epidemiol & Hlth Policy Res, Biostat & Biomath Unit, Sheba Med Ctr, Ramat Gan, Israel; [Freedman, Laurence; Huppert, Amit] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Goldberg, Y (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-3200003 Haifa, Israel.	yairgo@technion.ac.il						[Anonymous], 2021, COVID 19 TREATM GUID; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Goldberg Y, 2021, PROTECTION PREVIOUS, DOI [DOI 10.1101/2021.04.20.21255670V1, 10.1101/2021.04.20.21255670, DOI 10.1101/2021.04.20.21255670]; Goldberg Y., 2021, WANING IMMUNITY BNT1, DOI [10.1101/2021.08.24.21262423v1, DOI 10.1101/2021.08.24.21262423, DOI 10.1101/2021.08.24.21262423V1]; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Muhsen K, 2021, LANCET REG HEALTH-EU, V7, DOI 10.1016/j.lanepe.2021.100130; Patalon T., 2021, SHORT TERM REDUCTION, DOI [10.1101/2021.08.29.21262792v1, DOI 10.1101/2021.08.29.21262792V1]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; R Development Core Team, 2009, R LANG ENV STAT COMP; Remschmidt C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1154-y	12	89	89	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2021	385	26					2421	2430		10.1056/NEJMoa2115926	http://dx.doi.org/10.1056/NEJMoa2115926		DEC 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS4FC	34879188	Bronze, Green Published			2022-12-28	WOS:000728090200001
J	Pawar, RD; Balaji, L; Grossestreuer, AV; Thompson, G; Holmberg, MJ; Issa, MS; Patel, PV; Kronen, R; Berg, KM; Moskowitz, A; Donnino, MW				Pawar, Rahul D.; Balaji, Lakshman; Grossestreuer, Anne, V; Thompson, Garrett; Holmberg, Mathias J.; Issa, Mahmoud S.; Patel, Parth, V; Kronen, Ryan; Berg, Katherine M.; Moskowitz, Ari; Donnino, Michael W.			Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness A Nationwide Retrospective Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							SEPTIC SHOCK; WERNICKE ENCEPHALOPATHY; GUIDELINES; DEFICIENCY	Background: Thiamine supplementation is recommended for patients with alcohol use disorder (AUD). The authors hypothesize that critically ill patients with AUD are commonly not given thiamine supplementation. Objective: To describe thiamine supplementation incidence in patients with AUD and various critical illnesses (alcohol withdrawal, septic shock, traumatic brain injury [TBI], and diabetic ketoacidosis [DKA]) in the United States. Design: Retrospective observational study. Setting: Cerner Health Facts database. Patients: Adult patients with a diagnosis of AUD who were admitted to the intensive care unit with alcohol withdrawal, septic shock, TBI, or DKA between 2010 and 2017. Measurements: Incidence and predicted probability of thiamine supplementation in alcohol withdrawal and other critical illnesses. Results: The study included 14 998 patients with AUD. Mean age was 52.2 years, 77% of participants were male, and in-hospital mortality was 9%. Overall, 7689 patients (51%) received thiamine supplementation. The incidence of thiamine supplementation was 59% for alcohol withdrawal, 26% for septic shock, 41% for TBI, and 24% for DKA. Most of those receiving thiamine (n = 3957 [52%]) received it within 12 hours of presentation in the emergency department. The predominant route of thiamine administration was enteral (n = 3119 [41%]). Limitation: Specific dosing and duration were not completely captured. Conclusion: Thiamine supplementation was not provided to almost half of all patients with AUD, raising a quality-of-care issue for this cohort. Supplementation was numerically less frequent in patients with septic shock, DKA, or TBI than in those with alcohol withdrawal. These data will be important for the design of quality improvement studies in critically ill patients with AUD. Primary funding source: National Institutes of Health.	[Pawar, Rahul D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hosp Med, Boston, MA 02215 USA; [Pawar, Rahul D.; Balaji, Lakshman; Grossestreuer, Anne, V; Thompson, Garrett; Holmberg, Mathias J.; Issa, Mahmoud S.; Patel, Parth, V; Berg, Katherine M.; Moskowitz, Ari] Beth Israel Deaconess Med Ctr, Ctr Resuscitat Sci, Boston, MA 02215 USA; [Balaji, Lakshman; Grossestreuer, Anne, V; Thompson, Garrett; Patel, Parth, V] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Holmberg, Mathias J.] Aarhus Univ Hosp, Dept Clin Med, Res Ctr Emergency Med, Aarhus, Denmark; [Holmberg, Mathias J.] Aarhus Univ, Aarhus, Denmark; [Holmberg, Mathias J.] Randers Reg Hosp, Dept Anesthesiol & Intens Care, Randers, Denmark; [Kronen, Ryan] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Berg, Katherine M.; Moskowitz, Ari; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Moskowitz, Ari] Beth Israel Deaconess Med Ctr, Montefiore Med Ctr, Ctr Resuscitat Sci & Div Pulm, Dept Med, Boston, MA 02215 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Ctr Resuscitat Sci, Dept Emergency Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Aarhus University; Aarhus University; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Donnino, MW (corresponding author), Beth Israel Deaconess Med Ctr, One Deaconess Rd,Rosenberg Bldg,2nd Floor, Boston, MA 02215 USA.	mdonnino@bidmc.harvard.edu	Holmberg, Mathias/GWQ-7813-2022; Pawar, Rahul/ABC-8896-2020	Pawar, Rahul/0000-0002-9347-0129; Thompson, Garrett/0000-0002-2676-6843; Holmberg, Mathias Johan/0000-0001-5816-337X; Balaji, Lakshman/0000-0001-7189-4775; issa, mahmoud S/0000-0002-9920-9490; Kronen, Ryan/0000-0003-4455-0699	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [1R03 AA026093]; National Institutes of Health [5R01 DK112886-05, 5K24 HL127101-08]	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By grant 1R03 AA026093 from the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health. In addition, Dr. Donnino is supported in part by grants 5R01 DK112886-05 and 5K24 HL127101-08 from the National Institutes of Health.	[Anonymous], 2020, J ADDICT MED, V14, P1, DOI 10.1097/ADM.0000000000000633; Attaluri P, 2018, AM J MED SCI, V356, P382, DOI 10.1016/j.amjms.2018.06.015; Crook MA, 2014, NUTRITION, V30, P953, DOI 10.1016/j.nut.2014.03.003; Dabar G, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0039-7; Day Gregory S, 2020, CMAJ Open, V8, pE383, DOI 10.9778/cmajo.20200029; Donnino MW, 2016, CRIT CARE MED, V44, P360, DOI 10.1097/CCM.0000000000001572; Ferguson RK, 1997, ALCOHOL ALCOHOLISM, V32, P493; Galvin R, 2010, EUR J NEUROL, V17, P1408, DOI 10.1111/j.1468-1331.2010.03153.x; Holmberg MJ, 2018, J CRIT CARE, V43, P61, DOI 10.1016/j.jcrc.2017.08.022; Isenberg-Grzeda E, 2014, J ADDICT MED, V8, P1, DOI 10.1097/01.ADM.0000435320.72857.c8; Isenberg-Grzeda E, 2012, PSYCHOSOMATICS, V53, P507, DOI 10.1016/j.psym.2012.04.008; Kim HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-18; Lanska Douglas J, 2010, Handb Clin Neurol, V95, P445, DOI 10.1016/S0072-9752(08)02130-1; Latt N, 2014, INTERN MED J, V44, P911, DOI 10.1111/imj.12522; Lei YL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010010; MCCONACHIE I, 1988, INTENS CARE MED, V14, P628; Moskowitz A, 2020, J THORAC DIS, V12, pS78, DOI 10.21037/jtd.2019.12.82; Moskowitz A, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.06.008; Polegato BF, 2019, NUTR CLIN PRACT, V34, P558, DOI 10.1002/ncp.10234; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Saya RP, 2012, N AM J MED SCI, V4, P503, DOI 10.4103/1947-2714.102003; Sinha S, 2019, MAYO CLIN PROC, V94, P1065, DOI 10.1016/j.mayocp.2019.02.018; Subramanya SB, 2010, AM J PHYSIOL-GASTR L, V299, pG23, DOI 10.1152/ajpgi.00132.2010; Thomson AD, 2002, ALCOHOL ALCOHOLISM, V37, P513, DOI 10.1093/alcalc/37.6.513; van Stigt RM, 2019, NETH J CRIT CARE, V27, P93; Wai JM, 2019, J SUBST ABUSE TREAT, V99, P117, DOI 10.1016/j.jsat.2019.01.017; World Health Organization, 1999, THIAM DEF ITS PREV C	27	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					191	+		10.7326/M21-2103	http://dx.doi.org/10.7326/M21-2103		DEC 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	34871057	Green Accepted			2022-12-28	WOS:000729195200001
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Will GPs boost the booster rollout?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n3016	10.1136/bmj.n3016	http://dx.doi.org/10.1136/bmj.n3016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4DA	34876401	Bronze			2022-12-28	WOS:000730815800007
J	Slomski, A				Slomski, Anita			Statin Use Is Associated With Diabetes Progression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2120	2120						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874431				2022-12-28	WOS:000730077500006
J	Fauci, AS				Fauci, Anthony S.			Victories against AIDS have lessons for COVID-19	NATURE			English	Editorial Material									[Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov							0	3	3	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					9	9		10.1038/d41586-021-03569-1	http://dx.doi.org/10.1038/d41586-021-03569-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XE8WW	34845339	Bronze			2022-12-28	WOS:000723664400001
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK approves monoclonal antibody sotrovimab for over 12s at high risk	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Food and Drug Administration, COR COV 19 UPD FDA A; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2697; Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2083; Medicines and Healthcare Products Regulatory Agency, 2021, REG APPR XEV SOTR	4	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2990	10.1136/bmj.n2990	http://dx.doi.org/10.1136/bmj.n2990			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857518	Bronze			2022-12-28	WOS:000732779300004
J	Djumagulov, M; Demeshkina, N; Jenner, L; Rozov, A; Yusupov, M; Yusupova, G				Djumagulov, Muminjon; Demeshkina, Natalia; Jenner, Lasse; Rozov, Alexey; Yusupov, Marat; Yusupova, Gulnara			Accuracy mechanism of eukaryotic ribosome translocation	NATURE			English	Article							ELONGATION-FACTOR 2; TRANSFER-RNA; 80S RIBOSOME; TRANSLATION; PURIFICATION; MOVEMENTS; FIDELITY; ROTATION; EEF2	Translation of the genetic code into proteins is realized through repetitions of synchronous translocation of messenger RNA (mRNA) and transfer RNAs (tRNA) through the ribosome. In eukaryotes translocation is ensured by elongation factor 2 (eEF2), which catalyses the process and actively contributes to its accuracy(1). Although numerous studies point to critical roles for both the conserved eukaryotic posttranslational modification diphthamide in eEF2 and tRNA modifications in supporting the accuracy of translocation, detailed molecular mechanisms describing their specific functions are poorly understood. Here we report a high-resolution X-ray structure of the eukaryotic 80S ribosome in a translocation-intermediate state containing mRNA, naturally modified eEF2 and tRNAs. The crystal structure reveals a network of stabilization of codon-anticodon interactions involving diphthamide(1) and the hypermodified nucleoside wybutosine at position 37 of phenylalanine tRNA, which is also known to enhance translation accuracy(2). The model demonstrates how the decoding centre releases a codon-anticodon duplex, allowing its movement on the ribosome, and emphasizes the function of eEF2 as a 'pawl' defining the directionality of translocation(3). This model suggests how eukaryote-specific elements of the 80S ribosome, eEF2 and tRNAs undergo large-scale molecular reorganizations to ensure maintenance of the mRNA reading frame during the complex process of translocation.	[Djumagulov, Muminjon; Demeshkina, Natalia; Jenner, Lasse; Rozov, Alexey; Yusupov, Marat; Yusupova, Gulnara] Univ Strasbourg, INSERM U1258, CNRS UMR7104, Inst Genet & Mol & Cellular Biol, Strasbourg, France; [Djumagulov, Muminjon; Rozov, Alexey] Urania Therapeut, Ostwald, France; [Demeshkina, Natalia] NHLBI, Biochem & Biophys Ctr, Bldg 10, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yusupov, M; Yusupova, G (corresponding author), Univ Strasbourg, INSERM U1258, CNRS UMR7104, Inst Genet & Mol & Cellular Biol, Strasbourg, France.	marat@igbmc.fr; gura@igbmc.fr	; Jenner, Lasse/H-1584-2017	Djumagulov, Muminjon/0000-0002-6900-0768; Jenner, Lasse/0000-0003-3917-8853; Rozov, Alexey/0000-0003-2545-1978	French State Fund [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; LabEx INRT funds; French National Research Agency [ANR-15-CE11-0021-01]; La Fondation pour la Recherche Medicale [DEQ20181039600]	French State Fund; LabEx INRT funds; French National Research Agency(French National Research Agency (ANR)); La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank the staff of the PXI beamline at the Swiss Light Source (Switzerland) and M. Wang for assistance during synchrotron data collection; N. Milicevic for the preparation of aminoacylated tRNAs samples; and I. Prokhorova for assistance with purification of the 80S ribosome and eEF2. Grant ANR-10-LABX-0030-INRT from a French State Fund managed by the ANR under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02 (to M.D.). M.D. started working on the project as an IGBMC International PhD Programme fellow supported by LabEx INRT funds. This work was supported by the French National Research Agency ANR-15-CE11-0021-01 (to G.Y.) and La Fondation pour la Recherche Medicale DEQ20181039600 (to M.Y.).	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Belardinelli R, 2016, NAT STRUCT MOL BIOL, V23, P342, DOI 10.1038/nsmb.3193; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bhatt PR, 2021, SCIENCE, V372, P1306, DOI 10.1126/science.abf3546; Carlson BA, 1999, VIROLOGY, V255, P2, DOI 10.1006/viro.1998.9569; Chen CL, 2016, P NATL ACAD SCI USA, V113, P7515, DOI 10.1073/pnas.1602668113; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Flis J, 2018, CELL REP, V25, P2676, DOI 10.1016/j.celrep.2018.11.040; GAVRILOVA LP, 1974, FEBS LETT, V45, P324, DOI 10.1016/0014-5793(74)80872-0; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khade PK, 2011, NAT STRUCT MOL BIOL, V18, P1300, DOI 10.1038/nsmb.2140; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Mechulam Y, 2007, METHOD ENZYMOL, V430, P265, DOI 10.1016/S0076-6879(07)30011-6; MESTERS JR, 1994, J CHROMATOGR A, V679, P93, DOI 10.1016/0021-9673(94)80314-5; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Murray J, 2016, ELIFE, V5, DOI 10.7554/eLife.13567; Noller HF, 2017, Q REV BIOPHYS, V50, DOI 10.1017/S0033583517000117; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Pellegrino S, 2018, J MOL BIOL, V430, P2677, DOI 10.1016/j.jmb.2018.06.006; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; Prokhorova I, 2017, P NATL ACAD SCI USA, V114, pE10899, DOI 10.1073/pnas.1715501114; Rossello-Tortella M, 2020, P NATL ACAD SCI USA, V117, P20785, DOI 10.1073/pnas.2003358117; Salsi E, 2016, J MOL BIOL, V428, P2248, DOI 10.1016/j.jmb.2016.03.032; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; SPIRIN AS, 1988, METHOD ENZYMOL, V164, P631; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Susorov D, 2018, J BIOL CHEM, V293, P5220, DOI 10.1074/jbc.RA117.000761; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Ulyanov NB, 2010, NEW J CHEM, V34, P910, DOI 10.1039/b9nj00754g; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Waas WF, 2007, J BIOL CHEM, V282, P26026, DOI 10.1074/jbc.M703391200; Wojdyla JA, 2018, J SYNCHROTRON RADIAT, V25, P293, DOI 10.1107/S1600577517014503; Zhou J, 2019, P NATL ACAD SCI USA, V116, P7813, DOI 10.1073/pnas.1901310116	37	1	1	4	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 16	2021	600	7889					543	+		10.1038/s41586-021-04131-9	http://dx.doi.org/10.1038/s41586-021-04131-9		DEC 2021	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XP3FN	34853469	Green Published, hybrid			2022-12-28	WOS:000724704400004
J	Soto-Acuna, S; Vargas, AO; Kaluza, J; Leppe, MA; Botelho, JF; Palma-Liberona, J; Simon-Gutstein, C; Fernandez, RA; Ortiz, H; Milla, V; Aravena, B; Manriquez, LME; Alarcon-Munoz, J; Pino, JP; Trevisan, C; Mansilla, H; Hinojosa, LF; Munoz-Walther, V; Rubilar-Rogers, D				Soto-Acuna, Sergio; Vargas, Alexander O.; Kaluza, Jonatan; Leppe, Marcelo A.; Botelho, Joao F.; Palma-Liberona, Jose; Simon-Gutstein, Carolina; Fernandez, Roy A.; Ortiz, Hector; Milla, Veronica; Aravena, Barbara; Manriquez, Leslie M. E.; Alarcon-Munoz, Jhonatan; Pablo Pino, Juan; Trevisan, Cristine; Mansilla, Hector; Felipe Hinojosa, Luis; Munoz-Walther, Vicente; Rubilar-Rogers, David			Bizarre tail weaponry in a transitional ankylosaur from subantarctic Chile	NATURE			English	Article							STRATIGRAPHIC FIT; SCELIDOSAURUS-HARRISONII; STEGOSAURIA DINOSAURIA; PHYLOGENY; ORNITHISCHIA; EVOLUTION; ENGLAND; DORSET; BASIN	Armoured dinosaurs are well known for their evolution of specialized tail weapons-paired tail spikes in stegosaurs and heavy tail clubs in advanced ankylosaurs(1). Armoured dinosaurs from southern Gondwana are rare and enigmatic, but probably include the earliest branches of Ankylosauria(2-4). Here we describe a mostly complete, semi-articulated skeleton of a small (approximately 2 m) armoured dinosaur from the late Cretaceous period of Magallanes in southernmost Chile, a region that is biogeographically related to West Antarctica(5). Stegouros elengassen gen. et sp. nov. evolved a large tail weapon unlike any dinosaur: a flat, frond-like structure formed by seven pairs of laterally projecting osteoderms encasing the distal half ofthe tail. Stegouros shows ankylosaurian cranial characters, but a largely ancestral postcranial skeleton, with some stegosaur-like characters. Phylogenetic analyses placed Stegouros in Ankylosauria; specifically, it is related to Kunbarrasaurus from Australia(6) and Antarctopelta from Antarctica(7), forming a Glade of Gondwanan ankylosaurs that split earliest from all other ankylosaurs. The large osteoderms and specialized tail vertebrae in Antarctopelta suggest that it had a tail weapon similar to Stegouros. We propose a new clade, the Parankylosauria, to include the first ancestor of Stegouros-but not Ankylosaurus-and all descendants ofthat ancestor.	[Soto-Acuna, Sergio; Vargas, Alexander O.; Kaluza, Jonatan; Leppe, Marcelo A.; Botelho, Joao F.; Palma-Liberona, Jose; Simon-Gutstein, Carolina; Fernandez, Roy A.; Ortiz, Hector; Milla, Veronica; Aravena, Barbara; Manriquez, Leslie M. E.; Alarcon-Munoz, Jhonatan; Pablo Pino, Juan; Trevisan, Cristine; Mansilla, Hector; Felipe Hinojosa, Luis; Munoz-Walther, Vicente; Rubilar-Rogers, David] Univ Chile, Fac Ciencias, Dept Biol, Red Paleontol U Chil, Santiago, Chile; [Soto-Acuna, Sergio; Alarcon-Munoz, Jhonatan; Pablo Pino, Juan; Felipe Hinojosa, Luis] Univ Chile, Fac Ciencias, Dept Ecol, Santiago, Chile; [Kaluza, Jonatan] Univ Maimonides, Fdn Hist Nat Felix de Azara, Buenos Aires, DF, Argentina; [Kaluza, Jonatan] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Leppe, Marcelo A.; Trevisan, Cristine; Mansilla, Hector] Inst Nacl Antartico Chileno, Lab Paleobiol, Punta Arenas, Chile; [Botelho, Joao F.; Palma-Liberona, Jose] Pontificia Univ Catolica Chile, Escuela Med Vet, Santiago, Chile; [Fernandez, Roy A.; Milla, Veronica] Univ Concepcion, Concepcion, Chile; [Ortiz, Hector] Univ Magallanes, Punta Arenas, Chile; [Manriquez, Leslie M. E.] Univ Vale Rio dos Sinos, Sao Leopoldo, Brazil; [Rubilar-Rogers, David] Museo Nacl Hist Nat Chile, Area Paleontol, Santiago, Chile	Universidad de Chile; Universidad de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Universidad de Magallanes; Universidade do Vale do Rio dos Sinos (Unisinos)	Soto-Acuna, S; Vargas, AO (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Red Paleontol U Chil, Santiago, Chile.; Soto-Acuna, S (corresponding author), Univ Chile, Fac Ciencias, Dept Ecol, Santiago, Chile.	sesotacu@ug.uchil.cl; alexvargas@uchil.cl	Hinojosa, Luis Felipe/J-7557-2017; Leppe, Marcelo/L-5447-2014	Leppe, Marcelo/0000-0002-1545-8167; Vargas, Alexander/0000-0002-2009-7116; Hinojosa, Luis Felipe/0000-0001-5646-649X; Fernandez, Roy A./0000-0002-2656-5312; Mansilla, Hector/0000-0003-3589-908X; Milla, Veronica/0000-0002-9849-0428; Soto Acuna, Sergio/0000-0002-9311-9355; Ortiz, Hector/0000-0001-6010-3990	Agencia Nacional de Investigacion y Desarrollo ANID (National Agency for Research and Development) of the Chilean Ministry of Science, Technology, Knowledge and Innovation through grant PIA Anillo [ACT172099]; FONDECYT [1190891, 1151389]	Agencia Nacional de Investigacion y Desarrollo ANID (National Agency for Research and Development) of the Chilean Ministry of Science, Technology, Knowledge and Innovation through grant PIA Anillo; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	We thank F. Suazo, E. Nunez, D. Bajor, J. P. Guevara, D. Flores, S. Jimenez, I. Meyer-Navia, S. Davis and members of the J. Clark team for help in the field and/or fossil preparation; Estancia Cerro Guido and especially the Matetic, Simunovic and Reyes families for granting access and important logistical support in the field; the Consejo de Monumentos Nacionales (National Monuments Council) of the Chilean Ministry of Culture, Arts and Heritage for fieldwork permits; M. Reguero for access and help with the Antarctopelta holotype; J. Vidal for technical support in the acquisition of CT images; and staff at the Willi Hennig society for free distribution of TNT software. This research was supported by the Agencia Nacional de Investigacion y Desarrollo ANID (National Agency for Research and Development) of the Chilean Ministry of Science, Technology, Knowledge and Innovation through grants PIA Anillo ACT172099 (to A.O.V.), FONDECYT 1190891 (to A.O.V.), FONDECYT 1151389 (to M.A.L.), and PhD scholarships for S.S.-A., J.A.-M., J.P.-L. and J.P.P.	Arbour V, 2020, ANAT REC, V303, P988, DOI 10.1002/ar.24093; Arbour VM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2299; Arbour VM, 2016, PALAEOGEOGR PALAEOCL, V449, P289, DOI 10.1016/j.palaeo.2016.02.033; Arbour VM, 2016, J SYST PALAEONTOL, V14, P385, DOI 10.1080/14772019.2015.1059985; Arbour VM, 2015, J ANAT, V227, P514, DOI 10.1111/joa.12363; Arbour VM, 2011, J PALEONTOL, V85, P298, DOI 10.1666/10-071.1; Burns ME, 2014, J VERTEBR PALEONTOL, V34, P835, DOI 10.1080/02724634.2014.840309; Carpenter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079887; Claraz J., 1988, DIARIO VIAJE EXPLORA; Currie P. J., 1990, DINOSAUR SYSTEMATICS, P269; de Ricqles Armand, 2001, Asociacion Paleontologica Argentina Publicacion Especial, V7, P171; Fls DBN, 2020, ZOOL J LINN SOC-LOND, V189, P47; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gutierrez NM, 2017, TECTONOPHYSICS, V695, P76, DOI 10.1016/j.tecto.2016.12.014; Han FL, 2018, J SYST PALAEONTOL, V16, P1159, DOI 10.1080/14772019.2017.1369185; Hone DWE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0947; Kirkland JI., 2013, J VERTEBR PALEONTOL, V2013, P163; Lamanna Matthew C., 2019, Advances in Polar Science, V30, P228, DOI 10.13679/j.advps.2019.0007; Leahey LG, 2015, PEERJ, V3, DOI 10.7717/peerj.1475; Maidment SCR, 2020, GONDWANA RES, V77, P82, DOI 10.1016/j.gr.2019.07.007; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Manriquez LME, 2019, J S AM EARTH SCI, V93, P102, DOI 10.1016/j.jsames.2019.04.010; Molnar Ralph E., 1996, Memoirs of the Queensland Museum, V39, P653; Molnar RE, 2001, LIFE O PAST, P341; Norman DB, 2021, ZOOL J LINN SOC-LOND, V191, P1, DOI 10.1093/zoolinnean/zlaa061; Norman DB, 2020, ZOOL J LINN SOC-LOND, V190, P1; Pereda-Suberbiola X, 2013, ALCHERINGA, V37, P65, DOI 10.1080/03115518.2012.702531; Pol D, 2004, CLADISTICS, V20, P64, DOI 10.1111/j.1096-0031.2003.00002.x; Pol D, 2001, CLADISTICS, V17, P285, DOI 10.1111/j.1096-0031.2001.tb00125.x; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Raven TJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4529; Raven TJ, 2017, PALAEONTOLOGY, V60, P401, DOI 10.1111/pala.12291; Reguero MA, 2021, J S AM EARTH SCI, V108, DOI 10.1016/j.jsames.2021.103358; Salgado L, 2006, GEODIVERSITAS, V28, P119; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Siddall ME, 1998, CLADISTICS, V14, P201, DOI 10.1111/j.1096-0031.1998.tb00333.x; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Weishampel, 2004, DINOSAURIA, P464; Wiersma JP, 2018, PEERJ, V6, DOI 10.7717/peerj.5016; Wills MA, 1999, SYST BIOL, V48, P559, DOI 10.1080/106351599260148	41	3	3	5	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					259	+		10.1038/s41586-021-04147-1	http://dx.doi.org/10.1038/s41586-021-04147-1		DEC 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34853468	Green Submitted			2022-12-28	WOS:000724704400002
J	Wallace-Thompson, L; Rose, J				Wallace-Thompson, Lauren; Rose, Jason			Improving support for children with autism and their families using a 100 day challenge framework	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Community-based support for autistic children and their families can prevent individuals from reaching crisis point and reduce inpatient admissions.(1) Lauren Wallace-Thompson and Jason Rose describe how they set up a joint initiative with Bromley Council and the parents and carers of children and young people with autism, and what changes this has introduced.	[Wallace-Thompson, Lauren] Ideas Alliance, Chichester, England		Wallace-Thompson, L (corresponding author), Ideas Alliance, Chichester, England.							[Anonymous], BBC NEWS; Crane L, 2016, AUTISM, V20, P153, DOI 10.1177/1362361315573636; Guidance NICE, AUTISM SPECTRUM DISO; Local Government Association, NAT STRAT AUT CHILDR; Long Term Plan NHS, 2019, LEARN DIS AUT; McKenzie R, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038411; NESTA, PEOPL POW RES 100 DA; R Development Core Team, 2009, R LANG ENV STAT COMP	8	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2954	10.1136/bmj.n2954	http://dx.doi.org/10.1136/bmj.n2954			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XH5YO	34848493	Bronze			2022-12-28	WOS:000725509900003
J	Mahase, E				Mahase, Elisabeth			Plans for same day emergency care are stalling from lack of investment, leaders warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, SOC ACUTE MED BENCHM	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2931	10.1136/bmj.n2931	http://dx.doi.org/10.1136/bmj.n2931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836874				2022-12-28	WOS:000727787900001
J	Rae, M; Marshall, M				Rae, Maggie; Marshall, Martin			General practice and public health: fostering collaboration for better health for populations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2916	10.1136/bmj.n2916	http://dx.doi.org/10.1136/bmj.n2916			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824087	Bronze, Green Submitted			2022-12-28	WOS:000744251500010
J	Yao, L; Ahmed, MM; Guyatt, GH; Yan, PJ; Hui, X; Wang, Q; Yang, KH; Tian, JH; Djulbegovic, B				Yao, Liang; Ahmed, Muhammad Muneeb; Guyatt, Gordon H.; Yan, Peijing; Hui, Xu; Wang, Qi; Yang, Kehu; Tian, Jinhui; Djulbegovic, Benjamin			Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-PRACTICE GUIDELINES; MANAGEMENT; GRADE; QUALITY; SOCIETY; DETERMINANTS; CONFIDENCE; DIAGNOSIS; COVID-19; STRENGTH	OBJECTIVE To investigate whether alignment of strength of recommendations with quality of evidence differs in consensus based versus evidence based guidelines. DESIGN Empirical analysis. DATA SOURCE Guidelines developed by the American College of Cardiology and the American Heart Association (ACC/ AHA) and the American Society of Clinical Oncology (ASCO) up to 27 March 2021. STUDY SELECTION Recommendations were clearly categorised as consensus or evidence based, were separated from the remainder of the text, and included both the quality of evidence and the strength of the recommendations. DATA EXTRACTION Paired authors independently extracted the recommendation characteristics, including type of recommendation (consensus or evidence based), grading system used for developing recommendations, strength of the recommendation, and quality of evidence. The study team also calculated the number of discordant recommendations (strong recommendations with low quality evidence) and inappropriate discordant recommendations (those that did not meet grading of recommendations assessment, development, and evaluation criteria of appropriateness). RESULTS The study included 12 ACC/AHA guidelines that generated 1434 recommendations and 69 ASCO guidelines that generated 1094 recommendations. Of the 504 ACC/AHA recommendations based on low quality evidence, 200 (40%) proved to be consensus based versus 304 (60%) evidence based; of the 404 ASCO recommendations based on low quality evidence, 292 (72%) were consensus based versus 112 (28%) that were evidence based. In both ACC/ AHA and ASCO guidelines, the consensus approach yielded more discordant recommendations (ACC/AHA: odds ratio 2.1, 95% confidence interval 1.5 to 3.1; ASCO: 2.9, 1.1 to 7.8) and inappropriate discordant recommendations (ACC/AHA: 2.6, 1.7 to 3.7; ASCO: 5.1, 1.6 to 16.0) than the evidence based approach. CONCLUSION Consensus based guidelines produce more recommendations violating the evidence based medicine principles than evidence based guidelines. Ensuring appropriate alignment of quality of evidence with the strength of recommendations is key to the development of "trustworthy" guidelines.	[Yao, Liang; Guyatt, Gordon H.; Wang, Qi] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Ahmed, Muhammad Muneeb] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Yan, Peijing] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu, Sichuan, Peoples R China; [Yan, Peijing] Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China; [Hui, Xu; Yang, Kehu; Tian, Jinhui] Lanzhou Univ, Evidence Based Med Ctr, Lanzhou, Gansu, Peoples R China; [Djulbegovic, Benjamin] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, Beckman Res Inst, Duarte, CA USA	McMaster University; McMaster University; McMaster University; Sichuan University; Sichuan University; Lanzhou University; City of Hope; Beckman Research Institute of City of Hope	Yao, L (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	yaol12@mcmaster.ca	Ahmed, Muhammad/ABG-7616-2021	Ahmed, Muhammad/0000-0003-4208-6247; Hui, Xu/0000-0002-1908-7818; Yao, Liang/0000-0003-4068-3136	Agency for Healthcare Research and Quality [R01HS024917]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported in part by grant number R01HS024917 from the Agency for Healthcare Research and Quality (BD and GHG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Agoritsas T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018593; Alexander PE, 2014, J CLIN EPIDEMIOL, V67, P629, DOI 10.1016/j.jclinepi.2013.09.020; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bekkering GE, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2006; Bohlius J, 2019, BLOOD ADV, V3, P1197, DOI 10.1182/bloodadvances.2018030387; Brito JP, 2013, J CLIN ENDOCR METAB, V98, P3246, DOI 10.1210/jc.2013-1814; Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300; Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054; Djulbegovic B, 2021, J CLIN EPIDEMIOL, V136, P1, DOI 10.1016/j.jclinepi.2021.02.025; Djulbegovic B, 2019, JAMA-J AM MED ASSOC, V322, P725, DOI 10.1001/jama.2019.9751; Djulbegovic B, 2017, LANCET, V390, P415, DOI 10.1016/S0140-6736(16)31592-6; Djulbegovic B, 2015, J CLIN EPIDEMIOL, V68, P727, DOI 10.1016/j.jclinepi.2014.12.015; Djulbegovic B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-120; Freedman AS, 2021, TREATMENT EXTRANODAL; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2016, J CLIN EPIDEMIOL, V80, P3, DOI 10.1016/j.jclinepi.2016.07.006; Hopkins C, 2021, CLIN OTOLARYNGOL, V46, P16, DOI 10.1111/coa.13636; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00270-8; La Brooy C, 2020, J RISK RES, V23, P664, DOI 10.1080/13669877.2019.1628094; Lo STH, 2020, HEART LUNG CIRC, V29, pE69, DOI 10.1016/j.hlc.2020.04.002; Loblaw DA, 2012, J CLIN ONCOL, V30, P3136, DOI 10.1200/JCO.2012.42.0489; Moerbeek M, 2003, J CLIN EPIDEMIOL, V56, P341, DOI 10.1016/S0895-4356(03)00007-6; NICE, 2017, CAT AD MAN; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Oncology ASoC, ASCO GUID METH MAN; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Snijders T.A., 1999, INTRO BASIC ADV MULT; Van Landeghem G, 2005, MULTIVAR BEHAV RES, V40, P423, DOI 10.1207/s15327906mbr4004_2; Ye ZK, 2020, CAN MED ASSOC J, V192, pE536, DOI 10.1503/cmaj.200648	35	12	13	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								e066045	10.1136/bmj-2021-066045	http://dx.doi.org/10.1136/bmj-2021-066045			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824101	hybrid, Green Published			2022-12-28	WOS:000744251500003
J	Rogier, M; Moritz, J; Robert, I; Lescale, C; Heyer, V; Abello, A; Martin, O; Capitani, K; Thomas, M; Thomas-Claudepierre, AS; Laffleur, B; Jouan, F; Pinaud, E; Tarte, K; Cogne, M; Conticello, SG; Soutoglou, E; Deriano, L; Reina-San-Martin, B				Rogier, Melanie; Moritz, Jacques; Robert, Isabelle; Lescale, Chloe; Heyer, Vincent; Abello, Arthur; Martin, Ophelie; Capitani, Katia; Thomas, Morgane; Thomas-Claudepierre, Anne-Sophie; Laffleur, Brice; Jouan, Florence; Pinaud, Eric; Tarte, Karin; Cogne, Michel; Conticello, Silvestro G.; Soutoglou, Evi; Deriano, Ludovic; Reina-San-Martin, Bernardo			Fam72a enforces error-prone DNA repair during antibody diversification	NATURE			English	Article							SOMATIC HYPERMUTATION; POLYMERASE-BETA; MISMATCH REPAIR; URACIL; REGION; AID; BREAKS	Efficient humoral responses rely on DNA damage, mutagenesis and error-prone DNA repair. Diversification of B cell receptors through somatic hypermutation and class-switch recombination are initiated by cytidine deamination in DNA mediated by activation-induced cytidine deaminase (AID)(1) and by the subsequent excision of the resulting uracils by uracil DNA glycosylase (UNG) and by mismatch repair proteins(1-3). Although uracils arising in DNA are accurately repaired(1-4), how these pathways are co-opted to generate mutations and double-strand DNA breaks in the context of somatic hypermutation and class-switch recombination is unknown(1-3). Here we performed a genome-wide CRISPR-Cas9 knockout screen for genes involved in class-switch recombination and identified FAM72A, a protein that interacts with the nuclear isoform of UNG (UNG2)(5) and is overexpressed in several cancers(5). We show that the FAM72A-UNG2 interaction controls the levels of UNG2 and that class-switch recombination is defective in Fam72a(-/-) B cells due to the upregulation of UNG2. Moreover, we show that somatic hypermutation is reduced in Fam72a(-/-) B cells and that its pattern is skewed upon upregulation of UNG2. Our results are consistent with a model in which FAM72A interacts with UNG2 to control its physiological level by triggering its degradation, regulating the level of uracil excision and thus the balance between error-prone and error-free DNA repair. Our findings have potential implications for tumorigenesis, as reduced levels of UNG2 mediated by overexpression of Fam72a would shift the balance towards mutagenic DNA repair, rendering cells more prone to acquire mutations.	[Rogier, Melanie; Moritz, Jacques; Robert, Isabelle; Heyer, Vincent; Abello, Arthur; Thomas-Claudepierre, Anne-Sophie; Reina-San-Martin, Bernardo] Inst Genet & Biol Mol & Cellulaire IGBMC, Illkirch Graffenstaden, France; [Rogier, Melanie; Moritz, Jacques; Robert, Isabelle; Heyer, Vincent; Abello, Arthur; Thomas-Claudepierre, Anne-Sophie; Reina-San-Martin, Bernardo] Inst Natl Sante & Rech Med INSERM, U1258, Illkirch Graffenstaden, France; [Rogier, Melanie; Moritz, Jacques; Robert, Isabelle; Heyer, Vincent; Abello, Arthur; Thomas-Claudepierre, Anne-Sophie; Reina-San-Martin, Bernardo] Ctr Natl Rech Sci CNRS, UMR7104, Illkirch Graffenstaden, France; [Rogier, Melanie; Moritz, Jacques; Robert, Isabelle; Heyer, Vincent; Abello, Arthur; Thomas-Claudepierre, Anne-Sophie; Reina-San-Martin, Bernardo] Univ Strasbourg, Illkirch Graffenstaden, France; [Lescale, Chloe; Deriano, Ludovic] Inst Pasteur, Immun & Canc Unit, Genome Integr, Equipe Labellisee Ligue Le Canc,INSERM U1223, Paris, France; [Martin, Ophelie; Soutoglou, Evi] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Capitani, Katia; Conticello, Silvestro G.] ISPRO, Core Res Lab, Florence, Italy; [Capitani, Katia] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Thomas, Morgane; Pinaud, Eric; Cogne, Michel] Univ Limoges, Inst Natl Sante & Rech Medicale INSERM, Ctr Natl Rech Sci CNRS,UMR7276, UMR1262,Controle Reponse Immune B & Lymphoprolife, F-UMR7276 Limoges, France; [Laffleur, Brice; Jouan, Florence; Tarte, Karin; Cogne, Michel] Univ Rennes 1, Inst Natl Sante & Rech Medicale INSERM, Etab Francais Sang Bretagne, UMR1236, Rennes, France; [Conticello, Silvestro G.] CNR, Inst Clin Physiol, Pisa, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Sussex; University of Siena; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges; Universite de Rennes; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Reina-San-Martin, B (corresponding author), Inst Genet & Biol Mol & Cellulaire IGBMC, Illkirch Graffenstaden, France.; Reina-San-Martin, B (corresponding author), Inst Natl Sante & Rech Med INSERM, U1258, Illkirch Graffenstaden, France.; Reina-San-Martin, B (corresponding author), Ctr Natl Rech Sci CNRS, UMR7104, Illkirch Graffenstaden, France.; Reina-San-Martin, B (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.	reinab@igbmc.fr	Capitani, Katia/AAD-1048-2022; Capitani, Katia/AAD-1432-2022; Conticello, Silvestro/G-9113-2011; tarte, karin/GXV-1815-2022; Deriano, Ludovic/D-2048-2019; PINAUD, Eric/O-8443-2016	Capitani, Katia/0000-0002-7725-6974; Conticello, Silvestro/0000-0002-4244-1846; tarte, karin/0000-0002-6809-917X; Deriano, Ludovic/0000-0002-9673-9525; Lescale, Chloe/0000-0003-0622-1149; Rogier, Melanie/0000-0002-0522-8931; Soutoglou, Evi/0000-0002-3724-5613; PINAUD, Eric/0000-0001-7405-9273; ROBERT, Isabelle/0000-0001-6533-8297	Ministere de l'Enseignement Superieur et de la Recherche, France; Fondation ARC [ARCPJA32020060002061]; La Ligue Contre le Cancer; Fondation Recherche Medicale [EQU201903007818]; Institut National du Cancer [INCa_13852]; Ligue Nationale contre le Cancer (Equipe labellisee); Agence Nationale de la Recherche [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]	Ministere de l'Enseignement Superieur et de la Recherche, France; Fondation ARC; La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation Recherche Medicale; Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank A. Frey for help with gRNA library subcloning and the CRISPR-Cas9 screen; B. Kavli for the anti-UNG1/2 antibody; L. Brino for help with gRNA library subcloning and CRISPR-Cas9 screen analysis; B. Jost, C. Thibault-Carpentier and D. Plassard for gRNA high-throughput sequencing on the GenomEast platform of IGBMC; D. Dembele, S. Sarnataro and N. Molina for help with Python scripts and gRNA extraction and counting; B. Heller for cell culture; C. Ebel and M. Philipps for cell sorting in the FlowCytometry Facility of IGBMC; M. Li for the GL-7 antibody, M. Selloum, D. Ali-Hadji and I. Goncalves Da Cruz for animal care; W. Yu for generating Xrcc4<SUP>-/-</SUP> CH12 cells; and C. Goujon for the HIV1-VPR cDNA. J.M. and M.T. were supported by the Ministere de l'Enseignement Superieur et de la Recherche, France, and the Fondation ARC. M.R. was supported by La Ligue Contre le Cancer. This study was supported by grants from the Fondation Recherche Medicale (Equipe FRM EQU201903007818 to B.R.-S.-M.), Institut National du Cancer (INCa_13852 to L.D. and B.R.-S.-M.), Fondation ARC (ARCPJA32020060002061 to B.R.-S.-M.), the Ligue Nationale contre le Cancer (Equipe labellisee to L.D.) and by the grant ANR-10-LABX-0030-INRT, a French state fund managed by the Agence Nationale de la Recherche under the program Investissements d'Avenir labelled ANR-10-IDEX-0002-02.	Andersen S, 2005, DNA REPAIR, V4, P1432, DOI 10.1016/j.dnarep.2005.08.004; Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Dev H, 2018, NAT CELL BIOL, V20, P954, DOI 10.1038/s41556-018-0140-1; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Eldin P, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02478-7; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Feng YQ, 2020, TRENDS IMMUNOL, V41, P586, DOI 10.1016/j.it.2020.04.009; Guo CG, 2008, CANCER RES, V68, P6118, DOI 10.1158/0008-5472.CAN-08-1259; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Jeevan-Raj BP, 2011, J EXP MED, V208, P1649, DOI 10.1084/jem.20110118; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Lescale C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10529; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; MacCarthy T, 2009, DNA REPAIR, V8, P137, DOI 10.1016/j.dnarep.2008.09.006; Martin OA, 2018, J IMMUNOL, V201, P950, DOI 10.4049/jimmunol.1800203; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Motohashi K, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0162-8; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nilsen H, 2005, ONCOGENE, V24, P3063, DOI 10.1038/sj.onc.1208480; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Sarno A, 2019, NUCLEIC ACIDS RES, V47, P4569, DOI 10.1093/nar/gkz145; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Stratigopoulou M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01084; Wu XM, 2007, J EXP MED, V204, P1677, DOI 10.1084/jem.20070756; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yousif AS, 2014, P NATL ACAD SCI USA, V111, pE1016, DOI 10.1073/pnas.1402391111; Zanotti KJ, 2016, DNA REPAIR, V38, P110, DOI 10.1016/j.dnarep.2015.11.011	36	10	10	5	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					329	+		10.1038/s41586-021-04093-y	http://dx.doi.org/10.1038/s41586-021-04093-y		NOV 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34819671				2022-12-28	WOS:000722128900008
J	Chiang, CH; Chiang, CH; Pickering, JW; Stoyanov, KM; Chew, DP; Neumann, JT; Ojeda, F; Sorensen, NA; Su, KY; Kavsak, P; Worster, A; Inoue, K; Johannessen, TR; Atar, D; Amann, M; Hochholzer, W; Mokhtari, A; Ekelund, U; Twerenbold, R; Mueller, C; Bahrmann, P; Buttinger, N; Dooley, M; Ruangsomboon, O; Nowak, RM; DeFilippi, CR; Peacock, WF; Neilan, TG; Liu, MCA; Hsu, WT; Lee, GH; Tang, PU; Ma, KSK; Westermann, D; Blankenberg, S; Giannitsis, E; Than, MP; Lee, CC				Chiang, Cho-Han; Chiang, Cho-Hung; Pickering, John W.; Stoyanov, Kiril M.; Chew, Derek P.; Neumann, Johannes T.; Ojeda, Francisco; Sorensen, Nils A.; Su, Ke-Ying; Kavsak, Peter; Worster, Andrew; Inoue, Kenji; Johannessen, Tonje R.; Atar, Dan; Amann, Michael; Hochholzer, Willibald; Mokhtari, Arash; Ekelund, Ulf; Twerenbold, Raphael; Mueller, Christian; Bahrmann, Philipp; Buttinger, Nicolas; Dooley, Maureen; Ruangsomboon, Onlak; Nowak, Richard M.; DeFilippi, Christopher R.; Peacock, William F.; Neilan, Tomas G.; Liu, Michael A.; Hsu, Wan-Ting; Lee, Gin Hoong; Tang, Pui-Un; Ma, Kevin Sheng-Kai; Westermann, Dirk; Blankenberg, Stefan; Giannitsis, Evangelos; Than, Martin P.; Lee, Chien-Chang			Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction	ANNALS OF INTERNAL MEDICINE			English	Review							HIGH-SENSITIVITY TROPONIN; HOUR RULE-OUT; CHEST-PAIN; EMERGENCY-DEPARTMENT; ST-ELEVATION; 0-HOUR/1-HOUR ALGORITHM; DIAGNOSTIC PROTOCOL; OUTCOMES; SAFETY; ASSAYS	Background: The 2020 European Society of Cardiology (ESC) guidelines recommend using the 0/1-hour and 0/2 hour algorithms over the 0/3-hour algorithm as the first and second choices of high-sensitivity cardiac troponin (hs-cTn)- based strategies for triage of patients with suspected acute myocardial infarction (AMI). Purpose: To evaluate the diagnostic accuracies of the ESC 0/1-hour, 0/2-hour, and 0/3-hour algorithms. Data Sources: PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus from 1 January 2011 to 31 December 2020. (PROSPERO: CRD42020216479) Study Selection: Prospective studies that evaluated the ESC 0/1-hour, 0/2-hour, or 0/3-hour algorithms in adult patients presenting with suspected AMI. Data Extraction: The primary outcome was index AMI. Twenty unique cohorts were identified. Primary data were obtained from investigators of 16 cohorts and aggregate data were extracted from 4 cohorts. Two independent authors assessed each study for methodological quality. Data Synthesis: A total of 32 studies (20 cohorts) with 30066 patients were analyzed. The 0/1-hour algorithm had a pooled sensitivity of 99.1% (95% CI, 98.5% to 99.5%) and negative predictive value (NPV) of 99.8% (CI, 99.6% to 99.9%) for ruling out AMI. The 0/2-hour algorithm had a pooled sensitivity of 98.6% (CI, 97.2% to 99.3%) and NPV of 99.6% (CI, 99.4% to 99.8%). The 0/3-hour algorithm had a pooled sensitivity of 93.7% (CI, 87.4% to 97.0%) and NPV of 98.7% (CI, 97.7% to 99.3%). Sensitivity of the 0/3-hour algorithm was attenuated in studies that did not use clinical criteria (GRACE score <140 and pain-free) compared with studies that used clinical criteria (90.2% [CI, 82.9 to 94.6] vs. 98.4% [CI, 88.6 to 99.8]). All 3 algorithms had similar specificities and positive predictive values for ruling in AMI, but heterogeneity across studies was substantial. Diagnostic performance was similar across the hs-cTnT (Elecsys; Roche), hs-cTnI (Architect; Abbott), and hs-cTnI (Centaur/Atellica; Siemens) assays. Limitation: Diagnostic accuracy, inclusion and exclusion criteria, and cardiac troponin sampling time varied among studies. Conclusion: The ESC 0/1-hour and 0/2-hour algorithms have higher sensitivities and NPVs than the 0/3-hour algorithm for index AMI.	[Chiang, Cho-Han] Harvard Med Sch, Boston, MA 02115 USA; [Chiang, Cho-Han] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chiang, Cho-Hung] Buddhist Tzu Chi Fdn, Taipei Tzu Chi Hosp, New Taipei, Taiwan; [Pickering, John W.] Univ Otago Christchurch, Christchurch Hosp, Christchurch, New Zealand; [Stoyanov, Kiril M.; Giannitsis, Evangelos] Univ Heidelberg Hosp, Heidelberg, Germany; [Chew, Derek P.] Flinders Univ South Australia, Adelaide, SA, Australia; [Neumann, Johannes T.] Monash Univ, Melbourne, Vic, Australia; [Neumann, Johannes T.; Ojeda, Francisco; Sorensen, Nils A.; Westermann, Dirk; Blankenberg, Stefan] Univ Heart & Vasc Ctr Hamburg, Hamburg, Germany; [Stoyanov, Kiril M.; Lee, Gin Hoong; Tang, Pui-Un] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Kavsak, Peter; Worster, Andrew] McMaster Univ, Hamilton, ON, Canada; [Inoue, Kenji] Juntendo Univ, Nerima Hosp, Tokyo, Japan; [Johannessen, Tonje R.; Atar, Dan] Univ Oslo, Oslo, Norway; [Johannessen, Tonje R.] Univ Oslo, Oslo Accid & Emergency Outpatient Clin, Oslo, Norway; [Atar, Dan] Oslo Univ Hosp, Ullevaal, Norway; [Amann, Michael; Hochholzer, Willibald] Univ Heart Ctr Freiburg Bad Krozingen, Bad Krozingen, Germany; [Mokhtari, Arash; Ekelund, Ulf] Lund Univ, Skane Univ Hosp, Lund, Sweden; [Twerenbold, Raphael] Univ Basel, Univ Heart & Vasc Ctr Hamburg, Basel, Switzerland; [Twerenbold, Raphael] German Ctr Cardiovasc Res DZHK, Hamburg, Germany; [Mueller, Christian] Univ Basel, Basel, Switzerland; [Bahrmann, Philipp] Friedrich Alexander Univ Erlangen Nuremberg, Nurnberg, Germany; [Buttinger, Nicolas; Dooley, Maureen] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Ruangsomboon, Onlak] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand; [Nowak, Richard M.] Henry Ford Hlth Syst, Detroit, MI USA; [DeFilippi, Christopher R.] Inova Heart & Vasc Inst, Falls Church, VA USA; [Peacock, William F.] Baylor Coll Med, Houston, TX 77030 USA; [Neilan, Tomas G.] Massachusetts Gen Hosp, Cardiovasc Imaging Res Ctr, Boston, MA 02114 USA; [Liu, Michael A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Hsu, Wan-Ting] Harvard Sch Publ Hlth, Boston, MA USA; [Ma, Kevin Sheng-Kai] Univ Penn, Ctr Global Hlth, Perelman Sch Med, Philadelphia, PA USA; [Ma, Kevin Sheng-Kai] Natl Taiwan Univ, Taipei, Taiwan; [Than, Martin P.] Univ Otago Christchurch, Christchurch Hosp, Christchurch, New Zealand; [Than, Martin P.] Univ Otago Christchurch, Christchurch Heart Inst, Christchurch, New Zealand; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Ctr Intelligent Healthcare, Taipei, Taiwan	Harvard University; Harvard Medical School; National Taiwan University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Christchurch Hospital New Zealand; University of Otago; Ruprecht Karls University Heidelberg; Flinders University South Australia; Monash University; National Taiwan University; National Taiwan University Hospital; McMaster University; Juntendo University; University of Oslo; University of Oslo; University of Oslo; Universitats Herzzentrum Freiburg; Lund University; Skane University Hospital; University of Basel; German Centre for Cardiovascular Research; University of Basel; University of Erlangen Nuremberg; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Mahidol University; Henry Ford Health System; Henry Ford Hospital; Inova Fairfax Hospital; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; Brown University; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; National Taiwan University; Christchurch Hospital New Zealand; University of Otago; University of Otago; National Taiwan University; National Taiwan University Hospital	Lee, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, 7 Chung Shan South Rd, Taipei, Taiwan.	cclee100@gmail.com	Ma, Kevin Sheng-Kai/GXA-0057-2022; Lee, Chien-Chang/HHM-5986-2022; Pickering, John/ABC-8089-2021; Müller, Christian/AAB-4783-2022; Stoyanov, Kiril/GZM-7970-2022	Ma, Kevin Sheng-Kai/0000-0002-9394-4144; Pickering, John/0000-0001-9475-0344; Müller, Christian/0000-0002-1120-6405; Stoyanov, Kiril/0000-0001-9698-9228; Sorensen, Nils Arne/0000-0002-7571-4847; CHIANG, CHO HUNG/0000-0002-7910-2338; Neumann, Johannes/0000-0002-9478-2757; LEE, CHIEN-CHANG/0000-0002-1243-2463; Ojeda, Francisco/0000-0003-4037-144X; Chiang, Cho Han/0000-0002-5757-6161; Ruangsomboon, Onlak/0000-0002-0848-7162; Chew, Derek/0000-0003-3593-296X; Kavsak, Peter/0000-0003-4576-4744; Blankenberg, Stefan/0000-0001-6488-2362	National Taiwan University Hospital [107-FTN11]	National Taiwan University Hospital(National Taiwan University)	By the National Taiwan University Hospital (grant 107-FTN11).	Amann M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032124; Ambavane A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187662; Anand A, 2019, CLIN CHEM, V65, P484, DOI 10.1373/clinchem.2018.298059; Andrews, 2018, CIRCULATION, V181, P16, DOI [10.1016/j.ahj.2016.07.013, DOI 10.1016/J.AHJ.2016.07.013]; Andruchow JE, 2020, CAN J EMERG MED, V22, P712, DOI 10.1017/cem.2020.349; Asselineau J, 2018, EPIDEMIOL INFECT, V146, P1556, DOI 10.1017/S0950268818001723; Badertscher P, 2018, CIRCULATION, V137, P2536, DOI 10.1161/CIRCULATIONAHA.118.034260; Bahrmann P, 2013, J AM MED DIR ASSOC, V14, P409, DOI 10.1016/j.jamda.2012.12.005; Boeddinghaus J, 2019, CLIN CHEM, V65, P893, DOI 10.1373/clinchem.2018.300061; Boeddinghaus J, 2018, CLIN CHEM, V64, P1347, DOI 10.1373/clinchem.2018.286906; Boeddinghaus J, 2016, CLIN CHEM, V62, P494, DOI 10.1373/clinchem.2015.249508; Buttinger N, 2019, HEART, V105, pA125, DOI 10.1136/heartjnl-2019-BCS.147; Chapman AR, 2019, HEART, V105, P616, DOI 10.1136/heartjnl-2018-314093; Chapman AR, 2017, JAMA-J AM MED ASSOC, V318, P1913, DOI 10.1001/jama.2017.17488; Chen DX, 2021, CLIN CHEM LAB MED, V59, P757, DOI 10.1515/cclm-2020-0367; Chew DP, 2019, CIRCULATION, V140, P1543, DOI 10.1161/CIRCULATIONAHA.119.042891; Chiang CH, 2020, HEART, V106, P985, DOI 10.1136/heartjnl-2019-316343; Collet JP, 2021, EUR HEART J, V42, P1289, DOI 10.1093/eurheartj/ehaa575; Eggers KM, 2016, EUR HEART J, V37, P2417, DOI 10.1093/eurheartj/ehw029; Eusebi P, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-88; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Haller PM, 2020, DIABETES CARE, V43, P460, DOI 10.2337/dc19-1327; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Johannessen TR, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2020-001296; Kavsak PA, 2013, CLIN CHEM, V59, P1407, DOI 10.1373/clinchem.2013.208595; Lee CC, 2020, AM J EMERG MED, V38, P1402, DOI 10.1016/j.ajem.2019.11.035; Leeflang MMG, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-82; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; Mokhtari A, 2016, J AM COLL CARDIOL, V67, P1531, DOI 10.1016/j.jacc.2016.01.059; Mueller C, 2016, ANN EMERG MED, V68, P76, DOI 10.1016/j.annemergmed.2015.11.013; Nejatian A, 2017, J AM COLL CARDIOL, V69, P2622, DOI 10.1016/j.jacc.2017.03.586; Neumann JT, 2019, NEW ENGL J MED, V380, P2529, DOI 10.1056/NEJMoa1803377; Nowak RM, 2020, ANN EMERG MED, V76, P1, DOI 10.1016/j.annemergmed.2019.12.008; Parikh R, 2009, INDIAN J OPHTHALMOL, V57, P217, DOI 10.4103/0301-4738.49397; Pickering JW, 2020, CLIN CHIM ACTA, V505, P15, DOI 10.1016/j.cca.2020.02.009; Pickering JW, 2017, ANN INTERN MED, V166, P715, DOI 10.7326/M16-2562; Pickering JW, 2016, CIRCULATION, V134, P1532, DOI 10.1161/CIRCULATIONAHA.116.022677; Pickering JW, 2016, HEART, V102, P1270, DOI 10.1136/heartjnl-2015-308505; Pines JM, 2009, ACAD EMERG MED, V16, P617, DOI 10.1111/j.1553-2712.2009.00456.x; Reichlin T, 2015, AM J MED, V128, P369, DOI 10.1016/j.amjmed.2014.10.032; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Ruangsomboon O, 2021, INT J CARDIOL, V322, P23, DOI 10.1016/j.ijcard.2020.08.099; Gimenez MR, 2015, AM J MED, V128, P861, DOI 10.1016/j.amjmed.2015.01.046; Sandoval Y, 2020, CIRC-CARDIOVASC QUAL, V13, P450, DOI 10.1161/CIRCOUTCOMES.120.006565; Shiozaki M, 2020, INT J CARDIOL, V320, P1, DOI 10.1016/j.ijcard.2020.07.037; Shiozaki M, 2017, INT J CARDIOL, V249, P32, DOI 10.1016/j.ijcard.2017.09.009; Stoyanov KM, 2020, EUR HEART J-ACUTE CA, V9, P39, DOI 10.1177/2048872619861911; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Than M, 2014, JAMA INTERN MED, V174, P51, DOI 10.1001/jamainternmed.2013.11362; Than M, 2013, INT J CARDIOL, V166, P752, DOI 10.1016/j.ijcard.2012.09.171; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Than MP, 2016, ANN EMERG MED, V68, P93, DOI 10.1016/j.annemergmed.2016.01.001; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Twerenbold R, 2019, J AM COLL CARDIOL, V74, P483, DOI 10.1016/j.jacc.2019.05.046; Twerenbold R, 2018, J AM COLL CARDIOL, V72, P620, DOI 10.1016/j.jacc.2018.05.040; Umemneku Chikere Chinyereugo M, 2019, PLoS One, V14, pe0223832, DOI 10.1371/journal.pone.0223832; Westwood ME, 2021, CLIN CHEM, V67, P237, DOI 10.1093/clinchem/hvaa280; Wildi K, 2019, INT J CARDIOL, V283, P41, DOI 10.1016/j.ijcard.2018.11.140; Wildi K, 2016, AM HEART J, V181, P16, DOI 10.1016/j.ahj.2016.07.013; Wildi K, 2016, EUR HEART J-ACUTE CA, V5, P399, DOI 10.1177/2048872616642952; Zhelev Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h15	65	17	17	5	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					1	4		10.7326/M21-1499	http://dx.doi.org/10.7326/M21-1499		NOV 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0X3ZW	34807719				2022-12-28	WOS:000729199100001
J	Montori, V				Montori, Victor			A movement for common care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Fuelled by the medicalisation of life and an ever-expanding remit, healthcare has become industrialised and unsustainable. Sustainable healthcare requires a shift from industrial healthcare to careful and kind care as well as addressing the social and environmental determinants of health. Caring for, about, and with each other is a social determinant of health, writes Victor Montori	[Montori, Victor] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Montori, V (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Allwood D, 2022, BMJ LEAD, V6, P125, DOI 10.1136/leader-2021-000451; Camps V., 2021, TIEMPO CUIDADOS OTRA; Dowling E., 2021, WHAT CAUSED IT CAN W; Hakim J, 2020, CARE MANIFESTO POLIT; Haraldsson G.D., 2021, GOING PUBLIC ICELAND; Kleinman A, 2020, PERSPECT BIOL MED, V63, P458, DOI 10.1353/pbm.2020.0033; Marmot M, 2020, BUILD BACK FAIRER CO; Montori V, 2019, NEJM, V5, DOI [10.1056/CAT.19.0696, DOI 10.1056/CAT.19.0696]; Montori V, 2017, WHY WE REVOLT PATIEN; Pinevich Y, 2021, APPL CLIN INFORM, V12, P788, DOI 10.1055/s-0041-1733909; Tolentino Jia, 2020, NEW YORKER; Tronto J, 2015, WHO CARES; Tran VT, 2020, MAYO CLIN PROC, V95, P504, DOI 10.1016/j.mayocp.2019.09.004; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2886	10.1136/bmj.n2886	http://dx.doi.org/10.1136/bmj.n2886			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815240	Bronze			2022-12-28	WOS:000722577100007
J	Dyer, C				Dyer, Clare			Dudley trust fined 2.5m pound over deaths of two patients from infection	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2021	375								n2864	10.1136/bmj.n2864	http://dx.doi.org/10.1136/bmj.n2864			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3LL	34810159				2022-12-28	WOS:000730089900006
J	Stuart, JC				Stuart, Jessica C.			The Little Things	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stuart, Jessica C.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Stuart, JC (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991	1	0	0	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2021	2023		10.1056/NEJMp2112424	http://dx.doi.org/10.1056/NEJMp2112424		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XC3KG	34797616				2022-12-28	WOS:000720683100001
J	Zylka, MJ				Zylka, Mark J.			A Nobel Prize for Sensational Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECEPTOR; CHANNEL		[Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.							Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Kefauver JM, 2020, NATURE, V587, P567, DOI 10.1038/s41586-020-2933-1; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moran MM, 2018, BRIT J PHARMACOL, V175, P2185, DOI 10.1111/bph.14044; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9	7	1	1	4	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2021	385	25					2392	2394		10.1056/NEJMcibr2116227	http://dx.doi.org/10.1056/NEJMcibr2116227		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE4WZ	34818477				2022-12-28	WOS:000721972400001
J	Rubin, R				Rubin, Rita			Support for Primary Care Clinicians in Underserved Areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2000	2000						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812880				2022-12-28	WOS:000724001500044
J	Rubin, R				Rubin, Rita			First Thymus Tissue Product Approved for Rare Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2003	2003		10.1001/jama.2021.20538	http://dx.doi.org/10.1001/jama.2021.20538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812884				2022-12-28	WOS:000724001500052
J	Mahase, E				Mahase, Elisabeth			Changes in behaviour last year led to fall in antibiotic resistant infections	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		UK Health Security Agency, ENGL SURV PROGR ANT	1	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2853	10.1136/bmj.n2853	http://dx.doi.org/10.1136/bmj.n2853			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799370	Bronze			2022-12-28	WOS:000723212300011
J	Fleming, N				Fleming, Nic			How to work in vaccine science	NATURE			English	Editorial Material							IMMUNITY; SPIKE											Chen Wen-Hsiang, 2020, bioRxiv, DOI 10.1101/2020.05.15.098079; Chen WH, 2014, HUM VACC IMMUNOTHER, V10, P648, DOI 10.4161/hv.27464; Chia WN, 2021, LANCET MICROBE, V2, pE240, DOI 10.1016/S2666-5247(21)00025-2; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; van de Berg D, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00322-7; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]	6	0	0	4	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 11	2021	599	7884					S1	S3		10.1038/d41586-021-03056-7	http://dx.doi.org/10.1038/d41586-021-03056-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XC3CM	34815563	Bronze			2022-12-28	WOS:000721895200001
J	Gearty, SV; Dundar, F; Zumbo, P; Espinosa-Carrasco, G; Shakiba, M; Sanchez-Rivera, FJ; Socci, ND; Trivedi, P; Lowe, SW; Lauer, P; Mohibullah, N; Viale, A; DiLorenzo, TP; Betel, D; Schietinger, A				Gearty, Sofia, V; Dundar, Friederike; Zumbo, Paul; Espinosa-Carrasco, Gabriel; Shakiba, Mojdeh; Sanchez-Rivera, Francisco J.; Socci, Nicholas D.; Trivedi, Prerak; Lowe, Scott W.; Lauer, Peter; Mohibullah, Neeman; Viale, Agnes; DiLorenzo, Teresa P.; Betel, Doron; Schietinger, Andrea			An autoimmune stem-like CD8 T cell population drives type 1 diabetes	NATURE			English	Article							MOUSE; FINGOLIMOD; DISCOVERY; EFFECTOR; PROGRAM; ISLETS; MICE; CD4+	CD8 T cell-mediated autoimmune diseases result from the breakdown of self-tolerance mechanisms in autoreactive CD8 T cells(1). How autoimmune T cell populations arise and are sustained, and the molecular programmes defining the autoimmune T cell state, are unknown. In type 1 diabetes, beta-cell-specific CD8 T cells destroy insulin-producing beta-cells. Here we followed the fate of beta-cell-specific CD8 T cells in non-obese diabetic mice throughout the course of type 1 diabetes. We identified a stem-like autoimmune progenitor population in the pancreatic draining lymph node (pLN), which self-renews and gives rise to pLN autoimmune mediators. pLN autoimmune mediators migrate to the pancreas, where they differentiate further and destroy beta-cells. Whereas transplantation of as few as 20 autoimmune progenitors induced type 1 diabetes, as many as 100,000 pancreatic autoimmune mediators did not. Pancreatic autoimmune mediators are short-lived, and stem-like autoimmune progenitors must continuously seed the pancreas to sustain beta-cell destruction. Single-cell RNA sequencing and clonal analysis revealed that autoimmune CD8 T cells represent unique T cell differentiation states and identified features driving the transition from autoimmune progenitor to autoimmune mediator. Strategies aimed at targeting the stem-like autoimmune progenitor pool could emerge as novel and powerful immunotherapeutic interventions for type 1 diabetes.	[Gearty, Sofia, V; Espinosa-Carrasco, Gabriel; Shakiba, Mojdeh; Trivedi, Prerak; Schietinger, Andrea] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Gearty, Sofia, V; Schietinger, Andrea] Weill Cornea Med, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA; [Dundar, Friederike; Zumbo, Paul] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Dundar, Friederike; Zumbo, Paul; Betel, Doron] Weill Cornell Med, Appl Bioinformat Core, New York, NY 10065 USA; [Sanchez-Rivera, Francisco J.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol Program, 1275 York Ave, New York, NY 10021 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA; [Lauer, Peter] Aduro Biotech, Berkeley, CA USA; [Mohibullah, Neeman; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Integrated Genom Operat Core, 1275 York Ave, New York, NY 10021 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Div Endocrinol, Dept Med, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Einstein Mt Sinai Diabet Res Ctr, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA; [Betel, Doron] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA; [Betel, Doron] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Cornell University	Schietinger, A (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Schietinger, A (corresponding author), Weill Cornea Med, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA.; Betel, D (corresponding author), Weill Cornell Med, Appl Bioinformat Core, New York, NY 10065 USA.; Betel, D (corresponding author), Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA.; Betel, D (corresponding author), Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA.	dob2014@med.cornell.edu; schietia@mskcc.org	Espinosa Carrasco, Gabriel/AFR-8047-2022	Dundar, Friederike/0000-0002-2301-112X; , Scott/0000-0002-5284-9650; Gearty, Sofia/0000-0001-8633-3663	NIH [T32GM007739]; NIH NIDDK [F30DK122691]; NIH NCI [DP2CA225212]; Lloyd Old STAR Award of the Cancer Research Institute; Josie Robertson Foundation; MSKCC Core Grant [P30CA008748]; Weill Cornell Medicine Core Laboratories Center; NIH NIAID [R01AI123730]; MSKCC TROT programme [5T32CA160001]; GMTEC Postdoctoral Researcher Innovation Grant; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lloyd Old STAR Award of the Cancer Research Institute; Josie Robertson Foundation; MSKCC Core Grant; Weill Cornell Medicine Core Laboratories Center; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MSKCC TROT programme; GMTEC Postdoctoral Researcher Innovation Grant; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	We thank the members of the Schietinger laboratory, M. Li (MSKCC) and S. Reiner (Columbia University) for helpful discussions; K. Herold (Yale University) for reviewing data and discussion; H. Appleby and E. Bruno for technical support; S. Miakicheva for help with experiments; the MSKCC Flow Cytometry Core, especially R. Gardner; the Integrated Genomics Operation Core, especially A. Farina; M. Philip (Vanderbilt University) for critical feedback on the manuscript; and S. Monette (Tri-Institutional Laboratory of Comparative Pathology, MSKCC) for pathological evaluation of insulitis. This work was supported by the following funding sources: Medical Scientist Training Programme grant NIH T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program (S.V.G.), NIH NIDDK F30DK122691 (S.V.G.), NIH NCI DP2CA225212 (A.S.), Lloyd Old STAR Award of the Cancer Research Institute (A.S.), Josie Robertson Foundation (A.S), the MSKCC Core Grant P30CA008748, Weill Cornell Medicine Core Laboratories Center (P.Z., F.D. and D.B.), NIH NIAID R01AI123730 (T.P.D.). F.J.S.-R. was partially supported by the MSKCC TROT programme (5T32CA160001), a GMTEC Postdoctoral Researcher Innovation Grant and is a HHMI Hanna Gray Fellow. The MSKCC Integrated Genomics Operation Core was supported by Cycle for Survival and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Abdelsamed HA, 2020, NAT IMMUNOL, V21, P578, DOI 10.1038/s41590-020-0633-5; Amezquita RA, 2020, NAT METHODS, V17, P137, DOI 10.1038/s41592-019-0654-x; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; [Anonymous], 2020, DEGREPORT REPORT DEG; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chee J, 2014, J IMMUNOL, V192, P572, DOI 10.4049/jimmunol.1302100; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Culina S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ehlers MR, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0659-5; Escobar G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb9726; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw430; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kim HJ, 2020, BIOINFORMATICS, V36, P4137, DOI 10.1093/bioinformatics/btaa282; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Magnuson AM, 2015, P NATL ACAD SCI USA, V112, P1511, DOI 10.1073/pnas.1423769112; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Marini F, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2879-1; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Philip M, 2022, NAT REV IMMUNOL, V22, P209, DOI 10.1038/s41577-021-00574-3; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schauder DM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013452118; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Sims EK, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc8980; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; THIVOLET C, 1991, J IMMUNOL, V146, P85; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Unanue ER, 2014, ANNU REV IMMUNOL, V32, P579, DOI 10.1146/annurev-immunol-032712-095941; van Loosdregt J, 2018, J IMMUNOL, V201, P2193, DOI 10.4049/jimmunol.1800633; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zakharov PN, 2020, J EXP MED, V217, DOI 10.1084/jem.20192362	56	15	14	21	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					156	+		10.1038/s41586-021-04248-x	http://dx.doi.org/10.1038/s41586-021-04248-x			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	34847567	Green Accepted			2022-12-28	WOS:000750429600035
J	Moberly, T				Moberly, Tom			A healthcare system close to collapse in Afghanistan	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2021	375								n3019	10.1136/bmj.n3019	http://dx.doi.org/10.1136/bmj.n3019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1KZ	34880000	Bronze			2022-12-28	WOS:000740890600007
J	Davidson, KW; Barry, MJ; Mangione, CM; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Silverstein, M; Stevermer, J; Tseng, CW; Wong, JB				Davidson, Karina W.; Barry, Michael J.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ORAL-HEALTH; ADOLESCENTS; FLUORIDE	IMPORTANCE Dental caries is the most common chronic disease in children in the US. According to the 2011-2016 National Health and Nutrition Examination Survey, approximately 23% of children aged 2 to 5 years had dental caries in their primary teeth. Prevalence is higher in Mexican American children (33%) and non-Hispanic Black children (28%) than in non-Hispanic White children (18%). Dental caries in early childhood is associated with pain, loss of teeth, impaired growth, decreased weight gain, negative effects on quality of life, poor school performance, and future dental caries. OBJECTIVE To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on screening and interventions to prevent dental caries in children younger than 5 years. POPULATION Asymptomatic children younger than 5 years. EVIDENCE ASSESSMENT The USPSTF concludes with moderate certainty that there is a moderate net benefit of preventing future dental caries with oral fluoride supplementation at recommended doses in children 6 months or older whose water supply is deficient in fluoride. The USPSTF concludes with moderate certainty that there is a moderate net benefit of preventing future dental caries with fluoride varnish application in all children younger than 5 years. The USPSTF concludes that the evidence is insufficient on performing routine oral screening examinations for dental caries by primary care clinicians in children younger than 5 years and that the balance of benefits and harms of screening cannot be determined. RECOMMENDATION The USPSTF recommends that primary care clinicians prescribe oral fluoride supplementation starting at age 6 months for children whose water supply is deficient in fluoride. (B recommendation) The USPSTF recommends that primary care clinicians apply fluoride varnish to the primary teeth of all infants and children starting at the age of primary tooth eruption. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening examinations for dental caries performed by primary care clinicians in children younger than 5 years.	[Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori] Univ Massachusetts Med Sch, Worcester, MA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Stevermer, James] Univ Missouri, Columbia, MO USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Northwell Health; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Yeshiva University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; George Mason University; University of Virginia; New York University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Davidson, KW (corresponding author), Feinstein Inst Med Res, 130 E 59th St,Ste 14C, New York, NY 10032 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				American Academy of Pediatric Dentistry, 2020, REFERENCE MANUAL PED, P288; [Anonymous], 2013, DENT CARIES CAVITIES; [Anonymous], GUID FLUOR THER; [Anonymous], POL US XYL PED DENT; [Anonymous], 2021, PROC MAN; [Anonymous], MY WAT FLUOR; [Anonymous], CHILD HLTH; Bader JD, 2004, AM J PREV MED, V26, P315, DOI 10.1016/j.amepre.2003.12.001; Bleach C., 2019, SURVEILLANCE, V46, P27; Caufield PW, 2000, PEDIATR CLIN N AM, V47, P1001, DOI 10.1016/S0031-3955(05)70255-8; CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1; Chou R., 2021, AHRQ PUBLICATION; Chou R, 2021, JAMA-J AM MED ASSOC, V326, P2179, DOI 10.1001/jama.2021.15658; Clark MB, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-034637; Clark MB, 2014, PEDIATRICS, V134, P626, DOI 10.1542/peds.2014-1699; Crystal YO, 2017, PEDIATR DENT, V39, pE135; Dooley D, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2014-3532; Dye BA, 2017, J AM DENT ASSOC, V148, P550, DOI 10.1016/j.adaj.2017.04.013; Gao S S, 2016, JDR Clin Trans Res, V1, P201, DOI 10.1177/2380084416661474; Garcia RI, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160372; Institute of Medicine and National Research Council, 2011, IMPR AC OR HLTH CAR; Lewis CW, 2009, ACAD PEDIATR, V9, P457, DOI 10.1016/j.acap.2009.09.016; Maguire Anne, 2014, Evid Based Dent, V15, P38, DOI 10.1038/sj.ebd.6401019; Moyer VA, 2014, PEDIATRICS, V133, P1102, DOI 10.1542/peds.2014-0483; National Center for Health Statistics, HLTH PEOPL 2010 FIN; Nicolae A, 2018, PAED CHILD HEALT-CAN, V23, P111, DOI 10.1093/pch/pxx155; Tinanoff N, 2009, ACAD PEDIATR, V9, P396, DOI 10.1016/j.acap.2009.08.006; US Department of Health and Human Services, 2000, OR HLTH AM REP SURG; Weiss PA, 2003, PEDIATRICS, V111, P1113	29	9	10	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2172	2178		10.1001/jama.2021.20007	http://dx.doi.org/10.1001/jama.2021.20007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874412	Bronze			2022-12-28	WOS:000730077500020
J	Dyer, C				Dyer, Clare			Covid-19: High Court overturns decision to ban GP from posting views on pandemic on social media	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n3033	10.1136/bmj.n3033	http://dx.doi.org/10.1136/bmj.n3033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4DA	34876397	Bronze			2022-12-28	WOS:000730815800015
J	Slomski, A				Slomski, Anita			Preemptive Treatment Reduced Autism Symptom Severity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2120	2120						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XO3GR	34874432				2022-12-28	WOS:000730077500005
J	Teakell, JM; Molony, DA				Teakell, Jade M.; Molony, Donald A.			In afebrile men with UTIs, 7 d of ciprofloxacin or trimethoprim-sulfamethoxazole was noninferior to 14 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Teakell, Jade M.; Molony, Donald A.] Univ Texas Houston, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Teakell, JM (corresponding author), Univ Texas Houston, McGovern Med Sch, Houston, TX 77030 USA.							Crellin E, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k341; Drekonja DM, 2013, JAMA INTERN MED, V173, P62, DOI 10.1001/2013.jamainternmed.829	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC141	JC141		10.7326/ACPJ202112210-141	http://dx.doi.org/10.7326/ACPJ202112210-141		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871046				2022-12-28	WOS:000729196400001
J	Sun, HT; Lu, ZN; Singh, A; Zhou, YJ; Zheng, E; Zhou, M; Wang, JH; Wu, XW; Hu, ZS; Gu, ZH; Campbell, JL; Zheng, L; Shen, BH				Sun, Haitao; Lu, Zhaoning; Singh, Amanpreet; Zhou, Yajing; Zheng, Eric; Zhou, Mian; Wang, Jinhui; Wu, Xiwei; Hu, Zunsong; Gu, Zhaohui; Campbell, Judith L.; Zheng, Li; Shen, Binghui			Error-prone, stress-induced 3' flap-based Okazaki fragment maturation supports cell survival	SCIENCE			English	Article							INTERNAL TANDEM DUPLICATION; EUKARYOTIC DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; FEN1 MUTATIONS; YEAST; GENE; ENDONUCLEASE-1; INHIBITOR; NUCLEASE	How cells with DNA replication defects acquire mutations that allow them to escape apoptosis under environmental stress is a long-standing question. Here, we report that an error-prone Okazaki fragment maturation (OFM) pathway is activated at restrictive temperatures in rad27 Delta yeast cells. Restrictive temperature stress activated Dun1, facilitating transformation of unprocessed 5' flaps into 3' flaps, which were removed by 3' nucleases, including DNA polymerase delta (Pol delta). However, at certain regions, 3' flaps formed secondary structures that facilitated 3' end extension rather than degradation, producing alternative duplications with short spacer sequences, such as pol3 internal tandem duplications. Consequently, little 5' flap was formed, suppressing rad27 Delta-induced lethality at restrictive temperatures. We define a stress-induced, error-prone OFM pathway that generates mutations that counteract replication defects and drive cellular evolution and survival.	[Sun, Haitao; Lu, Zhaoning; Singh, Amanpreet; Zhou, Yajing; Zheng, Eric; Zhou, Mian; Zheng, Li; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Zheng, Eric] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Wang, Jinhui; Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Hu, Zunsong; Gu, Zhaohui] City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Santa Barbara; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; California Institute of Technology; California Institute of Technology	Zheng, L; Shen, BH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA.	lzheng@coh.org; bshen@coh.org	Wang, Jin/GYA-2019-2022	Zheng, Eric/0000-0003-0897-1218; Hu, Zunsong/0000-0003-3167-7148	NIH [R50 CA211397, R01 CA073764, R01 CA085344]; National Cancer Institute of the NIH [P30 CA033572]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R50 CA211397 to L.Z. and R01 CA073764 and R01 CA085344 to B.S. Research reported in this publication includes work performed by City of Hope shared resources supported by the National Cancer Institute of the NIH under award number P30 CA033572.	Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cao B, 2020, NUCLEIC ACIDS RES, V48, P6715, DOI 10.1093/nar/gkaa473; Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fitzgerald DM, 2017, ANNU REV CANC BIOL, V1, P119, DOI 10.1146/annurev-cancerbio-050216-121919; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Jackson JR, 2000, CANCER RES, V60, P566; Jaehnig EJ, 2013, CELL REP, V4, P174, DOI 10.1016/j.celrep.2013.05.041; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu SB, 2015, EMBO J, V34, P1829, DOI 10.15252/embj.201489865; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Marino-Enriquez A, 2018, AM J SURG PATHOL, V42, P335, DOI 10.1097/PAS.0000000000000993; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; REENAN RAG, 1992, GENETICS, V132, P975; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; Sriramachandran AM, 2020, MOL CELL, V78, P975, DOI 10.1016/j.molcel.2020.03.027; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Toulmay A, 2006, YEAST, V23, P825, DOI 10.1002/yea.1397; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Treco Douglas A, 2008, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1302s82; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2011, CELL RES, V21, P1052, DOI 10.1038/cr.2011.35; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	51	5	5	4	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1253	+		10.1126/science.abj1013	http://dx.doi.org/10.1126/science.abj1013			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855483	Green Accepted			2022-12-28	WOS:000728578700057
J	Davies, A; Velickovic, P; Buesing, L; Blackwell, S; Zheng, DI; Tomasev, N; Tanburn, R; Battaglia, P; Blundell, C; Juhasz, A; Lackenby, M; Williamson, G; Hassabis, D; Kohli, P				Davies, Alex; Velickovic, Petar; Buesing, Lars; Blackwell, Sam; Zheng, Daniel; Tomasev, Nenad; Tanburn, Richard; Battaglia, Peter; Blundell, Charles; Juhasz, Andras; Lackenby, Marc; Williamson, Geordie; Hassabis, Demis; Kohli, Pushmeet			Advancing mathematics by guiding human intuition with AI	NATURE			English	Article								A framework through which machine learning can guide mathematicians in discovering new conjectures and theorems is presented and shown to yield mathematical insight on important open problems in different areas of pure mathematics. The practice of mathematics involves discovering patterns and using these to formulate and prove conjectures, resulting in theorems. Since the 1960s, mathematicians have used computers to assist in the discovery of patterns and formulation of conjectures(1), most famously in the Birch and Swinnerton-Dyer conjecture(2), a Millennium Prize Problem(3). Here we provide examples of new fundamental results in pure mathematics that have been discovered with the assistance of machine learning-demonstrating a method by which machine learning can aid mathematicians in discovering new conjectures and theorems. We propose a process of using machine learning to discover potential patterns and relations between mathematical objects, understanding them with attribution techniques and using these observations to guide intuition and propose conjectures. We outline this machine-learning-guided framework and demonstrate its successful application to current research questions in distinct areas of pure mathematics, in each case showing how it led to meaningful mathematical contributions on important open problems: a new connection between the algebraic and geometric structure of knots, and a candidate algorithm predicted by the combinatorial invariance conjecture for symmetric groups(4). Our work may serve as a model for collaboration between the fields of mathematics and artificial intelligence (AI) that can achieve surprising results by leveraging the respective strengths of mathematicians and machine learning.	[Davies, Alex; Velickovic, Petar; Buesing, Lars; Blackwell, Sam; Zheng, Daniel; Tomasev, Nenad; Tanburn, Richard; Battaglia, Peter; Blundell, Charles; Juhasz, Andras; Hassabis, Demis; Kohli, Pushmeet] DeepMind, London, England; [Lackenby, Marc] Univ Oxford, Oxford, England; [Williamson, Geordie] Univ Sydney, Sydney, NSW, Australia	University of Oxford; University of Sydney	Davies, A; Kohli, P (corresponding author), DeepMind, London, England.	adavies@deepmind.com; pushmeet@deepmind.com	Juhasz, Andras/O-2503-2014	Tomasev, Nenad/0000-0003-1624-0220; Williamson, Geordie/0000-0003-3672-5284				Appel K. I., 1989, EVERY PLANAR MAP IS, V98; BIRCH BJ, 1965, J REINE ANGEW MATH, V218, P79; Bishop C.M., 2006, PATTERN RECOGN; Blundell C., COMBINATORIAL INVARI; Borwein J., 2008, MATH EXPT; Bradbury J., 2018, JAX COMPOSABLE TRANS; Braden T, 2001, MATH ANN, V321, P533; Brenti F., 2002, SEMIN LOTHAR COMBIN, V49, pB49B; Brenti F, 2006, ADV MATH, V202, P555, DOI 10.1016/j.aim.2005.01.011; Bronstein M. M., 2021, GEOMETRIC DEEP LEARN; Burton B. A., 2020, P 36 INT S COMP GEOM; Carifio J, 2017, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2017)157; Carlson J., 2006, MILLENNIUM PRIZE PRO; Culler M., 2020, SNAPPY COMPUTER PROG; Curtis C. W., 1966, REPRESENTATION THEOR, V356; Davies A., SIGNATURE CUSP GEOME; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; FAJTLOWICZ S, 1988, DISCRETE MATH, V72, P113, DOI 10.1016/0012-365X(88)90199-9; Gilmer J, 2017, PR MACH LEARN RES, V70; Hadamard J., 1997, MATHEMATICIANS MIND; He Y.-H., MACHINE LEARNING MAT; Heal K., 2020, DEEP LEARNING GAUSS; Hoche R., 1866, NICOMACHI GERASENI P, V2; Hughes M. C., 2016, NEURAL NETWORK APPRO; Jejjala V, 2019, PHYS LETT B, V799, DOI 10.1016/j.physletb.2019.135033; Kanigel R., 2016, MAN WHO KNEW INFINIT; Kashaev RM, 1997, LETT MATH PHYS, V39, P269, DOI 10.1023/A:1007364912784; Khovanov M, 2003, EXP MATH, V12, P365, DOI 10.1080/10586458.2003.10504505; Lample G., 2019, INT C LEARN REPR; Larson CE, 2005, DIMACS SER DISCRET M, V69, P297; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Levitt J. S. F., 2019, BIG DATA APPROACHES; MacKay D. J. C., 2003, INFORM THEORY INFERE; Martin A. B. A. D. I., 2015, **DATA OBJECT**, DOI 10.5281/zenodo.4724125; Paszke A., 2019, ADV NEURAL INFORM PR, V32, P8026, DOI DOI 10.48550/ARXIV.1912.01703; Peifer D., 2020, LEARNING SELECTION S; Poincare H., 1907, VALUE SCI ESSENTIAL; Raayoni G, 2021, NATURE, V590, P67, DOI 10.1038/s41586-021-03229-4; Raghu M., 2020, SURVEY DEEP LEARNING; Scholze P., 2021, HALF YEAR LIQUID TEN; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sundararajan M, 2017, PR MACH LEARN RES, V70; Tao T., 2016, THERES MORE MATH RIG; THURSTON WP, 1982, B AM MATH SOC, V6, P357, DOI 10.1090/S0273-0979-1982-15003-0; Velickovic P., 2019, NEURAL EXECUTION GRA; VERMA DN, 1968, B AM MATH SOC, V74, P160, DOI 10.1090/S0002-9904-1968-11921-4; Wagner A. Z., CONSTRUCTIONS COMBIN; Warrington GS, 2011, EXP MATH, V20, P457, DOI 10.1080/10586458.2011.565260; Xu K, 2015, PR MACH LEARN RES, V37, P2048	49	42	44	26	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					70	+		10.1038/s41586-021-04086-x	http://dx.doi.org/10.1038/s41586-021-04086-x			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34853458	hybrid, Green Published			2022-12-28	WOS:000724992500020
J	Feinmann, J				Feinmann, Jane			The BMJ appeal 2021-22: MSF is working to ensure the people of Afghanistan have access to healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Farge E., 2021, REUTERS NOV	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2907	10.1136/bmj.n2907	http://dx.doi.org/10.1136/bmj.n2907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853013				2022-12-28	WOS:000726688600013
J	Grigg, JB; Shanmugavadivu, A; Regen, T; Parkhurst, CN; Ahmed, A; Joseph, AM; Mazzucco, M; Gronke, K; Diefenbach, A; Eberl, G; Vartanian, T; Waisman, A; Sonnenberg, GF				Grigg, John B.; Shanmugavadivu, Arthi; Regen, Tommy; Parkhurst, Christopher N.; Ahmed, Anees; Joseph, Ann M.; Mazzucco, Michael; Gronke, Konrad; Diefenbach, Andreas; Eberl, Gerard; Vartanian, Timothy; Waisman, Ari; Sonnenberg, Gregory F.			Antigen-presenting innate lymphoid cells orchestrate neuroinflammation	NATURE			English	Article							T-CELLS; MOUSE MODEL; DISEASE; BRAIN; GAMMA; TRAFFICKING; ASSOCIATION; ACTIVATION; TOLERANCE; RESPONSES	Pro-inflammatory T cells in the central nervous system (CNS) are causally associated with multiple demyelinating and neurodegenerative diseases(1-)(6), but the pathways that control these responses remain unclear. Here we define a population of inflammatory group 3 innate lymphoid cells (ILC3s) that infiltrate the CNS in a mouse model of multiple sclerosis. These ILC3s are derived from the circulation, localize in proximity to infiltrating T cells in the CNS, function as antigen-presenting cells that restimulate myelin-specific T cells, and are increased in individuals with multiple sclerosis. Notably, antigen presentation by inflammatory ILC3s is required to promote T cell responses in the CNS and the development of multiple-sclerosis-like disease in mouse models. By contrast, conventional and tissue-resident ILC3s in the periphery do not appear to contribute to disease induction, but instead limit autoimmune T cell responses and prevent multiple-sclerosis-like disease when experimentally targeted to present myelin antigen. Collectively, our data define a population of inflammatory ILC3s that is essential for directly promoting T-cell-dependent neuroinflammation in the CNS and reveal the potential of harnessing peripheral tissue-resident ILC3s for the prevention of autoimmune disease.	[Grigg, John B.; Parkhurst, Christopher N.; Ahmed, Anees; Joseph, Ann M.; Sonnenberg, Gregory F.] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA; [Grigg, John B.; Parkhurst, Christopher N.; Ahmed, Anees; Joseph, Ann M.; Sonnenberg, Gregory F.] Cornell Univ, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Grigg, John B.; Parkhurst, Christopher N.; Ahmed, Anees; Joseph, Ann M.; Sonnenberg, Gregory F.] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA; [Shanmugavadivu, Arthi; Regen, Tommy; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Mazzucco, Michael; Vartanian, Timothy] Cornell Univ, Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10021 USA; [Gronke, Konrad; Diefenbach, Andreas] Charit Univ Med Berlin, Lab Innate Immun, Dept Microbiol Infect Dis & Immunol, Berlin, Germany; [Gronke, Konrad; Diefenbach, Andreas] Deutsch Rheuma Forschungszentrum DRFZ, Mucosal & Dev Immunol, Berlin, Germany; [Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France	Cornell University; Cornell University; Cornell University; Johannes Gutenberg University of Mainz; Cornell University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sonnenberg, GF (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Cornell Univ, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu	Regen, Tommy/GQH-6929-2022; Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530; Eberl, Gerard/0000-0002-1119-5638	National Institutes of Health [R01AI143842, R01AI123368, R01AI145989, R01AI162936, R21CA249284, U01AI095608]; Center for Advanced Digestive Care (CADC); Burroughs Wellcome Fund; Wade F.B. Thompson-Cancer Research Institute (CRI) CLIP Investigator grant; Meyer Cancer Center Collaborative Research Initiative; Dalton Family Foundation; Jill Roberts Institute for Research in Inflammatory Bowel Disease; NIAID of the National Institutes of Health [F31AI138389-01A1]; Deutsche Forschungsgemeinschaft (DFG) [AW1600/10-1, AW1600/11-1, AW1600/14-1]; National Multiple Sclerosis Society (NMSS) [RG 170728780]; National Institute of Allergy and Infectious Diseases (NIAID) Mucosal Immunology Studies Team (MIST); Crohn's and Colitis Foundation; Searle Scholars Program; American Asthma Foundation Scholar Award;  [T32DK116970]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Advanced Digestive Care (CADC); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wade F.B. Thompson-Cancer Research Institute (CRI) CLIP Investigator grant; Meyer Cancer Center Collaborative Research Initiative; Dalton Family Foundation; Jill Roberts Institute for Research in Inflammatory Bowel Disease; NIAID of the National Institutes of Health; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Institute of Allergy and Infectious Diseases (NIAID) Mucosal Immunology Studies Team (MIST); Crohn's and Colitis Foundation; Searle Scholars Program; American Asthma Foundation Scholar Award; 	We thank members of the Sonnenberg laboratory for discussions and critical reading of the manuscript; the Microbiome Core and Epigenomics Core of Weill Cornell Medicine and G. G. Putzel for technical assistance; C. Gai of Weill Cornell's Center of Comparative Medicine and Pathology (CCMP) for performing the parabiosis surgeries; and I. Ivanov of Columbia University for sharing mouse lines. The Sonnenberg laboratory is supported by the National Institutes of Health (R01AI143842, R01AI123368, R01AI145989, R01AI162936, R21CA249284 and U01AI095608), the National Institute of Allergy and Infectious Diseases (NIAID) Mucosal Immunology Studies Team (MIST), the Crohn's and Colitis Foundation, the Searle Scholars Program, the American Asthma Foundation Scholar Award, Pilot Project Funding from the Center for Advanced Digestive Care (CADC), an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, a Wade F.B. Thompson-Cancer Research Institute (CRI) CLIP Investigator grant, the Meyer Cancer Center Collaborative Research Initiative, the Dalton Family Foundation, L. and G. Greenberg, and the Jill Roberts Institute for Research in Inflammatory Bowel Disease. G.F.S. is a CRI Lloyd J. Old STAR. J.B.G is supported by the NIAID of the National Institutes of Health under award number F31AI138389-01A1; A.M.J is supported by T32DK116970; and the Waisman laboratory is supported by the Deutsche Forschungsgemeinschaft (DFG) grants AW1600/10-1, AW1600/11-1 and AW1600/14-1, as well as by the National Multiple Sclerosis Society (NMSS) grant RG 170728780.	Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Arlehamn CSL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15626-w; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Browne TC, 2013, J IMMUNOL, V190, P2241, DOI 10.4049/jimmunol.1200947; Bryant PW, 2002, ADV IMMUNOL, V80, P71, DOI 10.1016/S0065-2776(02)80013-X; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Croxford AL, 2009, J IMMUNOL, V182, P1237, DOI 10.4049/jimmunol.182.3.1237; Degn M, 2016, MULT SCLER J, V22, P1013, DOI 10.1177/1352458515609795; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dobes J, 2018, EUR J IMMUNOL, V48, P546, DOI 10.1002/eji.201747267; Dulken B, 2019, NATURE, V571, P205, DOI 10.1038/s41586-019-1362-5; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FALLIS RJ, 1989, J NEUROIMMUNOL, V22, P93, DOI 10.1016/0165-5728(89)90039-8; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Giles DA, 2018, J CLIN INVEST, V128, P5322, DOI 10.1172/JCI123708; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hatfield JK, 2015, CELL IMMUNOL, V297, P69, DOI 10.1016/j.cellimm.2015.06.006; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kipnis J., 2018, CURR PROTOC IMMUNOL, V121, P50, DOI [10.1002/cpim.50, DOI 10.1002/CPIM.V121.110.1002/CPIM.50, 10.1002/cpim.v121.110.1002/cpim.50, DOI 10.1002/CPIM.50]; Koda T, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01757-w; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lin YC, 2015, ANN CLIN TRANSL NEUR, V2, P445, DOI 10.1002/acn3.181; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lodygin D, 2019, NATURE, V566, P503, DOI 10.1038/s41586-019-0964-2; Mair F, 2014, EUR J IMMUNOL, V44, P37, DOI 10.1002/eji.201343653; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Serafini B, 2016, J NEUROPATH EXP NEUR, V75, P877, DOI 10.1093/jnen/nlw063; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Waisman A, 2018, J MOL MED, V96, P1279, DOI 10.1007/s00109-018-1709-7; Yamano T, 2019, J EXP MED, V216, P1027, DOI 10.1084/jem.20181430; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017	67	12	12	8	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 23	2021	600	7890					707	+		10.1038/s41586-021-04136-4	http://dx.doi.org/10.1038/s41586-021-04136-4		DEC 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XT2KA	34853467	Green Accepted			2022-12-28	WOS:000724704400003
J	McNutt, EJ; Hatala, KG; Miller, C; Adams, J; Casana, J; Deane, AS; Dominy, NJ; Fabian, K; Fannin, LD; Gaughan, S; Gill, SV; Gurtu, J; Gustafson, E; Hill, AC; Johnson, C; Kallindo, S; Kilham, B; Kilham, P; Kim, E; Liutkus-Pierce, C; Maley, B; Prabhat, A; Reader, J; Rubin, S; Thompson, NE; Thornburg, R; Williams-Hatala, EM; Zimmer, B; Musiba, CM; DeSilva, JM				McNutt, Ellison J.; Hatala, Kevin G.; Miller, Catherine; Adams, James; Casana, Jesse; Deane, Andrew S.; Dominy, Nathaniel J.; Fabian, Kallisti; Fannin, Luke D.; Gaughan, Stephen; Gill, Simone, V; Gurtu, Josephat; Gustafson, Ellie; Hill, Austin C.; Johnson, Camille; Kallindo, Said; Kilham, Benjamin; Kilham, Phoebe; Kim, Elizabeth; Liutkus-Pierce, Cynthia; Maley, Blaine; Prabhat, Anjali; Reader, John; Rubin, Shirley; Thompson, Nathan E.; Thornburg, Rebeca; Williams-Hatala, Erin Marie; Zimmer, Brian; Musiba, Charles M.; DeSilva, Jeremy M.			Footprint evidence of early hominin locomotor diversity at Laetoli, Tanzania	NATURE			English	Article							PLIOCENE FOOTPRINTS; ENGARE SERO; FOOT; OLD; FOSSIL; BIOMECHANICS; MORPHOLOGY; ETHIOPIA; ILERET; MOTION	Bipedal trackways discovered in 1978 at Laetoli site G, Tanzania and dated to 3.66 million years ago are widely accepted as the oldest unequivocal evidence of obligate bipedalism in the human lineage(1-3). Another trackway discovered two years earlier at nearby site A was partially excavated and attributed to a hominin, but curious affinities with bears (ursids) marginalized its importance to the paleoanthropological community, and the location of these footprints fell into obscurity(3-5). In 2019, we located, excavated and cleaned the site A trackway, producing a digital archive using 3D photogrammetry and laser scanning. Here we compare the footprints at this site with those of American black bears, chimpanzees and humans, and we show that they resemble those of hominins more than ursids. In fact, the narrow step width corroborates the original interpretation of a small, cross-stepping bipedal hominin. However, the inferred foot proportions, gait parameters and 3D morphologies of footprints at site A are readily distinguished from those at site G, indicating that a minimum of two hominin taxa with different feet and gaits coexisted at Laetoli.	[McNutt, Ellison J.] Ohio Univ, Dept Biomed Sci, Heritage Coll Med, Athens, OH 45701 USA; [McNutt, Ellison J.; Kim, Elizabeth] Univ Southern Calif, Keck Sch Med, Dept Integrat Anat Sci, Los Angeles, CA 90007 USA; [Hatala, Kevin G.; Williams-Hatala, Erin Marie] Chatham Univ, Dept Biol, Pittsburgh, PA 15232 USA; [Miller, Catherine; Casana, Jesse; Dominy, Nathaniel J.; Fannin, Luke D.; DeSilva, Jeremy M.] Dartmouth Coll, Ecol Evolut Environm & Soc Grad Program, Hanover, NH 03755 USA; [Miller, Catherine; Casana, Jesse; Dominy, Nathaniel J.; Fannin, Luke D.; Hill, Austin C.; Johnson, Camille; Prabhat, Anjali; DeSilva, Jeremy M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Adams, James] Dartmouth Coll, Dartmouth Lib, Hanover, NH 03755 USA; [Adams, James; Gaughan, Stephen] Dartmouth Coll, Informat Technol & Consulting, Hanover, NH 03755 USA; [Deane, Andrew S.] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Fabian, Kallisti; Gurtu, Josephat; Kallindo, Said] Dept Cultural Heritage, Ngorongoro Conservat Area Author, Arusha, Tanzania; [Gill, Simone, V] Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA; [Gustafson, Ellie; Thornburg, Rebeca; Musiba, Charles M.] Univ Colorado, Dept Anthropol, Denver, CO 80202 USA; [Hill, Austin C.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Kilham, Benjamin; Kilham, Phoebe] Kilham Bear Ctr, Lyme, NH USA; [Liutkus-Pierce, Cynthia; Zimmer, Brian] Appalachian State Univ, Dept Geol & Environm Sci, Boone, NC 28608 USA; [Maley, Blaine] Idaho Coll Osteopath Med, Dept Anat, Meridian, ID USA; [Reader, John] UCL, Dept Anthropol, London, England; [Rubin, Shirley] Napa Valley Coll, Dept Anthropol, Napa, CA USA; [Thompson, Nathan E.] NYIT Coll Osteopath Med, Dept Anat, Old Westbury, NY USA; [Musiba, Charles M.; DeSilva, Jeremy M.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Musiba, Charles M.] Inst Super Politecn Tecnol & Ciencias, Luanda Angola, Angola	University System of Ohio; Ohio University; University of Southern California; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Indiana University System; Indiana University Bloomington; Boston University; University of Colorado System; University of Colorado Denver; University of Pennsylvania; University of North Carolina; Appalachian State University; University of London; University College London; New York Institute Technology; University of Witwatersrand	McNutt, EJ (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Med, Athens, OH 45701 USA.; McNutt, EJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Integrat Anat Sci, Los Angeles, CA 90007 USA.	ejmcnutt@ohio.edu	Dominy, Nathaniel Jay/A-6151-2013	Dominy, Nathaniel Jay/0000-0001-5916-418X; Adams, James/0000-0002-0008-7877; Fannin, Luke/0000-0003-4810-4442; Prabhat, Anjali/0000-0003-0654-3455; Rubin, Shirley/0000-0002-0520-207X	National Geographic [8748-10]; Leakey Foundation [71483-001]; National Science Foundation [BCS-1128170, DGE-080163, BCE-1730822]; GRFP [1840344]; Smithsonian Institution's Human Origins Program; Evolving Earth Foundation; Explorers Club; Claire Garber Goodman Fund-Dartmouth College	National Geographic(National Geographic Society); Leakey Foundation; National Science Foundation(National Science Foundation (NSF)); GRFP(National Science Foundation (NSF)); Smithsonian Institution's Human Origins Program; Evolving Earth Foundation; Explorers Club; Claire Garber Goodman Fund-Dartmouth College	We thank R. Tuttle for his mentorship and inspiration; M. Larkin for her help collecting bear footprint data; R. Leakey, B. Wood, H. de Lumley, T. White, R. Crompton, R. Clarke, W. Harcourt-Smith, C. Stringer, H. Bonney and the London Natural History Museum, and J. Kibii and the National Museum of Kenya for assistance as we attempted to track down photographs and casts of the Laetoli A footprints; J. Sappington for photographic support; and V. Rossi and A. Metallo for help with 3D visualization; the Director General of Tanzania Commission for Science and Technology (COSTECH) for granting our team the COSTECH Research Permits (2019-370-NA-2019-2016); F. Manongi, J. Mwankunda and M. Mwambungu for allowing us to camp and work at Laetoli. Funding for this research was provided by the National Geographic (8748-10), Leakey Foundation (71483-001), National Science Foundation (BCS-1128170, DGE-080163, BCE-1730822, GRFP (No. 1840344), the Smithsonian Institution's Human Origins Program, the Evolving Earth Foundation, the Explorers Club, and the Claire Garber Goodman Fund-Dartmouth College.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bennett M. R., 2014, HUMAN FOOTPRINTS FOS, P101; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Budka M., 2016, DIGTRACE PRO V 1 8 1; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; COHEN A, 1991, Palaios, V6, P371, DOI 10.2307/3514964; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; D'Aout K, 2010, AM J PHYS ANTHROPOL, V141, P515, DOI 10.1002/ajpa.21169; Day M.H., 1991, P199; DeSilva J, 2019, AM J PHYS ANTHROPOL, V168, P63, DOI 10.1002/ajpa.23750; DeSilva JM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7723; DeSilva JM, 2013, AM J PHYS ANTHROPOL, V151, P495, DOI 10.1002/ajpa.22287; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Fukushima T., 1955, J BONE JT SURG, V37, P1311; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Harcourt-Smith WE, 2005, AM J PHYS ANTHROPOL, P112; Harrison T., 2011, PALEONTOLOGY GEOLOGY, P1; Hatala KG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64095-0; Hatala KG, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0235; Hatala KG, 2016, J HUM EVOL, V90, P38, DOI 10.1016/j.jhevol.2015.08.009; Hatala KG, 2013, J HUM EVOL, V65, P21, DOI 10.1016/j.jhevol.2013.03.009; LEAKEY M, 1978, ANTIQUITY, V52, P133, DOI 10.1017/S0003598X00071969; Leakey M., 1984, DISCLOSING AUTOBIOGR; LEAKEY M.D., 1987, LAETOLI PLIOCENE SIT; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1979, NATL GEOGR, V155, P446; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Liutkus-Pierce CM, 2016, PALAEOGEOGR PALAEOCL, V463, P68, DOI 10.1016/j.palaeo.2016.09.019; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Masao FT, 2016, ELIFE, V5, DOI 10.7554/eLife.19568; Meldrum DJ, 2011, J AFR EARTH SCI, V60, P1, DOI 10.1016/j.jafrearsci.2011.01.003; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; Musiba C., 2010, PALEOANTHROPOLOGY, V2010, pA0001; Musiba C, 2008, ICHNOS, V15, P166, DOI 10.1080/10420940802470383; Nagi R., 2012, P 2012 AUTOCARTO; O'Neill MC, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0205; Pelissero A., 2019, PAL SOC M ALB NM; Pelissero A. J., 2017, COMP ANAL NEWLY DISC; Pelissero AJ, 2017, AM J PHYS ANTHROPOL, V162, P312; Raichlen DA, 2017, J HUM EVOL, V107, P134, DOI 10.1016/j.jhevol.2017.04.002; Roach NT, 2018, J HUM EVOL, V122, P70, DOI 10.1016/j.jhevol.2018.04.014; Roach NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26374; Su DF, 2008, J HUM EVOL, V55, P672, DOI 10.1016/j.jhevol.2008.07.003; Thompson NE, 2018, J HUM EVOL, V125, P27, DOI 10.1016/j.jhevol.2018.09.006; Tuttle R.H., 1985, P129; Tuttle R.H., 1991, P187; Tuttle R.H., 1987, P503; TUTTLE RH, 1990, NAT HIST, P60; TUTTLE RH, 1981, PHILOS T R SOC B, V292, P89, DOI 10.1098/rstb.1981.0016; TUTTLE RH, 1984, AM J PHYS ANTHROPOL, V63, P230; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Wickham Hadley, 2021, CRAN; Wickham Hadley, 2020, CRAN; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zimmer B, 2018, QUATERNARY SCI REV, V198, P226, DOI 10.1016/j.quascirev.2018.07.006	57	7	7	7	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 16	2021	600	7889					468	+		10.1038/s41586-021-04187-7	http://dx.doi.org/10.1038/s41586-021-04187-7		DEC 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XP3FN	34853470	hybrid, Green Published			2022-12-28	WOS:000724666000003
J	Abdalla, SM; Koya, SF; Jamieson, M; Verma, M; Haldane, V; Jung, AS; Singh, S; Nordstrom, A; Obaid, T; Legido-Quigley, H; McNab, C				Abdalla, Salma M.; Koya, Shaffi Fazaludeen; Jamieson, Margaret; Verma, Monica; Haldane, Victoria; Jung, Anne-Sophie; Singh, Sudhvir; Nordstroem, Anders; Obaid, Thoraya; Legido-Quigley, Helena; McNab, Christine			Investing in trust and community resilience: lessons from the early months of the first digital pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Abdalla, Salma M.; Singh, Sudhvir; Legido-Quigley, Helena; McNab, Christine] Independent Panel Pandem Preparedness & Response, Global Hlth Campus, Geneva, Switzerland; [Abdalla, Salma M.; Koya, Shaffi Fazaludeen] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Jamieson, Margaret; Haldane, Victoria] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Verma, Monica; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Jung, Anne-Sophie; Legido-Quigley, Helena] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Singh, Sudhvir] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	Boston University; University of Toronto; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; University of Auckland	Abdalla, SM (corresponding author), Independent Panel Pandem Preparedness & Response, Global Hlth Campus, Geneva, Switzerland.; Abdalla, SM (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.	abdallas@bu.edu	Koya, Shaffi Fazaludeen/AAU-3040-2021	Koya, Shaffi Fazaludeen/0000-0002-1220-5754; Jung, Anne-Sophie/0000-0001-7039-7830; Singh, Sudhvir/0000-0002-9915-6755	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response. Open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	[Anonymous], 2020, UN NEWS; [Anonymous], 2021, BBC NEWS 0312; [Anonymous], 2021, BBC NEWS 0103; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Dalton RJ, 2005, INT REV SOCIOL, V15, P133, DOI 10.1080/03906700500038819; Global Preparedness Monitoring Board, 2021, WORDS ACT COMM CTR A; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Han Q, 2021, PSYCHOL MED, DOI 10.1017/S0033291721001306; Independent Panel, 2021, CTR COMM PAND PREP R; King C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4032-2; Koliou M, 2020, SUSTAIN RESIL INFRAS, V5, P131, DOI 10.1080/23789689.2017.1418547; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; Nay O, 2020, LANCET PUBLIC HEALTH, V5, pE238, DOI 10.1016/S2468-2667(20)30092-X; Putterman L., 1998, EC VALUES ORG, P408, DOI DOI 10.1017/CBO9781139174855.017; Quinn Sandra, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.3e4a5ea39d8620494e2a2c874a3c4201; Revie S., 1968, BEHAV SCI, V13, DOI [10.1177/106591296702000316, DOI 10.1177/106591296702000316]; Yip WF, 2021, LANCET REG HEALTH-W, V7, DOI 10.1016/j.lanwpc.2020.100091	17	5	5	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067487	10.1136/bmj-2021-067487	http://dx.doi.org/10.1136/bmj-2021-067487			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840130	hybrid, Green Published			2022-12-28	WOS:000740896100016
J	Crivellin, A; Hoferichter, M				Crivellin, Andreas; Hoferichter, Martin			Hints of lepton flavor universality violations Mounting evidence shows where the standard model may be incomplete	SCIENCE			English	Editorial Material									[Crivellin, Andreas] Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Crivellin, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Crivellin, Andreas] CERN Theory Div, CH-1211 Geneva 23, Switzerland; [Hoferichter, Martin] Univ Bern, Albert Einstein Ctr Fundamental Phys, Inst Theoret Phys, Sidlerstr 5, CH-3012 Bern, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Bern	Crivellin, A (corresponding author), Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Crivellin, A (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.; Crivellin, A (corresponding author), CERN Theory Div, CH-1211 Geneva 23, Switzerland.	andreas.crivellin@cern.ch; hoferichter@itp.unibe.ch			Swiss National Science Foundation [PP00P21 76884, PCEFP2 181117]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Support by the Swiss National Science Foundation, under project nos. PP00P21 76884 (A.C.) and PCEFP2 181117 (M.H.), is acknowledged.	Abada A, 2019, EUR PHYS J C, V79, DOI 10.1140/epjc/s10052-019-6904-3; Abi B, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.141801; Aebischer J, 2020, EUR PHYS J C, V80, DOI 10.1140/epjc/s10052-020-7817-x; Amhis Y, 2021, EUR PHYS J C, V81, DOI 10.1140/epjc/s10052-020-8156-7; Aoyama T, 2020, PHYS REP, V887, P1, DOI 10.1016/j.physrep.2020.07.006; Bobeth C, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/12/040; Bobeth C, 2021, EUR PHYS J C, V81, DOI 10.1140/epjc/s10052-021-09724-2; Capdevila B, 2018, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2018)093; Crivellin A, 2021, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2021)135; Crivellin A, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.111801; Hardy JC, 2020, PHYS REV C, V102, DOI 10.1103/PhysRevC.102.045501; LHCb Collaboration, 2021, ARXIV210311769 LHCB; Sirunyan A. M, 2021, JHEP, V2021, P208; Zyla P. A., 2020, PROG THEOR EXP PHYS, V2020, DOI [DOI 10.1093/ptep/ptaa104, DOI 10.1093/ptep/ptac097]	14	11	11	3	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1051	1052		10.1126/science.abk2450	http://dx.doi.org/10.1126/science.abk2450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822302	Green Submitted			2022-12-28	WOS:000725668600019
J	Foley, CD; Xie, CJ; Guo, H; Suits, AG				Foley, Casey D.; Xie, Changjian; Guo, Hua; Suits, Arthur G.			Orbiting resonances in formaldehyde reveal coupling of roaming, radical, and molecular channels	SCIENCE			English	Article							PHOTODISSOCIATION; DISSOCIATION; TRANSITION; DYNAMICS; ATOM; DISTRIBUTIONS; PROGRAM; STATE; H2CO	The roaming chemical reaction mechanism involves near-dissociation of an energized molecule to radicals that leads instead to intramolecular reaction after reorientation at long range. Surprisingly, no clear quantum signatures of roaming have been observed to date, despite the quantum nature of the roaming event. We found evidence of quantum dynamics in the photodissociation of formaldehyde near the roaming threshold. This is ascribed to resonances associated to H+HCO(K-a = 1) that have a profound impact on the CO rotational and translational energy distributions and cause the roaming fraction to vary by a factor of 2 over an energy range of 10 cm(-1). The roaming pathway serves both to modulate and report on the complex vibrational dynamics and coupling among the three dissociation pathways in the excited molecule as it decays to products.	[Foley, Casey D.; Suits, Arthur G.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Xie, Changjian] Northwest Univ, Inst Modern Phys, Shaanxi Key Lab Theoret Phys Frontiers, Xian 710127, Shaanxi, Peoples R China; [Xie, Changjian; Guo, Hua] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	University of Missouri System; University of Missouri Columbia; Chinese Academy of Sciences; Northwest University Xi'an; University of New Mexico	Suits, AG (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.; Guo, H (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	hguo@unm.edu; suitsa@missouri.edu	; Guo, Hua/J-2685-2014	Xie, Changjian/0000-0002-2062-430X; Suits, Arthur/0000-0001-5405-8361; Guo, Hua/0000-0001-9901-053X	Army Research Office MURI [W911NF-19-1-0283, W911NF-17-1-0099]; National Natural Science Foundation of China [22073073]	Army Research Office MURI(MURI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by Army Research Office MURI grants W911NF-19-1-0283 (H.G. and A.G.S.) and W911NF-17-1-0099 (A.G.S.), and by National Natural Science Foundation of China grant 22073073 (C.X.).	Andrews DU, 2013, J PHYS CHEM A, V117, P7631, DOI 10.1021/jp405582z; Araujo M, 2008, J PHYS CHEM A, V112, P7489, DOI 10.1021/jp803152g; Bowman JM, 2017, CHEM SOC REV, V46, P7615, DOI 10.1039/c7cs00578d; Bowman JM, 2011, ANNU REV PHYS CHEM, V62, P531, DOI 10.1146/annurev-physchem-032210-103518; CHANDLER DW, 1987, J CHEM PHYS, V87, P1445, DOI 10.1063/1.453276; Csaszar AG, 2020, PHYS CHEM CHEM PHYS, V22, P15081, DOI 10.1039/d0cp00960a; DAI HL, 1985, J CHEM PHYS, V82, P1688, DOI 10.1063/1.448401; Endo T, 2020, SCIENCE, V370, P1072, DOI 10.1126/science.abc2960; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Farnum JD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715586; Foley C. D., 2021, ZENODO, DOI [10.5281/zenodo.4975789, DOI 10.5281/ZENODO.4975789]; Foley C. D., 2021, ZENODO; Fu BN, 2011, J AM CHEM SOC, V133, P7957, DOI 10.1021/ja201559r; Guan YF, 2021, J CHEM THEORY COMPUT, V17, P4157, DOI 10.1021/acs.jctc.1c00370; Guan YF, 2020, J PHYS CHEM A, V124, P10132, DOI 10.1021/acs.jpca.0c08948; Guo H, 1998, J CHEM PHYS, V108, P2466, DOI 10.1063/1.475629; Guo H, 2007, REV COMP CH, V25, P285, DOI 10.1002/9780470189078.ch7; Harding LB, 2007, PHYS CHEM CHEM PHYS, V9, P4055, DOI 10.1039/b705390h; Harding LB, 2012, J PHYS CHEM A, V116, P6967, DOI 10.1021/jp303581k; Houston PL, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4982823; Houston PL, 2016, J PHYS CHEM A, V120, P5103, DOI 10.1021/acs.jpca.6b00488; HU XC, 1991, J COMPUT CHEM, V12, P1014, DOI 10.1002/jcc.540120814; HUTSON JM, 1990, J CHEM PHYS, V92, P157, DOI 10.1063/1.458485; JOB VA, 1969, J MOL SPECTROSC, V30, P365, DOI 10.1016/0022-2852(69)90274-4; Klippenstein SJ, 2011, J PHYS CHEM A, V115, P14370, DOI 10.1021/jp208347j; Kramida, 2020, NIST ATOMIC SPECTRA; Lahankar SA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2202241; Li AY, 2013, J PHYS CHEM A, V117, P5052, DOI 10.1021/jp4049988; Li HW, 2019, NAT CHEM, V11, P123, DOI 10.1038/s41557-018-0186-5; Light JC, 2000, ADV CHEM PHYS, V114, P263, DOI 10.1002/9780470141731.ch4; Lin SY, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.022703; Liu KP, 2012, ADV CHEM PHYS, V149, P1; LOGE GW, 1983, J CHEM PHYS, V79, P196, DOI 10.1063/1.445556; Mauguiere FAL, 2017, ANNU REV PHYS CHEM, V68, P499, DOI 10.1146/annurev-physchem-052516-050613; MOORE CB, 1983, ANNU REV PHYS CHEM, V34, P525, DOI 10.1146/annurev.pc.34.100183.002521; Quinn MS, 2020, SCIENCE, V369, P1592, DOI 10.1126/science.abc4088; Quinn MS, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4983138; Reid SA, 1996, J PHYS CHEM-US, V100, P474, DOI 10.1021/jp952843w; SATO Y, 1995, J PHYS CHEM-US, V99, P16307, DOI 10.1021/j100044a017; SCHINKE R, 1986, FARADAY DISCUSS, V82, P111, DOI 10.1039/dc9868200111; Shepler BC, 2011, J PHYS CHEM LETT, V2, P834, DOI 10.1021/jz2002138; Spence R, 1935, J CHEM SOC, P338, DOI 10.1039/jr9350000338; Suits AG, 2008, ACCOUNTS CHEM RES, V41, P873, DOI 10.1021/ar8000734; Suits AG, 2020, ANNU REV PHYS CHEM, V71, P77, DOI 10.1146/annurev-physchem-050317-020929; Terentis AC, 1998, J CHEM PHYS, V108, P3187, DOI 10.1063/1.475736; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; Townsend D, 2003, REV SCI INSTRUM, V74, P2530, DOI 10.1063/1.1544053; VANZEE RD, 1993, J CHEM PHYS, V99, P1664, DOI 10.1063/1.465335; VANZEE RD, 1992, J CHEM PHYS, V97, P3235, DOI 10.1063/1.463010; Wang XH, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0194; Western CM, 2017, J QUANT SPECTROSC RA, V186, P221, DOI 10.1016/j.jqsrt.2016.04.010; Yin HM, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1902863; Zare R. N, 1988, ANGULAR MOMENTUM QUA; Zhang J. Z. H., 1999, THEORY APPL QUANTUM	55	6	6	5	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1122	+		10.1126/science.abk0634	http://dx.doi.org/10.1126/science.abk0634			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822294				2022-12-28	WOS:000725668600045
J	Gonzales, KAU; Polak, L; Matos, I; Tierney, MT; Gola, A; Wong, E; Infarinato, NR; Nikolova, M; Luo, SJ; Liu, SQ; Novak, JSS; Lay, K; Pasolli, HA; Fuchs, E				Gonzales, Kevin Andrew Uy; Polak, Lisa; Matos, Irina; Tierney, Matthew T.; Gola, Anita; Wong, Ellen; Infarinato, Nicole R.; Nikolova, Maria; Luo, Shijing; Liu, Siqi; Novak, Jesse S. S.; Lay, Kenneth; Pasolli, Hilda Amalia; Fuchs, Elaine			Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories	SCIENCE			English	Article							HAIR FOLLICLE; WOUND REPAIR; TRANSCRIPTION FACTORS; HOMEOSTASIS; SKIN; PURIFICATION; POPULATIONS; GENERATION; PLASTICITY; CHROMATIN	Immune and tissue stem cells retain an epigenetic memory of inflammation that intensifies sensitivity to future encounters. We investigated whether and to what consequence stem cells possess and accumulate memories of diverse experiences. Monitoring a choreographed response to wounds, we found that as hair follicle stem cells leave their niche, migrate to repair damaged epidermis, and take up long-term foreign residence there, they accumulate long-lasting epigenetic memories of each experience, culminating in post-repair epigenetic adaptations that sustain the epidermal transcriptional program and surface barrier. Each memory is distinct, separable, and has its own physiological impact, collectively endowing these stem cells with heightened regenerative ability to heal wounds and broadening their tissue-regenerating tasks relative to their naive counterparts.	[Gonzales, Kevin Andrew Uy; Polak, Lisa; Matos, Irina; Tierney, Matthew T.; Gola, Anita; Wong, Ellen; Infarinato, Nicole R.; Nikolova, Maria; Liu, Siqi; Novak, Jesse S. S.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Dev & Cell B, New York, NY 10065 USA; [Matos, Irina] Genentech Inc, Immunol Discovery, San Francisco, CA 94080 USA; [Luo, Shijing] Jones Day Intellectual Property Law Firm, New York, NY 10281 USA; [Lay, Kenneth] ASTAR, Lab Human Genet & Therapeut, Inst Med Biol, Singapore 138648, Singapore; [Pasolli, Hilda Amalia] Rockefeller Univ, Electron Microscopy Resource Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Roche Holding; Genentech; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Dev & Cell B, New York, NY 10065 USA.	fuchslb@rockefeller.edu		Wong, Ellen/0000-0001-5183-2884; Pasolli, Hilda Amalia/0000-0003-3899-3530; Gonzales, Kevin Andrew/0000-0001-7418-965X; Tierney, Matthew/0000-0002-6428-7181; Gola, Anita/0000-0003-1431-1398; Matos, Irina/0000-0001-6100-8020				Adam RC, 2020, NAT CELL BIOL, V22, P640, DOI 10.1038/s41556-020-0513-0; Adam RC, 2018, CELL STEM CELL, V22, P398, DOI 10.1016/j.stem.2017.12.004; Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Aragona M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14684; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; de Laval B, 2020, CELL STEM CELL, V26, P657, DOI 10.1016/j.stem.2020.01.017; Divangahi M, 2021, NAT IMMUNOL, V22, P2, DOI 10.1038/s41590-020-00845-6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ge YJ, 2018, NAT REV GENET, V19, P311, DOI 10.1038/nrg.2018.9; Ge YJ, 2017, CELL, V169, P636, DOI 10.1016/j.cell.2017.03.042; Gonzales KAU, 2017, DEV CELL, V43, P387, DOI 10.1016/j.devcel.2017.10.001; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gur-Cohen S, 2019, SCIENCE, V366, P1218, DOI 10.1126/science.aay4509; Haensel D, 2020, CELL REP, V30, P3932, DOI 10.1016/j.celrep.2020.02.091; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Johnson CB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585402; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; KUBLER MD, 1993, J INVEST DERMATOL, V100, P785, DOI 10.1111/1523-1747.ep12476492; Larsen SB, 2021, CELL STEM CELL, V28, P1758, DOI 10.1016/j.stem.2021.07.001; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Niec RE, 2021, CELL, V184, P3361, DOI 10.1016/j.cell.2021.05.036; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Park S, 2017, NAT CELL BIOL, V19, P155, DOI 10.1038/ncb3472; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavan S, 2003, DEV CELL, V5, P415, DOI 10.1016/S1534-5807(03)00261-2; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strudwick XL, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.603508; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Yang H, 2017, CELL, V169, P483, DOI 10.1016/j.cell.2017.03.038; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	11	12	12	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1097	+	eabh2444	10.1126/science.abh2444	http://dx.doi.org/10.1126/science.abh2444			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822296	Green Accepted			2022-12-28	WOS:000725668600040
J	Randolph, HE; Fiege, JK; Thielen, BK; Mickelson, CK; Shiratori, M; Barroso-Batista, J; Langlois, RA; Barreiro, LB				Randolph, Haley E.; Fiege, Jessica K.; Thielen, Beth K.; Mickelson, Clayton K.; Shiratori, Mari; Barroso-Batista, Joao; Langlois, Ryan A.; Barreiro, Luis B.			Genetic ancestry effects on the response to viral infection are pervasive but cell type specific	SCIENCE			English	Article							INFLUENZA-A VIRUS; RNA VIRUSES; GENOME; DETERMINANTS; ADAPTATION; GENERATION; CYTOSCAPE; SYSTEM	Humans differ in their susceptibility to infectious disease, partly owing to variation in the immune response after infection. We used single-cell RNA sequencing to quantify variation in the response to influenza infection in peripheral blood mononuclear cells from European- and African-ancestry males. Genetic ancestry effects are common but highly cell type specific. Higher levels of European ancestry are associated with increased type I interferon pathway activity in early infection, which predicts reduced viral titers at later time points. Substantial population-associated variation is explained by cis-expression quantitative trait loci that are differentiated by genetic ancestry. Furthermore, genetic ancestry-associated genes are enriched among genes correlated with COVID-19 disease severity, suggesting that the early immune response contributes to ancestry-associated differences for multiple viral infection outcomes.	[Randolph, Haley E.; Barreiro, Luis B.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Fiege, Jessica K.; Mickelson, Clayton K.; Langlois, Ryan A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Fiege, Jessica K.; Mickelson, Clayton K.; Langlois, Ryan A.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Thielen, Beth K.] Univ Minnesota, Dept Pediat, Div Pediat Infect Dis & Immunol, Minneapolis, MN USA; [Shiratori, Mari; Barroso-Batista, Joao; Barreiro, Luis B.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Barreiro, Luis B.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; University of Chicago	Barreiro, LB (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.; Barreiro, LB (corresponding author), Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA.; Barreiro, LB (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	lbarreiro@uchicago.edu		Mickelson, Clayton/0000-0002-5418-412X; Langlois, Ryan/0000-0002-0515-571X; Randolph, Haley/0000-0003-2044-1180; Barreiro, Luis/0000-0001-9456-367X; Shiratori, Mari/0000-0001-9641-0343; Thielen, Beth/0000-0001-5922-0241	National Science Foundation Graduate Research Fellowship [DGE-1746045]; Ruth L. Kirschstein National Research Service Award [F31-HL156419];  [R01-GM134376];  [P30-DK042086]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported by grant R01-GM134376 and P30-DK042086 to L.B.B.; H.E.R. was supported by a National Science Foundation Graduate Research Fellowship (DGE-1746045) and a Ruth L. Kirschstein National Research Service Award (F31-HL156419).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; [Anonymous], SCIENCE; Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chandrasekhar R, 2017, INFLUENZA OTHER RESP, V11, P479, DOI 10.1111/irv.12483; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Ciancanelli MJ, 2016, CURR OPIN IMMUNOL, V38, P109, DOI 10.1016/j.coi.2015.12.002; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Enard D, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0575; Enard D, 2018, CELL, V175, P360, DOI 10.1016/j.cell.2018.08.034; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Heaton H, 2020, NAT METHODS, V17, P615, DOI 10.1038/s41592-020-0820-1; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hou WQ, 2012, BLOOD, V119, P3128, DOI 10.1182/blood-2011-09-379479; Huang JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002766; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kenney AD, 2017, ANNU REV GENET, V51, P241, DOI 10.1146/annurev-genet-120116-023425; Ko JY, 2021, CLIN INFECT DIS, V72, pE695, DOI 10.1093/cid/ciaa1419; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JS, 2020, NAT REV IMMUNOL, V20, P585, DOI 10.1038/s41577-020-00429-3; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050508; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu C, 2021, CELL, V184, P1836, DOI 10.1016/j.cell.2021.02.018; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Oliva M, 2020, SCIENCE, V369, P1331, DOI 10.1126/science.aba3066; Pallares LF, 2020, G3-GENES GENOM GENET, V10, P143, DOI 10.1534/g3.119.400821; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prive F, 2018, BIOINFORMATICS, V34, P2781, DOI 10.1093/bioinformatics/bty185; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Randolph H. E., 2021, ZENODO, DOI [10.5281/zenodo.4273999, DOI 10.5281/ZENODO.4273999]; Randolph H. E., 2021, ZENODO, DOI [10.5281/zenodo.4273999, DOI 10.5281/ZENODO.4273999.REFERENCES]; Ren XW, 2021, CELL, V184, P1895, DOI 10.1016/j.cell.2021.01.053; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomsen MM, 2019, EUR J IMMUNOL, V49, P2111, DOI 10.1002/eji.201848083; Urbut SM, 2019, NAT GENET, V51, P187, DOI 10.1038/s41588-018-0268-8; Wei JJ, 2019, MOL IMMUNOL, V113, P38, DOI 10.1016/j.molimm.2017.12.026; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Xia C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01908; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang Q, 2020, HUM GENET, V139, P941, DOI 10.1007/s00439-019-02108-3; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; ZHENG GX, 2017, NATURE, V0008; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhou SR, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01281-1	65	12	12	3	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1127	+		10.1126/science.abg0928	http://dx.doi.org/10.1126/science.abg0928			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822289	Green Accepted			2022-12-28	WOS:000725668600046
J	Li, TQ; Stayrook, SE; Tsutsui, Y; Zhang, JN; Wang, YY; Li, HY; Proffitt, A; Krimmer, SG; Ahmed, M; Belliveau, O; Walker, IX; Mudumbi, KC; Suzuki, Y; Lax, I; Alvarado, D; Lemmon, MA; Schlessinger, J; Klein, DE				Li, Tongqing; Stayrook, Steven E.; Tsutsui, Yuko; Zhang, Jianan; Wang, Yueyue; Li, Hengyi; Proffitt, Andrew; Krimmer, Stefan G.; Ahmed, Mansoor; Belliveau, Olivia; Walker, Ian X.; Mudumbi, Krishna C.; Suzuki, Yoshihisa; Lax, Irit; Alvarado, Diego; Lemmon, Mark A.; Schlessinger, Joseph; Klein, Daryl E.			Structural basis for ligand reception by anaplastic lymphoma kinase	NATURE			English	Article							TYROSINE KINASE; ALK; PROTEIN; ALPHA; MOTIF; CELL	The proto-oncogene ALK encodes anaplastic lymphoma kinase, a receptor tyrosine kinase that is expressed primarily in the developing nervous system. After development, ALK activity is associated with learning and memory(1) and controls energy expenditure, and inhibition of ALK can prevent diet-induced obesity(2). Aberrant ALK signalling causes numerous cancers(3). In particular, full-length ALK is an important driver in paediatric neuroblastoma(4,5), in which it is either mutated(6) or activated by ligand(7). Here we report crystal structures of the extracellular glycine-rich domain (GRD) of ALK, which regulates receptor activity by binding to activating peptides(8,9). Fusing the ALK GRD to its ligand enabled us to capture a dimeric receptor complex that reveals how ALK responds to its regulatory ligands. We show that repetitive glycines in the GRD form rigid helices that separate the major ligand-binding site from a distal polyglycine extension loop (PXL) that mediates ALK dimerization. The PXL of one receptor acts as a sensor for the complex by interacting with a ligand-bound second receptor. ALK activation can be abolished through PXL mutation or with PXL-targeting antibodies. Together, these results explain how ALK uses its atypical architecture for its regulation, and suggest new therapeutic opportunities for ALK-expressing cancers such as paediatric neuroblastoma.	[Li, Tongqing; Stayrook, Steven E.; Tsutsui, Yuko; Zhang, Jianan; Li, Hengyi; Krimmer, Stefan G.; Ahmed, Mansoor; Walker, Ian X.; Mudumbi, Krishna C.; Suzuki, Yoshihisa; Lax, Irit; Lemmon, Mark A.; Schlessinger, Joseph; Klein, Daryl E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Li, Tongqing; Stayrook, Steven E.; Tsutsui, Yuko; Zhang, Jianan; Wang, Yueyue; Li, Hengyi; Belliveau, Olivia; Walker, Ian X.; Mudumbi, Krishna C.; Lax, Irit; Lemmon, Mark A.; Schlessinger, Joseph; Klein, Daryl E.] Yale Univ, Yale Canc Biol Inst, West Haven, CT 06516 USA; [Proffitt, Andrew; Alvarado, Diego] Celldex Therapeut, New Haven, CT USA	Yale University; Yale University	Klein, DE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.; Klein, DE (corresponding author), Yale Univ, Yale Canc Biol Inst, West Haven, CT 06516 USA.	daryl.klein@yale.edu	WANG, YUE/GWQ-9256-2022; Ahmed, Mansoor/K-6748-2019	Belliveau, Olivia/0000-0002-0180-0240; Stayrook, Steven/0000-0002-1677-8293; Li, Tongqing/0000-0002-5272-4380; Lemmon, Mark/0000-0002-3379-5319; Krimmer, Stefan/0000-0002-5669-9071	NIH, NIGMS [R35 GM122485]; NIH, NCI [R01 CA248532]; National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NIH [S10 OD012289]	NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Alarcon, Y. Liu, J. Abraham and their laboratories for valuable discussions, as well as members of the Klein, Lemmon and Schlessinger laboratories; A. Reshetnyak, D. Puleo and J. Mohanty for their contributions. This work was supported by the NIH, NIGMS grant R35 GM122485 (to M.A.L.), and NCI grant R01 CA248532 (to D.E.K.). This work is based in part on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. GM/CA@APS has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The Eiger 16M detector at GM/CA-XSD was funded by NIH grant S10 OD012289.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Borenas M, 2021, EMBO J, V40, DOI 10.15252/embj.2020105784; Carpenter EL, 2012, ONCOGENE, V31, P4859, DOI 10.1038/onc.2011.647; CRICK FHC, 1955, NATURE, V176, P780, DOI 10.1038/176780a0; Dunne M, 2018, STRUCTURE, V26, P1573, DOI 10.1016/j.str.2018.07.017; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Guan JK, 2015, ELIFE, V4, DOI 10.7554/eLife.09811; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Jenni S, 2015, MOL CELL, V60, P941, DOI 10.1016/j.molcel.2015.10.026; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Murray PB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005916; Orthofer M, 2020, CELL, V181, P1246, DOI 10.1016/j.cell.2020.04.034; Patil, P NATL ACAD SCI US; Qin LY, 2017, BIOORG MED CHEM LETT, V27, P855, DOI 10.1016/j.bmcl.2017.01.016; Reshetnyak AV, 2021, NATURE, V600, P153, DOI 10.1038/s41586-021-04140-8; Reshetnyak AV, 2018, P NATL ACAD SCI USA, V115, P8340, DOI 10.1073/pnas.1807881115; Reshetnyak AV, 2015, P NATL ACAD SCI USA, V112, P15862, DOI 10.1073/pnas.1520099112; Sano R, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9732; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Trigg RM, 2018, CANCERS, V10, DOI 10.3390/cancers10040113; Vadas O, 2017, METHOD ENZYMOL, V583, P143, DOI 10.1016/bs.mie.2016.09.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Warkentin E, 2017, PROTEINS, V85, P2017, DOI 10.1002/prot.25355; Weiss JB, 2012, PHARMACOL BIOCHEM BE, V100, P566, DOI 10.1016/j.pbb.2011.10.024; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Youn SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02803-z; Zhang HB, 2014, P NATL ACAD SCI USA, V111, P15741, DOI 10.1073/pnas.1412009111	41	5	5	7	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					148	+		10.1038/s41586-021-04141-7	http://dx.doi.org/10.1038/s41586-021-04141-7		NOV 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34819665	Green Accepted			2022-12-28	WOS:000722150800005
J	Limb, M				Limb, Matthew			Workforce: health leaders lament lost chance to secure safe staffing in Health and Care Bill	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2876	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2900	10.1136/bmj.n2900	http://dx.doi.org/10.1136/bmj.n2900			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819314				2022-12-28	WOS:000740893700011
J	Nabel, KG; Clark, SA; Shankar, S; Pan, JH; Clark, LE; Yang, P; Coscia, A; McKay, LGA; Varnum, HH; Brusic, V; Tolan, NV; Zhou, GH; Desjardins, M; Turbett, SE; Kanjilal, S; Sherman, AC; Dighe, A; LaRocque, RC; Ryan, ET; Tylek, C; Cohen-Solal, JF; Darcy, AT; Tavella, D; Clabbers, A; Fan, Y; Griffiths, A; Correia, IR; Seagal, J; Baden, LR; Charles, RC; Abraham, J				Nabel, Katherine G.; Clark, Sarah A.; Shankar, Sundaresh; Pan, Junhua; Clark, Lars E.; Yang, Pan; Coscia, Adrian; McKay, Lindsay G. A.; Varnum, Haley H.; Brusic, Vesna; Tolan, Nicole, V; Zhou, Guohai; Desjardins, Michael; Turbett, Sarah E.; Kanjilal, Sanjat; Sherman, Amy C.; Dighe, Anand; LaRocque, Regina C.; Ryan, Edward T.; Tylek, Casey; Cohen-Solal, Joel F.; Darcy, Anhdao T.; Tavella, Davide; Clabbers, Anca; Fan, Yao; Griffiths, Anthony; Correia, Ivan R.; Seagal, Jane; Baden, Lindsey R.; Charles, Richelle C.; Abraham, Jonathan			Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain	SCIENCE			English	Article							SPIKE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; MUTATIONS; EVOLUTION; VIRUS; BAT; P.1	Many studies have examined the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants on neutralizing antibody activity after they have become dominant strains. Here, we evaluate the consequences of further viral evolution. We demonstrate mechanisms through which the SARS-CoV-2 receptor binding domain (RBD) can tolerate large numbers of simultaneous antibody escape mutations and show that pseudotypes containing up to seven mutations, as opposed to the one to three found in previously studied variants of concern, are more resistant to neutralization by therapeutic antibodies and serum from vaccine recipients. We identify an antibody that binds the RBD core to neutralize pseudotypes for all tested variants but show that the RBD can acquire an N-linked glycan to escape neutralization. Our findings portend continued emergence of escape variants as SARS-CoV-2 adapts to humans.	[Nabel, Katherine G.; Clark, Sarah A.; Shankar, Sundaresh; Pan, Junhua; Clark, Lars E.; Yang, Pan; Coscia, Adrian; Varnum, Haley H.; Brusic, Vesna; Abraham, Jonathan] Harvard Med Sch, Blavatnik Inst, Dept Microbiol, Boston, MA 02115 USA; [McKay, Lindsay G. A.; Griffiths, Anthony] Boston Univ, Dept Microbiol, Sch Med, Boston, MA 02118 USA; [McKay, Lindsay G. A.; Griffiths, Anthony] Boston Univ, Natl Emerging Infect Dis Labs, Sch Med, Boston, MA 02118 USA; [Tolan, Nicole, V] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhou, Guohai; Baden, Lindsey R.] Brigham & Womens Hosp, Ctr Clin Invest, Boston, MA 02115 USA; [Desjardins, Michael; Kanjilal, Sanjat; Sherman, Amy C.; Baden, Lindsey R.; Abraham, Jonathan] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Desjardins, Michael] Ctr Hosp Univ Montreal, Dept Med, Div Infect Dis, Montreal, PQ H2X 0C1, Canada; [Turbett, Sarah E.; LaRocque, Regina C.; Ryan, Edward T.; Charles, Richelle C.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Turbett, Sarah E.; Dighe, Anand] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kanjilal, Sanjat] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02215 USA; [Kanjilal, Sanjat] Harvard Med Sch, Boston, MA 02215 USA; [Ryan, Edward T.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02215 USA; [Tylek, Casey; Cohen-Solal, Joel F.; Darcy, Anhdao T.; Tavella, Davide; Clabbers, Anca; Fan, Yao; Correia, Ivan R.; Seagal, Jane] AbbVie Biores Ctr, Worcester, MA 01605 USA; [Baden, Lindsey R.; Abraham, Jonathan] Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA; [Abraham, Jonathan] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Universite de Montreal; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; AbbVie; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Abraham, J (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Microbiol, Boston, MA 02115 USA.; Abraham, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA.; Abraham, J (corresponding author), Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA.; Abraham, J (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	jonathan_abraham@hms.harvard.edu	COHEN-SOLAL, Joel/AGI-0161-2022; Dighe, Anand/AAP-9640-2020	COHEN-SOLAL, Joel/0000-0002-1385-2566; Nabel Smith, Katherine/0000-0002-4429-7075; Clark, Lars/0000-0002-6093-7597; McKay, Lindsay/0000-0003-0369-9067; Shankar, Sundaresh/0000-0001-9340-9945; Clark, Sarah/0000-0001-9944-0919; Coscia, Adrian/0000-0002-6836-9993; Pan, Junhua/0000-0002-0070-955X; Tolan, Nicole/0000-0002-7239-1843; Kanjilal, Sanjat/0000-0002-1221-5725	Massachusetts Consortium on Pathogen Readiness (MassCPR); Star-Friedman Award Challenge for Promising Scientific Research; Harvard Clinical and Translational Science Center; National Center for Advancing Translational Science [1UL1TR002541-01]; Chleck Family Foundation; Centers for Disease Control and Prevention [U01CK000490]; National Institute of General Medical Sciences [T32GM007753]	Massachusetts Consortium on Pathogen Readiness (MassCPR); Star-Friedman Award Challenge for Promising Scientific Research; Harvard Clinical and Translational Science Center; National Center for Advancing Translational Science; Chleck Family Foundation; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the Massachusetts Consortium on Pathogen Readiness (MassCPR) (J.A.). J.A. was also supported by the Star-Friedman Award Challenge for Promising Scientific Research. L.R.B. is supported by the Harvard Clinical and Translational Science Center, from the National Center for Advancing Translational Science (1UL1TR002541-01); by Barbara and Amos Hostetter; and by the Chleck Family Foundation. S.E.T., R.C.L., E.T.R., and R.C.C. receive grant support from the Centers for Disease Control and Prevention (U01CK000490). K.G.N., A.C., and H.H.V. are supported by award T32GM007753 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aho K, 2015, METHODS ECOL EVOL, V6, P121, DOI 10.1111/2041-210X.12304; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Bricogne G., 2017, BUSTER VERSION 2103; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Clark SA, 2021, CELL, V184, P2605, DOI 10.1016/j.cell.2021.03.027; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Du S, 2020, CELL, V183, P1013, DOI 10.1016/j.cell.2020.09.035; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Grant OC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71748-7; Greaney AJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi9915; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Harbison AM, 2022, CHEM SCI, V13, P386, DOI 10.1039/d1sc04832e; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hurlburt Nicholas K, 2020, bioRxiv, DOI [10.1038/s41467-020-19231-9, 10.1101/2020.06.12.148692]; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang L, 2021, CELL, V184, P4392, DOI 10.1016/j.cell.2021.07.007; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Liu Hejun, 2020, bioRxiv, DOI [10.1016/j.immuni.2020.10.023, 10.1101/2020.08.02.233536]; Liu KF, 2021, CELL, V184, P3438, DOI 10.1016/j.cell.2021.05.031; Lv Huibin, 2020, bioRxiv, DOI 10.1101/2020.03.15.993097; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; Mehdipour AR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100425118; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Starr Tyler N, 2021, Cell Rep Med, V2, P100255, DOI [10.1101/2021.02.17.431683, 10.1016/j.xcrm.2021.100255]; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Suryamohan K, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02030-3; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Wang Pengfei, 2021, bioRxiv, DOI [10.1016/j.chom.2021.04.007, 10.1101/2021.03.01.433466]; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Watanabe Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16567-0; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yuan Meng, 2021, Science, V373, P818, DOI [10.1101/2021.02.16.430500, 10.1126/science.abh1139]; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhang SY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21767-3; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu X, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001237; Zhu YM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc9999	79	26	26	7	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					282	+	eabl6251	10.1126/science.abl6251	http://dx.doi.org/10.1126/science.abl6251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5IG	34855508	Green Published			2022-12-28	WOS:000784254700001
J	Sourimant, J; Lieber, CM; Aggarwal, M; Cox, RM; Wolf, JD; Yoon, JJ; Toots, M; Ye, C; Sticher, Z; Kolykhalov, AA; Martinez-Sobrido, L; Bluemling, GR; Natchus, MG; Painter, GR; Plemper, RK				Sourimant, Julien; Lieber, Carolin M.; Aggarwal, Megha; Cox, Robert M.; Wolf, Josef D.; Yoon, Jeong-Joong; Toots, Mart; Ye, Chengin; Sticher, Zachary; Kolykhalov, Alexander A.; Martinez-Sobrido, Luis; Bluemling, Gregory R.; Natchus, Michael G.; Painter, George R.; Plemper, Richard K.			4 '-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication	SCIENCE			English	Review							MECHANISM; LOAD	The COVID-19 pandemic has underscored the critical need for broad-spectrum therapeutics against respiratory viruses. Respiratory syncytial virus (RSV) is a major threat to pediatric patients and older adults. We describe 4'-fluorouridine (4'-FlU, EIDD-2749), a ribonucleoside analog that inhibits RSV, related RNA viruses, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with high selectivity index in cells and human airway epithelia organoids. Polymerase inhibition within in vitro RNA-dependent RNA polymerase assays established for RSV and SARS-CoV-2 revealed transcriptional stalling after incorporation. Once-daily oral treatment was highly efficacious at 5 milligrams per kilogram (mg/kg) in RSV-infected mice or 20 mg/kg in ferrets infected with different SARS-CoV-2 variants of concern, initiated 24 or 12 hours after infection, respectively. These properties define 4'-FlU as a broad-spectrum candidate for the treatment of RSV, SARS-CoV-2, and related RNA virus infections.	[Sourimant, Julien; Lieber, Carolin M.; Aggarwal, Megha; Cox, Robert M.; Wolf, Josef D.; Yoon, Jeong-Joong; Toots, Mart; Plemper, Richard K.] Georgia State Univ, Ctr Translat Antiviral Res, Atlanta, GA 30303 USA; [Ye, Chengin; Martinez-Sobrido, Luis] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Sticher, Zachary; Kolykhalov, Alexander A.; Bluemling, Gregory R.; Natchus, Michael G.; Painter, George R.] Emory Univ, Emory Inst Drug Dev, Atlanta, GA 30322 USA; [Kolykhalov, Alexander A.; Bluemling, Gregory R.; Painter, George R.] Drug Innovat Ventures & Emory Dr, Atlanta, GA 30322 USA; [Painter, George R.] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA; [Plemper, Richard K.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Texas Biomedical Research Institute; Emory University; Emory University; Emory University	Plemper, RK (corresponding author), Georgia State Univ, Ctr Translat Antiviral Res, Atlanta, GA 30303 USA.; Plemper, RK (corresponding author), Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA.	rplemper@gsu.edu	Martinez-Sobrido, Luis/ACJ-7853-2022	Martinez-Sobrido, Luis/0000-0001-7084-0804; Ye, Chengjin/0000-0002-1934-9494; Sourimant, Julien/0000-0002-1660-1666; Sticher, Zachary/0000-0002-7022-1410; Wolf, Josef/0000-0003-2507-6944; Yoon, JeongJoong/0000-0001-9379-0416	Public Health Service grants from the NIH/NIAID [AI153400, AI071002, AI141222]	Public Health Service grants from the NIH/NIAID	This work was supported in part by Public Health Service grants AI153400, AI071002, and AI141222 (to R.K.P.) from the NIH/NIAID. The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cockerill GS, 2019, J MED CHEM, V62, P3206, DOI 10.1021/acs.jmedchem.8b01361; Coleman SM, 2015, FUTURE VIROL, V10, P169, DOI 10.2217/FVL.14.96; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Cox RM, 2018, J BIOL CHEM, V293, P16761, DOI 10.1074/jbc.RA118.004862; Dangerfield T. L., 2021, STAR PROTOC, V2, P100357, DOI DOI 10.1016/XPR0.2021.100357MEDLINE; DeVincenzo J, 2022, J INFECT DIS, V225, P2087, DOI 10.1093/infdis/jiaa716; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fearns R, 2017, VIRUS RES, V234, P87, DOI 10.1016/j.virusres.2017.01.008; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Kokic G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20542-0; Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011; Ludeke B, 2020, VIROLOGY, V540, P66, DOI 10.1016/j.virol.2019.11.002; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Oberfeld B, 2020, CELL, V181, P954, DOI 10.1016/j.cell.2020.04.013; Painter GR, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104597; Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104; Rha B, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-3611; Richardson P, 2021, EXPERT OPIN DRUG DIS, V16, P1261, DOI 10.1080/17460441.2021.1933427; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Shi T, 2020, J INFECT DIS, V222, pS577, DOI 10.1093/infdis/jiz059; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Tchesnokov EP, 2020, J BIOL CHEM, V295, P16156, DOI 10.1074/jbc.AC120.015720; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Toots M, 2020, TRANSL RES, V218, P16, DOI 10.1016/j.trsl.2019.12.002; Toots M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax5866; Ye CJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2111593118; Yoon Jeong-Joong, 2018, Antimicrob Agents Chemother, V62, DOI [10.1128/aac.00766-18, 10.1128/AAC.00766-18]	33	12	12	18	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					161	+		10.1126/science.abj5508	http://dx.doi.org/10.1126/science.abj5508			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	34855509				2022-12-28	WOS:000742401600027
J	Wang, YH; Eddison, M; Fleishman, G; Weigert, M; Xu, SJ; Wang, T; Rokicki, K; Goina, C; Henry, FE; Lemire, AL; Schmidt, U; Yang, H; Svoboda, K; Myers, EW; Saalfeld, S; Korff, W; Sternson, SM; Tillberg, PW				Wang, Yuhan; Eddison, Mark; Fleishman, Greg; Weigert, Martin; Xu, Shengjin; Wang, Tim; Rokicki, Konrad; Goina, Cristian; Henry, Fredrick E.; Lemire, Andrew L.; Schmidt, Uwe; Yang, Hui; Svoboda, Karel; Myers, Eugene W.; Saalfeld, Stephan; Korff, Wyatt; Sternson, Scott M.; Tillberg, Paul W.			EASI-FISH for thick tissue defines lateral hypothalamus spatio-molecular organization	CELL			English	Article							SINGLE CELLS; MOUSE; NEURONS; AREA; RNA; EXPRESSION; PARALLEL; RAT; POPULATIONS; PROJECTIONS	Determining the spatial organization and morphological characteristics of molecularly defined cell types is a major bottleneck for characterizing the architecture underpinning brain function. We developed Expansion Assisted Iterative Fluorescence In Situ Hybridization (EASI-FISH) to survey gene expression in brain tissue, as well as a turnkey computational pipeline to rapidly process large EASI-FISH image datasets. EASI-FISH was optimized for thick brain sections (300 mm) to facilitate reconstruction of spatio-molecular domains that generalize across brains. Using the EASI-FISH pipeline, we investigated the spatial distribution of dozens of molecularly defined cell types in the lateral hypothalamic area (LHA), a brain region with poorly defined anatomical organization. Mapping cell types in the LHA revealed nine spatially and molecularly defined subregions. EASI-FISH also facilitates iterative reanalysis of scRNA-seq datasets to determine marker-genes that further dissociated spatial and morphological heterogeneity. The EASI-FISH pipeline democratizes mapping molecularly defined cell types, enabling discoveries about brain organization.	[Wang, Yuhan; Eddison, Mark; Fleishman, Greg; Xu, Shengjin; Wang, Tim; Rokicki, Konrad; Goina, Cristian; Henry, Fredrick E.; Lemire, Andrew L.; Yang, Hui; Svoboda, Karel; Saalfeld, Stephan; Korff, Wyatt; Sternson, Scott M.; Tillberg, Paul W.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Weigert, Martin; Schmidt, Uwe; Myers, Eugene W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Weigert, Martin] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Yang, Hui] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Sternson, Scott M.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Xu, Shengjin] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China; [Henry, Fredrick E.] Adapt Biotechnol, 1551 Eastlake Ave E,Ste 200, Seattle, WA 98102 USA	Howard Hughes Medical Institute; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Diego; Chinese Academy of Sciences	Sternson, SM; Tillberg, PW (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.; Sternson, SM (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA.	ssternson@health.ucsd.edu; tillbergp@janelia.hhmi.org		Rokicki, Konrad/0000-0002-2799-9833; Korff, Wyatt/0000-0001-8396-1533; Lemire, Andrew/0000-0002-0624-3789; Eddison, Mark/0000-0003-0280-8137; Wang, Yuhan/0000-0003-4447-5043	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was conducted by the multiFISH Project Team at Janelia Research Campus and funded by the Howard Hughes Medical Institute. D. Alcor and M. DeSantis: microscopy support; A. Hu, M. Copeland, S.C. Michael, K.M. McGowan: histology support; Vivarium and C. Magnus: animal support; L. Wang: cell sorting; S. Preibisch, H. Otsuna, D. Ackerman: software support; T. Lionnet (NYU School of Medicine): Airlocalize software; P. Hanslovsky, I. Pisarev, J. Bogovic: imaging software; L. Lavis, S. Banala: fluorescent dyes; S. Long: smFISH methods; J. Hahn at USC: LHA anatomy; A. Osowski, M. Jefferies, G. Ihrke: administrative and staff support; BioRender: schematics.	Alon S, 2021, SCIENCE, V371, P481, DOI 10.1126/science.aax2656; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Brown JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38143-9; Brown JA, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00009; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cembrowski MS, 2018, CELL, V173, P1280, DOI 10.1016/j.cell.2018.03.031; Chen F, 2016, NAT METHODS, V13, P679, DOI 10.1038/nmeth.3899; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Choi HMT, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165753; Codeluppi S, 2018, NAT METHODS, V15, P932, DOI 10.1038/s41592-018-0175-z; Cressie N., 2011, STAT SPATIO TEMPORAL; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUBE D, 1979, J HISTOCHEM CYTOCHEM, V27, P1577, DOI 10.1177/27.12.391994; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gao RX, 2019, SCIENCE, V363, P245, DOI 10.1126/science.aau8302; GEERAEDTS LMG, 1990, J COMP NEUROL, V294, P537, DOI 10.1002/cne.902940404; Grimm JB, 2017, ACS CENTRAL SCI, V3, P975, DOI 10.1021/acscentsci.7b00247; Gur D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20088-1; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hahn JD, 2019, P NATL ACAD SCI USA, V116, P8018, DOI 10.1073/pnas.1819448116; Hahn JD, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00066; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Horjales-Araujo E, 2014, NEUROSCIENCE, V277, P87, DOI 10.1016/j.neuroscience.2014.06.043; KAHN D, 1980, ENDOCRINOLOGY, V107, P47, DOI 10.1210/endo-107-1-47; KAWANA E, 1981, J HIRNFORSCH, V22, P535; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Kolmac C, 1999, ANAT EMBRYOL, V199, P265, DOI 10.1007/s004290050227; Kurt G, 2019, NEUROPHARMACOLOGY, V154, P13, DOI 10.1016/j.neuropharm.2018.09.038; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Luo LQ, 2018, NEURON, V98, P256, DOI 10.1016/j.neuron.2018.03.040; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mickelsen LE, 2019, NAT NEUROSCI, V22, P642, DOI 10.1038/s41593-019-0349-8; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; Napari contributors, 2019, Napari: A Multi-Dimensional Image Viewer for Python, DOI [10.5281/zenodo.3555620, DOI 10.5281/ZENODO.3555620]; Nicovich P. R., 2019, MULTIMODAL CELL TYPE, DOI [10.1101/525451, DOI 10.1101/525451]; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Patterson CM, 2015, ENDOCRINOLOGY, V156, P1692, DOI 10.1210/en.2014-1986; Petrovich GD, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00014; Pietzsch T, 2015, NAT METHODS, V12, P481, DOI 10.1038/nmeth.3392; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Qian XY, 2020, NAT METHODS, V17, P101, DOI 10.1038/s41592-019-0631-4; Romanov RA, 2020, NATURE, V582, P246, DOI 10.1038/s41586-020-2266-0; Rossi MA, 2021, NEURON, V109, P3823, DOI 10.1016/j.neuron.2021.09.020; Rossi MA, 2019, SCIENCE, V364, P1271, DOI 10.1126/science.aax1184; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schmidt U, 2018, LECT NOTES COMPUT SC, V11071, P265, DOI 10.1007/978-3-030-00934-2_30; Shah S, 2017, NEURON, V94, P752, DOI 10.1016/j.neuron.2017.05.008; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Smith K, 2015, NAT METHODS, V12, P404, DOI [10.1038/nmeth.3323, 10.1038/NMETH.3323]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stuber GD, 2016, NAT NEUROSCI, V19, P198, DOI 10.1038/nn.4220; Tang M, 2021, BIOINFORMATICS, V37, P2212, DOI 10.1093/bioinformatics/btaa956; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tillberg PW, 2016, NAT BIOTECHNOL, V34, P987, DOI 10.1038/nbt.3625; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; VEENING JG, 1987, NEUROSCIENCE, V22, P537, DOI 10.1016/0306-4522(87)90351-4; Vizgen, 2021, VIZG DAT REL V1 0; Wallace ML, 2017, NEURON, V94, P138, DOI 10.1016/j.neuron.2017.03.017; Waller L.A., 2004, APPL SPATIAL STAT PU; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Weigert M, 2020, IEEE WINT CONF APPL, P3655, DOI 10.1109/WACV45572.2020.9093435; Xu SJ, 2020, SCIENCE, V370, P313, DOI 10.1126/science.abb2494; Yushkevich P.A., 2016, ALZHEIMERS DEMENT, V12; Zappia L, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy083; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85	80	14	14	13	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2021	184	26					6361	+		10.1016/j.cell.2021.11.024	http://dx.doi.org/10.1016/j.cell.2021.11.024		DEC 2021	42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XW1JX	34875226	hybrid, Green Published			2022-12-28	WOS:000735385600003
J	Callaway, E; Ledford, H				Callaway, Ewen; Ledford, Heidi			HOW BAD IS OMICRON? WHAT SCIENTISTS KNOW SO FAR	NATURE			English	News Item																		Pulliam J. R. C, PREPRINT MEDRXIV, DOI [10.1101/2021.11.11.21266068(2021), DOI 10.1101/2021.11.11.21266068(2021)]; Schmidt F, 2021, NATURE, V600, P512, DOI 10.1038/s41586-021-04005-0	2	106	111	9	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					197	199		10.1038/d41586-021-03614-z	http://dx.doi.org/10.1038/d41586-021-03614-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL0PT	34857948	Bronze			2022-12-28	WOS:000727856300008
J	Donato, AA				Donato, Anthony A.			In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Donato, Anthony A.] Tower Hlth Reading Hosp, Reading, PA 19611 USA		Donato, AA (corresponding author), Tower Hlth Reading Hosp, Reading, PA 19611 USA.								0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC135	JC135		10.7326/ACPJ202112210-135	http://dx.doi.org/10.7326/ACPJ202112210-135		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871054				2022-12-28	WOS:000729197500002
J	Murray, H; Petrie, C				Murray, Heather; Petrie, Casey			In suspected ACS, an unmasked 0/1-h vs. masked 0/3-h hs-cTnT protocol did not differ for death or MI at 1 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Murray, Heather; Petrie, Casey] Queens Univ, Kingston, ON, Canada	Queens University - Canada	Murray, H (corresponding author), Queens Univ, Kingston, ON, Canada.		Murray, Heather/GQY-8016-2022					Carlton EW, 2020, HEART, V106, P1586, DOI 10.1136/heartjnl-2020-316692; Roos A, 2017, J AM COLL CARDIOL, V70, P2226, DOI 10.1016/j.jacc.2017.08.064; Shah ASV, 2018, LANCET, V392, P919, DOI 10.1016/S0140-6736(18)31923-8	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC139	JC139		10.7326/ACPJ202112210-139	http://dx.doi.org/10.7326/ACPJ202112210-139		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871061				2022-12-28	WOS:000729197200001
J	Voute, C; Guevara, M; Schwerdtle, PN				Voute, Caroline; Guevara, Maria; Schwerdtle, Patricia Nayna			A failure of ambition on climate action will amplify humanitarian needs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Voute, Caroline; Guevara, Maria; Schwerdtle, Patricia Nayna] Med Sans Frontieres, Toronto, ON, Canada; [Schwerdtle, Patricia Nayna] Heidelberg Univ, Fac Med, Heidelberg Inst Global Hlth HIGH, Heidelberg, Germany; [Schwerdtle, Patricia Nayna] Heidelberg Univ, Univ Hosp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Voute, C (corresponding author), Med Sans Frontieres, Toronto, ON, Canada.							[Anonymous], 2004, PRECAUTIONARY PRINCI; [Anonymous], 2021, EV DOLL PLEDG TACKL; [Anonymous], 2021, STAT CLIM 2020 TIES; [Anonymous], 2021, GLOBAL REPORT INTERN; Hackett F., 2021, LANCET COUNTDOWN HLT; Lawrence J, 2020, CLIM RISK MANAG, V29, DOI 10.1016/j.crm.2020.100234; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Xu YY, 2017, P NATL ACAD SCI USA, V114, P10315, DOI 10.1073/pnas.1618481114	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3008	10.1136/bmj.n3008	http://dx.doi.org/10.1136/bmj.n3008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862159	Bronze			2022-12-28	WOS:000729712200024
J	Xomalis, A; Zheng, XZ; Chikkaraddy, R; Koczor-Benda, Z; Miele, E; Rosta, E; Vandenbosch, GAE; Martinez, A; Baumberg, JJ				Xomalis, Angelos; Zheng, Xuezhi; Chikkaraddy, Rohit; Koczor-Benda, Zsuzsanna; Miele, Ermanno; Rosta, Edina; Vandenbosch, Guy A. E.; Martinez, Alejandro; Baumberg, Jeremy J.			Detecting mid-infrared light by molecular frequency upconversion in dual-wavelength nanoantennas	SCIENCE			English	Article							INFRARED-SPECTROSCOPY; ROOM-TEMPERATURE; MICROWAVE; PLASMONS	Coherent interconversion of signals between optical and mechanical domains is enabled by optomechanical interactions. Extreme light-matter coupling produced by confining light to nanoscale mode volumes can then access single mid-infrared (MIR) photon sensitivity. Here, we used the infrared absorption and Raman activity of molecular vibrations in plasmonic nanocavities to demonstrate frequency upconversion. We converted approximately 10-micrometer-wavelength incoming light to visible light by surface-enhanced Raman scattering (SERS) in doubly resonant antennas that enhanced upconversion by more than 10(10). We showed 140% amplification of the SERS anti-Stokes emission when an MIR pump was tuned to a molecular vibrational frequency, obtaining lowest detectable powers of 1 to 10 microwatts per square micrometer at room temperature. These results have potential for low-cost and large-scale infrared detectors and spectroscopic techniques.	[Xomalis, Angelos; Zheng, Xuezhi; Chikkaraddy, Rohit; Miele, Ermanno; Baumberg, Jeremy J.] Univ Cambridge, NanoPhoton Ctr, Dept Phys, Cavendish Lab, Cambridge, England; [Zheng, Xuezhi; Vandenbosch, Guy A. E.] Katholieke Univ Leuven, Dept Elect Engn ESAT TELEMIC, Leuven, Belgium; [Koczor-Benda, Zsuzsanna; Rosta, Edina] UCL, Dept Phys & Astron, London, England; [Miele, Ermanno] Univ Cambridge, Dept Chem, Cambridge, England; [Miele, Ermanno] Faraday Inst, Harwell Sci & Innovat Campus, Oxford, England; [Martinez, Alejandro] Univ Politecn Valencia, Nanophoton Technol Ctr, Valencia, Spain	University of Cambridge; KU Leuven; University of London; University College London; University of Cambridge; Universitat Politecnica de Valencia	Baumberg, JJ (corresponding author), Univ Cambridge, NanoPhoton Ctr, Dept Phys, Cavendish Lab, Cambridge, England.	jjb12@cam.ac.uk	Chikkaraddy, Rohit/P-7111-2016; Martínez, Alejandro/D-8616-2014; XOMALIS, ANGELOS/AAD-4880-2022; Baumberg, Jeremy/C-1409-2009	Chikkaraddy, Rohit/0000-0002-3840-4188; Martínez, Alejandro/0000-0001-5448-0140; XOMALIS, ANGELOS/0000-0001-8406-9571; Rosta, Edina/0000-0002-9823-4766; Koczor-Benda, Zsuzsanna/0000-0002-6714-0337; Baumberg, Jeremy/0000-0002-9606-9488	European Union [829067, 861950, 883703]; Engineering and Physical Sciences Research Council (EPSRC) (Cambridge NanoDTC grants) [EP/L015978/1, EP/L027151/1, EP/S022953/1, EP/P029426/1, EP/R020965/1]; KU Leuven Internal Funds [C14/19/083, IDN/20/014, KA/20/019]; FWO [G090017N]; Trinity College, University of Cambridge; EPSRC [EP/L027151/1, EP/R013012/1, EP/P020194/1]; ERC [757850 BioNet]	European Union(European Commission); Engineering and Physical Sciences Research Council (EPSRC) (Cambridge NanoDTC grants)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); KU Leuven Internal Funds; FWO(FWO); Trinity College, University of Cambridge(University of Cambridge); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC(European Research Council (ERC)European Commission)	This work was supported by the European Union's Horizon 2020 Research and Innovation Program under grant agreements 829067 (THOR), 861950 (POSEIDON), and 883703 (PICOFORCE) and by the Engineering and Physical Sciences Research Council (EPSRC) (Cambridge NanoDTC grants EP/L015978/1, EP/L027151/1, EP/S022953/1, EP/P029426/1, and EP/R020965/1). X.Z. acknowledges support from KU Leuven Internal Funds C14/19/083, IDN/20/014, KA/20/019, and FWO G090017N. R.C. acknowledges support from Trinity College, University of Cambridge. Z.K.B. and E.R. acknowledge funding from the EPSRC (EP/R013012/1, EP/L027151/1) and ERC project 757850 BioNet. We are grateful to the UK Materials and Molecular Modelling Hub, which is partially funded by EPSRC (EP/P020194/1), for computational resources.	Allison RS, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081310; Azzam W, 2003, LANGMUIR, V19, P8262, DOI 10.1021/la030165w; BANDEEN WR, 1961, J GEOPHYS RES, V66, P3169, DOI 10.1029/JZ066i010p03169; Barreda AI, 2021, PHOTONICS RES, V9, P2398, DOI 10.1364/PRJ.433761; Baumberg JJ, 2019, NAT MATER, V18, P668, DOI 10.1038/s41563-019-0290-y; Benz F, 2016, SCIENCE, V354, P726, DOI 10.1126/science.aah5243; Benz F, 2016, J PHYS CHEM LETT, V7, P2264, DOI 10.1021/acs.jpclett.6b00986; Benz F, 2015, NANO LETT, V15, P669, DOI 10.1021/nl5041786; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Chikkaraddy R., 2021, ARXIV210810171PHYSIC; Chikkaraddy R, 2016, NATURE, V535, P127, DOI 10.1038/nature17974; Coppens ZJ, 2013, NANO LETT, V13, P1023, DOI 10.1021/nl304208s; Crampton KT, 2016, J PHYS CHEM C, V120, P20943, DOI 10.1021/acs.jpcc.6b02760; Dam JS, 2012, NAT PHOTONICS, V6, P788, DOI [10.1038/NPHOTON.2012.231, 10.1038/nphoton.2012.231]; Elrod MJ, 1999, J CHEM EDUC, V76, P1702, DOI 10.1021/ed076p1702; Forsch M, 2020, NAT PHYS, V16, P69, DOI 10.1038/s41567-019-0673-7; HANEL RA, 1972, J GEOPHYS RES, V77, P2629, DOI 10.1029/JC077i015p02629; Jiang WT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14863-3; Junaid S, 2019, OPTICA, V6, P702, DOI 10.1364/OPTICA.6.000702; Kleemann ME, 2017, ACS NANO, V11, P850, DOI 10.1021/acsnano.6b07350; Koczor-Benda Z., PHYS REV X; Koczor-Benda Z, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.041035; Kuze A, 2009, APPL OPTICS, V48, P6716, DOI 10.1364/AO.48.006716; Kviatkovsky I, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd0264; Lombardi A, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011016; Losada J, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2019.2896200; Miller OD, 2016, OPT EXPRESS, V24, P3329, DOI 10.1364/OE.24.003329; Roelli P, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.031057; Rogalski A, 2002, INFRARED PHYS TECHN, V43, P187, DOI 10.1016/S1350-4495(02)00140-8; SCHAUBERT DH, 1984, IEEE T ANTENN PROPAG, V32, P77, DOI 10.1109/TAP.1984.1143193; Schwarz B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5085; Shao LB, 2019, OPTICA, V6, P1498, DOI 10.1364/OPTICA.6.001498; Tittl A, 2018, SCIENCE, V360, P1105, DOI 10.1126/science.aas9768; Valev VK, 2013, OPT LETT, V38, P2256, DOI 10.1364/OL.38.002256; Wu T, 2021, ACS PHOTONICS, V8, P1522, DOI 10.1021/acsphotonics.1c00336; Wu T, 2021, ACS PHOTONICS, V8, P307, DOI 10.1021/acsphotonics.0c01569; Xomalis A., 2021, DETECTING MIDINFRARE, DOI [10.17863/CAM.77640, DOI 10.17863/CAM.77640]; Xomalis A, 2021, SCIENCE, V374, P1268, DOI 10.1126/science.abk2593; Xomalis A, 2021, NANO LETT, V21, P2512, DOI 10.1021/acs.nanolett.0c04987; Xomalis A, 2020, ACS NANO, V14, P10562, DOI 10.1021/acsnano.0c04600; Yampolsky S, 2014, NAT PHOTONICS, V8, P650, DOI [10.1038/nphoton.2014.143, 10.1038/NPHOTON.2014.143]; Yesilkoy F, 2019, NAT PHOTONICS, V13, P390, DOI 10.1038/s41566-019-0394-6; Zheng X, 2012, IEEE PHOTONICS J, V4, P267, DOI 10.1109/JPHOT.2012.2185222; Zheng XZ, 2019, ADV THEOR SIMUL, V2, DOI 10.1002/adts.201900087	44	22	21	50	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1268	+		10.1126/science.abk2593	http://dx.doi.org/10.1126/science.abk2593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855505	Green Submitted, Green Published			2022-12-28	WOS:000728578700060
J	Dyer, O				Dyer, Owen			Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Farley J., 2021, FDA ANT DRUGS ADV CO; FDA, 2021, FDA BRIEF DOC ANT DR; FDA, 2021, BRIEF DOC ANT DRUGS; FDA, 2021, ANTIMICROBIAL DRUGS; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2713; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2697; Merck, 2021, PFIZ PROV US GOV 10; Regeneron, 2021, REG EV REGEN COV NEX	8	14	14	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2984	10.1136/bmj.n2984	http://dx.doi.org/10.1136/bmj.n2984			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857644	Bronze			2022-12-28	WOS:000732779300011
J	Rutter, H; Parker, S; Stahl-Timmins, W; Noakes, C; Smyth, A; Macbeth, R; Fitzgerald, S; Freeman, ALJ				Rutter, Harry; Parker, Simon; Stahl-Timmins, Will; Noakes, Catherine; Smyth, Alexandra; Macbeth, Ron; Fitzgerald, Shaun; Freeman, Alexandra L. J.			Visualising SARS-CoV-2 transmission routes and mitigations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNICATION; UNCERTAINTY; BENEFITS; FORMATS; HARMS; GRADE; FACTS; RISK		[Rutter, Harry] Univ Bath, Bath, Avon, England; [Parker, Simon] Def Sci & Technol Lab, Salisbury, Wilts, England; [Stahl-Timmins, Will] BMJ, London, England; [Noakes, Catherine] Univ Leeds, Sch Civil Engn, Leeds, W Yorkshire, England; [Smyth, Alexandra] Royal Acad Engn, London, England; [Macbeth, Ron] Hlth & Safety Execut, Buxton, England; [Fitzgerald, Shaun] Univ Cambridge, Ctr Climate Repair Cambridge, Cambridge, England; [Freeman, Alexandra L. J.] Univ Cambridge, Winton Ctr Risk & Evidence Commun, Cambridge, England	University of Bath; Defence Science & Technology Laboratory; University of Leeds; University of Cambridge; University of Cambridge	Rutter, H (corresponding author), Univ Bath, Bath, Avon, England.	h.r.rutter@bath.ac.uk	Rutter, Harry/HCI-8765-2022; , Simon/J-1812-2019	, Simon/0000-0002-9451-3987; Rutter, Harry/0000-0002-9322-0656; Freeman, Alexandra/0000-0002-4115-161X				Akl EA, 2007, J CLIN EPIDEMIOL, V60, P1298, DOI 10.1016/j.jclinepi.2007.03.011; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Brick C, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.190876; Dergham J, 2021, J CLIN MED, V10, DOI 10.3390/jcm10122696; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Freeman ALJ, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.201721; Galesic M, 2009, HEALTH PSYCHOL, V28, P210, DOI 10.1037/a0014474; Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Heneghan C.J., 2021, F1000RESEARCH, V10, DOI [10.12688/f1000research.52091.1, DOI 10.12688/F1000RESEARCH.52091.1]; Hultcrantz M, 2017, J CLIN EPIDEMIOL, V87, P4, DOI 10.1016/j.jclinepi.2017.05.006; Jeong HW, 2020, CLIN MICROBIOL INFEC, V26, P1520, DOI 10.1016/j.cmi.2020.07.020; Jiao L, 2021, GASTROENTEROLOGY, V160, P1647, DOI 10.1053/j.gastro.2020.12.001; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Jones B, 2021, BUILD ENVIRON, V191, DOI 10.1016/j.buildenv.2021.107617; Jones NR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3223; King MF, 2022, INDOOR AIR, V32, DOI 10.1111/ina.12938; Kraay ANM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3425-x; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; McDowell M, 2019, MED DECIS MAKING, V39, P41, DOI 10.1177/0272989X18818166; McDowell Michelle, 2016, MDM Policy Pract, V1, p2381468316665365, DOI 10.1177/2381468316665365; Meng XJ, 2021, GASTROENTEROLOGY, V160, P1467, DOI 10.1053/j.gastro.2021.01.005; Miller SL, 2021, INDOOR AIR, V31, P314, DOI 10.1111/ina.12751; Milton DK, 2020, J PEDIAT INF DIS SOC, V9, P413, DOI 10.1093/jpids/piaa079; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morelli F, 2021, AM J TROP MED HYG, V104, P814, DOI 10.4269/ajtmh.20-1098; Onakpoya IJ, 2021, F1000 RES, DOI [10.12688/ f1000research.51590.2, DOI 10.12688/F1000RESEARCH.51590.2]; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Port JR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25156-8; Rutter H, 2021, BMJ OPEN, V11; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Salas J, 2021, PAIS; Schwartz LM, 2013, P NATL ACAD SCI USA, V110, P14069, DOI 10.1073/pnas.1214646110; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Umakanthan S, 2020, POSTGRAD MED J, V96, P753, DOI 10.1136/postgradmedj-2020-138234; van der Bles AM, 2020, P NATL ACAD SCI USA, V117, P7672, DOI 10.1073/pnas.1913678117; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; Woloshin S, 2011, ANN INTERN MED, V155, P87, DOI 10.7326/0003-4819-155-2-201107190-00004; World Health Organization, 2020, 2020 MOD TRANSM VIR; World Health Organization, 2021, COR DIS COVID 19 IS; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295	41	8	8	4	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								e065312	10.1136/bmj-2021-065312	http://dx.doi.org/10.1136/bmj-2021-065312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853080	Bronze, Green Published			2022-12-28	WOS:000726688600012
J	Hopson, C				Hopson, Chris			As we head into a tough winter, the NHS is under huge pressure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hopson, Chris] NHS Providers, London, England		Hopson, C (corresponding author), NHS Providers, London, England.							[Anonymous], 2021, STATE PROVIDER SECTO	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2945	10.1136/bmj.n2945	http://dx.doi.org/10.1136/bmj.n2945			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34844955	Bronze			2022-12-28	WOS:000740896100013
J	O'Dowd, A				O'Dowd, Adrian			Why I... play Santa Claus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2898	10.1136/bmj.n2898	http://dx.doi.org/10.1136/bmj.n2898			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34844934	Bronze			2022-12-28	WOS:000740896100004
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	131	136	3	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2943	10.1136/bmj.n2943	http://dx.doi.org/10.1136/bmj.n2943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34845008	Bronze			2022-12-28	WOS:000740896100011
J	Chakera, A				Chakera, Alifia			Driving down embedded emissions from medical nitrous oxide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Introducing a sustainability variable into NHS procurement and intervention decisions could reduce healthcare's climate impact, writes Alifia Chakera	[Chakera, Alifia] Scottish Govt, Med Nitrous Oxide Mitigat Hlth Infrastruct Div, Edinburgh, Midlothian, Scotland		Chakera, A (corresponding author), Scottish Govt, Med Nitrous Oxide Mitigat Hlth Infrastruct Div, Edinburgh, Midlothian, Scotland.							Alali E, 2021, INTRO HLTH CLIMATE E, DOI [10.31219/osf.io/ fkjzy, DOI 10.31219/OSF.IO/FKJZY]; Faculty of public health special interest group, SUSTAIN DEV; Muller R, 2021, AMBIO, V50, P35, DOI 10.1007/s13280-020-01428-3; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Tennison I, 2021, LANCET PLANET HEALTH, V5, pE84, DOI 10.1016/S2542-5196(20)30271-0	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2922	10.1136/bmj.n2922	http://dx.doi.org/10.1136/bmj.n2922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836914	Bronze			2022-12-28	WOS:000727787900005
J	Ellis, EC				Ellis, Erle C.			The Dawn of Everything: A New History of Humanity	SCIENCE			English	Book Review									[Ellis, Erle C.] Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Ellis, EC (corresponding author), Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21250 USA.	ece@umbc.edu	Ellis, Erle C./B-8264-2008	Ellis, Erle C./0000-0002-2006-3362				Graeber D., 2021, DAWN EVERYTHING NEW	1	0	0	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1061	1061		10.1126/science.abm1652	http://dx.doi.org/10.1126/science.abm1652			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822293				2022-12-28	WOS:000725668600024
J	Peiry, KK				Peiry, Katharina Kummer			Triggers for treaty negotiations: could lessons from environmental protection inform a prospective pandemic treaty?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												katharina.kummer@ecoconsult.ch			Global Health Centre, Graduate Institute, Geneva	Global Health Centre, Graduate Institute, Geneva	This article is part of a collection of articles on a global pandemic treaty. The collection was proposed by the Global Health Centre at the Graduate Institute. The BMJ edited and made the decisions to publish the articles. Article handling and open access fees are funded by a research project at the Global Health Centre, Graduate Institute, Geneva. Kamran Abbasi and Juliet Dobson are the editors for The BMJ.	[Anonymous], 1987, UNEP LONDON GUIDELIN; [Anonymous], 1973, CONVENTION INT TRADE; [Anonymous], 2010, NAGOYA PROTOCOL ACCE; [Anonymous], 1985, FAO CODE CONDUCT DIS; [Anonymous], 1989, BASEL CONVENTION CON; [Anonymous], 1998, ROTTERDAM CONVENTION; Bodansky D, 2001, GLOBAL ENVIRON ACCOR, P23; Egziabher TBG, CARTAGENA PROTOCOL B; International Maritime Organization, CONV PREV MAR POLL D; International Maritime Organization, INT CONV PREV POLL S; Kummer K., 1995, INT MANAGEMENT HAZAR, Vfirst; Matthews GVT., 2013, RAMSAR CONVENTION WE; Ramsar, 1971, RAMSAR CONVENTION WE; Secretariat of the Convention on Biological Diversity, 2007, HDB CONV BIOL DIV IN, V3rd; The Vienna Convention for the Protection of the Ozone Layer, 1987, VIENNA CONVENTION PR; United Nations, 1994, UN CONV DES; WHO, 2021, COV 19 SHOWS WHY UN; WHO, ENVIRON HEALTH-GLOB; Wijnstekers W., 2011, EVOLUTION CITES, V9th ed	19	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								e068903	10.1136/bmj-2021-068903	http://dx.doi.org/10.1136/bmj-2021-068903			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836926	Green Published, hybrid			2022-12-28	WOS:000727787900009
J	Ucar, H; Watanabe, S; Noguchi, J; Morimoto, Y; Iino, Y; Yagishita, S; Takahashi, N; Kasai, H				Ucar, Hasan; Watanabe, Satoshi; Noguchi, Jun; Morimoto, Yuichi; Iino, Yusuke; Yagishita, Sho; Takahashi, Noriko; Kasai, Haruo			Mechanical actions of dendritic-spine enlargement on presynaptic exocytosis	NATURE			English	Article							LONG-TERM POTENTIATION; MEMBRANE-FUSION; VESICLES; CYTOSKELETON; PLASTICITY; CAMKII; SNARE	Synaptic transmission involves cell-to-cell communication at the synaptic junction between two neurons, and chemical and electrical forms of this process have been extensively studied. In the brain, excitatory glutamatergic synapses are often made on dendritic spines that enlarge during learning(1-5). As dendritic spines and the presynaptic terminals are tightly connected with the synaptic cleft(6), the enlargement may have mechanical effects on presynaptic functions(7). Here we show that fine and transient pushing of the presynaptic boutons with a glass pipette markedly promotes both the evoked release of glutamate and the assembly of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins(8-12)-as measured by Forster resonance transfer (FRET) and fluorescence lifetime imaging-in rat slice culture preparations(13). Both of these effects persisted for more than 20 minutes. The increased presynaptic FRET was independent of cytosolic calcium (Ca2+), but dependent on the assembly of SNARE proteins and actin polymerization in the boutons. Notably, a low hypertonic solution of sucrose (20 mM) had facilitatory effects on both the FRET and the evoked release without inducing spontaneous release, in striking contrast with a high hypertonic sucrose solution (300 mM), which induced exocytosis by itself(14). Finally, spine enlargement induced by two-photon glutamate uncaging enhanced the evoked release and the FRET only when the spines pushed the boutons by their elongation. Thus, we have identified a mechanosensory and transduction mechanism(15) in the presynaptic boutons, in which the evoked release of glutamate is enhanced for more than 20 min.	[Ucar, Hasan; Watanabe, Satoshi; Noguchi, Jun; Morimoto, Yuichi; Iino, Yusuke; Yagishita, Sho; Takahashi, Noriko; Kasai, Haruo] Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Fac Med, Tokyo, Japan; [Ucar, Hasan; Morimoto, Yuichi; Iino, Yusuke; Yagishita, Sho; Kasai, Haruo] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, UTIAS, Tokyo, Japan; [Watanabe, Satoshi; Noguchi, Jun] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan; [Takahashi, Noriko] Kitasato Univ, Dept Physiol, Sch Med, Sagamihara, Kanagawa, Japan	University of Tokyo; University of Tokyo; National Center for Neurology & Psychiatry - Japan; Kitasato University	Kasai, H (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Fac Med, Tokyo, Japan.; Kasai, H (corresponding author), Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, UTIAS, Tokyo, Japan.	hkasai@m.u-tokyo.ac.jp	Yagishita, Sho/HII-4239-2022; UCAR, Hasan/GVU-3251-2022	Yagishita, Sho/0000-0003-2854-773X; Noguchi, Jun/0000-0002-8350-791X; Takahashi, Noriko/0000-0003-1025-1690; Morimoto, Yuichi/0000-0002-1750-5297	CREST from JST [JPMJCR21E2, JPMJCR1652]; KAKENHI from JSPS [JP20H05685, JP21K15203, JP21K07535, JP18K06497, JP19J10613, JP21K20682, JP20K15893, JP21H05176, JP21H02594, JP17K08530, JP20K07280]; SRPBS from AMED [JP20dm0107120]; Brain/MINDS from AMED [JP21dm0207069]; World Premier International Research Center Initiative (WPI) from MEXT; Takeda Science Foundation; Fugaku Trust for Medical Research	CREST from JST(Core Research for Evolutional Science and Technology (CREST)); KAKENHI from JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SRPBS from AMED; Brain/MINDS from AMED; World Premier International Research Center Initiative (WPI) from MEXT; Takeda Science Foundation(Takeda Science Foundation (TSF)); Fugaku Trust for Medical Research	We thank H. Murakoshi for providing ShadowG and paCaMKII; M. Iino for discussion; and S. Fujii, C. Fujinami, Y. Sakata, R. Yonemoto, H. Ohno and A. Kurabayashi for their technical assistance. This work was supported by CREST (JPMJCR21E2 and JPMJCR1652 to H.K.) from JST, KAKENHI (JP20H05685 to H.K., JP21K15203 to H.U., JP21K07535 to S.W., JP18K06497 to J.N., JP19J10613 and JP21K20682 to Y.M., JP20K15893 to Y.I., JP21H05176 and JP21H02594 to S.Y., and JP17K08530 and JP20K07280 to N.T.) from JSPS, SRPBS (JP20dm0107120 to H.K.) and Brain/MINDS (JP21dm0207069 to S.Y.) from AMED, the World Premier International Research Center Initiative (WPI) from MEXT, Takeda Science Foundation (to S.Y.) and a grant-in-aid of The Fugaku Trust for Medical Research (to H.K.).	Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Chang JY, 2017, NEURON, V94, P800, DOI 10.1016/j.neuron.2017.04.041; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dana H, 2019, NAT METHODS, V16, P649, DOI 10.1038/s41592-019-0435-6; de Vivo L, 2017, SCIENCE, V355, P507, DOI 10.1126/science.aah5982; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Doussau F, 2000, BIOCHIMIE, V82, P353, DOI 10.1016/S0300-9084(00)00217-0; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/NMETH.1596, 10.1038/nmeth.1596]; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Hannezo E, 2019, CELL, V178, P12, DOI 10.1016/j.cell.2019.05.052; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Herring BE, 2016, ANNU REV PHYSIOL, V78, P351, DOI 10.1146/annurev-physiol-021014-071753; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; IINO M, 1981, J PHYSIOL-LONDON, V320, P449, DOI 10.1113/jphysiol.1981.sp013961; Iino Y, 2020, NATURE, V579, P555, DOI 10.1038/s41586-020-2115-1; Imig C, 2014, NEURON, V84, P416, DOI 10.1016/j.neuron.2014.10.009; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kasai H, 2005, J PHYSIOL-LONDON, V568, P891, DOI 10.1113/jphysiol.2005.093047; Kasai H, 2021, NAT REV NEUROSCI, V22, P407, DOI 10.1038/s41583-021-00467-3; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kishimoto T, 2006, EMBO J, V25, P673, DOI 10.1038/sj.emboj.7600983; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Leung RWK, 2011, BIOMED OPT EXPRESS, V2, P2517, DOI 10.1364/BOE.2.002517; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Murakoshi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15334; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Noguchi J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50445-0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Shibata ACE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21025-6; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takahashi N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9531; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; TAPLEY P, 1992, ONCOGENE, V7, P371; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723	41	9	9	6	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 23	2021	600	7890					686	+		10.1038/s41586-021-04125-7	http://dx.doi.org/10.1038/s41586-021-04125-7		NOV 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XT2KA	34819666				2022-12-28	WOS:000722128900006
J	Mahase, E				Mahase, Elisabeth			NHS charging system for migrants harmful, unjust, and not cost effective, report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Morris M, 2021, TRUE UNIVERSAL CARE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2872	10.1136/bmj.n2872	http://dx.doi.org/10.1136/bmj.n2872			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815251				2022-12-28	WOS:000722577100001
J	Kneebone, R; Houstoun, W; Houghton, N				Kneebone, Roger; Houstoun, Will; Houghton, Natasha			Medicine, magic, and online performance	LANCET			English	Editorial Material									[Kneebone, Roger] Imperial Coll London, Fac Med, Dept Surg & Canc, Surg Educ,Div Surg, London, England; [Kneebone, Roger; Houghton, Natasha] Chelsea & Westminster Hosp, Acad Surg, Ctr Engagement & Simulat Sci, London SW10 9NH, England; [Houstoun, Will] Imperial Coll London, Fac Med, London, England; [Houstoun, Will] Ctr Performance Sci, Magician Residence, London, England	Imperial College London; Imperial College London; Imperial College London	Kneebone, R (corresponding author), Imperial Coll London, Fac Med, Dept Surg & Canc, Surg Educ,Div Surg, London, England.; Kneebone, R (corresponding author), Chelsea & Westminster Hosp, Acad Surg, Ctr Engagement & Simulat Sci, London SW10 9NH, England.	r.kneebone@imperial.ac.uk			Medical Education Research Unit (MERU) at Imperial College London	Medical Education Research Unit (MERU) at Imperial College London	We acknowledge the support of the Medical Education Research Unit (MERU) at Imperial College London.		0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1868	1869						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801098	Green Published, Bronze			2022-12-28	WOS:000720912600016
J	Kar, P				Kar, Partha			Partha Kar: Holding up a mirror to racism in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com						[Anonymous], 2021, GUARDIAN 1116	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2832	10.1136/bmj.n2832	http://dx.doi.org/10.1136/bmj.n2832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799369	hybrid			2022-12-28	WOS:000723212300013
J	Al-Jawaldeh, A; Bekele, H; de Silva, A; Gomes, F; Untoro, J; Wickramasinghe, K; Williams, J; Branca, F				Al-Jawaldeh, Ayoub; Bekele, Hana; de Silva, Angela; Gomes, Fabio; Untoro, Juliawati; Wickramasinghe, Kremlin; Williams, Julianne; Branca, Francesco			A new global policy framework for adolescent nutrition?	LANCET			English	Editorial Material									[Al-Jawaldeh, Ayoub] World Hlth Org Reg Off Eastern Mediterranean, Cairo, Egypt; [Bekele, Hana] World Hlth Org Reg Off Afr, Cite Du Djoue, Rep Congo; [de Silva, Angela] World Hlth Org Reg Off South East Asia, Delhi, India; [Gomes, Fabio] World Hlth Org Reg Off Amer, Washington, DC USA; [Gomes, Fabio] Pan Amer Hlth Org, Washington, DC USA; [Untoro, Juliawati] World Hlth Org Reg Off Western Pacific, Manila, Philippines; [Wickramasinghe, Kremlin; Williams, Julianne] WHO European Off Prevent & Control Noncommunicabl, Moscow, Russia; [Branca, Francesco] World Hlth Org, Dept Nutr & Food Safety, CH-1202 Geneva, Switzerland	World Health Organization; World Health Organization; Pan American Health Organization; World Health Organization; World Health Organization	Branca, F (corresponding author), World Hlth Org, Dept Nutr & Food Safety, CH-1202 Geneva, Switzerland.	brancaf@who.int	Al-Jawaldeh, Ayoub/O-2841-2019	Al-Jawaldeh, Ayoub/0000-0001-7387-8277				FAO Cambodia Helen Keller International Cambodia., 2020, EMP YOUTH FOOD SYST; Food Safety and Standards Authority of India, 2019, SAF FOODS HLTH DIET; Hargreaves D, 2022, LANCET, V399, P198, DOI 10.1016/S0140-6736(21)01593-2; Kenya Ministry of Health, 2018, KEN NAT NUTR ACT PLA; McGuire S, 2015, ADV NUTR, V6, P134, DOI 10.3945/an.114.007781; Megally R., 2021, F1000Research, V9, DOI 10.12688/f1000research.25853.2; Ministry of Health and Sports, 2013, GUIA AL AD; Neufeld LM, 2022, LANCET, V399, P185, DOI 10.1016/S0140-6736(21)01687-1; Norris SA, 2022, LANCET, V399, P172, DOI 10.1016/S0140-6736(21)01590-7; WHO, 2019, ESS NUTR ACT MAINSTR; WHO, 2019, MON RESTR DIG MARK U; WHO, 2017, GLOB ACC ACT HLTH AD; WHO, 2006, ADOLESCENT NUTR REV; WHO UNICEF, 2021, HELPING ADOLESCENTS	14	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					125	127		10.1016/S0140-6736(21)02694-5	http://dx.doi.org/10.1016/S0140-6736(21)02694-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34856187				2022-12-28	WOS:000740652500007
J	Chaturvedi, S; Vasen, G; Pablo, M; Chen, XY; Beutler, N; Kumar, A; Tanner, E; Illouz, S; Rahgoshay, D; Burnett, J; Holguin, L; Chen, PY; Ndjamen, B; Ott, M; Rodick, R; Rogers, T; Smith, DM; Weinberger, LS				Chaturvedi, Sonali; Vasen, Gustavo; Pablo, Michael; Chen, Xinyue; Beutler, Nathan; Kumar, Arjun; Tanner, Elizabeth; Illouz, Sylvia; Rahgoshay, Donna; Burnett, John; Holguin, Leo; Chen, Pei-Yi; Ndjamen, Blaise; Ott, Melanie; Rodick, Robert; Rogers, Thomas; Smith, Davey M.; Weinberger, Leor S.			Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance	CELL			English	Article							VIRUS; CORONAVIRUS; INFLUENZA; IMMUNITY; VACCINE; PATHOGENESIS; DYNAMICS; DESIGN; RNAS; LIVE	Viral-deletion mutants that conditionally replicate and inhibit the wild-type virus (i.e., defective interfering particles, DIPs) have long been proposed as single-administration interventions with high genetic barriers to resistance. However, theories predict that robust, therapeutic DIPs (i.e., therapeutic interfering particles, TIPs) must conditionally spread between cells with R-0 >1. Here, we report engineering of TIPs that conditionally replicate with SARS-CoV-2, exhibit R-0 >1, and inhibit viral replication 10- to 100-fold. Inhibition occurs via competition for viral replication machinery, and a single administration of TIP RNA inhibits SARS-CoV-2 sustainably in continuous cultures. Strikingly, TIPs maintain efficacy against neutralization-resistant variants (e.g., B.1.351). In hamsters, both prophylactic and therapeutic intranasal administration of lipid-nanoparticle TIPs durably suppressed SARS-CoV-2 by 100-fold in the lungs, reduced pro-inflammatory cytokine expression, and prevented severe pulmonary edema. These data provide proof of concept for a class of single-administration antivirals that may circumvent current requirements to continually update medical countermeasures against new variants.	[Chaturvedi, Sonali; Vasen, Gustavo; Pablo, Michael; Chen, Xinyue; Kumar, Arjun; Tanner, Elizabeth; Weinberger, Leor S.] Gladstone Inst, Gladstone UCSF Ctr Cell Circuitry, San Francisco, CA 94158 USA; [Chaturvedi, Sonali; Vasen, Gustavo; Pablo, Michael; Chen, Xinyue; Kumar, Arjun; Tanner, Elizabeth; Chen, Pei-Yi; Ott, Melanie; Weinberger, Leor S.] Gladstone Inst, Gladstone Inst Virol, San Francisco, CA 94158 USA; [Ndjamen, Blaise] Gladstone Inst, Histol & Light Microscopy Core, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Illouz, Sylvia; Rahgoshay, Donna; Rodick, Robert] VxBiosciences Inc, Berkeley, CA 94707 USA; [Beutler, Nathan; Rogers, Thomas; Smith, Davey M.] Univ Calif San Diego, Dept Med, San Diego, CA 92121 USA; [Burnett, John; Holguin, Leo] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; City of Hope; Beckman Research Institute of City of Hope	Weinberger, LS (corresponding author), Gladstone Inst, Gladstone UCSF Ctr Cell Circuitry, San Francisco, CA 94158 USA.; Weinberger, LS (corresponding author), Gladstone Inst, Gladstone Inst Virol, San Francisco, CA 94158 USA.; Weinberger, LS (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Weinberger, LS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	sonali.chaturvedi@gladstone.ucsf.edu; leor.weinberger@gladstone.ucsf.edu	chen, xinyue/HHR-9308-2022	Chaturvedi, Sonali/0000-0002-9175-8110; HOLGUIN, LEO/0000-0002-8462-187X; Tanner, Elizabeth/0000-0001-9445-6620; Pablo, Michael/0000-0001-9738-8109; Chen, Xinyue/0000-0001-8288-7685; Burnett, John/0000-0002-8817-6064; Vasen, Gustavo/0000-0002-5968-2312; Kumar, Arjun/0000-0002-4354-5612; Beutler, Nathan/0000-0003-3240-9524	NIH [P30 AI027763, S10 RR028962]; James B. Pendleton Trust; Gladstone Genomics Core; US Army Medical Infectious Disease Research Program [MTEC 2020-492]; NIH NIDA [DP1DA051144-01S1]; Histology Core	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Trust; Gladstone Genomics Core; US Army Medical Infectious Disease Research Program; NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Histology Core	We thank the late Dr. John Holland for many wonderful insightful discussions, J. Gimlett and S. Kumar for initiating the DARPA INTERCEPT program, which drove significant expansion of the TIP initiative, and the US Army Medical In-fectious Diseases Research Program (MIDRP) for invaluable support without which this work would not have been possible. We thank D. Finzi (NIAID) for bridge funding enabling this work. We thank K. Claiborn for editing; S. Larkin for administrative support; L. Minall, F.N.N. Pitchai, T. Tabata, L. Buie, S. Ab-dullah, and J. Doudna for technical guidance; and the Gladstone-UCSF CFAR flow-cytometry core, funded by NIH grants P30 AI027763 and S10 RR028962 and the James B. Pendleton Trust, as well as the Gladstone Genomics and Histology Cores, and D. Bulkley (UCSF EM Core) . This work was sup-ported by Pamela and Edward Taft (to L.S.W.) , US Army Medical Infectious Disease Research Program (MTEC 2020-492) (to L.S.W.) , and NIH NIDA DP1DA051144-01S1 (to L.S.W.) .	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Abdelnabi R, 2021, EBIOMEDICINE, V72, DOI 10.1016/j.ebiom.2021.103595; Abdelnabi R, 2021, J INFECT DIS, V224, P749, DOI 10.1093/infdis/jiab361; Akpinar F, 2016, J VIROL, V90, P1599, DOI 10.1128/JVI.02190-15; BARIC RS, 1988, J VIROL, V62, P4280, DOI 10.1128/JVI.62.11.4280-4287.1988; Batra, SCIENCE, V370; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; CHAN AP, 2020, BIORXIV, V2006; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cotter G, 2001, CURR OPIN CARDIOL, V16, P159, DOI 10.1097/00001573-200105000-00001; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Dm K., 1990, VIROLOGY, P77; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Goyal A, 2021, ELIFE, V10, DOI 10.7554/eLife.63537; Graham, 2001, 427948 BIORXIV, V2021; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Han YL, 2021, NATURE, V589, P270, DOI 10.1038/s41586-020-2901-9; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; HORSTMANN DM, 1985, REV INFECT DIS, V7, pS80; Hurt C ., 2021, TOP ANTIVIR MED, V29, P33; Iserman C, 2020, MOL CELL, V80, P1078, DOI 10.1016/j.molcel.2020.11.041; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; JOHNSON PR, 1986, J INFECT DIS, V154, P121, DOI 10.1093/infdis/154.1.121; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Kaur N, 2021, INFECT GENET EVOL, V89, DOI 10.1016/j.meegid.2020.104490; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kim KS, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001128; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; MAKINO S, 1990, J VIROL, V64, P6045, DOI 10.1128/JVI.64.12.6045-6053.1990; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Martinez DR, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109450; Metzger VT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002015; Meylan S, 2018, CELL, V172, P1228, DOI 10.1016/j.cell.2018.01.037; Nelson J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6893; Neuhauser M, 2004, PSYCHOL REP, V94, P189; Notton T, 2021, MBIO, V12, DOI 10.1128/mBio.01724-20; Patalon, 2021, COMP SARS COV 2 NATU, DOI [10.1101/2021., DOI 10.1101/2021]; Perelson, 2020, 20201772 MEDRXIV, V2009; Perelson AS, 1997, AIDS, V11, pS17; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Petrova VN, 2018, NAT REV MICROBIOL, V16, P60, DOI [10.1038/nrmicro.2017.146, 10.1038/nrmicro.2017.118]; Rangan R, 2020, RNA, V26, P937, DOI 10.1261/rna.076141.120; Rast LI, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004799; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Rosenke K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22580-8; Rouzine IM, 2013, J VIROL, V87, P2081, DOI 10.1128/JVI.02741-12; Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300; Sahoo Debashis, 2021, bioRxiv, DOI 10.1101/2020.09.21.305698; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHNIPPER LE, 1980, P NATL ACAD SCI-BIOL, V77, P2270, DOI 10.1073/pnas.77.4.2270; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Tapia F, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00275; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Tuttle J ., 2021, TOP ANTIVIR MED, V29, P32; Vignuzzi M, 2019, NAT MICROBIOL, V4, P1075, DOI 10.1038/s41564-019-0465-y; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weinberger LS, 2003, J VIROL, V77, P10028, DOI 10.1128/JVI.77.18.10028-10036.2003; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Zeller R., 2008, CSH PROTOC, V2008, DOI [10.1101/pdb.prot4986, DOI 10.1101/PDB.PROT4986]; Zhang NN, 2020, CELL, V182, P1271, DOI 10.1016/j.cell.2020.07.024; Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	73	10	10	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6022	+		10.1016/j.cell.2021.11.004	http://dx.doi.org/10.1016/j.cell.2021.11.004		DEC 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FJ	34838159	Bronze, Green Published			2022-12-28	WOS:000730754300006
J	Boreskie, P; Lang, E				Boreskie, Patrick; Lang, Eddy			PRIORITY risk model predicted critical outcomes in patients hospitalized with COVID-19	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Boreskie, Patrick] Univ Manitoba, Winnipeg, MB, Canada; [Lang, Eddy] Univ Calgary, Calgary, AB, Canada	University of Manitoba; University of Calgary	Boreskie, P (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.			Boreskie, Patrick/0000-0001-7744-6500				Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579; Ebell MH, 2021, J AM BOARD FAM MED, V34, pS127, DOI 10.3122/jabfm.2021.S1.200464; Finelli L, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6556; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	4	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC143	JC143		10.7326/ACPJ202112210-143	http://dx.doi.org/10.7326/ACPJ202112210-143		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871045				2022-12-28	WOS:000729197100001
J	[Anonymous]				[Anonymous]			Update to living WHO guideline on drugs for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n2936	10.1136/bmj.n2936	http://dx.doi.org/10.1136/bmj.n2936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YZ2NB	34872907				2022-12-28	WOS:000755316900001
J	Chen, W; Roelli, P; Hu, HT; Verlekar, S; Amirtharaj, SP; Barreda, AI; Kippenberg, TJ; Kovylina, M; Verhagen, E; Martinez, A; Galland, C				Chen, Wen; Roelli, Philippe; Hu, Huatian; Verlekar, Sachin; Amirtharaj, Sakthi Priya; Barreda, Angela, I; Kippenberg, Tobias J.; Kovylina, Miroslavna; Verhagen, Ewold; Martinez, Alejandro; Galland, Christophe			Continuous-wave frequency upconversion with a molecular optomechanical nanocavity	SCIENCE			English	Article							ENHANCED RAMAN-SCATTERING; SPECTROSCOPY; RADIATION; MICROWAVE; ARRAYS	Coherent upconversion of terahertz and mid-infrared signals into visible light opens new horizons for spectroscopy, imaging, and sensing but represents a challenge for conventional nonlinear optics. Here, we used a plasmonic nanocavity hosting a few hundred molecules to demonstrate optomechanical transduction of submicrowatt continuous-wave signals from the mid-infrared (32 terahertz) onto the visible domain at ambient conditions. The incoming field resonantly drives a collective molecular vibration, which imprints a coherent modulation on a visible pump laser and results in upconverted Raman sidebands with subnatural linewidth. Our dual-band nanocavity offers an estimated 13 orders of magnitude enhancement in upconversion efficiency per molecule. Our results demonstrate that molecular cavity optomechanics is a flexible paradigm for frequency conversion leveraging tailorable molecular and plasmonic properties.	[Chen, Wen; Roelli, Philippe; Verlekar, Sachin; Amirtharaj, Sakthi Priya; Kippenberg, Tobias J.; Galland, Christophe] Ecole Polytech Fed Lausanne EPFL, Inst Phys, CH-1015 Lausanne, Switzerland; [Hu, Huatian] Wuhan Inst Technol, Hubei Key Lab Opt Informat & Pattern Recognit, Wuhan 430205, Peoples R China; [Barreda, Angela, I] Friedrich Schiller Univ Jena, Abbe Ctr Photon, Inst Appl Phys, D-07745 Jena, Germany; [Kovylina, Miroslavna; Martinez, Alejandro] Univ Politecn Valencia, Nanophoton Technol Ctr, Valencia 46022, Spain; [Verhagen, Ewold] AMOLF, Ctr Nanophoton, NL-1098 XG Amsterdam, Netherlands; [Roelli, Philippe] CIC NanoGUNE BRTA, Nanoopt Grp, E-20018 San Sebastian, Spain	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Wuhan Institute of Technology; Friedrich Schiller University of Jena; Universitat Politecnica de Valencia; AMOLF	Galland, C (corresponding author), Ecole Polytech Fed Lausanne EPFL, Inst Phys, CH-1015 Lausanne, Switzerland.	chris.galland@epfl.ch	Martínez, Alejandro/D-8616-2014; Galland, Christophe/AAX-1624-2021; Verhagen, Ewold/J-9419-2013	Martínez, Alejandro/0000-0001-5448-0140; Galland, Christophe/0000-0001-5627-0796; Roelli, Philippe/0000-0002-1582-2301; Hu, Huatian/0000-0001-8284-9494; Kippenberg, Tobias J./0000-0002-3408-886X; Amirtharaj, Sakthi Priya/0000-0002-4276-3407; Barreda, Angela/0000-0003-1090-6108	European Union [829067, 820196, 732894]; Swiss National Science Foundation [170684, 198898]; Alexander von Humboldt Foundation	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work received funding from the European Union's Horizon 2020 Research and Innovation Program under grant agreement nos. 829067 (FET Open THOR), 820196 (ERC CoG QTONE), and 732894 (HOT). C.G. acknowledges support from the Swiss National Science Foundation (project nos. 170684 and 198898). This work is part of the research program of the Netherlands Organisation for Scientific Research (NWO). A.I.B. acknowledges financial support by the Alexander von Humboldt Foundation.	Ahmed A, 2021, ACS PHOTONICS, V8, P1863, DOI 10.1021/acsphotonics.1c00645; Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Artur C, 2011, J PHYS CHEM LETT, V2, P3002, DOI 10.1021/jz2013787; Bachmann L, 2003, INSTRUM SCI TECHNOL, V31, P47, DOI 10.1081/CI-120018406; Bagci T, 2014, NATURE, V507, P81, DOI 10.1038/nature13029; Balram KC, 2016, NAT PHOTONICS, V10, P346, DOI [10.1038/nphoton.2016.46, 10.1038/NPHOTON.2016.46]; Barh A, 2019, ADV OPT PHOTONICS, V11, P952, DOI 10.1364/AOP.11.000952; Baumberg JJ, 2019, NAT MATER, V18, P668, DOI 10.1038/s41563-019-0290-y; Belacel C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01840-6; Benz F, 2016, SCIENCE, V354, P726, DOI 10.1126/science.aah5243; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Chen W, 2021, SCIENCE, V374, P1264, DOI 10.1126/science.abk3106; Chu YW, 2020, APPL PHYS LETT, V117, DOI 10.1063/5.0021088; Ciampa F, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020609; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; De Bruyne S, 2018, CRIT REV CL LAB SCI, V55, P1, DOI 10.1080/10408363.2017.1414142; del Pino J, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.277401; Forsch M, 2020, NAT PHYS, V16, P69, DOI 10.1038/s41567-019-0673-7; Garcia-Vidal FJ, 2010, REV MOD PHYS, V82, P729, DOI 10.1103/RevModPhys.82.729; Gordon R, 2019, NANOTECHNOLOGY, V30, DOI 10.1088/1361-6528/ab0435; Green MA, 2008, SOL ENERG MAT SOL C, V92, P1305, DOI 10.1016/j.solmat.2008.06.009; Haghighi IM, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.034031; Hasselbeck MP, 2004, APPL PHYS LETT, V85, P173, DOI 10.1063/1.1769588; Higginbotham AP, 2018, NAT PHYS, V14, P1038, DOI 10.1038/s41567-018-0210-0; Huck C, 2015, ACS PHOTONICS, V2, P1489, DOI 10.1021/acsphotonics.5b00390; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Junaid S, 2018, OPT EXPRESS, V26, P2203, DOI 10.1364/OE.26.002203; Kalashnikov DA, 2016, NAT PHOTONICS, V10, P98, DOI 10.1038/NPHOTON.2015.252; Karstad K, 2005, OPT LASER ENG, V43, P537, DOI 10.1016/j.optlaseng.2004.05.006; KHOSROFIAN JM, 1983, APPL OPTICS, V22, P3406, DOI 10.1364/AO.22.003406; Kneipp K, 1996, PHYS REV LETT, V76, P2444, DOI 10.1103/PhysRevLett.76.2444; Koczor-Benda Z., 2021, MAT CLOUD; Lambert NJ, 2020, ADV QUANTUM TECHNOL, V3, DOI 10.1002/qute.201900077; Lauk N, 2020, QUANTUM SCI TECHNOL, V5, DOI 10.1088/2058-9565/ab788a; Le F, 2008, ACS NANO, V2, P707, DOI 10.1021/nn800047e; Lindner C, 2021, OPT EXPRESS, V29, P4035, DOI 10.1364/OE.415365; Liu XZ, 2021, NAT MATER, V20, P1210, DOI 10.1038/s41563-021-00972-x; Lombardi A, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011016; Losada J, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2019.2896200; Maehrlein S, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.127402; Mestres P, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.92; Mirhosseini M, 2020, NATURE, V588, P599, DOI 10.1038/s41586-020-3038-6; Mueller NS, 2021, ACS NANO, V15, P5523, DOI 10.1021/acsnano.1c00352; Nielsen MP, 2017, SCIENCE, V358, P1179, DOI 10.1126/science.aao1467; Olmon RL, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235147; Radnaev AG, 2010, NAT PHYS, V6, P894, DOI [10.1038/NPHYS1773, 10.1038/nphys1773]; Roelli P, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.031057; Roelli P, 2016, NAT NANOTECHNOL, V11, P164, DOI [10.1038/NNANO.2015.264, 10.1038/nnano.2015.264]; Roellig TL, 2020, J ASTRON TELESC INST, V6, DOI 10.1117/1.JATIS.6.4.041503; Rogalski A, 2019, INFRARED TERAHERTZ D, V3; Roke S, 2012, ANNU REV PHYS CHEM, V63, P353, DOI 10.1146/annurev-physchem-032511-143748; Ru E. C. L., 2009, PRINCIPLES SURFACE E, P465; Salamin Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13490-x; Schmidt MK, 2017, FARADAY DISCUSS, V205, P31, DOI 10.1039/c7fd00145b; Schmidt MK, 2016, ACS NANO, V10, P6291, DOI 10.1021/acsnano.6b02484; Shalabney A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6981; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Temporao G, 2006, OPT LETT, V31, P1094, DOI 10.1364/OL.31.001094; Thijssen R, 2015, NANO LETT, V15, P3971, DOI 10.1021/acs.nanolett.5b00858; Tian CS, 2014, SURF SCI REP, V69, P105, DOI 10.1016/j.surfrep.2014.05.001; Tidemand-Lichtenberg P, 2016, J OPT SOC AM B, V33, pD28, DOI 10.1364/JOSAB.33.000D28; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Traverso AJ, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.063602; Tseng YP, 2018, OPT MATER EXPRESS, V8, P1313, DOI 10.1364/OME.8.001313; Ummethala S, 2019, NAT PHOTONICS, V13, P519, DOI 10.1038/s41566-019-0475-6; Vainsencher A, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4955408; Van Laer R, 2018, APL PHOTONICS, V3, DOI 10.1063/1.5042428; Velez ST, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb0260; Velez ST, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.041007; Vivien L, 2020, SMART PHOTONIC OPTOE, V11284; Wang H, 2007, ANGEW CHEM INT EDIT, V46, P9040, DOI 10.1002/anie.200702072; Xomalis A, 2021, SCIENCE, V374, P1268, DOI 10.1126/science.abk2593; Yampolsky S, 2014, NAT PHOTONICS, V8, P650, DOI [10.1038/nphoton.2014.143, 10.1038/NPHOTON.2014.143]; Yang JJ, 2016, ACS PHOTONICS, V3, P395, DOI 10.1021/acsphotonics.5b00559; Yao Y, 2014, NANO LETT, V14, P6526, DOI 10.1021/nl503104n; Zhang Y, 2020, ACS PHOTONICS, V7, P1676, DOI 10.1021/acsphotonics.0c00032	79	24	24	74	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1264	+		10.1126/science.abk3106	http://dx.doi.org/10.1126/science.abk3106			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855500	Green Submitted, Green Published			2022-12-28	WOS:000728578700059
J	Longpre, MA				Longpre, Marc-Antoine			Reactivation of Cumbre Vieja volcano	SCIENCE			English	Editorial Material									[Longpre, Marc-Antoine] CUNY Queens Coll, Sch Earth & Environm Sci, Queens, NY 11367 USA; [Longpre, Marc-Antoine] CUNY, Grad Ctr, Earth & Environm Sci, New York, NY 10016 USA; [Longpre, Marc-Antoine] Woods Hole Oceanog Inst, Geol & Geophys, Woods Hole, MA 02543 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Woods Hole Oceanographic Institution	Longpre, MA (corresponding author), CUNY Queens Coll, Sch Earth & Environm Sci, Queens, NY 11367 USA.; Longpre, MA (corresponding author), CUNY, Grad Ctr, Earth & Environm Sci, New York, NY 10016 USA.; Longpre, MA (corresponding author), Woods Hole Oceanog Inst, Geol & Geophys, Woods Hole, MA 02543 USA.	mlongpre@qc.cuny.edu						Copernicus Sentinel-5P Mapping Portal, 2021, 5P MAPP PORT MAPS VO; Fernandez J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82292-3; Flightradar24, 2021, PALM AIRP; Houghton BF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21455-2; Instituto Geografico Nacional, 2021, CAT TERR; Lacassin R., 2020, GEOSCI COMMUN, V3, P129, DOI [10.5194/gc-3-129-2020, DOI 10.5194/GC-3-129-2020]; Longpre MA, 2021, J VOLCANOL GEOTH RES, V419, DOI 10.1016/j.jvolgeores.2021.107363; Lopez C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051846; Lopez C, 2018, EGU GEN ASS C; Passarelli L, 2012, GEOPHYS J INT, V188, P1025, DOI 10.1111/j.1365-246X.2011.05298.x; Sennert S.K., 2021, WEEKLY VOLCANIC ACTI; Torres-Gonzalez PA, 2020, J VOLCANOL GEOTH RES, V392, DOI 10.1016/j.jvolgeores.2019.106757	12	12	12	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1197	1198		10.1126/science.abm9423	http://dx.doi.org/10.1126/science.abm9423			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855493				2022-12-28	WOS:000728578700036
J	Hu, YW; Yu, MJ; Zhu, D; Sinclair, N; Shams-Ansari, A; Shao, LB; Holzgrafe, J; Puma, E; Zhang, M; Loncar, M				Hu, Yaowen; Yu, Mengjie; Zhu, Di; Sinclair, Neil; Shams-Ansari, Amirhassan; Shao, Linbo; Holzgrafe, Jeffrey; Puma, Eric; Zhang, Mian; Loncar, Marko			On-chip electro-optic frequency shifters and beam splitters	NATURE			English	Article							MODULATOR; GAS	Efficient frequency shifting and beam splitting are important for a wide range of applications, including atomic physics(1,2), microwave photonics(3-6), optical communication(7,8) and photonic quantum computing(9-14). However, realizing gigahertz-scale frequency shifts with high efficiency, low loss and tunability-in particular using a miniature and scalable device-is challenging because it requires efficient and controllable nonlinear processes. Existing approaches based on acousto-optics(6,15-17), all-optical wave mixing(10,13,18-22) and electro-optics(23-27) are either limited to low efficiencies or frequencies, or are bulky. Furthermore, most approaches are not bi-directional, which renders them unsuitable for frequency beam splitters. Here we demonstrate electro-optic frequency shifters that are controlled using only continuous and single-tone microwaves. This is accomplished by engineering the density of states of, and coupling between, optical modes in ultralow-loss waveguides and resonators in lithium niobate nanophotonics(28). Our devices, consisting of two coupled ring-resonators, provide frequency shifts as high as 28 gigahertz with an on-chip conversion efficiency of approximately 90 per cent. Importantly, the devices can be reconfigured as tunable frequency-domain beam splitters. We also demonstrate a non-blocking and efficient swap of information between two frequency channels with one of the devices. Finally, we propose and demonstrate a scheme for cascaded frequency shifting that allows shifts of 119.2 gigahertz using a 29.8 gigahertz continuous and single-tone microwave signal. Our devices could become building blocks for future high-speed and large-scale classical information processors(7,29) as well as emerging frequency-domain photonic quantum computers(9,11,14). Engineering of the coupling between optical modes in a lithium niobate chip enables the realization of tunable, bi-directional and low-loss electro-optic frequency shifters controlled using only continuous and single-tone microwaves.	[Hu, Yaowen; Yu, Mengjie; Zhu, Di; Sinclair, Neil; Shams-Ansari, Amirhassan; Shao, Linbo; Holzgrafe, Jeffrey; Puma, Eric; Loncar, Marko] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Hu, Yaowen] Harvard Univ, Dept Phys, Cambridge, MA USA; [Sinclair, Neil] CALTECH, Div Phys Math & Astron, Pasadena, CA USA; [Sinclair, Neil] Alliance Quantum Technol AQT, Pasadena, CA USA; [Zhang, Mian] HyperLight Corp, Cambridge, MA USA	Harvard University; Harvard University; California Institute of Technology	Loncar, M (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	loncar@seas.harvard.edu	Zhu, Di/GYA-3197-2022	Zhu, Di/0000-0003-0210-1860; Yu, Mengjie/0000-0002-7815-4195; Hu, Yaowen/0000-0002-0127-1959; Shao, Linbo/0000-0002-0615-7848				Demtroder W., 2008, LASER SPECTROSCOPY, V2; Eggleton BJ, 2019, NAT PHOTONICS, V13, P664, DOI 10.1038/s41566-019-0498-z; Fan LR, 2016, NAT PHOTONICS, V10, P766, DOI [10.1038/NPHOTON.2016.206, 10.1038/nphoton.2016.206]; Fandino JS, 2017, NAT PHOTONICS, V11, P124, DOI [10.1038/NPHOTON.2016.233, 10.1038/nphoton.2016.233]; Frankel MY, 1998, J LIGHTWAVE TECHNOL, V16, P859, DOI 10.1109/50.669019; Ghelfi P, 2014, NATURE, V507, P341, DOI 10.1038/nature13078; He LY, 2019, OPT LETT, V44, P2314, DOI 10.1364/OL.44.002314; Heuck M, 2019, NEW J PHYS, V21, DOI 10.1088/1367-2630/ab09a7; Hu JZ, 2017, SCIENCE, V358, P1078, DOI 10.1126/science.aan5614; Hu YW, 2020, OPTICA, V7, P1189, DOI 10.1364/OPTICA.395114; HUANG JM, 1992, PHYS REV LETT, V68, P2153, DOI 10.1103/PhysRevLett.68.2153; IZUTSU M, 1981, IEEE J QUANTUM ELECT, V17, P2225, DOI 10.1109/JQE.1981.1070678; JOHNSON LM, 1988, J LIGHTWAVE TECHNOL, V6, P109, DOI 10.1109/50.3974; Joshi C, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.143601; Joshi C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03254-4; Khan S, 2020, APL PHOTONICS, V5, DOI 10.1063/1.5145105; Kittlaus EA, 2018, NAT PHOTONICS, V12, P613, DOI 10.1038/s41566-018-0254-9; Kobayashi T, 2016, NAT PHOTONICS, V10, P441, DOI 10.1038/nphoton.2016.74; Kohlhaas R, 2012, OPT LETT, V37, P1005, DOI 10.1364/OL.37.001005; Kues M, 2019, NAT PHOTONICS, V13, P170, DOI 10.1038/s41566-019-0363-0; Kues M, 2017, NATURE, V546, P622, DOI 10.1038/nature22986; Li Q, 2016, NAT PHOTONICS, V10, P406, DOI [10.1038/NPHOTON.2016.64, 10.1038/nphoton.2016.64]; Liu QY, 2019, OPTICA, V6, P778, DOI 10.1364/OPTICA.6.000778; Lo HP, 2017, OPTICA, V4, P919, DOI 10.1364/OPTICA.4.000919; Lu HH, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.030502; Lukens JM, 2020, J LIGHTWAVE TECHNOL, V38, P1678, DOI 10.1109/JLT.2019.2953363; Lukens JM, 2017, OPTICA, V4, P8, DOI 10.1364/OPTICA.4.000008; Marpaung D, 2019, NAT PHOTONICS, V13, P80, DOI 10.1038/s41566-018-0310-5; Pelc JS, 2012, OPT EXPRESS, V20, P19075, DOI 10.1364/OE.20.019075; Preble SF, 2007, NAT PHOTONICS, V1, P293, DOI 10.1038/nphoton.2007.72; Puigibert MG, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.083601; Raymer MG, 2010, OPT COMMUN, V283, P747, DOI 10.1016/j.optcom.2009.10.057; Savchenkov AA, 2009, OPT LETT, V34, P1300, DOI 10.1364/OL.34.001300; Sinclair N, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053603; Sohn DB, 2018, NAT PHOTONICS, V12, P91, DOI 10.1038/s41566-017-0075-2; Soltani M, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.043808; Supradeepa VR, 2012, NAT PHOTONICS, V6, P186, DOI [10.1038/nphoton.2011.350, 10.1038/NPHOTON.2011.350]; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08969-6; Wang C, 2018, NATURE, V562, P101, DOI 10.1038/s41586-018-0551-y; Wright LJ, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.023601; Xu MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17806-0; Yoo SJB, 1996, J LIGHTWAVE TECHNOL, V14, P955, DOI 10.1109/50.511595; Yuan LQ, 2018, OPTICA, V5, P1396, DOI 10.1364/OPTICA.5.001396; Zhang M, 2019, NAT PHOTONICS, V13, P36, DOI 10.1038/s41566-018-0317-y; Zhang M, 2017, OPTICA, V4, P1536, DOI 10.1364/OPTICA.4.001536	46	24	25	31	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					587	+		10.1038/s41586-021-03999-x	http://dx.doi.org/10.1038/s41586-021-03999-x			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819680	Green Submitted, Green Accepted			2022-12-28	WOS:000722366200017
J	Ledford, H				Ledford, Heidi			HOW VACCINATION AFFECTS THE RISK OF LONG COVID	NATURE			English	News Item						SARS-CoV-2; Infection; Vaccines		Coronavirus vaccines reduce the risk of developing COVID-19 - but studies disagree on their protective effect against long COVID.					Robber, Grades/AAC-5491-2022					Antonelli M, 2022, LANCET INFECT DIS, V22, P43, DOI 10.1016/S1473-3099(21)00460-6; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Cohn BA, 2022, SCIENCE, V375, P331, DOI 10.1126/science.abm0620; Harrison, 2021, PREPRINT MEDRXIV, DOI 10.26.21265508; Krumholz H., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.07.23.21261030, DOI 10.1101/2021.07.23.21261030]; Massey D., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.07.21.21260391, DOI 10.1101/2021.07.21.21260391]; Office for National Statistics, 2021, COR COVID 19 VACC SE; Office for National Statistics, 2021, UPD EST PREV POST SY; Stephenson T., 2021, PREPRINT RES SQUARE, DOI [10.21203/rs.3.rs-798316/v1, DOI 10.21203/RS.3.RS-798316/V1]	9	26	26	17	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					546	548		10.1038/d41586-021-03495-2	http://dx.doi.org/10.1038/d41586-021-03495-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XC3CL	34815580	Bronze			2022-12-28	WOS:000721895100013
J	Saito, A; Irie, T; Suzuki, R; Maemura, T; Nasser, H; Uriu, K; Kosugi, Y; Shirakawa, K; Sadamasu, K; Kimura, I; Ito, J; Wu, JQ; Iwatsuki-Horimoto, K; Ito, M; Yamayoshi, S; Loeber, S; Tsuda, M; Wang, L; Ozono, S; Butlertanaka, EP; Tanaka, YL; Shimizu, R; Shimizu, K; Yoshimatsu, K; Kawabata, R; Sakaguchi, T; Tokunaga, K; Yoshida, I; Asakura, H; Nagashima, M; Kazuma, Y; Nomura, R; Horisawa, Y; Yoshimura, K; Takaori-Kondo, A; Imai, M; Tanaka, S; Nakagawa, S; Ikeda, T; Fukuhara, T; Kawaoka, Y; Sato, K				Saito, Akatsuki; Irie, Takashi; Suzuki, Rigel; Maemura, Tadashi; Nasser, Hesham; Uriu, Keiya; Kosugi, Yusuke; Shirakawa, Kotaro; Sadamasu, Kenji; Kimura, Izumi; Ito, Jumpei; Wu, Jiaqi; Iwatsuki-Horimoto, Kiyoko; Ito, Mutsumi; Yamayoshi, Seiya; Loeber, Samantha; Tsuda, Masumi; Wang, Lei; Ozono, Seiya; Butlertanaka, Erika P.; Tanaka, Yuri L.; Shimizu, Ryo; Shimizu, Kenta; Yoshimatsu, Kumiko; Kawabata, Ryoko; Sakaguchi, Takemasa; Tokunaga, Kenzo; Yoshida, Isao; Asakura, Hiroyuki; Nagashima, Mami; Kazuma, Yasuhiro; Nomura, Ryosuke; Horisawa, Yoshihito; Yoshimura, Kazuhisa; Takaori-Kondo, Akifumi; Imai, Masaki; Tanaka, Shinya; Nakagawa, So; Ikeda, Terumasa; Fukuhara, Takasuke; Kawaoka, Yoshihiro; Sato, Kei		Genotype Phenotype Japan G2P-Japan	Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation	NATURE			English	Article							MEASLES-VIRUS; ALIGNMENT; FUSION	During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, at the time of writing, four variants of concern are considered to be potentially hazardous to human society(1). The recently emerged B.1.617.2/Delta variant of concern is closely associated with the COVID-19 surge that occurred in India in the spring of 2021 (ref.(2)). However, the virological properties of B.1.617.2/Delta remain unclear. Here we show that the B.1.617.2/Delta variant is highly fusogenic and notably more pathogenic than prototypic SARS-CoV-2 in infected hamsters. The P681R mutation in the spike protein, which is highly conserved in this lineage, facilitates cleavage of the spike protein and enhances viral fusogenicity. Moreover, we demonstrate that the P681R-bearing virus exhibits higher pathogenicity compared with its parental virus. Our data suggest that the P681R mutation is a hallmark of the virological phenotype of the B.1.617.2/Delta variant and is associated with enhanced pathogenicity.	[Saito, Akatsuki; Butlertanaka, Erika P.; Tanaka, Yuri L.] Univ Miyazaki, Fac Agr, Dept Vet Sci, Miyazaki, Japan; [Saito, Akatsuki] Univ Miyazaki, Ctr Anim Dis Control, Miyazaki, Japan; [Saito, Akatsuki] Univ Miyazaki, Grad Sch Med & Vet Med, Miyazaki, Japan; [Irie, Takashi; Kawabata, Ryoko; Sakaguchi, Takemasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Suzuki, Rigel; Shimizu, Kenta; Fukuhara, Takasuke] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Maemura, Tadashi; Iwatsuki-Horimoto, Kiyoko; Ito, Mutsumi; Yamayoshi, Seiya; Imai, Masaki; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Japan; [Maemura, Tadashi; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA; [Nasser, Hesham; Shimizu, Ryo; Ikeda, Terumasa] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Mol Virol & Genet, Kumamoto, Japan; [Nasser, Hesham] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt; [Uriu, Keiya; Kosugi, Yusuke; Kimura, Izumi; Ito, Jumpei; Sato, Kei] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Div Syst Virol,Dept Infect Dis Control, Tokyo, Japan; [Shirakawa, Kotaro; Kazuma, Yasuhiro; Nomura, Ryosuke; Horisawa, Yoshihito; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Sadamasu, Kenji; Yoshida, Isao; Asakura, Hiroyuki; Nagashima, Mami; Yoshimura, Kazuhisa] Tokyo Metropolitan Inst Publ Hlth, Tokyo, Japan; [Wu, Jiaqi; Nakagawa, So] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan; [Wu, Jiaqi; Nakagawa, So; Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Yamayoshi, Seiya; Imai, Masaki; Kawaoka, Yoshihiro] Natl Ctr Global Hearth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Japan; [Loeber, Samantha] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Tsuda, Masumi; Wang, Lei; Tanaka, Shinya] Hokkaido Univ, Fac Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Tsuda, Masumi; Wang, Lei; Tanaka, Shinya] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido, Japan; [Ozono, Seiya; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Shimizu, Ryo] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan; [Yoshimatsu, Kumiko] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan	University of Miyazaki; University of Miyazaki; University of Miyazaki; Hiroshima University; Hokkaido University; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Kumamoto University; Egyptian Knowledge Bank (EKB); Suez Canal University; University of Tokyo; Kyoto University; Tokyo Metropolitan Institute of Public Health; Tokai University; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison; Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); Kumamoto University; Hokkaido University	Fukuhara, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.; Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Japan.; Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA.; Ikeda, T (corresponding author), Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Mol Virol & Genet, Kumamoto, Japan.; Sato, K (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Div Syst Virol,Dept Infect Dis Control, Tokyo, Japan.; Nakagawa, S (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan.; Nakagawa, S; Sato, K (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.; Kawaoka, Y (corresponding author), Natl Ctr Global Hearth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Japan.; Tanaka, S (corresponding author), Hokkaido Univ, Fac Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan.; Tanaka, S (corresponding author), Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido, Japan.	tanaka@med.hokudai.ac.jp; so@tokai.ac.jp; ikedat@kumamoto-u.ac.jp; fukut@pop.med.hokudai.ac.jp; yoshihiro.kawaoka@wisc.edu; KeiSato@g.ecc.u-tokyo.ac.jp	Tanaka, Shinya/D-3586-2011; Nakagawa, So/Q-2712-2015; Tokunaga, Kenzo/Q-9914-2018	Nakagawa, So/0000-0003-1760-3839; Tokunaga, Kenzo/0000-0002-2625-5322; Tanaka, Shinya/0000-0001-6470-3301; Ikeda, Terumasa/0000-0003-2869-9450; SAITO, AKATSUKI/0000-0002-2792-4399; Yamayoshi, Seiya/0000-0001-7768-5157; Morimatsu, Kumiko/0000-0002-0062-2753; Shirakawa, Kotaro/0000-0002-7469-1276; Loeber, Samantha/0000-0003-4921-2357; Nasser, Hesham/0000-0001-9163-1665	AMED Research Program on Emerging and Re-emerging Infectious Diseases [20fk0108163, 20fk0108401, 21fk0108617, 19fk0108113, JP20fk0108412, 20fk0108146, 20fk0108270, 20fk0108413, 20fk0108451]; AMED Research Program on HIV/AIDS [21fk0410033, 21fk0410039]; AMED Japan Program for Infectious Diseases Research and Infrastructure [20wm0325009, 21wm0325009, 21wm0125002]; JST A-STEP [JPMJTM20SL]; JST SICORP (e-ASIA) [JPMJSC20U1]; JST SICORP [JPMJSC21U5]; JST CREST [JPMJCR20H6, JPMJCR20H4]; JSPS KAKENHI [19K06382, 18K07156, 21K07060]; Scientific Research B [18H02662, 21H02737]; JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) [18KK0447]; JSPS Core-to-Core Program [JPJSCCA20190008]; JSPS Research Fellow [DC1 19J20488]; JSPS Leading Initiative for Excellent Young Researchers (LEADER); ONO Medical Research Foundation; Ichiro Kanehara Foundation; Lotte Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Sumitomo Foundation; Uehara Foundation; Takeda Science Foundation; Tokyo Biochemical Research Foundation; Mitsubishi Foundation; Shin-Nihon Foundation of Advanced Medical Research; Tsuchiya Foundation; Research Institute for Microbial Diseases, Osaka University; Kumamoto University COVID-19 Research Projects (AMABIE); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University	AMED Research Program on Emerging and Re-emerging Infectious Diseases; AMED Research Program on HIV/AIDS; AMED Japan Program for Infectious Diseases Research and Infrastructure; JST A-STEP; JST SICORP (e-ASIA); JST SICORP; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research B(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research); JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Research Fellow(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Leading Initiative for Excellent Young Researchers (LEADER); ONO Medical Research Foundation; Ichiro Kanehara Foundation; Lotte Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science; Sumitomo Foundation; Uehara Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Biochemical Research Foundation; Mitsubishi Foundation; Shin-Nihon Foundation of Advanced Medical Research; Tsuchiya Foundation(Tsuchiya Foundation); Research Institute for Microbial Diseases, Osaka University; Kumamoto University COVID-19 Research Projects (AMABIE); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University	We thank all of the members belonging to The Genotype to Phenotype Japan (G2P-Japan) Consortium; the staff at the National Institute for Infectious Diseases, Japan, and J. Gohda (The University of Tokyo, Japan) for providing virus isolates and reagents; and all of the COVID-19 vaccine study participants at Kyoto University Hospital. An anti-HIV-1 p24 monoclonal antibody (183-H12-5C, ARP-3537) was obtained through the NIH HIV Reagent Program, NIAID, NIH (contributed by B. Chesebro and K. Wehrly). The supercomputing resource was provided by the Human Genome Center at The University of Tokyo and the NIG supercomputer at ROIS National Institute of Genetics. This study was supported in part by AMED Research Program on Emerging and Re-emerging Infectious Diseases (20fk0108163, to A.S.; 20fk0108401, to T.F.; 21fk0108617, to T.F.; 19fk0108113, to Y. Kawaoka; JP20fk0108412, to Y. Kawaoka; 20fk0108146, to K. Sato; 20fk0108270, to K. Sato; 20fk0108413, to T. Ikeda, S.N. and K. Sato; and 20fk0108451, to A.S., T. Irie, A.T.-K., G2P-Japan Consortium, S.N., T. Ikeda, T.F. and K. Sato); the AMED Research Program on HIV/AIDS (21fk0410033, to A.S.; and 21fk0410039, to K. Sato); the AMED Japan Program for Infectious Diseases Research and Infrastructure (20wm0325009, to A.S.; 21wm0325009, to A.S.; and 21wm0125002, to Y. Kawaoka); JST A-STEP (JPMJTM20SL, to T. Ikeda); JST SICORP (e-ASIA) (JPMJSC20U1, to K. Sato); JST SICORP (JPMJSC21U5, to K. Sato), JST CREST (JPMJCR20H6, to S.N.; and JPMJCR20H4, to K. Sato); JSPS KAKENHI Grant-in-Aid for Scientific Research C (19K06382, to A.S.; 18K07156, to K. Tokunaga; and 21K07060, to K. Tokunaga), Scientific Research B (18H02662, to K. Sato; and 21H02737, to K. Sato); the JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) (18KK0447, to K. Sato); the JSPS Core-to-Core Program (JPJSCCA20190008, A. Advanced Research Networks, to K. Sato); the JSPS Research Fellow DC1 19J20488 (to I.K.); the JSPS Leading Initiative for Excellent Young Researchers (LEADER) (to T. Ikeda); the ONO Medical Research Foundation (to K. Sato); the Ichiro Kanehara Foundation (to K. Sato); the Lotte Foundation (to K. Sato); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. Sato); the Daiichi Sankyo Foundation of Life Science (to K. Sato); the Sumitomo Foundation (to K. Sato); the Uehara Foundation (to K. Sato); the Takeda Science Foundation (to T. Ikeda and K. Sato); The Tokyo Biochemical Research Foundation (to K. Sato); the Mitsubishi Foundation (to T. Ikeda); the Shin-Nihon Foundation of Advanced Medical Research (to T. Ikeda); the Tsuchiya Foundation (to T. Irie); a Grant for Joint Research Projects of the Research Institute for Microbial Diseases, Osaka University (to A.S.); an intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE) (to T. Ikeda); the Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS (to T. Ikeda); and the Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University (to K. Sato).	[Anonymous], 2021, SARS COV 2 VARIANT C; [Anonymous], 2021, TRACKING SARS COV 2; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Corti D, 2021, CELL, V184, P3086, DOI [10.1016/j.cell.2021.05.005, 10.1016/j.cell.2021.07.027]; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Ikeda T, 2019, J GEN VIROL, V100, P1140, DOI 10.1099/jgv.0.001276; Ikeda T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007010; Ikegame S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026027118; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kimura I., 2021, SARS COV 2 LAMBDA VA, DOI [DOI 10.1101/2021.07.28.454085, 10.1101/2021.07.28.454085, https://doi.org/10.1101/2021.07.28.454085]; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Matsuda Z., 2011, CURR PROTOC CELL BIO, V50, DOI [10.1002/0471143030.cb2609s50, DOI 10.1002/0471143030.CB2609S50]; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Motozono C, 2021, CELL HOST MICROBE, V29, P1124, DOI 10.1016/j.chom.2021.06.006; Mugisha CS, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00658-20; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ozono S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21118-2; Ozono S, 2020, J BIOL CHEM, V295, P13023, DOI 10.1074/jbc.RA120.013887; Peacock TP, 2021, NAT MICROBIOL, V6, P899, DOI 10.1038/s41564-021-00908-w; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Rausch T, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6635-8; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rossi F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-89; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Singh J, 2021, NAT MED, V27, P1131, DOI 10.1038/s41591-021-01397-4; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Sultana T, 2019, J VIROL, V93, DOI 10.1128/JVI.00986-19; Torii S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109014; Twohig K. A., 2021, LANCET INFECT DIS, DOI [10.1016/S0140-6736(21)01358-1, DOI 10.1016/S0140-6736(21)01358-1]; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; Watanabe S, 2013, J VIROL, V87, P2648, DOI 10.1128/JVI.02632-12; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1	47	142	142	4	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					300	+		10.1038/s41586-021-04266-9	http://dx.doi.org/10.1038/s41586-021-04266-9		NOV 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW6UU	34823256	Green Published, hybrid			2022-12-28	WOS:000741978200001
J	Slomski, A				Slomski, Anita			Daily COVID-19 Tests Compared With Isolation After School Exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2001	2001		10.1001/jama.2021.20471	http://dx.doi.org/10.1001/jama.2021.20471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812866	Bronze			2022-12-28	WOS:000724001500046
J	Shepherd, A; Hanckel, B				Shepherd, Adam; Hanckel, Benjamin			Ensuring equal access to care for all transgender people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shepherd, Adam] Kings Coll London, London, England; [Hanckel, Benjamin] Western Sydney Univ, Penrith, NSW, Australia	University of London; King's College London; Western Sydney University	Shepherd, A (corresponding author), Kings Coll London, London, England.							Pearce R., 2018, UNDERSTANDING TRANSH; Shepherd A, 2021, HEALTH SOCIOL REV, V30, P41, DOI 10.1080/14461242.2020.1854618; Stroumsa D, 2019, NEW ENGL J MED, V380, P1885, DOI 10.1056/NEJMp1811491	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2858	10.1136/bmj.n2858	http://dx.doi.org/10.1136/bmj.n2858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799414	Bronze			2022-12-28	WOS:000723212300015
J	Wise, J				Wise, Jacqui			Reverse cuts to children's centres, peers urge government	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, BEST START LIF VIS 1; Public Services Committee, 2021, 95 HL PUBL SERV COMM	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2851	10.1136/bmj.n2851	http://dx.doi.org/10.1136/bmj.n2851			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799358				2022-12-28	WOS:000723212300003
J	Iacobucci, G				Iacobucci, Gareth			Overcrowding and long delays in A&E caused over 4000 deaths last year in England, analysis shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Association of Ambulance Chief Executives, 2021, DEL HOSP HAND IMP AS; NHS Digital, HOSP ACC EM ACT 2019; NHS England, A E ATT EM ADM; Royal College of Emergency Medicine, 2021, RCEM ACUT INS SER CR	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2021	375								n2835	10.1136/bmj.n2835	http://dx.doi.org/10.1136/bmj.n2835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR5EW	34794954				2022-12-28	WOS:000750016000001
J	Jordan, D; Barnes, T; Haegel, N; Repins, I				Jordan, Dirk; Barnes, Teresa; Haegel, Nancy; Repins, Ingrid			Build solar-energy systems to last - save billions	NATURE			English	Editorial Material									[Jordan, Dirk; Barnes, Teresa; Repins, Ingrid] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Barnes, Teresa] Natl Renewable Energy Lab, Mat Reliabil, Golden, CO USA; [Haegel, Nancy] Natl Renewable Energy Lab, Mat Sci Ctr, Golden, CO USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Jordan, D (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	dirk.jordan@nrel.gov						Beinert AJ, 2020, PROG PHOTOVOLTAICS, V28, P717, DOI 10.1002/pip.3263; Busby JW, 2021, ENERGY RES SOC SCI, V77, DOI 10.1016/j.erss.2021.102106; Eder GC, 2019, SOL ENERG MAT SOL C, V203, DOI 10.1016/j.solmat.2019.110194; Gaulding EA, 2021, IEEE PHOT SPEC CONF, P1735, DOI 10.1109/PVSC43889.2021.9519058; Jordan DC, 2020, PROG PHOTOVOLTAICS, V28, P739, DOI 10.1002/pip.3262; Oudheusden F., 2020, SOLAR STORM SELECT 2; Spinella L, 2021, IEEE PHOT SPEC CONF, P108, DOI 10.1109/PVSC43889.2021.9518566; Tracy J, 2019, IEEE PHOT SPEC CONF, P874, DOI 10.1109/PVSC40753.2019.8981140	8	6	6	4	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					215	217		10.1038/d41586-021-03626-9	http://dx.doi.org/10.1038/d41586-021-03626-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XL0PT	34876664	Bronze, Green Submitted			2022-12-28	WOS:000727856300014
J	Donato, AA				Donato, Anthony A.			In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Donato, Anthony A.] Tower Hlth Reading Hosp, Reading, PA 19611 USA		Donato, AA (corresponding author), Tower Hlth Reading Hosp, Reading, PA 19611 USA.							Contou D, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03449-6; Cuker A, 2021, BLOOD ADV, V5, P3951, DOI 10.1182/bloodadvances.2021005493; Hippensteel JA, 2020, AM J PHYSIOL-LUNG C, V319, pL211, DOI 10.1152/ajplung.00199.2020; Kollias A, 2021, VASC MED, V26, P415, DOI 10.1177/1358863X21995566; National Institutes of Health (NIH), 2021, COVID 19 TREATM GUID	5	1	1	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC134	JC135		10.7326/ACPJ202112210-134	http://dx.doi.org/10.7326/ACPJ202112210-134		DEC 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871053				2022-12-28	WOS:000729197500001
J	Willett, LR; Kim, S				Willett, Laura Rees; Kim, Sarang			In paroxysmal AF, first-line catheter ablation vs. antiarrhythmic drugs reduces atrial arrhythmia recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Willett, Laura Rees; Kim, Sarang] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Willett, LR (corresponding author), Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.							Lafuente-Lafuente C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub4; Mujovic N, 2017, ADV THER, V34, P1897, DOI 10.1007/s12325-017-0590-z; Sethi NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186856; Turagam MK, 2019, ANN INTERN MED, V170, P41, DOI 10.7326/M18-0992	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC140	JC140		10.7326/ACPJ202112210-140	http://dx.doi.org/10.7326/ACPJ202112210-140		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871055				2022-12-28	WOS:000729198600001
J	Gordon, R				Gordon, Reuven			Room-temperature mid-infrared detectors	SCIENCE			English	Editorial Material							OPTOMECHANICS		[Gordon, Reuven] Univ Victoria, Dept Elect & Comp Engn, Victoria, BC, Canada	University of Victoria	Gordon, R (corresponding author), Univ Victoria, Dept Elect & Comp Engn, Victoria, BC, Canada.	rgordon@uvic.ca						Ahmed A, 2012, NANO LETT, V12, P2625, DOI 10.1021/nl301029e; Benz F, 2016, SCIENCE, V354, P726, DOI 10.1126/science.aah5243; Chen W., 2021, SCIENCE, V374, P1264; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Roelli P, 2016, NAT NANOTECHNOL, V11, P164, DOI [10.1038/NNANO.2015.264, 10.1038/nnano.2015.264]; Xomalis A, 2021, SCIENCE, V374, P1268, DOI 10.1126/science.abk2593	8	0	0	13	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1201	1202		10.1126/science.abm4252	http://dx.doi.org/10.1126/science.abm4252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855487				2022-12-28	WOS:000728578700039
J	Lam, KWF; Csizmadia, S; Astudillo-Defru, N; Bonfils, X; Gandolfi, D; Padovan, S; Esposito, M; Hellier, C; Hirano, T; Livingston, J; Murgas, F; Smith, AMS; Collins, KA; Mathur, S; Garcia, RA; Howell, SB; Santos, NC; Dai, F; Ricker, GR; Vanderspek, R; Latham, DW; Seager, S; Winn, JN; Jenkins, JM; Albrecht, S; Almenara, JM; Artigau, E; Barragan, O; Bouchy, F; Cabrera, J; Charbonneau, D; Chaturvedi, P; Chaushev, A; Christiansen, JL; Cochran, WD; De Meideiros, JR; Delfosse, X; Diaz, RF; Doyon, R; Eigmuller, P; Figueira, P; Forveille, T; Fridlund, M; Gaisne, G; Goffo, E; Georgieva, I; Grziwa, S; Guenther, E; Hatzes, AP; Johnson, MC; Kabath, P; Knudstrup, E; Korth, J; Lewin, P; Lissauer, JJ; Lovis, C; Luque, R; Melo, C; Morgan, EH; Morris, R; Mayor, M; Narita, N; Osborne, HLM; Palle, E; Pepe, F; Persson, CM; Quinn, SN; Rauer, H; Redfield, S; Schlieder, JE; Segransan, D; Serrano, LM; Smith, JC; Subjak, J; Twicken, JD; Udry, S; Van Eylen, V; Vezie, M				Lam, Kristine W. F.; Csizmadia, Szilard; Astudillo-Defru, Nicola; Bonfils, Xavier; Gandolfi, Davide; Padovan, Sebastiano; Esposito, Massimiliano; Hellier, Coel; Hirano, Teruyuki; Livingston, John; Murgas, Felipe; Smith, Alexis M. S.; Collins, Karen A.; Mathur, Savita; Garcia, Rafael A.; Howell, Steve B.; Santos, Nuno C.; Dai, Fei; Ricker, George R.; Vanderspek, Roland; Latham, David W.; Seager, Sara; Winn, Joshua N.; Jenkins, Jon M.; Albrecht, Simon; Almenara, Jose M.; Artigau, Etienne; Barragan, Oscar; Bouchy, Francois; Cabrera, Juan; Charbonneau, David; Chaturvedi, Priyanka; Chaushev, Alexander; Christiansen, Jessie L.; Cochran, William D.; De Meideiros, Jose R.; Delfosse, Xavier; Diaz, Rodrigo F.; Doyon, Rene; Eigmueller, Philipp; Figueira, Pedro; Forveille, Thierry; Fridlund, Malcolm; Gaisne, Guillaume; Goffo, Elisa; Georgieva, Iskra; Grziwa, Sascha; Guenther, Eike; Hatzes, Artie P.; Johnson, Marshall C.; Kabath, Petr; Knudstrup, Emil; Korth, Judith; Lewin, Pablo; Lissauer, Jack J.; Lovis, Christophe; Luque, Rafael; Melo, Claudio; Morgan, Edward H.; Morris, Robert; Mayor, Michel; Narita, Norio; Osborne, Hannah L. M.; Palle, Enric; Pepe, Francesco; Persson, Carina M.; Quinn, Samuel N.; Rauer, Heike; Redfield, Seth; Schlieder, Joshua E.; Segransan, Damien; Serrano, Luisa M.; Smith, Jeffrey C.; Subjak, Jan; Twicken, Joseph D.; Udry, Stephane; Van Eylen, Vincent; Vezie, Michael			GJ 367b: A dense, ultrashort-period sub-Earth planet transiting a nearby red dwarf star	SCIENCE			English	Article							ERROR-CORRECTION; SIZED EXOPLANET; SUPER-EARTHS; MASS; STELLAR; TELESCOPE; MERCURY; MODEL	Ultrashort-period (USP) exoplanets have orbital periods shorter than 1 day. Precise masses and radii of USP exoplanets could provide constraints on their unknown formation and evolution processes. We report the detection and characterization of the USP planet GJ 367b using high-precision photometry and radial velocity observations. GJ 367b orbits a bright (V-band magnitude of 10.2), nearby, and red (M-type) dwarf star every 7.7 hours. GJ 367b has a radius of 0.718 +/- 0.054 Earth-radii and a mass of 0.546 +/- 0.078 Earth-masses, making it a sub-Earth planet. The corresponding bulk density is 8.106 +/- 2.165 grams per cubic centimeter-close to that of iron. An interior structure model predicts that the planet has an iron core radius fraction of 86 +/- 5%, similar to that of Mercury's interior.	[Lam, Kristine W. F.; Chaushev, Alexander; Rauer, Heike] Tech Univ Berlin, Ctr Astron & Astrophys, D-10585 Berlin, Germany; [Lam, Kristine W. F.; Csizmadia, Szilard; Padovan, Sebastiano; Smith, Alexis M. S.; Eigmueller, Philipp; Rauer, Heike] German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; [Astudillo-Defru, Nicola] Univ Catolica Santisima Concepcion, Dept Matemat & Fis Aplicadas, Concepcion, Chile; [Bonfils, Xavier; Almenara, Jose M.; Artigau, Etienne; Cabrera, Juan; Delfosse, Xavier; Forveille, Thierry; Gaisne, Guillaume] Univ Grenoble Alpes, CNRS, Inst Planetol & Astrophys Grenoble, F-38000 Grenoble, France; [Gandolfi, Davide; Goffo, Elisa; Serrano, Luisa M.] Univ Torino, Dipartimento Fis, I-10125 Turin, Italy; [Padovan, Sebastiano] WorkGrp Solut GmbH European Org Exploitat Meteoro, D-64295 Darmstadt, Germany; [Esposito, Massimiliano; Chaturvedi, Priyanka; Goffo, Elisa; Guenther, Eike; Hatzes, Artie P.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Hellier, Coel] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Hirano, Teruyuki] Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo, Japan; [Livingston, John] Univ Tokyo, Dept Astron, Tokyo, Japan; [Murgas, Felipe; Mathur, Savita; Luque, Rafael; Narita, Norio; Palle, Enric] Inst Astrofis Canarias, Tenerife 38205, Spain; [Murgas, Felipe; Mathur, Savita; Luque, Rafael; Palle, Enric] Univ La Laguna, Dept Astrofis, Tenerife 38206, Spain; [Collins, Karen A.; Latham, David W.; Charbonneau, David; Quinn, Samuel N.] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA USA; [Garcia, Rafael A.] Univ Paris Saclay, Inst Rech Lois Fondamentales Universe, Commissariat Energie Atom & Energies Alternat, F-91191 Gif Sur Yvette, France; [Garcia, Rafael A.] Univ Paris Saclay, Univ Paris Diderot, CNRS,Sorbonne Paris Cite,Astrophys Instrumentat &, Commissariat Energie Atom & Energies Alternat, F-91191 Gif Sur Yvette, France; [Howell, Steve B.; Jenkins, Jon M.; Lissauer, Jack J.; Morris, Robert; Smith, Jeffrey C.; Twicken, Joseph D.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Santos, Nuno C.; Figueira, Pedro] Univ Porto, Ctr Astrofis, Inst Astrofis & Cienciasdo Espaco, P-4150762 Porto, Portugal; [Santos, Nuno C.] Univ Porto, Fac Ciencias, Dept Fis & Astron, P-4169007 Porto, Portugal; [Dai, Fei] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Ricker, George R.; Vanderspek, Roland; Seager, Sara; Morgan, Edward H.; Vezie, Michael] MIT, Dept Phys, Cambridge, MA 02139 USA; [Ricker, George R.; Vanderspek, Roland; Seager, Sara; Morgan, Edward H.; Vezie, Michael] MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Seager, Sara] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Seager, Sara] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Winn, Joshua N.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Albrecht, Simon; Knudstrup, Emil] Aarhus Univ, Stellar Astrophys Ctr, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Barragan, Oscar] Univ Oxford, Subdept Astrophys, Dept Phys, Oxford, England; [Bouchy, Francois; Lovis, Christophe; Mayor, Michel; Pepe, Francesco; Segransan, Damien; Udry, Stephane] Univ Geneva, Geneva Observ, CH-1290 Versoix, Switzerland; [Christiansen, Jessie L.] CALTECH, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Cochran, William D.] Univ Texas Austin, Ctr Planetary Syst Habitabil, Austin, TX 78712 USA; [Cochran, William D.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [De Meideiros, Jose R.] Univ Fed Rio Grande do Norte, Dept Fis, BR-59072970 Natal, RN, Brazil; [Diaz, Rodrigo F.] Univ Nacl San Martin, Int Ctr Adv Studies, Escuela Ciencia & Tecnol, CONICET, Campus Miguelete, Buenos Aires, DF, Argentina; [Diaz, Rodrigo F.] Univ Nacl San Martin, Inst Ciencias Fis, Escuela Ciencia & Tecnol, CONICET, Campus Miguelete, Buenos Aires, DF, Argentina; [Doyon, Rene] Univ Montral, Inst Rech Exoplantes, Montreal, PQ H3C 3J7, Canada; [Figueira, Pedro; Melo, Claudio] European Southern Observ, Santiago, Chile; [Fridlund, Malcolm; Georgieva, Iskra; Persson, Carina M.] Chalmers Univ Technol, Dept Space Earth & Environm, Onsala Space Observ, S-43992 Onsala, Sweden; [Fridlund, Malcolm] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Grziwa, Sascha; Korth, Judith] Univ Cologne, Rhein Inst Umweltforsch, D-50931 Cologne, Germany; [Johnson, Marshall C.] Las Cumbres Observ, Goleta, CA USA; [Kabath, Petr; Subjak, Jan] Czech Acad Sci, Astron Inst, Ondrejov 25165, Czech Republic; [Korth, Judith] Chalmers Univ Technol, Dept Space Earth & Environm, Astron & Plasma Phys, S-41296 Gothenburg, Sweden; [Lewin, Pablo] Maury Lewin Astron Observ, Glendora, CA USA; [Lissauer, Jack J.] Stanford Univ, Geol Sci Dept, Stanford, CA 94305 USA; [Morris, Robert; Smith, Jeffrey C.; Twicken, Joseph D.] Search Extraterr Intelligence Inst, Mountain View, CA USA; [Narita, Norio] Univ Tokyo, Komaba Inst Sci, Tokyo, Japan; [Narita, Norio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Narita, Norio] Astrobiol Ctr, Tokyo, Japan; [Osborne, Hannah L. M.; Van Eylen, Vincent] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Rauer, Heike] Free Univ Berlin, Inst Geol Sci, D-12249 Berlin, Germany; [Redfield, Seth] Wesleyan Univ, Astron Dept, Middletown, CT USA; [Redfield, Seth] Wesleyan Univ, Van Vleck Observ, Middletown, CT 06457 USA; [Schlieder, Joshua E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Subjak, Jan] Charles Univ Prague, Astron Inst, Prague 18000, Czech Republic	Technical University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Universidad Catolica de la Santisima Concepcion; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of Turin; Keele University; Tokyo Institute of Technology; University of Tokyo; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Smithsonian Institution; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universidade do Porto; Universidade do Porto; California Institute of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University; Aarhus University; University of Oxford; University of Geneva; California Institute of Technology; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Universidade Federal do Rio Grande do Norte; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universite de Montreal; European Southern Observatory; Chalmers University of Technology; Leiden University; Leiden University - Excl LUMC; University of Cologne; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Chalmers University of Technology; Stanford University; University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Astrobiology Center (ABC); University of London; University College London; Free University of Berlin; Wesleyan University; Wesleyan University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Charles University Prague	Lam, KWF (corresponding author), Tech Univ Berlin, Ctr Astron & Astrophys, D-10585 Berlin, Germany.; Lam, KWF (corresponding author), German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany.	kristine.lam@dlr.de	Subjak, Jan/AGF-0343-2022; Cochran, William D/M-4421-2014; Figueira, Pedro/J-4916-2013; Korth, Judith/AAD-4541-2022; Santos, Nuno/E-9957-2011	Cochran, William D/0000-0001-9662-3496; Figueira, Pedro/0000-0001-8504-283X; Korth, Judith/0000-0002-0076-6239; Livingston, John/0000-0002-4881-3620; Lewin, Pablo/0000-0003-0828-6368; Christiansen, Jessie/0000-0002-8035-4778; Bouchy, Francois/0000-0002-7613-393X; Astudillo-Defru, Nicola/0000-0002-8462-515X; Murgas, Felipe/0000-0001-9087-1245; Hellier, Coel/0000-0002-3439-1439; Gandolfi, Davide/0000-0001-8627-9628; Pepe, Francesco/0000-0002-9815-773X; Latham, David/0000-0001-9911-7388; Van Eylen, Vincent/0000-0001-5542-8870; udry, Stephane/0000-0001-7576-6236; Esposito, Massimiliano/0000-0002-6893-4534; /0000-0003-1257-5146; Albrecht, Simon/0000-0003-1762-8235; Padovan, Sebastiano/0000-0002-8652-3704; Barragan, Oscar/0000-0003-0563-0493; Cabrera, Juan/0000-0001-6653-5487; Hirano, Teruyuki/0000-0003-3618-7535; Santos, Nuno/0000-0003-4422-2919; Bonfils, Xavier/0000-0001-9003-8894	Deutsche Forschungsgemeinschaft [PA525/18-1, PA525/19-1, PA525/20-1, HA3279/12-1, RA714/14-1, SPP 1992]; JSPS KAKENHI [JP19K14783, JP18H01265, JP18H05439, JP20K14518]; JST PRESTO [JPMJPR1775]; PLATO CNES grant; GOLF CNES grant; MSMT [LTT20015]; Spanish Ministry of Science and Innovation [RYC-2015-17697, PID2019-107187GB-I00]; Fundacao para a Ciencia e a Tecnologia; FEDER through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao [UID/FIS/04434/2019, UIDB/04434/2020, UIDP/04434/2020, PTDC/FIS-AST/32113/2017, POCI-01-0145-FEDER-032113, PTDC/FIS-AST/28953/2017, POCI-01-0145-FEDER-028953]; Investissements d'Avenir program [ANR-15-IDEX-02]; CNPq Brazilian agency; CAPES Brazilian agency; FAPERN Brazilian agency; FONDECYT [3180063]; Danish National Research Foundation [DNRF106]; Cassa di Risparmio di Torino foundation [2018.2323]; Deutsche Forschungsgemeinschaft Research Unit 2440, Matter Under Planetary Interior Conditions: High Pressure Planetary and Plasma Physics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST)); PLATO CNES grant; GOLF CNES grant; MSMT(Ministry of Education, Youth & Sports - Czech Republic); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao; Investissements d'Avenir program(French National Research Agency (ANR)); CNPq Brazilian agency(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Brazilian agency(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERN Brazilian agency(Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Danish National Research Foundation(Danmarks Grundforskningsfond); Cassa di Risparmio di Torino foundation; Deutsche Forschungsgemeinschaft Research Unit 2440, Matter Under Planetary Interior Conditions: High Pressure Planetary and Plasma Physics	K.W.F.L., Sz.Cs., M.E., S.G., A.P.H., and H.R. were supported by Deutsche Forschungsgemeinschaft grants PA525/18-1, PA525/19-1, PA525/20-1, HA3279/12-1, and RA714/14-1 within the DFG Schwerpunkt SPP 1992, Exploring the Diversity of Extrasolar Planets. Sz.Cs. is supported by Deutsche Forschungsgemeinschaft Research Unit 2440, Matter Under Planetary Interior Conditions: High Pressure Planetary and Plasma Physics. T.H. was supported by JSPS KAKENHI grant no. JP19K14783, and N.N. was supported by JSPS KAKENHI grant nos. JP18H01265 and JP18H05439 and JST PRESTO grant no. JPMJPR1775. J.L. is supported by JSPS KAKENHI grant no. JP20K14518. R.A.G. acknowledges support from PLATO and GOLF CNES grants. P.K. acknowledges support from the MSMT grant LTT20015. S.M. acknowledges support by the Spanish Ministry of Science and Innovation with the Ramon y Cajal fellowship no. RYC-2015-17697 and grant no. PID2019-107187GB-I00. N.C.S. was supported by Fundacao para a Ciencia e a Tecnologia through national funds and by FEDER through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao grants UID/FIS/04434/2019, UIDB/04434/2020, UIDP/04434/2020, PTDC/FIS-AST/32113/2017 and POCI-01-0145-FEDER-032113, and PTDC/FIS-AST/28953/2017 and POCI-01-0145-FEDER-028953. X.D. and G.G. acknowledge funding in the framework of the Investissements d'Avenir program (ANR-15-IDEX-02), Origin of Life project of the Universite GrenobleAlpes. J.R.D.M. acknowledges grants from CNPq, CAPES, and FAPERN Brazilian agencies. N.A.-D. acknowledges support from FONDECYT project 3180063. Resources for the production of the SPOC data products were provided by the NASA High-End Computing (HEC) program through the NASA Advanced Supercomputing (NAS) Division at Ames Research Center. S.A. is supported by the Danish National Research Foundation (grant agreement no. DNRF106). D.G. and L.M.S. acknowledge financial support from the Cassa di Risparmio di Torino foundation under grant no. 2018.2323, "Gaseous or rocky? Unveiling the nature of small worlds."	Almenara JM, 2018, MON NOT R ASTRON SOC, V478, P460, DOI 10.1093/mnras/sty1050; Angus R, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab3c53; Antoniadis-Karnavas A, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/201937194; Astudillo-Defru N, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201527078; Astudillo-Defru N, 2017, ASTRON ASTROPHYS, V602, DOI 10.1051/0004-6361/201630153; Barnes SA, 2010, ASTROPHYS J, V722, P222, DOI 10.1088/0004-637X/722/1/222; Barnes SA, 2010, ASTROPHYS J, V721, P675, DOI 10.1088/0004-637X/721/1/675; Barragan O, 2018, ASTRON ASTROPHYS, V612, DOI 10.1051/0004-6361/201732217; Baumeister P, 2020, ASTROPHYS J, V889, DOI 10.3847/1538-4357/ab5d32; Bensby T, 2003, ASTRON ASTROPHYS, V410, P527, DOI 10.1051/0004-6361:20031213; Bishop CM., 1995, NEURAL NETWORKS PATT; Bonfils X, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201014704; Bridger A, 2010, SOFTWARE CYBERINFRAS, V7740; Brown AGA, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833051; Brown TM, 2013, PUBL ASTRON SOC PAC, V125, P1031, DOI 10.1086/673168; Cabrera J, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219337; Morales JC, 2010, ASTROPHYS J, V718, P502, DOI 10.1088/0004-637X/718/1/502; Carter JA, 2009, ASTROPHYS J, V704, P51, DOI 10.1088/0004-637X/704/1/51; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Ceillier T, 2017, ASTRON ASTROPHYS, V605, DOI 10.1051/0004-6361/201629884; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Chen JJ, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/17; Ciardi DR, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/16; Cifuentes C, 2020, ASTRON ASTROPHYS, V642, DOI 10.1051/0004-6361/202038295; Claret A, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201629705; Collins KA, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/153/2/77; Costa E, 2006, ASTRON J, V132, P2360, DOI 10.1086/508233; Covino S, 2004, PROC SPIE, V5492, P1613, DOI 10.1117/12.551532; Croll B, 2006, PUBL ASTRON SOC PAC, V118, P1354, DOI 10.1086/507773; Csizmadia S, 2020, MON NOT R ASTRON SOC, V496, P4442, DOI 10.1093/mnras/staa349; Csizmadia S, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201526763; Cutri R.M., 2003, 2MASS ALL SKY CATALO; Dai F, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa9065; Dorn C, 2017, ASTRON ASTROPHYS, V597, DOI 10.1051/0004-6361/201628749; Dressing CD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/45; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Eigmuller P, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa5d0b; Garcia RA, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201423888; Garcia RA, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201323326; Gaudi BS, 2007, ASTROPHYS J, V655, P550, DOI 10.1086/509910; Gillon M, 2017, NATURE, V542, P456, DOI 10.1038/nature21360; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Grziwa S, 2012, MON NOT R ASTRON SOC, V420, P1045, DOI 10.1111/j.1365-2966.2011.19970.x; Hatzes, 2019, DOPPLER METHOD DETEC; Hatzes AP, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424025; Hatzes AP, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014795; Hirano T, 2018, ASTRON J, V155, DOI 10.3847/1538-3881/aaa9c1; Howell SB, 2021, FRONT ASTRON SPACE, V8, DOI 10.3389/fspas.2021.635864; Howell SB, 2016, ASTROPHYS J LETT, V829, DOI 10.3847/2041-8205/829/1/L2; Howell SB, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/19; Huber D, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/143; Jenkins JM, 2002, ASTROPHYS J, V575, P493, DOI 10.1086/341136; Jenkins JM, 2016, PROC SPIE, V9913, DOI 10.1117/12.2233418; Jenkins JM, 2010, PROC SPIE, V7740, DOI 10.1117/12.856764; Jontof-Hutter D, 2015, NATURE, V522, P321, DOI 10.1038/nature14494; Jorgensen BR, 2005, ASTRON ASTROPHYS, V436, P127, DOI 10.1051/0004-6361:20042185; Korth J, 2020, THESIS U ZU KOLN; Kraus AL, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/48; Lam, 2021, ARXIV210811822ASTROP; Leger A, 2011, ICARUS, V213, P1, DOI 10.1016/j.icarus.2011.02.004; Lester KV, 2021, ASTRON J, V162, DOI 10.3847/1538-3881/ac0d06; Li J, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/aaf44d; Lo Curto G., 2015, MESSENGER, V162, P9; Lopez ED, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/1; Lovis C, 2007, ASTRON ASTROPHYS, V468, P1115, DOI 10.1051/0004-6361:20077249; Kempton EMR, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aadf6f; Malavolta L, 2018, ASTRON J, V155, DOI 10.3847/1538-3881/aaa5b5; Mann AW, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/64; Martins BLC, 2020, ASTROPHYS J SUPPL S, V250, DOI 10.3847/1538-4365/aba73f; Mathur S, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913266; Matson RA, 2018, ASTRON J, V156, DOI 10.3847/1538-3881/aac778; Maxted PFL, 2011, PUBL ASTRON SOC PAC, V123, P547, DOI 10.1086/660007; Mayor M., 2003, MESSENGER, V114, P20; McQuillan A, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/24; Morton T.D., 2015, ISOCHRONES STELLAR M; MURDOCH KA, 1993, ASTROPHYS J, V413, P349, DOI 10.1086/173003; Patra KC, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa6d75; Pettitt A. N, 2013, ARXIV13062144ASTROPH; Pires S, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201322361; Pollacco DL, 2006, PUBL ASTRON SOC PAC, V118, P1407, DOI 10.1086/508556; PRESS WH, 1992, NUMERICAL RECIPES; Prusti T, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629272; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Ricker GR, 2016, PROC SPIE, V9904, DOI 10.1117/12.2232071; Saar SH, 1997, ASTROPHYS J, V485, P319, DOI 10.1086/304392; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SALPETER EE, 1967, PHYS REV, V158, P876, DOI 10.1103/PhysRev.158.876; Santerne A, 2018, NAT ASTRON, V2, P393, DOI 10.1038/s41550-018-0420-5; Santos ARG, 2019, ASTROPHYS J SUPPL S, V244, DOI 10.3847/1538-4365/ab3b56; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Scott N.J., 2019, AASDIVISION EXTREME, V51; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Smith AMS, 2014, CONTRIB ASTRON OBS S, V43, P500; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; Smith JC, 2012, PUBL ASTRON SOC PAC, V124, P1000, DOI 10.1086/667697; Stassun KG, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab3467; Stassun KG, 2018, ASTROPHYS J, V862, DOI 10.3847/1538-4357/aacafc; Stelzer B, 2013, MON NOT R ASTRON SOC, V431, P2063, DOI 10.1093/mnras/stt225; Stumpe MC, 2014, PUBL ASTRON SOC PAC, V126, P100, DOI 10.1086/674989; Stumpe MC, 2012, PUBL ASTRON SOC PAC, V124, P985, DOI 10.1086/667698; Mascareno AS, 2020, ASTRON ASTROPHYS, V639, DOI 10.1051/0004-6361/202037745; Sullivan PW, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/77; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torres G, 2013, ASTRON NACHR, V334, P4, DOI 10.1002/asna.201211743; Twicken JD, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aab694; Winn J. N, 2010, ARXIV10012010ASTROPH; Yee SW, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/836/1/77; Zechmeister M, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201731483; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296; Zeng L, 2019, P NATL ACAD SCI USA, V116, P9723, DOI 10.1073/pnas.1812905116; Zeng L, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/2/127; Zeng L, 2013, PUBL ASTRON SOC PAC, V125, P227, DOI 10.1086/669163	124	10	10	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1271	+		10.1126/science.aay3253	http://dx.doi.org/10.1126/science.aay3253			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855492	Green Submitted, Green Accepted			2022-12-28	WOS:000728578700061
J	Spinelli, JB; Rosen, PC; Sprenger, HG; Puszynska, AM; Mann, JL; Roessler, JM; Cangelosi, AL; Henne, A; Condon, KJ; Zhang, T; Kunchok, T; Lewis, CA; Chandel, NS; Sabatini, DM				Spinelli, Jessica B.; Rosen, Paul C.; Sprenger, Hans-Georg; Puszynska, Anna M.; Mann, Jessica L.; Roessler, Julian M.; Cangelosi, Andrew L.; Henne, Antonia; Condon, Kendall J.; Zhang, Tong; Kunchok, Tenzin; Lewis, Caroline A.; Chandel, Navdeep S.; Sabatini, David M.			Fumarate is a terminal electron acceptor in the mammalian electron transport chain	SCIENCE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; REDUCTIVE CARBOXYLATION; CANCER-CELLS; COMPLEX-I; OXYGEN; HYPOXIA; SUCCINATE; ACCUMULATION; METABOLISM	For electrons to continuously enter and flow through the mitochondrial electron transport chain (ETC), they must ultimately land on a terminal electron acceptor (TEA), which is known to be oxygen in mammals. Paradoxically, we find that complex I and dihydroorotate dehydrogenase (DHODH) can still deposit electrons into the ETC when oxygen reduction is impeded. Cells lacking oxygen reduction accumulate ubiquinol, driving the succinate dehydrogenase (SDH) complex in reverse to enable electron deposition onto fumarate. Upon inhibition of oxygen reduction, fumarate reduction sustains DHODH and complex I activities. Mouse tissues display varying capacities to use fumarate as a TEA, most of which net reverse the SDH complex under hypoxia. Thus, we delineate a circuit of electron flow in the mammalian ETC that maintains mitochondrial functions under oxygen limitation.	[Spinelli, Jessica B.; Rosen, Paul C.; Sprenger, Hans-Georg; Puszynska, Anna M.; Mann, Jessica L.; Roessler, Julian M.; Cangelosi, Andrew L.; Henne, Antonia; Condon, Kendall J.; Zhang, Tong; Kunchok, Tenzin; Lewis, Caroline A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Spinelli, Jessica B.; Rosen, Paul C.; Sprenger, Hans-Georg; Puszynska, Anna M.; Mann, Jessica L.; Roessler, Julian M.; Cangelosi, Andrew L.; Condon, Kendall J.; Zhang, Tong] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Rosen, Paul C.; Mann, Jessica L.; Roessler, Julian M.; Cangelosi, Andrew L.; Condon, Kendall J.; Zhang, Tong; Sabatini, David M.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwestern University; Feinberg School of Medicine	Spinelli, JB (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Spinelli, JB (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.	spinelli@wi.mit.edu		Zhang, Tong/0000-0003-4745-8580; Rosen, Paul/0000-0001-7414-454X; Spinelli, Jessica/0000-0003-3657-4578; /0000-0002-9515-8892	NCI [F31 CA254162-01, K00CA234839]; DFG (Deutsche Forschungsgemeinschaft) [SP 1897/1-1]; Hope Funds for Cancer Research [HFCR-20-03-01]; William N. and Bernice E. Bumpus Fellowship; NIH F31 predoctoral fellowship [F31 5F31DK113665]; MIT School of Science Fellowship in Cancer Research; NSF fellowship [2016197106]; NIH [R35CA197532, 5P01AG049665];  [R01CA219859]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Hope Funds for Cancer Research; William N. and Bernice E. Bumpus Fellowship; NIH F31 predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT School of Science Fellowship in Cancer Research; NSF fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was funded by an R01 application granted to D.M.S. (R01CA219859). J.B.S. is funded by the NCI F99/K00 predoctoral to postdoctoral transition fellowship (K00CA234839) and P.C.R. by a predoctoral fellowship from the NCI (F31 CA254162-01). H.G.S. is funded by the DFG (Deutsche Forschungsgemeinschaft; SP 1897/1-1) and is a Hope Funds for Cancer Research Fellow supported by the Hope Funds for Cancer Research (HFCR-20-03-01). A.M.P. is funded by a William N. and Bernice E. Bumpus Fellowship, A.L.C. by an NIH F31 predoctoral fellowship (F31 5F31DK113665), K.J.C. by an MIT School of Science Fellowship in Cancer Research and an NSF fellowship (2016197106), and N.S.C. by NIH grants (R35CA197532 and 5P01AG049665). D.M.S. is formerly an investigator of the Howard Hughes Medical Institute.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Anso E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529; Ast T, 2019, NAT METAB, V1, P858, DOI 10.1038/s42255-019-0105-0; Bajzikova M, 2019, CELL METAB, V29, P399, DOI 10.1016/j.cmet.2018.10.014; Bisbach CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107606; Boukalova S, 2016, MOL CANCER THER, V15, P2875, DOI 10.1158/1535-7163.MCT-15-1021; Brown KK, 2017, CANCER DISCOV, V7, P391, DOI 10.1158/2159-8290.CD-16-0611; Burger N, 2020, FREE RADICAL BIO MED, V147, P37, DOI 10.1016/j.freeradbiomed.2019.11.028; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Chan SW, 2009, METHODS MOL BIOL, V554, P183, DOI 10.1007/978-1-59745-521-3_12; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chinopoulos C, 2019, INT J BIOCHEM CELL B, V115, DOI 10.1016/j.biocel.2019.105580; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Condon KJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022120118; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia-Bermudez J, 2018, NAT CELL BIOL, V20, P775, DOI 10.1038/s41556-018-0118-z; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Heinrich P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36293-4; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; HOCHACHKA PW, 1976, EUR J APPL PHYSIOL O, V35, P235, DOI 10.1007/BF00423282; Jain IH, 2020, CELL, V181, P716, DOI 10.1016/j.cell.2020.03.029; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lau AN, 2020, ANNU REV CANC BIOL, V4, P17, DOI 10.1146/annurev-cancerbio-030419-033333; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; Martinez-Reyes I, 2020, NATURE, V585, P288, DOI 10.1038/s41586-020-2475-6; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Palm F, 2006, CLIN EXP PHARMACOL P, V33, P997, DOI 10.1111/j.1440-1681.2006.04473.x; Peacock AJ, 1998, BRIT MED J, V317, P1063; Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pershad HR, 1999, BBA-BIOENERGETICS, V1412, P262, DOI 10.1016/S0005-2728(99)00066-3; Reddy A, 2020, CELL, V183, P62, DOI 10.1016/j.cell.2020.08.039; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tielens AGM, 1998, BBA-BIOENERGETICS, V1365, P71, DOI 10.1016/S0005-2728(98)00045-0; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; WILSON DF, 1988, J BIOL CHEM, V263, P2712; Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420; Zhang J, 2018, CELL REP, V23, P2617, DOI 10.1016/j.celrep.2018.04.104; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015	64	26	26	23	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1227	+		10.1126/science.abi7495	http://dx.doi.org/10.1126/science.abi7495			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855504	Green Accepted			2022-12-28	WOS:000728578700053
J	Vignieri, S				Vignieri, Sacha			The Great Bear Rescue: Saving the Gobi Bears	SCIENCE			English	Book Review																		STEWART H, 2020, GREAT BEAR RESCUE SA	1	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1190	1190						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855482				2022-12-28	WOS:000728578700019
J	Amunts, K; Lippert, T				Amunts, Katrin; Lippert, Thomas			Brain research challenges supercomputing Big data obtained from unraveling human brain structure raise processing demands	SCIENCE			English	Editorial Material									[Amunts, Katrin] Forschungszentrum Julich, INM 1, Inst Neurowissensch & Med, Julich, Germany; [Lippert, Thomas] Forschungszentrum Julich, Julich Supercomp Ctr, Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Amunts, K (corresponding author), Forschungszentrum Julich, INM 1, Inst Neurowissensch & Med, Julich, Germany.	k.amunts@fz-juelich.de; th.lippert@fz.juelich.de			European Union's Horizon 2020 Research and Innovation Programme [945539]	European Union's Horizon 2020 Research and Innovation Programme	The authors are supported by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement no. 945539 (HBP SGA3).	Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Axer Markus, 2011, Front Neuroinform, V5, P34, DOI 10.3389/fninf.2011.00034; Brittin CA, 2021, NATURE, V591, P105, DOI 10.1038/s41586-021-03284-x; Einevoll GT, 2019, NEURON, V102, P735, DOI 10.1016/j.neuron.2019.03.027; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Leuze C, 2021, NEUROIMAGE, V228, DOI 10.1016/j.neuroimage.2020.117692; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Mota B, 2019, P NATL ACAD SCI USA, V116, P15253, DOI 10.1073/pnas.1716956116; Rockland KS, 2020, BRAIN STRUCT FUNCT, V225, P1327, DOI 10.1007/s00429-019-02023-3; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Suarez E., 2019, CONT HIGH PERFORMANC, VThree, P223; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Zeineh MM, 2017, CEREB CORTEX, V27, P1779, DOI 10.1093/cercor/bhw010; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019	14	3	4	5	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1054	1055		10.1126/science.abl8519	http://dx.doi.org/10.1126/science.abl8519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822267				2022-12-28	WOS:000725668600021
J	Iacobucci, G				Iacobucci, Gareth			Over half of general practices in England would quit primary care networks, indicative ballot shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2564; NHS, 2021, OUR PLAN IMPR ACC PA	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2924	10.1136/bmj.n2924	http://dx.doi.org/10.1136/bmj.n2924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836930				2022-12-28	WOS:000727787900017
J	Khan, M; Yoo, SJ; Clijsters, M; Backaert, W; Vanstapel, A; Speleman, K; Lietaer, C; Choi, S; Hether, TD; Marcelis, L; Nam, A; Pan, LL; Reeves, JW; Van Bulck, P; Zhou, H; Bourgeois, M; Debaveye, Y; De Munter, P; Gunst, J; Jorissen, M; Lagrou, K; Lorent, N; Neyrinck, A; Peetermans, M; Thal, DR; Vandenbriele, C; Wauters, J; Mombaerts, P; Van Gerven, L				Khan, Mona; Yoo, Seung-Jun; Clijsters, Marnick; Backaert, Wout; Vanstapel, Arno; Speleman, Kato; Lietaer, Charlotte; Choi, Sumin; Hether, Tyler D.; Marcelis, Lukas; Nam, Andrew; Pan, Liuliu; Reeves, Jason W.; Van Bulck, Pauline; Zhou, Hai; Bourgeois, Marc; Debaveye, Yves; De Munter, Paul; Gunst, Jan; Jorissen, Mark; Lagrou, Katrien; Lorent, Natalie; Neyrinck, Arne; Peetermans, Marijke; Thal, Dietmar Rudolf; Vandenbriele, Christophe; Wauters, Joost; Mombaerts, Peter; Van Gerven, Laura			Article Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb	CELL			English	Article							RNA; NERVE; EPITHELIUM; RECEPTOR; ANATOMY; IDENTIFICATION; LOCALIZATION; MORPHOLOGY; INFECTION; OUTBREAK	Anosmia, the loss of smell, is a common and often the sole symptom of COVID-19. The onset of the sequence of pathobiological events leading to olfactory dysfunction remains obscure. Here, we have developed a postmortem bedside surgical procedure to harvest endoscopically samples of respiratory and olfactory mucosae and whole olfactory bulbs. Our cohort of 85 cases included COVID-19 patients who died a few days after infection with SARS-CoV-2, enabling us to catch the virus while it was still replicating. We found that sustentacular cells are the major target cell type in the olfactory mucosa. We failed to find evidence for infection of olfactory sensory neurons, and the parenchyma of the olfactory bulb is spared as well. Thus, SARS-CoV-2 does not appear to be a neurotropic virus. We postulate that transient insufficient support from sustentacular cells triggers transient olfactory dysfunction in COVID-19. Olfactory sensory neurons would become affected without getting infected.	[Khan, Mona; Yoo, Seung-Jun; Zhou, Hai; Mombaerts, Peter] Max Planck Res Unit Neurogenet, Frankfurt, Germany; [Clijsters, Marnick; Jorissen, Mark; Van Gerven, Laura] Katholieke Univ Leuven, Dept Neurosci Expt Otorhinolaryngol Rhinol Res, Leuven, Belgium; [Backaert, Wout; Van Gerven, Laura] Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium; [Backaert, Wout; Van Gerven, Laura] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Allergy & Clin Immunol Res Unit, Leuven, Belgium; [Vanstapel, Arno] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium; [Speleman, Kato; Lietaer, Charlotte] AZ SintJan BruggeOostende AV, Dept Otorhinolaryngol Head & Neck Surg, Brugge, Belgium; [Hether, Tyler D.; Nam, Andrew; Pan, Liuliu; Reeves, Jason W.] NanoString Technol Inc, Seattle, WA USA; [Bourgeois, Marc] AZ SintJan BruggeOostende AV, Dept Anesthesiol & Intens Care Med, Brugge, Belgium; [Debaveye, Yves; Gunst, Jan] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Debaveye, Yves; Gunst, Jan] Katholieke Univ Leuven, Lab Intens Care Med, Dept Cellular & Mol Med, Leuven, Belgium; [De Munter, Paul; Wauters, Joost] Univ Hosp Leuven, Dept Gen Internal Med, Leuven, Belgium; [De Munter, Paul] Katholieke Univ Leuven, Lab Clin Infect & Inflammatory Disorders, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Lagrou, Katrien] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium; [Lagrou, Katrien] Univ Hosp Leuven, Natl Reference Ctr Resp Pathogens, Leuven, Belgium; [Lagrou, Katrien] Katholieke Univ Leuven, Lab Clin Bacteriol & Mycol, Dep Microbiol Immunol & Transplantat, Leuven, Belgium; [Lorent, Natalie] Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium; [Neyrinck, Arne] Univ Hosp Leuven, Dept Anesthesia, Leuven, Belgium; [Neyrinck, Arne] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [Thal, Dietmar Rudolf] Katholieke Univ Leuven, Lab Neuropathol, Dept Imaging & Pathol, Leuven, Belgium; [Thal, Dietmar Rudolf] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium; [Vandenbriele, Christophe] Univ Hosp Leuven, Dept Cardiovasc Dis, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Mombaerts, P (corresponding author), Max Planck Res Unit Neurogenet, Frankfurt, Germany.; Van Gerven, L (corresponding author), Katholieke Univ Leuven, Dept Neurosci Expt Otorhinolaryngol Rhinol Res, Leuven, Belgium.; Van Gerven, L (corresponding author), Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium.; Van Gerven, L (corresponding author), Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Allergy & Clin Immunol Res Unit, Leuven, Belgium.	peter.mombaerts@gen.mpg.de; laura.vangerven@uzleuven.be	Van Gerven, Laura/ABG-5800-2021; Gunst, Jan/L-9099-2018; Vanstapel, Arno/AAD-6103-2020; Thal, Dietmar R/O-7483-2018; Vandenbriele, Christophe/ABF-7540-2020; Peetermans, Marijke/H-1389-2015	Van Gerven, Laura/0000-0002-5325-7956; Gunst, Jan/0000-0003-2470-6393; Vanstapel, Arno/0000-0003-2412-8001; Thal, Dietmar R/0000-0002-1036-1075; Vandenbriele, Christophe/0000-0001-5151-6400; Marcelis, Lukas/0000-0002-5446-1801; Backaert, Wout/0000-0001-7942-3345; Lietaer, Charlotte/0000-0003-2957-5433; Peetermans, Marijke/0000-0002-9230-1403; Clijsters, Marnick/0000-0002-8055-9669	University Hospitals Leuven (KOOR-UZ Leuven); Research Foundation Flanders (FWO) [1833317N, 18B2222N]; Max Planck Society	University Hospitals Leuven (KOOR-UZ Leuven); Research Foundation Flanders (FWO)(FWO); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank the nurses, doctors, and staff of the COVID-19 ICUs and wards of the University Hospitals Leuven and the General Hospital Sint-Jan Brugge-Oostende and the transplant coordination team of the University Hospitals Leuven for their unwavering support and enthusiastic cooperation; Bart De Beir, Olivia Dimanski, Ling Li, Florian Lindenblatt, and Erick Rea Escalante for technical support; Patrick Meeze and Tillman Suhr for drawings; Ayse Dereli for inspiring discussions; and Thomas Boehm, Nils-Goran Larsson, and Bert Vandeloo for comments on a draft of the manuscript. C.V. and L.V.G. were supported by post-doctoral grants from the University Hospitals Leuven (KOOR-UZ Leuven). J.W. and L.V.G. were supported by Research Foundation Flanders (FWO): Senior Clinical Investigator Fellowship 1833317N and 18B2222N respectively. P.M. acknowledges the financial support of the Max Planck Society.	Acevedo C, 2019, FEBS LETT, V593, P601, DOI 10.1002/1873-3468.13346; Ahn JH, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148517; [Anonymous], HEAD NECK SURG, V146, P674; Auton A., 2021, UGT2A1 UGT2A2 LOCUS, DOI [10.1101/2021.05.28.21257993, DOI 10.1101/2021.05.28.21257993]; Balcom EF, 2021, BRAIN, V144, P3576, DOI 10.1093/brain/awab302; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Barnes IHA, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6583-3; Beechem JM, 2020, METHODS MOL BIOL, V2055, P563, DOI 10.1007/978-1-4939-9773-2_25; Boulagnon-Rombi C, 2017, J NEUROPATH EXP NEUR, V76, P289, DOI 10.1093/jnen/nlx008; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Brant AC, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00643-z; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burke JM, 2021, RNA, V27, P1318, DOI 10.1261/rna.078923.121; Butowt R, 2021, ACTA NEUROPATHOL, V141, P809, DOI 10.1007/s00401-021-02314-2; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cecchini MP, 2022, NEUROL SCI, V43, P99, DOI 10.1007/s10072-021-05635-y; Ceulemans LJ, 2021, LANCET RESP MED, V9, pE78, DOI 10.1016/S2213-2600(21)00240-X; Ceulemans LJ, 2021, LANCET RESP MED, V9, P315, DOI 10.1016/S2213-2600(20)30524-5; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Cooper KW, 2020, NEURON, V107, P219, DOI 10.1016/j.neuron.2020.06.032; COSTANZO RM, 1989, J NEUROCYTOL, V18, P381, DOI 10.1007/BF01190841; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; de Melo GD, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8396; Delorey TM, 2021, NATURE, V595, P107, DOI 10.1038/s41586-021-03570-8; DIAERESISERS JCL, 2020, LARYNGO RHINO OTOL, V99, P287; Durante MA, 2020, NAT NEUROSCI, V23, P323, DOI 10.1038/s41593-020-0587-9; Eliezer M, 2020, JAMA OTOLARYNGOL, V146, P674, DOI 10.1001/jamaoto.2020.0832; ENGSTROM H, 1953, ACTA OTO-LARYNGOL, V43, P11, DOI 10.3109/00016485309119814; Escada P, 2013, ACTA MEDICA PORT, V26, P200; FAVRE JJ, 1995, SURG RADIOL ANAT, V17, P133, DOI 10.1007/BF01627573; Finkel Y, 2021, NATURE, V594, P240, DOI 10.1038/s41586-021-03610-3; Fodoulian L, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101839; Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759; Gagliardi S, 2021, BRAIN BEHAV IMMUN, V97, P13, DOI 10.1016/j.bbi.2021.05.012; Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Holbrook EH, 2005, LARYNGOSCOPE, V115, P2144, DOI 10.1097/01.MLG.0000181493.83661.CE; Holbrook EH, 2011, LARYNGOSCOPE, V121, P1687, DOI 10.1002/lary.21856; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Hwang Chi-Shin, 2006, Acta Neurol Taiwan, V15, P26; Iwasaki A, 2016, ANNU REV IMMUNOL, V34, P575, DOI 10.1146/annurev-immunol-032414-112315; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Jarhult JD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86500-y; Jerby-Arnon L, 2021, NAT MED, V27, P289, DOI 10.1038/s41591-020-01212-6; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Kachramanoglou C, 2013, NEUROSURGERY, V72, P170, DOI 10.1227/NEU.0b013e31827b99be; Kassam Amin, 2005, Neurosurg Focus, V19, pE3; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kirschenbaum D, 2020, LANCET, V396, P166, DOI 10.1016/S0140-6736(20)31525-7; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Lechien JR, 2021, J INTERN MED, V290, P451, DOI 10.1111/joim.13209; Lee Ivan T, 2020, medRxiv, DOI 10.1101/2020.05.08.20092866; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Liang FY, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050493; Liang FY, 2018, J ANAT, V232, P674, DOI 10.1111/joa.12777; Liu Jun, 2020, bioRxiv, DOI 10.1101/2020.04.21.042911; Lopez-Elizalde R, 2018, CLIN ANAT, V31, P109, DOI 10.1002/ca.23003; Martin DP, 2021, CELL, V184, P5189, DOI 10.1016/j.cell.2021.09.003; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; Mazzatenta A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.589409; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Menke JR, 2015, ACTA NEUROPATHOL, V130, P441, DOI 10.1007/s00401-015-1459-3; Merritt CR, 2020, NAT BIOTECHNOL, V38, P586, DOI 10.1038/s41587-020-0472-9; MORRISON EE, 1992, MICROSC RES TECHNIQ, V23, P49, DOI 10.1002/jemt.1070230105; MORRISON EE, 1990, J COMP NEUROL, V297, P1, DOI 10.1002/cne.902970102; NAESSEN R, 1970, ACTA OTO-LARYNGOL, V70, P51, DOI 10.3109/00016487009181858; Patel BV, 2021, INTENS CARE MED, V47, P549, DOI 10.1007/s00134-021-06389-z; Peacock TP, 2021, J GEN VIROL, V102, DOI 10.1099/jgv.0.001584; Pinna FD, 2013, INT ARCH OTORHINOLAR, V17, P131, DOI 10.7162/S1809-97772013000200004; Renaud M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15352; Salazar I, 2019, HAND CLINIC, V164, P47, DOI 10.1016/B978-0-444-63855-7.00004-6; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Song ER, 2021, J EXP MED, V218, DOI 10.1084/jem.20202135; Sudre CH, 2021, LANCET DIGIT HEALTH, V3, pE577, DOI 10.1016/S2589-7500(21)00115-1; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Suzuki Y, 1996, J COMP NEUROL, V376, P509, DOI 10.1002/(SICI)1096-9861(19961223)376:4<509::AID-CNE1>3.0.CO;2-5; Tanos T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181151; Thakur KT, 2021, BRAIN, V144, P2696, DOI 10.1093/brain/awab148; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Vaira LA, 2020, J LARYNGOL OTOL, V134, P1123, DOI 10.1017/S0022215120002455; Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI [10.1002/lary.28753, 10.1002/lary.28692]; Vaira LA, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10010062; Van Aerde N, 2020, INTENS CARE MED, V46, P2083, DOI 10.1007/s00134-020-06244-7; Van Gerven L, 2020, RHINOLOGY, V58, P289, DOI 10.4193/Rhin20.119; Vasvari G, 2005, MINIM INVAS NEUROSUR, V48, P25, DOI 10.1055/s-2004-830180; Villar PS, 2021, FEBS J, V288, P3799, DOI 10.1111/febs.15620; Villar PS, 2017, J NEUROSCI, V37, P5736, DOI 10.1523/JNEUROSCI.2640-16.2017; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weiss SR, 2020, J EXP MED, V217, DOI 10.1084/jem.20200537; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; Whitcroft KL, 2020, JAMA-J AM MED ASSOC, V323, P2512, DOI 10.1001/jama.2020.8391; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Xydakis MS, 2021, LANCET NEUROL, V20, P753, DOI 10.1016/S1474-4422(21)00182-4; Xydakis MS, 2020, LANCET INFECT DIS, V20, P1015, DOI 10.1016/S1473-3099(20)30293-0; Yang AC, 2021, NATURE, V595, P565, DOI 10.1038/s41586-021-03710-0; Yeung ML, 2021, CELL, V184, P2212, DOI 10.1016/j.cell.2021.02.053; Yewdell JW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009509; Zapiec B, 2017, BRAIN, V140, P2722, DOI 10.1093/brain/awx208; Zhang K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe7386; Ziegler Carly G K, 2021, bioRxiv, DOI [10.1016/j.cell.2021.07.023, 10.1101/2021.02.20.431155]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zugaj M, 2021, RHINOLOGY, V59, P226, DOI 10.4193/Rhin20.610	107	80	80	9	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2021	184	24					5932	+		10.1016/j.cell.2021.10.027	http://dx.doi.org/10.1016/j.cell.2021.10.027		NOV 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XC8CR	34798069	Green Published, hybrid			2022-12-28	WOS:000722237500003
J	Weissbourd, B; Momose, T; Nair, A; Kennedy, A; Hunt, B; Anderson, DJ				Weissbourd, Brandon; Momose, Tsuyoshi; Nair, Aditya; Kennedy, Ann; Hunt, Bridgett; Anderson, David J.			A genetically tractable jellyfish model for systems and evolutionary neuroscience	CELL			English	Article							TRANSPOSABLE ELEMENT; STEM-CELLS; NERVE NET; DIFFERENTIATION; CIRCUITRY; ABLATION; AGLANTHA	Jellyfish are radially symmetric organisms without a brain that arose more than 500 million years ago. They achieve organismal behaviors through coordinated interactions between autonomously functioning body parts. Jellyfish neurons have been studied electrophysiologically, but not at the systems level. We introduce Clytia hemisphaerica as a transparent, genetically tractable jellyfish model for systems and evolutionary neuroscience. We generate stable F-1 transgenic lines for cell-type-specific conditional ablation and whole-organism GCaMP imaging. Using these tools and computational analyses, we find that an apparently diffuse network of RFamide-expressing umbrellar neurons is functionally subdivided into a series of spatially localized subassemblies whose synchronous activation controls directional food transfer from the tentacles to the mouth. These data reveal an unanticipated degree of structured neural organization in this species. Clytia affords a platform for systems-level studies of neural function, behavior, and evolution within a clade of marine organisms with growing ecological and economic importance.	[Weissbourd, Brandon; Nair, Aditya; Kennedy, Ann; Hunt, Bridgett; Anderson, David J.] CALTECH, Div Biol & Biol Engn, 140-18, Pasadena, CA 91125 USA; [Weissbourd, Brandon; Nair, Aditya; Kennedy, Ann; Hunt, Bridgett; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Weissbourd, Brandon; Nair, Aditya; Kennedy, Ann; Hunt, Bridgett; Anderson, David J.] CALTECH, Tianqiao & Chrissy Chen Inst Neurosci, Pasadena, CA 91125 USA; [Momose, Tsuyoshi] Sorbonne Univ, CNRS, Lab Biol Dev Villefranche Sur Mer LBDV, F-06230 Villefranche Sur Mer, France; [Kennedy, Ann] Northwestern Univ, Feinberg Sch Med, Dept Neurosci, Chicago, IL 60611 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Northwestern University; Feinberg School of Medicine	Weissbourd, B; Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn, 140-18, Pasadena, CA 91125 USA.; Weissbourd, B; Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.; Weissbourd, B; Anderson, DJ (corresponding author), CALTECH, Tianqiao & Chrissy Chen Inst Neurosci, Pasadena, CA 91125 USA.	bweissb@gmail.com; wuwei@caltech.edu		Nair, Aditya/0000-0001-5242-5527; Momose, Tsuyoshi/0000-0002-3806-3408; Weissbourd, Brandon/0000-0001-5422-3873	CRBM/Ser-vice Aquario (FR 3761; EMBRC-France) [ANR-10-INBS-0002]; Caltech Center for Evolutionary Sci-ence; Whitman Center of the MBL; Life Sciences Research Foundation; NINDS [K99NS119749]; NIMH [K99MH117264]; ANR [ANR-17-CE13-0016]; ASSEMBLE Plus JRA3 (EU Horizon 2020) [730984]; Agency of Science, Technology and Research, Singapore	CRBM/Ser-vice Aquario (FR 3761; EMBRC-France); Caltech Center for Evolutionary Sci-ence; Whitman Center of the MBL; Life Sciences Research Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ANR(French National Research Agency (ANR)); ASSEMBLE Plus JRA3 (EU Horizon 2020); Agency of Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	We thank the Marine Resources Center of the MBL (Woods Hole, MA) and J. Malamy for an introduction to Clytia; E. Houliston and R. Copley for Clytia re-sources and advice; M.D.C. Lamadrid for illustrations; S. Ekker for Tol2 re-agents; J. Williams for software; A. Collazo for imaging support; and J. Parker, D. Prober, and Anderson lab members for feedback. We thank the CRBM/Ser-vice Aquario (FR 3761; EMBRC-France, managed by ANR-10-INBS-0002) for support. This work was supported by the Caltech Center for Evolutionary Sci-ence, the Whitman Center of the MBL, the Life Sciences Research Foundation (to B.W.) , NINDS (K99NS119749 to B.W.) , and NIMH (K99MH117264 to A.K.) . Content is the authors' sole responsibility and not that of NIH. T.M. was sup-ported by ANR (ANR-17-CE13-0016, i-MMEJ) and ASSEMBLE Plus JRA3 (EU Horizon 2020 No. 730984) . A.N. was supported by a Scholarship from the Agency of Science, Technology and Research, Singapore. D.J.A. is an Investigator of the Howard Hughes Medical Institute.	Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Arendt D, 2016, NAT REV NEUROSCI, V17, P61, DOI 10.1038/nrn.2015.15; Artigas GQ, 2018, ELIFE, V7, DOI 10.7554/eLife.29555; Badhiwala KN, 2021, ELIFE, V10, DOI 10.7554/eLife.64108; Bosch TCG, 2017, TRENDS NEUROSCI, V40, P92, DOI 10.1016/j.tins.2016.11.005; Cartwright P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001121; Chari T., 2021, WHOLE ANIMAL MULTIPL, DOI [10.1101/2021.01.22.427844, DOI 10.1101/2021.01.22.427844]; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Costello JH, 2021, ANNU REV MAR SCI, V13, P375, DOI 10.1146/annurev-marine-031120-091442; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Daniels RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100637; Dupre C, 2017, CURR BIOL, V27, P1085, DOI 10.1016/j.cub.2017.02.049; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elsayed GF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13239; Fourrage C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130206; Graham WM, 2014, FRONT ECOL ENVIRON, V12, P515, DOI 10.1890/130298; Groger H, 2000, SCI MAR, V64, P107; Hays GC, 2018, TRENDS ECOL EVOL, V33, P874, DOI 10.1016/j.tree.2018.09.001; Houliston E, 2010, TRENDS GENET, V26, P159, DOI 10.1016/j.tig.2010.01.008; Hyman LH, 1940, BIOL BULL-US, V79, P282, DOI 10.2307/1537823; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Kamran Z, 2017, BMC DEV BIOL, V17, DOI 10.1186/s12861-017-0160-2; Katsuki T, 2013, CURR BIOL, V23, pR592, DOI 10.1016/j.cub.2013.03.057; KING MG, 1981, J EXP BIOL, V94, P203; Klimovich A, 2019, NAT PROTOC, V14, P2069, DOI 10.1038/s41596-019-0173-3; Koga A, 1996, NATURE, V383, P30, DOI 10.1038/383030a0; Kunzel T, 2010, DEV BIOL, V348, P120, DOI 10.1016/j.ydbio.2010.08.017; Lechable M, 2020, BIOL OPEN, V9, DOI 10.1242/bio.051268; Leclere L, 2019, NAT ECOL EVOL, V3, P801, DOI 10.1038/s41559-019-0833-2; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Lopes-dos-Santos V, 2013, J NEUROSCI METH, V220, P149, DOI 10.1016/j.jneumeth.2013.04.010; MACKIE GO, 1985, ACTA ZOOL-STOCKHOLM, V66, P199, DOI 10.1111/j.1463-6395.1985.tb00840.x; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Mackie GO, 2003, J EXP BIOL, V206, P2487, DOI 10.1242/jeb.00450; Marcenko V. A., 1967, MATH USSR, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Meech R. W., 2019, OXFORD RES ENCY NEUR; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Momose T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30188-0; Nath RD, 2017, CURR BIOL, V27, P2984, DOI 10.1016/j.cub.2017.08.014; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Ni J, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0062-z; Passano L.M., 1973, Publications Seto Mar Biol Lab, V20, P615; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Romanes G.J., 1885, JELLY FISH STAR FISH; Satterlie RA, 2002, CAN J ZOOL, V80, P1654, DOI 10.1139/Z02-132; Satterlie RA, 2008, J EXP BIOL, V211, P3467, DOI 10.1242/jeb.018952; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; See JZ, 2018, ELIFE, V7, DOI 10.7554/eLife.35587; Segalin Cristina, 2020, MOUSE ACTION RECOGNI, DOI [10.1101/2020.07.26.222299, DOI 10.1101/2020.07.26.222299, 10.1101/2020.07.26.222299, 2020. 1, 2, 5, 6, 7]; Sinigaglia C, 2020, ELIFE, V9, DOI 10.7554/eLife.54868; Tabor KM, 2014, J NEUROPHYSIOL, V112, P834, DOI 10.1152/jn.00228.2014; Tzouanas CN, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102490; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; WEBER C, 1989, CELL TISSUE RES, V255, P275; White DT, 2013, METHODS, V62, P232, DOI 10.1016/j.ymeth.2013.03.017; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yoo SBM, 2020, NEURON, V105, P712, DOI 10.1016/j.neuron.2019.11.013; Yu K, 2017, METHODS MOL BIOL, V1472, P13, DOI 10.1007/978-1-4939-6343-0_2; Zhou P, 2018, ELIFE, V7, DOI 10.7554/eLife.28728	61	8	8	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2021	184	24					5854	+		10.1016/j.cell.2021.10.021	http://dx.doi.org/10.1016/j.cell.2021.10.021		NOV 2021	36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XC8CW	34822783	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000722238100005
J	Kmietowicz, Z				Kmietowicz, Zosia			Back health bill amendments to make England smoke free by 2030, medical leaders urge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, DELIVERING SMOKEFREE; Department of Health and Social Care, 2019, ADV OUR HLTH PREV 20; Hopkinson NS, 2021, BMJ-BRIT MED J	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2841	10.1136/bmj.n2841	http://dx.doi.org/10.1136/bmj.n2841			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799359				2022-12-28	WOS:000723212300009
J	Sfeir, MM; Snayd, M				Sfeir, Maroun M.; Snayd, Mary			Serologic Testing for Hepatitis B	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION	A 27-year-old woman presented with elevated transaminase levels and a positive hepatitis B surface antigen test result. How do you interpret these test results?	[Sfeir, Maroun M.] Univ Connecticut, Ctr Hlth, Dept Pathol & Lab Med, Farmington, CT USA; [Snayd, Mary] Univ Connecticut, Ctr Hlth, Dept Med, Div Infect Dis, Farmington, CT USA	University of Connecticut; University of Connecticut	Sfeir, MM (corresponding author), Univ Connecticut, Ctr Hlth, Clin Microbiol Labs, Dept Pathol & Lab Med, Farmington, CT 06053 USA.	sfeir@uchc.edu						Amini A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2772-3; Chou R, 2020, JAMA-J AM MED ASSOC, V324, P2423, DOI 10.1001/jama.2020.19750; Makvandi M, 2016, WORLD J GASTROENTERO, V22, P8720, DOI 10.3748/wjg.v22.i39.8720; Patel EU, 2019, CLIN INFECT DIS, V69, P709, DOI 10.1093/cid/ciz001; Raimondo G, 2019, J HEPATOL, V71, P397, DOI 10.1016/j.jhep.2019.03.034; Terrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI 10.1002/cld.728; Yuen MF, 2010, GUT, V59, P1389, DOI 10.1136/gut.2010.209148	7	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2021	326	23					2423	2424		10.1001/jama.2021.19803	http://dx.doi.org/10.1001/jama.2021.19803		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC5RI	34797375				2022-12-28	WOS:000720515700001
J	Gilbert, PB; Montefiori, DC; McDermott, A; Fong, YY; Benkeser, D; Deng, WP; Zhou, HH; Houchens, CR; Martins, K; Jayashankar, L; Castellino, F; Flach, B; Lin, BC; O'Connell, S; McDanal, C; Eaton, A; Sarzotti-Kelsoe, M; Lu, YW; Yu, CC; Borate, B; van der Laan, LWP; Hejazi, N; Huynh, C; Miller, J; El Sahly, HM; Baden, LR; Baron, M; De la Cruz, L; Gay, C; Kalams, S; Kelley, CF; Andrasik, MP; Kublin, JG; Corey, L; Neuzil, KM; Carpp, LN; Pajon, R; Follmann, D; Donis, RO; Koup, RA				Gilbert, Peter B.; Montefiori, David C.; McDermott, Adrian; Fong, Youyi; Benkeser, David; Deng, Weiping; Zhou, Honghong; Houchens, Christopher R.; Martins, Karen; Jayashankar, Lakshmi; Castellino, Flora; Flach, Britta; Lin, Bob C.; O'Connell, Sarah; McDanal, Charlene; Eaton, Amanda; Sarzotti-Kelsoe, Marcella; Lu, Yiwen; Yu, Chenchen; Borate, Bhavesh; van der Laan, Lars W. P.; Hejazi, Nima; Huynh, Chuong; Miller, Jacqueline; El Sahly, Hana M.; Baden, Lindsey R.; Baron, Mira; De la Cruz, Luis; Gay, Cynthia; Kalams, Spyros; Kelley, Colleen F.; Andrasik, Michele P.; Kublin, James G.; Corey, Lawrence; Neuzil, Kathleen M.; Carpp, Lindsay N.; Pajon, Rolando; Follmann, Dean; Donis, Ruben O.; Koup, Richard A.		Immune Assays Team; Moderna Inc Team; Coronavirus Vaccine Prevention Net; US Govt USG CoVPN Biostat Team	Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial	SCIENCE			English	Article							SENSITIVITY-ANALYSIS; PROTECTION	In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as correlates of protection. These immune markers were measured at the time of second vaccination and 4 weeks later, with values reported in standardized World Health Organization international units. All markers were inversely associated with COVID-19 risk and directly associated with vaccine efficacy. Vaccine recipients with postvaccination 50% neutralization titers 10, 100, and 1000 had estimated vaccine efficacies of 78% (95% confidence interval, 54 to 89%), 91% (87 to 94%), and 96% (94 to 98%), respectively. These results help define immune marker correlates of protection and may guide approval decisions for messenger RNA (mRNA) COVID-19 vaccines and other COVID-19 vaccines.	[Gilbert, Peter B.; Fong, Youyi; Lu, Yiwen; Yu, Chenchen; Borate, Bhavesh; van der Laan, Lars W. P.; Hejazi, Nima; Andrasik, Michele P.; Kublin, James G.; Corey, Lawrence; Carpp, Lindsay N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Gilbert, Peter B.; Fong, Youyi] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Montefiori, David C.; McDanal, Charlene; Eaton, Amanda; Sarzotti-Kelsoe, Marcella] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Montefiori, David C.; McDanal, Charlene; Eaton, Amanda; Sarzotti-Kelsoe, Marcella] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [McDermott, Adrian; Flach, Britta; Lin, Bob C.; O'Connell, Sarah; Koup, Richard A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Benkeser, David] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Deng, Weiping; Zhou, Honghong; Miller, Jacqueline; Pajon, Rolando] Moderna Inc, Cambridge, MA USA; [Houchens, Christopher R.; Martins, Karen; Jayashankar, Lakshmi; Castellino, Flora; Huynh, Chuong; Donis, Ruben O.] Biomed Adv Res & Dev Author, Washington, DC USA; [Hejazi, Nima] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [El Sahly, Hana M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Baden, Lindsey R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Baron, Mira] Palm Beach Res Ctr, W Palm Beach, FL USA; [De la Cruz, Luis] Keystone Vitalink Res, Greenville, SC USA; [Gay, Cynthia] Univ North Carolina Chapel Hill, Sch Med, UNC HIV Cure Ctr, Dept Med,Div Infect Dis, Chapel Hill, NC USA; [Kalams, Spyros] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Kelley, Colleen F.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Kelley, Colleen F.] Grady Hlth Syst, Atlanta, GA USA; [Corey, Lawrence] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Neuzil, Kathleen M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD USA; [Follmann, Dean] NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Rollins School Public Health; University of California System; University of California Berkeley; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vanderbilt University; Emory University; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	pgilbert@fredhutch.org	Kilgore, Paul E/L-1462-2013; Laboratory Core, HIV STD/AGD-7085-2022; Kelley, Colleen F/O-4819-2016	Kilgore, Paul E/0000-0003-3214-4482; Kelley, Colleen F/0000-0001-5611-0119; Gilbert, Peter/0000-0002-2662-9427; Novack, Lewis/0000-0001-7508-1720; Hejazi, Nima/0000-0002-7127-2789; Gay, Cynthia/0000-0002-3620-3059	Public Health Service; National Institute of Allergy and Infectious Diseases; National Institutes of Health [S10OD028685]; Office of Research Infrastructure Programs; Moderna, Inc.; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority [75A50120C00034]; Infectious Disease Clinical Research Consortium Leadership Group through the National Institute for Allergy and Infectious Diseases [UM1 AI148684-03]	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs; Moderna, Inc.; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority; Infectious Disease Clinical Research Consortium Leadership Group through the National Institute for Allergy and Infectious Diseases	This study was supported by the Public Health Service; the National Institute of Allergy and Infectious Diseases; National Institutes of Health grant UM1AI068635 (to P.B.G.); the Office of Research Infrastructure Programs; National Institutes of Health grant (S10OD028685) (Fred Hutchinson Cancer Research Center); Moderna, Inc. Federal funds from the Office of the Assistant Secretary for Preparedness and Response; the Biomedical Advanced Research and Development Authority, contract no. 75A50120C00034 (Moderna, Inc.); and the Infectious Disease Clinical Research Consortium Leadership Group through the National Institute for Allergy and Infectious Diseases, grant UM1 AI148684-03 (to K.M.N.).	Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Addetia A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02107-20; Andrasik MP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258858; [Anonymous], [No title captured], DOI 10.5281/zenodo.5593130; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Benkeser D., 2021, ARXIV210302643STATME; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Cohen MS, 2021, JAMA-J AM MED ASSOC, V326, P46, DOI [10.1001/jama.2021.8828, 10.1001/jama.2021.88282021.]; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; Cowling BJ, 2019, CLIN INFECT DIS, V68, P1713, DOI 10.1093/cid/ciy759; Cromer D, 2021, 21259504 MEDRXIV, DOI [10.1101/2021.06.29.21259504, DOI 10.1101/2021.06.29.21259504]; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Earle Kristen A, 2021, Vaccine, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Gilbert P. B., 2021, COVID-19 Prevention Network Immune Correlates Analyses, DOI 10.5281/zenodo.5593130; Gilbert P. B., 2021, COVID 19 PREVENTION; Gilbert P. B., 2018, PLOTKINS VACCINES, Vseventh, P3; Gilbert P. B., 2021, ARXIV210705734STATME; He X, 2021, CELL, V184, P3467, DOI 10.1016/j.cell.2021.05.040; Kertes J, 2021, 21262957 MEDRXIV, DOI [10.1101/2021.09.01.21262957, DOI 10.1101/2021.09.01.21262957]; Kertes J., 2021, MEDRXIV, DOI DOI 10.1101/2021.09.01.21262957; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Koup RA, 2021, NAT MED, V27, P1493, DOI 10.1038/s41591-021-01484-6; Krause PR, 2021, LANCET, V398, P1377, DOI 10.1016/S0140-6736(21)02046-8; Kristiansen PA, 2021, LANCET, V397, P1347, DOI 10.1016/S0140-6736(21)00527-4; Lumley T., 2010, COMPLEX SURVEYS GUID, V565; Magaret CA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006952; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Moderna, 2021, MOD ANN TEENCOVE STU; Neidich SD, 2019, J CLIN INVEST, V129, P4838, DOI 10.1172/JCI126391; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Reynaldi A., 2021, 21259504 MEDRXIV, DOI [10.1101/2021.06.29.21259504, DOI 10.1101/2021.06.29.21259504]; Shen XY, 2021, CELL HOST MICROBE, V29, P529, DOI 10.1016/j.chom.2021.03.002; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2021, EM US AUTH VACC PREV, P18; US Food and Drug Administration, MOD COVID 19 VACC; US Food and Drug Administration (FDA), 2021, COVID 19 VACC COVID; US-FDA, 2021, FDA APPR 1 COVID 19; van der Laan L., 2021, ARXIV210711459STATME; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Weller C., 2021, WELLCOME OPINIO 0606; Westfall P. H, 1993, SERIES PROBABILITY S, V279; WHO International Standard, 2020, 1 WHO INT STANDARD A; Williamson B. D, 2020, ARXIV200403683STATME; Williamson B. D, 2021, VIMP PERFORM INFEREN; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn; World Health Organization, 2021, COR DIS COVID 19 COV; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284	57	228	228	43	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					43	+	eabm3425	10.1126/science.abm3425	http://dx.doi.org/10.1126/science.abm3425			83	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34812653	Green Published			2022-12-28	WOS:000740261400037
J	Mendelson, M; Venter, F; Moshabela, M; Gray, G; Blumberg, L; de Oliveira, T; Madhi, SA				Mendelson, Marc; Venter, Francois; Moshabela, Mosa; Gray, Glenda; Blumberg, Lucille; de Oliveira, Tulio; Madhi, Shabir A.			The political theatre of the UK's travel ban on South Africa Comment	LANCET			English	Editorial Material									[Mendelson, Marc] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Venter, Francois] Univ Witwatersrand, Ezintsha Sub Div Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Moshabela, Mosa] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Gray, Glenda] South African Med Res Council, Off President, Tygerberg, South Africa; [Blumberg, Lucille] Right Care, Tshwane, South Africa; [Blumberg, Lucille] Univ Stellenbosch, Fac Hlth Sci, Cape Town, South Africa; [de Oliveira, Tulio] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa; [de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform, Durban, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, African Med Res Council Vaccines & Infect Dis, Analyt Res Unit, Johannesburg, South Africa	University of Cape Town; University of Witwatersrand; University of Kwazulu Natal; South African Medical Research Council; Stellenbosch University; University of Kwazulu Natal; University of Kwazulu Natal; University of Witwatersrand	Mendelson, M (corresponding author), Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa.	marc.mendelson@uct.ac.za		de Oliveira, Tulio/0000-0002-3027-5254				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2021, BBC NEWS 1127; [Anonymous], 2021, FINANC TIMES; Blakely R, 2021, TIMES 1201; Business Insider SA, 2020, BUSINESS INSIDE 1224; Chung H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1943; Grepin KA, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004537; Huang Y, 2004, LEARNING SARS PREPAR, P116, DOI DOI 10.17226/10915; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Meyn C., 2021, HILL; Ministry of Health Government of New Zealand, 2021, COVID 19 EL STRAT AO; Picheta R., 2021, THE CNN; South African Tourism, ANN REP 2018 2019; Statista, NUMB COVID 19 VACC D; Strauss M, 2021, REUTERS 1126; UK Government, 2021, FOR TRAV ADV S AFR; WHO, 2021, CLASSIFICATION OMICR; World Health Organization, 2020, UPD WHO REC INT TRAF	18	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2021	398	10318					2211	2213		10.1016/S0140-6736(21)02752-5	http://dx.doi.org/10.1016/S0140-6736(21)02752-5		DEC 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XQ3YW	34871546	Bronze, Green Published			2022-12-28	WOS:000731484500004
J	Sammut, SJ; Crispin-Ortuzar, M; Chin, SF; Provenzano, E; Bardwell, HA; Ma, WX; Cope, W; Dariush, A; Dawson, SJ; Abraham, JE; Dunn, J; Hiller, L; Thomas, J; Cameron, DA; Bartlett, JMS; Hayward, L; Pharoah, PD; Markowetz, F; Rueda, OM; Earl, HM; Caldas, C				Sammut, Stephen-John; Crispin-Ortuzar, Mireia; Chin, Suet-Feung; Provenzano, Elena; Bardwell, Helen A.; Ma, Wenxin; Cope, Wei; Dariush, Ali; Dawson, Sarah-Jane; Abraham, Jean E.; Dunn, Janet; Hiller, Louise; Thomas, Jeremy; Cameron, David A.; Bartlett, John M. S.; Hayward, Larry; Pharoah, Paul D.; Markowetz, Florian; Rueda, Oscar M.; Earl, Helena M.; Caldas, Carlos			Multi-omic machine learning predictor of breast cancer therapy response	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; COPY NUMBER ANALYSIS; NEOADJUVANT CHEMOTHERAPY; SOMATIC MUTATIONS; TUMORS REVEALS; LANDSCAPE; PACLITAXEL; SIGNATURES; EXCLUSION; FRAMEWORK	Breast cancers are complex ecosystems of malignant cells and the tumour microenvironment(1). The composition of these tumour ecosystems and interactions within them contribute to responses to cytotoxic therapy(2). Efforts to build response predictors have not incorporated this knowledge. We collected clinical, digital pathology, genomic and transcriptomic profiles of pre-treatment biopsies of breast tumours from 168 patients treated with chemotherapy with or without HER2 (encoded by ERBB2)-targeted therapy before surgery. Pathology end points (complete response or residual disease) at surgery(3) were then correlated with multi-omic features in these diagnostic biopsies. Here we showthat response to treatment is modulated by the pre-treated tumour ecosystem, and its multi-omics landscape can be integrated in predictive models using machine learning. The degree of residual disease following therapy is monotonically associated with pre-therapy features, including tumour mutational and copy number landscapes, tumour proliferation, immune infiltration and T cell dysfunction and exclusion. Combining these features into a multi-omic machine learning model predicted a pathological complete response in an external validation cohort (75 patients) with an area under the curve of 0.87. In conclusion, response to therapy is determined by the baseline characteristics of the totality of the tumour ecosystem captured through data integration and machine learning. This approach could be used to develop predictors for other cancers.	[Sammut, Stephen-John; Crispin-Ortuzar, Mireia; Chin, Suet-Feung; Bardwell, Helen A.; Cope, Wei; Dariush, Ali; Markowetz, Florian; Rueda, Oscar M.; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Sammut, Stephen-John; Abraham, Jean E.; Earl, Helena M.; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge, England; [Sammut, Stephen-John; Provenzano, Elena; Abraham, Jean E.; Pharoah, Paul D.; Earl, Helena M.; Caldas, Carlos] Univ Cambridge, CRUK Cambridge Ctr, Cambridge Expt Canc Med Ctr ECMC, Cambridge, England; [Sammut, Stephen-John; Provenzano, Elena; Abraham, Jean E.; Pharoah, Paul D.; Earl, Helena M.; Caldas, Carlos] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Sammut, Stephen-John; Provenzano, Elena; Abraham, Jean E.; Pharoah, Paul D.; Earl, Helena M.; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Ma, Wenxin] Univ Cambridge, Sch Clin Med, Cambridge, England; [Dariush, Ali] Univ Cambridge, Inst Astron, Cambridge, England; [Dawson, Sarah-Jane] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Dawson, Sarah-Jane] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Dawson, Sarah-Jane] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Dunn, Janet; Hiller, Louise] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Thomas, Jeremy; Cameron, David A.; Bartlett, John M. S.; Hayward, Larry] Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Thomas, Jeremy] Q2 Lab Solut, Livingston, Scotland; [Bartlett, John M. S.] Ontario Inst Canc Res, Toronto, ON, Canada; [Bartlett, John M. S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Pharoah, Paul D.] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Rueda, Oscar M.] Univ Cambridge, MRC Biostat Unit, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Warwick; University of Edinburgh; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Caldas, C (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England.; Caldas, C (corresponding author), Univ Cambridge, Dept Oncol, Cambridge, England.; Caldas, C (corresponding author), Univ Cambridge, CRUK Cambridge Ctr, Cambridge Expt Canc Med Ctr ECMC, Cambridge, England.; Caldas, C (corresponding author), Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge, England.; Caldas, C (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.	carlos.caldas@cruk.cam.ac.uk		Sammut, Stephen John/0000-0003-4472-904X; Dunn, Janet/0000-0001-7313-4446; chin, suet-feung/0000-0001-5697-1082; Earl, Helena/0000-0003-1549-8094; Dawson, Sarah-Jane/0000-0002-8276-0374	Wellcome Trust PhD Clinical Training Fellowship [106566/Z/14/Z]; Junior Research Fellowship from Trinity College, Cambridge; University of Cambridge; Cancer Research UK (CRUK) [A17197, A19274]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; Medical Research Council (UK) [MC_UU_00002/16]; CRUK [A17197, A27657, A29580]; NIHR Senior Investigator Award [NF-SI-0515-10090]; European Research Council Advanced Award [694620]; F. Hoffman La Roche; CRUK Cambridge Centre; Mark Foundation Institute for Integrated Cancer Medicine	Wellcome Trust PhD Clinical Training Fellowship(Wellcome Trust); Junior Research Fellowship from Trinity College, Cambridge; University of Cambridge(University of Cambridge); Cancer Research UK (CRUK)(Cancer Research UK); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); NIHR Senior Investigator Award; European Research Council Advanced Award(European Research Council (ERC)); F. Hoffman La Roche; CRUK Cambridge Centre; Mark Foundation Institute for Integrated Cancer Medicine	S.-J.S. was supported by a Wellcome Trust PhD Clinical Training Fellowship (grant number 106566/Z/14/Z). M.C.-O. was supported by a Junior Research Fellowship from Trinity College, Cambridge, and a Borysiewicz Fellowship from the University of Cambridge. F.M. was supported by funding from Cancer Research UK (CRUK) (grant numbers A17197 and A19274). O.M.R. was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) and the Medical Research Council (UK; MC_UU_00002/16). C.C. was supported by funding from CRUK (grant numbers A17197, A27657 and A29580), an NIHR Senior Investigator Award (grant number NF-SI-0515-10090) and a European Research Council Advanced Award (grant number 694620). The ARTemis molecular profiling dataset was funded in part by an unrestricted academic grant from F. Hoffman La Roche (grant administered by the University of Cambridge). The Programme received infrastructure funding from the CRUK Cambridge Centre and the Mark Foundation Institute for Integrated Cancer Medicine. We are grateful for the generosity of all the patients that donated samples for analysis; all the staff at the Cambridge Breast Cancer Research Unit for facilitating the collection and processing of samples; and the CRUK Cambridge Institute Core Facilities (Genomics, Bioinformatics, Histopathology and Biorepository) for support during the execution of this project.	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Alberro JA, 2018, LANCET ONCOL, V19, P27, DOI 10.1016/S1470-2045(17)30777-5; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ali HR, 2017, ANN ONCOL, V28, P1832, DOI 10.1093/annonc/mdx266; Ali HR, 2020, NAT CANCER, V1, P163, DOI 10.1038/s43018-020-0026-6; Ali HR, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0682-8; Ali HR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0431-1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Bonnefoi H, 2011, LANCET ONCOL, V12, P527, DOI 10.1016/S1470-2045(11)70094-8; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Callari M, 2016, CLIN CANCER RES, V22, P337, DOI 10.1158/1078-0432.CCR-15-0757; dos Reis FJC, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0852-3; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Danaher P, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0215-8; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Earl HM, 2015, LANCET ONCOL, V16, P656, DOI 10.1016/S1470-2045(15)70137-3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Horak CE, 2013, CLIN CANCER RES, V19, P1587, DOI 10.1158/1078-0432.CCR-12-1359; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Jin X, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2652-z; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Ju C, 2018, J APPL STAT, V45, P2800, DOI 10.1080/02664763.2018.1441383; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kazeev, 2021, FAST VERSION DELONGS; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Lee JK, 2010, CLIN CANCER RES, V16, P711, DOI 10.1158/1078-0432.CCR-09-2247; Lesurf R, 2017, ANN ONCOL, V28, P1070, DOI 10.1093/annonc/mdx048; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Marusyk A, 2020, CANCER CELL, V37, P471, DOI 10.1016/j.ccell.2020.03.007; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; NICE, 2018, EARL LOC ADV BREAST; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Provenzano E, 2015, MODERN PATHOL, V28, P1185, DOI 10.1038/modpathol.2015.74; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Royal College of Physians, 2016, PATH REP BREAST DIS; Salgado, 2019, ANN ONCOL, V30, piii2; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Seshan VE, 2018, DNACOPY DNA COPY NUM; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Symmans WF, 2017, J CLIN ONCOL, V35, P1049, DOI 10.1200/JCO.2015.63.1010; Sztupinszki Z, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0066-6; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yuan H, 2015, CLIN CANCER RES, V21, P4365, DOI 10.1158/1078-0432.CCR-14-3354; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137	83	33	34	26	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					623	+		10.1038/s41586-021-04278-5	http://dx.doi.org/10.1038/s41586-021-04278-5		DEC 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34875674	hybrid, Green Published			2022-12-28	WOS:000742254700001
J	Bartlett, SD				Bartlett, Stephen D.			Programming a quantum phase of matter	SCIENCE			English	Editorial Material									[Bartlett, Stephen D.] Univ Sydney, Ctr Engn Quantum Syst, Sch Phys, Sydney, NSW, Australia	University of Sydney	Bartlett, SD (corresponding author), Univ Sydney, Ctr Engn Quantum Syst, Sch Phys, Sydney, NSW, Australia.	stephen.bartlett@sydney.edu.au	Bartlett, Stephen D/A-4163-2008	Bartlett, Stephen D/0000-0003-4387-670X				Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Satzinger KJ, 2021, SCIENCE, V374, P1237, DOI 10.1126/science.abi8378; Semeghini G, 2021, SCIENCE, V374, P1242, DOI 10.1126/science.abi8794	5	0	0	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1200	1201		10.1126/science.abl8910	http://dx.doi.org/10.1126/science.abl8910			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855480				2022-12-28	WOS:000728578700038
J	Sheng, GJ; Arias, AM; Sutherland, A				Sheng, Guojun; Arias, Alfonso Martinez; Sutherland, Ann			The primitive streak and cellular principles of building an amniote body through gastrulation	SCIENCE			English	Review							MESENCHYMAL TRANSITION; MESODERM SPECIFICATION; MOUSE EMBRYO; MOVEMENTS; EVOLUTION; LAYER; MORPHOGENESIS; DYNAMICS; GENE; INTERCALATION	The primitive streak, a transient embryonic structure, marks bilateral symmetry in mammalian and avian embryos and helps confer anterior-posterior and dorsal-ventral spatial information to early differentiating cells during gastrulation. Its recapitulation in vitro may facilitate derivation of tissues and organs with in vivo-like complexity. Proper understanding of the primitive streak and what it entails in human development is key to achieving such research objectives. Here we provide an overview of the primitive streak and conclude that this structure is neither conserved nor necessary for gastrulation or early lineage diversification. We offer a model in which the primitive streak is viewed as part of a morphologically diverse yet molecularly conserved process of spatial coordinate acquisition. We predict that recapitulation of the primitive streak is dispensable for development in vitro.	[Sheng, Guojun] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Arias, Alfonso Martinez] Univ Pompeu Fabra, Doctor Aiguader, DCEXS, Syst Bioengn, 88 ICREA,Pag Lluis Co 23, Barcelona, Spain; [Sutherland, Ann] Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA 22903 USA	Kumamoto University; Pompeu Fabra University; University of Virginia	Sheng, GJ (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.; Arias, AM (corresponding author), Univ Pompeu Fabra, Doctor Aiguader, DCEXS, Syst Bioengn, 88 ICREA,Pag Lluis Co 23, Barcelona, Spain.; Sutherland, A (corresponding author), Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA 22903 USA.	sheng@kumamoto-u.ac.jp; alfonso.martineza@upf.edu; as9n@virginia.edu		Martinez Arias, Alfonso/0000-0002-1781-564X; Sutherland, Ann/0000-0003-1925-2825	JST e-ASIA Joint Research Project [JPMJSC19E5]; JSPS Kakenhi [18H02452, 21H02490]; Takeda Science Foundation; ERC Advanced Investigator Grant [MiniEmbryoBluePrint-834580]; National Institute for Child Health and Human Development [1R01HD087093]	JST e-ASIA Joint Research Project; JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ERC Advanced Investigator Grant; National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	G.S. is supported by JST e-ASIA Joint Research Project JPMJSC19E5, JSPS Kakenhi 18H02452 and 21H02490, and Takeda Science Foundation grants. A.M.A. is supported by an ERC Advanced Investigator Grant (MiniEmbryoBluePrint-834580). A.S. is supported by a grant from the National Institute for Child Health and Human Development (1R01HD087093).	Alev C, 2013, DEVELOPMENT, V140, P2691, DOI 10.1242/dev.094318; Amadei G, 2021, DEV CELL, V56, P366, DOI 10.1016/j.devcel.2020.12.004; Arendt D, 1999, MECH DEVELOP, V81, P3, DOI 10.1016/S0925-4773(98)00226-3; BALLARD WW, 1976, BIOSCIENCE, V26, P36, DOI 10.2307/1297297; Beccari L, 2018, NATURE, V562, P272, DOI 10.1038/s41586-018-0578-0; Belahbib H, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4715-9; BELLAIRS R, 1967, J EMBRYOL EXP MORPH, V17, P195; Bertocchini F, 2013, DEV GROWTH DIFFER, V55, P52, DOI 10.1111/dgd.12014; Brunet T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3821; Budgett JS., 1901, T ZOOL SOC LONDON, V16, P115, DOI [DOI 10.1111/J.1096-3642.1901.TB00028.X, 10.1111/j.1096-3642.1901.tb00028.x]; Caldarelli P., 463661 BIORXIV, DOI [10.1101/ 2021.10.08.463661, DOI 10.1101/2021.10.08.463661]; Carter AM, 2013, ANNU REV ANIM BIOSCI, V1, P443, DOI 10.1146/annurev-animal-031412-103653; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chavatte-Palmer P, 2007, GYNECOL OBSTET INVES, V64, P166, DOI 10.1159/000101742; Chhabra S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000498; Chuai M., 462938 BIORXIV, DOI [10.1101/2021.10.03.462938, DOI 10.1101/2021.10.03.462938]; Coolen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002676; DHEW ETHICS ADVISORY BOARD, 1979, HEW SUPP RES INV HUM; Elinson RP, 2012, WIRES DEV BIOL, V1, P345, DOI 10.1002/wdev.23; Ereskovsky AV, 2013, DEV GENES EVOL, V223, P5, DOI 10.1007/s00427-012-0399-3; Fahey B, 2010, EVOL DEV, V12, P601, DOI 10.1111/j.1525-142X.2010.00445.x; Franklin S, 2019, COMP STUD SOC HIST, V61, P743, DOI 10.1017/S0010417519000252; Fu JP, 2021, NAT MATER, V20, P132, DOI 10.1038/s41563-020-00829-9; Ghimire S, 2021, DEV BIOL, V474, P100, DOI 10.1016/j.ydbio.2021.01.006; Girgin MU, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25237-8; Gokbuget D, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.164772; Haeckel E., 1874, JENAISCHE Z NATURWIS, P1; Haeckel E, 1872, KALKSCHWAMME MONOGRA; Halacheva V, 2011, DEV DYNAM, V240, P1905, DOI 10.1002/dvdy.22687; Hamidi S, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.184960; Hashmi A., 2020, BIORXIV, DOI [10.1101/2020.05.21.105551, DOI 10.1101/2020.05.21.105551]; Hassoun R, 2009, DIFFERENTIATION, V78, P301, DOI 10.1016/j.diff.2009.07.006; Hay ED, 1995, ACTA ANAT, V154, P8; Heemskerk I, 2016, DEV DYNAM, V245, P976, DOI [10.1002/DVDY.24432, 10.1002/dvdy.24432]; Hurney CA, 2015, MECH DEVELOP, V136, P99, DOI 10.1016/j.mod.2014.12.007; Imuta Y, 2014, MECH DEVELOP, V132, P44, DOI 10.1016/j.mod.2014.01.004; JURAND A, 1974, J EMBRYOL EXP MORPH, V32, P1; Kaneda T, 2012, DEV BIOL, V369, P1, DOI 10.1016/j.ydbio.2012.05.019; Keller R., 2004, P171; Kerr J. G, 1900, P R SOC LOND, V65, P160, DOI [10.1098/rspl.1899.0017, DOI 10.1098/RSPL.1899.0017]; Lawson A, 2001, GENESIS, V29, P188, DOI 10.1002/gene.1023; Leys SP, 2005, INTEGR COMP BIOL, V45, P342, DOI 10.1093/icb/45.2.342; Lovell-Badge R, 2021, STEM CELL REP, V16, P1398, DOI 10.1016/j.stemcr.2021.05.012; Manfrin A, 2019, NAT METHODS, V16, P640, DOI 10.1038/s41592-019-0455-2; Martyn I, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.179564; Morgani SM, 2018, ELIFE, V7, DOI 10.7554/eLife.32839; Moris N, 2020, NATURE, V582, P410, DOI 10.1038/s41586-020-2383-9; Muncie JM, 2020, DEV CELL, V55, P679, DOI 10.1016/j.devcel.2020.10.015; Nahaboo W, 2021, METHODS MOL BIOL, V2179, P135, DOI 10.1007/978-1-0716-0779-4_12; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nakaya Y, 2013, J CELL BIOL, V202, P637, DOI 10.1083/jcb.201302075; Nakaya Y, 2009, CELL ADHES MIGR, V3, P160, DOI 10.4161/cam.3.2.7373; NEW DAT, 1959, J EMBRYOL EXP MORPH, V7, P146; Pander C., 1817, BEITRAGE ENTWICKELUN; Pasteels J, 1940, BIOL REV CAMB PHILOS, V15, P59, DOI 10.1111/j.1469-185X.1940.tb00942.x; Rossant J, 2018, SCIENCE, V360, P1075, DOI 10.1126/science.aas9302; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; Rulle A, 2018, CELLS TISSUES ORGANS, V205, P256, DOI 10.1159/000493276; Saadaoui M, 2020, SCIENCE, V367, P453, DOI 10.1126/science.aaw1965; Salinas-Saavedra M, 2018, ELIFE, V7, DOI 10.7554/eLife.36740; Sarasin P., 1887, ERGEBNISSE NATURWISS; Sauka-Spengler T, 2003, DEV BIOL, V263, P296, DOI 10.1016/j.ydbio.2003.07.009; Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00236-w; Sheng GJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.198036; Sheng GJ, 2015, DEV BIOL, V401, P17, DOI 10.1016/j.ydbio.2014.10.003; Shook DR, 2008, J EXP ZOOL PART B, V310B, P111, DOI 10.1002/jez.b.21204; Shook DR, 2008, J EXP ZOOL PART B, V310B, P85, DOI 10.1002/jez.b.21198; Shook DR, 2002, DEV BIOL, V248, P220, DOI 10.1006/dbio.2002.0718; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Sozen B, 2018, NAT CELL BIOL, V20, P979, DOI 10.1038/s41556-018-0147-7; Stankova V, 2015, DEVELOPMENT, V142, P92, DOI 10.1242/dev.111583; Stern C.D., 2004, GASTRULATION CELLS E; Stower M, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.262; Stower MJ, 2015, DEV DYNAM, V244, P1144, DOI 10.1002/dvdy.24300; Swiers G, 2010, DEV BIOL, V343, P138, DOI 10.1016/j.ydbio.2010.04.002; Takeuchi M, 2009, DEV BIOL, V332, P90, DOI 10.1016/j.ydbio.2009.05.543; TAM PPL, 1993, MICROSC RES TECHNIQ, V26, P301, DOI 10.1002/jemt.1070260405; Turner DA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0063-7; Turner DA, 2014, BIOL OPEN, V3, P614, DOI 10.1242/bio.20148409; van den Brink SC, 2014, DEVELOPMENT, V141, P4231, DOI 10.1242/dev.113001; Veenvliet JV, 2020, SCIENCE, V370, P1291, DOI 10.1126/science.aba4937; Vianello S., 2020, BIORXIV, V2020, DOI [10.1101/2020.06.07.138883, DOI 10.1101/2020.06.07.138883]; VIEBAHN C, 1995, ANAT EMBRYOL, V192, P159; Viebahn C, 2002, DEVELOPMENT, V129, P2355; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Warnock M., 1984, REP COMM INQ HUM FER; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; WILSON V, 1995, DEVELOPMENT, V121, P877; Xu PF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23653-4; Xue XF, 2018, NAT MATER, V17, P633, DOI 10.1038/s41563-018-0082-9	93	3	3	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1213	+	eabg1727	10.1126/science.abg1727	http://dx.doi.org/10.1126/science.abg1727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855481				2022-12-28	WOS:000728578700049
J	Waters, A				Waters, Adele			Welsh GPs are awarded 3% pay rise	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Waters, Adele] BMJ, London, England		Waters, A (corresponding author), BMJ, London, England.							National Association of Primary Care, 2021, PERS CAR PROGR	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3009	10.1136/bmj.n3009	http://dx.doi.org/10.1136/bmj.n3009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862169				2022-12-28	WOS:000729712200004
J	Albin, O; Mills, JP; Saint, S; Swanson, M; Deng, JC				Albin, Owen; Mills, John P.; Saint, Sanjay; Swanson, Michele; Deng, Jane C.			A "Fluid" Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEGIONNAIRES-DISEASE; OUTBREAK; FLINT		[Albin, Owen; Mills, John P.; Saint, Sanjay; Swanson, Michele; Deng, Jane C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Albin, Owen; Mills, John P.; Saint, Sanjay; Swanson, Michele; Deng, Jane C.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Albin, Owen; Mills, John P.; Saint, Sanjay; Swanson, Michele; Deng, Jane C.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Albin, O (corresponding author), Univ Michigan, Med Sch, 1500 E Med Ctr Dr,Univ Hosp S F4009, Ann Arbor, MI 48109 USA.	oalbin@med.umich.edu		Albin, Owen/0000-0002-1659-4902				Bargellini A, 2013, CASE REP MED, V2013, DOI 10.1155/2013/303712; Beaute J, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.27.30566; Byrne BG, 2018, MBIO, V9, DOI [10.1128/mBio.00016-18, 10.1128/mbio.00016-18]; Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176; DUTKA BJ, 1984, SCI TOTAL ENVIRON, V39, P237, DOI 10.1016/0048-9697(84)90081-0; Gleason JA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0118-4; Jasper AS, 2021, CLIN INFECT DIS, V72, P1979, DOI 10.1093/cid/ciaa441; Michigan Department of Health & Human Services, 2019, MICH EXP INCR LEG CA; Muder R R, 1987, Semin Respir Infect, V2, P242; National Academy of Science, 2020, MAN LEG WAT SYST; Rhoads WJ, 2017, ENVIRON SCI TECHNOL, V51, P11986, DOI 10.1021/acs.est.7b01589; Shimada T, 2009, CHEST, V136, P1576, DOI 10.1378/chest.08-2602; Soda EA, 2017, MMWR-MORBID MORTAL W, V66, P584, DOI 10.15585/mmwr.mm6622e1; Sopena N, 1998, CHEST, V113, P1195, DOI 10.1378/chest.113.5.1195; Zahran S, 2018, P NATL ACAD SCI USA, V115, pE1730, DOI 10.1073/pnas.1718679115	15	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2021	385	23					2180	2185		10.1056/NEJMcps2108991	http://dx.doi.org/10.1056/NEJMcps2108991			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE4VC	34874634				2022-12-28	WOS:000741124300015
J	Dyer, C				Dyer, Clare			Treatment withdrawal: judges to get advice about visiting patients after decision on covid patient is overturned	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2193	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2939	10.1136/bmj.n2939	http://dx.doi.org/10.1136/bmj.n2939			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34844949				2022-12-28	WOS:000740896100008
J	Haldane, V; Jung, AS; Neill, R; Singh, S; Wu, SS; Jamieson, M; Verma, M; Tan, M; De Foo, C; Abdalla, SM; Shrestha, P; Chua, AQ; Nordstrom, A; Legido-Quigley, H				Haldane, Victoria; Jung, Anne-Sophie; Neill, Rachel; Singh, Sudhvir; Wu, Shishi; Jamieson, Margaret; Verma, Monica; Tan, Melisa; De Foo, Chuan; Abdalla, Salma M.; Shrestha, Pami; Chua, Alvin Qijia; Nordstrom, Anders; Legido-Quigley, Helena			From response to transformation: how countries can strengthen national pandemic preparedness and response systems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEW-ZEALAND; COVID-19		[Haldane, Victoria; Legido-Quigley, Helena] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Jung, Anne-Sophie; Jamieson, Margaret] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Neill, Rachel] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wu, Shishi] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Verma, Monica; Tan, Melisa; De Foo, Chuan; Shrestha, Pami; Chua, Alvin Qijia; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Verma, Monica; Tan, Melisa; De Foo, Chuan; Shrestha, Pami; Chua, Alvin Qijia; Legido-Quigley, Helena] NUHS, Singapore, Singapore; [Abdalla, Salma M.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	University of London; London School of Hygiene & Tropical Medicine; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; National University of Singapore; National University of Singapore; Boston University	Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.; Legido-Quigley, H (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Legido-Quigley, H (corresponding author), NUHS, Singapore, Singapore.	ephhlq@nus.edu.sg	Foo, Chuan De/AAJ-9844-2021; Chua, Alvin Qijia/GQH-3027-2022	Foo, Chuan De/0000-0001-7254-4881; Chua, Alvin Qijia/0000-0001-6920-1204; Singh, Sudhvir/0000-0002-9915-6755; Jung, Anne-Sophie/0000-0001-7039-7830				Alwan NA, 2020, LANCET, V395, P1036, DOI 10.1016/S0140-6736(20)30667-X; Ballard M, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002550; Burki T, 2021, LANCET INFECT DIS, V21, P922, DOI 10.1016/S1473-3099(21)00344-3; Chiriboga D, 2020, LANCET, V395, P1690, DOI 10.1016/S0140-6736(20)31145-4; Chua AQ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003317; De Foo C, 2021, LANCET, V398, P1547, DOI 10.1016/S0140-6736(21)02186-3; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Lopes MF, 2021, NAT IMMUNOL, V22, P256, DOI 10.1038/s41590-021-00875-8; Government NZ, ACC FOOD ESS IT 2020; Greer SL, 2021, CORONAVIRUS POLITICS, P615, DOI 10.3998/mpub.11927713; Jefferies S, 2020, LANCET PUBLIC HEALTH, V5, pE612, DOI 10.1016/S2468-2667(20)30225-5; Kaweenuttayanon N, 2021, B WORLD HEALTH ORGAN, V99, P393, DOI 10.2471/BLT.20.274308; Kickbusch I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h81; Kim DH., 1999, INTRO SYSTEMS THINKI; Lavine JS, 2021, SCIENCE, V371, P741, DOI 10.1126/science.abe6522; Maani K., 2007, SYSTEMS THINKING SYS, V(2nd; Maani N, 2020, MILBANK Q, V98, P250, DOI 10.1111/1468-0009.12463; Malta M, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100878; Manauis CM, 2020, JACEP OPEN, V1, P549, DOI 10.1002/emp2.12134; McKee M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4024; Mehra P, 2020, HINDU; New Zealand Ministry of Health, IN COVID 19 MAOR RES; Park J, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105198; Rawal V., 2020, ARE DISTRESS DEATHS; Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932; Stowe J, 2021, JAMA-J AM MED ASSOC, V325, P86, DOI 10.1001/jama.2020.21369; Tay J, 2010, ANN ACAD MED SINGAP, V39, P313; Taylor L, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3575; The Independent Panel for Pandemic Preparedness & Response, 2021, COVID 19 MAK IT LAST; Uruguay Presdiency, 2020, MED GOB AT EM SAN CO; World Health Organization, 2005, STRENGTH PREP HLTH E; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8	32	7	7	5	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067507	10.1136/bmj-2021-067507	http://dx.doi.org/10.1136/bmj-2021-067507			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840139	hybrid, Green Published			2022-12-28	WOS:000740896100019
J	Mahase, E				Mahase, Elisabeth			Childhood obesity: are new treatment centres the solution?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							MANAGEMENT											Banks J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616319; Burchett HED, 2018, PREV MED, V106, P1, DOI 10.1016/j.ypmed.2017.08.025; Edmunds L, 2001, BMJ-BRIT MED J, V323, P916, DOI 10.1136/bmj.323.7318.916; Hayre J, 2021, ARCH DIS CHILD, V106, P1145, DOI 10.1136/archdischild-2020-320552; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2994; NHS Digital, NATL CHILD MEASUREME; Wise J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1556	7	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2910	10.1136/bmj.n2910	http://dx.doi.org/10.1136/bmj.n2910			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824086				2022-12-28	WOS:000744251500009
J	Lok, P				Lok, Pat			Time waits for no one	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												plok@bmj.com						Dobson J, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2425; Iacobucci G, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2572; Lok P, 2021, CAN BE ENV CONSCIOUS; Sharp Scratch, MIND GEND HLTH GAP; Sharp Scratch, SUP MED; Sharp Scratch, WHAT IS HIDD CURR; Tanne JH, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2634; Wilkinson E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2466	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2857	10.1136/bmj.n2857	http://dx.doi.org/10.1136/bmj.n2857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819297				2022-12-28	WOS:000740893700003
J	Wang, Q; Li, DH; Cao, GC; Shi, QP; Zhu, J; Zhang, MY; Cheng, H; Wen, Q; Xu, H; Zhu, LQ; Zhang, H; Perry, RJ; Spadaro, O; Yang, YN; He, SQ; Chen, Y; Wang, BC; Li, GQ; Liu, ZH; Yang, CX; Wu, XL; Zhou, LB; Zhou, QH; Ju, ZY; Lu, HY; Xin, YJ; Yang, XY; Wang, CC; Liu, Y; Shulman, GI; Dixit, VD; Lu, LG; Yang, HW; Flavell, RA; Yin, ZN				Wang, Qian; Li, Dehai; Cao, Guangchao; Shi, Qiping; Zhu, Jing; Zhang, Mingyue; Cheng, Hao; Wen, Qiong; Xu, Hao; Zhu, Leqing; Zhang, Hua; Perry, Rachel J.; Spadaro, Olga; Yang, Yunfan; He, Shengqi; Chen, Yong; Wang, Baocheng; Li, Guangqiang; Liu, Zonghua; Yang, Caixian; Wu, Xiaoli; Zhou, Libing; Zhou, Qinghua; Ju, Zhenyu; Lu, Hongyun; Xin, Yongjie; Yang, Xiaoyong; Wang, Cunchuan; Liu, Yong; Shulman, Gerald I.; Dixit, Vishwa Deep; Lu, Ligong; Yang, Hengwen; Flavell, Richard A.; Yin, Zhinan			IL-27 signalling promotes adipocyte thermogenesis and energy expenditure	NATURE			English	Article							BROWN ADIPOSE-TISSUE; INDUCTION; OBESITY; KINASE; MICE	Thermogenesis in brown and beige adipose tissue has important roles in maintaining body temperature and countering the development of metabolic disorders such as obesity and type 2 diabetes(1,2). Although much is known about commitment and activation of brown and beige adipose tissue, its multiple and abundant immunological factors have not been well characterized(3-6). Here we define a critical role of IL-27-IL-27R alpha signalling in improving thermogenesis, protecting against diet-induced obesity and ameliorating insulin resistance. Mechanistic studies demonstrate that IL-27 directly targets adipocytes, activating p38 MAPK-PGC-1 alpha signalling and stimulating the production of UCP1. Notably, therapeutic administration of IL-27 ameliorated metabolic morbidities in well-established mouse models of obesity. Consistently, individuals with obesity show significantly decreased levels of serum IL-27, which can be restored after bariatric surgery. Collectively, these findings show that IL-27 has an important role in orchestrating metabolic programs, and is a highly promising target for anti-obesity immunotherapy.	[Wang, Qian; Li, Dehai; Cao, Guangchao; Zhu, Jing; Zhang, Mingyue; Wen, Qiong; Zhang, Hua; Liu, Zonghua; Zhou, Qinghua; Lu, Hongyun; Xin, Yongjie; Lu, Ligong; Yang, Hengwen; Yin, Zhinan] Jinan Univ, Zhuhai Inst Translat Med, Zhuhai Peoples Hosp, Guangdong Prov Key Lab Tumor Intervent Diag & Tre, Zhuhai, Peoples R China; [Wang, Qian; Li, Dehai; Cao, Guangchao; Zhu, Jing; Zhang, Mingyue; Wen, Qiong; Zhu, Leqing; Zhang, Hua; Li, Guangqiang; Liu, Zonghua; Zhou, Qinghua; Yang, Hengwen; Yin, Zhinan] Jinan Univ, Biomed Translat Res Inst, Fac Med Sci, Guangzhou, Peoples R China; [Shi, Qiping] Jinan Univ, Affiliated Hosp 1, Dept Endocrine, Guangzhou, Peoples R China; [Cheng, Hao] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China; [Xu, Hao; Spadaro, Olga; Dixit, Vishwa Deep; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Zhu, Leqing; Li, Guangqiang] Jinan Univ, Affiliated Hosp 1, Fac Med Sci, Guangzhou, Peoples R China; [Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Med, New Haven, CT USA; [Perry, Rachel J.; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [Spadaro, Olga; Yang, Yunfan; Yang, Xiaoyong; Dixit, Vishwa Deep] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT USA; [He, Shengqi; Chen, Yong; Liu, Yong] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China; [Wang, Baocheng] Tsinghua Univ, Tsinghua Berkeley Shenzhen Inst, Shenzhen, Peoples R China; [Yang, Caixian] Guangzhou Med Univ, Qingyuan Peoples Hosp, Dept Endocrine, Affiliated Hosp 6, Qingyuan, Peoples R China; [Wu, Xiaoli] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China; [Zhou, Libing] Jinan Univ, Guangdong Hong Kong Macau Inst CNS Regenerat, Minist Educ, CNS Regenerat Collaborat Joint Lab, Guangzhou, Peoples R China; [Ju, Zhenyu] Jinan Univ, Inst Aging & Regenerat Med, Key Lab Regenerat Med, Minist Educ, Guangzhou, Peoples R China; [Wang, Cunchuan] Jinan Univ, Affiliated Hosp 1, Dept Surg, Guangzhou, Peoples R China	Jinan University; Jinan University; Jinan University; Shanghai Jiao Tong University; Yale University; Jinan University; Yale University; Yale University; Yale University; Wuhan University; Tsinghua University; Guangzhou Medical University; Tianjin University; Jinan University; Jinan University; Jinan University	Lu, LG; Yang, HW; Yin, ZN (corresponding author), Jinan Univ, Zhuhai Inst Translat Med, Zhuhai Peoples Hosp, Guangdong Prov Key Lab Tumor Intervent Diag & Tre, Zhuhai, Peoples R China.; Yang, HW; Yin, ZN (corresponding author), Jinan Univ, Biomed Translat Res Inst, Fac Med Sci, Guangzhou, Peoples R China.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA.	lu_ligong@163.com; hengwenyang@jnu.edu.cn; richard.flavell@yale.edu; tzhinan@jnu.edu.cn	Yang, Yunfan/AAN-9231-2020; yang, hengwen/GQH-7922-2022	Yang, Yunfan/0000-0002-5266-7208; Cao, Guangchao/0000-0003-2069-3396; Wang, Qian/0000-0003-4755-7001; Chen, Yong/0000-0002-0723-8105; yang, hengwen/0000-0002-6418-1985; Perry, Rachel/0000-0003-0748-8064	National Key Research and Development Program of China [2020YFA0803502, 2017YFA0205200]; National Natural Science Foundation of China [31830021, 32030036, 31420103901, 81771957, 32070121, 31800721, 31500742]; 111 Project [B16021]; Science and Technology Department of Guangdong Province of China [2014A030308003]; China Postdoctoral Science Foundation [2018M633278, 2020M683159, 2020M673045]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Science and Technology Department of Guangdong Province of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank A. Xu from Hongkong University, L. Ye from the Third Military Medical University, B. Li from Shanghai Jiao Tong University, Y. Qiu from Peking University, Y. Huo from Guangzhou Medical University and J. Chen from Sun Yat-Sen University for discussion, comments and technical guidance; and C. Cote for English language editing of this manuscript. This work is supported by the National Key Research and Development Program of China (no. 2020YFA0803502 to Z.Y.; no. 2017YFA0205200 to L.L.), the National Natural Science Foundation of China (nos 31830021, 32030036 and 31420103901 to Z.Y.; no. 81771957 to L.L.; no. 32070121 to H.Y.; no. 31800721 to Q. Wang; and no. 31500742 to Q.S.), the 111 Project (no. B16021 to Z.Y.), the Incubating Program from the Science and Technology Department of Guangdong Province of China (no. 2014A030308003 to Z.Y.), China Postdoctoral Science Foundation (nos 2018M633278 and 2020M683159 to Q. Wang; no. 2020M673045 to H.Z.).	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Hoffmann TJ, 2018, GENETICS, V210, P499, DOI 10.1534/genetics.118.301479; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kissig M, 2016, CELL, V166, P258, DOI 10.1016/j.cell.2016.06.038; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Nam H, 2016, OBESITY, V24, P157, DOI 10.1002/oby.21351; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Vargas-Alarcon G, 2019, CYTOKINE, V114, P32, DOI 10.1016/j.cyto.2018.11.028; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wolfrum C, 2019, HANDB EXP PHARMACOL, V251, P37, DOI 10.1007/164_2018_146; Yang B, 2017, J INVEST DERMATOL, V137, P1166, DOI 10.1016/j.jid.2017.01.010; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Zhang S, 2013, HEPATOLOGY, V57, P1620, DOI 10.1002/hep.26166	23	15	16	61	312	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					314	+		10.1038/s41586-021-04127-5	http://dx.doi.org/10.1038/s41586-021-04127-5		NOV 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34819664				2022-12-28	WOS:000722128900005
J	Hawkins, AT; Samuels, LR				Hawkins, Alexander T.; Samuels, Lauren R.			Use of Confidence Intervals in Interpreting Nonstatistically Significant Results	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POWER	This Guide to Statistics and Methods describes how confidence intervals can be used to help in the interpretation of nonsignificant findings across all study designs.	[Hawkins, Alexander T.] Vanderbilt Univ, Dept Surg, Sect Colon & Rectal Surg, Med Ctr, Nashville, TN 37232 USA; [Samuels, Lauren R.] Vanderbilt Univ, Dept Biostat, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Hawkins, AT (corresponding author), Vanderbilt Univ, Sect Colon & Rectal Surg, MCN, 1161 21st Ave 5,Room D5248, Nashville, TN 37232 USA.	alex.hawkins@vumc.org			National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health [K23DK118192]	National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Hawkins' work on this article was supported by the National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health under award No. K23DK118192.	Amrhein V, 2019, AM STAT, V73, P262, DOI 10.1080/00031305.2018.1543137; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Harrell F., 2021, GLOSS STAT TERMS; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hung ML, 2018, JAMA SURG, V153, P1098, DOI 10.1001/jamasurg.2018.2659; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; Quintana M, 2017, JAMA-J AM MED ASSOC, V318, P1605, DOI 10.1001/jama.2017.15574	8	6	6	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2068	2069		10.1001/jama.2021.16172	http://dx.doi.org/10.1001/jama.2021.16172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812882	Green Accepted			2022-12-28	WOS:000724001500026
J	Hinton, R; Jasper, U; Jha, S				Hinton, Rachael; Jasper, Ulla; Jha, Siddhartha			Moving beyond tokenism in our approach to human rights in digital health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hinton, Rachael] Fdn Botnar, Basel, Switzerland		Hinton, R (corresponding author), Fdn Botnar, Basel, Switzerland.							[Anonymous], 2018, GUID RESP PROT FULF; [Anonymous], ETHICS GOVERNANCE AR; [Anonymous], 2021, GLOB STRAT DIG HLTH; Birnbaum F, 2015, ACAD EMERG MED, V22, P754, DOI 10.1111/acem.12692; Ebert I., 2020, BUSINESS HUMAN RIGHT; EXpert Panel on effective ways of investing in Health (EXPH), ASS IMP DIG TRANSF H; Germann S, 2020, MHEALTH, V6, DOI 10.21037/mhealth-2019-di-11; Gostin Lawrence, 1994, Health Hum Rights, V1, P58, DOI 10.2307/4065262; Hunt P, 2006, HLTH HUMAN RIGHTS WO, V6; Kickbusch I., 2020, BMJ-BRIT MED J; Leslie D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n304; Mungoven R, 2016, WALKING TALK EXPLORI; Office of the High Commissioner for Human Rights, GUID PRINCIPL BUS HU; Office of the High Commissioner for Human Rights and World Health Organization, RIGHT HLTH FACT SHEE; The Danish Institute for Human Rights, 2020, HUMAN RIGHTS IMPACT	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2021	375								n2873	10.1136/bmj.n2873	http://dx.doi.org/10.1136/bmj.n2873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3LL	34810203	Bronze			2022-12-28	WOS:000730089900001
J	Salas, RN				Salas, Renee N.			Remembering the mission on healthcare's path to decarbonisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Salas, Renee N.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Salas, RN (corresponding author), Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA.							[Anonymous], Global spending on health: a world in transition; Eckelman MJ, 2020, HEALTH AFFAIR, V39, P2071, DOI 10.1377/hlthaff.2020.01247; Salas RN, 2021, NEW ENGL J MED, V385, P967, DOI 10.1056/NEJMp2109160; Salas RN, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3785; Salas Renee N, 2019, N Engl J Med, V381, pe13, DOI 10.1056/NEJMp1906035; Watts N, 2021, LANCET, V397, P129, DOI 10.1016/S0140-6736(20)32290-X; Welsby D, 2021, NATURE, V597, P230, DOI 10.1038/s41586-021-03821-8	7	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2847	10.1136/bmj.n2847	http://dx.doi.org/10.1136/bmj.n2847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799383	Bronze			2022-12-28	WOS:000723212300017
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			An urgent challenge for Europe: from tackling liver diseases to protecting liver health	LANCET			English	Editorial Material							LANCET STANDING COMMISSION		[Kleinert, Sabine; Horton, Richard] The Lancet, London EC2Y 5AS, England		Kleinert, S (corresponding author), The Lancet, London EC2Y 5AS, England.	sabine.kleinert@lancet.com						HM Revenues and Customs UK Government, 2021, AUT BUDG 2021 OV TAX; Karlsen TH, 2022, LANCET, V399, P61, DOI 10.1016/S0140-6736(21)01701-3; Manns MP, 2018, LANCET, V392, P621, DOI 10.1016/S0140-6736(18)31734-3; Williams R, 2020, LANCET, V395, P226, DOI 10.1016/S0140-6736(19)32908-3; Williams R, 2018, LANCET, V392, P2398, DOI 10.1016/S0140-6736(18)32561-3; Williams R, 2018, LANCET, V391, P1097, DOI 10.1016/S0140-6736(17)32866-0; Williams R, 2017, LANCET, V389, P2053, DOI 10.1016/S0140-6736(16)32234-6; Williams R, 2015, LANCET, V386, P2098, DOI 10.1016/S0140-6736(15)00680-7; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; World Health Organization, 2021, COMM DET HLTH FACT S	10	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					7	9		10.1016/S0140-6736(21)02726-4	http://dx.doi.org/10.1016/S0140-6736(21)02726-4		DEC 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YA3YW	34863357				2022-12-28	WOS:000738273800005
J	Cui, C; Wang, JW; Fagerberg, E; Chen, PM; Connolly, KA; Damo, M; Cheung, JF; Mao, TY; Askari, AS; Chen, ST; Fitzgerald, B; Foster, GG; Eisenbarth, SC; Zhao, HY; Craft, J; Joshi, NS				Cui, Can; Wang, Jiawei; Fagerberg, Eric; Chen, Ping-Min; Connolly, Kelli A.; Damo, Martina; Cheung, Julie F.; Mao, Tianyang; Askari, Adnan S.; Chen, Shuting; Fitzgerald, Brittany; Foster, Gena G.; Eisenbarth, Stephanie C.; Zhao, Hongyu; Craft, Joseph; Joshi, Nikhil S.			Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses	CELL			English	Article							TERTIARY LYMPHOID STRUCTURES; LUNG-CANCER; IMMUNE CONTEXTURE; DENDRITIC CELLS; MOUSE MODELS; PLASMA-CELL; IL-21; ANTIGEN; IMMUNOTHERAPY; EFFECTOR	CD4 T follicular helper (TFH) cells support B cells, which are critical for germinal center (GC) formation, but the importance of TFH-B cell interactions in cancer is unclear. We found enrichment of TFH cell transcriptional signature correlates with GC B cell signature and with prolonged survival in individuals with lung adenocarcinoma (LUAD). We further developed a murine LUAD model in which tumor cells express B cell-and T cell-recognized neoantigens. Interactions between tumor-specific TFH and GC B cells, as well as interleukin (IL)-21 primarily produced by TFH cells, are necessary for tumor control and effector CD8 T cell function. Development of TFH cells requires B cells and B cell-recognized neoantigens. Thus, tumor neoantigens can regulate the fate of tumor-specific CD4 T cells by facilitating their interactions with tumor-specific B cells, which in turn promote anti-tumor immunity by enhancing CD8 T cell effector functions.	[Cui, Can; Fagerberg, Eric; Chen, Ping-Min; Connolly, Kelli A.; Damo, Martina; Cheung, Julie F.; Mao, Tianyang; Askari, Adnan S.; Chen, Shuting; Fitzgerald, Brittany; Foster, Gena G.; Eisenbarth, Stephanie C.; Craft, Joseph; Joshi, Nikhil S.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Wang, Jiawei] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06510 USA; [Eisenbarth, Stephanie C.; Craft, Joseph] Yale Univ, Dept Internal Med Rheumatol Allergy & Immunol, Sch Med, New Haven, CT 06520 USA; [Eisenbarth, Stephanie C.] Yale Univ, Dept Lab Med, Sch Med, New Haven, CT 06519 USA; [Zhao, Hongyu] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Craft, J; Joshi, NS (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Craft, J (corresponding author), Yale Univ, Dept Internal Med Rheumatol Allergy & Immunol, Sch Med, New Haven, CT 06520 USA.	joseph.craft@yale.edu; nikhil.joshi@yale.edu	Cui, Can/AAA-2665-2021; Wang, Jiawei/ABD-2573-2021	Cui, Can/0000-0003-4736-4330; Wang, Jiawei/0000-0003-2627-4897; Cheung, Julie/0000-0003-1346-0930; Mao, Tianyang/0000-0001-9251-8592; Askari, Adnan/0000-0001-9511-4702; Fagerberg, Eric/0000-0003-0313-3717	NCI [K22CA200912, 1RO1CA237037-01A1]; NIH [R37AR40072, AR074545]; Yale SPORE in Lung Cancer [1P50CA196530 1P50CA196530]; Yale Cancer Center; Gruber Science Fellowship; Yale Immunobiology NIH T32 training grant [5T32AI007019]; Richard K. Gershon Research Fellowship	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale SPORE in Lung Cancer; Yale Cancer Center; Gruber Science Fellowship; Yale Immunobiology NIH T32 training grant; Richard K. Gershon Research Fellowship	We thank the N.S.J. and J.C. laboratory members for reviewing the manuscript; Z. Chen, C. Yang, and N. Ruddle for helpful discussions; and W. Wei for important guidance on statistical analysis. We also thank the Yale Flow Cytometry Core, Yale Keck DNA Sequencing Facility, Yale School of Medicine Histology Facility, and NIH Tetramer Core Facility. SWHEL mice were kindly provided by Dr. Robert Brink. Figures 2A, S4B, S6A, and S6B and the graphical abstract were created with https://www.biorender.com.This work was supported by grants from the NCI (K22CA200912 and 1RO1CA237037-01A1 to N.S.J.), NIH (R37AR40072 and AR074545 to J.C.), and Yale SPORE in Lung Cancer (1P50CA196530 1P50CA196530 to N.S.J. and J.C.) and a Pilot Grant from Yale Cancer Center (to N.S.J. and J.C.). C.C. was supported by the Gruber Science Fellowship and Richard K. Gershon Research Fellowship. J.F.C., K.A.C., and B.F. were supported by the Yale Immunobiology NIH T32 training grant (5T32AI007019).	Akama-Garren EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep16836; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Arias DAA, 2014, CANCER IMMUNOL RES, V2, P207, DOI 10.1158/2326-6066.CIR-13-0121; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bocharnikov AV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130062; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Bruno TC, 2017, CANCER IMMUNOL RES, V5, P898, DOI 10.1158/2326-6066.CIR-17-0075; Burnett DL, 2018, SCIENCE, V360, P223, DOI 10.1126/science.aao3859; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Chen Y, 2021, NAT IMMUNOL, V22, P996, DOI 10.1038/s41590-021-00965-7; Choi YS, 2013, CURR OPIN IMMUNOL, V25, P366, DOI 10.1016/j.coi.2013.04.003; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Connolly KA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg7836; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Damo M, 2021, NAT BIOTECHNOL, V39, P64, DOI 10.1038/s41587-020-0613-1; Deng SS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132000; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Engelhard VH, 2018, J IMMUNOL, V200, P432, DOI 10.4049/jimmunol.1701269; Ettinger DS, 2019, J NATL COMPR CANC NE, V17, P1464, DOI 10.6004/jnccn.2019.0059; Ferris ST, 2020, NATURE, V584, P624, DOI 10.1038/s41586-020-2611-3; Fitzgerald Brittany, 2021, Cell Rep Methods, V1, DOI 10.1016/j.crmeth.2021.100080; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Garaud S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129641; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Gettinger SN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05032-8; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Griss J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12160-2; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hanna NH, 2020, J CLIN ONCOL, V38, P1608, DOI 10.1200/JCO.19.03022; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hennequin A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1054598; Herbst RS, 2020, NEW ENGL J MED, V383, P1328, DOI 10.1056/NEJMoa1917346; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2020, P NATL ACAD SCI USA, V117, P4292, DOI 10.1073/pnas.1917298117; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; Jiang XD, 2019, J EXP MED, V216, P2854, DOI 10.1084/jem.20190801; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Kim N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16164-1; Kolenbrander A, 2018, IMMUNOLOGY, V153, P214, DOI 10.1111/imm.12834; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Lapointe R, 2003, CANCER RES, V63, P2836; Lee-Chang C, 2021, J EXP MED, V218, DOI 10.1084/jem.20200913; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21241-0; Li YJ, 2015, J NEUROIMMUNOL, V278, P239, DOI 10.1016/j.jneuroim.2014.11.011; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Liu M, 2020, NATURE, V587, P115, DOI 10.1038/s41586-020-2836-1; Lizotte PH, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89014; Lu YW, 2020, CELL, V180, P1081, DOI 10.1016/j.cell.2020.02.015; Magen A, 2019, CELL REP, V29, P3019, DOI 10.1016/j.celrep.2019.10.131; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McFadden DG, 2016, P NATL ACAD SCI USA, V113, pE6409, DOI 10.1073/pnas.1613601113; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; Milpied P, 2018, NAT IMMUNOL, V19, P1013, DOI 10.1038/s41590-018-0181-4; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; MITCHISON N A, 1971, European Journal of Immunology, V1, P10, DOI 10.1002/eji.1830010103; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Noel G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139905; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Ott PA, 2020, CELL, V183, P347, DOI 10.1016/j.cell.2020.08.053; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rakaee M, 2021, BRIT J CANCER, V124, P1680, DOI 10.1038/s41416-021-01307-y; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ren HM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb5590; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Roberti MP, 2020, NAT MED, V26, P919, DOI 10.1038/s41591-020-0882-8; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; Ruffin AT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23355-x; RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Schabath MB, 2019, CANCER EPIDEM BIOMAR, V28, P1563, DOI 10.1158/1055-9965.EPI-19-0221; Schenkel JM, 2021, IMMUNITY, V54, P2338, DOI 10.1016/j.immuni.2021.08.026; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Schumacher TN, 2016, CURR OPIN IMMUNOL, V41, P98, DOI 10.1016/j.coi.2016.07.005; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sharonov GV, 2020, NAT REV IMMUNOL, V20, P294, DOI 10.1038/s41577-019-0257-x; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Silina K, 2018, CANCER RES, V78, P1308, DOI 10.1158/0008-5472.CAN-17-1987; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Sondergaard H, 2009, TISSUE ANTIGENS, V74, P467, DOI 10.1111/j.1399-0039.2009.01382.x; Stach M, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-116294; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Truxova I, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0446-3; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; Vanhersecke L, 2021, NAT CANCER, V2, P794, DOI 10.1038/s43018-021-00232-6; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Voabil P, 2021, NAT MED, V27, P1250, DOI 10.1038/s41591-021-01398-3; Wang Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01691; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Weinstein JS, 2018, J EXP MED, V215, P337, DOI 10.1084/jem.20170457; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Wells DK, 2020, CELL, V183, P818, DOI 10.1016/j.cell.2020.09.015; Wieland A, 2021, NATURE, V597, P274, DOI 10.1038/s41586-020-2931-3; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yamanouchi S, 1998, EUR J IMMUNOL, V28, P696, DOI 10.1002/(SICI)1521-4141(199802)28:02<696::AID-IMMU696>3.0.CO;2-N; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zander RA, 2018, CELL REP, V23, P1230, DOI 10.1016/j.celrep.2018.04.048; Zhang BY, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay2754; Zhang YY, 2021, CANCER CELL, V39, P1578, DOI 10.1016/j.ccell.2021.09.010; Zhou T, 2020, NATURE, V583, P609, DOI 10.1038/s41586-020-2422-6; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	163	59	62	19	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6101	+		10.1016/j.cell.2021.11.007	http://dx.doi.org/10.1016/j.cell.2021.11.007		DEC 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YJ0DU	34852236	Green Accepted, Bronze			2022-12-28	WOS:000744210600003
J	Arbel, R; Hammerman, A; Sergienko, R; Friger, M; Peretz, A; Netzer, D; Yaron, S				Arbel, Ronen; Hammerman, Ariel; Sergienko, Ruslan; Friger, Michael; Peretz, Alon; Netzer, Doron; Yaron, Shlomit			BNT162b2 Vaccine Booster and Mortality Due to Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background The emergence of the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 and the reduced effectiveness over time of the BNT162b2 vaccine (Pfizer-BioNTech) led to a resurgence of coronavirus disease 2019 (Covid-19) cases in populations that had been vaccinated early. On July 30, 2021, the Israeli Ministry of Health approved the use of a third dose of BNT162b2 (booster) to cope with this resurgence. Evidence regarding the effectiveness of the booster in lowering mortality due to Covid-19 is still needed. Methods We obtained data for all members of Clalit Health Services who were 50 years of age or older at the start of the study and had received two doses of BNT162b2 at least 5 months earlier. The mortality due to Covid-19 among participants who received the booster during the study period (booster group) was compared with that among participants who did not receive the booster (nonbooster group). A Cox proportional-hazards regression model with time-dependent covariates was used to estimate the association of booster status with death due to Covid-19, with adjustment for sociodemographic factors and coexisting conditions. Results A total of 843,208 participants met the eligibility criteria, of whom 758,118 (90%) received the booster during the 54-day study period. Death due to Covid-19 occurred in 65 participants in the booster group (0.16 per 100,000 persons per day) and in 137 participants in the nonbooster group (2.98 per 100,000 persons per day). The adjusted hazard ratio for death due to Covid-19 in the booster group, as compared with the nonbooster group, was 0.10 (95% confidence interval, 0.07 to 0.14; P<0.001). Conclusions Participants who received a booster at least 5 months after a second dose of BNT162b2 had 90% lower mortality due to Covid-19 than participants who did not receive a booster. Effect of Booster on Mortality Due to Covid-19 in Israel Among 843,208 participants in Israel who were 50 years of age or older and had received two doses of the BNT162b2 vaccine at least 5 months earlier, those who received a booster had 90% lower mortality due to Covid-19 than those who did not receive a booster. The study period was 54 days; adverse effects were not recorded.	[Arbel, Ronen; Hammerman, Ariel; Peretz, Alon; Netzer, Doron; Yaron, Shlomit] Clalit Hlth Serv, Community Med Serv Div, Tel Aviv, Israel; [Arbel, Ronen] Sapir Coll, Maximizing Hlth Outcomes Res Lab, Sderot, Israel; [Sergienko, Ruslan; Friger, Michael] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel	Clalit Health Services; Ben Gurion University	Arbel, R (corresponding author), Clalit Hlth Serv, Arlozorov 101, IL-6209804 Tel Aviv, Israel.	ronenarb@clalit.org.il		Arbel, Ronen/0000-0002-6058-8665				[Anonymous], 2021, DAIL NEW CONF COVID; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Bar -On YM, 2021, EPIDEMIOLOGY, DOI [DOI 10.1101/2021.10.07.21264626, 10.1101/2021.10.07. 21264626]; Barda N, 2021, NEW ENGL J MED, V385, P1078, DOI 10.1056/NEJMoa2110475; Booth A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247461; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Evans SJW, 2021, NEW ENGL J MED, V385, P650, DOI 10.1056/NEJMe2110605; Goldberg Y., 2021, WANING IMMUNITY BNT1, DOI [10.1101/2021.08.24.21262423v1, DOI 10.1101/2021.08.24.21262423, DOI 10.1101/2021.08.24.21262423V1]; Keehner J, 2021, NEW ENGL J MED, V385, P1330, DOI 10.1056/NEJMc2112981; Krause PR, 2021, LANCET, V398, P1377, DOI 10.1016/S0140-6736(21)02046-8; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n971; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Self WH, 2021, MMWR-MORBID MORTAL W, V70, P1337, DOI 10.15585/mmwr.mm7038e1; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345; Zhang ZH, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.02.12	18	135	136	5	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2021	385	26					2413	2420		10.1056/NEJMoa2115624	http://dx.doi.org/10.1056/NEJMoa2115624		DEC 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS4FC	34879190	Green Published, Bronze			2022-12-28	WOS:000728089800001
J	Zarocostas, J				Zarocostas, John			Hope for nutrition summit as global hunger spikes	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2061	2062						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863339	Green Published, Bronze			2022-12-28	WOS:000726564200007
J	Mahase, E				Mahase, Elisabeth			Aducanumab: 4 in 10 high dose trial participants experienced brain swelling or bleeding	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1503; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1462; Salloway S, 2022, JAMA NEUROL, V79, P13, DOI 10.1001/jamaneurol.2021.4161	3	4	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2975	10.1136/bmj.n2975	http://dx.doi.org/10.1136/bmj.n2975			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853005				2022-12-28	WOS:000726688600003
J	Seeberg, KA; Borgeraas, H; Hofso, D; Smastuen, MC; Kvan, NP; Grimnes, JO; Lindberg, M; Fatima, F; Seeberg, LT; Sandbu, R; Hjelmesoth, J; Hertel, JK				Seeberg, Kathrine Aglen; Borgeraas, Heidi; Hofso, Dag; Smastuen, Milada Cvancarova; Kvan, Nils Petter; Grimnes, John Olav; Lindberg, Morten; Fatima, Farhat; Seeberg, Lars Thomas; Sandbu, Rune; Hjelmesoth, Joran; Hertel, Jens Kristoffer			Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis A Randomized Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							FATTY LIVER-DISEASE; BARIATRIC SURGERY; NAFLD; PATHOPHYSIOLOGY; QUANTIFICATION	Background: Weight loss improves fatty liver disease. No randomized trial has compared the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) on liver fat content and fibrosis. Objective: To compare the 1-year effects of SG and RYGB on hepatic steatosis and fibrosis. Design: Single-center, randomized, controlled trial (Oseberg [ObesitySurgery in Tonsberg]). (ClinicalTrials.gov: NCT01778738) Setting: Tertiary care obesity center in Norway. Participants: 100 patients (65% female; mean age, 47.5 years; mean body mass index, 42 kg/m(2)) with type 2 diabetes mellitus (T2DM). Intervention: From January 2013 to February 2018, patients were randomly assigned (1:1 ratio) to SG or RYGB. Measurements: The primary outcome was remission of T2DM (previously published). Predefined secondary outcomes in the present study were hepatic steatosis and fibrosis assessed by magnetic resonance imaging (liver fat fraction), enhanced liver fibrosis (ELF) test, noninvasive indices, and liver enzymes. Results: Liver fat fraction declined similarly after SG (-19.7% [95% CI, -22.5% to -16.9%]) and RYGB (-21.5% [CI, -24.3% to -18.6%]) from surgery to 1-year follow-up, and almost all patients (SG, 94%; RYGB, 100%) had no or low-grade steatosis at 1 year. The ELF score category remained stable in 77% of patients, but 18% experienced worsening of fibrosis at 1 year, with no substantial between-group difference. Limitations: Single-center study, short follow-up time, and lack of power for secondary outcomes. Conclusion: With an almost complete clearance of liver fat 1 year after surgery, RYGB and SG were both highly effective in reducing hepatic steatosis. Bariatric surgery had less influence on degree of fibrosis in the short term, but assessment of long-term progression is warranted.	[Seeberg, Kathrine Aglen; Borgeraas, Heidi; Hofso, Dag; Smastuen, Milada Cvancarova; Fatima, Farhat; Sandbu, Rune; Hjelmesoth, Joran; Hertel, Jens Kristoffer] Vestfold Hosp Trust, Morbid Obes Ctr, Pb 2168, N-3103 Tonsberg, Norway; [Seeberg, Kathrine Aglen; Hofso, Dag] Vestfold Hosp Trust, Dept Med, Tonsberg, Norway; [Seeberg, Kathrine Aglen; Fatima, Farhat] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Smastuen, Milada Cvancarova] Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Oslo, Norway; [Kvan, Nils Petter; Grimnes, John Olav] Vestfold Hosp Trust, Dept Radiol, Tonsberg, Norway; [Lindberg, Morten] Vestfold Hosp Trust, Dept Lab Med, Tonsberg, Norway; [Seeberg, Lars Thomas; Sandbu, Rune] Vestfold Hosp Trust, Dept Surg, Tonsberg, Norway; [Hjelmesoth, Joran] Univ Oslo, Inst Clin Med, Dept Endocrinol, Morbid Obes & Prevent Med, Oslo, Norway	University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo	Hertel, JK (corresponding author), Vestfold Hosp Trust, Morbid Obes Ctr, Pb 2168, N-3103 Tonsberg, Norway.	jehert@siv.no		sandbu, rune/0000-0002-0055-8675; hofso, dag/0000-0002-8877-1162; Borgeraas, Heidi/0000-0002-8357-4688; Lindberg, Morten/0000-0002-5568-7810; Fatima, Farhat/0000-0002-5549-8649	Vestfold Hospital Trust; South-Eastern Norway Regional Health Authority	Vestfold Hospital Trust; South-Eastern Norway Regional Health Authority	Vestfold Hospital Trust and the South-Eastern Norway Regional Health Authority.	Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Billeter AT, 2016, OBES SURG, V26, P1867, DOI 10.1007/s11695-015-2006-y; Borgeraas H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024573; Caldwell S, 2010, DIGEST DIS, V28, P162, DOI 10.1159/000282081; Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123; Chavez-Talavera O, 2017, GASTROENTEROLOGY, V152, P1679, DOI 10.1053/j.gastro.2017.01.055; Day J, 2019, J APPL LAB MED, V3, P815, DOI 10.1373/jalm.2018.027359; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Esterson YB, 2018, CLIN LIVER DIS, V22, P93, DOI 10.1016/j.cld.2017.08.005; Fakhry TK, 2019, SURG OBES RELAT DIS, V15, P502, DOI 10.1016/j.soard.2018.12.002; Froylich D, 2016, SURG OBES RELAT DIS, V12, P127, DOI 10.1016/j.soard.2015.04.004; Hofso D, 2019, LANCET DIABETES ENDO, V7, P912, DOI 10.1016/S2213-8587(19)30344-4; Kalinowski P, 2017, ANN SURG, V266, P738, DOI 10.1097/SLA.0000000000002397; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Laursen TL, 2019, WORLD J HEPATOL, V11, P138, DOI 10.4254/wjh.v11.i2.138; Lee Y, 2019, CLIN GASTROENTEROL H, V17, P1040, DOI 10.1016/j.cgh.2018.10.017; Luo RB, 2018, SURG ENDOSC, V32, P1675, DOI 10.1007/s00464-017-5846-9; Ma XZ, 2009, RADIOGRAPHICS, V29, P1253, DOI 10.1148/rg.295085186; Manne V, 2018, CLIN LIVER DIS, V22, P23, DOI 10.1016/j.cld.2017.08.007; Mathurin P, 2009, GASTROENTEROLOGY, V137, P532, DOI 10.1053/j.gastro.2009.04.052; Nickel F, 2018, OBES SURG, V28, P1342, DOI 10.1007/s11695-017-3012-z; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Perysinakis I, 2019, OBES SURG, V29, P1058, DOI 10.1007/s11695-019-03705-x; Petroni ML, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4747; Polyzos SA, 2019, HORM METAB RES, V51, P134, DOI 10.1055/a-0713-1330; Qu YL, 2019, EUR RADIOL, V29, P5180, DOI 10.1007/s00330-019-06071-5; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Schuppan D, 2018, J HEPATOL, V68, P238, DOI 10.1016/j.jhep.2017.11.012; Sheka AC, 2020, JAMA-J AM MED ASSOC, V323, P1175, DOI 10.1001/jama.2020.2298; Talavera-Urquijo E, 2018, OBES SURG, V28, P142, DOI 10.1007/s11695-017-2805-4; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Wang WT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00374; Xourafas D, 2012, OBES SURG, V22, P1540, DOI 10.1007/s11695-012-0677-1	36	4	4	3	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					74	+		10.7326/M21-1962	http://dx.doi.org/10.7326/M21-1962		NOV 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34843380				2022-12-28	WOS:000729197400001
J	Aggarwal, NK				Aggarwal, Neil Krishan			The Legacy of James McCune Smith, MD-The First US Black Physician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AFRICAN-AMERICAN		[Aggarwal, Neil Krishan] Columbia Univ, New York, NY 10032 USA; [Aggarwal, Neil Krishan] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Aggarwal, NK (corresponding author), Columbia Univ, New York State Psychiat Inst, Dept Psychiat, 1051 Riverside Dr,Unit 11, New York, NY 10032 USA.	neil.aggarwal@nyspi.columbia.edu						Baker RB, 2008, JAMA-J AM MED ASSOC, V300, P306, DOI 10.1001/jama.300.3.306; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Lujan HL, 2019, ADV PHYSIOL EDUC, V43, P134, DOI 10.1152/advan.00119.2018; Ishino FMA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124321; Morgan TM, 2003, J NATL MED ASSOC, V95, P603; Owoseni AV, 2020, NEW ENGL J MED, V383, P2204, DOI 10.1056/NEJMp2027850; Smith James McCune, 2006, WORKS JM SMITH BLACK; Smith JM., 1844, NEW YORK J MED COLLA, V2, P56; Smith JM., 1846, OFFICE MERCHANTS MAG	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2021	326	22					2245	2246		10.1001/jama.2021.18511	http://dx.doi.org/10.1001/jama.2021.18511		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XQ5NW	34842893	Bronze			2022-12-28	WOS:000725789800001
J	Fu, EL; Evans, M; Carrero, JJ; Putter, H; Clase, CM; Caskey, FJ; Szymczak, M; Torino, C; Chesnaye, NC; Jager, KJ; Wanner, C; Dekker, FW; van Diepen, M				Fu, Edouard L.; Evans, Marie; Carrero, Juan-Jesus; Putter, Hein; Clase, Catherine M.; Caskey, Fergus J.; Szymczak, Maciej; Torino, Claudia; Chesnaye, Nicholas C.; Jager, Kitty J.; Wanner, Christoph; Dekker, Friedo W.; van Diepen, Merel			Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-PRACTICE GUIDELINE; STAGE RENAL-DISEASE; PERITONEAL-DIALYSIS; START DIALYSIS; HEMODIALYSIS; SURVIVAL; IMPACT; COMORBIDITY; OUTCOMES; THERAPY	OBJECTIVE To identify the optimal estimated glomerular filtration rate (eGFR) at which to initiate dialysis in people with advanced chronic kidney disease. DESIGN Nationwide observational cohort study. SETTING National Swedish Renal Registry of patients referred to nephrologists. PARTICIPANTS Patients had a baseline eGFR between 10 and 20 mL/min/1.73 m(2) and were included between 1 January 2007 and 31 December 2016, with follow-up until 1 June 2017. MAIN OUTCOME MEASURES The strict design criteria of a clinical trial were mimicked by using the cloning, censoring, and weighting method to eliminate immortal time bias, lead time bias, and survivor bias. A dynamic marginal structural model was used to estimate adjusted hazard ratios and absolute risks for five year all cause mortality and major adverse cardiovascular events (composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) for 15 dialysis initiation strategies with eGFR values between 4 and 19 mL/min/1.73 m(2) in increments of 1 mL/min/1.73 m(2). An eGFR between 6 and 7 mL/min/1.73 m(2) (eGFR(6-7)) was taken as the reference. RESULTS Among 10 290 incident patients with advanced chronic kidney disease (median age 73 years; 3739 (36%) women; median eGFR 16.8 mL/min/1.73 m(2)), 3822 started dialysis, 4160 died, and 2446 had a major adverse cardiovascular event. A parabolic relation was observed for mortality, with the lowest risk for eGFR(15-16). Compared with dialysis initiation at eGFR(6-7), initiation at eGFR(15-16) was associated with a 5.1% (95% confidence interval 2.5% to 6.9%) lower absolute five year mortality risk and 2.9% (0.2% to 5.5%) lower risk of a major adverse cardiovascular event, corresponding to hazard ratios of 0.89 (95% confidence interval 0.87 to 0.92) and 0.94 (0.91 to 0.98), respectively. This 5.1% absolute risk difference corresponded to a mean postponement of death of 1.6 months over five years of follow-up. However, dialysis would need to be started four years earlier. When emulating the intended strategies of the Initiating Dialysis Early and Late (IDEAL) trial (eGFR(10-14)v eGFR(5-7)) and the achieved eGFRs in IDEAL (eGFR(7-10)v eGFR(5-7)), hazard ratios for all cause mortality were 0.96 (0.94 to 0.99) and 0.97 (0.94 to 1.00), respectively, which are congruent with the findings of the randomised IDEAL trial. CONCLUSIONS Very early initiation of dialysis was associated with a modest reduction in mortality and cardiovascular events. For most patients, such a reduction may not outweigh the burden of a substantially longer period spent on dialysis.	[Fu, Edouard L.; Dekker, Friedo W.; van Diepen, Merel] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Evans, Marie] Karolinska Inst, Dept Clin Intervent & Technol, Stockholm, Sweden; [Carrero, Juan-Jesus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Putter, Hein] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Clase, Catherine M.] McMaster Univ, Dept Med & Hlth Res Methods, Evidence & Impact, Hamilton, ON, Canada; [Caskey, Fergus J.] Univ Bristol, Sch Med, Populat Hlth Sci, Bristol, Avon, England; [Szymczak, Maciej] Wroclaw Med Univ, Dept Nephrol & Transplantat Med, Wroclaw, Poland; [Torino, Claudia] IFC CNR, Clin Epidemiol & Pathophysiol Renal Dis & Hyperte, Reggio Di Calabria, Italy; [Chesnaye, Nicholas C.; Jager, Kitty J.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Acad Univ Med Ctr, ERA EDTA Registry,Dept Med Informat, Amsterdam, Netherlands; [Wanner, Christoph] Univ Hosp Wurzburg, Div Nephrol, Wurzburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska Institutet; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; McMaster University; University of Bristol; Wroclaw Medical University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Amsterdam; Vrije Universiteit Amsterdam; University of Wurzburg	Fu, EL (corresponding author), Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands.	edfu@bwh.harvard.edu	Fu, Edouard L./AAR-4751-2020; Chesnaye, Nicholas/G-5707-2013; Putter, Hein/C-2244-2018	Fu, Edouard L./0000-0002-9698-6825; Chesnaye, Nicholas/0000-0003-4883-9174; Clase, Catherine/0000-0002-4538-5958; Caskey, Fergus/0000-0002-5199-3925; Szymczak, Maciej/0000-0002-1248-081X; Putter, Hein/0000-0001-5395-1422	Swedish Research Council [2019-01059]; Center of Innovative Medicine (CIMED) Karolinska; Stockholm City Council (ALF Medicine)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center of Innovative Medicine (CIMED) Karolinska; Stockholm City Council (ALF Medicine)	JJC obtained support from the Swedish Research Council (2019-01059). ME was supported by the Center of Innovative Medicine (CIMED) Karolinska and Stockholm City Council (ALF Medicine). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; Bozorgmehri S, 2021, HEMODIAL INT, V25, P188, DOI 10.1111/hdi.12912; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Buchanan AL, 2014, AIDS RES HUM RETROV, V30, P1170, DOI [10.1089/aid.2014.0037, 10.1089/AID.2014.0037]; Cain LE, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1212; Chan CT, 2019, KIDNEY INT, V96, P37, DOI 10.1016/j.kint.2019.01.017; Chau EM., 2016, CAN J KIDNEY HEALTH, V3; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Cohen LM, 2014, CLIN J AM SOC NEPHRO, V9, P840, DOI 10.2215/CJN.02690314; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Coronel F, 2009, SCAND J UROL NEPHROL, V43, P148, DOI 10.1080/00365590802602903; Couillerot-Peyrondet AL, 2017, EUR J HEALTH ECON, V18, P459, DOI 10.1007/s10198-016-0801-6; Crews DC, 2014, AM J KIDNEY DIS, V63, P806, DOI 10.1053/j.ajkd.2013.12.010; Dabrowska-Bender M, 2018, PATIENT PREFER ADHER, V12, P577, DOI 10.2147/PPA.S156356; Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015; Eriksson JK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012062; Evans M, 2011, J INTERN MED, V269, P289, DOI 10.1111/j.1365-2796.2010.02280.x; Evans M, 2017, NEPHROL DIAL TRANSPL, V32, P1892, DOI 10.1093/ndt/gfw328; Fink JC, 1999, AM J KIDNEY DIS, V34, P694, DOI 10.1016/S0272-6386(99)70395-1; Fu EL, 2021, CLIN KIDNEY J, V14, P1317, DOI 10.1093/ckj/sfaa242; Fu EL, 2021, J AM SOC NEPHROL, V32, P424, DOI 10.1681/ASN.2020050682; Fu EL, 2021, AM J KIDNEY DIS, V77, P719, DOI 10.1053/j.ajkd.2020.10.006; Fu EL, 2019, NEPHROL DIAL TRANSPL, V34, P1629, DOI 10.1093/ndt/gfy283; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hernan MA, 2016, J CLIN EPIDEMIOL, V79, P70, DOI 10.1016/j.jclinepi.2016.04.014; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hernan MA, 2011, EPIDEMIOLOGY, V22, P368, DOI 10.1097/EDE.0b013e3182109296; Hsu CY, 2020, JAMA INTERN MED, V180, P1647, DOI 10.1001/jamainternmed.2020.5009; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Jain AK, 2014, AM J KIDNEY DIS, V63, P798, DOI 10.1053/j.ajkd.2013.10.054; Janmaat CJ, 2017, CLIN EPIDEMIOL, V9, P217, DOI 10.2147/CLEP.S127695; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Kloecker DE, 2020, ANN INTERN MED, V172, P541, DOI 10.7326/M19-3286; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mann Bikaramjit S, 2014, Can J Kidney Health Dis, V1, P3, DOI 10.1186/2054-3581-1-3; Maringe C, 2020, INT J EPIDEMIOL, V49, P1719, DOI 10.1093/ije/dyaa057; Mazairac AHA, 2013, NEPHROL DIAL TRANSPL, V28, P1865, DOI 10.1093/ndt/gft045; Mohnen SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220800; Murphy E, 2021, NEPHROL DIAL TRANSPL, V36, P975, DOI 10.1093/ndt/gfaa209; Nacak H, 2016, NEPHROL DIAL TRANSPL, V31, P306, DOI 10.1093/ndt/gfv431; Nesrallah GE, 2014, CAN MED ASSOC J, V186, P112, DOI 10.1503/cmaj.130363; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Safiri S, 2019, ANN RHEUM DIS, V78, P1463, DOI 10.1136/annrheumdis-2019-215920; Sawhney S, 2009, NEPHROL DIAL TRANSPL, V24, P3186, DOI 10.1093/ndt/gfp189; Shiao CC, 2008, PERITON DIALYSIS INT, V28, P73; Sjolander A, 2011, AM J EPIDEMIOL, V174, P1204, DOI 10.1093/aje/kwr249; Stel VS, 2009, NEPHROL DIAL TRANSPL, V24, P3175, DOI 10.1093/ndt/gfp264; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P829, DOI 10.1053/j.ajkd.2012.01.015; Swedish Renal Registry, ANN REP; Tang SCW, 2007, NEPHROL DIAL TRANSPL, V22, P1926, DOI 10.1093/ndt/gfm109; Tangri N, 2021, J AM SOC NEPHROL, V32, P1791, DOI 10.1681/ASN.2020091254; Tattersall J, 2011, NEPHROL DIAL TRANSPL, V26, P2082, DOI 10.1093/ndt/gfr168; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; United States Renal Data System, 2020, 2020 USRDS ANN DAT R; van Geloven N, 2017, NEPHROL DIAL TRANSPL, V32, P53, DOI 10.1093/ndt/gfx012; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Watanabe Y, 2015, THER APHER DIAL, V19, P67, DOI 10.1111/1744-9987.12294; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909; Young JG, 2020, STAT MED, V39, P1199, DOI 10.1002/sim.8471	68	7	7	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e066306	10.1136/bmj-2021-066306	http://dx.doi.org/10.1136/bmj-2021-066306			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34844936	Green Published, hybrid			2022-12-28	WOS:000740896100015
J	Jung, AS; Haldane, V; Neill, R; Wu, SS; Jamieson, M; Verma, M; Tan, M; De Foo, C; Abdalla, SM; Shrestha, P; Chua, AQ; Bristol, N; Singh, S; Bartos, M; Mabuchi, S; Bonk, M; McNab, C; Werner, GK; Panjabi, R; Nordstrom, A; Legido-Quigley, H				Jung, Anne-Sophie; Haldane, Victoria; Neill, Rachel; Wu, Shishi; Jamieson, Margaret; Verma, Monica; Tan, Melisa; De Foo, Chuan; Abdalla, Salma M.; Shrestha, Pami; Chua, Alvin Qijia; Bristol, Nellie; Singh, Sudhvir; Bartos, Michael; Mabuchi, Shunsuke; Bonk, Mathias; McNab, Christine; Werner, George K.; Panjabi, Raj; Nordstrom, Anders; Legido-Quigley, Helena			National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jung, Anne-Sophie; Legido-Quigley, Helena] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Haldane, Victoria; Jamieson, Margaret] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Neill, Rachel] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wu, Shishi] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Verma, Monica; Tan, Melisa; De Foo, Chuan; Shrestha, Pami; Chua, Alvin Qijia; Legido-Quigley, Helena] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Abdalla, Salma M.; Bristol, Nellie; Singh, Sudhvir; Bartos, Michael; Mabuchi, Shunsuke; Bonk, Mathias; McNab, Christine; Werner, George K.; Panjabi, Raj; Nordstrom, Anders; Legido-Quigley, Helena] Independent Panel Pandem Preparedness & Response, Geneva, Switzerland; [Abdalla, Salma M.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Singh, Sudhvir] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	University of London; London School of Hygiene & Tropical Medicine; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; Boston University; University of Auckland	Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.; Legido-Quigley, H (corresponding author), Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Legido-Quigley, H (corresponding author), Independent Panel Pandem Preparedness & Response, Geneva, Switzerland.	ephhlq@nus.edu.sg	Chua, Alvin Qijia/GQH-3027-2022; Foo, Chuan De/AAJ-9844-2021	Chua, Alvin Qijia/0000-0001-6920-1204; Foo, Chuan De/0000-0001-7254-4881; Jung, Anne-Sophie/0000-0001-7039-7830; Singh, Sudhvir/0000-0002-9915-6755; Neill, Rachel/0000-0002-1110-5479	World Health Organisation; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	World Health Organisation(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by the Independent Panel for Pandemic Preparedness and Response. Open access fees were funded by the World Health Organisation and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	[Anonymous], 2020, LANCET INFECT DIS, V20, P875, DOI 10.1016/S1473-3099(20)30565-X; Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907; Curtice K, 2020, LANCET, V395, P1753, DOI 10.1016/S0140-6736(20)31242-3; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Diop BZ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002699; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Dummer TJB, 2008, CAN MED ASSOC J, V178, P1177, DOI 10.1503/cmaj.071783; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Firestone MJ, 2020, MMWR-MORBID MORTAL W, V69, P1771, DOI 10.15585/mmwr.mm6947e1; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Gilmore B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003188; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Haldane V, BMJ-BRIT MED J; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Hartley DM, 2020, JAMA-J AM MED ASSOC, V323, P1908, DOI 10.1001/jama.2020.5910; James A., 2020, SUPPRESSION MITIGATI, DOI [10.1101/2020.03.26.20044677, DOI 10.1101/2020.03.26.20044677]; Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013; Kayi I, 2020, INFECT DIS CLIN MICR, V2, P30, DOI [10.36519/idcm.2020.0009, DOI 10.36519/IDCM.2020.0009, 10.36519/idcm.2020. 0009]; Kim DH., 1999, INTRO SYSTEMS THINKI; Leach M, 2021, WORLD DEV, V138, DOI 10.1016/j.worlddev.2020.105233; Lebrasseur A, 2021, DISABIL HEALTH J, V14, DOI 10.1016/j.dhjo.2020.101014; Maani K., 2007, SYSTEMS THINKING SYS, V(2nd; Maragakis L., 2020, CORONAVIRUS 2 WAVE W; Loembe MM, 2020, NAT MED, V26, P999, DOI 10.1038/s41591-020-0961-x; Moore GF, 2019, EVALUATION-US, V25, P23, DOI 10.1177/1356389018803219; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morgan M. G., 2002, RISK COMMUNICATION M; Mormina M., 2020, CONVERSATION; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Shadmi E, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01218-z; Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500; Smith J., 2019, Gender and Development, V27, P355, DOI 10.1080/13552074.2019.1615288; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; van Zandvoort K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01789-2; von Tigerstrom B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002629; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; World Health Organization, 2007, COMMUNITY HLTH WORKE; World Health Organization, 2020, OLD PEOPL COVID 19; World Health Organization, 2017, WHO COMM ENG FRAM QU; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]	41	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e068954	10.1136/bmj-2021-068954	http://dx.doi.org/10.1136/bmj-2021-068954			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840138	hybrid, Green Published			2022-12-28	WOS:000740896100024
J	Jayabalan, M; Caballero, ME; Cordero, AD; White, BM; Asalone, KC; Moore, MM; Irabor, EG; Watkins, SE; Walters-Conte, KB; Taraboletti, A; Hartings, MR; Chow, BY; Saeed, BA; Bracht, KA; Bracht, JR				Jayabalan, Monessha; Caballero, Madeline E.; Cordero, Alyssa D.; White, Brandyn M.; Asalone, Kathryn C.; Moore, Madison M.; Irabor, Esohe G.; Watkins, Shari E.; Walters-Conte, Kathryn B.; Taraboletti, Alexandra; Hartings, Matthew R.; Chow, Brenda Y.; Saeed, Bushra A.; Bracht, Kathryn A.; Bracht, John R.			Unrealized potential from smaller institutions: Four strategies for advancing STEM diversity	CELL			English	Editorial Material								Diversity within science, technology, engineering, and mathematics (STEM) remains disturbingly low. Relative to larger, highly funded universities, smaller schools harbor more diverse student demographics and more limited resources. Here, we propose four strategies leveraging the unique advantages of smaller institutions to advance underrepresented scholars along STEM pathways.	[Jayabalan, Monessha; Caballero, Madeline E.; Cordero, Alyssa D.; Asalone, Kathryn C.; Chow, Brenda Y.; Bracht, John R.] Amer Univ, Dept Biol, Washington, DC 20016 USA; [White, Brandyn M.; Moore, Madison M.; Irabor, Esohe G.] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Watkins, Shari E.] Amer Univ, Ctr Teaching Res & Learning, Washington, DC 20016 USA; [Walters-Conte, Kathryn B.] Amer Univ, Dept Phys, Washington, DC 20016 USA; [Taraboletti, Alexandra] Univ Dist Columbia, Chem Dept, Washington, DC 20008 USA; [Hartings, Matthew R.] Amer Univ, Dept Chem, Washington, DC 20016 USA; [Saeed, Bushra A.] Univ Dist Columbia, Community Coll, Life & Phys Sci Dept, Washington, DC 20002 USA	American University; Howard University; American University; American University; University of the District of Columbia; American University; University of the District of Columbia	Bracht, JR (corresponding author), Amer Univ, Dept Biol, Washington, DC 20016 USA.	jbracht@american.edu	Taraboletti, Alexandra/M-5483-2019	Taraboletti, Alexandra/0000-0002-8779-483X; White, Brandyn/0000-0002-1928-1493; Caballero, Madeline/0000-0002-2723-4013; Asalone, Kathryn/0000-0002-6777-8701; Irabor, Esohe/0000-0001-6369-4888; Jayabalan, Monessha/0000-0002-5796-982X; Cordero, Alyssa/0000-0001-7745-2062; Hartings, Matthew/0000-0003-0658-939X				Gable R., 2021, HIDDEN CURRICULUM 1; Gin LE, 2021, CBE-LIFE SCI EDUC, V20, DOI 10.1187/cbe.21-04-0108; Ginther DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205929; Hernandez PR, 2018, BIOSCIENCE, V68, P204, DOI 10.1093/biosci/bix163; Hernandez PR, 2013, J EDUC PSYCHOL, V105, P89, DOI 10.1037/a0029691; Hinton AO, 2020, CELL, V183, P568, DOI 10.1016/j.cell.2020.09.029; Lundy-Wagner V., 2013, INT J DOCTORAL STUDI, V8, P151; Malotky MKH, 2020, J MICROBIOL BIOL EDU, V21, DOI 10.1128/jmbe.v21i1.1939; McGee E. O., 2018, SCI EFFECTIVE MENTOR, P51, DOI 10.17226/25568; National Center for Science and Engineering Sta- tistics National Science Foundation, 2019, 21308 NSF; National Science Board National Science Foundation, 2019, NSB20197 NAT SCI BOA; Smith JL, 2017, BIOSCIENCE, V67, P638, DOI 10.1093/biosci/bix050; U.S. Department of Education Office of Planning Evaluation and Policy Development and Office of the Under Secretary, 2016, ADV DIV INCL HIGH ED; Waterman R., 2018, EXPANDING CURE MODEL, V1st	14	4	4	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2021	184	24					5845	5850		10.1016/j.cell.2021.10.030	http://dx.doi.org/10.1016/j.cell.2021.10.030		NOV 2021	6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XC8CW	34822781	Bronze			2022-12-28	WOS:000722238100003
J	Alves, L				Alves, Lise			Brazilian scientists reject national award	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1862	1862						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801093				2022-12-28	WOS:000720912600011
J	Horton, R				Horton, Richard			Offline: The flies of our remorse	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1861	1861						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801092	Bronze			2022-12-28	WOS:000720912600010
J	Glass, J				Glass, Jonathan			Avoiding the trap of causality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Glass, Jonathan] Guys & St Thomass Fdn Trust, London, England		Glass, J (corresponding author), Guys & St Thomass Fdn Trust, London, England.	jonathan.glass@gstt.nhs.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2021	375								n3040	10.1136/bmj.n3040	http://dx.doi.org/10.1136/bmj.n3040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1KZ	34880004	Bronze			2022-12-28	WOS:000740890600010
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on . . . the pub landlord	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lawrence F, 2020, GUARDIAN; Maugham Jo, 2021, TWITTER	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2021	375								n3017	10.1136/bmj.n3017	http://dx.doi.org/10.1136/bmj.n3017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4CS	34872914				2022-12-28	WOS:000730815000008
J	White, DB; Villarroel, L; Hick, JL				White, Douglas B.; Villarroel, Lisa; Hick, John L.			Inequitable Access to Hospital Care - Protecting Disadvantaged Populations during Public Health Emergencies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[White, Douglas B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, Pittsburgh, PA 15260 USA; [Villarroel, Lisa] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Hick, John L.] Hennepin Healthcare, Minneapolis, MN USA; [Hick, John L.] Univ Minnesota, Minneapolis, MN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Arizona Department of Health Services; University of Minnesota System; University of Minnesota Twin Cities	White, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, Pittsburgh, PA 15260 USA.							Allen M., 2021, DYING WAITLIST; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Kadri SS, 2021, ANN INTERN MED, V174, P1240, DOI 10.7326/M21-1213; Rosenthal BM, 2020, NEW YORK TIMES	4	4	4	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2211	2214		10.1056/NEJMp2114767	http://dx.doi.org/10.1056/NEJMp2114767		DEC 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XL4CS	34874647	Bronze			2022-12-28	WOS:000726232100001
J	Wise, J				Wise, Jacqui			Plans to reform adult social care fall short of promises, say critics	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of health and Social Care, 2021, PEOPL HEART CAR AD S; Wise J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2207	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2980	10.1136/bmj.n2980	http://dx.doi.org/10.1136/bmj.n2980			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857540				2022-12-28	WOS:000732779300002
J	Salson, C; Majer, C; Pautier, P; Gouy, S; Morice, P				Salson, Claire; Majer, Chaef; Pautier, Patricia; Gouy, Sebastien; Morice, Philippe			Unexplained uterine atrophy following neoadjuvant chemotherapy in fertility sparing management of cervical cancer	LANCET			English	Editorial Material									[Salson, Claire; Gouy, Sebastien; Morice, Philippe] Inst Gustave Roussy, Dept Surg, Canc Campus, F-94805 Villejuif, France; [Majer, Chaef] Inst Gustave Roussy, Dept Imaging, Canc Campus, Villejuif, France; [Pautier, Patricia] Inst Gustave Roussy, Dept Med Oncol, Canc Campus, Villejuif, France; [Morice, Philippe] Univ Paris Saclay, Lnserm U 1030, Le Kremlin Bicetre, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Morice, P (corresponding author), Inst Gustave Roussy, Dept Surg, Canc Campus, F-94805 Villejuif, France.	philippe.morice@gustaveroussy.fr							0	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					E17	E17						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XD7PT	34838181				2022-12-28	WOS:000722897200001
J	Gage, FH				Gage, Fred H.			Adult neurogenesis in neurological diseases Dysregulated inflammatory responses and neuron maturation are observed in diseased human brains	SCIENCE			English	Editorial Material							CELLS		[Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu			JPB Foundation; Dolby Foundation; American Heart Association; Paul G. Allen Frontiers Group [19PABH134610000]; National Institute on Aging	JPB Foundation; Dolby Foundation; American Heart Association(American Heart Association); Paul G. Allen Frontiers Group; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Thanks to M. L. Gage, S. Parylak,J. Jones, H. Song,S. Schaffer, and S. Jessberger for helpful comments and suggestions. I thank the JPB Foundation, the Dolby Foundation, the American Heart Association, the Paul G. Allen Frontiers Group (19PABH134610000), and the National Institute on Aging for support.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Kheirbek MA, 2013, CELL, V153, P1183, DOI 10.1016/j.cell.2013.05.033; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Schafer ST, 2015, J NEUROSCI, V35, P4983, DOI 10.1523/JNEUROSCI.4130-14.2015; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Terreros-Roncal J, 2021, SCIENCE, V374, P1106, DOI 10.1126/science.abl5163; Tobin MK, 2019, CELL STEM CELL, V24, P974, DOI 10.1016/j.stem.2019.05.003; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006	15	6	6	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1049	1050		10.1126/science.abm7468	http://dx.doi.org/10.1126/science.abm7468			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822282				2022-12-28	WOS:000725668600018
J	Geier, S; Thaicharoen, N; Hainaut, C; Franz, T; Salzinger, A; Tebben, A; Grimshandl, D; Zurn, G; Weidemuller, M				Geier, Sebastian; Thaicharoen, Nithiwadee; Hainaut, Clement; Franz, Titus; Salzinger, Andre; Tebben, Annika; Grimshandl, David; Zurn, Gerhard; Weidemuller, Matthias			Floquet Hamiltonian engineering of an isolated many-body spin system	SCIENCE			English	Article							QUANTUM; ORDER; MODEL	Controlling interactions is the key element for the quantum engineering of many-body systems. Using time-periodic driving, a naturally given many-body Hamiltonian of a closed quantum system can be transformed into an effective target Hamiltonian that exhibits vastly different dynamics. We demonstrate such Floquet engineering with a system of spins represented by Rydberg states in an ultracold atomic gas. By applying a sequence of spin manipulations, we change the symmetry properties of the effective Heisenberg XYZ Hamiltonian. As a consequence, the relaxation behavior of the total spin is drastically modified. The observed dynamics can be qualitatively captured by a semiclassical simulation. Engineering a wide range of Hamiltonians opens vast opportunities for implementing quantum simulation of nonequilibrium dynamics in a single experimental setting.	[Geier, Sebastian; Thaicharoen, Nithiwadee; Hainaut, Clement; Franz, Titus; Salzinger, Andre; Tebben, Annika; Grimshandl, David; Zurn, Gerhard; Weidemuller, Matthias] Heidelberg Univ, Phys Inst, Neuenheimer Feld 226, D-69120 Heidelberg, Germany; [Thaicharoen, Nithiwadee] Chiang Mai Univ, Fac Sci, Res Ctr Quantum Technol, 239 Huay Kaew Rd, Chiang Mai 50200, Thailand	Ruprecht Karls University Heidelberg; Chiang Mai University	Thaicharoen, N; Weidemuller, M (corresponding author), Heidelberg Univ, Phys Inst, Neuenheimer Feld 226, D-69120 Heidelberg, Germany.; Thaicharoen, N (corresponding author), Chiang Mai Univ, Fac Sci, Res Ctr Quantum Technol, 239 Huay Kaew Rd, Chiang Mai 50200, Thailand.	thaicharoen@physi.uni-heidelberg.de; weidemueller@uni-heidelberg.de	; Weidemuller, Matthias/N-2232-2014	Tebben, Annika/0000-0002-9485-2532; Thaicharoen, Nithiwadee/0000-0003-1980-8213; Zurn, Gerhard/0000-0001-5475-9088; Weidemuller, Matthias/0000-0001-5639-5126; Franz, Titus/0000-0002-4162-9193; Salzinger, Andre/0000-0001-5736-281X; Geier, Sebastian/0000-0002-0729-4377; Hainaut, Clement/0000-0002-5315-4092	DFG under Germany's Excellence Strategy [EXC 2181/1 - 390900948]; European Commission FET flagship project PASQuanS [817482]; DFG (German Research Foundation) [273811115 - SFB 1225 ISOQUANT]; DFG Priority Program 1929 "GiRyd" [WE2661/12-2]; Heidelberg Center for Quantum Dynamics; European Union's Horizon 2020 program under Marie Sklodowska-Curie grant [798402]; Alexander von Humboldt Foundation; Heidelberg University (LGFG)	DFG under Germany's Excellence Strategy(German Research Foundation (DFG)); European Commission FET flagship project PASQuanS; DFG (German Research Foundation)(German Research Foundation (DFG)); DFG Priority Program 1929 "GiRyd"(German Research Foundation (DFG)); Heidelberg Center for Quantum Dynamics; European Union's Horizon 2020 program under Marie Sklodowska-Curie grant; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Heidelberg University (LGFG)	This work has been supported by the DFG under Germany's Excellence Strategy EXC 2181/1 - 390900948 (the Heidelberg STRUCTURES Excellence Cluster) and the European Commission FET flagship project PASQuanS (grant no. 817482). It is funded by the DFG (German Research Foundation) -Project-ID 273811115 - SFB 1225 ISOQUANT, and the DFG Priority Program 1929 "GiRyd" (WE2661/12-2). Support by the Heidelberg Center for Quantum Dynamics is acknowledged. N.T. received funding from the European Union's Horizon 2020 program under Marie Sklodowska-Curie grant agreement no. 798402. C.H. is supported by the Alexander von Humboldt Foundation. T.F. received a graduate scholarship from the Heidelberg University (LGFG).	Barredo D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.113002; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Browaeys A, 2020, NAT PHYS, V16, P132, DOI 10.1038/s41567-019-0733-z; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Choi J, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.031002; Comparat D, 2010, J OPT SOC AM B, V27, pA208, DOI 10.1364/JOSAB.27.00A208; Dmitriev DV, 2002, J EXP THEOR PHYS+, V95, P538, DOI 10.1134/1.1513828; Ferreira-Cao M, 2020, J PHYS B-AT MOL OPT, V53, DOI 10.1088/1361-6455/ab7427; Flaschner N, 2016, SCIENCE, V352, P1091, DOI 10.1126/science.aad4568; Floquet G., 1883, ANN SCI ECOLE NORM S, V12, P47, DOI DOI 10.24033/ASENS.220; Garttner M, 2017, NAT PHYS, V13, P781, DOI [10.1038/NPHYS4119, 10.1038/nphys4119]; Geier S., 2021, Zenodo, DOI 10.5281/zenodo.5336554; Geier S., Zenodo, V2021, DOI 10.5281/zenodo.5336584; Geier S., 2021, ZENODO, DOI [10.5281/zenodo.5506835, DOI 10.5281/ZENODO.5506835]; Goldman N, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031027; Gross C, 2017, SCIENCE, V357, P995, DOI 10.1126/science.aal3837; HAEBERLEN U, 1968, PHYS REV, V175, P453, DOI 10.1103/PhysRev.175.453; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Jepsen PN, 2020, NATURE, V588, P403, DOI 10.1038/s41586-020-3033-y; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Jurcevic P, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.080501; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Landsman KA, 2019, NATURE, V567, P61, DOI 10.1038/s41586-019-0952-6; Orioli AP, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.063601; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Schachenmayer J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011022; SHIRLEY JH, 1965, PHYS REV, V138, pB979, DOI 10.1103/PhysRev.138.B979; Sibalic N, 2017, COMPUT PHYS COMMUN, V220, P319, DOI 10.1016/j.cpc.2017.06.015; Signoles A, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.011011; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; WAUGH JS, 1968, PHYS REV LETT, V20, P180, DOI 10.1103/PhysRevLett.20.180; Wei KX, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.070501; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483	38	8	8	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1149	+		10.1126/science.abd9547	http://dx.doi.org/10.1126/science.abd9547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822286	Green Submitted			2022-12-28	WOS:000725668600050
J	Ma, DX; Lin, KB; Dong, YT; Choubisa, H; Proppe, AH; Wu, D; Wang, YK; Chen, B; Li, PC; Fan, JZ; Yuan, FL; Johnston, A; Liu, Y; Kang, YT; Lu, ZH; Wei, ZH; Sargent, EH				Ma, Dongxin; Lin, Kebin; Dong, Yitong; Choubisa, Hitarth; Proppe, Andrew H.; Wu, Dan; Wang, Ya-Kun; Chen, Bin; Li, Peicheng; Fan, James Z.; Yuan, Fanglong; Johnston, Andrew; Liu, Yuan; Kang, Yuetong; Lu, Zheng-Hong; Wei, Zhanhua; Sargent, Edward H.			Distribution control enables efficient reduced-dimensional perovskite LEDs	NATURE			English	Article							LIGHT-EMITTING-DIODES; FILMS	The efficiency and operating lifetimes of perovskite light-emitting diodes is improved by using a fluorinated triphenylphosphine oxide additive to control the cation diffusion during film deposition and passivate the surface. Light-emitting diodes (LEDs) based on perovskite quantum dots have shown external quantum efficiencies (EQEs) of over 23% and narrowband emission, but suffer from limited operating stability(1). Reduced-dimensional perovskites (RDPs) consisting of quantum wells (QWs) separated by organic intercalating cations show high exciton binding energies and have the potential to increase the stability and the photoluminescence quantum yield(2,3). However, until now, RDP-based LEDs have exhibited lower EQEs and inferior colour purities(4-6). We posit that the presence of variably confined QWs may contribute to non-radiative recombination losses and broadened emission. Here we report bright RDPs with a more monodispersed QW thickness distribution, achieved through the use of a bifunctional molecular additive that simultaneously controls the RDP polydispersity while passivating the perovskite QW surfaces. We synthesize a fluorinated triphenylphosphine oxide additive that hydrogen bonds with the organic cations, controlling their diffusion during RDP film deposition and suppressing the formation of low-thickness QWs. The phosphine oxide moiety passivates the perovskite grain boundaries via coordination bonding with unsaturated sites, which suppresses defect formation. This results in compact, smooth and uniform RDP thin films with narrowband emission and high photoluminescence quantum yield. This enables LEDs with an EQE of 25.6% with an average of 22.1 +/- 1.2% over 40 devices, and an operating half-life of two hours at an initial luminance of 7,200 candela per metre squared, indicating tenfold-enhanced operating stability relative to the best-known perovskite LEDs with an EQE exceeding 20%(1,4-6).	[Ma, Dongxin; Dong, Yitong; Choubisa, Hitarth; Proppe, Andrew H.; Wang, Ya-Kun; Chen, Bin; Fan, James Z.; Yuan, Fanglong; Johnston, Andrew; Liu, Yuan; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Lin, Kebin; Wei, Zhanhua] Huaqiao Univ, Xiamen Key Lab Optoelect Mat & Adv Mfg, Inst Luminescent Mat & Informat Displays, Coll Mat Sci & Engn, Xiamen, Peoples R China; [Wu, Dan] Shenzhen Technol Univ, Coll New Mat & New Energies, Shenzhen, Peoples R China; [Li, Peicheng; Yuan, Fanglong; Lu, Zheng-Hong] Univ Toronto, Dept Mat Sci & Engn, Toronto, ON, Canada; [Kang, Yuetong] Univ Victoria, Dept Chem, Victoria, BC, Canada; [Kang, Yuetong] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Sch Mat Sci & Engn, Beijing, Peoples R China	University of Toronto; Huaqiao University; Shenzhen Technology University; University of Toronto; University of Victoria; University of Science & Technology Beijing	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.; Wei, ZH (corresponding author), Huaqiao Univ, Xiamen Key Lab Optoelect Mat & Adv Mfg, Inst Luminescent Mat & Informat Displays, Coll Mat Sci & Engn, Xiamen, Peoples R China.	weizhanhua@hqu.edu.cn; ted.sargent@utoronto.ca	WU, Dan/ABA-7265-2020; Liu, Yuan/U-3401-2019	WU, Dan/0000-0003-1411-6103; Liu, Yuan/0000-0001-8611-1673; Dong, Yitong/0000-0002-7069-3725; Ma, Dongxin/0000-0002-9790-5951; Wang, Ya-Kun/0000-0002-8970-6856; Kang, Yuetong/0000-0001-8354-0392				BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Braly IL, 2018, NAT PHOTONICS, V12, P355, DOI 10.1038/s41566-018-0154-z; Cho C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14401-1; Cho HC, 2015, SCIENCE, V350, P1222, DOI 10.1126/science.aad1818; deQuilettes DW, 2016, ACS ENERGY LETT, V1, P438, DOI 10.1021/acsenergylett.6b00236; Dong YT, 2020, NAT NANOTECHNOL, V15, P668, DOI 10.1038/s41565-020-0714-5; Dou LT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6404; Forrest SR, 2003, ADV MATER, V15, P1043, DOI 10.1002/adma.200302151; Gao XP, 2019, ADV SCI, V6, DOI 10.1002/advs.201900941; Hong K, 2018, J MATER CHEM C, V6, P2189, DOI 10.1039/c7tc05658c; Ilavsky J, 2012, J APPL CRYSTALLOGR, V45, P324, DOI 10.1107/S0021889812004037; JELLISON GE, 1993, THIN SOLID FILMS, V234, P416, DOI 10.1016/0040-6090(93)90298-4; Jena AK, 2019, CHEM REV, V119, P3036, DOI 10.1021/acs.chemrev.8b00539; Jiang YZ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20555-9; Jiang Z, 2015, J APPL CRYSTALLOGR, V48, P917, DOI 10.1107/S1600576715004434; Kim YH, 2021, NAT PHOTONICS, V15, P148, DOI 10.1038/s41566-020-00732-4; Kong LM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21522-8; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G., 2001, VIENNA AB INITIO SIM; Li HH, 2020, SOL ENERGY, V212, P48, DOI 10.1016/j.solener.2020.10.066; Lin KB, 2018, NATURE, V562, P245, DOI 10.1038/s41586-018-0575-3; Lin-Vien D., 1991, HDB INFRARED RAMAN C, V3; Lin-Vien D, 1991, HDB INFRARED RAMAN C; Ly KT, 2017, NAT PHOTONICS, V11, P63, DOI 10.1038/NPHOTON.2016.230; Ma DX, 2020, J AM CHEM SOC, V142, P5126, DOI 10.1021/jacs.9b12323; Meng SS, 2018, ORG ELECTRON, V61, P351, DOI 10.1016/j.orgel.2018.06.014; Miyata A, 2015, NAT PHYS, V11, P582, DOI 10.1038/NPHYS3357; Perdew JP, 1998, PHYS REV LETT, V80, P891, DOI 10.1103/PhysRevLett.80.891; Quan LN, 2018, ADV MATER, V30, DOI 10.1002/adma.201801996; Quintero-Bermudez R, 2018, NAT MATER, V17, P900, DOI 10.1038/s41563-018-0154-x; Richter JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13941; Shen HB, 2019, NAT PHOTONICS, V13, P192, DOI 10.1038/s41566-019-0364-z; Shen Y, 2019, ADV MATER, V31, DOI 10.1002/adma.201901517; Sun CJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22529-x; Wang HR, 2020, JOULE, V4, P1977, DOI 10.1016/j.joule.2020.07.002; Won YH, 2019, NATURE, V575, P634, DOI 10.1038/s41586-019-1771-5; Wu TL, 2018, NAT PHOTONICS, V12, P235, DOI 10.1038/s41566-018-0112-9; Xing GC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14558; Xing GC, 2014, NAT MATER, V13, P476, DOI [10.1038/NMAT3911, 10.1038/nmat3911]; Zhao BD, 2018, NAT PHOTONICS, V12, P783, DOI 10.1038/s41566-018-0283-4; Zhu RD, 2014, OPT EXPRESS, V22, pA1783, DOI 10.1364/OE.22.0A1783	41	101	101	98	292	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 25	2021	599	7886					594	+		10.1038/s41586-021-03997-z	http://dx.doi.org/10.1038/s41586-021-03997-z			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC9YM	34819678				2022-12-28	WOS:000722366200018
J	Winston, LG; Winkler, ML; Kheterpal, A; Villalba, JA				Winston, Lisa G.; Winkler, Marisa L.; Kheterpal, Arvin; Villalba, Julian A.			Case 36-2021: A 22-Year-Old Man with Pain and Erythema of the Left Hand	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION	A Man with Pain and Erythema of the Left Hand A 22-year-old man was admitted with pain and erythema of the left hand. On the day of admission, he awoke with pain and swelling of the hand that involved the second and fourth fingers. Over several hours, the pain progressed and bullae began to form. The patient had recently begun practicing taxidermy. A diagnostic test was performed.	[Winston, Lisa G.] Zuckerberg San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Winston, Lisa G.] Univ Calif San Francisco, Ctr Trauma, Dept Med, San Francisco, CA 94143 USA; [Winkler, Marisa L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kheterpal, Arvin] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Villalba, Julian A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Winkler, Marisa L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kheterpal, Arvin] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Villalba, Julian A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Winston, LG (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA.; Winston, LG (corresponding author), Univ Calif San Francisco, Ctr Trauma, Dept Med, San Francisco, CA 94143 USA.		Villalba, Julian/AAK-4222-2020	Villalba, Julian/0000-0001-9230-8747				American Society for Microbiology, 2017, SENT LEV CLIN LAB GU; Centers for Disease Control and Prevention, 2020, BIOSAFETY MICROBIOLO, V6th; Centers for Disease Control and Prevention, 2016, HUNT RISKS; Centers for Disease Control and Prevention, 2021, MAPS STAT PLAG US; Dunbar SA, 2000, J CLIN MICROBIOL, V38, P1302, DOI 10.1128/JCM.38.3.1302-1304.2000; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Hendricks K., 2019, CDC YELLOW BOOK; Hjetland Reidar, 1995, Tidsskrift for den Norske Laegeforening, V115, P2780; Jean S, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.02031-18; Kuhl JT, 2003, CUTIS, V71, P288; Negron ME., 2019, CDC YELLOW BOOK; Reboli AC., 2005, MANDELL DOUGLAS BENN, P2496; Roess AA, 2010, NEW ENGL J MED, V363, P2621, DOI 10.1056/NEJMoa1007407; Sidwa T, 2020, EMERG INFECT DIS, V26, P2815, DOI 10.3201/eid2612.200470; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Tan EM, 2017, ZOONOSES PUBLIC HLTH, V64, pe65, DOI 10.1111/zph.12348; Veraldi S, 2009, CLIN EXP DERMATOL, V34, P859, DOI 10.1111/j.1365-2230.2009.03444.x; Wang QN, 2010, VET MICROBIOL, V140, P405, DOI 10.1016/j.vetmic.2009.08.012	18	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2078	2086		10.1056/NEJMcpc2107357	http://dx.doi.org/10.1056/NEJMcpc2107357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC3KG	34818483				2022-12-28	WOS:000721915400013
J	Yan, JH; Qin, YY; Zhao, H; Sun, Y; Gong, F; Li, R; Sun, XX; Ling, XF; Li, H; Hao, CF; Tan, JC; Yang, J; Zhu, YM; Liu, FH; Chen, DW; Wei, DM; Lu, JJ; Ni, TX; Zhou, W; Wu, KL; Gao, Y; Shi, YH; Lu, Y; Zhang, T; Wu, W; Ma, X; Ma, HL; Fu, J; Zhang, JQ; Meng, QX; Zhang, HP; Legro, RS; Chen, ZJ				Yan, Junhao; Qin, Yingying; Zhao, Han; Sun, Yun; Gong, Fei; Li, Rong; Sun, Xiaoxi; Ling, Xiufeng; Li, Hong; Hao, Cuifang; Tan, Jichun; Yang, Jing; Zhu, Yimin; Liu, Fenghua; Chen, Dawei; Wei, Daimin; Lu, Juanjuan; Ni, Tianxiang; Zhou, Wei; Wu, Keliang; Gao, Yuan; Shi, Yuhua; Lu, Yao; Zhang, Ting; Wu, Wei; Ma, Xiang; Ma, Hailan; Fu, Jing; Zhang, Junqiang; Meng, Qingxia; Zhang, Heping; Legro, Richard S.; Chen, Zi-Jiang			Live Birth with or without Preimplantation Genetic Testing for Aneuploidy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; FRESH; IMPLANTATION; EMBRYOS	Background Embryo selection with preimplantation genetic testing for aneuploidy (PGT-A) may improve pregnancy outcomes after initial embryo transfer. However, it remains uncertain whether PGT-A improves the cumulative live-birth rate as compared with conventional in vitro fertilization (IVF). Methods In this multicenter, randomized, controlled trial, we randomly assigned subfertile women with three or more good-quality blastocysts to undergo either PGT-A or conventional IVF; all the women were between 20 and 37 years of age. Three blastocysts were screened by next-generation sequencing in the PGT-A group or were chosen by morphologic criteria in the conventional-IVF group and then were successively transferred one by one. The primary outcome was the cumulative live-birth rate after up to three embryo-transfer procedures within 1 year after randomization. We hypothesized that the use of PGT-A would result in a cumulative live-birth rate that was no more than 7 percentage points higher than the rate after conventional IVF, which would constitute the noninferiority margin for conventional IVF as compared with PGT-A. Results A total of 1212 patients underwent randomization, and 606 were assigned to each trial group. Live births occurred in 468 women (77.2%) in the PGT-A group and in 496 (81.8%) in the conventional-IVF group (absolute difference, -4.6 percentage points; 95% confidence interval [CI], -9.2 to -0.0; P<0.001). The cumulative frequency of clinical pregnancy loss was 8.7% and 12.6%, respectively (absolute difference, -3.9 percentage points; 95% CI, -7.5 to -0.2). The incidences of obstetrical or neonatal complications and other adverse events were similar in the two groups. Conclusions Among women with three or more good-quality blastocysts, conventional IVF resulted in a cumulative live-birth rate that was noninferior to the rate with PGT-A. (Funded by the National Natural Science Foundation of China and others; ClinicalTrials.gov number, .) Live Birth after Genetic Testing for Aneuploidy In this multicenter, randomized, controlled trial comparing preimplantation genetic testing for aneuploidy (PGT-A) with conventional IVF in women with a good prognosis, the conventional-IVF group had a cumulative live-birth rate that was noninferior to that after PGT-A at 1 year.	[Yan, Junhao; Qin, Yingying; Wei, Daimin; Lu, Juanjuan; Ni, Tianxiang; Zhou, Wei; Wu, Keliang; Gao, Yuan; Shi, Yuhua; Chen, Zi-Jiang] Shandong Univ, Ctr Reprod Med, Cheeloo Coll Med, Key Lab Reprod Endocrinol,Minist Educ, Jinan, Shandong, Peoples R China; [Yan, Junhao; Qin, Yingying; Zhao, Han; Wei, Daimin; Lu, Juanjuan; Ni, Tianxiang; Zhou, Wei; Wu, Keliang; Gao, Yuan; Shi, Yuhua; Chen, Zi-Jiang] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Shandong, Peoples R China; [Yan, Junhao; Qin, Yingying; Zhao, Han; Wei, Daimin; Lu, Juanjuan; Ni, Tianxiang; Zhou, Wei; Wu, Keliang; Gao, Yuan; Shi, Yuhua; Chen, Zi-Jiang] Shandong Univ, Shandong Key Lab Reprod Med, Jinan, Shandong, Peoples R China; [Yan, Junhao; Qin, Yingying; Zhao, Han; Wei, Daimin; Lu, Juanjuan; Ni, Tianxiang; Zhou, Wei; Wu, Keliang; Gao, Yuan; Shi, Yuhua; Chen, Zi-Jiang] Shandong Univ, Shandong Prov Clin Res Ctr Reprod Hlth, Jinan, Shandong, Peoples R China; [Sun, Yun; Lu, Yao; Zhang, Ting; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med,Shanghai Key Lab Assisted Reprod &, Shanghai, Peoples R China; [Sun, Xiaoxi; Fu, Jing] Fudan Univ, Obstet & Gynecol Hosp, Shanghai JIAI Genet & IVF Inst, Key Lab Female Reprod Endocrine Related Dis Obste, Shanghai, Peoples R China; [Gong, Fei; Ma, Hailan] Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha, Peoples R China; [Gong, Fei; Ma, Hailan] Cent South Univ, Reprod & Genet Hosp CITIC Xiangya, Changsha, Peoples R China; [Li, Rong] Peking Univ Third Hosp, Natl Clin Res Ctr Obstet & Gynecol, Key Lab Assisted Reprod, Minist Educ,Ctr Reprod Med,Dept Obstet & Gynecol, Beijing, Peoples R China; [Li, Rong] Peking Univ Third Hosp, Beijing Key Lab Reprod Endocrinol & Assisted, Beijing, Peoples R China; [Ling, Xiufeng; Zhang, Junqiang] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Obstet & Gynecol Hosp, Dept Reprod Med, Nanjing, Peoples R China; [Wu, Wei; Ma, Xiang] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Reprod Med, Nanjing, Peoples R China; [Li, Hong; Meng, Qingxia] Nanjing Med Univ, Suzhou Municipal Hosp, Suzhou, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Ctr Reprod Med, Yantai, Peoples R China; [Tan, Jichun] China Med Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Key Lab Reprod Dysfunct Dis & Fertil Remodeling L, Shenyang, Peoples R China; [Yang, Jing] Wuhan Univ, Ctr Reprod Med, Wuhan, Peoples R China; [Zhu, Yimin] Zhejiang Univ, Womens Hosp, Dept Reprod Endocrinol, Key Lab Reprod Genet,Sch Med, Hangzhou, Peoples R China; [Liu, Fenghua] Guangdong Women & Children Hosp, Dept Reproduct Hlth & Infertil, Guangzhou, Peoples R China; [Chen, Dawei] Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Dept Obstet & Gynecol, Hefei, Peoples R China; [Zhao, Han] Yale Univ, Dept Biostat, Sch Publ Hlth, New Haven, CT USA; [Legro, Richard S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Shandong University; Shandong University; Shandong University; Shandong University; Shanghai Jiao Tong University; Fudan University; Central South University; Central South University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; China Medical University; Wuhan University; Zhejiang University; Anhui Medical University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chen, ZJ (corresponding author), Shandong Univ, Ctr Reprod Med, Cheeloo Coll Med, Key Lab Reprod Endocrinol,Minist Educ, Jinan, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Shandong Univ, Shandong Key Lab Reprod Med, Jinan, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Clin Res Ctr Reprod Hlth, Jinan, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med,Shanghai Key Lab Assisted Reprod &, Shanghai, Peoples R China.	chenzijiang@hotmail.com	Zhang, He/GXN-0028-2022; Wu, Ke/HCQ-3503-2022; Chen, Zi-Jiang/GOE-6119-2022					Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Capalbo A, 2017, FERTIL STERIL, V107, P1098, DOI 10.1016/j.fertnstert.2017.03.023; Duffy JMN, 2021, FERTIL STERIL, V115, P201, DOI 10.1016/j.fertnstert.2020.11.013; Eaton JL, 2020, OBSTET GYNECOL, V135, P709, DOI 10.1097/AOG.0000000000003695; Farfalli VI, 2007, GYNECOL OBSTET INVES, V64, P161, DOI 10.1159/000101741; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Ghobara T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003414.pub3; Greco E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124381; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Joshi N, 2012, OBSTET GYNECOL, V120, P843, DOI 10.1097/AOG.0b013e318269c0e9; Kemper JM, 2020, HUM REPROD, V35, P2408, DOI 10.1093/humrep/deaa224; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Margalioth EJ, 2006, HUM REPROD, V21, P3036, DOI 10.1093/humrep/del305; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Munne S, 2019, FERTIL STERIL, V112, P1071, DOI 10.1016/j.fertnstert.2019.07.1346; Ozgur K, 2019, J ASSIST REPROD GEN, V36, P629, DOI 10.1007/s10815-018-01399-1; Pandian Z, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003357.pub3; Penzias A, 2020, FERTIL STERIL, V114, P246, DOI 10.1016/j.fertnstert.2020.05.014; Roeca C, 2020, J ASSIST REPROD GEN, V37, P2283, DOI 10.1007/s10815-020-01874-8; Rubio C, 2017, FERTIL STERIL, V107, P1122, DOI 10.1016/j.fertnstert.2017.03.011; Sacchi L, 2019, J ASSIST REPROD GEN, V36, P2493, DOI 10.1007/s10815-019-01609-4; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Sermon K, 2016, MOL HUM REPROD, V22, P545, DOI 10.1093/molehr/gaw034; Shi YH, 2018, NEW ENGL J MED, V378, P126, DOI 10.1056/NEJMoa1705334; Singla S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16796-3; Sugiura-Ogasawara M, 2012, HUM REPROD, V27, P2297, DOI 10.1093/humrep/des179; Verpoest W, 2018, HUM REPROD, V33, P1767, DOI 10.1093/humrep/dey262; Victor AR, 2019, FERTIL STERIL, V111, P280, DOI 10.1016/j.fertnstert.2018.10.019; Victor AR, 2019, HUM REPROD, V34, P181, DOI 10.1093/humrep/dey327; Wilkinson J, 2017, HUM REPROD, V32, P1155, DOI 10.1093/humrep/dex063; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Zhang L, 2019, J ASSIST REPROD GEN, V36, P165, DOI 10.1007/s10815-018-1322-2	32	41	41	11	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2047	2058		10.1056/NEJMoa2103613	http://dx.doi.org/10.1056/NEJMoa2103613			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC3KG	34818479	Bronze			2022-12-28	WOS:000721915400009
J	Dyer, O				Dyer, Owen			A record 100 000 people in the US died from overdoses in 12 months of the pandemic, says CDC	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control, 2021, PROVISIONAL DRUG OVE	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2021	375								n2865	10.1136/bmj.n2865	http://dx.doi.org/10.1136/bmj.n2865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3LL	34810214				2022-12-28	WOS:000730089900003
J	Neufeld, LM; Andrade, EB; Suleiman, AB; Barker, M; Beal, T; Blum, LS; Demmler, KM; Dogra, S; Hardy-Johnson, P; Lahiri, A; Larson, N; Roberto, CA; Rodriguez-Ramirez, S; Sethi, V; Shamah-Levy, T; Strommer, S; Tumilowicz, A; Weller, S; Zou, ZY				Neufeld, Lynnette M.; Andrade, Eduardo B.; Suleiman, Ahna Ballonoff; Barker, Mary; Beal, Ty; Blum, Lauren S.; Demmler, Kathrin M.; Dogra, Surabhi; Hardy-Johnson, Polly; Lahiri, Anwesha; Larson, Nicole; Roberto, Christina A.; Rodriguez-Ramirez, Sonia; Sethi, Vani; Shamah-Levy, Teresa; Strommer, Sofia; Tumilowicz, Alison; Weller, Susie; Zou, Zhiyong			Food choice in transition: adolescent autonomy, agency, and the food environment	LANCET			English	Article							DISORDERED EATING BEHAVIORS; TEENAGE BRAIN SENSITIVITY; MIDDLE-INCOME COUNTRIES; SOCIAL MEDIA; DIETARY-INTAKE; HEALTHY FOOD; CHILDREN; YOUTH; PERCEPTIONS; OBESITY	Dietary intake during adolescence sets the foundation for a healthy life, but adolescents are diverse in their dietary patterns and in factors that influence food choice. More evidence to understand the key diet-related issues and the meaning and context of food choices for adolescents is needed to increase the potential for impactful actions. The aim of this second Series paper is to elevate the importance given to adolescent dietary intake and food choice, bringing a developmental perspective to inform policy and programmatic actions to improve diets. We describe patterns of dietary intake, then draw on existing literature to map how food choice can be influenced by unique features of adolescent development. Pooled qualitative data is then combined with evidence from the literature to explore ways in which adolescent development can interact with sociocultural context and the food environment to influence food choice. Irrespective of context, adolescents have a lot to say about why they eat what they eat, and insights into factors that might motivate them to change. Adolescents must be active partners in shaping local and global actions that support healthy eating patterns. Efforts to improve food environments and ultimately adolescent food choice should harness widely shared adolescent values beyond nutrition or health.	[Neufeld, Lynnette M.] Global Alliance Improved Nutr, Geneva, Switzerland; [Andrade, Eduardo B.] Getulio Vargas Fdn FGV, Brazilian Sch Publ & Business Adm EBAPE, Rio De Janeiro, Brazil; [Suleiman, Ahna Ballonoff] Calif State Univ Sacramento, Dept Publ Hlth, Sacramento, CA 95819 USA; [Barker, Mary; Strommer, Sofia] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Barker, Mary; Hardy-Johnson, Polly; Strommer, Sofia] Southampton Gen Hosp, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England; [Barker, Mary] Univ Southampton, Sch Hlth Sci, Fac Environm & Life Sci, Southampton, Hants, England; [Beal, Ty; Blum, Lauren S.] Global Alliance Improved Nutr, Washington, DC USA; [Demmler, Kathrin M.] Global Alliance Improved Nutr, London, England; [Dogra, Surabhi] Lancet Standing Commiss Adolescent Hlth & Wellbei, Noida, India; [Lahiri, Anwesha] Inst Econ Growth, New Delhi, India; [Larson, Nicole] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Roberto, Christina A.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Rodriguez-Ramirez, Sonia; Shamah-Levy, Teresa] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Sethi, Vani] UNICEF India, New Delhi, India; [Tumilowicz, Alison] Bill & Melinda Gates Fdn, Seattle, WA USA; [Weller, Susie] Univ Southampton, Southampton Gen Hosp, Clin Eth & Law Southampton, Primary Care Populat Sci & Med Educ, Southampton, Hants, England; [Zou, Zhiyong] Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Beijing, Peoples R China; [Zou, Zhiyong] Natl Hlth Commiss Key Lab Reprod Hlth, Beijing, Peoples R China	Getulio Vargas Foundation; California State University System; California State University Sacramento; University of Southampton; University of Southampton; University of Southampton; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; Instituto Nacional de Salud Publica; Bill & Melinda Gates Foundation; University of Southampton; Peking University	Neufeld, LM (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	lneufeld@gainhealth.org	Rodríguez-Ramírez, Sonia/AAB-8988-2022; Andrade, Eduardo B./H-7745-2013	Rodríguez-Ramírez, Sonia/0000-0002-5439-4389; Andrade, Eduardo B./0000-0002-2930-8151; Beal, Ty/0000-0002-0398-9825; Lahiri, Anwesha/0000-0002-4112-4929; Zou, Zhiyong/0000-0001-5049-5425; Barker, Mary/0000-0003-2976-0217; Hardy-Johnson, Polly/0000-0001-9659-1447; Larson, Nicole/0000-0002-1082-6311; Weller, Susan/0000-0002-6839-876X; Dogra, Surabhi/0000-0003-4136-2115	Fondation Botnar; Wellcome Trust; Aditya and Megha Mittal Foundation; National Natural Science Foundation of China [82073573]; UK NIHR Programme Grants for Applied Research [RP-PG-0216-20004]	Fondation Botnar; Wellcome Trust(Wellcome TrustEuropean Commission); Aditya and Megha Mittal Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK NIHR Programme Grants for Applied Research	This work received funding support from Fondation Botnar and the Wellcome Trust. Neither organisation played any role in writing the manuscript or the decision to submit for publication. We gratefully acknowledge support from Mona Ghadirian, Heather Kelahan, and Jamie Marquis to the systematic review of dietary intake evidence. The data for the India case study were analysed from the Comprehensive National Nutrition Survey (CNNS) 2016-18, conducted under the leadership of the Ministry of Health and Family Welfare (MoHFW), Government of India, and Technical Advisory Committee designated by the MoHFW, in collaboration with UNICEF and the Population Council. The CNNS (a previous survey from which we extracted data for the India case study) was funded through a generous grant from the Aditya and Megha Mittal Foundation. The China National Nutrition Survey was supported by the National Natural Science Foundation of China (82073573). Mexico's National Survey of Health and Nutrition was funded by the Secretary of Health of Mexico through a grant to the National Institutes of Public Health, Mexico. We are grateful to the collaborators of the TALENT consortium for making their data available (details of the consortium in appendix). EACH-B is funded by the UK NIHR Programme Grants for Applied Research (RP-PG-0216-20004). The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. VS and AL note that the statements in this publication are the views of the authors and do not necessarily reflect the policies or views of UNICEF.	Aboujaoude E, 2015, J ADOLESCENT HEALTH, V57, P10, DOI 10.1016/j.jadohealth.2015.04.011; Adams EL, 2020, OBESITY, V28, P2056, DOI 10.1002/oby.22996; Allcott H, 2019, Q J ECON, V134, P1793, DOI 10.1093/qje/qjz015; Alruwaily A, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-4057; Anderson, 2014, J HABERMAS KEY CONCE, P91; Anderson L, 2012, J PUBLIC POLICY MARK, V31, P240, DOI 10.1509/jppm.08.043; Andretti B, 2021, PREV MED, V146, DOI 10.1016/j.ypmed.2021.106456; Androutsos O, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030930; Aurino E, 2017, ECON HUM BIOL, V25, P99, DOI 10.1016/j.ehb.2016.10.007; Banna JC, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2724-7; Barker ME, 2021, PUBLIC HEALTH NUTR, V24, P5309, DOI 10.1017/S1368980020002244; Barry, 1991, ADOLESCENCE ANTHR IN; Beal T, 2019, FOOD NUTR BULL, V40, P444, DOI 10.1177/0379572119848287; Blum LS, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12841; Blum LS, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12833; Boulianne S, 2020, MEDIA COMMUN-LISBON, V8, P208, DOI 10.17645/mac.v8i2.2768; Bragg MA, 2018, J ADOLESCENT HEALTH, V62, P5, DOI 10.1016/j.jadohealth.2017.06.016; Brown C, 2015, APPETITE, V95, P29, DOI 10.1016/j.appet.2015.06.018; Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679; Cardoos SL, 2017, PSYCHONEUROENDOCRINO, V81, P14, DOI 10.1016/j.psyneuen.2017.03.013; Chandra-Mouli V, 2017, J ADOLESCENT HEALTH, V61, pS5, DOI 10.1016/j.jadohealth.2017.07.012; Clark H, 2020, LANCET, V395, P605, DOI 10.1016/S0140-6736(19)32540-1; Coleman-Jensen A., 2020, Economic Research Report - Economic Research Service, USDA; Contento IR, 2006, J ADOLESCENT HEALTH, V38, P575, DOI 10.1016/j.jadohealth.2005.05.025; Crockett L.J., 1995, PATHWAYS ADOLESCENCE; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Dahl RE, 2018, NATURE, V554, P441, DOI 10.1038/nature25770; Davidson Emma, 2019, Qual Quant, V53, P363, DOI 10.1007/s11135-018-0757-y; Davies B, 2020, BODY IMAGE, V33, P101, DOI 10.1016/j.bodyim.2020.02.009; Depauw E, 2019, ECON HIST REV, V72, P925, DOI 10.1111/ehr.12745; Diez J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071511; Dodge K.A., 2008, UNDERSTANDING PEER I, P181, DOI 10.1111/j.1475-3588.2011.00617_10.x; Downs SM, 2020, FOODS, V9, DOI 10.3390/foods9040532; EAT UNICEF., 2020, DIETS CHILDR AD UNL; El-Ammari A, 2020, PUBLIC HEALTH NUTR, V23, P996, DOI 10.1017/S1368980019003641; Falconi A, 2014, J DEV ORIG HLTH DIS, V5, P171, DOI 10.1017/S2040174414000105; Fleming-Milici F, 2020, APPETITE, V146, DOI 10.1016/j.appet.2019.104501; Folkvord F, 2020, CURR ADDICT REP, V7, P431, DOI 10.1007/s40429-020-00338-4; Freeman B, 2014, AM J PUBLIC HEALTH, V104, pE56, DOI 10.2105/AJPH.2014.302167; Galvan A, 2013, CURR DIR PSYCHOL SCI, V22, P88, DOI 10.1177/0963721413480859; Gangemi K, 2020, J SCH NURS, V36, P193, DOI 10.1177/1059840518800777; Gebremariam MK, 2012, SCAND J PUBLIC HEALT, V40, P491, DOI 10.1177/1403494812454948; Green MA, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/s12889-018-5383-z, 10.1186/S12889-018-5383-z]; Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025; Hagg E, 2018, INT J MED INFORM, V115, P92, DOI 10.1016/j.ijmedinf.2018.04.010; Haines J, 2006, PEDIATRICS, V117, pE209, DOI 10.1542/peds.2005-1242; Hall BJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027047; Hall KD, 2019, CELL METAB, V30, P226, DOI 10.1016/j.cmet.2019.05.020; Hargreaves D, 2022, LANCET, V399, P198, DOI 10.1016/S0140-6736(21)01593-2; Hargreaves SM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051406; Harrell M, 2015, J APPL RES CHILD, V6, P18; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hearst MO, 2012, PUBLIC HEALTH NUTR, V15, P299, DOI 10.1017/S1368980011002114; Herforth A, 2015, FOOD SECUR, V7, P505, DOI 10.1007/s12571-015-0455-8; Herr RS, 2010, J GLOB ETHICS, V6, P239; Islam SMS, 2019, HEALTH POLICY TECHN, V8, P96, DOI 10.1016/j.hlpt.2019.01.001; Kabir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198801; Keats EC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121978; Kelly C, 2019, APPETITE, V132, P182, DOI 10.1016/j.appet.2018.08.021; Kemper JA, 2021, APPETITE, V160, DOI 10.1016/j.appet.2020.105073; Kenney EL, 2020, HEALTH AFFAIR, V39, P1122, DOI 10.1377/hlthaff.2020.00133; Korda H, 2013, HEALTH PROMOT PRACT, V14, P15, DOI 10.1177/1524839911405850; Kurschner S, 2020, ANN NY ACAD SCI, V1468, P16, DOI 10.1111/nyas.14183; Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564; Lee AM, 2019, METAB SYNDR RELAT D, V17, P347, DOI 10.1089/met.2019.0006; Lee J, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz013; Lou C., 2019, J INTERACTIVE ADVERT, V19, P58, DOI DOI 10.1080/15252019.2018.1533501; Majabadi HA, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.23890; Maxfield A, 2016, ECOL FOOD NUTR, V55, P341, DOI 10.1080/03670244.2016.1181064; McClure AC, 2013, AM J PREV MED, V45, P560, DOI 10.1016/j.amepre.2013.06.011; McElhaney K.B., 2009, ANN CHILD DEV, P358, DOI [https://doi.org/10.1002/9780470479193.adlpsy001012, DOI 10.1002/9780470479193.ADLPSY001012]; Menzel JE, 2010, BODY IMAGE, V7, P261, DOI 10.1016/j.bodyim.2010.05.004; Ministry of Health and Family Welfare G. O. I. UNICEF PopulationCouncil, 2019, COMPR NAT NUTR SURV; Montgomery KC, 2012, PEDIATR CLIN N AM, V59, P659, DOI 10.1016/j.pcl.2012.03.022; Morrow V, 2017, SOC SCI MED, V182, P1, DOI 10.1016/j.socscimed.2017.04.004; Murphy G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072181; Neff RA, 2018, PUBLIC HEALTH NUTR, V21, P1835, DOI 10.1017/S1368980017004190; Noll PRES, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43611-x; Norris SA, 2022, LANCET, V399, P172, DOI 10.1016/S0140-6736(21)01590-7; O'Keeffe GS, 2011, PEDIATRICS, V127, P800, DOI 10.1542/peds.2011-0054; Orben A, 2020, LANCET CHILD ADOLESC, V4, P634, DOI 10.1016/S2352-4642(20)30186-3; Ortiz-Ospina, 2019, OUR WORLD DATA; Palla L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082235; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Peper JS, 2013, J COGNITIVE NEUROSCI, V25, P2141, DOI 10.1162/jocn_a_00445; Pfeifer JH, 2018, CHILD DEV PERSPECT, V12, P158, DOI 10.1111/cdep.12279; Pilar L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061991; Poushter, 2018, SOCIAL MEDIA USE CON; Powell LM, 2013, AM J PREV MED, V45, P453, DOI 10.1016/j.amepre.2013.06.003; Powell PK, 2021, APPETITE, V161, DOI 10.1016/j.appet.2021.105130; Puhl RM, 2016, PEDIATR OBES, V11, P241, DOI 10.1111/ijpo.12051; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Qutteina Y, 2019, OBES REV, V20, P1708, DOI 10.1111/obr.12929; Raman S, 2016, HEALTH CARE WOMEN IN, V37, P1119, DOI 10.1080/07399332.2016.1140171; Richards D, 2015, J PAEDIATR CHILD H, V51, P1152, DOI 10.1111/jpc.13023; Ronto R, 2021, HEALTH PROMOT J AUST, V32, P458, DOI 10.1002/hpja.384; Rudloff Silvia, 2019, Mol Cell Pediatr, V6, P4, DOI 10.1186/s40348-019-0091-z; Sacks G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114172; Sadeghirad B, 2016, OBES REV, V17, P945, DOI 10.1111/obr.12445; Sadler Richard C, 2016, Can J Public Health, V107, P5346, DOI 10.17269/cjph.107.5346; Sanchez-Sabate R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071220; Scully M, 2012, APPETITE, V58, P1, DOI 10.1016/j.appet.2011.09.020; Sherman LE, 2018, CHILD DEV, V89, P37, DOI 10.1111/cdev.12838; Smit CR, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02975; Somerville LH, 2013, CURR DIR PSYCHOL SCI, V22, P121, DOI 10.1177/0963721413476512; Starcevic V, 2015, WORLD PSYCHIATRY, V14, P97, DOI 10.1002/wps.20195; Stigler MH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-9; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; Swaminathan S, 2009, HEALTH EDUC J, V68, P94, DOI 10.1177/0017896909103845; Tabacchi G, 2019, NUTR METAB CARDIOVAS, V29, P761, DOI 10.1016/j.numecd.2019.03.013; Tiggemann M, 2013, INT J EAT DISORDER, V46, P630, DOI 10.1002/eat.22141; Tremblay L, 2009, EAT BEHAV, V10, P75, DOI 10.1016/j.eatbeh.2008.12.001; Trethewey E, 2019, APPETITE, V142, DOI 10.1016/j.appet.2019.104386; Turner C, 2018, GLOB FOOD SECUR-AGR, V18, P93, DOI 10.1016/j.gfs.2018.08.003; UN Food Systems Summit, YOUTH MOV LEADS CHAR; UNICEF, 2018, FOOD SYST CHILDR AD; Vandevijvere S, 2018, INT J PUBLIC HEALTH, V63, P1099, DOI 10.1007/s00038-018-1158-7; Vijayapushpam T, 2003, PUBLIC HEALTH NUTR, V6, P683, DOI 10.1079/PHN2003478; Weaver LJ, 2019, HUM ORGAN, V78, P122, DOI 10.17730/0018-7259.78.2.122; Weller S, 2021, PUBLIC HEALTH NUTR, V24, P5238, DOI 10.1017/S1368980020001810; WHO, 2004, JOINT FAO WHO WORKSH; Wills W, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091605; World Food Programme, 2018, FORM RES INF AD PROG; World Food Programme, 2019, FORM RES INF AD PROG	127	22	22	21	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					185	197		10.1016/S0140-6736(21)01687-1	http://dx.doi.org/10.1016/S0140-6736(21)01687-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34856191				2022-12-28	WOS:000740652500024
J	Norris, SA; Frongillo, EA; Black, MM; Dong, YH; Fall, C; Lampl, M; Liese, AD; Naguib, M; Prentice, A; Rochat, T; Stephensen, CB; Tinago, CB; Ward, KA; Wrottesley, SV; Patton, GC				Norris, Shane A.; Frongillo, Edward A.; Black, Maureen M.; Dong, Yanhui; Fall, Caroline; Lampl, Michelle; Liese, Angela D.; Naguib, Mariam; Prentice, Ann; Rochat, Tamsen; Stephensen, Charles B.; Tinago, Chiwoneso B.; Ward, Kate A.; Wrottesley, Stephanie V.; Patton, George C.			Nutrition in adolescent growth and development	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; BODY-COMPOSITION; INTRAUTERINE EXPOSURE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; SEX-DIFFERENCES; PROTEIN-INTAKE; ADULT HEIGHT; AGE; CHILDHOOD	During adolescence, growth and development are transformative and have profound consequences on an individual's health in later life, as well as the health of any potential children. The current generation of adolescents is growing up at a time of unprecedented change in food environments, whereby nutritional problems of micronutrient deficiency and food insecurity persist, and overweight and obesity are burgeoning. In a context of pervasive policy neglect, research on nutrition during adolescence specifically has been underinvested, compared with such research in other age groups, which has inhibited the development of adolescent-responsive nutritional policies. One consequence has been the absence of an integrated perspective on adolescent growth and development, and the role that nutrition plays. Through late childhood and early adolescence, nutrition has a formative role in the timing and pattern of puberty, with consequences for adult height, muscle, and fat mass accrual, as well as risk of non-communicable diseases in later life. Nutritional effects in adolescent development extend beyond musculoskeletal growth, to cardiorespiratory fitness, neurodevelopment, and immunity. High rates of early adolescent pregnancy in many countries continue to jeopardise the growth and nutrition of female adolescents, with consequences that extend to the next generation. Adolescence is a nutrition-sensitive phase for growth, in which the benefits of good nutrition extend to many other physiological systems.	[Norris, Shane A.; Rochat, Tamsen; Wrottesley, Stephanie V.] Univ Witwatersrand, Dept Paediat, SAMRC Dev Pathways Hlth Res Unit, ZA-2193 Johannesburg, South Africa; [Norris, Shane A.] Univ Southampton, Hlth Res Inst, Sch Hlth & Human Dev, Southampton, Hants, England; [Fall, Caroline; Ward, Kate A.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Liese, Angela D.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Black, Maureen M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Black, Maureen M.] RTI Int, Res Triangle Pk, NC USA; [Dong, Yanhui] Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Beijing, Peoples R China; [Lampl, Michelle] Emory Univ, Emory Ctr Study Human Hlth, Atlanta, GA 30322 USA; [Naguib, Mariam] McGill Univ, Dept Med, Montreal, PQ, Canada; [Prentice, Ann] MRC Nutr & Bone Hlth Grp, Cambridge, England; [Prentice, Ann; Ward, Kate A.] London Sch Hyg & Trop Med, MRC Unit Gambia, London, England; [Stephensen, Charles B.] Univ Calif Davis, USDA Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Stephensen, Charles B.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Tinago, Chiwoneso B.] West Chester Univ, Dept Hlth, W Chester, PA USA; [Patton, George C.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	University of Witwatersrand; University of Southampton; University of Southampton; University of South Carolina System; University of South Carolina Columbia; University System of Maryland; University of Maryland Baltimore; Research Triangle Institute; Peking University; Emory University; McGill University; University of London; London School of Hygiene & Tropical Medicine; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Murdoch Children's Research Institute; University of Melbourne	Norris, SA (corresponding author), Univ Witwatersrand, Dept Paediat, SAMRC Dev Pathways Hlth Res Unit, ZA-2193 Johannesburg, South Africa.	shane.norris@wits.ac.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Wrottesley, Stephanie/0000-0002-5419-2920; Dong, Yanhui/0000-0003-2519-3200; Rochat, Tamsen Jean/0000-0002-5223-770X; Black, Maureen/0000-0002-6427-4639; Ward, Kate/0000-0001-7034-6750	Fondation Botnar; Wellcome Trust; DSI-NRF Centre of Excellence in Human Development at the University of the Witwatersrand; South African Medical Research Council; National Health and Medical Research Council Senior Principal Research Fellowship; UK Medical Research Council [U105960371, U123261351, MR/P006965/1]; UK Department for International Development, under the Medical Research Council-Department for International Development Concordat agreement; Wellcome Trust Intermediate Fellowship In Public Health and Tropical Medicine [211374/Z/18/Z]; Joint Global Health Trials within the UK Department for International Development; National Institutes of Health [R01 DK106424]	Fondation Botnar; Wellcome Trust(Wellcome Trust); DSI-NRF Centre of Excellence in Human Development at the University of the Witwatersrand; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development, under the Medical Research Council-Department for International Development Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Intermediate Fellowship In Public Health and Tropical Medicine(Wellcome Trust); Joint Global Health Trials within the UK Department for International Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work received funding support from Fondation Botnar and the Wellcome Trust. Neither organisation played any role in writing the manuscript or the decision to submit for publication. We thank Majid Ezzati for sharing the data for figure 1. We thank Lukhanyo Nyati for assisting with the modelling of body composition data from the Birth to Twenty Plus Cohort. We thank the principal investigators of the COHORTS collaboration in Brazil, India, Philippines, Guatemala, and South Africa for permission to show the data in figure 4. SAN is supported by the DSI-NRF Centre of Excellence in Human Development at the University of the Witwatersrand and the South African Medical Research Council. GCP is supported by a National Health and Medical Research Council Senior Principal Research Fellowship. AP and KAW received funding for The Gambian studies described in panel 1 from the UK Medical Research Council (programme codes U105960371 and U123261351) and the UK Department for International Development, under the Medical Research Council-Department for International Development Concordat agreement. TR is supported by a Wellcome Trust Intermediate Fellowship In Public Health and Tropical Medicine (211374/Z/18/Z) and receives salary support from Joint Global Health Trials within the UK Department for International Development, Wellcome Trust, and the UK Medical Research Council grant (MR/P006965/1). MMB is supported by a grant from the National Institutes of Health (R01 DK106424).	Aghaee S, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1661-x; Akresh R, 2012, AM ECON REV, V102, P273, DOI 10.1257/aer.102.3.273; Akseer N, 2017, ANN NY ACAD SCI, V1393, P3, DOI 10.1111/nyas.13336; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Aris IM, 2019, OBESITY, V27, P1661, DOI 10.1002/oby.22592; Aurino E, 2016, BOYS EAT BETTER GIRL; Bamishigbin ON, 2019, SOC SCI MED, V232, P106, DOI 10.1016/j.socscimed.2019.04.031; Baxter-Jones ADG, 2011, J BONE MINER RES, V26, P1729, DOI 10.1002/jbmr.412; Benefice E, 2011, ANN HUM BIOL, V38, P500, DOI 10.3109/03014460.2011.564207; Blakemore SJ, 2019, LANCET, V393, P2030, DOI 10.1016/S0140-6736(19)31013-X; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Brix N, 2019, INT J EPIDEMIOL, V48, P1684, DOI 10.1093/ije/dyz125; Bupp MRG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01269; Callahan BP, 2015, CANCERS, V7, P2037, DOI 10.3390/cancers7040875; Carwile JL, 2015, HUM REPROD, V30, P675, DOI 10.1093/humrep/deu349; Chang Hua-Pin, 2018, BMC Endocr Disord, V18, P66, DOI 10.1186/s12902-018-0271-1; Cheng HL, 2019, BRIT J NUTR, V122, P274, DOI 10.1017/S0007114519001326; Cheng TS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003017; Corley RP, 2015, BEHAV GENET, V45, P294, DOI 10.1007/s10519-015-9719-5; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Baere S, 2016, J PHYS ACT HEALTH, V13, P993, DOI 10.1123/jpah.2015-0596; de Wilde JA, 2015, ANN HUM BIOL, V42, P38, DOI 10.3109/03014460.2014.926988; Dibba B, 2002, AM J CLIN NUTR, V76, P681, DOI 10.1093/ajcn/76.3.681; Dibba B, 2000, AM J CLIN NUTR, V71, P544; DREIZEN S, 1967, J PEDIATR-US, V70, P256, DOI 10.1016/S0022-3476(67)80420-7; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fall CHD, 2016, LANCET GLOB HEALTH, V4, pE787, DOI 10.1016/S2214-109X(16)30263-7; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Goddings AL, 2021, ARCH DIS CHILD, V106, P967, DOI 10.1136/archdischild-2020-319341; Gunther ALB, 2010, J NUTR, V140, P565, DOI 10.3945/jn.109.114934; Haas JD, 2006, FOOD NUTR BULL, V27, pS212, DOI 10.1177/15648265060274S505; Henriksson H, 2020, EUR HEART J, V41, P1503, DOI 10.1093/eurheartj/ehz774; Henriksson P, 2019, ANN INTERN MED, V170, P230, DOI 10.7326/M18-1861; Holmqvist G, 2017, FAMINES STUNTING ARE; Hsu JW, 2016, BRIT J NUTR, V115, P759, DOI 10.1017/S0007114515005279; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; InterLACE Study Team, 2019, HUM REPROD, V34, P881, DOI 10.1093/humrep/dez015; Isasi CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149923; Javaid MK, 2011, OSTEOPOROSIS INT, V22, P69, DOI 10.1007/s00198-010-1224-3; Katzmarzyk PT, 2012, PEDIATR OBES, V7, pE42, DOI 10.1111/j.2047-6310.2012.00073.x; Kelishadi R, 2017, CHILD OBES, V13, P332, DOI 10.1089/chi.2016.0176; Khrimian L, 2017, MOL METAB, V6, P1610, DOI 10.1016/j.molmet.2017.10.001; Klastrup LK, 2019, MOL GENET GENOMICS, V294, P1, DOI 10.1007/s00438-018-1492-8; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; Koren N, 2014, J NUTR BIOCHEM, V25, P623, DOI 10.1016/j.jnutbio.2014.01.012; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Kuh D, 2016, INT J EPIDEMIOL, V45, P1113, DOI 10.1093/ije/dyw131; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lagerros YT, 2012, EUR J EPIDEMIOL, V27, P799, DOI 10.1007/s10654-012-9721-7; Lampl M, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22983; Lassi ZS, 2017, ANN NY ACAD SCI, V1393, P51, DOI 10.1111/nyas.13332; Leroy JL, 2020, ADV NUTR, V11, P1032, DOI 10.1093/advances/nmaa020; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Lowe CJ, 2020, LANCET CHILD ADOLESC, V4, P388, DOI 10.1016/S2352-4642(19)30404-3; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Marques A, 2015, MED SCI SPORT EXER, V47, P575, DOI 10.1249/MSS.0000000000000426; Marshall TA, 2018, J NUTR, V148, P1144, DOI 10.1093/jn/nxy071; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; McCormack SE, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.1769; MCCULLOUGH JM, 1984, AM J PHYS ANTHROPOL, V65, P169, DOI 10.1002/ajpa.1330650209; Mintjens S, 2018, SPORTS MED, V48, P2577, DOI 10.1007/s40279-018-0974-5; Mohajeri MH, 2018, NUTR REV, V76, P481, DOI 10.1093/nutrit/nuy009; Moodie JL, 2020, ADV NUTR, V11, P951, DOI 10.1093/advances/nmaa007; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Noonan KJ, 1998, J ORTHOPAED RES, V16, P500, DOI 10.1002/jor.1100160416; Obri A, 2018, NAT REV ENDOCRINOL, V14, P174, DOI 10.1038/nrendo.2017.181; Olivo G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081907; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Perkins JM, 2016, NUTR REV, V74, P149, DOI 10.1093/nutrit/nuv105; Portrait FRM, 2017, ECON HUM BIOL, V27, P339, DOI 10.1016/j.ehb.2017.09.008; Rahimi A, 2019, INT J PEDIATR-MASSHA, V7, P10583, DOI 10.22038/ijp.2019.43390.3618; Remer T, 2010, J CLIN ENDOCR METAB, V95, P3002, DOI 10.1210/jc.2009-2583; Rhines AS, 2013, TUBERCULOSIS, V93, P104, DOI 10.1016/j.tube.2012.10.012; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; RIVERA JA, 1995, J NUTR, V125, pS1068; Rodriguez G, 2004, INT J OBESITY, V28, pS54, DOI 10.1038/sj.ijo.0802805; Scharner S., 2019, CLIN NUTR EXP, V28, P22, DOI [10.1016/j.yclnex.2019.02.001, DOI 10.1016/J.YCLNEX.2019.02.001]; SCHOLL TO, 1993, J AM COLL NUTR, V12, P101; Sederquist B, 2014, J MOL ENDOCRINOL, V53, pT35, DOI 10.1530/JME-14-0006; Seitz J, 2014, Z KINDER JUG-PSYCH, V42, P7, DOI 10.1024/1422-4917/a000265; Sharma U, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00215; Siervogel RM, 2003, HORM RES, V60, P36, DOI 10.1159/000071224; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Singer K, 2017, J CLIN INVEST, V127, P65, DOI [10.1172/JCI88882, 10.1172/jci88882]; Song S, 2008, POP STUD-J DEMOG, V62, P305, DOI 10.1080/00324720802313553; Sperling MA, 2018, PEDIAT ENDOCRINOLOGY, V5, pe5; Trikudanathan S, 2013, J CLIN ENDOCR METAB, V98, P236, DOI 10.1210/jc.2012-1785; Ulijaszek S. J., 2001, BNF Nutrition Bulletin, V26, P43, DOI 10.1046/j.1467-3010.2001.00098.x; UN, WORLD FERT PATT 2015; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Ward KA, 2014, J CLIN ENDOCR METAB, V99, P3169, DOI 10.1210/jc.2014-1150; Ward K, 2012, P NUTR SOC, V71, P27, DOI 10.1017/S0029665111003375; WHO, 2020, ADOLESCENT PREGNANCY; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wodon Q, 2017, EC IMPACTS CHILD MAR; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yokoya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050994; Zhong LL, 2015, INT J MOL SCI, V16, P19225, DOI 10.3390/ijms160819225; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	108	30	30	49	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					172	184		10.1016/S0140-6736(21)01590-7	http://dx.doi.org/10.1016/S0140-6736(21)01590-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34856190	Green Accepted			2022-12-28	WOS:000740652500023
J	Chou, R; Pappas, M; Dana, T; Selph, S; Hart, E; Fu, RF; Schwarz, E				Chou, Roger; Pappas, Miranda; Dana, Tracy; Selph, Shelley; Hart, Erica; Fu, Rongwei F.; Schwarz, Eli			Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; EARLY-CHILDHOOD CARIES; FLUORIDE VARNISH APPLICATIONS; PRESCHOOL-CHILDREN; HEALTH-PROMOTION; PRIMARY TEETH; CARE; FLUOROSIS; DENTITION; PROVIDERS	IMPORTANCE A 2014 review for the US Preventive Services Task Force (USPSTF) found that oral fluoride supplementation and topical fluoride use were associated with reduced caries incidence in children younger than 5 years. OBJECTIVE To update the 2014 review on dental caries screening and preventive interventions to inform the USPSTF. DATA SOURCES Ovid MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews (to September 2020); surveillance through July 23, 2021. STUDY SELECTION Randomized clinical trials (RCTs) on screening, preventive interventions, referral to dental care; cohort studies on screening and referral; studies on diagnostic accuracy of primary care oral examination or risk assessment; and a systematic review on risk of fluorosis included in prior USPSTF reviews. DATA EXTRACTION AND SYNTHESIS One investigator abstracted data; a second checked accuracy. Two investigators independently rated study quality. RESULTS Thirty-two studies (19 trials, 9 observational studies, and 4 nonrandomized clinical intervention studies [total 106 694 participants] and 1 systematic review [19 studies]) were included. No study evaluated effects of primary care screening on clinical outcomes. One study (n = 258) found primary care pediatrician examination associated with a sensitivity of 0.76 (95% CI. 0.55 to 0.91) and specificity of 0.95 (95% CI, 0.92 to 0.98) for identifying a child with cavities, and 1 study found a risk assessment tool associated with sensitivity of 0.53 and specificity of 0.77 (n = 697, CIs not reported) for a child with future caries. No new trials of dietary fluoride supplementation were identified. For prevention, topical fluoride compared with placebo or no topical fluoride was associated with decreased caries burden (13 trials, n = 5733; mean caries increment [difference in decayed, missing, and filled teeth or surfaces], -0,94 [95% CI, -1,74 to -0,34]) and likelihood of incident caries (12 trials, n = 8177; RR, 0.80 [95% CI, 0.66 to 0.95]; absolute risk difference, -7%) in higher-risk populations or settings, with no increased fluorosis risk. Evidence on other preventive interventions was limited (education, xylitol) or unavailable (silver diamine fluoride), and no study directly evaluated primary care dentistry referral vs no referral. CONCLUSIONS AND RELEVANCE There was no direct evidence on benefits and harms of primary care oral health screening or referral to dentist. Dietary fluoride supplementation and fluoride varnish were associated with improved caries outcomes in higher-risk children and settings.	[Chou, Roger; Pappas, Miranda; Dana, Tracy; Selph, Shelley; Hart, Erica; Fu, Rongwei F.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97239 USA; [Fu, Rongwei F.; Schwarz, Eli] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland State Univ, Portland, OR 97239 USA; [Schwarz, Eli] Oregon Hlth & Sci Univ, Sch Dent, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Portland State University; Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 Sw Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500009i, HHSA29032014T]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA290201500009i, PRISM order HHSA29032014T, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force.	Agouropoulos A, 2014, J DENT, V42, P1277, DOI 10.1016/j.jdent.2014.07.020; Anderson M, 2017, J DENT, V65, P83, DOI 10.1016/j.jdent.2017.07.009; Anderson M, 2016, CARIES RES, V50, P17, DOI 10.1159/000442675; [Anonymous], 2019, OR HLTH SURV REP TRE; [Anonymous], Human Development Report 2020; [Anonymous], 2021, PROC MAN; Autio-Gold Jaana, 2008, Dent Today, V27, P64; Bader J.D., 2004, DENT CARIES PREVENTI; Bader JD, 2004, AM J PREV MED, V26, P315, DOI 10.1016/j.amepre.2003.12.001; Basir L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4783-9; Bawden JW, 1998, J PUBLIC HEALTH DENT, V58, P266, DOI 10.1111/j.1752-7325.1998.tb03007.x; Beil H, 2014, AM J PUBLIC HEALTH, V104, P1979, DOI 10.2105/AJPH.2013.301325; Beil H, 2012, MED CARE, V50, P749, DOI 10.1097/MLR.0b013e3182551713; Blackburn J, 2017, JAMA PEDIATR, V171, P335, DOI 10.1001/jamapediatrics.2016.4514; Chou R., 2021, AHRQ PUBLICATION; Chou Roger, 2014, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA218; Chou R, 2013, PEDIATRICS, V132, P332, DOI 10.1542/peds.2013-1469; Dooley D, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2014-3532; Dye BA, 2017, J AM DENT ASSOC, V148, P550, DOI 10.1016/j.adaj.2017.04.013; FROSTELL G, 1991, CARIES RES, V25, P304, DOI 10.1159/000261381; HAMBERG L, 1971, LANCET, V1, P441; Harris Rebecca, 2004, Community Dent Health, V21, P71; HENNON DK, 1972, J PEDIATR-US, V80, P1018, DOI 10.1016/S0022-3476(72)80016-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holgerson PL, 2009, ACTA ODONTOL SCAND, V67, P106, DOI 10.1080/00016350802714734; Hu D, 1998, Chin J Dent Res, V1, P17; Institute of Medicine; National Research Council, 2011, IMPR ACC OR HLTH CAR; Ismail AI, 2008, J AM DENT ASSOC, V139, P1457, DOI 10.14219/jada.archive.2008.0071; Jiang EM, 2014, J DENT, V42, P1543, DOI 10.1016/j.jdent.2014.10.002; Jiang H, 2005, J DENT RES, V84, P265, DOI 10.1177/154405910508400311; Kranz AM, 2014, J DENT RES, V93, P633, DOI 10.1177/0022034514536731; Kranz AM, 2014, AM J PUBLIC HEALTH, V104, pE92, DOI 10.2105/AJPH.2014.301972; Latifi-Xhemajli B, 2019, COMMUNITY DENT HLTH, V36, P190, DOI 10.1922/CDH_4453Begzati05; Lawrence HP, 2008, COMMUNITY DENT ORAL, V36, P503, DOI 10.1111/j.1600-0528.2008.00427.x; Lin Yng-Tzer J., 2000, Journal of Clinical Dentistry, V11, P104; MacRitchie HMB, 2012, COMMUNITY DENT ORAL, V40, P37, DOI 10.1111/j.1600-0528.2011.00630.x; MARGOLIS FJ, 1967, AM J DIS CHILD, V113, P670, DOI 10.1001/archpedi.1967.02090210084007; MARGOLIS FJ, 1975, AM J DIS CHILD, V129, P794, DOI 10.1001/archpedi.1975.02120440020006; McMahon AD, 2020, CARIES RES, V54, P274, DOI 10.1159/000509680; Memarpour M, 2016, CARIES RES, V50, P433, DOI 10.1159/000446877; Memarpour M, 2015, MED PRIN PRACT, V24, P231, DOI 10.1159/000379750; Moyer VA, 2014, PEDIATRICS, V133, P1102, DOI 10.1542/peds.2014-0483; Munoz-Millan P, 2018, COMMUNITY DENT ORAL, V46, P63, DOI 10.1111/cdoe.12330; Nicolae A, 2018, PAED CHILD HEALT-CAN, V23, P111, DOI 10.1093/pch/pxx155; Oliveira BH, 2014, CARIES RES, V48, P228, DOI 10.1159/000356863; Oscarson P, 2006, EUR ARCH PAEDIATR DE, V7, P142, DOI 10.1007/BF03262555; Pierce KM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e82; dos Santos APP, 2016, PEDIATR DENT, V38, P414; Ruff RR, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2891-1; Ruff RR, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0514-6; Sen B, 2016, HEALTH SERV RES, V51, P2242, DOI 10.1111/1475-6773.12469; SERWINT JR, 1993, PEDIATRICS, V92, P233; Slade GD, 2011, COMMUNITY DENT ORAL, V39, P29, DOI 10.1111/j.1600-0528.2010.00561.x; Tickle M, 2017, J DENT RES, V96, P741, DOI 10.1177/0022034517702330; Tickle M, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20710; Weintraub JA, 2006, J DENT RES, V85, P172, DOI 10.1177/154405910608500211; Wiener R Constance, 2018, J Dent Hyg, V92, P23; Zhan L, 2012, J DENT RES, V91, pS85, DOI 10.1177/0022034511434354	58	6	6	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2179	2192		10.1001/jama.2021.15658	http://dx.doi.org/10.1001/jama.2021.15658			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XO3GR	34874413	Bronze			2022-12-28	WOS:000730077500021
J	Dunne, C; Lang, E				Dunne, Cody; Lang, Eddy			WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dunne, Cody; Lang, Eddy] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada	University of Calgary	Dunne, C (corresponding author), Univ Calgary, Dept Emergency Med, Calgary, AB, Canada.							Schunemann HJ, 2020, J CLIN EPIDEMIOL, V127, P202, DOI 10.1016/j.jclinepi.2020.05.030; Siemieniuk RAC, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2231; World Health Organization (WHO), 2021, THERAPEUTICS COVID 1; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC6	JC6		10.7326/J21-0009	http://dx.doi.org/10.7326/J21-0009		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34871050				2022-12-28	WOS:000729194900001
J	Torjesen, I				Torjesen, Ingrid			Mental health units: new law targets inappropriate use of force	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Torjesen, Ingrid] BMJ, London, England		Torjesen, I (corresponding author), BMJ, London, England.							Law Senis, 2018, BBC NEWS 1101	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n3032	10.1136/bmj.n3032	http://dx.doi.org/10.1136/bmj.n3032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP4DA	34876455				2022-12-28	WOS:000730815800008
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word ... Taking therapeutic care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								In healthcare there are different forms of taking care or taking precautions. When using a therapeutic intervention, one takes care by implementing it appropriately. When the appropriate intervention is pharmacological that means giving an appropriate formulation of a medication in an appropriate dosage regimen. If the intervention might cause harm, but the benefit:harm balance is favourable, one might do nothing apart from monitoring or one might introduce a preventive strategy, such as the use of mesna when giving an oxazaphosphorine such as cyclophosphamide. Vaccination and contraception are both examples of precautionary measures that have an excellent benefit:harm balance. But when the benefit:harm balance of an intervention is unfavourable the precaution to be taken is avoidance of the intervention. That, and only that, form of precaution, avoidance to avoid harm, is a defining feature of the precautionary principle.	[Aronson, Jeffrey K.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England.	jeffrey.aronson@phc.ox.ac.uk		Aronson, Jeffrey/0000-0003-1139-655X				[Anonymous], 2021, OED; [Anonymous], 1859, REV N AM REV, V89, P165; Aronson JK, 2004, BRIT J CLIN PHARMACO, V57, P229, DOI 10.1111/j.1365-2125.2004.02090.x; British Pharmacological Society, 10 PRINC GOOD PRESCR; Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3010	10.1136/bmj.n3010	http://dx.doi.org/10.1136/bmj.n3010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862174	Bronze			2022-12-28	WOS:000729712200009
J	Religia, P				Religia, Pijar			My weekly assignment	SCIENCE			English	Editorial Material									[Religia, Pijar] Osaka Univ, Suita, Osaka, Japan	Osaka University	Religia, P (corresponding author), Osaka Univ, Suita, Osaka, Japan.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1290	1290						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855478				2022-12-28	WOS:000728578700064
J	Satzinger, KJ; Liu, YJ; Smith, A; Knapp, C; Newman, M; Jones, C; Chen, Z; Quintana, C; Mi, X; Dunsworth, A; Gidney, C; Aleiner, I; Arute, F; Arya, K; Atalaya, J; Babbush, R; Bardin, JC; Barends, R; Basso, J; Bengtsson, A; Bilmes, A; Broughton, M; Buckley, BB; Buell, DA; Burkett, B; Bushnell, N; Chiaro, B; Collins, R; Courtney, W; Demura, S; Derk, AR; Eppens, D; Erickson, C; Faoro, L; Farhi, E; Fowler, AG; Foxen, B; Giustina, M; Greene, A; Gross, JA; Harrigan, MP; Harrington, SD; Hilton, J; Hong, S; Huang, T; Huggins, WJ; Ioffe, LB; Isakov, SV; Jeffrey, E; Jiang, Z; Kafri, D; Kechedzhi, K; Khattar, T; Kim, S; Klimov, PV; Korotkov, AN; Kostritsa, F; Landhuis, D; Laptev, P; Locharla, A; Lucero, E; Martin, O; McClean, JR; McEwen, M; Miao, KC; Mohseni, M; Montazeri, S; Mruczkiewicz, W; Mutus, J; Naaman, O; Neeley, M; Neill, C; Niu, MY; O'Brien, TE; Opremcak, A; Pato, B; Petukhov, A; Rubin, NC; Sank, D; Shvarts, V; Strain, D; Szalay, M; Villalonga, B; White, TC; Yao, Z; Yeh, P; Yoo, J; Zalcman, A; Neven, H; Boixo, S; Megrant, A; Chen, Y; Kelly, J; Smelyanskiy, V; Kitaev, A; Knap, M; Pollmann, F; Roushan, P				Satzinger, K. J.; Liu, Y-J; Smith, A.; Knapp, C.; Newman, M.; Jones, C.; Chen, Z.; Quintana, C.; Mi, X.; Dunsworth, A.; Gidney, C.; Aleiner, I; Arute, F.; Arya, K.; Atalaya, J.; Babbush, R.; Bardin, J. C.; Barends, R.; Basso, J.; Bengtsson, A.; Bilmes, A.; Broughton, M.; Buckley, B. B.; Buell, D. A.; Burkett, B.; Bushnell, N.; Chiaro, B.; Collins, R.; Courtney, W.; Demura, S.; Derk, A. R.; Eppens, D.; Erickson, C.; Faoro, L.; Farhi, E.; Fowler, A. G.; Foxen, B.; Giustina, M.; Greene, A.; Gross, J. A.; Harrigan, M. P.; Harrington, S. D.; Hilton, J.; Hong, S.; Huang, T.; Huggins, W. J.; Ioffe, L. B.; Isakov, S., V; Jeffrey, E.; Jiang, Z.; Kafri, D.; Kechedzhi, K.; Khattar, T.; Kim, S.; Klimov, P., V; Korotkov, A. N.; Kostritsa, F.; Landhuis, D.; Laptev, P.; Locharla, A.; Lucero, E.; Martin, O.; McClean, J. R.; McEwen, M.; Miao, K. C.; Mohseni, M.; Montazeri, S.; Mruczkiewicz, W.; Mutus, J.; Naaman, O.; Neeley, M.; Neill, C.; Niu, M. Y.; O'Brien, T. E.; Opremcak, A.; Pato, B.; Petukhov, A.; Rubin, N. C.; Sank, D.; Shvarts, V; Strain, D.; Szalay, M.; Villalonga, B.; White, T. C.; Yao, Z.; Yeh, P.; Yoo, J.; Zalcman, A.; Neven, H.; Boixo, S.; Megrant, A.; Chen, Y.; Kelly, J.; Smelyanskiy, V; Kitaev, A.; Knap, M.; Pollmann, F.; Roushan, P.			Realizing topologically ordered states on a quantum processor	SCIENCE			English	Article							ENTANGLEMENT; ENTROPY	The discovery of topological order has revised the understanding of quantum matter and provided the theoretical foundation for many quantum error-correcting codes. Realizing topologically ordered states has proven to be challenging in both condensed matter and synthetic quantum systems. We prepared the ground state of the toric code Hamiltonian using an efficient quantum circuit on a superconducting quantum processor. We measured a topological entanglement entropy near the expected value of -ln2 and simulated anyon interferometry to extract the braiding statistics of the emergent excitations. Furthermore, we investigated key aspects of the surface code, including logical state injection and the decay of the nonlocal order parameter. Our results demonstrate the potential for quantum processors to provide insights into topological quantum matter and quantum error correction.	[Satzinger, K. J.; Newman, M.; Jones, C.; Chen, Z.; Quintana, C.; Mi, X.; Dunsworth, A.; Gidney, C.; Aleiner, I; Arute, F.; Arya, K.; Atalaya, J.; Babbush, R.; Bardin, J. C.; Barends, R.; Basso, J.; Bengtsson, A.; Bilmes, A.; Broughton, M.; Buckley, B. B.; Buell, D. A.; Burkett, B.; Bushnell, N.; Chiaro, B.; Collins, R.; Courtney, W.; Demura, S.; Derk, A. R.; Eppens, D.; Erickson, C.; Farhi, E.; Fowler, A. G.; Foxen, B.; Giustina, M.; Greene, A.; Gross, J. A.; Harrigan, M. P.; Harrington, S. D.; Hilton, J.; Hong, S.; Huang, T.; Huggins, W. J.; Ioffe, L. B.; Isakov, S., V; Jeffrey, E.; Jiang, Z.; Kafri, D.; Kechedzhi, K.; Khattar, T.; Kim, S.; Klimov, P., V; Korotkov, A. N.; Kostritsa, F.; Landhuis, D.; Laptev, P.; Locharla, A.; Lucero, E.; Martin, O.; McClean, J. R.; McEwen, M.; Miao, K. C.; Mohseni, M.; Montazeri, S.; Mruczkiewicz, W.; Mutus, J.; Naaman, O.; Neeley, M.; Neill, C.; Niu, M. Y.; O'Brien, T. E.; Opremcak, A.; Pato, B.; Petukhov, A.; Rubin, N. C.; Sank, D.; Shvarts, V; Strain, D.; Szalay, M.; Villalonga, B.; White, T. C.; Yao, Z.; Yeh, P.; Yoo, J.; Zalcman, A.; Neven, H.; Boixo, S.; Megrant, A.; Chen, Y.; Kelly, J.; Smelyanskiy, V; Kitaev, A.; Roushan, P.] Google Quantum AI, Mountain View, CA 94043 USA; [Liu, Y-J; Smith, A.; Knap, M.; Pollmann, F.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Liu, Y-J; Knap, M.; Pollmann, F.] Munich Ctr Quantum Sci & Technol MCQST, Schellingstr 4, D-80799 Munich, Germany; [Smith, A.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Smith, A.] Univ Nottingham, Ctr Math & Theoret Phys Quantum Nonequilibrium Sy, Nottingham NG7 2RD, England; [Knapp, C.; Kitaev, A.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Knapp, C.; Kitaev, A.] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Knapp, C.; Kitaev, A.] CALTECH, Walter Burke Inst Theoret Phys, Pasadena, CA USA; [Bardin, J. C.] Univ Massachusetts, Dept Elect & Comp Engn, Amherst, MA 01003 USA; [Faoro, L.] Sorbonne Univ, Lab Phys Theor & Hautes Energies, F-75005 Paris, France; [Greene, A.] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Korotkov, A. N.] Univ Calif Riverside, Dept Elect & Comp Engn, Riverside, CA USA; [McEwen, M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Knap, M.] Tech Univ Munich, Inst Adv Study, D-85748 Garching, Germany; [Knapp, C.] Microsoft, Stn Q, Santa Barbara, CA USA	Google Incorporated; Technical University of Munich; University of Nottingham; University of Nottingham; California Institute of Technology; California Institute of Technology; California Institute of Technology; University of Massachusetts System; University of Massachusetts Amherst; UDICE-French Research Universities; Sorbonne Universite; Massachusetts Institute of Technology (MIT); University of California System; University of California Riverside; University of California System; University of California Santa Barbara; Technical University of Munich; Microsoft	Satzinger, KJ; Roushan, P (corresponding author), Google Quantum AI, Mountain View, CA 94043 USA.; Pollmann, F (corresponding author), Tech Univ Munich, Dept Phys, D-85748 Garching, Germany.; Pollmann, F (corresponding author), Munich Ctr Quantum Sci & Technol MCQST, Schellingstr 4, D-80799 Munich, Germany.	ksatz@google.com; frank.pollmann@tum.de; pedramr@google.com	; Knap, Michael/H-3344-2011	Pollmann, Frank/0000-0003-0320-9304; Satzinger, Kevin/0000-0001-5865-0813; Knapp, Christina/0000-0002-5982-8107; Liu, Yu-Jie/0000-0002-7657-9464; Knap, Michael/0000-0002-7093-9502	Technical University of Munich-Institute for Advanced Study - German Excellence Initiative; European Union FP7 [291763]; Max Planck Gesellschaft (MPG) through the International Max Planck Research School for Quantum Science and Technology (IMPRS-QST); Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) [EXC-2111-390814868]; DFG [KN1254/2-1]; European Research Council (ERC) under the European Union [771537, 851161]; Royal Commission for the Exhibition of 1851; Walter Burke Institute for Theoretical Physics at Caltech; IQIM, an NSF Frontier center - Gordon and Betty Moore Foundation; Packard Foundation; Simons Foundation	Technical University of Munich-Institute for Advanced Study - German Excellence Initiative; European Union FP7(European Commission); Max Planck Gesellschaft (MPG) through the International Max Planck Research School for Quantum Science and Technology (IMPRS-QST); Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Royal Commission for the Exhibition of 1851; Walter Burke Institute for Theoretical Physics at Caltech; IQIM, an NSF Frontier center - Gordon and Betty Moore Foundation; Packard Foundation(The David & Lucile Packard Foundation); Simons Foundation	F.P., Y.-J.L., A.S., and M.K. acknowledge support from the Technical University of Munich-Institute for Advanced Study, funded by the German Excellence Initiative and the European Union FP7 under grant agreement 291763; the Max Planck Gesellschaft (MPG) through the International Max Planck Research School for Quantum Science and Technology (IMPRS-QST); the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany's Excellence Strategy-EXC-2111-390814868, TRR80, and DFG grant KN1254/2-1; and from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreements 771537 and 851161). A.S. was supported by a Research Fellowship from the Royal Commission for the Exhibition of 1851. C.K. was supported by the Walter Burke Institute for Theoretical Physics at Caltech, and by the IQIM, an NSF Frontier center funded by the Gordon and Betty Moore Foundation, the Packard Foundation, and the Simons Foundation.	Adye T., 2011, P PHYSTAT 2011 WORKS, P313, DOI DOI 10.5170/CERN-2011-006.313; Andersen CK, 2020, NAT PHYS, V16, P875, DOI 10.1038/s41567-020-0920-y; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Bonderson P, 2017, ANN PHYS-NEW YORK, V385, P399, DOI 10.1016/j.aop.2017.07.018; Bravyi S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050401; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Bravyi S, 2021, PHYS REV A, V103, DOI 10.1103/PhysRevA.103.042605; Brydges T, 2019, SCIENCE, V364, P260, DOI 10.1126/science.aau4963; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chen ZJ, 2021, NATURE, V595, P383, DOI 10.1038/s41586-021-03588-y; DAgostini G., 1995, Nuclear Instruments & Methods in Physics Research, Section A (Accelerators, Spectrometers, Detectors and Associated Equipment), V362, P487, DOI 10.1016/0168-9002(95)00274-X; Dai HN, 2017, NAT PHYS, V13, P1195, DOI 10.1038/NPHYS4243; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Elben A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.050406; Erhard A, 2021, NATURE, V589, P220, DOI 10.1038/s41586-020-03079-6; Feng GR, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022305; Flammia ST, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.261601; Fowler A.G., 2018, ARXIV180806709; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Foxen B, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.120504; Freedman MH, 2001, FOUND COMPUT MATH, V1, P325, DOI 10.1007/s102080010013; Freedman MH, 1998, P NATL ACAD SCI USA, V95, P98, DOI 10.1073/pnas.95.1.98; Gottesman D, 2006, QUANTUM INFORM PROCE; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Hamma A, 2005, PHYS LETT A, V337, P22, DOI 10.1016/j.physleta.2005.01.060; Horsman C, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123011; Huang HY, 2020, NAT PHYS, V16, P1050, DOI 10.1038/s41567-020-0932-7; Jiang L, 2008, NAT PHYS, V4, P482, DOI 10.1038/nphys943; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kitaev A. Y., 1998, QUANTUM CODES LATTIC; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Levin M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.245316; Levin MA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045110; Liu C, 2019, OPTICA, V6, P264, DOI 10.1364/OPTICA.6.000264; Lu CY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.030502; Luo ZH, 2018, NAT PHYS, V14, P160, DOI 10.1038/NPHYS4281; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Nachman B, 2020, NPJ QUANTUM INFORM, V6, DOI 10.1038/s41534-020-00309-7; Pachos JK, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083010; Park AJ, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/4/043043; Pollmann F., 2021, ARXIV211002020QUANTP; Rahmani A, 2020, PRX QUANTUM, V1, DOI 10.1103/PRXQuantum.1.020309; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Schwemmer C, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.080403; Semeghini G, 2021, SCIENCE, V374, P1242, DOI 10.1126/science.abi8794; Song C, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.030502; TUKEY JW, 1958, ANN MATH STAT, V29, P614; van Enk SJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110503; Vermersch B, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.023604; Wallman JJ, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.052325; Webb Z, 2016, QUANTUM INF COMPUT, V16, P1379; Wen X. G., 1990, International Journal of Modern Physics B, V4, P239, DOI 10.1142/S0217979290000139; Zhong YP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.110501; Zhu HJ, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.062336	60	50	50	6	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1237	+		10.1126/science.abi8378	http://dx.doi.org/10.1126/science.abi8378			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855491	Green Accepted, Green Submitted			2022-12-28	WOS:000728578700054
J	Woolston, C				Woolston, Chris			WORKPLACE DIVERSITY: GOOD INTENTIONS ARE NOT ENOUGH	NATURE			English	Editorial Material																			0	8	8	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					177	179		10.1038/d41586-021-03043-y	http://dx.doi.org/10.1038/d41586-021-03043-y			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XE8WW	34845341				2022-12-28	WOS:000723664400007
J	Oliver, D				Oliver, David			David Oliver: Lessons for NHS staff from the Grenfell inquiry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Akbar Arifa., 2021, GUARDIAN 1019; [Anonymous], 2021, GRENFELL VALUE ENG N; [Anonymous], 2019, BBC NEWS 1029	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2921	10.1136/bmj.n2921	http://dx.doi.org/10.1136/bmj.n2921			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH5YO	34848395	Bronze			2022-12-28	WOS:000725509900010
J	Ramchandani, R; Kazatchkine, M; Liu, J; Sudan, P; Dybul, M; Matsoso, P; Nordstrom, A; Phelan, A; Legido-Quigley, H; Singh, S; Mabuchi, S				Ramchandani, Rohit; Kazatchkine, Michel; Liu, Joanne; Sudan, Preeti; Dybul, Mark; Matsoso, Precious; Nordstrom, Anders; Phelan, Alexandra; Legido-Quigley, Helena; Singh, Sudhvir; Mabuchi, Shunsuke			Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ramchandani, Rohit] Antara Global Hlth Advisors, Toronto, ON, Canada; [Ramchandani, Rohit; Mabuchi, Shunsuke] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Ramchandani, Rohit; Liu, Joanne; Sudan, Preeti; Dybul, Mark; Matsoso, Precious] Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada; [Ramchandani, Rohit] Balsillie Sch Int Affairs, Waterloo, ON, Canada; [Kazatchkine, Michel] Iendependent Panel Pandem Preparedness & Response, Geneva, Switzerland; [Liu, Joanne] McGill Univ, Sch Populat & Global Hlth, Montreal, PQ, Canada; [Dybul, Mark] Georgetown Univ, Washington, DC 20057 USA; [Phelan, Alexandra; Legido-Quigley, Helena; Singh, Sudhvir; Mabuchi, Shunsuke] Independent Panel Pandem Preparedness & Response, Geneva, Switzerland; [Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Singh, Sudhvir] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Singh, Sudhvir] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Waterloo; University of Waterloo; McGill University; Georgetown University; National University of Singapore; University of Auckland; University of London; London School of Hygiene & Tropical Medicine	Mabuchi, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.; Mabuchi, S (corresponding author), Independent Panel Pandem Preparedness & Response, Geneva, Switzerland.	shunsuke.mabuchi@gmail.com		Ramchandani, Rohit/0000-0003-4111-7670; Singh, Sudhvir/0000-0002-9915-6755	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response. Open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	[Anonymous], 2021, NATURE, V589, P170, DOI 10.1038/d41586-021-00044-9; Boehme C, 2021, NAT MED, V27, P367, DOI 10.1038/s41591-020-01215-3; Bulc B, ACCELERATING GLOBAL; Callarman T., 2006, VALUE CHAINS VERSUS, P1; Cohen J., 2020, SCIENCE; COVAX, 2021, LIV VACC ROLL OUT; Doshi P, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4037; Henry DA, 2021, MED J AUSTRALIA, V215, P149, DOI 10.5694/mja2.51182; Independent Panel for Pandemic Preparedness and Response, 2021, BACKGR PAP 5 MAIN RE; Kay C., 2021, BLOOMBERG; Kazatchkine M, 2021, S HOST VIRT IND PAN; Lurie N, 2021, LANCET, V397, P1229, DOI 10.1016/S0140-6736(21)00503-1; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2422; Mehrotra DV, 2021, ANN INTERN MED, V174, P221, DOI 10.7326/M20-6169; Nguyen A., 2021, WHAT DOES COVAXS LAT; Nkengasong J, 2021, BUILDING NEW PUBLIC; Our World in Data, 2021, COV LEAST ON VACC LM; Porter M., 2008, COMPETITIVE ADVANTAG; Ramchandani R, 2016, EMULATING COMMERCIAL; Ritchie H, 2021, CORONAVIRUS COVID 19; Smith-Nonini S, 2006, SOC ANAL, V50, P233, DOI 10.3167/015597706780459331; So AD, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4750; Torreele E, 2021, BMJ OPINION; Wadvalla BA, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1949; World Health Organization, 2020, COV ANN ADD DEALS AC	25	4	4	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067488	10.1136/bmj-2021-067488	http://dx.doi.org/10.1136/bmj-2021-067488			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840135	hybrid, Green Published			2022-12-28	WOS:000740896100017
J	Wu, SS; Neill, R; De Foo, C; Chua, AQ; Jung, AS; Haldane, V; Abdalla, SM; Guan, WJ; Singh, S; Nordstrom, A; Legido-Quigley, H				Wu, Shishi; Neill, Rachel; De Foo, Chuan; Chua, Alvin Qijia; Jung, Anne-Sophie; Haldane, Victoria; Abdalla, Salma M.; Guan, Wei-jie; Singh, Sudhvir; Nordstrom, Anders; Legido-Quigley, Helena			Aggressive containment, suppression, and mitigation of covid-19: lessons learnt from eight countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNITY ENGAGEMENT		[Wu, Shishi] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Neill, Rachel] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [De Foo, Chuan; Chua, Alvin Qijia; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Jung, Anne-Sophie; Legido-Quigley, Helena] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Haldane, Victoria] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Abdalla, Salma M.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Guan, Wei-jie] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China; [Guan, Wei-jie] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China; [Singh, Sudhvir] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; Boston University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; University of Auckland	Wu, SS (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	shishi.wu@utoronto.ca	Foo, Chuan De/AAJ-9844-2021; Chua, Alvin Qijia/GQH-3027-2022	Foo, Chuan De/0000-0001-7254-4881; Chua, Alvin Qijia/0000-0001-6920-1204; Neill, Rachel/0000-0002-1110-5479; Jung, Anne-Sophie/0000-0001-7039-7830; Singh, Sudhvir/0000-0002-9915-6755	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response, open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	Alon T., 2020, 27273 NBER; Alvelda P, 2020, INET BLOG; Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907; Barker KM, 2020, HEALTH POLICY PLANN, V35, P416, DOI 10.1093/heapol/czz174; Bradford L, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa034; Carter SE, 2017, J HEALTH COMMUN, V22, P66, DOI 10.1080/10810730.2016.1216204; Chen HF, 2022, J PUBLIC HEALTH-UK, V44, P716, DOI 10.1093/pubmed/fdab136; Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P389, DOI 10.1007/s10654-020-00649-w; Chua AQ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n486; De Foo C, 2021, LANCET, V398, P1547, DOI 10.1016/S0140-6736(21)02186-3; Duong DM, 2020, ASIA-PAC J PUBLIC HE, V32, P161, DOI 10.1177/1010539520927290; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Gillespie A, 2016, GLOB HEALTH-SCI PRAC, V4, P626, DOI 10.9745/GHSP-D-16-00226; Goggin G, 2020, MEDIA INT AUST, V177, P61, DOI 10.1177/1329878X20949770; Goudsmit J, 2020, EUR J EPIDEMIOL, V35, P331, DOI 10.1007/s10654-020-00635-2; Government of Argentina,, 2020, SE SUM NUEV ACC DET; Government of Singapore, 2020, NEWLEVEL 25 RULES AU; Gray L, 2021, J ROY SOC NEW ZEAL, V51, pS107, DOI 10.1080/03036758.2021.1879179; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9; Ho G., 2021, STRAITS TIMES; Illmer A, BBC, V2021; James A., 2020, SUPPRESSION MITIGATI, DOI [10.1101/2020.03.26.20044677, DOI 10.1101/2020.03.26.20044677]; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kaufmann D, 2011, HAGUE J RULE LAW, V3, P220, DOI 10.1017/S1876404511200046; Kayi I, 2020, INFECT DIS CLIN MICR, V2, P30, DOI [10.36519/idcm.2020.0009, DOI 10.36519/IDCM.2020.0009, 10.36519/idcm.2020. 0009]; Kerkhoff AD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239400; Kochanczyk M, 2020, PARETO BASED EVALUAT; Konig Michael, 2021, Inter Econ, V56, P32, DOI 10.1007/s10272-021-0948-y; Lapolla P, 2020, DIGIT HEALTH, V6, DOI 10.1177/2055207620941673; Lee A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3410; Lewis D, 2020, NATURE, V588, P384, DOI 10.1038/d41586-020-03518-4; Loayza N.V., 2020, MACROECONOMIC POLICY, DOI [10.1596/33540, DOI 10.1596/33540]; Lokuge K, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01934-5; Makary M, WALL STR J, V2021; Meyerowitz-Katz G, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006653; Ministry of Health New Zealand,, NZ COV TRAC APP; Ministry of Trade and Industry Singapore, 2021, MTI UPGR 2021 GDP GR; Ng TC, 2021, JAMA INTERN MED, V181, P913, DOI 10.1001/jamainternmed.2021.1644; Norheim OF, 2021, NAT MED, V27, P10, DOI 10.1038/s41591-020-01204-6; OECD, 2021, Q GDP; Oliu-Barton M, 2021, LANCET, V397, P2234, DOI 10.1016/S0140-6736(21)00978-8; Our World in Data, CUM CONF COVID 19 CA; Our World in Data, 2021, TOT CONF COVID 19 DE; Philippe C, ZERO COVID STRATEGY; Phillips N, 2021, NATURE, V590, P382, DOI 10.1038/d41586-021-00396-2; Sirleaf EJ, 2021, LANCET, V398, P101, DOI 10.1016/S0140-6736(21)01095-3; Tollefson J, 2020, NATURE, V586, P190, DOI 10.1038/d41586-020-02800-9; Uganda Bureau of Statistics,, Q GDP; van Zandvoort K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01789-2; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; WHO, 2020, WHO COR COVID 19 DAS; WHO, 2019, THEM PAP STAT COUNTR; Wilde H, ASSS MECH VENTILATOR; World Health Organization, PUBL HLTH SURV COVID; World Health Organization. Global Preparedness Monitoring Board, 2019, ANN REP GLOB PREP HL	56	9	9	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067508	10.1136/bmj-2021-067508	http://dx.doi.org/10.1136/bmj-2021-067508			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840136	hybrid, Green Published			2022-12-28	WOS:000740896100020
J	Hueffel, JA; Sperger, T; Funes-Ardoiz, I; Ward, JS; Rissanen, K; Schoenebeck, F				Hueffel, Julian A.; Sperger, Theresa; Funes-Ardoiz, Ignacio; Ward, Jas S.; Rissanen, Kari; Schoenebeck, Franziska			Accelerated dinuclear palladium catalyst identification through unsupervised machine learning	SCIENCE			English	Article							PHOSPHORUS LIGANDS; DESCRIPTORS; PREDICTION; ACYLATION; SCOPE	Although machine learning bears enormous potential to accelerate developments in homogeneous catalysis, the frequent need for extensive experimental data can be a bottleneck for implementation. Here, we report an unsupervised machine learning workflow that uses only five experimental data points. It makes use of generalized parameter databases that are complemented with problem-specific in silico data acquisition and clustering. We showcase the power of this strategy for the challenging problem of speciation of palladium (Pd) catalysts, for which a mechanistic rationale is currently lacking. From a total space of 348 ligands, the algorithm predicted, and we experimentally verified, a number of phosphine ligands (including previously never synthesized ones) that give dinuclear Pd-(I) complexes over the more common Pd-(0) and Pd-(II) species.	[Hueffel, Julian A.; Sperger, Theresa; Funes-Ardoiz, Ignacio; Schoenebeck, Franziska] Rhein Westfal TH Aachen, Inst Organ Chem, Landoltweg 1, D-52074 Aachen, Germany; [Ward, Jas S.; Rissanen, Kari] Univ Jyvaskyla, Dept Chem, POB 35, Jyvaskyla 40014, Finland	RWTH Aachen University; University of Jyvaskyla	Schoenebeck, F (corresponding author), Rhein Westfal TH Aachen, Inst Organ Chem, Landoltweg 1, D-52074 Aachen, Germany.	franziska.schoenebeck@rwth-aachen.de	Funes-Ardoiz, Ignacio/AGV-6808-2022; Rissanen, Kari T/B-5688-2008; Funes-Ardoiz, Ignacio/E-8659-2017	Rissanen, Kari T/0000-0002-7282-8419; Funes-Ardoiz, Ignacio/0000-0002-5843-9660; Ward, Jas/0000-0001-9089-9643; Huffel, Julian Alexander/0000-0001-6218-8502; Sperger, Theresa/0000-0002-3870-9870	Volkswagen Foundation; Alexander von Humboldt Foundation; DFG (German Research Foundation) Cluster of Excellence 2186 ("The Fuel Science Center") [390919832]; RWTH Aachen University [jara0091]	Volkswagen Foundation(Volkswagen); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DFG (German Research Foundation) Cluster of Excellence 2186 ("The Fuel Science Center")(German Research Foundation (DFG)); RWTH Aachen University	This work was funded by the Volkswagen Foundation (Momentum Program), the Alexander von Humboldt Foundation (fellowship to I.F.-A.), and the DFG (German Research Foundation) Cluster of Excellence 2186 ("The Fuel Science Center" - ID: 390919832). Calculations were performed with computing resources granted by JARA-HPC from RWTH Aachen University under project "jara0091."	A. X. S. Bruker Inc., 2017, SAINT; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Ahneman DT, 2018, SCIENCE, V360, P186, DOI 10.1126/science.aar5169; Amar Y, 2019, CHEM SCI, V10, P6697, DOI 10.1039/c9sc01844a; [Anonymous], **DATA OBJECT**, DOI 10.5281/zenodo.5541842; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Barrios-Landeros F, 2008, J AM CHEM SOC, V130, P5842, DOI 10.1021/ja711159y; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bholowalia P., 2014, INT J COMP APPL, V105, P17, DOI 10.5120/18405-9674; Bilbrey JA, 2013, J COMPUT CHEM, V34, P1189, DOI 10.1002/jcc.23217; Brethome AV, 2019, ACS CATAL, V9, P2313, DOI 10.1021/acscatal.8b04043; Bunten KA, 2002, COORDIN CHEM REV, V233, P41, DOI 10.1016/S0010-8545(02)00099-1; Carpenter J.E., 1987, THESIS U WISCONSIN M; CARPENTER JE, 1988, J MOL STRUC-THEOCHEM, V46, P41, DOI 10.1016/0166-1280(88)80248-3; Chakraborti AK, 2003, TETRAHEDRON, V59, P7661, DOI 10.1016/j.tet.2003.08.007; Chen LY, 2016, J AM CHEM SOC, V138, P6392, DOI 10.1021/jacs.6b03215; Chen XY, 2019, ANGEW CHEM INT EDIT, V58, P11395, DOI 10.1002/anie.201906063; Coley CW, 2017, ACS CENTRAL SCI, V3, P434, DOI 10.1021/acscentsci.7b00064; Diehl CJ, 2019, ANGEW CHEM INT EDIT, V58, P211, DOI 10.1002/anie.201811380; Doherty R, 2006, DALTON T, P4310, DOI 10.1039/b607490a; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Durand DJ, 2019, CHEM REV, V119, P6561, DOI 10.1021/acs.chemrev.8b00588; Fey N, 2006, CHEM-EUR J, V12, P291, DOI 10.1002/chem.200500891; Foscato M, 2020, ACS CATAL, V10, P2354, DOI 10.1021/acscatal.9b04952; FOSTER JP, 1980, J AM CHEM SOC, V102, P7211, DOI 10.1021/ja00544a007; Fricke C, 2021, ANGEW CHEM INT EDIT, V60, P3355, DOI 10.1002/anie.202011825; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Funes-Ardoiz I, 2020, CHEM-US, V6, P1904, DOI 10.1016/j.chempr.2020.07.008; Gao HY, 2018, ACS CENTRAL SCI, V4, P1465, DOI 10.1021/acscentsci.8b00357; Gomes G.d.P., 2021, TRENDS CHEM, V3, P96, DOI DOI 10.1016/j.trechm.2020.12.006; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hartwig J. F, 2009, ORGANOTRANSITION MET; Hooft R. W. W., 1998, COLLECT; Hueffel J. A., 2021, J HUEFFEL PDDIMER PD; Hueffel J. A., 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5541842; Jackson K., 2018, **DATA OBJECT**, DOI 10.5281/zenodo.1320768; Jover J, 2010, ORGANOMETALLICS, V29, P6245, DOI 10.1021/om100648v; Keaveney ST, 2018, ANGEW CHEM INT EDIT, V57, P12573, DOI 10.1002/anie.201808386; Kirlikovali KO, 2018, DALTON T, V47, P3684, DOI 10.1039/c8dt00119g; Kundu G, 2020, ANGEW CHEM INT EDIT, V59, P21930, DOI 10.1002/anie.202009115; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu ZH, 2014, ORG LETT, V16, P236, DOI 10.1021/ol4030875; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Mann G, 2003, ORGANOMETALLICS, V22, P2775, DOI 10.1021/om030230x; Milo A, 2015, SCIENCE, V347, P737, DOI 10.1126/science.1261043; Mitchell JBO, 2014, WIRES COMPUT MOL SCI, V4, P468, DOI 10.1002/wcms.1183; Moret M.-E., 2019, NONNOBLE METAL CATAL; Newman SG, 2011, J AM CHEM SOC, V133, P1778, DOI 10.1021/ja110377q; Niemeyer ZL, 2016, NAT CHEM, V8, P611, DOI [10.1038/nchem.2501, 10.1038/NCHEM.2501]; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohlmann DM, 2012, J AM CHEM SOC, V134, P13716, DOI 10.1021/ja303822c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Proutiere F, 2014, ORGANOMETALLICS, V33, P6879, DOI 10.1021/om5009605; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; REED AE, 1985, J CHEM PHYS, V83, P1736, DOI 10.1063/1.449360; Reid JP, 2019, NATURE, V571, P343, DOI 10.1038/s41586-019-1384-z; Rigaku Oxford Diffraction, 2018, CRYSALISPRO VERSION; Rosales AR, 2019, NAT CATAL, V2, P41, DOI 10.1038/s41929-018-0193-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Sheldrick G. M., 1996, SADABS VERS 2008 2; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Smellie A, 2004, J CHEM INF COMP SCI, V44, P1929, DOI 10.1021/ci0499222; Stambuli JP, 2002, ANGEW CHEM INT EDIT, V41, P4746, DOI 10.1002/anie.200290036; Stambuli JP, 2001, J AM CHEM SOC, V123, P2677, DOI 10.1021/ja0058435; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; STROHMEIER W, 1967, CHEM BER-RECL, V100, P2812, DOI 10.1002/cber.19671000907; The pandas development team, 2020, **DATA OBJECT**, DOI [10.5281/zenodo.3715232, DOI 10.5281/ZENODO.3715232]; TOLMAN CA, 1970, J AM CHEM SOC, V92, P2953, DOI 10.1021/ja00713a006; TOLMAN CA, 1977, CHEM REV, V77, P313, DOI 10.1021/cr60307a002; Toyao T, 2020, ACS CATAL, V10, P2260, DOI 10.1021/acscatal.9b04186; Weinhold F., 1988, STRUCTURE SMALL MOL, P227, DOI DOI 10.1007/978-1-4684-7424-4_24; Wolfram Research Inc, 2020, MATH VERSION 122; Yuan C., 2019, THE J, V2, P226, DOI [10.3390/j2020016, DOI 10.3390/J2020016]; Zahrt AF, 2019, SCIENCE, V363, P247, DOI 10.1126/science.aau5631	78	16	16	29	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1134	+		10.1126/science.abj0999	http://dx.doi.org/10.1126/science.abj0999			86	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822285				2022-12-28	WOS:000725668600047
J	Nolan, T				Nolan, Tom			Tom Nolan's research reviews-26 November 2021	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nolan, Tom] BMJ, London, England		Nolan, T (corresponding author), BMJ, London, England.							Del Prato S, 2021, LANCET, V398, P1811, DOI 10.1016/S0140-6736(21)02188-7; Jariwala N, 2022, JAMA INTERN MED, V182, P86, DOI 10.1001/jamainternmed.2021.6594; Korley FK, 2021, NEW ENGL J MED, V385, P1951, DOI 10.1056/NEJMoa2103784; Nazarzadeh M, 2021, LANCET, V398, P1803, DOI 10.1016/S0140-6736(21)01920-6; Pieske B, 2021, JAMA-J AM MED ASSOC, V326, P1919, DOI 10.1001/jama.2021.18463	5	0	0	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2938	10.1136/bmj.n2938	http://dx.doi.org/10.1136/bmj.n2938			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836915	Bronze			2022-12-28	WOS:000727787900014
J	Song, TC; Sun, QC; Anderson, E; Wang, C; Qian, JM; Taniguchi, T; Watanabe, K; McGuire, MA; Stohr, R; Xiao, D; Cao, T; Wrachtrup, J; Xu, XD				Song, Tiancheng; Sun, Qi-Chao; Anderson, Eric; Wang, Chong; Qian, Jimin; Taniguchi, Takashi; Watanabe, Kenji; McGuire, Michael A.; Stohr, Rainer; Xiao, Di; Cao, Ting; Wrachtrup, Jorg; Xu, Xiaodong			Direct visualization of magnetic domains and moire magnetism in twisted 2D magnets	SCIENCE			English	Article							WAALS; FERROMAGNETISM; STATES	Moire superlattices of twisted nonmagnetic two-dimensional (2D) materials are highly controllable platforms for the engineering of exotic correlated and topological states. Here, we report emerging magnetic textures in small-angle twisted 2D magnet chromium triiodide (CrI3). Using single-spin quantum magnetometry, we directly visualized nanoscale magnetic domains and periodic patterns, a signature of moire magnetism, and measured domain size and magnetization. In twisted bilayer CrI3, we observed the coexistence of antiferromagnetic (AFM) and ferromagnetic (FM) domains with disorder-like spatial patterns. In twisted double-trilayer CrI3, AFM and FM domains with periodic patterns appear, which is in good agreement with the calculated spatial magnetic structures that arise from the local stacking-dependent interlayer exchange interactions in CrI3 moire superlattices. Our results highlight magnetic moire superlattices as a platform for exploring nanomagnetism.	[Song, Tiancheng; Anderson, Eric; Xu, Xiaodong] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Sun, Qi-Chao; Stohr, Rainer; Wrachtrup, Jorg] Univ Stuttgart, Phys Inst 3, D-70569 Stuttgart, Germany; [Wang, Chong; Xiao, Di] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Qian, Jimin; Cao, Ting; Xu, Xiaodong] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [McGuire, Michael A.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Stohr, Rainer] Univ Stuttgart, Ctr Appl Quantum Technol, D-70569 Stuttgart, Germany; [Wrachtrup, Jorg] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	University of Washington; University of Washington Seattle; University of Stuttgart; Carnegie Mellon University; University of Washington; University of Washington Seattle; National Institute for Materials Science; National Institute for Materials Science; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Stuttgart; Max Planck Society	Xu, XD (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.; Wrachtrup, J (corresponding author), Univ Stuttgart, Phys Inst 3, D-70569 Stuttgart, Germany.; Xu, XD (corresponding author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.; Wrachtrup, J (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.	j.wrachtrup@pi3.uni-stuttgart.de; xuxd@uw.edu	McGuire, Michael/B-5453-2009; Xiao, Di/B-1830-2008; Cao, Ting/GPC-5837-2022; Watanabe, Kenji/H-2825-2011; Sun, Qi-Chao/L-7210-2013	McGuire, Michael/0000-0003-1762-9406; Xiao, Di/0000-0003-0165-6848; Cao, Ting/0000-0003-1300-6084; Watanabe, Kenji/0000-0003-3701-8119; Song, Tiancheng/0000-0002-6845-6624; Anderson, Eric/0000-0002-1357-6645; , Rainer/0000-0002-3476-344X; Sun, Qi-Chao/0000-0003-2320-2134	US Department of Energy (DOE), Basic Energy Sciences, Materials Sciences and Engineering Division [DE-SC0018171]; DOE BES [DE-SC0012509]; Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) program [FA9550-19-1-0390]; NSF MRSEC [DMR-1719797]; Micron Foundation; DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; Elemental Strategy Initiative by the MEXT, Japan [JPMXP0112101001]; JSPS KAKENHI [JP20H00354]; CREST, JST [JPMJCR15F3]; state of Washington; Boeing Distinguished Professorship in Physics; EU through ASTERIQS, European Research Council through ERC [742610]; DFG [GRK 2642, FOR 2724]; BW Foundation through project SPOC	US Department of Energy (DOE), Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); DOE BES(United States Department of Energy (DOE)); Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Micron Foundation; DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); state of Washington; Boeing Distinguished Professorship in Physics; EU through ASTERIQS, European Research Council through ERC; DFG(German Research Foundation (DFG)); BW Foundation through project SPOC	This work was mainly supported by the US Department of Energy (DOE), Basic Energy Sciences, Materials Sciences and Engineering Division (DE-SC0018171). Theoretical understanding of stacking-dependent interlayer magnetism was partially supported by DOE BES DE-SC0012509. Sample fabrication and magneto-optical measurements were partially supported by the Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) program, grant FA9550-19-1-0390. The computational imaging analysis was partially supported by NSF MRSEC DMR-1719797. T.C. acknowledges support from the Micron Foundation. M.A.M. was supported by the DOE, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan, grant JPMXP0112101001, JSPS KAKENHI grant JP20H00354, and the CREST (JPMJCR15F3), JST. X.X. acknowledges support from the state of Washington-funded Clean Energy Institute and the Boeing Distinguished Professorship in Physics. J.W. acknowledges funding by the EU through ASTERIQS, European Research Council through ERC grant 742610, SMel, the DFG through GRK 2642 and FOR 2724, and the BW Foundation through project SPOC.	Andrei EY, 2020, NAT MATER, V19, P1265, DOI 10.1038/s41563-020-00840-0; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; Barry JF, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.015004; Broadway DA, 2020, PHYS REV APPL, V14, DOI 10.1103/PhysRevApplied.14.024076; Burch KS, 2018, NATURE, V563, P47, DOI 10.1038/s41586-018-0631-z; Cantos-Prieto F, 2021, NANO LETT, V21, P3379, DOI 10.1021/acs.nanolett.0c04794; Carr S, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.224102; Dovzhenko Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05158-9; Dreau A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195204; Du CH, 2017, SCIENCE, V357, P195, DOI 10.1126/science.aak9611; Fabre F, 2021, PHYS REV MATER, V5, DOI 10.1103/PhysRevMaterials.5.034008; GAMMEL PL, 1987, PHYS REV LETT, V59, P2592, DOI 10.1103/PhysRevLett.59.2592; Gibertini M, 2019, NAT NANOTECHNOL, V14, P408, DOI 10.1038/s41565-019-0438-6; Gong C, 2019, SCIENCE, V363, P706, DOI 10.1126/science.aav4450; Gong C, 2017, NATURE, V546, P265, DOI 10.1038/nature22060; Hejazi K, 2020, P NATL ACAD SCI USA, V117, P10721, DOI 10.1073/pnas.2000347117; Huang B, 2020, NAT MATER, V19, P1276, DOI 10.1038/s41563-020-0791-8; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; Jang SW, 2019, PHYS REV MATER, V3, DOI 10.1103/PhysRevMaterials.3.031001; Jiang PH, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.144401; Kennes DM, 2021, NAT PHYS, V17, P155, DOI 10.1038/s41567-020-01154-3; Kim K, 2016, NANO LETT, V16, P1989, DOI 10.1021/acs.nanolett.5b05263; Li TX, 2019, NAT MATER, V18, P1303, DOI 10.1038/s41563-019-0506-1; Lima EA, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006006; Mak KF, 2019, NAT REV PHYS, V1, P646, DOI 10.1038/s42254-019-0110-y; Reith P, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.5001390; Schoenfeld RS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030802; Sivadas N, 2018, NANO LETT, V18, P7658, DOI 10.1021/acs.nanolett.8b03321; Song T., 2021, **DATA OBJECT**, DOI [10.7910/DVN/CE0NCC, DOI 10.7910/DVN/CE0NCC]; Song TC, 2019, NAT MATER, V18, P1298, DOI 10.1038/s41563-019-0505-2; Song TC, 2018, SCIENCE, V360, P1214, DOI 10.1126/science.aar4851; Soriano D, 2019, SOLID STATE COMMUN, V299, DOI 10.1016/j.ssc.2019.113662; Sun QC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22239-4; Sung J, 2020, NAT NANOTECHNOL, V15, P750, DOI 10.1038/s41565-020-0728-z; Tetienne JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7733; Tetienne JP, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103033; Thiel L, 2019, SCIENCE, V364, P973, DOI 10.1126/science.aav6926; Tong QJ, 2018, NANO LETT, V18, P7194, DOI 10.1021/acs.nanolett.8b03315; Uri A, 2020, NATURE, V581, P47, DOI 10.1038/s41586-020-2255-3; Wang C, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.247201; Weston A, 2020, NAT NANOTECHNOL, V15, P592, DOI 10.1038/s41565-020-0682-9; Xie H., 2021, ARXIV210313537CONDMA; Xu Y., 2021, ARXIV210309850CONDMA; Xu Y., 2021, ARXIV210309850CONDMA; Yoo H, 2019, NAT MATER, V18, P448, DOI 10.1038/s41563-019-0346-z	45	32	32	43	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1140	+		10.1126/science.abj7478	http://dx.doi.org/10.1126/science.abj7478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822270	Green Submitted			2022-12-28	WOS:000725668600048
J	Balaich, J; Estrella, M; Wu, GJ; Jeffrey, PD; Biswas, A; Zhao, LP; Korennykh, A; Donia, MS				Balaich, Jared; Estrella, Michael; Wu, Guojun; Jeffrey, Philip D.; Biswas, Abhishek; Zhao, Liping; Korennykh, Alexei; Donia, Mohamed S.			The human microbiome encodes resistance to the antidiabetic drug acarbose	NATURE			English	Article							GUT MICROBIOME; COMPLEX; FAMILY; RIBOKINASE; PHOSPHATE; DYNAMICS; BACTERIA; SEQUENCE; ENZYME	The human microbiome encodes a large repertoire of biochemical enzymes and pathways, most of which remain uncharacterized. Here, using a metagenomics-based search strategy, we discovered that bacterial members of the human gut and oral microbiome encode enzymes that selectively phosphorylate a clinically used antidiabetic drug, acarbose(1,2), resulting in its inactivation. Acarbose is an inhibitor of both human and bacterial alpha-glucosidases(3), limiting the ability of the target organism to metabolize complex carbohydrates. Using biochemical assays, X-ray crystallography and metagenomic analyses, we show that microbiome-derived acarbose kinases are specific for acarbose, provide their harbouring organism with a protective advantage against the activity of acarbose, and are widespread in the microbiomes of western and non-western human populations. These results provide an example of widespread microbiome resistance to a non-antibiotic drug, and suggest that acarbose resistance has disseminated in the human microbiome as a defensive strategy against a potential endogenous producer of a closely related molecule.	[Balaich, Jared; Estrella, Michael; Jeffrey, Philip D.; Biswas, Abhishek; Korennykh, Alexei; Donia, Mohamed S.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Wu, Guojun; Zhao, Liping] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Biochem & Microbiol, Ctr Microbiome Nutr & Hlth, New Brunswick, NJ USA; [Biswas, Abhishek] Princeton Univ, Res Comp, Off Informat Technol, Princeton, NJ 08544 USA; [Zhao, Liping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Minist Educ, Lab Syst Biomed, Shanghai, Peoples R China; [Donia, Mohamed S.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ USA; [Donia, Mohamed S.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ USA	Princeton University; Rutgers State University New Brunswick; Princeton University; Shanghai Jiao Tong University; Princeton University; Princeton University	Donia, MS (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ USA.; Donia, MS (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ USA.; Donia, MS (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ USA.	donia@princeton.edu	Wu, Guuojun/AHB-4249-2022	Wu, Guuojun/0000-0002-7910-2813; Donia, Mohamed/0000-0002-9604-2912; Jeffrey, Philip/0000-0002-4351-5341; Biswas, Abhishek/0000-0002-8074-2543; Estrella, Michael/0000-0002-1721-9418	NIH [1DP2AI124441, 1R01GM110161]; Pew Biomedical Scholars Program; Burroughs Wellcome Foundation [1013579]; Vallee Foundation; National Institute of General Medicine Sciences (NIGMS) [T32GM007388]; DOE Office of Science [DE-SC0012704]; NIH (NIGMS) through a Biomedical Technology Research Resource P41 grant [P41GM111244]; DOE Office of Biological and Environmental Research [KP1605010]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Biomedical Scholars Program; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Vallee Foundation; National Institute of General Medicine Sciences (NIGMS); DOE Office of Science(United States Department of Energy (DOE)); NIH (NIGMS) through a Biomedical Technology Research Resource P41 grant; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank the NSLS-2 AMX and FMX beamline staff for their assistance with data collection and the crystallography core facility at the Department of Molecular Biology, Princeton University. We thank M. Cahn and M. Elmassry for assistance with metagenomic data analysis; S. Chatterjee for general assistance; and the rest of the Donia laboratory for discussions. Funding for this project was provided by an NIH Director's New Innovator Award (1DP2AI124441) and the Pew Biomedical Scholars Program to M.S.D.; an NIH grant (1R01GM110161), a Burroughs Wellcome Foundation Grant (1013579) and an award from The Vallee Foundation to A.K. J.B. is funded by a training grant from the National Institute of General Medicine Sciences (NIGMS) (T32GM007388) and L.Z. is a CIFAR fellow. This research used the AMX and FMX beamlines of the National Synchrotron Light Source II, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract no. DE-SC0012704. The Life Science Biomedical Technology Research resource, which supports AMX and FMX, is primarily supported by the NIH (NIGMS) through a Biomedical Technology Research Resource P41 grant (P41GM111244), and by the DOE Office of Biological and Environmental Research (KP1605010).	Abu-Ali GS, 2018, NAT MICROBIOL, V3, P356, DOI 10.1038/s41564-017-0084-4; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AHR HJ, 1989, ARZNEIMITTEL-FORSCH, V39-2, P1254; Baxter NT, 2019, MSPHERE, V4, DOI [10.1128/mSphere.00528-18, 10.1128/msphere.00528-18]; Benitez-Paez A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-311; Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Drepper A, 1996, J ANTIBIOT, V49, P664, DOI 10.7164/antibiotics.49.664; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Fung TC, 2019, NAT MICROBIOL, V4, P2064, DOI 10.1038/s41564-019-0540-4; Goeke K, 1996, J ANTIBIOT, V49, P661, DOI 10.7164/antibiotics.49.661; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Guo X, 2012, LETT APPL MICROBIOL, V55, P162, DOI 10.1111/j.1472-765X.2012.03274.x; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Bastard Q, 2018, ALIMENT PHARM THER, V47, P332, DOI 10.1111/apt.14451; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; MARUHAMA Y, 1980, TOHOKU J EXP MED, V132, P453, DOI 10.1620/tjem.132.453; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McAuley M, 2019, CARBOHYD RES, V486, DOI 10.1016/j.carres.2019.107839; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Parducci RE, 2006, BIOCHEMISTRY-US, V45, P9291, DOI 10.1021/bi060026o; Patnode ML, 2019, CELL, V179, P59, DOI 10.1016/j.cell.2019.08.011; Peterson SN, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Rockser Y, 2009, J BIOTECHNOL, V140, P114, DOI 10.1016/j.jbiotec.2008.10.016; Santilli AD, 2018, ACS CHEM BIOL, V13, P1165, DOI 10.1021/acschembio.8b00309; Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z; SCHMIDT DD, 1977, NATURWISSENSCHAFTEN, V64, P535, DOI 10.1007/BF00483561; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Su BL, 2015, J DIABETES, V7, P729, DOI 10.1111/1753-0407.12232; Sugimoto Y, 2019, SCIENCE, V366, P1332, DOI 10.1126/science.aax9176; Szafranski SP, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.17; Villmones HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23198-5; Wehmeier UF, 2004, APPL MICROBIOL BIOT, V63, P613, DOI 10.1007/s00253-003-1477-2; Wehmeier UF, 2003, BIOCATAL BIOTRANSFOR, V21, P279, DOI 10.1080/102424120310001614388; Whang A, 2019, EBIOMEDICINE, V39, P591, DOI 10.1016/j.ebiom.2018.11.046; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; YEUNG MK, 1994, J BACTERIOL, V176, P4173, DOI 10.1128/JB.176.13.4173-4176.1994; Yoon SH, 2003, CARBOHYD RES, V338, P1969, DOI 10.1016/S0008-6215(03)00293-3; Zhang MC, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000717; Zhang XY, 2017, DIABETES THER, V8, P293, DOI 10.1007/s13300-017-0226-y; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	62	7	8	12	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 2	2021	600	7887					110	+		10.1038/s41586-021-04091-0	http://dx.doi.org/10.1038/s41586-021-04091-0		NOV 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG8IW	34819672				2022-12-28	WOS:000722128900002
J	Sachs, RE; Bagley, N				Sachs, Rachel E.; Bagley, Nicholas			Medicare Coverage of Aducanumab - Implications for State Budgets	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Medicare Coverage of Aducanumab CMS is considering whether and under what circumstances Medicare will pay for aducanumab for Alzheimer's disease. A restrictive coverage determination could save the federal government money, but it would also shift substantial costs to states.	[Sachs, Rachel E.] Washington Univ, Sch Law, St Louis, MO 63110 USA; [Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Sachs, RE (corresponding author), Washington Univ, Sch Law, St Louis, MO 63110 USA.							[Anonymous], 2006, PAYMENT COVERED OUTP; Medicaid and CHIP Payment and Access Commission, 2021, REP C MED CHIP; National Association of Medicaid Directors, 2021, COMMUNICATION 0811	3	2	2	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2021	385	22					2019	2021		10.1056/NEJMp2115297	http://dx.doi.org/10.1056/NEJMp2115297		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XC3KG	34797617				2022-12-28	WOS:000720682900001
J	Dyer, O				Dyer, Owen			Covid-19: Doctors will refuse to limit use of antiviral drug to unvaccinated patients, say ethicists	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ledford H, 2021, NATURE, V599, P358, DOI 10.1038/d41586-021-03074-5; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2422	2	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2855	10.1136/bmj.n2855	http://dx.doi.org/10.1136/bmj.n2855			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799344	Bronze			2022-12-28	WOS:000723212300007
J	Mahase, E				Mahase, Elisabeth			Covid-19: AstraZeneca says its antibody drug AZD7442 is effective for preventing and reducing severe illness	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ring S., 2021, BLOOMBERG	1	13	13	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2860	10.1136/bmj.n2860	http://dx.doi.org/10.1136/bmj.n2860			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799345	Bronze			2022-12-28	WOS:000723212300008
J	Romo, ML; Patel, RC; Edwards, JK; Humphrey, JM; Musick, BS; Bernard, C; Maina, MW; Brazier, E; Castelnuovo, B; Penner, J; Wyka, K; Cardoso, SW; Ly, PS; Kunzekwenyika, C; Cortes, CP; Panczak, R; Kelvin, EA; Wools-Kaloustian, KK; Nash, D				Romo, Matthew L.; Patel, Rena C.; Edwards, Jessie K.; Humphrey, John M.; Musick, Beverly S.; Bernard, Caitlin; Maina, Mercy W.; Brazier, Ellen; Castelnuovo, Barbara; Penner, Jeremy; Wyka, Katarzyna; Cardoso, Sandra Wagner; Ly, Penh Sun; Kunzekwenyika, Cordelia; Cortes, Claudia P.; Panczak, Radoslaw; Kelvin, Elizabeth A.; Wools-Kaloustian, Kara K.; Nash, Denis		Int Epidemiology Databases Evaluat	Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; OPEN-LABEL; EFAVIRENZ; PREGNANCY; EFFICACY; SAFETY; EMTRICITABINE; ALAFENAMIDE; EXPOSURE; THERAPY	Background: The transition to dolutegravir-containing anti-retroviral therapy (ART) in low- and middle-income countries (LMICs) was complicated by an initial safety signal in May 2018 suggesting that exposure to dolutegravir at conception was possibly associated with infant neural tube defects. On the basis of additional evidence, in July 2019, the World Health Organization recommended dolutegravir for all adults and adolescents living with HIV. Objective: To describe dolutegravir uptake and disparities by sex and age group in LMICs. Design: Observational cohort study. Setting: 87 sites that began using dolutegravir in 11 LMICs in the Asia-Pacific; Caribbean, Central and South America network for HIV epidemiology (CCASAnet); and sub-Saharan African regions of the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. Patients: 134 672 patients aged 16 years or older who received HIV care from January 2017 through March 2020. Measurements: Sex, age group, and dolutegravir uptake (that is, newly initiating ART with dolutegravir or switching to dolutegravir from another regimen). Results: Differences in dolutegravir uptake among females of reproductive age (16 to 49 years) emerged after the safety signal. By the end of follow-up, the cumulative incidence of dolutegravir uptake among females 16 to 49 years old was 29.4% (95% CI, 29.0% to 29.7%) compared with 57.7% (CI, 57.2% to 58.3%) among males 16 to 49 years old. This disparity was greater in countries that began implementing dolutegravir before the safety signal and initially had highly restrictive policies versus countries with a later rollout. Dolutegravir uptake was similar among females and males aged 50 years or older. Limitation: Follow-up was limited to 6 to 8 months after international guidelines recommended expanding access to dolutegravir. Conclusion: Substantial disparities in dolutegravir uptake affecting females of reproductive age through early 2020 are documented. Although this disparity was anticipated because of country-level restrictions on access, the results highlight its extent and initial persistence.	[Romo, Matthew L.; Brazier, Ellen; Wyka, Katarzyna; Kelvin, Elizabeth A.; Nash, Denis] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY USA; [Romo, Matthew L.; Brazier, Ellen; Kelvin, Elizabeth A.; Nash, Denis] CUNY, Inst Implementat Sci Populat Hlth, New York, NY USA; [Patel, Rena C.] Univ Washington, Dept Med, Seattle, WA USA; [Patel, Rena C.] Univ Washington, Dept Global Hlth, Seattle, DC USA; [Edwards, Jessie K.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Humphrey, John M.; Wools-Kaloustian, Kara K.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Musick, Beverly S.] Indiana Univ Sch Med, Dept Biostat & Hlth Data Sci, Indianapolis, IN USA; [Bernard, Caitlin] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA; [Maina, Mercy W.] Moi Teaching & Referral Hosp, Dept Pharm, Eldoret, Kenya; [Castelnuovo, Barbara] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Penner, Jeremy] Family AIDS Care & Educ Serv, Kisumu, Kenya; [Penner, Jeremy] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Cardoso, Sandra Wagner] Fundacao Oswaldo Cruz, Lab Pesquisa Clin HIV AIDS, Inst Nacl Infectol, Rio De Janeiro, Brazil; [Ly, Penh Sun] Minist Hlth, Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Kunzekwenyika, Cordelia] SolidarMed, Masvingo, Zimbabwe; [Cortes, Claudia P.] Univ Chile, Dept Med, Santiago, Chile; [Cortes, Claudia P.] Fdn Arriaran, Santiago, Chile; [Panczak, Radoslaw] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	City University of New York (CUNY) System; City University of New York (CUNY) System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Makerere University; University of British Columbia; Fundacao Oswaldo Cruz; Universidad de Chile; University of Bern	Romo, ML; Nash, D (corresponding author), 55 West 125th St,6th Floor, New York, NY 10027 USA.	matthew.romo@sph.cuny.edu; denis.nash@sph.cuny.edu	Nash, Denis/AFI-7485-2022; Cortes, Claudia P/AAF-7326-2020; Mayige, Mary/GLU-6412-2022; Prozesky, Hans Walter/ABE-6956-2020	Cortes, Claudia P/0000-0001-9101-9783; Mayige, Mary/0000-0003-4861-7870; Prozesky, Hans Walter/0000-0001-9715-3449; Penner, Jeremy/0000-0001-6443-1748; Edwards, Jessie/0000-0002-1741-335X; Nyakato, Patience/0000-0002-8418-8500; Cornell, Morna/0000-0001-7149-8799; Patten, Gabriela/0000-0003-2511-1367; Bernard, Caitlin/0000-0002-6753-1098; Murenzi, Gad/0000-0002-5513-5522; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304; Johnson, Leigh/0000-0002-2717-011X; Romo, Matthew/0000-0002-3038-0644; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institute on Alcohol Abuse and Alcoholism; National Institute of Diabetes and Digestive and Kidney Diseases; Fogarty International Center; National Library of Medicine; Office of the Director [U01AI069907, U01AI069923, U01AI096299, U01AI069911, U01AI069924]; National Institute of Allergy and Infectious Diseases [K23AI120855]; Harmonist project [R24AI124872]	National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harmonist project	Research reported in this article was supported by the National Institutes of Health's National Institute of Allergy and Infectious Diseases; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the National Cancer Institute; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the National Institute on Alcohol Abuse and Alcoholism; the National Institute of Diabetes and Digestive and Kidney Diseases; the Fogarty International Center; the National Library of Medicine; and the Office of the Director under award numbers U01AI069907 (Asia-Pacific), U01AI069923 (CCASAnet), U01AI096299 (Central Africa), U01AI069911 (East Africa), and U01AI069924 (Southern Africa). Informatics resources are supported by the Harmonist project (R24AI124872). Dr. Patel's effort was supported by the National Institute of Allergy and Infectious Diseases (K23AI120855). Dr. Humphrey's effort was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23HD105495).	AALEN OO, 1978, SCAND J STAT, V5, P141; Alhassan Y, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09991-w; Barr BAT, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02066-6; Bernard C, 2020, 23 INT AID C AIDS 20; Calmy A, LANCET HIV; Caniglia EC, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100615; Chouchana L, 2020, LANCET INFECT DIS, V20, P405, DOI 10.1016/S1473-3099(20)30117-1; De Santis M, 2002, ARCH INTERN MED, V162, P355, DOI 10.1001/archinte.162.3.355; Departamento de Vigilncia,, 2018, PREV CONTR IST HIV A; Dorward J, 2021, LANCET HIV, V8, pe158, DOI 10.1016/S2352-3018(20)30359-3; Duda SN, 2020, MEDRXIV, DOI [10.1101/2020.07.22.20159921, DOI 10.1101/2020.07.22.20159921]; Dugdale CM, 2019, ANN INTERN MED, V170, P614, DOI 10.7326/M18-3358; Ford N, 2014, AIDS, V28, pS123, DOI 10.1097/QAD.0000000000000231; Fundaro C, 2002, AIDS, V16, P299, DOI 10.1097/00002030-200201250-00025; Gupta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164619; Hauser A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003397; Hegdahl HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148502; Humphrey J, 2020, 23 INT AIDS C AIDS 2; Kant A, 2019, DRUG SAFETY, V42, P35, DOI 10.1007/s40264-018-0729-0; Kanters S, 2020, ECLINICALMEDICINE, V28, DOI 10.1016/j.eclinm.2020.100573; Kintu K, 2020, LANCET HIV, V7, pE332, DOI 10.1016/S2352-3018(20)30050-3; Lockman S, 2021, LANCET, V397, P1276, DOI 10.1016/S0140-6736(21)00314-7; Pereira GFM, 2021, LANCET HIV, V8, pe33, DOI 10.1016/S2352-3018(20)30268-X; Ministerio da Sade (Mozambique), 2019, 042103DNSP019 MIN SA; Ministry of Health Community Development Gender Elderly and Children (Tanzania) National AIDS Control Programme., 2019, NAT GUID MAN HIV AID, V7th; Ministry of Health (Kenya), 2018, MOHNASCOPDPPHCT002; Ministry of Health (Kenya), 2019, MOHADM112; Ministry of Health (Lesotho), 2019, ADD NAT GUID US ANT; Ministry of Health (Rwanda), TRANSM CIRC CHANG HI; Ministry of Health (Uganda), CONSOLIDATED GUIDELI; Mofenson LM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25352; Money D, 2019, BJOG-INT J OBSTET GY, V126, P1338, DOI 10.1111/1471-0528.15838; National Center for HIV/AIDS Dermatology and STD., OP GUID US DOL DTG A; National Medicines and Therapeutics Policy Advisory Committee (NMTPAC) AIDS and TB Directorate of the Ministry of Health and Child Care (Zimbabwe)., 2019, ADD 2016 GUID ANT TH; Phillips AN, 2020, LANCET HIV, V7, pE193, DOI 10.1016/S2352-3018(19)30400-X; Phillips AN, 2019, LANCET HIV, V6, pE116, DOI 10.1016/S2352-3018(18)30317-5; Raesima MM, 2019, NEW ENGL J MED, V381, P885, DOI 10.1056/NEJMc1908155; Siedner MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19801-x; U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2019, HAIT COUNTR OP PLAN; U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2019, DEM REP CONG COUNTR; UNAIDS UNICEF., PROGR REP ALL IEND A; Venter WDF, 2020, LANCET HIV, V7, pE666, DOI 10.1016/S2352-3018(20)30241-1; Vitoria M, 2018, AIDS, V32, P1551, DOI 10.1097/QAD.0000000000001845; WHO, CONSOLIDATED GUIDELI; World Health Organization, UPD REC 1 LIN 2 LIN; World Health Organization, POL BRIEF UPD REC 1; World Health Organization, HIV DRUG RES REP 201; World Health Organization, POT SAF ISS AFF WOM; World Health Organization, 2006, ANT THER HIV INF AD; Zash R, 2020, J INT AIDS SOC, V23, P183; Zash R, 2019, NEW ENGL J MED, V381, P827, DOI 10.1056/NEJMoa1905230; Zash R, 2018, NEW ENGL J MED, V379, P979, DOI 10.1056/NEJMc1807653	52	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					84	+		10.7326/M21-3037	http://dx.doi.org/10.7326/M21-3037			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34843382	Green Accepted			2022-12-28	WOS:000790293700032
J	Saraux, A; Devauchelle-Pensec, V				Saraux, Alain; Devauchelle-Pensec, Valerie			Primary Sjogren's syndrome: new beginning for evidence-based trials	LANCET			English	Editorial Material							DOUBLE-BLIND; RITUXIMAB; FATIGUE		[Saraux, Alain] Ctr Hosp Univ Cavale Blanche, Dept Rheumatol, Brest, France; [Saraux, Alain; Devauchelle-Pensec, Valerie] Univ Brest, INSERM UMR 1227, Labex Immunotherapy, Graft,Oncol, F-29609 Brest, France	CHU Brest; Universite de Bretagne Occidentale	Saraux, A (corresponding author), Ctr Hosp Univ Cavale Blanche, Dept Rheumatol, Brest, France.; Saraux, A (corresponding author), Univ Brest, INSERM UMR 1227, Labex Immunotherapy, Graft,Oncol, F-29609 Brest, France.	alain.saraux@chu-brest.fr						Baer AN, 2021, ANN RHEUM DIS, V80, P339, DOI 10.1136/annrheumdis-2020-218599; Bowman SJ, 2022, LANCET, V399, P161, DOI 10.1016/S0140-6736(21)02251-0; Bowman SJ, 2017, ARTHRITIS RHEUMATOL, V69, P1440, DOI 10.1002/art.40093; Brito-Zeron P, 2020, RHEUMATOLOGY, V59, P2350, DOI 10.1093/rheumatology/kez578; Cornec D, 2017, ARTHRIT CARE RES, V69, P528, DOI 10.1002/acr.22974; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; Felten R, 2021, ANN RHEUM DIS, V80, P329, DOI [10.1136/annrheumdis-2020-218467, 10.1136/annrheumdis-2021-219882]; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Norheim KB, 2012, PLOS ONE, V7, P429, DOI 10.1371/journal.pone.0030123; Parodis I, 2022, ANN RHEUM DIS, V81, P15, DOI 10.1136/annrheumdis-2021-221270; Sankar V, 2004, ARTHRITIS RHEUM-US, V50, P2240, DOI 10.1002/art.20299; Seror R, 2016, ANN RHEUM DIS, V75, P382, DOI 10.1136/annrheumdis-2014-206008; St Clair EW, 2018, ARTHRITIS RHEUMATOL, V70, P1470, DOI 10.1002/art.40513	16	3	3	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					121	122		10.1016/S0140-6736(21)02644-1	http://dx.doi.org/10.1016/S0140-6736(21)02644-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34861169				2022-12-28	WOS:000740652500005
J	Karim, SSA; Karim, QA				Karim, Salim S. Abdool; Karim, Quarraisha Abdool			Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic	LANCET			English	Editorial Material									[Karim, Salim S. Abdool] Ctr AIDS Programme Res South Africa, ZA-4001 Durban, South Africa; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Karim, SSA (corresponding author), Ctr AIDS Programme Res South Africa, ZA-4001 Durban, South Africa.	salim.abdoolkarim@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X				Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; [Anonymous], 2021, FREQUENTLY ASKED QUE; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Department of Health Government of South Africa, 2021, COVID 19; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; GISAID, 2021, 10985872 HUM SEQ COL; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Luo Chun Huai, 2021, medRxiv, DOI 10.1101/2021.08.15.21262077; Rosenberg ES, 2022, NEW ENGL J MED, V386, P116, DOI 10.1056/NEJMoa2116063; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; The Lancet COVID-19 Commission Task Force on Public Health Measures to Suppress the Pandemic, 2021, LANCET COVID 19 COMM; Townsend JP, 2021, LANCET MICROBE, V2, pE666, DOI 10.1016/S2666-5247(21)00219-6; van Kampen JJA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20568-4; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; World Health Organization, 2020, WHO; World Health Organization, 2021, UPD OM	17	483	494	52	231	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2021	398	10317					2126	+		10.1016/S0140-6736(21)02758-6	http://dx.doi.org/10.1016/S0140-6736(21)02758-6		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XN4HM	34871545	Bronze, Green Published			2022-12-28	WOS:000729467800022
J	McCartney, M				McCartney, Margaret			Bureaucracy has created a mess for Novavax volunteers like me	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com						Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659	1	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2021	375								n2995	10.1136/bmj.n2995	http://dx.doi.org/10.1136/bmj.n2995			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1KZ	34880047	Bronze			2022-12-28	WOS:000740890600006
J	Mathew, R				Mathew, Rammya			Rammya Mathew: The true cost of unnecessary investigations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net						Elwenspoek MMC, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2319; O'Sullivan JW, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4666; Watson J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l175	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n2996	10.1136/bmj.n2996	http://dx.doi.org/10.1136/bmj.n2996			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4DA	34876398	Bronze			2022-12-28	WOS:000730815800002
J	Ospina-Tascon, GA; Calderon-Tapia, LE; Garcia, AF; Zarama, V; Gomez-Alvarez, F; Alvarez-Saa, T; Pardo-Otalvaro, S; Bautista-Rincon, DF; Vargas, MP; Aldana-Diaz, JL; Marulanda, A; Gutierrez, A; Varon, J; Gomez, M; Ochoa, ME; Escobar, E; Umana, M; Diez, J; Tobon, GJ; Albornoz, LL; Florez, CAC; Ruiz, GO; Caceres, EL; Reyes, LF; Damiani, LP; Cavalcanti, AB				Ospina-Tascon, Gustavo A.; Eduardo Calderon-Tapia, Luis; Garcia, Alberto F.; Zarama, Virginia; Gomez-Alvarez, Freddy; Alvarez-Saa, Tatiana; Pardo-Otalvaro, Stephania; Bautista-Rincon, Diego F.; Vargas, Monica P.; Aldana-Diaz, Jose L.; Marulanda, Angela; Gutierrez, Alejandro; Varon, Janer; Gomez, Monica; Ochoa, Maria E.; Escobar, Elena; Umana, Mauricio; Diez, Julio; Tobon, Gabriel J.; Albornoz, Ludwig L.; Celemin Florez, Carlos Augusto; Ortiz Ruiz, Guillermo; Leonardo Caceres, Eder; Felipe Reyes, Luis; Petri Damiani, Lucas; Cavalcanti, Alexandre B.		HiFLo-Covid Investigators	Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NASAL CANNULA; LUNG INJURY; MANAGEMENT; OUTCOMES; DISEASE	IMPORTANCE The effect of high-flow oxygen therapy vs conventional oxygen therapy has not been established in the setting of severe COVID-19. OBJECTIVE To determine the effect of high-flow oxygen therapy through a nasal cannula compared with conventional oxygen therapy on need for endotracheal intubation and clinical recovery in severe COVID-19. DESIGN, SETTING, AND PARTICIPANTS Randomized, open-label clinical trial conducted in emergency and intensive care units in 3 hospitals in Colombia. A total of 220 adults with respiratory distress and a ratio of partial pressure of arterial oxygen to fraction of inspired oxygen of less than 200 due to COVID-19 were randomized from August 2020 to January 2021, with last follow-up on February 10, 2021. INTERVENTIONS Patients were randomly assigned to receive high-flow oxygen through a nasal cannula (n = 109) or conventional oxygen therapy (n = 111). MAIN OUTCOMES AND MEASURES The co-primary outcomes were need for intubation and time to clinical recovery until day 28 as assessed by a 7-category ordinal scale (range, 1-7, with higher scores indicating a worse condition). Effects of treatments were calculated with a Cox proportional hazards model adjusted for hypoxemia severity, age, and comorbidities. RESULTS Among 220 randomized patients, 199 were included in the analysis (median age, 60 years; n = 65 women [32.7%)). Intubation occurred in 34 (34.3%) randomized to high-flow oxygen therapy and in 51(51.0%) randomized to conventional oxygen therapy (hazard ratio, 0.62; 95% CI, 0.39-0.96; P = .03). The median time to clinical recovery within 28 days was 11 (IQR, 9-14) days in patients randomized to high-flow oxygen therapy vs 14 (IQR, 11-19) days in those randomized to conventional oxygen therapy (hazard ratio, 1.39; 95% CI, 1.00-1.92; P = .047). Suspected bacterial pneumonia occurred in 13 patients (13.1%) randomized to high-flow oxygen and in 17 (17.0%) of those randomized to conventional oxygen therapy, while bacteremia was detected in 7 (7.1%) vs 11(11.0%), respectively. CONCLUSIONS AND RELEVANCE Among patients with severe COVID-19, use of high-flow oxygen through a nasal cannula significantly decreased need for mechanical ventilation support and time to clinical recovery compared with conventional low-flow oxygen therapy.	[Ospina-Tascon, Gustavo A.; Eduardo Calderon-Tapia, Luis; Garcia, Alberto F.; Zarama, Virginia; Gomez-Alvarez, Freddy; Alvarez-Saa, Tatiana; Pardo-Otalvaro, Stephania; Bautista-Rincon, Diego F.; Vargas, Monica P.; Aldana-Diaz, Jose L.; Marulanda, Angela; Gutierrez, Alejandro; Varon, Janer; Gomez, Monica; Ochoa, Maria E.; Escobar, Elena; Umana, Mauricio; Diez, Julio] Fdn Valle Lili, Dept Intens Care, Ave Simon Bolivar Carrera 98, Cali 760031, Colombia; [Ospina-Tascon, Gustavo A.; Eduardo Calderon-Tapia, Luis; Garcia, Alberto F.; Aldana-Diaz, Jose L.; Marulanda, Angela; Escobar, Elena] Univ Icesi, Translat Med Lab Crit Care TransLab CCM, Cali, Colombia; [Tobon, Gabriel J.; Albornoz, Ludwig L.] Fdn Valle Lili Univ Icesi, Dept Pathol & Lab Med, Cali, Colombia; [Celemin Florez, Carlos Augusto; Ortiz Ruiz, Guillermo] Univ Bosque, SubRed Ctr Oriente, Dept Cuidado Crit, Bogota, Colombia; [Leonardo Caceres, Eder; Felipe Reyes, Luis] Clin Univ La Sabana, Dept Crit Care, Chia, Colombia; [Felipe Reyes, Luis] Univ La Sabana, Dept Infect Dis, Chia, Colombia; [Petri Damiani, Lucas; Cavalcanti, Alexandre B.] Univ Sao Paulo, HCor Res Inst, Hosp Coracao, Fac Med, Sao Paulo, Brazil	Universidad ICESI; Fundacion Valle del Lili; Universidad ICESI; Universidad El Bosque; Universidad de La Sabana; Universidad de La Sabana; Hospital do Coracao - HCor; Universidade de Sao Paulo	Ospina-Tascon, GA (corresponding author), Fdn Valle Lili, Dept Intens Care, Ave Simon Bolivar Carrera 98, Cali 760031, Colombia.	gusospin@gmail.com	Reyes, Luis Felipe/ACX-9822-2022; García, Alberto/HDO-5321-2022	ALVAREZ SAA, TATIANA/0000-0002-4568-4667; Diez-Sepulveda, Julio/0000-0002-8483-3717; Albornoz, Ludwig L./0000-0002-5433-0780; Caceres, Eder/0000-0003-1286-4423; Ortiz, Guillermo/0000-0002-3374-5709	Centro de Investigaciones Clinicas, Fundacion Valle del Lili, Cali, Colombia	Centro de Investigaciones Clinicas, Fundacion Valle del Lili, Cali, Colombia	This study received funds and logistic support from the Centro de Investigaciones Clinicas, Fundacion Valle del Lili, Cali, Colombia.	Alhazzani W., 2020, INTENS CARE MED, V46, P854, DOI [DOI 10.1007/s00134-020-06022-5, 10.1007/s00134-020-06022-5]; Azoulay E, 2018, JAMA-J AM MED ASSOC, V320, P2099, DOI 10.1001/jama.2018.14282; Bennett JA, 2002, HEART LUNG, V31, P262, DOI 10.1067/mhl.2002.124554; Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Calligaro GL, 2020, ECLINICALMEDICINE, V28, DOI 10.1016/j.eclinm.2020.100570; Carrillo A, 2012, INTENS CARE MED, V38, P458, DOI 10.1007/s00134-012-2475-6; Corley A, 2011, BRIT J ANAESTH, V107, P998, DOI 10.1093/bja/aer265; Demoule A, 2020, AM J RESP CRIT CARE, V202, P1039, DOI 10.1164/rccm.202005-2007LE; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Grieco DL, 2021, JAMA-J AM MED ASSOC, V325, P1731, DOI 10.1001/jama.2021.4682; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Mauri T, 2017, AM J RESP CRIT CARE, V195, P1207, DOI 10.1164/rccm.201605-0916OC; Piraino T, 2019, RESP CARE, V64, P638, DOI 10.4187/respcare.06735; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Rochwerg B, 2019, INTENS CARE MED, V45, P563, DOI 10.1007/s00134-019-05590-5; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Tobin MJ, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00692-6; Tobin MJ, 2020, AM J RESP CRIT CARE, V201, P1319, DOI 10.1164/rccm.202004-1076ED; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	25	43	44	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2161	2171		10.1001/jama.2021.20714	http://dx.doi.org/10.1001/jama.2021.20714			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874419	Bronze, Green Published			2022-12-28	WOS:000730077500019
J	Voelker, R				Voelker, Rebecca			Public-Private Partnership Sets Its Sights on New Gene Therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2121	2121						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874437				2022-12-28	WOS:000730077500007
J	Dyer, O				Dyer, Owen			Covid-19: South Africa's surge in cases deepens alarm over omicron variant	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Healy M., 2021, LOS ANGELES TIMES; Msomi N, 2021, NATURE, V600, P33, DOI 10.1038/d41586-021-03546-8; Pulliam JRC vSC, INCREASED RISK SARS, DOI 10.1101/2021.11.11.21266068 (2021)	3	31	32	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3013	10.1136/bmj.n3013	http://dx.doi.org/10.1136/bmj.n3013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862184	Bronze			2022-12-28	WOS:000729712200013
J	Schievink, WI				Schievink, Wouter, I			Spontaneous Intracranial Hypotension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review								Spontaneous intracranial hypotension is a condition characterized by a lower-than-normal volume of cerebrospinal fluid (CSF) because of leakage of CSF through the dural membrane at one or multiple sites. The loss of CSF results in displacement of cerebral structures, causing headache and other neurologic symptoms.(1) The term "spontaneous" in relation to the disorder is used to differentiate it from intracranial hypotension caused by CSF leaks of known cause, such as craniospinal trauma, spinal surgery, or most commonly, lumbar puncture or spinal anesthesia. Although CSF pressure in this disorder, as measured by manometry during lumbar puncture, may be normal,(2) it is often lower than normal (with the normal value considered to be 6 to 25 cm of water, or 4.4 to 18.4 mm Hg), and the term "hypotension" continues to be used. Spontaneous intracranial hypotension assumes clinical importance as a treatable cause of headache and other manifestations, including dizziness, mental dullness, and behavioral changes, but the variability in clinical presentation makes diagnosis difficult.(1)	[Schievink, Wouter, I] Cedars Sinai Med Ctr, Dept Neurosurg, 127 S San Vicente Blvd,Ste A6600, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Schievink, WI (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, 127 S San Vicente Blvd,Ste A6600, Los Angeles, CA 90048 USA.	schievinkw@cshs.org						Amrhein TJ, 2016, AM J NEURORADIOL, V37, P1951, DOI 10.3174/ajnr.A4842; Beck J, 2016, NEUROLOGY, V87, P1220, DOI 10.1212/WNL.0000000000003122; Brinjikji W, 2021, AM J NEURORADIOL, V42, P882, DOI 10.3174/ajnr.A7014; D'Antona L, 2021, JAMA NEUROL, V78, P329, DOI 10.1001/jamaneurol.2020.4799; Dobrocky T, 2019, JAMA NEUROL, V76, P580, DOI 10.1001/jamaneurol.2018.4921; Duvall JR, 2019, CEPHALALGIA, V39, P1847, DOI 10.1177/0333102419881673; Farb RI, 2019, AM J NEURORADIOL, V40, P745, DOI 10.3174/ajnr.A6016; Ferrante E, 2021, J NEUROL SCI, V425, DOI 10.1016/j.jns.2021.117467; Hani L, 2020, NEUROLOGY, V95, pE247, DOI 10.1212/WNL.0000000000009812; Hani L, 2022, J NEUROL, V269, P1439, DOI 10.1007/s00415-021-10710-7; Kranz PG, 2016, AM J NEURORADIOL, V37, P1374, DOI 10.3174/ajnr.A4689; Kranz PG, 2016, CEPHALALGIA, V36, P1209, DOI 10.1177/0333102415623071; Kumar N, 2021, ANN NEUROL, V89, P1068, DOI 10.1002/ana.26083; Mamlouk MD, 2021, RADIOLOGY, V299, P409, DOI 10.1148/radiol.2021204231; Mokri B, 1998, NEUROLOGY, V51, P786, DOI 10.1212/WNL.51.3.786; Morishima R, 2019, J NEUROL, V266, P2679, DOI 10.1007/s00415-019-09469-9; Pagani-Estevez GL, 2019, REGION ANESTH PAIN M, V44, P212, DOI 10.1136/rapm-2018-000021; Schievink WI, 2021, NEUROL-CLIN PRACT, V11, pE691, DOI 10.1212/CPJ.0000000000001084; Schievink WI, 2022, CEPHALALGIA, V42, P312, DOI 10.1177/03331024211048510; Schievink WI, 2021, NEUROLOGY, V97, pE1964, DOI 10.1212/WNL.0000000000012786; Schievink WI, 2021, ANN NEUROL, V90, P514, DOI 10.1002/ana.26175; Schievink WI, 2021, HEADACHE, V61, P387, DOI 10.1111/head.14048; Schievink WI, 2019, J NEUROSURG-SPINE, V31, P902, DOI 10.3171/2019.6.SPINE19487; Schievink WI, 2018, NEUROLOGY, V90, pE1638, DOI 10.1212/WNL.0000000000005477; Schievink WI, 2018, OPER NEUROSURG, V15, P505, DOI 10.1093/ons/opy029; Schievink WI, 2016, NEUROLOGY, V87, P673, DOI 10.1212/WNL.0000000000002986; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Tay ASMS, 2021, JAMA NEUROL, V78, P1275, DOI 10.1001/jamaneurol.2021.2868	28	11	11	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2021	385	23					2173	2178		10.1056/NEJMra2101561	http://dx.doi.org/10.1056/NEJMra2101561			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE4VC	34874632				2022-12-28	WOS:000741124300013
J	Brown, AJH; Bradley, SJ; Marshall, FH; Bown, GA; Bennett, KA; Brown, J; Cansfield, JE; Cross, DM; de Graaf, C; Hudson, BD; Dwomoh, L; Dias, JM; Errey, JC; Hurrell, E; Liptrot, J; Mattedi, G; Molloy, C; Nathan, PJ; Okrasa, K; Osborne, G; Patel, JC; Pickworth, M; Robertson, N; Shahabi, S; Bundgaard, C; Phillips, K; Broad, LM; Goonawardena, AV; Morairty, SR; Browning, M; Perini, F; Dawson, GR; Deakin, JFW; Smith, RT; Sexton, PM; Warneck, J; Vinson, M; Tasker, T; Tehan, BG; Teobald, B; Christopoulos, A; Langmead, CJ; Jazayeri, A; Cooke, RM; Rucktooa, P; Congreve, MS; Weir, M; Tobin, AB				Brown, Alastair J. H.; Bradley, Sophie J.; Marshall, Fiona H.; Bown, Giles A.; Bennett, Kirstie A.; Brown, Jason; Cansfield, Julie E.; Cross, David M.; de Graaf, Chris; Hudson, Brian D.; Dwomoh, Louis; Dias, Joao M.; Errey, James C.; Hurrell, Edward; Liptrot, Jan; Mattedi, Giulio; Molloy, Colin; Nathan, Pradeep J.; Okrasa, Krzysztof; Osborne, Greg; Patel, Jayesh C.; Pickworth, Mark; Robertson, Nathan; Shahabi, Shahram; Bundgaard, Christoffer; Phillips, Keith; Broad, Lisa M.; Goonawardena, Anushka V.; Morairty, Stephen R.; Browning, Michael; Perini, Francesca; Dawson, Gerard R.; Deakin, John F. W.; Smith, Robert T.; Sexton, Patrick M.; Warneck, Julie; Vinson, Mary; Tasker, Tim; Tehan, Benjamin G.; Teobald, Barry; Christopoulos, Arthur; Langmead, Christopher J.; Jazayeri, Ali; Cooke, Robert M.; Rucktooa, Prakash; Congreve, Miles S.; Weir, Malcolm; Tobin, Andrew B.			From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease	CELL			English	Article							ALLOSTERIC MODULATORS; CHOLINESTERASE-INHIBITORS; CHOLINERGIC HYPOTHESIS; BEHAVIORAL SYMPTOMS; SELECTIVE AGONISTS; CRYSTAL-STRUCTURE; BINDING MODE; MEMORY; XANOMELINE; PAM	Current therapies for Alzheimer's disease seek to correct for defective cholinergic transmission by preventing the breakdown of acetylcholine through inhibition of acetylcholinesterase, these however have limited clinical efficacy. An alternative approach is to directly activate cholinergic receptors responsible for learning and memory. The M1-muscarinic acetylcholine (M1) receptor is the target of choice but has been hampered by adverse effects. Here we aimed to design the drug properties needed for a well-tolerated M1-agonist with the potential to alleviate cognitive loss by taking a stepwise translational approach from atomic structure, cell/tissue-based assays, evaluation in preclinical species, clinical safety testing, and finally establishing activity in memory centers in humans. Through this approach, we rationally designed the optimal properties, including selectivity and partial agonism, into HTL9936-a potential candidate for the treatment of memory loss in Alzheimer's disease. More broadly, this demonstrates a strategy for targeting difficult GPCR targets from structure to clinic.	[Brown, Alastair J. H.; Bradley, Sophie J.; Marshall, Fiona H.; Bown, Giles A.; Bennett, Kirstie A.; Brown, Jason; Cansfield, Julie E.; Cross, David M.; de Graaf, Chris; Hudson, Brian D.; Dias, Joao M.; Errey, James C.; Hurrell, Edward; Liptrot, Jan; Mattedi, Giulio; Nathan, Pradeep J.; Okrasa, Krzysztof; Osborne, Greg; Patel, Jayesh C.; Pickworth, Mark; Robertson, Nathan] Sosei Heptares, Steinmetz Bldg,Granta Pk, Cambridge CB21 6DG, England; [Dwomoh, Louis; Molloy, Colin; Tobin, Andrew B.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow G12 8QQ, Lanark, Scotland; [Cross, David M.] Cross Pharma Consulting Ltd, 20-22 Wenlock Rd, London N17GU, England; [Nathan, Pradeep J.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Herchel Smith Bldg, Cambridge CB2 0SZ, England; [Shahabi, Shahram; Bundgaard, Christoffer; Phillips, Keith; Broad, Lisa M.] Eli Lilly & Co, Neurosci Discovery, Erl Wood Manor, Surrey GU20 6PH, England; [Bundgaard, Christoffer] H Lundbeck & Co AS, Neurosci Res, Ottiliavej 9, DK-2500 Copenhagen, Denmark; [Goonawardena, Anushka V.; Morairty, Stephen R.] SRI Int, Ctr Neurosci, Biosci Div, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Browning, Michael; Dawson, Gerard R.] Univ Oxford, Warneford Hosp, Univ Dept Psychiat, Oxford OX1 2JD, England; [Browning, Michael] P1vital, Manor House,Howbery Buisness Pk, Wallingford OX1 08BA, Oxon, England; [Perini, Francesca] Duke NUS Med Sch, Ctr Cognit Neurosci, 8 Coll Rd, Singapore 169857, Singapore; [Deakin, John F. W.] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England; [Sexton, Patrick M.; Langmead, Christopher J.; Jazayeri, Ali] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Sexton, Patrick M.; Langmead, Christopher J.; Jazayeri, Ali] Monash Univ, Dept Pharmacol, 12222, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Cryoelect Microscopy Membrane Proteins, Parkville, Vic 3052, Australia; [Nathan, Pradeep J.; Warneck, Julie] Protogenia Consulting Ltd, POB 289, Ely CB7 9DR, England; [Teobald, Barry] Merck Res Labs, Rahway, NJ 07065 USA; [Bown, Giles A.; Cooke, Robert M.] OMass Therapeut, Schrodinger Bldg,Heatley Rd,,Oxford Sci Pk, Oxford OX4 4GE, England; [Dias, Joao M.] Pfizer, Struct Biol & Biophys, East 42nd St, New York, NY 10017 USA; [Errey, James C.] Evotec UK Ltd, 114 Innovat Dr,Pk, Milton OX14 4RZ, Abingdon, England; [Robertson, Nathan] OXGENE Biotechnol, Medawar Ctr, Robert Robinson Ave, Oxford OX4 4HG, England; [Vinson, Mary] Autolus Therapeut PLC, Mediaworks 5, 191 Wood Lane, London W12 7FP, England; [Christopoulos, Arthur; Tobin, Andrew B.] Sitryx Therapeut Ltd, Oxford Sci Pk, Oxford OX4 4GA, England	Heptares Therapeutics Ltd.; University of Glasgow; University of Cambridge; Eli Lilly; Lundbeck Corporation; SRI International; University of Oxford; National University of Singapore; University of Manchester; Monash University; Monash University; Monash University; Merck & Company; Pfizer; Evotec	Tobin, AB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow G12 8QQ, Lanark, Scotland.; Tobin, AB (corresponding author), Sitryx Therapeut Ltd, Oxford Sci Pk, Oxford OX4 4GA, England.	malcolm.weir@soseiheptares.com; andrew.tobin@glasgow.ac.uk		Dwomoh, Louis/0000-0001-7024-6450; Robertson, Nathan/0000-0002-5449-2501; Rucktooa, Prakash/0000-0003-2050-7389; Perini, francesca/0000-0001-6558-5060	University of Glasgow Lord Kelvin Adam Smith Fellowship; MRC MICA [MR/P019366/1]; Wellcome Trust Collaborative Award [201529/Z/16/Z]; SULSA Dementia Seed Funding; BSU facilities at the Cancer Research UK Beatson Institute [C596/A17196]	University of Glasgow Lord Kelvin Adam Smith Fellowship; MRC MICA; Wellcome Trust Collaborative Award(Wellcome Trust); SULSA Dementia Seed Funding; BSU facilities at the Cancer Research UK Beatson Institute	We wish to acknowledge Andrew S. Dore for assistance with analysis of the crystallographic data, Alex Godwood for assistance with analysis of theefficacy data, and Geor Bakker for help with additional analysis of the fMRI and EEG data. This work is partially funded by a University of Glasgow Lord Kelvin Adam Smith Fellowship (S.J.B.) ; an MRC MICA, MR/P019366/1 (A.B.T., S.J.B.,) ; a Wellcome Trust Collaborative Award, 201529/Z/16/Z (A.B.T., A.C., P.M.S.) ; SULSA Dementia Seed Funding (A.B.T.) . We acknowledge the BSU facilities at the Cancer Research UK Beatson Institute (C596/A17196) and the Biological Services at the University of Glasgow. We also thank Simon Brooke and Helen Sanger for conducting assays on the muscarinic receptor expressing cell lines. AUTHOR CONTRIBUTIONS A.J.H.B., G.A.B., M.S.C., R.M.C., A.J., C.J.L., F.H.M., T.T., B.G.T., M.W., and A.B.T. devised the program of work. A.B.T., A.J.H.B., and F.H.M. wrote the pa-per with assistance from all other authors. J.E.C., M.P., M.S.C., and G.A.B. devised and carried out the chemical syntheses. D.M.C., J.L., P.J.N., M.V., J.W., and T.T. developed and oversaw the clinical program. S.J.B.com piled and analyzed data, contributed to writing paper, and conducted prion mouse work and pharmacology. A.C. and P.M.S. contributed to mouse prion work and analysis of structural biology. L.M.B.; ligand synthesis, mouse pharmaco-kinetic studies. K.P., S.S., and L.M.B.; in vivo electrophysiology. C.B. and D.M.C.; pharmacokinetics. N.R., J.B., J.C.E., and J.C.P. devised and carried out the conformational thermostabilization and mutagenesis of the receptor, characterised expression constructs, and performed radioligand binding anal-ysis of mutants. K.O. established protocols for expression, purification, mass spectrometry QC, and optimised protein concentration for LCP crystallization trials. Computational analysis of the structure and modeling was carried out by B.G.T. and R.T.S. J.F.W.D. and P.R. established the platform/protocols for LCP crystallization and solved the structure. K.A.B., J.B., E.H., and G.O. carried out and analyzed the in vitro pharmacology data. C.d.G. and G.M. conducted mo-lecular dynamic analysis and contributed to structural biology analysis. B.D.H. and L.D. conducted biased ligand experiments. A.V.G. and S.R.M. developed and analyzed NHP EEG data. F.P., M.B., G.R.D., and J.F.W.D. supported development, oversight, and analysis of clinical fMRI study. T.T. and M.W. are shareholders and board members of Sosei Heptares. The authors A.J.H.B., G.A.B., K.A.B., J.B., J.E.C., M.S.C., R.M.C., J.C.E., E.H., A.J., C.J.L., J.L., F.H.M., P.J.N., K.O., G.O., J.C.P., M.P., N.R., P.R., B.G.T., R.T.S., C.d.G., G.M., and B.T. are or have been employees of Heptares Therapeutics and are shareholders of Sosei Heptares.	Alt A, 2016, J PHARMACOL EXP THER, V356, P293, DOI 10.1124/jpet.115.226910; Antonova E, 2009, MEMORY, V17, P125, DOI 10.1080/09658210802077348; Antonova E, 2011, J PSYCHOPHARMACOL, V25, P1256, DOI 10.1177/0269881110379285; Araujo JA, 2011, J ALZHEIMERS DIS, V26, P143, DOI 10.3233/JAD-2011-110005; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bender AM, 2017, ACS CHEM NEUROSCI, V8, P435, DOI 10.1021/acschemneuro.7b00001; Bentham P, 2004, LANCET, V363, P2105; Bodick NC, 1997, ALZ DIS ASSOC DIS, V11, pS16; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Bradley SJ, 2020, NAT CHEM BIOL, V16, P240, DOI 10.1038/s41589-019-0453-9; Bradley SJ, 2018, MOL PHARMACOL, V93, P645, DOI 10.1124/mol.118.111872; Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; Brannan SK, 2021, NEW ENGL J MED, V384, P717, DOI 10.1056/NEJMoa2017015; Budzik B, 2010, ACS MED CHEM LETT, V1, P244, DOI 10.1021/ml100105x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Congreve M, 2017, TRENDS PHARMACOL SCI, V38, P837, DOI 10.1016/j.tips.2017.05.010; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Davoren JE, 2017, J MED CHEM, V60, P6649, DOI 10.1021/acs.jmedchem.7b00597; Davoren JE, 2016, J MED CHEM, V59, P6313, DOI 10.1021/acs.jmedchem.6b00544; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Douchamps V, 2017, BEHAV PHARMACOL, V28, P112, DOI 10.1097/FBP.0000000000000300; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engers JL, 2018, ACS MED CHEM LETT, V9, P917, DOI 10.1021/acsmedchemlett.8b00261; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Felder CC, 2018, NEUROPHARMACOLOGY, V136, P449, DOI 10.1016/j.neuropharm.2018.01.028; Fish I, 2017, J MED CHEM, V60, P9239, DOI 10.1021/acs.jmedchem.7b01113; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Ghoshal A, 2016, NEUROPSYCHOPHARMACOL, V41, P598, DOI 10.1038/npp.2015.189; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Inglis F, 2002, INT J CLIN PRACT, P45; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jazayeri A, 2017, CHEM REV, V117, P21, DOI 10.1021/acs.chemrev.6b00119; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c2; Kooistra AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28288; Kooistra AJ, 2015, J CHEM INF MODEL, V55, P1045, DOI 10.1021/acs.jcim.5b00066; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Laurent B, 2015, BIOINFORMATICS, V31, P1478, DOI 10.1093/bioinformatics/btu822; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Magnani F, 2016, NAT PROTOC, V11, P1554, DOI 10.1038/nprot.2016.088; Maksymetz J, 2019, BIOL PSYCHIAT, V85, P989, DOI 10.1016/j.biopsych.2019.02.020; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miszta P, 2018, NUCLEIC ACIDS RES, V46, pW387, DOI 10.1093/nar/gky429; Moran SP, 2018, NEUROPSYCHOPHARMACOL, V43, P1763, DOI 10.1038/s41386-018-0033-9; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nathan PJ, 2013, INT J NEUROPSYCHOPH, V16, P721, DOI 10.1017/S1461145712000752; Olsen RHJ, 2020, NAT CHEM BIOL, V16, P841, DOI 10.1038/s41589-020-0535-8; Porter AC, 2002, BRAIN RES, V944, P82, DOI 10.1016/S0006-8993(02)02721-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rook JM, 2017, ACS CHEM NEUROSCI, V8, P866, DOI 10.1021/acschemneuro.6b00429; Roos K, 2019, J CHEM THEORY COMPUT, V15, P1863, DOI 10.1021/acs.jctc.8b01026; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Snyder Peter J, 2005, Alzheimers Dement, V1, P126, DOI 10.1016/j.jalz.2005.09.004; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Thompson Sarah, 2004, Expert Opin Drug Saf, V3, P425, DOI 10.1517/14740338.3.5.425; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Vass M, 2019, J MED CHEM, V62, P3784, DOI 10.1021/acs.jmedchem.8b00836; Voss Tiffini, 2018, Alzheimers Dement (N Y), V4, P173, DOI 10.1016/j.trci.2018.03.004; Vuckovic Z, 2019, P NATL ACAD SCI USA, V116, P26001, DOI 10.1073/pnas.1914446116; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	82	12	13	14	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2021	184	24					5886	+		10.1016/j.cell.2021.11.001	http://dx.doi.org/10.1016/j.cell.2021.11.001		NOV 2021	39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XC8CW	34822784	Green Submitted, Bronze			2022-12-28	WOS:000722238100007
J	Gogolla, N				Gogolla, Nadine			The brain remembers where and how inflammation struck	CELL			English	Editorial Material							IMMUNE-SYSTEM	Y Our immune system and brain interact on multiple scales, but how the brain represents and remembers immune challenges remains unclear. In this issue of Cell, Koren et al. (2021) reveal that the brain's insular cortex stores information about inflammation in the body. Strikingly, these immunological "memory engrams'' can restore the initial disease state when reactivated.	[Gogolla, Nadine] Max Planck Inst Neurobiol, Circuits Emot Res Grp, Martinsried, Germany; [Gogolla, Nadine] Max Planck Inst Psychiat, Dept Emot Res, Munich, Germany	Max Planck Society; Max Planck Society	Gogolla, N (corresponding author), Max Planck Inst Neurobiol, Circuits Emot Res Grp, Martinsried, Germany.; Gogolla, N (corresponding author), Max Planck Inst Psychiat, Dept Emot Res, Munich, Germany.	ngogolla@neuro.mpg.de		Gogolla, Nadine/0000-0003-3754-7133	Max-Planck Society; European Research Council under the European Union [758448]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council under the European Union(European Research Council (ERC))	I would like to thank Alexandra S. Klein, Meryl Malezieux, and Jacob B. Dahan for feedback on a prior version of this manuscript. This work was supported by the Max-Planck Society and the European Research Council under the European Union's Horizon 2020 research and innovationprogram (ERC-2017-STG, grant agreement no 758448) .	Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; DeNardo LA, 2019, NAT NEUROSCI, V22, P460, DOI 10.1038/s41593-018-0318-7; Gibney SM, 2013, J NEUROIMMUNE PHARM, V8, P900, DOI 10.1007/s11481-013-9462-8; Gogolla N, 2017, CURR BIOL, V27, pR580, DOI 10.1016/j.cub.2017.05.010; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Josselyn SA, 2020, SCIENCE, V367, P39, DOI 10.1126/science.aaw4325; Koren T, 2021, CELL, V184, P5902, DOI 10.1016/j.cell.2021.10.013; Lu CB, 2016, NEUROSCI BULL, V32, P191, DOI 10.1007/s12264-016-0016-y; Sweis BM, 2021, CURR OPIN NEUROBIOL, V67, P199, DOI 10.1016/j.conb.2020.11.017	10	4	4	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2021	184	24					5851	5853		10.1016/j.cell.2021.11.002	http://dx.doi.org/10.1016/j.cell.2021.11.002		NOV 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XC8CW	34822782	Bronze			2022-12-28	WOS:000722238100004
J	Mahase, E				Mahase, Elisabeth			Sanitation workers: covid-19's forgotten frontline	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WaterAid, SAN WORK FORG FRONTL	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2875	10.1136/bmj.n2875	http://dx.doi.org/10.1136/bmj.n2875			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819312	Bronze			2022-12-28	WOS:000740893700006
J	Ellison-Barnes, A; Johnson, S; Gudzune, K				Ellison-Barnes, Alejandra; Johnson, Sara; Gudzune, Kimberly			Trends in Obesity Prevalence Among Adults Aged 18 Through 25 Years, 1976-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							URBANIZATION	This study uses nationally representative data from the National Health and Nutrition Examination Survey to examine changes in obesity prevalence in the US over the last 4 decades among adults aged 18 through 25 years.	[Ellison-Barnes, Alejandra; Gudzune, Kimberly] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Johnson, Sara] Johns Hopkins Univ, Sch Med, Div Gen Pediat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Ellison-Barnes, A (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Room 8034, Baltimore, MD 21287 USA.	aelliso6@jhmi.edu		JOHNSON, SARA/0000-0003-4532-1847	National Institutes of Health [5T32HL007180]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Ellison-Barnes was supported by training grant 5T32HL007180 from the National Institutes of Health.	Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P2419, DOI 10.1001/jama.2018.7270; Hochberg Z, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00918; Ogden CL, 2018, JAMA-J AM MED ASSOC, V319, P2410, DOI 10.1001/jama.2018.5158; Pi-Sunyer FX, 1998, OBES RES, V6, p51S	6	11	11	3	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2073	2074		10.1001/jama.2021.16685	http://dx.doi.org/10.1001/jama.2021.16685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812876	Green Published			2022-12-28	WOS:000724001500028
J	Slomski, A				Slomski, Anita			Pembrolizumab Boosts Breast and Cervical Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2001	2001		10.1001/jama.2021.19200	http://dx.doi.org/10.1001/jama.2021.19200			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812867				2022-12-28	WOS:000724001500045
J	Lau, JYW; Pittayanon, R; Kwek, A; Tang, RS; Chan, H; Rerknimitr, R; Lee, J; Ang, TL; Suen, BY; Yu, YY; Chan, FKL; Sung, JJY				Lau, James Y. W.; Pittayanon, Rapat; Kwek, Andrew; Tang, Raymond S.; Chan, Heyson; Rerknimitr, Rungsun; Lee, June; Ang, Tiing Leong; Suen, Bing-Yee; Yu, Yuan-yuan; Chan, Francis K. L.; Sung, Joseph J. Y.			Comparison of a Hemostatic Powder and Standard Treatment in the Control of Active Bleeding From Upper Nonvariceal Lesions A Multicenter, Noninferiority, Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HEMOSPRAY; EXPERIENCE; EFFICACY; SAFETY; ULCERS	Background: The effectiveness of the hemostatic powder TC-325 as a single endoscopic treatment for acute nonvariceal upper gastrointestinal bleeding is uncertain. Objective: To compare TC-325 with standard endoscopic hemostatic treatments in the control of active bleeding from nonvariceal upper gastrointestinal causes. Design: One-sided, noninferiority, randomized, controlled trial. (ClinicalTrials.gov: NCT02534571). Setting: University teaching hospitals in the Asia-Pacific region. Patients: 224 adult patients with acute bleeding from a nonvariceal cause on upper gastrointestinal endoscopy. Intervention: TC-325 (n = 111) or standard hemostatic treatment (n = 113). Measurements: The primary outcome was control of bleeding within 30 days. Other outcomes included failure to control bleeding during index endoscopy, recurrent bleeding after initial hemostasis, further interventions, blood transfusion, hospitalization, and death. Results: 224 patients were enrolled (136 with gastroduodenal ulcers [60.7%], 33 with tumors [14.7%], and 55 with other causes of bleeding [24.6%]). Bleeding was controlled within 30 days in 100 of 111 patients (90.1%) in the TC-325 group and 92 of 113 (81.4%) in the standard treatment group (risk difference, 8.7 percentage points [1-sided 95% CI, 0.95 percentage point]). There were fewer failures of hemostasis during index endoscopy with TC-325 (3 [2.7%] vs. 11 [9.7%]; odds ratio, 0.26 [CI, 0.07 to 0.95]). Recurrent bleeding within 30 days did not differ between groups (9 [8.1%] vs. 10 [8.8%]). The need for further interventions also did not differ between groups (further endoscopic treatment: 8 [7.2%] vs. 10 [8.8%]; angiography: 2 [1.8%] vs. 4 [3.5%]; surgery: 1 [0.9%] vs. 0). There were 14 deaths in each group (12.6% vs. 12.4%). Limitation: Clinicians were not blinded to treatment. Conclusion: TC-325 is not inferior to standard treatment in the endoscopic control of bleeding from nonvariceal upper gastrointestinal causes. Primary funding source: General Research Fund to the University Grants Committee, Hong Kong SAR Government.	[Lau, James Y. W.; Tang, Raymond S.; Chan, Heyson; Suen, Bing-Yee; Chan, Francis K. L.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China; [Pittayanon, Rapat; Rerknimitr, Rungsun] Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok, Thailand; [Pittayanon, Rapat; Rerknimitr, Rungsun] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand; [Kwek, Andrew; Lee, June; Ang, Tiing Leong] Changi Gen Hosp, Singapore, Singapore; [Yu, Yuan-yuan] Prince Wales Hosp, Dept Surg, Shatin, Room 64026,Lui Chee Woo Clin Sci Bldg, Hong Kong, Peoples R China; [Sung, Joseph J. Y.] Nanyang Technol Univ, Singapore, Singapore	Chinese University of Hong Kong; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Changi General Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lau, JYW (corresponding author), Prince Wales Hosp, Dept Surg, Shatin, Room 64026,Lui Chee Woo Clin Sci Bldg, Hong Kong, Peoples R China.	lau-jyw@surgery.cuhk.edu.hk	Chan, Francis K. L./F-4851-2010; Lau, James/O-2612-2016	Chan, Francis K. L./0000-0001-7388-2436; Lau, James/0000-0003-0122-4068; Tang, Raymond Shing-Yan/0000-0002-2433-8036	General Research Fund [2140948]	General Research Fund	By a General Research Fund to the University Grants Committee (no. 2140948), Hong Kong SAR Government.	Baracat FI, 2020, SURG ENDOSC, V34, P317, DOI 10.1007/s00464-019-06769-z; Barkun AN, 2009, GASTROINTEST ENDOSC, V69, P786, DOI 10.1016/j.gie.2008.05.031; Chen YI, 2020, GASTROINTEST ENDOSC, V91, P321, DOI 10.1016/j.gie.2019.08.005; Chen Yen-I, 2015, Gastrointest Endosc Clin N Am, V25, P535, DOI 10.1016/j.giec.2015.02.008; Haddara S, 2016, ENDOSCOPY, V48, P1084, DOI 10.1055/s-0042-116148; Holster IL, 2013, ENDOSCOPY, V45, P63, DOI 10.1055/s-0032-1325793; Kwek BEA, 2017, J DIGEST DIS, V18, P323, DOI 10.1111/1751-2980.12481; Leontiadis GI, 2005, ALIMENT PHARM THER, V21, P1055, DOI 10.1111/j.1365-2036.2005.02441.x; Masci E, 2014, SCAND J GASTROENTERO, V49, P1290, DOI 10.3109/00365521.2014.946080; Smith LA, 2014, J CLIN GASTROENTEROL, V48, pE89, DOI 10.1097/MCG.0000000000000054; Sulz MC, 2014, ENDOSCOPY, V46, P619, DOI 10.1055/s-0034-1365505; Sung JJY, 2011, ENDOSCOPY, V43, P291, DOI 10.1055/s-0030-1256311; Yau AHL, 2014, CAN J GASTROENTEROL, V28, P72, DOI 10.1155/2014/759436	13	5	5	4	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					171	+		10.7326/M21-0975	http://dx.doi.org/10.7326/M21-0975		DEC 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	34871051				2022-12-28	WOS:000729195300001
J	Slomski, A				Slomski, Anita			Methylphenidate Treats Apathy in Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2120	2120						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874434				2022-12-28	WOS:000730077500004
J	Devi, S				Devi, Sharmila			Health warnings over UNRWA funding shortfall	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2063	2063						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863340				2022-12-28	WOS:000726564200008
J	Devi, S				Devi, Sharmila			Calls for international solutions to EU-Belarus border crisis	LANCET			English	Editorial Material																			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2064	2064						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863341				2022-12-28	WOS:000726564200009
J	Prasad, A				Prasad, Aarathi			Martin Griffiths: serving communities affected by violence	LANCET			English	Biographical-Item																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2067	2067						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863342				2022-12-28	WOS:000726564200011
J	Wise, J				Wise, Jacqui			Covid-19: Build on success of vaccination programme in reaching ethnic minority groups, report recommends	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, FINAL REPORT PROGR A	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3003	10.1136/bmj.n3003	http://dx.doi.org/10.1136/bmj.n3003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862202	Bronze			2022-12-28	WOS:000729712200002
J	Geiller, T; Sadeh, S; Rolotti, SV; Blockus, H; Vancura, B; Negrean, A; Murray, AJ; Rozsa, B; Polleux, F; Clopath, C; Losonczy, A				Geiller, Tristan; Sadeh, Sadra; Rolotti, Sebastian, V; Blockus, Heike; Vancura, Bert; Negrean, Adrian; Murray, Andrew J.; Rozsa, Balazs; Polleux, Franck; Clopath, Claudia; Losonczy, Attila			Local circuit amplification of spatial selectivity in the hippocampus	NATURE			English	Article; Early Access							FUNCTIONAL-ORGANIZATION; SYNAPTIC PLASTICITY; CA1 PLACE; NETWORK	Local circuit architecture facilitates the emergence of feature selectivity in the cerebral cortex(1). In the hippocampus, it remains unknown whether local computations supported by specific connectivity motifs(2) regulate the spatial receptive fields of pyramidal cells(3). Here we developed an in vivo electroporation method for monosynaptic retrograde tracing(4) and optogenetics manipulation at single-cell resolution to interrogate the dynamic interaction of place cells with their microcircuitry during navigation. We found a local circuit mechanism in CA1 whereby the spatial tuning of an individual place cell can propagate to a functionally recurrent subnetwork(5) to which it belongs. The emergence of place fields in individual neurons led to the development of inverse selectivity in a subset of their presynaptic interneurons, and recruited functionally coupled place cells at that location. Thus, the spatial selectivity of single CA1 neurons is amplified through local circuit plasticity to enable effective multi-neuronal representations that can flexibly scale environmental features locally without degrading the feedforward input structure.	[Geiller, Tristan; Rolotti, Sebastian, V; Blockus, Heike; Vancura, Bert; Negrean, Adrian; Polleux, Franck; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Geiller, Tristan; Rolotti, Sebastian, V; Blockus, Heike; Vancura, Bert; Negrean, Adrian; Polleux, Franck; Losonczy, Attila] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA; [Sadeh, Sadra; Clopath, Claudia] Imperial Coll London, Bioengn Dept, London, England; [Murray, Andrew J.] UCL, Sainsbury Wellcome Ctr, London, England; [Rozsa, Balazs] Inst Expt Med, Budapest, Hungary; [Polleux, Franck; Losonczy, Attila] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10027 USA	Columbia University; Columbia University; Imperial College London; University of London; University College London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Columbia University	Geiller, T; Losonczy, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.; Geiller, T; Losonczy, A (corresponding author), Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA.; Losonczy, A (corresponding author), Columbia Univ, Kavli Inst Brain Sci, New York, NY 10027 USA.	tcg2117@columbia.edu; al2856@columbia.edu	Balazs, Rozsa/C-6306-2015	Balazs, Rozsa/0000-0003-1427-7003; Sadeh, Sadra/0000-0001-8159-5461; Polleux, Franck/0000-0003-4313-0481	National Institute of Mental Health (NIMH) [1R01MH124047, 1R01MH124867]; National Institute of Neurological Disorders and Stroke (NINDS) [1U19NS104590, 1U01NS115530]; Kavli Foundation; NIH [T32GN007367, 1S10OD023587-01]; NIMH [F30MH125628, F31MH117892]; Gatsby Charitable Foundation [GAT3361]; Wellcome Trust [090843/F/09/Z, 200790/Z/16/Z]; NINDS [R01NS067557, R21NS109753-442 01A1, K99NS115984-01]; Biotechnology and Biological Sciences Research Council [BB/N013956/1, BB/N019008/1]; Simons Foundation [564408]; EPSRC [EP/R035806/1]; Zuckerman Institute's Cellular Imaging platform	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Kavli Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Simons Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Zuckerman Institute's Cellular Imaging platform	A.L. is supported by the National Institute of Mental Health (NIMH) 1R01MH124047 and 1R01MH124867; the National Institute of Neurological Disorders and Stroke (NINDS) 1U19NS104590 and 1U01NS115530; and the Kavli Foundation. B.V. is supported by (NIH) T32GN007367 and (NIMH) F30MH125628. A.J.M. is supported by the Gatsby Charitable Foundation (GAT3361) and the Wellcome Trust (090843/F/09/Z). S.V.R. is supported by (NIMH) F31MH117892. F.P. is supported by (NINDS) R01NS067557 and R21NS109753-442 01A1. H.B. is supported by (NINDS) K99NS115984-01. C.C. is supported by the Biotechnology and Biological Sciences Research Council (BB/N013956/1 and BB/N019008/1), the Wellcome Trust (200790/Z/16/Z), the Simons Foundation (564408) and the EPSRC (EP/R035806/1). We thank the Zuckerman Institute's Cellular Imaging platform for instrument use and technical advice. Imaging was performed with support from the Zuckerman Institute's Cellular Imaging platform and the NIH (1S10OD023587-01). We thank S. Siegelbaum and members of the Losonczy laboratory for comments on the manuscript.	Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; English DF, 2017, NEURON, V96, P505, DOI 10.1016/j.neuron.2017.09.033; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Geiller T, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.013; Geiller T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14531; Grienberger C, 2017, NAT NEUROSCI, V20, P417, DOI 10.1038/nn.4486; Guzman SJ, 2016, SCIENCE, V353, P1117, DOI 10.1126/science.aaf1836; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kaifosh P, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00080; Kaufman AM, 2020, NEURON, V105, P1018, DOI 10.1016/j.neuron.2019.12.029; Keemink SW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21640-2; Kesner RP, 2015, NEUROSCI BIOBEHAV R, V48, P92, DOI 10.1016/j.neubiorev.2014.11.009; Magee JC, 2020, ANNU REV NEUROSCI, V43, P95, DOI 10.1146/annurev-neuro-090919-022842; Mehta MR, 2015, HIPPOCAMPUS, V25, P756, DOI 10.1002/hipo.22472; Miller KD, 2016, CURR OPIN NEUROBIOL, V37, P75, DOI 10.1016/j.conb.2016.01.008; Najafi F, 2020, NEURON, V105, P165, DOI 10.1016/j.neuron.2019.09.045; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Rossi LF, 2020, NATURE, V588, P648, DOI 10.1038/s41586-020-2894-4; Sadeh S, 2021, NAT REV NEUROSCI, V22, P21, DOI 10.1038/s41583-020-00390-z; Stachenfeld KL, 2017, NAT NEUROSCI, V20, P1643, DOI 10.1038/nn.4650; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Xu HT, 2014, CELL, V157, P1552, DOI 10.1016/j.cell.2014.03.067; Yang SG, 2014, P NATL ACAD SCI USA, V111, P12919, DOI 10.1073/pnas.1405468111	32	9	9	6	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature												10.1038/s41586-021-04169-9	http://dx.doi.org/10.1038/s41586-021-04169-9		DEC 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XG3OS	34853473	Green Submitted, Green Accepted			2022-12-28	WOS:000724666000006
J	Waller, I; Anderson, A				Waller, Isaac; Anderson, Ashton			Quantifying social organization and political polarization in online platforms	NATURE			English	Article							NEWS	Mass selection into groups of like-minded individuals may be fragmenting and polarizing online society, particularly with respect to partisan differences(1-4). However, our ability to measure the social makeup of online communities and in turn, to understand the social organization of online platforms, is limited by the pseudonymous, unstructured and large-scale nature of digital discussion. Here we develop a neural-embedding methodology to quantify the positioning of online communities along social dimensions by leveraging large-scale patterns of aggregate behaviour. Applying our methodology to 5.1 billion comments made in 10,000 communities over 14 years on Reddit, we measure how the macroscale community structure is organized with respect to age, gender and US political partisanship. Examining political content, we find that Reddit underwent a significant polarization event around the 2016 US presidential election. Contrary to conventional wisdom, however, individual-level polarization is rare; the system-level shift in 2016 was disproportionately driven by the arrival of new users. Political polarization on Reddit is unrelated to previous activity on the platform and is instead temporally aligned with external events. We also observe a stark ideological asymmetry, with the sharp increase in polarization in 2016 being entirely attributable to changes in right-wing activity. This methodology is broadly applicable to the study of online interaction, and our findings have implications for the design of online platforms, understanding the social contexts of online behaviour, and quantifying the dynamics and mechanisms of online polarization.	[Waller, Isaac; Anderson, Ashton] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto	Anderson, A (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	ashton@cs.toronto.edu		Waller, Isaac/0000-0003-4283-2502	National Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF)	This research was supported by the National Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation (CFI) and the Ontario Research Fund (ORF).	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], 2021, REDDIT PRIVACY POLIC; [Anonymous], 2018, EXAMINATION 2016 ELE; Bail CA, 2018, P NATL ACAD SCI USA, V115, P9216, DOI 10.1073/pnas.1804840115; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620; Bolukbasi T, 2016, ADV NEUR IN, V29; Bourdieu P., 1984, DISTINCTION SOCIAL C; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; Brynjolfsson E, 1996, P INT C INF SYST, V5; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Crenshaw K.W., 2017, INTERSECTIONALITY ES; Del Vicario M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37825; DiMaggio P, 1996, AM J SOCIOL, V102, P690, DOI 10.1086/230995; Farrell H, 2012, ANNU REV POLIT SCI, V15, P35, DOI 10.1146/annurev-polisci-030810-110815; Flaxman S, 2016, PUBLIC OPIN QUART, V80, P298, DOI 10.1093/poq/nfw006; Garg N, 2018, P NATL ACAD SCI USA, V115, pE3635, DOI 10.1073/pnas.1720347115; Hawley G., 2017, MAKING SENSE ALT RIG; Iyengar S, 2009, J COMMUN, V59, P19, DOI 10.1111/j.1460-2466.2008.01402.x; Kozlowski AC, 2019, AM SOCIOL REV, V84, P905, DOI 10.1177/0003122419877135; Kumar S, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P933, DOI 10.1145/3178876.3186141; Levy O, 2014, ADV NEUR IN, V27; Levy O, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P302, DOI 10.3115/v1/p14-2050; Martin Trevor, 2017, P 2 WORKSHOP NLP COM, P27, DOI DOI 10.1016/J.BIOACTMAT.2017.02.002; McLuhan M., 1962, GUTENBERG GALAXY MAK; Pariser E., 2011, FILTER BUBBLE WHAT I; SCHLECHTWEG D, 2019, PREPRINT; Shi F, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0079; Simmel G., 1955, CONFLICT WEB GROUP A; Sunstein C. R., 2018, REPUBLIC DIVIDED DEM; van Dijck, 2013, CULTURE CONNECTIVITY; Waller I, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P1954, DOI 10.1145/3308558.3313729	33	5	5	11	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					264	+		10.1038/s41586-021-04167-x	http://dx.doi.org/10.1038/s41586-021-04167-x		DEC 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XL6FG	34853472	Green Submitted			2022-12-28	WOS:000724666000001
J	Bennell, KL; Lawford, BJ; Keating, C; Brown, C; Kasza, J; Mackenzie, D; Metcalf, B; Kimp, AJ; Egerton, T; Spiers, L; Proietto, J; Sumithran, P; Harris, A; Quicke, JG; Hinman, RS				Bennell, Kim L.; Lawford, Belinda J.; Keating, Catherine; Brown, Courtney; Kasza, Jessica; Mackenzie, Dave; Metcalf, Ben; Kimp, Alexander J.; Egerton, Thorlene; Spiers, Libby; Proietto, Joseph; Sumithran, Priya; Harris, Anthony; Quicke, Jonathan G.; Hinman, Rana S.			Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-TRIALS; CONSENSUS DEVELOPMENT; SELF-EFFICACY; HIP; PATIENT; RECOMMENDATIONS; OVERWEIGHT; ADULTS; PAIN; IMPROVEMENT	Background: Scalable knee osteoarthritis programs are needed to deliver recommended education, exercise, and weight loss interventions. Objective: To evaluate two 6-month, telehealth-delivered exercise programs, 1 with and 1 without dietary intervention. Design: 3-group, parallel randomized (5:5:2) trial. (Australian New Zealand Clinical Trials Registry: ACTRN12618000930280). Setting: Australian private health insurance members. Participants: 415 persons with symptomatic knee osteoarthritis and a body mass index between 28 and 40 kg/m2 who were aged 45 to 80 years. Intervention: All groups received access to electronic osteoarthritis information (control). The exercise program comprised 6 physiotherapist consultations via videoconference for exercise, self-management advice, and behavioral counseling, plus exercise equipment and resources. The diet and exercise program included an additional 6 dietitian consultations for a ketogenic very-low-calorie diet (2 formulated meal replacements and a low-carbohydrate meal daily) followed by a transition to healthy eating, as well as nutrition and behavioral resources. Measurements: Primary outcomes were changes in knee pain (numerical rating scale [NRS] of 0 to 10, higher indicating worse) and physical function (Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC]; scale, 0 to 68, higher indicating worse) at 6 months (primary time point) and 12 months. Secondary outcomes were weight, physical activity, quality of life, mental health, global change, satisfaction, willingness to have surgery, orthopedic appointments, and knee surgery. Results: A total of 379 participants (91%) provided 6-month primary outcomes, and 372 (90%) provided 12-month primary outcomes. At 6 months, both programs were superior to control for pain (between-group mean difference in change on NRS: diet and exercise, -1.5 [95% CI, -2.1 to -0.8]; exercise, -0.8 [CI, -1.5 to -0.2]) and function (between-group mean difference in change on WOMAC: diet and exercise, -9.8 [CI, -12.5 to -7.0]; exercise, -7.0 [CI, -9.7 to -4.2]). The diet and exercise program was superior to exercise (pain, -0.6 [CI, -1.1 to -0.2]; function, -2.8 [CI, -4.7 to -0.8]). Findings were similar at 12 months. Limitation: Participants and clinicians were unblinded. Conclusion: Telehealth-delivered exercise and diet programs improved pain and function in people with knee osteoarthritis and overweight or obesity. A dietary intervention conferred modest additional pain and function benefits over exercise. Primary funding source: Medibank, the Medibank Better Health Foundation Research Fund, and a National Health and Medical Research Council Centre of Research Excellence.	[Bennell, Kim L.; Lawford, Belinda J.; Mackenzie, Dave; Metcalf, Ben; Kimp, Alexander J.; Egerton, Thorlene; Spiers, Libby; Hinman, Rana S.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Sch Hlth Sci, Dept Physiotherapy, Melbourne, Vic, Australia; [Keating, Catherine; Brown, Courtney] Medibank, Melbourne, Vic, Australia; [Kasza, Jessica] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Proietto, Joseph; Sumithran, Priya] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Harris, Anthony] Monash Univ, Ctr Hlth Econ, Melbourne, Vic, Australia; [Quicke, Jonathan G.] Keele Univ, Sch Med, Keele, Staffs, England	University of Melbourne; Monash University; University of Melbourne; Monash University; Keele University	Bennell, KL (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Sch Hlth Sci, Ctr Hlth Exercise & Sports Med,Dept Physiotherapy, Melbourne, Vic 3010, Australia.	k.bennell@unimelb.edu	Lawford, Belinda/AFD-5834-2022	Lawford, Belinda/0000-0002-0392-6058; Egerton, Thorlene/0000-0003-4751-7624; Kimp, Alexander/0000-0003-2757-2239; Mackenzie, David/0000-0003-3604-9378; Kasza, Jessica/0000-0002-8940-0136	Medibank; Medibank Better Health Foundation Research Fund; National Health and Medical Research Council Centre of Research Excellence [APP1079078]	Medibank; Medibank Better Health Foundation Research Fund; National Health and Medical Research Council Centre of Research Excellence	By Medibank and the Medibank Better Health Foundation Research Fund, as well as a National Health and Medical Research Council Centre of Research Excellence (APP1079078).	Ackerman IN, 2018, ARTHRIT CARE RES, V70, P877, DOI 10.1002/acr.23414; Allen KD, 2017, BEST PRACT RES CL RH, V31, P746, DOI 10.1016/j.berh.2018.05.003; Allen KD, 2016, BEST PRACT RES CL RH, V30, P503, DOI 10.1016/j.berh.2016.09.003; Australian and New Zealand Obesity Society, AUSTR OB MAN ALG; Bannuru RR, 2019, OSTEOARTHR CARTILAGE, V27, P1578, DOI 10.1016/j.joca.2019.06.011; Bastick AN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0670-x; Bellamy N, 1997, J RHEUMATOL, V24, P799; BELLAMY N, 1992, J RHEUMATOL, V19, P451; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennell KL, 2021, LANCET REG HEALTH-W, V12, DOI 10.1016/j.lanwpc.2021.100187; Bennell KL, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3166-z; Bennell KL, 2017, ANN INTERN MED, V166, P453, DOI 10.7326/M16-1714; Chen AT, 2020, OSTEOARTHR CARTILAGE, V28, P1154, DOI 10.1016/j.joca.2020.05.007; CLARK MM, 1991, J CONSULT CLIN PSYCH, V59, P739, DOI 10.1037/0022-006X.59.5.739; Delbaere K, 2010, BRIT J SPORT MED, V44, P1029, DOI 10.1136/bjsm.2009.060350; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Hall M, 2018, OSTEOARTHR CARTILAGE, V26, P495, DOI 10.1016/j.joca.2018.01.018; Hall M, 2019, SEMIN ARTHRITIS RHEU, V48, P765, DOI 10.1016/j.semarthrit.2018.06.005; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Higgins DM, 2020, PAIN MED, V21, P2563, DOI 10.1093/pm/pnaa043; Hinman RS, 2017, ARTHRIT CARE RES, V69, P1834, DOI 10.1002/acr.23218; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Johnston SS, 2020, OBES SCI PRACT, V6, P139, DOI 10.1002/osp4.398; Kelly JT, 2016, AM J CLIN NUTR, V104, P1693, DOI 10.3945/ajcn.116.136333; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; Lovibond SH, 1991, MANUAL DEPRESSION AN, V2nd; McAlindon TE, 2015, OSTEOARTHR CARTILAGE, V23, P747, DOI 10.1016/j.joca.2015.03.005; McHugh M, 2020, ARTHRIT CARE RES, V72, P219, DOI 10.1002/acr.24235; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Mihalko SL, 2019, TRANSL BEHAV MED, V9, P227, DOI 10.1093/tbm/iby037; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; National Health and Medical Research Council, 2001, CLIN PRACT GUID MAN; National Institute for Health and Care Excellence, 2014, OST CAR MAN AD; Norton K., 2011, PREEXERCISE SCREENIN; O'Brien KM, 2018, OSTEOARTHR CARTILAGE, V26, P485, DOI 10.1016/j.joca.2018.01.003; O'Brien KM, 2018, PEERJ, V6, DOI 10.7717/peerj.5846; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; Runhaar J, 2019, OSTEOARTHR CARTILAGE, V27, P1118, DOI 10.1016/j.joca.2019.04.009; Sakellariou G, 2017, ANN RHEUM DIS, V76, P1484, DOI 10.1136/annrheumdis-2016-210815; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Sumithran P, 2013, EUR J CLIN NUTR, V67, P759, DOI 10.1038/ejcn.2013.90; ten Klooster PM, 2006, PAIN, V121, P151, DOI 10.1016/j.pain.2005.12.021; The Royal Australian College of General Practitioners, 2018, GUIDELINE MANAGEMENT; Torio CM., 2016, HEALTHCARE COST UTIL; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; United States Bone and Joint Initiative, 2020, BURDEN MUSCULOSKELET, V4th; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wang YY, 2013, RHEUMATOLOGY, V52, P1033, DOI 10.1093/rheumatology/kes419; Webb EJ, 2021, PUBLIC HEALTH NUTR, V24, P338, DOI 10.1017/S1368980020002529; Williamson DA, 2015, OBESITY, V23, P2319, DOI 10.1002/oby.21358	53	6	6	6	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					198	+		10.7326/M21-2388	http://dx.doi.org/10.7326/M21-2388		NOV 2021	20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE4HR	34843383				2022-12-28	WOS:000729195900001
J	Romo, ML; Patel, RC; Edwards, JK; Humphrey, JM; Musick, BS; Bernard, C; Maina, MW; Brazier, E; Castelnuovo, B; Penner, J; Wyka, K; Cardoso, SW; Ly, PS; Kunzekwenyika, C; Cort, CP; Panczak, R; Kelvin, EA; Wools-Kaloustian, KK; Nash, D				Romo, Matthew L.; Patel, Rena C.; Edwards, Jessie K.; Humphrey, John M.; Musick, Beverly S.; Bernard, Caitlin; Maina, Mercy W.; Brazier, Ellen; Castelnuovo, Barbara; Penner, Jeremy; Wyka, Katarzyna; Cardoso, Sandra Wagner; Ly, Penh Sun; Kunzekwenyika, Cordelia; Cort, Claudia P.; Panczak, Radoslaw; Kelvin, Elizabeth A.; Wools-Kaloustian, Kara K.; Nash, Denis			Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity	ANNALS OF INTERNAL MEDICINE			English	Article; Early Access						Design; Observational cohort study	TENOFOVIR DISOPROXIL FUMARATE; OPEN-LABEL; ANTIRETROVIRAL THERAPY; EFAVIRENZ; PREGNANCY; PHASE-3; EMTRICITABINE; MULTICENTER; ALAFENAMIDE; EXPOSURE	Background: The transition to dolutegravir-containing antiretroviral therapy (ART) in low- and middle-income countries (LMICs) was complicated by an initial safety signal in May 2018 suggesting that exposure to dolutegravir at conception was possibly associated with infant neural tube defects. On the basis of additional evidence, in July 2019, the World Health Organization recommended dolutegravir for all adults and adolescents living with HIV. Objective: To describe dolutegravir uptake and disparities by sex and age group in LMICs. Design: Observational cohort study. Setting: 87 sites that began using dolutegravir in 11 LMICs in the Asia-Pacific; Caribbean, Central and South America network for HIV epidemiology (CCASAnet); and sub-Saharan African regions of the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. Patients: 134 672 patients aged 16 years or older who received HIV care from January 2017 through March 2020. Measurements: Sex, age group, and dolutegravir uptake (that is, newly initiating ART with dolutegravir or switching to dolutegravir from another regimen). Results: Differences in dolutegravir uptake among females of reproductive age (16 to 49 years) emerged after the safety signal. By the end of follow-up, the cumulative incidence of dolutegravir uptake among females 16 to 49 years old was 29.4% (95% CI, 29.0% to 29.7%) compared with 57.7% (CI, 57.2% to 58.3%) among males 16 to 49 years old. This disparity was greater in countries that began implementing dolutegravir before the safety signal and initially had highly restrictive policies versus countries with a later rollout. Dolutegravir uptake was similar among females and males aged 50 years or older. Limitation: Follow-up was limited to 6 to 8 months after international guidelines recommended expanding access to dolutegravir. Conclusion: Substantial disparities in dolutegravir uptake affecting females of reproductive age through early 2020 are documented. Although this disparity was anticipated because of country-level restrictions on access, the results highlight its extent and initial persistence.	[Romo, Matthew L.; Brazier, Ellen; Wyka, Katarzyna; Kelvin, Elizabeth A.; Nash, Denis] CUNY, Dept Epidemiol & Biostat, CUNY Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Romo, Matthew L.; Brazier, Ellen; Kelvin, Elizabeth A.; Nash, Denis] CUNY Inst Implementat Sci Populat Hlth, New York, NY USA; [Patel, Rena C.] Univ Washington, Dept Med, Seattle, WA USA; [Patel, Rena C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Edwards, Jessie K.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Humphrey, John M.; Wools-Kaloustian, Kara K.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Musick, Beverly S.] Indiana Univ Sch Med, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46202 USA; [Bernard, Caitlin] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Maina, Mercy W.] Moi Teaching & Referral Hosp, Dept Pharm, Eldoret, Kenya; [Castelnuovo, Barbara] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Penner, Jeremy] Family AIDS Care & Educ Serv, Kisumu, Kenya; [Penner, Jeremy] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Cardoso, Sandra Wagner] Fundacao Oswaldo Cruz, Inst Nacl Infectol, Lab Pesquisa Clin HIV AIDS, Rio De Janeiro, Brazil; [Ly, Penh Sun] Minist Hlth, Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Kunzekwenyika, Cordelia] SolidarMed, Masvingo, Zimbabwe; [Cort, Claudia P.] Univ Chile, Dept Med, Santiago, Chile; [Cort, Claudia P.] Fdn Arriaran, Santiago, Chile; [Panczak, Radoslaw] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	City University of New York (CUNY) System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Makerere University; University of British Columbia; Fundacao Oswaldo Cruz; Universidad de Chile; University of Bern	Romo, ML; Nash, D (corresponding author), 55 West 125th St,6th Floor, New York, NY 10027 USA.	matthew.romo@sph.cuny.edu; denis.nash@sph.cuny.edu	Nash, Denis/AFI-7485-2022; Cortes, Claudia P/AAF-7326-2020; Mayige, Mary/GLU-6412-2022; Prozesky, Hans Walter/ABE-6956-2020	Cortes, Claudia P/0000-0001-9101-9783; Mayige, Mary/0000-0003-4861-7870; Prozesky, Hans Walter/0000-0001-9715-3449; Penner, Jeremy/0000-0001-6443-1748; Edwards, Jessie/0000-0002-1741-335X; Nyakato, Patience/0000-0002-8418-8500; Cornell, Morna/0000-0001-7149-8799; Patten, Gabriela/0000-0003-2511-1367; Bernard, Caitlin/0000-0002-6753-1098; Murenzi, Gad/0000-0002-5513-5522; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304; Johnson, Leigh/0000-0002-2717-011X; Romo, Matthew/0000-0002-3038-0644; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health.	AALEN OO, 1978, SCAND J STAT, V5, P141; Alhassan Y, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09991-w; Barr BAT, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02066-6; Bernard C, 2020, 23 INT AID C AIDS 20; Calmy A, 2020, LANCET HIV, V7, pE677, DOI 10.1016/S2352-3018(20)30238-1; Caniglia EC, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100615; Chouchana L, 2020, LANCET INFECT DIS, V20, P405, DOI 10.1016/S1473-3099(20)30117-1; De Santis M, 2002, ARCH INTERN MED, V162, P355, DOI 10.1001/archinte.162.3.355; Departamento de Vigilancia Prevencao e Controle das IST do HIV/AIDS e das Hepatites Virais (Brazil), 2018, 10 DIAHVSVSMS DEP VI; Dorward J, 2021, LANCET HIV, V8, pe158, DOI 10.1016/S2352-3018(20)30359-3; Duda SN, IEDEA DATA EXCHANGE, DOI [10.1101/2020.07.22.20159921, DOI 10.1101/2020.07.22.20159921]; Dugdale CM, 2019, ANN INTERN MED, V170, P614, DOI 10.7326/M18-3358; Ford N, 2014, AIDS, V28, pS123, DOI 10.1097/QAD.0000000000000231; Fundaro C, 2002, AIDS, V16, P299, DOI 10.1097/00002030-200201250-00025; Gupta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164619; Hauser A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003397; Hegdahl HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148502; Humphrey J, 2020, 23 INT AIDS C AIDS 2; Kant A, 2019, DRUG SAFETY, V42, P35, DOI 10.1007/s40264-018-0729-0; Kanters S, 2020, ECLINICALMEDICINE, V28, DOI 10.1016/j.eclinm.2020.100573; Kintu K, 2020, LANCET HIV, V7, pE332, DOI 10.1016/S2352-3018(20)30050-3; Lockman S, 2021, LANCET, V397, P1276, DOI 10.1016/S0140-6736(21)00314-7; Pereira GFM, 2021, LANCET HIV, V8, pe33, DOI 10.1016/S2352-3018(20)30268-X; Minist~erio da Saude (Mozambique), 2019, 042103SP019 MIN SAU; Ministry of Health Community Development Gender Elderly and Children (Tanzania) National AIDS Control Programme., 2019, NAT GUID MAN HIV AID, V7th; Ministry of Health (Kenya), 2018, MOHNASCOPDPPHCT002; Ministry of Health (Kenya), 2019, MOHADM112; Ministry of Health (Lesotho), 2019, ADD NAT GUID US ANT; Ministry of Health (Rwanda), TRANSM CIRC CHANG HI; Ministry of Health (Uganda), CONSOLIDATED GUIDELI; Mofenson LM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25352; Money D, 2019, BJOG-INT J OBSTET GY, V126, P1338, DOI 10.1111/1471-0528.15838; National Center for HIV/AIDS Dermatology and STD., OP GUID US DOL DTG A; National Medicines and Therapeutics Policy Advisory Committee (NMTPAC) AIDS and TB Directorate of the Ministry of Health and Child Care (Zimbabwe)., 2019, ADD 2016 GUID ANT TH; Phillips AN, 2020, LANCET HIV, V7, pE193, DOI 10.1016/S2352-3018(19)30400-X; Phillips AN, 2019, LANCET HIV, V6, pE116, DOI 10.1016/S2352-3018(18)30317-5; Raesima MM, 2019, NEW ENGL J MED, V381, P885, DOI 10.1056/NEJMc1908155; Siedner MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19801-x; U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2019, HAIT COUNTR OP PLAN; U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2019, DEM REP CONG COUNTR; UNAIDS UNICEF, PROGR REP ALL END AD; Venter WDF, 2020, LANCET HIV, V7, pE666, DOI 10.1016/S2352-3018(20)30241-1; Vitoria M, 2018, AIDS, V32, P1551, DOI 10.1097/QAD.0000000000001845; WHO, CONSOLIDATED GUIDELI; World Health Organization, UPD REC FIRSTL 2 LIN; World Health Organization, POL BRIEF UPD REC 1; World Health Organization, HIV DRUG RES REP 201; World Health Organization, POT SAF ISS AFF WOM; World Health Organization, 2006, ANT THER HIV INF AD; Zash R, 2020, J INT AIDS SOC, V23, P183; Zash R, 2019, NEW ENGL J MED, V381, P827, DOI 10.1056/NEJMoa1905230; Zash R, 2018, NEW ENGL J MED, V379, P979, DOI 10.1056/NEJMc1807653	52	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.												10.7326/M21-3037	http://dx.doi.org/10.7326/M21-3037		NOV 2021	18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN0HH	34843382	Green Accepted			2022-12-28	WOS:000729195600001
J	Lane, R				Lane, Richard			Pascale Ondoa: strengthening laboratory medicine in Africa	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					1955	1955						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD7PT	34838166				2022-12-28	WOS:000722897200012
J	Hoste, E				Hoste, Esther			Stem cells remember insults Wounding mobilizes stem cells that accumulate epigenetic memories and regenerate skin	SCIENCE			English	Editorial Material									[Hoste, Esther] VIB Ctr Inflammat Res, Ghent, Belgium; [Hoste, Esther] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hoste, E (corresponding author), VIB Ctr Inflammat Res, Ghent, Belgium.; Hoste, E (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	esther.hoste@irc.vib-ugent.be			FWO (Fonds Wetenschappelijk Onderzoek) postdoctoral fellowship	FWO (Fonds Wetenschappelijk Onderzoek) postdoctoral fellowship	E.H. is supported by an FWO (Fonds Wetenschappelijk Onderzoek) postdoctoral fellowship.	Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Del Poggetto E., SCIENCE, V373; Divangahi M., NAT IMMUNOL, V22; Gonzales K.A., SCIENCE, V374; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Thornton CA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21515-7	8	0	0	6	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1052	1053		10.1126/science.abm6806	http://dx.doi.org/10.1126/science.abm6806			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822297				2022-12-28	WOS:000725668600020
J	Meng, L				Meng, Lin			Green with phenology	SCIENCE			English	Editorial Material							TEMPERATURE		[Meng, Lin] Lawrence Berkeley Natl Lab, Climate & Ecosyst Sci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Meng, L (corresponding author), Lawrence Berkeley Natl Lab, Climate & Ecosyst Sci Div, Berkeley, CA 94720 USA.	linmeng@lbl.gov	meng, li/GVT-2063-2022					Basler D, 2014, TREE PHYSIOL, V34, P377, DOI 10.1093/treephys/tpu021; Bornstein R.D., 1968, J APPL METEOROL CLIM, V7, P575, DOI [10.1175/1520-0450(1968)007***0575:ootuhi***2.0.co;2, DOI 10.1175/1520-0450(1968)007<0575:OOTUHI>2.0.CO;2]; Flynn DFB, 2018, NEW PHYTOL, V219, P1353, DOI 10.1111/nph.15232; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Kyba CCM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701528; Li X, 2019, REMOTE SENS ENVIRON, V222, P267, DOI 10.1016/j.rse.2018.12.036; Li XC, 2017, GLOBAL CHANGE BIOL, V23, P2818, DOI 10.1111/gcb.13562; Meng L, 2021, GLOBAL CHANGE BIOL, V27, P2914, DOI 10.1111/gcb.15575; Meng L, 2020, P NATL ACAD SCI USA, V117, P4228, DOI 10.1073/pnas.1911117117; Meng L, 2020, AGR FOREST METEOROL, V281, DOI 10.1016/j.agrformet.2019.107832; Piao SL, 2019, GLOBAL CHANGE BIOL, V25, P1922, DOI 10.1111/gcb.14619; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Roman MO, 2018, REMOTE SENS ENVIRON, V210, P113, DOI 10.1016/j.rse.2018.03.017; Templ B, 2018, INT J BIOMETEOROL, V62, P1109, DOI 10.1007/s00484-018-1512-8; USA National Phenology Network, 2017, PLANT AN PHEN DAT	15	3	3	7	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1065	1066		10.1126/science.abm8136	http://dx.doi.org/10.1126/science.abm8136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822274				2022-12-28	WOS:000725668600031
J	Paterlini, M				Paterlini, Marta			Paraplegic man is first person to be allowed to die by assisted suicide in Italy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2927	10.1136/bmj.n2927	http://dx.doi.org/10.1136/bmj.n2927			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836929				2022-12-28	WOS:000727787900010
J	Lewis, DM; Doble, E				Lewis, Dana M.; Doble, Emma			We need more patient and public reviews on research papers-and the resources to do so	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Dana@OpenAPS.org	Lewis, Dana/ABG-5187-2021	Lewis, Dana/0000-0001-9176-6308				[Anonymous], BMJ HEALTH CARE INFO; Boivin A, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k5147; Commission on Race and Ethnic Disparities, 2021, BMJ-BRIT MED J; Lewis D, 2021, BMJ HEALTH CARE INFO, V28, DOI 10.1136/bmjhci-2021-100471; Salmi L, 2021, BMJ HEALTH CARE INFO, V28, DOI 10.1136/bmjhci-2021-100392; Schroter S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023357	6	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2891	10.1136/bmj.n2891	http://dx.doi.org/10.1136/bmj.n2891			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819302	Bronze			2022-12-28	WOS:000740893700008
J	Altmann, D; Boyton, R				Altmann, Daniel; Boyton, Rosemary			Covid-19 caseload in the UK-assessments and mitigations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Altmann, Daniel] Imperial Coll, Fac Med, Dept Immunol & Inflammat, London, England; [Boyton, Rosemary] Imperial Coll, Fac Med, Dept Infect Dis, London, England; [Boyton, Rosemary] Guys & St Thomas NHS Fdn Trust, Lung Div, Royal Brompton & Harefield Hosp, London, England	Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital	Altmann, D (corresponding author), Imperial Coll, Fac Med, Dept Immunol & Inflammat, London, England.							Altmann DM, 2021, SCIENCE, V371, P1103, DOI 10.1126/science.abg7404; Dolgin E., NATURE; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Pagel C, 2021, GUARDIAN 1007; Smyth C., ONLY 19 YOUNG TEENAG	5	3	3	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2021	375								n2843	10.1136/bmj.n2843	http://dx.doi.org/10.1136/bmj.n2843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9RR	34794957	Bronze			2022-12-28	WOS:000727793600012
J	Bowman, SJ; Fox, R; Dorner, T; Mariette, X; Papas, A; Grader-Beck, T; Fisher, BA; Barcelos, F; De Vita, S; Schulze-Koops, H; Moots, RJ; Junge, G; Woznicki, JN; Sopala, MA; Luo, WL; Hueber, W				Bowman, Simon J.; Fox, Robert; Doerner, Thomas; Mariette, Xavier; Papas, Athena; Grader-Beck, Thomas; Fisher, Benjamin A.; Barcelos, Filipe; De Vita, Salvatore; Schulze-Koops, Hendrik; Moots, Robert J.; Junge, Guido; Woznicki, Janice N.; Sopala, Monika A.; Luo, Wen-Lin; Hueber, Wolfgang			Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial	LANCET			English	Article							RITUXIMAB; METAANALYSIS	Background Sjogren's syndrome is an autoimmune disease characterised by dry eyes and mouth, systemic features, and reduced quality of life. There are no disease-modifying treatments. A new biologic, ianalumab (VAY736), with two modes of suppressing B cells, has previously shown preliminary efficacy. This dose-finding trial aimed to assess the safety and efficacy of different subcutaneous doses of ianalumab in patients with moderate to severe primary Sjogren's syndrome. Methods VAY736A2201 was a randomised, parallel, double-blind, placebo-controlled, phase 2b dose-finding study done in 56 centres in 19 countries. Patients aged 18-75 years with primary Sjogren's syndrome with moderate to severe disease activity (European Alliance of Associations for Rheumatology [EULAR] Sjogren's Syndrome Disease Activity Index [ESSDAI] score >= 6) and symptom severity (EULAR Sjogren's Syndrome Patient Reported Index score >= 5) were eligible. Participants were randomly assigned (1:1:1:1) to receive subcutaneous placebo or ianalumab (5 mg, 50 mg, or 300 mg) every 4 weeks for 24 weeks using a secure, online randomisation system. Randomisation was stratified by the ESSDAI score at baseline (>= 10 or <10). Study personnel and patients were masked to treatment assignment. The primary outcome was the change in ESSDAI score from baseline to 24 weeks in all randomly assigned patients. Dose-related change in disease activity (ESSDAI) from baseline at week 24 was assessed by multiple comparison procedure with modelling analysis. Safety was measured in all patients who received at least one dose of study drug. This trial is registered with ClinicalTtials.gov, NCT02962895. Findings Between June 27,2017, and Dec 06, 2018, 293 patients were screened, 190 of whom were randomly assigned (placebo n=49, ianalumab 5 mg n=47, ianalumab 50 mg n=47, ianalumab 300 mg n=47). Statistically significant dose-responses were seen for overall disease activity (ESSDAI score) in four of the five dose-response models tested (p<0.025 in four models, i:0.060 in one model). The ESSDAI score decreased from baseline in all ianalumab groups, with the maximal ESSDAI score change from baseline observed in the ianalumab 300 mg group: placebo-adjusted least-squares mean change from baseline -1.92 points (95% CI -4.15 to 0.32; p=0.092). There were four serious adverse events in three patients considered treatment-related (pneumonia [n=1] and gastroenteritis [n=1] in the placebo group; appendicitis plus tubo-ovarian abscess in the same patient in the ianalumab 50 mg group). Interpretation The study met its primary objective, showing a dose-related decrease in disease activity as measured by ESSDAI at week 24. Overall, ianalumab was well tolerated and safe, with no increase in infections. To our knowledge, this is the first large, randomised, controlled trial in primary Sjogren's syndrome that met its primary endpoint, and its results mean there is potential for more studies of this mechanism in the future. Copyright (C) 2021 Published by Elsevier Ltd. All rights reserved.	[Bowman, Simon J.; Fisher, Benjamin A.] Univ Hosp Birmingham NHS Fdn Trust, Dept Rheumatol, Birmingham B15 2TH, W Midlands, England; [Bowman, Simon J.; Fisher, Benjamin A.] Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Bowman, Simon J.; Fisher, Benjamin A.] Univ Birmingham, Natl Inst Hlth Res Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Bowman, Simon J.] Milton Keynes Univ Hosp, Dept Rheumatol, Milton Keynes, Bucks, England; [Fox, Robert] Scripps Mem Hosp & Res Inst, Rheumatol Clin, La Jolla, CA USA; [Doerner, Thomas] Charite, Dept Med Rheumatol & Clin Immunol, Berlin, Germany; [Doerner, Thomas] Deutsch Rheumaforsch Zentrum, Berlin, Germany; [Mariette, Xavier] Univ Paris Saclay, Hop Bicetre, AP HP, INSERM U1184, Le Kremlin Bicetre, France; [Papas, Athena] Tufts Sch Dent Med, Div Oral Med, Boston, MA USA; [Grader-Beck, Thomas] Johns Hopkins Sch Med, Div Rheumatol, Baltimore, MD USA; [Barcelos, Filipe] Nova Med Sch, Chron Dis Res Ctr, Lisbon, Portugal; [Barcelos, Filipe] Inst Portugues Reumatol, Lisbon, Portugal; [Barcelos, Filipe] Hosp Cuf Descobertas, Dept Rheumatol, Lisbon, Portugal; [De Vita, Salvatore] Univ Udine, Univ Hosp Santa Maria della Misericordia, Dept Med Area, Udine, Italy; [Schulze-Koops, Hendrik] Ludwig Maximilians Univ Munchen, Div Rheumatol & Clin Immunol, Dept Internal Med 4, Munich, Germany; [Moots, Robert J.] Liverpool Univ Hosp NHS Fdn Trust, Dept Rheumatol, Liverpool, Merseyside, England; [Moots, Robert J.] Edge Hill Univ, Liverpool, Merseyside, England; [Junge, Guido; Sopala, Monika A.; Hueber, Wolfgang] Novartis Pharmaceut, Basel, Switzerland; [Woznicki, Janice N.; Luo, Wen-Lin] Novartis Pharmaceut, E Hanover, NJ USA	University of Birmingham; University of Birmingham; University of Birmingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins Medicine; Hospital Santa Maria della Misericordia; University of Udine; University of Munich; Edge Hill University; Novartis; Novartis	Bowman, SJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Rheumatol, Birmingham B15 2TH, W Midlands, England.	simon.bowman@uhb.nhs.uk			Novartis	Novartis(Novartis)	We thank all patients, investigators, and study personnel for their willingness to participate in the study. The study was funded by Novartis. Medical writing support was funded by Novartis. June Mason drafted the manuscript, Gurleen Kaur developed figures, provided editorial support, and managed the submission. Preliminary results of this trial were presented in 2019 at the American College of Rheumatology, and in 2020 at the EULAR 2020 Congress and the Spanish Society of Rheumatology.	Ambrus JL, 2016, J CLIN MED, V5, DOI 10.3390/jcm5100087; Bechman K, 2020, J RHEUMATOL, V47, P28, DOI 10.3899/jrheum.190008; Bowman SJ, 2017, ARTHRITIS RHEUMATOL, V69, P1440, DOI 10.1002/art.40093; Bretz F, 2005, BIOMETRICS, V61, P738, DOI 10.1111/j.1541-0420.2005.00344.x; Demirkaya E, 2016, ARTHRITIS RHEUMATOL, V68, P1540, DOI 10.1002/art.39583; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; Dorner T, 2019, ANN RHEUM DIS, V78, P641, DOI 10.1136/annrheumdis-2018-214720; Felten R, 2021, ANN RHEUM DIS, V80, P329, DOI [10.1136/annrheumdis-2020-218467, 10.1136/annrheumdis-2021-219882]; Gandolfo Saviana, 2019, Clin Exp Rheumatol, V37 Suppl 118, P199; Grigoriadou Sofia, 2019, Clin Exp Rheumatol, V37 Suppl 118, P217; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Mariette X, 2018, NEW ENGL J MED, V378, P931, DOI 10.1056/NEJMcp1702514; Nocturne G, 2018, NAT REV RHEUMATOL, V14, P133, DOI 10.1038/nrrheum.2018.1; Pinheiro J, 2014, STAT MED, V33, P1646, DOI 10.1002/sim.6052; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Seror R, 2016, ANN RHEUM DIS, V75, P382, DOI 10.1136/annrheumdis-2014-206008; Tselios K, 2021, RHEUMATOLOGY, V60, P73, DOI 10.1093/rheumatology/keaa655; van Nimwegen JF, 2020, LANCET RHEUMATOL, V2, pE153, DOI 10.1016/S2665-9913(19)30160-2; Verstappen GM, 2017, CLIN IMMUNOL, V182, P62, DOI 10.1016/j.clim.2017.05.002; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vivino FB, 2016, RHEUM DIS CLIN N AM, V42, P531, DOI 10.1016/j.rdc.2016.03.010; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zou K, 2016, ANN RHEUM DIS, V75, P1964, DOI 10.1136/annrheumdis-2015-208387	24	19	19	13	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					161	171		10.1016/S0140-6736(21)02251-0	http://dx.doi.org/10.1016/S0140-6736(21)02251-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7YG	34861168				2022-12-28	WOS:000740652500022
J	Schousboe, JT; Sprague, BL; Abraham, L; O'Meara, ES; Onega, T; Advani, S; Henderson, LM; Wernli, KJ; Zhang, DY; Miglioretti, DL; Braithwaite, D; Kerlikowske, K				Schousboe, John T.; Sprague, Brian L.; Abraham, Linn; O'Meara, Ellen S.; Onega, Tracy; Advani, Shailesh; Henderson, Louise M.; Wernli, Karen J.; Zhang, Dongyu; Miglioretti, Diana L.; Braithwaite, Dejana; Kerlikowske, Karla			Cost-Effectiveness of Screening Mammography Beyond Age 75 Years A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; BREAST-CANCER; COMORBID CONDITIONS; WOMEN; SURVEILLANCE; BENEFITS; MODEL; OVERDIAGNOSIS; OUTCOMES; PROGRAM	Background: The cost-effectiveness of screening mammography beyond age 75 years remains unclear. Objective: To estimate benefits, harms, and cost-effectiveness of extending mammography to age 80, 85, or 90 years according to comorbidity burden. Design: Markov microsimulation model. Data Sources: SEER (Surveillance, Epidemiology, and End Results) program and Breast Cancer Surveillance Consortium. Target Population: U.S. women aged 65 to 90 years in groups defined by Charlson comorbidity score (CCS). Time Horizon: Lifetime. Perspective: National health payer. Outcome Measures: Breast cancer death, survival, and costs. Results of Base-Case Analysis: Extending biennial mammography from age 75 to 80 years averted 1.7, 1.4, and 1.0 breast cancer deaths and increased days of life gained by 5.8, 4.2, and 2.7 days per 1000 women for comorbidity scores of 0, 1, and 2, respectively. Annual mammography beyond age 75 years was not cost-effective, but extending biennial mammography to age 80 years was ($54 000, $65000, and $85000 per quality-adjusted life-year [QALY] gained for women with CCSs of 0, 1, and >= 2, respectively). Overdiagnosis cases were double the number of deaths averted from breast cancer. Results of Sensitivity Analysis: Costs per QALY gained were sensitive to changes in invasive cancer incidence and shift of breast cancer stage with screening mammography. Limitation: No randomized controlled trials of screening mammography beyond age 75 years are available to provide model parameter inputs. Conclusion: Although annual mammography is not cost-effective, biennial screening mammography to age 80 years is; however, the absolute number of deaths averted is small, especially for women with comorbidities. Women considering screening beyond age 75 years should weigh the potential harms of overdiagnosis versus the potential benefit of averting death from breast cancer.	[Sprague, Brian L.] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Sprague, Brian L.] Univ Vermont, Dept Radiol, Burlington, VT USA; [Abraham, Linn; O'Meara, Ellen S.; Wernli, Karen J.; Miglioretti, Diana L.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Onega, Tracy] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Onega, Tracy] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Advani, Shailesh] Georgetown Univ, Sch Med, Dept Oncol, Washington, DC USA; [Advani, Shailesh] Terasaki Inst Biomed Innovat, Los Angeles, CA USA; [Henderson, Louise M.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Zhang, Dongyu] Univ Florida, Canc Control & Populat Sci Program, Gainesville, FL USA; [Zhang, Dongyu] Univ Florida, Dept Epidemiol, Gainesville, FL USA; [Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Braithwaite, Dejana] Univ Florida, Dept Epidemiol, Canc Control & Populat Sci Program, Gainesville, FL USA; [Braithwaite, Dejana] Univ Florida, Inst Aging, Gainesville, FL USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Vet Affairs, VA Div Gen Internal Med, San Francisco, CA 94143 USA	University of Vermont; University of Vermont; Kaiser Permanente; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schousboe, JT (corresponding author), 3800 Pk Nicollet Blvd, St Louis Pk, MN 55416 USA.	john.schousboe@parknicollet.com	Zhang, Dongyu/M-7310-2019	Onega, Tracy/0000-0002-1633-3040; Schousboe, John/0000-0002-9329-0750; Miglioretti, Diana/0000-0002-5547-1833; Zhang, Dongyu/0000-0002-7845-4630	National Cancer Institute [R01 CA207361, P01 CA154292, U54CA163303, R01CA149365]; Patient-Centered Outcomes Research Institute [PCS-1504-30370]; Agency for Healthcare Research and Quality [R01 HS018366-01A1]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By National Cancer Institute grant R01 CA207361. Data collection was additionally supported by the BCSC with funding from the National Cancer Institute (grants P01 CA154292, U54CA163303, and R01CA149365), the Patient-Centered Outcomes Research Institute (grant PCS-1504-30370), and the Agency for Healthcare Research and Quality (grant R01 HS018366-01A1). Cancer data collection from BCSC was supported in part by several state public health departments and cancer registries (www.bcsc-research.org/about/work-acknowledgement).	Arias Elizabeth, 2011, Natl Vital Stat Rep, V59, P1; Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Centers for Medicare & Medicaid Services, OV MED PHYS FEE SCHE; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Demb J, 2020, JNCI-J NATL CANCER I, V112, P599, DOI 10.1093/jnci/djz172; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Expert Panel on Breast Imaging:, 2017, J Am Coll Radiol, V14, pS383, DOI 10.1016/j.jacr.2017.08.044; Garcia-Albeniz X, 2020, ANN INTERN MED, V172, P381, DOI 10.7326/M18-1199; Hendrick RE, 2018, RADIOLOGY, V287, P391, DOI 10.1148/radiol.2017171622; Janssen EM, 2019, MED DECIS MAKING, V39, P621, DOI 10.1177/0272989X19853516; Jewett PI, 2018, ANN EPIDEMIOL, V28, P65, DOI 10.1016/j.annepidem.2017.11.012; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lee CS, 2018, AM J ROENTGENOL, V210, P256, DOI 10.2214/AJR.17.18705; Lee KT, 2018, CLIN GERIATR MED, V34, P11, DOI 10.1016/j.cger.2017.09.002; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Lehman CD, 2017, RADIOLOGY, V283, P49, DOI 10.1148/radiol.2016161174; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Lowry KP, 2020, JNCI-J NATL CANCER I, V112, P582, DOI 10.1093/jnci/djz184; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Narayan A, 2017, BREAST CANCER RES TR, V164, P719, DOI 10.1007/s10549-017-4286-5; National Cancer Institute, BREAST CANC RISK ASS; National Cancer Institute Surveillance Epidemiology and End Results Program, SEER STAT SOFTW VERS; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Qaseem A, 2019, ANN INTERN MED, V170, P547, DOI 10.7326/M18-2147; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9	38	4	4	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					11	+		10.7326/M20-8076	http://dx.doi.org/10.7326/M20-8076			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34807717	Green Accepted			2022-12-28	WOS:000790293700023
J	Karlsen, TH; Sheron, N; Zelber-Sagi, S; Carrieri, P; Dusheiko, G; Bugianesi, E; Pryke, R; Hutchinson, SJ; Sangro, B; Martin, NK; Cecchini, M; Dirac, MA; Belloni, A; Serra-Burriel, M; Ponsioen, CY; Sheena, B; Lerouge, A; Devaux, M; Scott, N; Hellard, M; Verkade, HJ; Sturm, E; Marchesini, G; Yki-Jarvinen, H; Byrne, CD; Targher, G; Tur-Sinai, A; Barrett, D; Ninburg, M; Reic, T; Taylor, A; Rhodes, T; Treloar, C; Petersen, C; Schramm, C; Flisiak, R; Simonova, MY; Pares, A; Johnson, P; Cucchetti, A; Graupera, I; Lionis, C; Pose, E; Fabrellas, N; Ma, AT; Mendive, JM; Mazzaferro, V; Rutter, H; Cortez-Pinto, H; Kelly, D; Burton, R; Lazarus, JV; Gines, P; Buti, M; Newsome, PN; Burra, P; Manns, MP				Karlsen, Tom H.; Sheron, Nick; Zelber-Sagi, Shira; Carrieri, Patrizia; Dusheiko, Geoffrey; Bugianesi, Elisabetta; Pryke, Rachel; Hutchinson, Sharon J.; Sangro, Bruno; Martin, Natasha K.; Cecchini, Michele; Dirac, Mae Ashworth; Belloni, Annalisa; Serra-Burriel, Miquel; Ponsioen, Cyriel Y.; Sheena, Brittney; Lerouge, Alienor; Devaux, Marion; Scott, Nick; Hellard, Margaret; Verkade, Henkjan J.; Sturm, Ekkehard; Marchesini, Giulio; Yki-Jarvinen, Hannele; Byrne, Chris D.; Targher, Giovanni; Tur-Sinai, Aviad; Barrett, Damon; Ninburg, Michael; Reic, Tatjana; Taylor, Alison; Rhodes, Tim; Treloar, Carla; Petersen, Claus; Schramm, Christoph; Flisiak, Robert; Simonova, Marieta Y.; Pares, Albert; Johnson, Philip; Cucchetti, Alessandro; Graupera, Isabel; Lionis, Christos; Pose, Elisa; Fabrellas, Nuria; Ma, Ann T.; Mendive, Juan M.; Mazzaferro, Vincenzo; Rutter, Harry; Cortez-Pinto, Helena; Kelly, Deirdre; Burton, Robyn; Lazarus, Jeffrey, V; Gines, Pere; Buti, Maria; Newsome, Philip N.; Burra, Patrizia; Manns, Michael P.			The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality	LANCET			English	Review							HEPATITIS-C VIRUS; PERCEIVED WEIGHT DISCRIMINATION; CLINICAL-PRACTICE GUIDELINES; ULTRA-PROCESSED FOOD; HEPATOCELLULAR-CARCINOMA; HEALTH-CARE; BILIARY ATRESIA; ALCOHOL-CONSUMPTION; FOLLOW-UP; CARDIOVASCULAR-DISEASE		[Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Dept Transplantat Med, Oslo, Norway; [Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Res Inst Internal Med, Div Surg Inflammatory Dis & Transplantat, Oslo, Norway; [Karlsen, Tom H.] Univ Oslo, N-0424 Oslo, Norway; [Sheron, Nick] Kings Coll London, Fdn Liver Res, Inst Hepatol, London, England; [Zelber-Sagi, Shira] Univ Haifa, Fac Social Welf & Hlth Sci, Sch Publ Hlth, Haifa, Israel; [Zelber-Sagi, Shira] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Tel Aviv, Israel; [Carrieri, Patrizia] Aix Marseille Univ, Inst Rech Dev, ISSPAM,INSERM, Sci Econ & Sociales Sante & Traitement Informat, Marseille, France; [Dusheiko, Geoffrey] UCL, Sch Med, London, England; [Dusheiko, Geoffrey] Kings Coll Hosp London, London, England; [Bugianesi, Elisabetta] Univ Torino, Dept Med Sci, Div Gastroenterol, Turin, Italy; [Pryke, Rachel] Bewdley Med Ctr, Bewdley, England; [Hutchinson, Sharon J.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Hutchinson, Sharon J.] Publ Hlth Scotland, Clin & Protecting Hlth Directorate, Glasgow, Lanark, Scotland; [Sangro, Bruno] Clin Univ Navarra IDISNA, Liver Unit, Pamplona, Spain; [Sangro, Bruno] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain; [Martin, Natasha K.] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA; [Martin, Natasha K.] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Cecchini, Michele; Lerouge, Alienor; Devaux, Marion] Org Econ Cooperat & Dev, Hlth Div, Paris, France; [Dirac, Mae Ashworth] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Dirac, Mae Ashworth] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Dirac, Mae Ashworth; Sheena, Brittney] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Belloni, Annalisa] Publ Hlth England, Hlth Econ & Modelling Div, London, England; [Serra-Burriel, Miquel] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Ponsioen, Cyriel Y.] Amsterdam Univ Med Ctr, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Scott, Nick; Hellard, Margaret] Burnet Inst, Dis Eliminat Program, Melbourne, Vic, Australia; [Hellard, Margaret] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Hellard, Margaret] Univ Melbourne, Doherty Inst, Melbourne, Vic, Australia; [Hellard, Margaret] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Paediat Gastroenterol & Hepatol, Groningen, Netherlands; [Sturm, Ekkehard] Univ Childrens Hosp Tubingen, Div Paediat Gastroenterol & Hepatol, Tubingen, Germany; [Marchesini, Giulio] IRCCS St Orsola Malpighi Univ Hosp, Bologna, Italy; [Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Helsinki, Finland; [Byrne, Chris D.] Univ Southampton, Fac Med, Dept Nutr & Metab, Southampton, Hants, England; [Byrne, Chris D.] Univ Hosp Southampton, Biomed Res Ctr, Southampton Natl Inst Hlth Res, Southampton, Hants, England; [Byrne, Chris D.] Southampton Gen Hosp, Southampton, Hants, England; [Targher, Giovanni] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Tur-Sinai, Aviad] Max Stern Yezreel Valley Coll, Dept Hlth Syst Management, Yezreel Valley, Israel; [Barrett, Damon] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Gothenburg, Sweden; [Ninburg, Michael] World Hepatitis Alliance, London, England; [Reic, Tatjana] European Liver Patients Org, Brussels, Belgium; [Reic, Tatjana] Croatian Soc Liver Dis Hepatos, Split, Croatia; [Taylor, Alison] Childrens Liver Dis Fdn, Birmingham, W Midlands, England; [Rhodes, Tim] London Sch Hyg & Trop Med, London, England; [Treloar, Carla] Univ New South Wales, Ctr Social Res Hlth, Sydney, NSW, Australia; [Petersen, Claus] Hannover Med Sch, Dept Pediat Surg, Hannover, Germany; [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg Ctr Translat Immunol HCTI, Hamburg, Germany; [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Verkade, Henkjan J.; Sturm, Ekkehard; Schramm, Christoph] European Reference Network Hepatol Dis ERN RARE L, Hamburg, Germany; [Flisiak, Robert] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Simonova, Marieta Y.] Mil Med Acad, Dept Gastroenterol HPB Surg & Transplantat, Clin Gastroentrol, Sofia, Bulgaria; [Pares, Albert; Graupera, Isabel; Pose, Elisa; Ma, Ann T.; Gines, Pere] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain; [Pares, Albert; Graupera, Isabel; Pose, Elisa; Fabrellas, Nuria; Ma, Ann T.; Gines, Pere] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Pares, Albert; Graupera, Isabel; Fabrellas, Nuria; Gines, Pere] CIBEREHD, Madrid, Spain; [Johnson, Philip] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England; [Cucchetti, Alessandro] Univ Bologna, Dept Med & Surg Sci DIMEC, Alma Mater Studiorum, Bologna, Italy; [Graupera, Isabel; Pose, Elisa; Fabrellas, Nuria; Gines, Pere] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain; [Lionis, Christos] Univ Crete, Med Sch, Clin Social & Family Med, Iraklion, Greece; [Mendive, Juan M.] Inst Hlth Carlos III, Prevent & Hlth Promot Res Network RedIAPP, Madrid, Spain; [Mendive, Juan M.] Catalan Inst Hlth ICS, La Mina Hlth Ctr, Barcelona, Spain; [Mazzaferro, Vincenzo] Ist Nazl Tumori IRCCS Fdn INT, HPB Surg & Liver Transplantat, Milan, Italy; [Mazzaferro, Vincenzo] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Rutter, Harry] Univ Bath, Dept Social & Policy Sci, Bath, Avon, England; [Cortez-Pinto, Helena] Univ Lisbon, Clin Univ Gastrenterol & Lab Nutr, Fac Med, Lisbon, Portugal; [Kelly, Deirdre] Birmingham Womens & Childrens Hosp, Liver Unit, Birmingham, W Midlands, England; [Kelly, Deirdre] Univ Birmingham, Birmingham, W Midlands, England; [Burton, Robyn] Publ Hlth England, Alcohol Drugs Tobacco & Justice Div, London, England; [Lazarus, Jeffrey, V] Hosp Clin Barcelona, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Buti, Maria] CIBEREHD Inst Salud Carlos III, Madrid, Spain; [Buti, Maria] Hosp Univ Valle Hebron, Liver Unit, Barcelona, Spain; [Newsome, Philip N.] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, Birmingham, W Midlands, England; [Burra, Patrizia] Padua Univ Hosp, Dept Surg Oncol & Gastroenterol, Multivisceral Transplant Unit, Gastroenterol, Padua, Italy; [Manns, Michael P.] Hannover Med Sch, Hannover, Germany	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of London; King's College London; University College London; University of Haifa; Tel Aviv University; Sackler Faculty of Medicine; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; UCL Medical School; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Turin; Glasgow Caledonian University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of California System; University of California San Diego; University of Bristol; Organisation for Economic Co-operation & Development (OECD); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Public Health England; University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam; Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; University of Melbourne; University of Groningen; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Helsinki; University of Southampton; University of Southampton; University of Verona; University of Gothenburg; University of London; London School of Hygiene & Tropical Medicine; University of New South Wales Sydney; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Bialystok; Military Medical Academy Sofia; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Liverpool; University of Bologna; University of Barcelona; University of Crete; University of Milan; University of Bath; Universidade de Lisboa; Birmingham Women's Hospital; University of Birmingham; Public Health England; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; University of Birmingham; University of Padua; Azienda Ospedaliera - Universita di Padova; Hannover Medical School	Karlsen, TH (corresponding author), Univ Oslo, N-0424 Oslo, Norway.; Karlsen, TH (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Transplantat Med, Div Surg Inflammatory Dis & Transplantat, N-0424 Oslo, Norway.	t.h.karlsen@medisin.uio.no	Rutter, Harry/HCI-8765-2022; Tur-Sinai, Aviad/AAD-6886-2022; Mendive, Juan/AAZ-9277-2021; Pose, Elisa/AAE-1743-2022; Rhodes, Tim/DNJ-9679-2022; Lazarus, Jeffrey V./R-6248-2018; Serra-Burriel, Miquel/M-8662-2019; Sangro, Bruno/AFW-4106-2022; Newsome, Philip/D-4495-2018	Tur-Sinai, Aviad/0000-0002-4802-455X; Mendive, Juan/0000-0001-8095-7707; Lazarus, Jeffrey V./0000-0001-9618-2299; Serra-Burriel, Miquel/0000-0001-8595-1224; Sangro, Bruno/0000-0002-4177-6417; Targher, Giovanni/0000-0002-4325-3900; POSE MENDEZ, ELISA/0000-0002-0224-7686; Burra, Patrizia/0000-0002-8791-191X; Byrne, Christopher D/0000-0001-6322-7753; Rhodes, Tim/0000-0003-2400-9838; Carrieri, Patrizia/0000-0002-6794-4837; Newsome, Philip/0000-0001-6085-3652; Rutter, Harry/0000-0002-9322-0656	Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019-2023 Programme [CEX2018-000806-S]; Government of Catalonia through the CERCA Programme; European Commission [QLK6-CT-2001-00360, SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812, 211909, 227822, 261982, 283646, 676536, 870628, 654221, 823782]; DG Employment, Social Affairs Inclusion; German Ministry of Education and Research; Max Planck Society for the Advancement of Science; US National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_ BSR06-11, OGHA_04-064, HHSN271201300071C]; French National Agency for HIV, hepatitis and emerging infectious diseases research (ANRS/EMERGING INFECTIOUS DISEASES)	Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019-2023 Programme(Spanish Government); Government of Catalonia through the CERCA Programme; European Commission(European CommissionEuropean Commission Joint Research Centre); DG Employment, Social Affairs Inclusion; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); French National Agency for HIV, hepatitis and emerging infectious diseases research (ANRS/EMERGING INFECTIOUS DISEASES)	We dedicate this work to the memory of Roger Williams, in following up on his tireless efforts for the Lancet Commission on liver disease in the UK. The opinions expressed and arguments used herein are solely those of the authors and do not necessarily reflect the official views of the Organisation for Economic Co-operation and Development or of its member countries. We thank Christian Kuschel for work on the development of the HCV economic model. We thank Commissioners Angelos Hatzakis and Marina Maevskaya for useful discussions. We thank Neil Guha for helpful input to the primary care sections. We thank Nikolai Pushkarev and Peter Rice for helpful discussions on the recommendations of the Commission. We thank medical illustrator Kari Toverud for graphical assistance in developing figures 4, 15, and 19. We thank Ansgar Lohse for helpful discussions on the role of the European Reference Network for rare liver diseases (RARE-LIVER) and the RARE-LIVER team for relevant administrative support. We thank Vincent Karam and the European Liver Transplant Registry for providing detailed output when requested. We thank Sofia Blomqvist, Margaret Walker, Frauke Degenhardt, and Marit Maehle Grimsrud for technical assistance. We thank the EASL office for support in organising the physical meetings of the Commission and in administering the many formal and informal surveys performed. We thank Sabine Kleinert for invaluable supervision. We thank Camila Picchio, Adam Palayew, and Danielle Guy for input to early drafts of stigmarelated report sections. JVL acknowledges support to ISGlobal from the Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019-2023 Programme (CEX2018-000806-S) and from the Government of Catalonia through the CERCA Programme. This Commission uses data from SHARE Wave 7. The SHARE data collection has been funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193; COMPARE: CIT5-CT-2005-028857; SHARELIFE: CIT4-CT-2006-028812), FP7 (SHARE-PREP: GA No211909; SHARELEAP: GA No227822; SHARE M4: GA No261982; DASISH: GA No283646), and Horizon 2020 (SHARE-DEV3: GA No676536; SHARECOHESION: GA No870628; SERISS: GA No654221; SSHOC: GA No823782) and by DG Employment, Social Affairs & Inclusion. Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the US National Institute on Aging (U01_AG09740-13S2; P01_AG005842; P01_AG08291; P30_AG12815; R21_AG025169; Y1-AG-4553-01; IAG_ BSR06-11; OGHA_04-064; HHSN271201300071C), and from various national funding sources is gratefully acknowledged. PC acknowledges support by the French National Agency for HIV, hepatitis and emerging infectious diseases research (ANRS/EMERGING INFECTIOUS DISEASES). We thank Yossi Harel-Fisch and Riki Tesler for their help in providing HBSC data and their support in the analysis of these data. We thank Carina Ferreira-Borges and colleagues for approval to reprint the supplementary figure in the appendix (p 32).	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Aberg F, 2020, CLIN GASTROENTEROL H, V18, P995, DOI 10.1016/j.cgh.2019.06.036; Adams J, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001990, 10.1371/journal.pmed.1002045]; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ahmad AA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2921-8; Alcohol Policy Impact Case Study, 2019, ALC POL IMP CAS STUD; Alexander GC, 2020, ANN INTERN MED, V173, P57, DOI 10.7326/M20-1141; Anastasaki M, 2020, EUR J GEN PRACT, V26, P166, DOI 10.1080/13814788.2020.1851676; Anderson P, 2016, ADDICTION, V111, P1935, DOI 10.1111/add.13476; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Andrade RJ, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0105-0; Andrade RJ, 2019, J HEPATOL, V70, P1222, DOI 10.1016/j.jhep.2019.02.014; Angus C, 2019, ADDICTION, V114, P1489, DOI 10.1111/add.14631; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; [Anonymous], 2021, ECLINICALMEDICINE, V32; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Arora M, 2019, LANCET PUBLIC HEALTH, V4, pE549, DOI 10.1016/S2468-2667(19)30186-0; Ayala-Marin AM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00423; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Barry CL, 2014, OBESITY, V22, P466, DOI 10.1002/oby.20570; Bartlett SR, 2018, CLIN INFECT DIS, V67, P460, DOI 10.1093/cid/ciy210; Baumberg B, 2010, J EPIDEMIOL COMMUN H, V64, P473, DOI 10.1136/jech.2008.084855; Baumert TF, 2020, J HEPATOL, V73, P1303, DOI 10.1016/j.jhep.2020.10.017; BEATH S, 1993, J PEDIATR SURG, V28, P1044, DOI 10.1016/0022-3468(93)90515-M; BEATH SV, 1993, BRIT MED J, V307, P825, DOI 10.1136/bmj.307.6908.825; Belli LS, 2018, J HEPATOL, V69, P810, DOI 10.1016/j.jhep.2018.06.010; Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X; Bernts LHP, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1152-z; Beuers U, 2015, J HEPATOL, V63, P1285, DOI 10.1016/j.jhep.2015.06.031; Beynon C, 2012, BURDEN LIVER DIS INE; Biancarelli DL, 2019, DRUG ALCOHOL DEPEN, V198, P80, DOI 10.1016/j.drugalcdep.2019.01.037; Bischof GN, 2015, PSYCHOSOM MED, V77, P697, DOI 10.1097/PSY.0000000000000212; Bjorkstrom K, 2019, CLIN GASTROENTEROL H, V17, P2769, DOI 10.1016/j.cgh.2019.04.038; Blach S, 2021, J HEPATOL, V74, P31, DOI 10.1016/j.jhep.2020.07.042; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Blumberg BS, 1997, P NATL ACAD SCI USA, V94, P7121, DOI 10.1073/pnas.94.14.7121; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P1119, DOI 10.4161/hv.23827; Boerekamps A, 2018, CLIN INFECT DIS, V66, P1360, DOI 10.1093/cid/cix1007; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100113; Bonetti A, 2021, LANCET REG HEALTH-EU, V3, DOI 10.1016/j.lanepe.2021.100060; Boniface Sadie, 2017, BMJ Open, V7, pe013497, DOI 10.1136/bmjopen-2016-013497; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; Brewis A, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0337-x; Brinkmann-Sass C, 2020, EUROPEAN PATH REIMBU; Broyles LM, 2014, SUBST ABUS, V35, P217, DOI 10.1080/08897077.2014.930372; Burnes D, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2019.305123; Burton R, 2017, LANCET, V389, P1558, DOI 10.1016/S0140-6736(16)32420-5; Byrne CD, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2734; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Caballeria L, 2019, MED CLIN-BARCELONA, V153, P169, DOI 10.1016/j.medcli.2019.01.030; Caballeria L, 2018, CLIN GASTROENTEROL H, V16, P1138, DOI 10.1016/j.cgh.2017.12.048; Cancer Research UK, 2016, SUG TAX COULD PREV 3; Cannon G., 2019, ULTRAPROCESSED FOODS; Castera L, 2021, UNITED EUR GASTROENT, V9, P889, DOI 10.1002/ueg2.12120; Centis E, 2010, DIGEST DIS, V28, P267, DOI 10.1159/000282101; Chaillon A, 2019, CLIN INFECT DIS, V69, P1888, DOI 10.1093/cid/ciz063; Chan JCN, 2020, LANCET, V396, P2019, DOI 10.1016/S0140-6736(20)32374-6; Chandrashekhar V, 2020, SCIENCE, V369, P1419, DOI 10.1126/science.369.6510.1419; Chang ES, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0220857; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Chen QS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026726; Cholongitas E, 2007, AM J TRANSPLANT, V7, P685, DOI 10.1111/j.1600-6143.2007.01666.x; Clayton M, 2021, LIVER INT, V41, P683, DOI 10.1111/liv.14788; Colombo M, 2020, LIVER INT, V40, P136, DOI 10.1111/liv.14349; Committee on the Science of Changing Behavioral Health Social Norms Board on Behavioral Cognitive and Sensory Sciences Division of Behavioral and Social Sciences and Education National Academies of Sciences Engineering and Medicine, 2016, END DISCR PEOPL MENT; Cook JE, 2014, SOC SCI MED, V103, P101, DOI 10.1016/j.socscimed.2013.09.023; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; Corrigan Patrick W, 2009, World Psychiatry, V8, P75; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI 10.1176/appi.ps.201100529; Costa M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08495-x; Costa M, 2019, ALCOHOL TREAT Q, V37, P207, DOI 10.1080/07347324.2018.1514989; Cox AL, 2020, NAT REV GASTRO HEPAT, V17, P533, DOI 10.1038/s41575-020-0332-6; Cranwell J, 2016, CYBERPSYCH BEH SOC N, V19, P426, DOI 10.1089/cyber.2016.0093; Crocketta RA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009315.pub2; Cucchetti A, 2016, ALIMENT PHARM THER, V43, P814, DOI 10.1111/apt.13554; Cucchetti A, 2014, J HEPATOL, V61, P333, DOI 10.1016/j.jhep.2014.03.037; Currie D., 2020, SPOTL AD HLTH WELL B; Dai WJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008179; Davenport M, 2011, J PEDIATR SURG, V46, P1689, DOI 10.1016/j.jpedsurg.2011.04.013; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Mendonca RD, 2017, AM J HYPERTENS, V30, P358, DOI 10.1093/ajh/hpw137; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Douglass CH, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1162-z; Duffell E, 2021, J VIRAL HEPATITIS, V28, P1177, DOI 10.1111/jvh.13545; Duffell Erika F, 2017, Euro Surveill, V22, DOI 10.2807/1560-7917.ES.2017.22.9.30476; Durand F, 2011, J HEPATOL, V54, P401, DOI 10.1016/j.jhep.2010.09.001; Durazzo M, 2014, WORLD J GASTROENTERO, V20, P2127, DOI 10.3748/wjg.v20.i9.2127; Dutton GR, 2014, OBESITY, V22, P530, DOI 10.1002/oby.20438; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Eaton S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h181; El-Gohary M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208798; EMA, 2010, NONC EV DRUG IND LIV; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; EU, 2020, 2021 AG REP UND ASS; European Assoc Study Liver, 2018, J HEPATOL, V69, P154, DOI 10.1016/j.jhep.2018.03.018; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; European Assoc Study Liver, 2017, J HEPATOL, V66, P1047, DOI 10.1016/j.jhep.2016.12.003; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; European Centre for Disease Control and Prevention, 2018, PUBL HLTH GUID SCREE; European Centre for Disease Control and Prevention, 2017, HEP B C TEST ACT NEE; European Centre for Disease Prevention and Control, 2018, HEP B C EP SEL POP G; European Commission, 2020, COVID 19S IMP MIGR C; European Commission (2021c), 2021, PRESS RELEASE; European Parliament, 2021, EUR HLTH EM PREP RES; European Society for the Study of the Liver, 2018, HEPAHEALTH PROJ REP; Fabrellas N, 2020, HEPATOLOGY, V71, P1106, DOI 10.1002/hep.31117; Falla AM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2988-x; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Ford MM, 2018, J PUBLIC HEALTH MAN, V24, P41, DOI 10.1097/PHH.0000000000000519; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fouad Y, 2021, ALIMENT PHARM THER, V53, P1080, DOI 10.1111/apt.16346; Fouad Y, 2021, J HEPATOL, V74, P1254, DOI 10.1016/j.jhep.2020.12.035; Fouad Y, 2021, LIVER INT, V41, P255, DOI 10.1111/liv.14739; Fraser H, 2018, J HEPATOL, V68, P402, DOI 10.1016/j.jhep.2017.10.010; Fromme M, 2022, GUT, V71, P415, DOI 10.1136/gutjnl-2020-323729; Fruh SM, 2016, JNP-J NURSE PRACT, V12, P425, DOI 10.1016/j.nurpra.2016.05.013; Gallopel-Morvan K, 2017, ADDICTION, V112, P86, DOI 10.1111/add.13431; Garcia A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223649; Gauthier F, 1997, TOHOKU J EXP MED, V181, P97, DOI 10.1620/tjem.181.97; Geidl-Flueck B, 2021, J HEPATOL, V75, DOI 10.1016/j.jhep.2021.02.027; German Guideline Program in Oncology, 2015, EVIDENCE BASED GUIDE; Geurtsen ML, 2021, HEPATOLOGY, V73, P560, DOI 10.1002/hep.31611; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Gines P, 2016, LANCET GASTROENTEROL, V1, P256, DOI 10.1016/S2468-1253(16)30081-4; Goiana-da-Silva F, 2019, B WORLD HEALTH ORGAN, V97, P450, DOI 10.2471/BLT.18.220566; Golovaty I, 2020, J NUTR, V150, P91, DOI 10.1093/jn/nxz212; Grattagliano I, 2008, J GASTROINTEST LIVER, V17, P389; Graupera I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157371; Grebely J., 2020, CLIN INFECT DIS; Grove A., 2014, GLOB J HLTH SCI, V7, P210, DOI DOI 10.5539/GJHS.V7N2P210; Guha IN, 2006, GUT, V55, P1650, DOI 10.1136/gut.2006.091454; Hadler SC, 2013, VACCINE, V31, pJ66, DOI 10.1016/j.vaccine.2013.03.043; Hagstrom H, 2021, HEPATOLOGY, V74, P474, DOI 10.1002/hep.31726; Hagstrom H, 2016, J HEPATOL, V65, P363, DOI 10.1016/j.jhep.2016.03.019; Haigh L, 2019, CLIN GASTROENTEROL H, V17, P1364, DOI 10.1016/j.cgh.2018.10.044; Haldar D, 2019, J HEPATOL, V71, P313, DOI 10.1016/j.jhep.2019.04.011; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; Hall W, 2015, LANCET PSYCHIAT, V2, P105, DOI 10.1016/S2215-0366(14)00126-6; Harman DJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007516; Harris JL, 2015, NUTR REV, V73, P247, DOI 10.1093/nutrit/nuu061; Harris R, 2017, LANCET GASTROENTEROL, V2, P288, DOI 10.1016/S2468-1253(16)30205-9; Harrison P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i2850; Hart Carole L, 2010, BMJ, V340, pc1240, DOI 10.1136/bmj.c1240; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Heffernan A, 2019, LANCET, V393, P1319, DOI 10.1016/S0140-6736(18)32277-3; Henderson C, 2014, LANCET PSYCHIAT, V1, P467, DOI 10.1016/S2215-0366(14)00023-6; Hermetet C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183232; Heydtmann M, 2013, SCOT MED J, V58, P134, DOI 10.1177/0036933013490381; Himmelstein MS, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12453; Hirschfeld-Dicker L, 2019, ACTA PAEDIATR, V108, P712, DOI 10.1111/apa.14538; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Hope VD, 2014, EPIDEMIOL INFECT, V142, P270, DOI 10.1017/S0950268813000940; Horton R, 2020, LANCET, V396, P874, DOI 10.1016/S0140-6736(20)32000-6; Howard BV, 2002, CIRCULATION, V106, P523, DOI 10.1161/01.CIR.0000019552.77778.04; Howell J, 2021, J HEPATOL, V74, P535, DOI 10.1016/j.jhep.2020.09.013; Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6; Hudson B, 2018, LANCET GASTROENTEROL, V3, P95, DOI 10.1016/S2468-1253(17)30362-X; Huizar MI, 2021, PROG CARDIOVASC DIS, V64, P105, DOI 10.1016/j.pcad.2020.07.002; Hull SA, 2019, BRIT J GEN PRACT, V69, pE454, DOI 10.3399/bjgp19X704105; Hutchinson SJ, 2020, GUT, V69, P2223, DOI 10.1136/gutjnl-2019-320007; Hydes T, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044952; Innes H, 2020, PUBLIC HEALTH, V187, P165, DOI 10.1016/j.puhe.2020.07.017; Innes H, 2017, J HEPATOL, V66, P19, DOI 10.1016/j.jhep.2016.08.004; Innes HA, 2013, HEPATOLOGY, V57, P451, DOI 10.1002/hep.26051; Ivancovsky-Wajcman D, 2021, LIVER INT, V41, P2635, DOI 10.1111/liv.14996; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Izopet J, 2019, J CLIN VIROL, V120, P20, DOI 10.1016/j.jcv.2019.09.004; Jakab SS, 2019, CLIN GASTROENTEROL H, V17, P26, DOI 10.1016/j.cgh.2018.03.012; Jepsen P, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-3; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Jernigan D, 2017, ADDICTION, V112, P7, DOI 10.1111/add.13591; Ji D, 2020, J HEPATOL, V73, P451, DOI 10.1016/j.jhep.2020.03.044; Jin H, 2020, ADDICTION, V115, P2243, DOI 10.1111/add.15087; Jochmans I, 2017, TRANSPLANTATION, V101, P1542, DOI 10.1097/TP.0000000000001631; Johnson P, 2017, BRIT J CANCER, V116, P441, DOI 10.1038/bjc.2016.422; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Jung HS, 2019, AM J GASTROENTEROL, V114, P453, DOI 10.1038/s41395-018-0283-5; Just Drinks, 2016, MARK ALC ALC MARK IS; Karlsen TH, 2018, J HEPATOL, V68, P873, DOI 10.1016/j.jhep.2018.02.001; Kelly ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192763; Kim NH, 2018, LIVER INT, V38, P1487, DOI 10.1111/liv.13701; Kirby T, 2020, LANCET RESP MED, V8, P547, DOI 10.1016/S2213-2600(20)30228-9; Kleinert S, 2019, LANCET, V393, P724, DOI 10.1016/S0140-6736(18)33192-1; Kluge HHP, 2020, LANCET, V395, P1237, DOI 10.1016/S0140-6736(20)30791-1; Knaak Stephanie, 2014, Can J Psychiatry, V59, pS19; Kole AA, 2010, ORPHANET J RARE DIS, V5, pO4; Kondili LA, 2020, DIGEST LIVER DIS, V52, P947, DOI 10.1016/j.dld.2020.05.040; Krugman, 2021, VACCINES VERY EUROPE; Kudo M, 2018, LIVER CANCER, V7, P134, DOI 10.1159/000484619; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Kyle TK, 2014, OBESITY, V22, P1211, DOI 10.1002/oby.20727; Lal A, 2021, LANCET, V397, P61, DOI 10.1016/S0140-6736(20)32228-5; Lane MM, 2021, OBES REV, V22, DOI 10.1111/obr.13146; Larney S, 2017, LANCET GLOB HEALTH, V5, pE1208, DOI [10.1016/S2214-109X(17)30373-X, 10.1016/s2214-109x(17)30373-x]; Lazarus JV, 2021, LIVER INT, V41, P2295, DOI 10.1111/liv.14969; Lazarus JV, 2018, SEMIN LIVER DIS, V38, P181, DOI 10.1055/s-0038-1666841; Lazarus JV, 2017, J HEPATOL, V67, P665, DOI 10.1016/j.jhep.2017.06.033; Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Lilford RJ, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17280; Lin CL, 2018, ALIMENT PHARM THER, V48, P5, DOI 10.1111/apt.14683; Liu PY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181497; LIVERHOPE, 2017, LIVERHOPE PROJ; Lobstein T, 2017, ADDICTION, V112, P21, DOI 10.1111/add.13493; Loguercio C, 2011, DIGEST LIVER DIS, V43, P736, DOI 10.1016/j.dld.2011.04.013; Loomba R, 2013, AM J EPIDEMIOL, V177, P333, DOI 10.1093/aje/kws252; Loos RJF, 2022, NAT REV GENET, V23, P120, DOI 10.1038/s41576-021-00414-z; Low JTS, 2018, J HEPATOL, V69, P1260, DOI 10.1016/j.jhep.2018.08.028; Mahli A, 2016, DIGEST DIS, V34, P32, DOI 10.1159/000447279; Manns MP, 2018, LANCET, V392, P621, DOI 10.1016/S0140-6736(18)31734-3; Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6; Mantovani A, 2022, GUT, V71, P778, DOI 10.1136/gutjnl-2021-324191; Marinho RT, 2015, LIVER INT, V35, P746, DOI 10.1111/liv.12569; Marmot M., 2020, PANDEMIC SOCIOECONOM; Marshall AD, 2018, LANCET GASTROENTEROL, V3, P125, DOI 10.1016/S2468-1253(17)30284-4; Martin A, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009728.pub2, 10.1002/14651858.CD010971.pub2]; Maucort-Boulch D, 2018, INT J CANCER, V142, P2471, DOI 10.1002/ijc.31280; McCarthy M, 2016, BRIT J GEN PRACT, V66, P36, DOI 10.3399/bjgp16X683233; McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; Mendez-Sanchez N, 2021, J HEPATOL, V75, P221, DOI 10.1016/j.jhep.2021.04.021; Mialon M, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00638-4; Miglietta A, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.6.17-00278; Miguel M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018012; Mokaya J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7095-4; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P5, DOI 10.1017/S1368980017000234; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Morando F, 2013, J HEPATOL, V59, P257, DOI 10.1016/j.jhep.2013.03.010; Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002; Moubarac JC, 2014, CURR OBES REP, V3, P256, DOI 10.1007/s13679-014-0092-0; Mullish BH, 2014, ALIMENT PHARM THER, V40, P880, DOI 10.1111/apt.12925; Muth ND, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0282; Myers RP, 2011, J HEPATOL, V54, P462, DOI 10.1016/j.jhep.2010.07.015; National Harm Reduction Coalition, 2020, COVID 19 GUID PEOPL; National Health Service, 2021, ADV GUID; National Institute for Health and Care Excellence, 2015, CAR DYING AD LAST DA; National Institute for Health and Care Excellence, 2019, END LIF CAR AD SERV; Nayagam S, 2017, BMC INFECT DIS, V17, P107, DOI 10.1186/s12879-017-2778-x; Ndugga N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013620; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Newsome PN, 2018, GUT, V67, P6, DOI 10.1136/gutjnl-2017-314924; Nguyen VH, 2021, J INTERN MED, V289, P840, DOI 10.1111/joim.13203; Noori T, 2021, TRAVEL MED INFECT DI, V39, DOI 10.1016/j.tmaid.2020.101715; Nyblade L, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1256-2; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okamoto M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195147; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2; Organisation for Economic Co-operation and Development, 2021, PREV HARM ALC US, DOI [10.1787/6-4b4ffb-en, DOI 10.1787/6-4B4FFB-EN]; Organisation for Economic Cooperation and Development, 2019, HEAV BURD OB EC PREV; Oru E, 2021, LANCET GLOB HEALTH, V9, pE431, DOI 10.1016/S2214-109X(20)30505-2; Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033; Palmer AY, 2020, INT J DRUG POLICY, V76, DOI 10.1016/j.drugpo.2019.102633; Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818; Parkes Julie, 2012, Comp Hepatol, V11, P5, DOI 10.1186/1476-5926-11-5; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pellegrini M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072016; Petersen C, 2008, EUR J PEDIATR SURG, V18, P111, DOI 10.1055/s-2008-1038479; Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266; Piano S, 2017, AM J GASTROENTEROL, V112, P1575, DOI 10.1038/ajg.2017.253; Pimpin L, 2018, J HEPATOL, V69, P718, DOI 10.1016/j.jhep.2018.05.011; Pitcher AB, 2019, J THEOR BIOL, V481, P194, DOI 10.1016/j.jtbi.2018.11.013; Plank LD, 2015, CURR OPIN CLIN NUTR, V18, P501, DOI 10.1097/MCO.0000000000000205; Platt L, 2018, ADDICTION, V113, P545, DOI 10.1111/add.14012; Popkin BM, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003412; Pranata R, 2021, DIABETES METAB, V47, DOI 10.1016/j.diabet.2020.07.005; Public Health England, 2020, UNDERSTANDING IMPACT; Public Health England, 2021, ALCOHOL CONSUMPTION; Public Health England, 2020, ATL VAR; Puhl R, 2015, CURR OBES REP, V4, P182, DOI 10.1007/s13679-015-0153-z; Puigvehi M, 2019, JHEP REP, V1, P120, DOI 10.1016/j.jhepr.2019.05.001; Qi XL, 2018, LANCET GASTROENTEROL, V3, P708, DOI 10.1016/S2468-1253(18)30232-2; Scarpelli DQ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082371; Radley A, 2020, LANCET GASTROENTEROL, V5, P809, DOI 10.1016/S2468-1253(20)30120-5; Rana A, 2015, PEDIATRICS, V136, pE99, DOI 10.1542/peds.2014-3016; Rauber F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027546; Rehm J, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7040099; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Reimer KC, 2020, HEPATOL INT, V14, P8, DOI 10.1007/s12072-019-10001-4; Rezayat AA, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312117745223; Richman LS, 2014, SOC SCI MED, V103, P94, DOI 10.1016/j.socscimed.2013.12.029; Rigas G, 2020, OBES RES CLIN PRACT, V14, P487, DOI 10.1016/j.orcp.2020.08.003; Rizzetto M, 2021, J HEPATOL, V74, P1200, DOI 10.1016/j.jhep.2021.01.014; Rojas TR, 2019, INT J DRUG POLICY, V72, P61, DOI 10.1016/j.drugpo.2019.05.013; Royal College of Nursing, 2019, CAR PEOPL LIV DIS IN; Sachdeva Sonali, 2020, SN Compr Clin Med, V2, P2726, DOI 10.1007/s42399-020-00631-3; Saif-Ur-Rahman KM, 2021, PSYCHOGERIATRICS, V21, P418, DOI 10.1111/psyg.12670; Salisbury C, 2018, LANCET, V392, P41, DOI 10.1016/S0140-6736(18)31308-4; Saran U, 2016, J HEPATOL, V64, P203, DOI 10.1016/j.jhep.2015.08.028; Schattenberg JM, 2021, LIVER INT, V41, P1227, DOI 10.1111/liv.14825; Schlosser A, 2020, INT J DRUG POLICY, V83, DOI 10.1016/j.drugpo.2020.102896; Schnabel L, 2019, JAMA INTERN MED, V179, P490, DOI 10.1001/jamainternmed.2018.7289; Schwarz JM, 2017, GASTROENTEROLOGY, V153, P743, DOI 10.1053/j.gastro.2017.05.043; Schwarzfuchs D, 2012, NEW ENGL J MED, V367, P1373, DOI 10.1056/NEJMc1204792; Schwimmer JB, 2019, JAMA-J AM MED ASSOC, V321, P256, DOI 10.1001/jama.2018.20579; Scott N, 2020, LANCET GASTROENTEROL, V5, P940, DOI 10.1016/S2468-1253(20)30008-X; Sen G., 2007, UNEQUAL UNFAIR INEFF; Sepanlou SG, 2020, LANCET GASTROENTEROL, V5, P245, DOI 10.1016/S2468-1253(19)30349-8; Serinet MO, 2006, HEPATOLOGY, V44, P75, DOI 10.1002/hep.21219; Serper M, 2020, HEPATOLOGY, V72, P723, DOI 10.1002/hep.31276; Serra-Burriel M, 2019, J HEPATOL, V71, P1141, DOI 10.1016/j.jhep.2019.08.019; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; Shah ND, 2019, CLIN GASTROENTEROL H, V17, P2320, DOI 10.1016/j.cgh.2019.01.026; Sharma A, 2016, HEALTH ECON, V25, P1182, DOI 10.1002/hec.3388; Sheron N, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1860; Sheron N, 2016, J HEPATOL, V64, P957, DOI 10.1016/j.jhep.2015.11.006; Shiha G, 2021, LANCET GASTROENTEROL, V6, P73, DOI 10.1016/S2468-1253(20)30294-6; Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7; Simiies D, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.47.2001943; Singh S, 2017, WORLD J GASTROENTERO, V23, P6549, DOI 10.3748/wjg.v23.i36.6549; Sinn DH, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5508-5; Sipido KR, 2020, LANCET, V395, P1970, DOI 10.1016/S0140-6736(20)31411-2; Skouteris H, 2016, PEDIATR OBES, V11, P4, DOI 10.1111/ijpo.12011; Slimani N, 2009, EUR J CLIN NUTR, V63, pS206, DOI 10.1038/ejcn.2009.82; Smit C, 2021, LANCET HIV, V8, pE96, DOI 10.1016/S2352-3018(20)30301-5; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Spahlholz J, 2016, OBES REV, V17, P43, DOI 10.1111/obr.12343; Spolverato G, 2015, JAMA SURG, V150, P538, DOI 10.1001/jamasurg.2015.0219; Srivastava A, 2019, J HEPATOL, V71, P371, DOI 10.1016/j.jhep.2019.03.033; Srour B, 2020, JAMA INTERN MED, V180, P283, DOI 10.1001/jamainternmed.2019.5942; Stagg HR, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1300-2; Standing H, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017106; Standing HC, 2018, BRIT J GEN PRACT, V68, pE743, DOI 10.3399/bjgp18X699377; Steele EM, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0119-3; Steele EM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009892; Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180; Stephens C, 2021, J HEPATOL, V75, P86, DOI 10.1016/j.jhep.2021.01.029; Stine JG, 2018, ALIMENT PHARM THER, V48, P696, DOI 10.1111/apt.14937; Stockwell T, 2013, AM J PUBLIC HEALTH, V103, P2014, DOI 10.2105/AJPH.2013.301289; Stockwell Tim, 2012, Am J Public Health, V102, pe103, DOI 10.2105/AJPH.2012.301094; Suijkerbuijk AWM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207037; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Syed AM, 2015, EVAL PROGRAM PLANN, V52, P78, DOI 10.1016/j.evalprogplan.2015.03.006; Sylvester R, 2021, JGH OPEN, V5, P549, DOI 10.1002/jgh3.12460; Szakacs Z, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01028; Sze S, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100630; Szeto A, 2019, CAN J PSYCHIAT, V64, p5S, DOI 10.1177/0706743719842557; Tan M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2237; Tanajewski L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015659; Tapper EB, 2016, CLIN GASTROENTEROL H, V14, P753, DOI 10.1016/j.cgh.2015.08.041; Targher G, 2021, LANCET GASTROENTEROL, V6, pS78, DOI 10.1016/S2468-1253(21)00020-0; The Global Fund, 2021, POOL PROC MECH REF P; Thiele M, 2018, GASTROENTEROLOGY, V154, P1369, DOI 10.1053/j.gastro.2018.01.005; Thijssen M, 2019, LANCET GASTROENTEROL, V4, P315, DOI 10.1016/S2468-1253(19)30014-7; Thokala P, 2016, PHARMACOECONOMICS, V34, P741, DOI 10.1007/s40273-016-0387-y; Thomas DL, 2019, NEW ENGL J MED, V380, P2041, DOI 10.1056/NEJMra1810477; Thornicroft G, 2007, BRIT J PSYCHIAT, V190, P192, DOI 10.1192/bjp.bp.106.025791; Tilg H, 2010, Minerva Gastroenterol Dietol, V56, P159; Tilg H, 2020, NAT REV GASTRO HEPAT, V17, P387, DOI 10.1038/s41575-020-0316-6; Tomiyama AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1116-5; Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.011; Townsend SA, 2017, DIGEST DIS, V35, P371, DOI 10.1159/000456589; Trichopoulos D, 2011, JNCI-J NATL CANCER I, V103, P1686, DOI 10.1093/jnci/djr395; Trickey A, 2019, LANCET GASTROENTEROL, V4, P435, DOI 10.1016/S2468-1253(19)30085-8; Trooskin SB, 2015, J GEN INTERN MED, V30, P950, DOI 10.1007/s11606-015-3209-6; Trujols J, 2015, LANCET PSYCHIAT, V2, P292, DOI 10.1016/S2215-0366(15)00050-4; Tsochatzis EA, 2018, LANCET GASTROENTEROL, V3, P509, DOI 10.1016/S2468-1253(18)30077-3; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Tumiene B, 2021, J COMMUN GENET, V12, P231, DOI 10.1007/s12687-021-00520-9; Tzartzeva K, 2018, GASTROENTEROLOGY, V154, P1706, DOI 10.1053/j.gastro.2018.01.064; Udo T, 2016, INT J CLIN PRACT, V70, P1003, DOI 10.1111/ijcp.12902; UNICEF, 2020, SOC STIGM ASS COR DI; Ursic-Bedoya J, 2021, LIVER TRANSPLANT, V27, P34, DOI 10.1002/lt.25904; US Food & Drug Administration, 2009, DRUG IND LIV INJ PRE; vACCine covid-19 monitoring readinESS, 2020, WID IMP COVID 19 HLT; van Dalen W., 2018, ALCOHOL MARKETING RE; van den Heuvel WJA, 2011, EUR J AGEING, V8, P291, DOI 10.1007/s10433-011-0206-4; VBF, 2018, PROH ALC ADV NORW; Verkade HJ, 2016, J HEPATOL, V65, P631, DOI 10.1016/j.jhep.2016.04.032; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; Visscher BB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6331-7; Wade AJ, 2020, CLIN INFECT DIS, V70, P1900, DOI 10.1093/cid/ciz546; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wakeman SE, 2013, AM J PUBLIC HEALTH, V103, pE1, DOI 10.2105/AJPH.2012.301191; Walker JG, 2020, LANCET GLOB HEALTH, V8, pE244, DOI 10.1016/S2214-109X(19)30483-8; Wang QQ, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100688; Wang YJ, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa107; Ward Z, 2020, ADDICTION, V115, P1509, DOI 10.1111/add.14978; WHO, 2019, MON RESTR DIG MARK U; WHO, 2017, ACT PLAN HLTH SECT R; WHO, 2002, INNOVATIVE CARE CHRO; WHO, 2018, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Wiessing L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103345; Wijnhoven TMA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-806; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Williams J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082481; Williams R, 2020, LANCET, V395, P226, DOI 10.1016/S0140-6736(19)32908-3; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Wong ELY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-149; World Health Organization, 2014, World Health Organ Tech Rep Ser, P1; World Health Organization, 2016, REP COMM END CHILDH; World Health Organization, 2018, NO PUBLIC HLTH REFUG; World Health Organization, 2012, EUR ACT PLAN RED HAR; World Health Organization, 2021, ICD 11 MORT MORB STA; World Health Organization, 2016, FISC POL DIET PREV N; World Health Organization, 2019, GUID PRINC FRAM MAN; World Health Organization, 2020, LICENCE 200 BY NC SA; World Health Organization (WHO), 2011, BURD BEST BUYS RED E; Yamey G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n332; Yeoh EK, 2018, INT J CARDIOL, V258, P279, DOI 10.1016/j.ijcard.2017.11.057; Yki-J?rvinen HAP., 2020, NONALCOHOLIC FATTY L; Younossi ZM, 2013, ALIMENT PHARM THER, V37, P703, DOI 10.1111/apt.12265; Younossi ZM, 2022, CLIN GASTROENTEROL H, V20, pE1456, DOI 10.1016/j.cgh.2021.06.048; Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021; Younossi ZM, 2019, TRANSPLANTATION, V103, P22, DOI 10.1097/TP.0000000000002484; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yuksel HS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010347; Yurdaydin C, 2019, J HEPATOL, V70, P1008, DOI 10.1016/j.jhep.2018.12.022; Zein CO, 2011, J HEPATOL, V54, P753, DOI 10.1016/j.jhep.2010.07.040; Zelber-Sagi S, 2019, CLIN GASTROENTEROL H, V17, P1248, DOI 10.1016/j.cgh.2019.01.010; Zelber-Sagi S, 2017, WORLD J GASTROENTERO, V23, P1881, DOI 10.3748/wjg.v23.i10.1881; Zhao CQ, 2018, LIVER INT, V38, P503, DOI 10.1111/liv.13555	429	64	64	24	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					61	116		10.1016/S0140-6736(21)01701-3	http://dx.doi.org/10.1016/S0140-6736(21)01701-3		DEC 2021	56	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YA3YW	34863359	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000738273800022
J	Dunn, AS				Dunn, Andrew S.			Post-TKA abelacimab reduced VTE at 8 to 12 d compared with enoxaparin	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dunn, Andrew S.] Icahn Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, AS (corresponding author), Icahn Mt Sinai Sch Med, New York, NY 10029 USA.							Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Weitz JI, 2020, JAMA-J AM MED ASSOC, V323, P130, DOI 10.1001/jama.2019.20687	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC136	JC136		10.7326/ACPJ202112210-136	http://dx.doi.org/10.7326/ACPJ202112210-136		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871049				2022-12-28	WOS:000729195100001
J	Mahase, E				Mahase, Elisabeth			Covid-19: "Mix and match" primary vaccines are safe and effective, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Our World in Data, COR COV 19 VACC; Stuart ASV, LANCET, V2021	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								n3030	10.1136/bmj.n3030	http://dx.doi.org/10.1136/bmj.n3030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4DA	34876460	Bronze			2022-12-28	WOS:000730815800016
J	Richards, T				Richards, Tessa			Can you do what I'm asking you to do?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Richards, Tessa] BMJ, London, England		Richards, T (corresponding author), BMJ, London, England.							Gallacher KI, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0691-4; Mair FS, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2909; National Voices, DR WILL ZOOM YOU NOW; Nutbeam D, 2021, ANNU REV PUBL HEALTH, V42, P159, DOI 10.1146/annurev-publhealth-090419-102529; Providers NHS, WHAT PAT STAFF REALL; Santana S, 2021, J PUBLIC HEALTH MAN, V27, pS258, DOI 10.1097/PHH.0000000000001324	6	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3014	10.1136/bmj.n3014	http://dx.doi.org/10.1136/bmj.n3014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862178	Bronze			2022-12-28	WOS:000729712200001
J	An, ZJ; Wang, FZ; Pan, A; Yin, ZD; Rodewald, L; Feng, ZJ				An, Zhijie; Wang, Fuzhen; Pan, An; Yin, Zundong; Rodewald, Lance; Feng, Zijian			Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[An, Zhijie; Wang, Fuzhen; Yin, Zundong; Rodewald, Lance; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Pan, An] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan, Peoples R China; [Feng, Zijian] Chinese Prevent Med Assoc, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Huazhong University of Science & Technology	Feng, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China.; Feng, ZJ (corresponding author), Chinese Prevent Med Assoc, Beijing, Peoples R China.	fengzj@chinacdc.cn	Pan, An/C-5572-2011	Pan, An/0000-0002-1089-7945; Rodewald, Lance/0000-0003-2593-542X				COVID-19 Vaccine Tech Working Grp, 2021, CHINA CDC WEEKLY, V3, P459, DOI 10.46234/ccdcw2021.083; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Kang M, 2021, SSRN, DOI [10.2139/ssrn.3895639, DOI 10.2139/SSRN.3895639]; Larson HJ, 2021, SCIENCE, V371, P1289, DOI 10.1126/science.abi6488; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Li M., BOOSTER DOSE IS IMMU, DOI [DOI 10.1101/2021.08.03.21261544, 10.1101/2021.08.03.21261544]; Li Y, 2021, EMERG INFECT DIS, V27, P2288, DOI 10.3201/eid2709.202035; Li ZJ, 2021, NAT MED, V27, P740, DOI 10.1038/s41591-021-01308-7; Li ZJ, 2021, LANCET REG HEALTH-W, V8, DOI 10.1016/j.lanwpc.2021.100094; Li ZJ, 2020, LANCET PUBLIC HEALTH, V5, pE629, DOI 10.1016/S2468-2667(20)30266-8; Liu DW, 2015, VACCINE, V33, P4041, DOI 10.1016/j.vaccine.2015.04.060; Liu FF, 2021, CHINA CDC WEEKLY, V3, P527, DOI 10.46234/ccdcw2021.138; Liu ZK, 2021, CHINA CDC WEEKLY, V3, P581, DOI 10.46234/ccdcw2021.150; Orenstein W, 2019, HUM VACC IMMUNOTHER, V15, P2786, DOI 10.1080/21645515.2019.1682360; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; World Health Organization, COV 19 VACC TECHN DO; World Health Organization, WHO SAGE ROADM PRIOR; World Health Organization, TRACK SARS COV 2 VAR; Zhou L, 2021, CLIN INFECT DIS, V72, P332, DOI 10.1093/cid/ciaa725	20	6	7	6	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								e066125	10.1136/bmj-2021-066125	http://dx.doi.org/10.1136/bmj-2021-066125			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853010	Green Published, hybrid			2022-12-28	WOS:000732779300018
J	Bradshaw, O; Foy, R; Seal, AK; Darling, JC				Bradshaw, Olivia; Foy, Robbie; Seal, Arnab K.; Darling, Jonathan C.			Childhood constipation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROGNOSIS		[Bradshaw, Olivia] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Foy, Robbie] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Seal, Arnab K.] Leeds Commun Hlthcare NHS Trust, Leeds, W Yorkshire, England; [Seal, Arnab K.] Univ Leeds, Leeds, W Yorkshire, England; [Darling, Jonathan C.] Univ Leeds, Sch Med, Div Womens & Childrens Hlth, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds	Bradshaw, O (corresponding author), Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England.	o.bradshaw@nhs.net		Foy, Robbie/0000-0003-0605-7713				Bladder and Bowel UK, 2020, UND CONST FAEC IMP; Bongers MEJ, 2010, PEDIATRICS, V126, pE156, DOI 10.1542/peds.2009-1009; ERIC, ADV CHILDR CONST; ERIC, 2021, PAR GUID DISIMP; ERIC, 2021, PREP MACR LAX; Hyams JS, 2016, GASTROENTEROLOGY, V150, P1456, DOI 10.1053/j.gastro.2016.02.015; Koppen IJN, 2018, J PEDIATR-US, V199, P132, DOI 10.1016/j.jpeds.2018.03.066; Little S., 2020, CONSTIPATION; Malowitz S, 2016, J PEDIATR GASTR NUTR, V62, P600, DOI 10.1097/MPG.0000000000001011; National Institute for Health and Care Excellence, 2020, CONST CHILDR YOUNG P; Pijpers MAM, 2010, J PEDIATR GASTR NUTR, V50, P256, DOI 10.1097/MPG.0b013e3181afcdc3; Tabbers Merit M, 2010, BMJ Clin Evid, V2010; Thompson AP, 2021, JMIR PEDIATR PARENT, V4, DOI 10.2196/24851; van den Berg MM, 2006, AM J GASTROENTEROL, V101, P2401, DOI 10.1111/j.1572-0241.2006.00771.x; Waterham M, 2017, AUST FAM PHYSICIAN, V46, P908	15	1	1	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								e065046	10.1136/bmj-2021-065046	http://dx.doi.org/10.1136/bmj-2021-065046			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857512				2022-12-28	WOS:000732779300013
J	Tang, JL; Abbasi, K				Tang, Jin-Ling; Abbasi, Kamran			What can the world learn from China's response to covid-19?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tang, Jin-Ling; Abbasi, Kamran] The BMJ, London, England		Tang, JL (corresponding author), The BMJ, London, England.	jtang@bmj.com						An ZJ, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066125; Chen QL, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/BMJ-2021-066169; Du B, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066090; Gao WJ, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2342; Li YY, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066129; Tang JL, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2374; Tu HW, 2021, BMJ-BRIT MED J, V375, DOI [10.1136/bmj-2021-066121, 10.1136/BMJ-2021-066121]; Wei YY, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2365; Zhang Y, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2314; Zhou YBA, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2330	10	4	5	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2806	10.1136/bmj.n2806	http://dx.doi.org/10.1136/bmj.n2806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853017	Green Published, hybrid			2022-12-28	WOS:000732779300021
J	Yilmaz, D; Furst, A; Meaburn, K; Lezaja, A; Wen, YL; Altmeyer, M; Reina-San-Martin, B; Soutoglou, E				Yilmaz, Duygu; Furst, Audrey; Meaburn, Karen; Lezaja, Aleksandra; Wen, Yanlin; Altmeyer, Matthias; Reina-San-Martin, Bernardo; Soutoglou, Evi			Activation of homologous recombination in G1 preserves centromeric integrity	NATURE			English	Article							STRAND BREAK REPAIR; CENP-A; R-LOOPS; DNA; RECRUITMENT; PATHWAYS; MAINTENANCE; MECHANISMS; DEPOSITION; HJURP	Centromeric integrity is key for proper chromosome segregation during cell division(1). Centromeres have unique chromatin features that are essential for centromere maintenance(2). Although they are intrinsically fragile and represent hotspots for chromosomal rearrangements(3), little is known about how centromere integrity in response to DNA damage is preserved. DNA repair by homologous recombination requires the presence of the sister chromatid and is suppressed in the G1 phase of the cell cycle(4). Here we demonstrate that DNA breaks that occur at centromeres in G1 recruit the homologous recombination machinery, despite the absence of a sister chromatid. Mechanistically, we show that the centromere-specific histone H3 variant CENP-A and its chaperone HJURP, together with dimethylation of lysine 4 in histone 3 (H3K4me2), enable a succession of events leading to the licensing of homologous recombination in G1. H3K4me2 promotes DNA-end resection by allowing DNA damage-induced centromeric transcription and increased formation of DNA-RNA hybrids. CENP-A and HJURP interact with the deubiquitinase USP11, enabling formation of the RAD51-BRCA1-BRCA2 complex(5) and rendering the centromeres accessible to RAD51 recruitment and homologous recombination in G1. Finally, we show that inhibition of homologous recombination in G1 leads to centromeric instability and chromosomal translocations. Our results support a model in which licensing of homologous recombination at centromeric breaks occurs throughout the cell cycle to prevent the activation of mutagenic DNA repair pathways and preserve centromeric integrity.	[Yilmaz, Duygu; Furst, Audrey; Reina-San-Martin, Bernardo; Soutoglou, Evi] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Yilmaz, Duygu; Furst, Audrey; Reina-San-Martin, Bernardo; Soutoglou, Evi] Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France; [Yilmaz, Duygu; Furst, Audrey; Reina-San-Martin, Bernardo; Soutoglou, Evi] Ctr Natl Rech Sci, UMR7104, Illkirch Graffenstaden, France; [Yilmaz, Duygu; Furst, Audrey; Reina-San-Martin, Bernardo; Soutoglou, Evi] Univ Strasbourg, Strasbourg, France; [Lezaja, Aleksandra; Wen, Yanlin; Altmeyer, Matthias] Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland; [Meaburn, Karen; Soutoglou, Evi] Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Zurich	Soutoglou, E (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.; Soutoglou, E (corresponding author), Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France.; Soutoglou, E (corresponding author), Ctr Natl Rech Sci, UMR7104, Illkirch Graffenstaden, France.; Soutoglou, E (corresponding author), Univ Strasbourg, Strasbourg, France.; Soutoglou, E (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton, France.	E.Soutoglou@sussex.ac.uk	Altmeyer, Matthias/AAE-8186-2019; REINA-SAN-MARTIN, Bernardo/I-9484-2016	Altmeyer, Matthias/0000-0003-3780-1170; REINA-SAN-MARTIN, Bernardo/0000-0003-2083-6166; Soutoglou, Evi/0000-0002-3724-5613; Yilmaz, Duygu/0000-0002-4009-3147	UdS doctoral school; Fondation pour la Recherche Medicale (FRM); European Research Council (ERC) under the European Union [ERC-2015-COG-682939]; Agence Nationale de la Recherche [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; Academy of Medical Sciences (AMS); Swiss National Science Foundation [PP00P3_179057]	UdS doctoral school; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Research Council (ERC) under the European Union(European Research Council (ERC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Caldecott, D. Durocher, Y. Dalal for critical reading of the manuscript and members of the Soutoglou laboratory for comments; A. Nussenzweig for the BRCA1 antibody; A. Sfeir for the pol theta<SUP>-/-</SUP> MEFs; A. Aguilera and K. Mekhail for RNAseH plasmids; D. Skalnik and G. Stewart for the SETD1A and Delta SET plasmids; Y. Dalal for the GFP-CENPA and GFP-HJURP plasmids; Daniel Foltz for the mCherry-LacI-HJURP plasmid; and the IGBMC Imaging Center for support. D.Y. was supported by the Ministerial fellowship from the UdS doctoral school and the Fondation pour la Recherche Medicale (FRM). The E.S. laboratory was supported by the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation program (ERC-2015-COG-682939) and by ANR-10-LABX-0030-INRT, managed by the Agence Nationale de la Recherche under the program Investissements d'Avenir labelled ANR-10-IDEX-0002-02 and the Academy of Medical Sciences (AMS). M.A. acknowledges research funding from the Swiss National Science Foundation (PP00P3_179057).	Abraham KJ, 2020, NATURE, V585, P298, DOI 10.1038/s41586-020-2497-0; Akimov V, 2018, NAT STRUCT MOL BIOL, V25, P631, DOI 10.1038/s41594-018-0084-y; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Barra V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06545-y; Beh TT, 2017, PROG MOL SUBCELL BIO, V56, P541, DOI 10.1007/978-3-319-58592-5_22; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Bonifacino, 2012, CURRENT PROTOCOLS CE; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Dalal, 2014, ELIFE, V3; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Feretzaki M, 2020, NATURE, V587, P303, DOI 10.1038/s41586-020-2815-6; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Giunta S, 2017, P NATL ACAD SCI USA, V114, P1928, DOI 10.1073/pnas.1615133114; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hedouin S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42520; Kabeche L, 2018, SCIENCE, V359, P108, DOI 10.1126/science.aan6490; Khristich AN, 2020, J BIOL CHEM, V295, P4134, DOI 10.1074/jbc.REV119.007678; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Liu SJ, 2021, CELL, V184, P1314, DOI 10.1016/j.cell.2021.01.048; Marnef A, 2021, NAT CELL BIOL, V23, P305, DOI 10.1038/s41556-021-00663-4; Martinez C, 2011, CARCINOGENESIS, V32, P796, DOI 10.1093/carcin/bgr069; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; McFarlane RJ, 2010, TRENDS GENET, V26, P209, DOI 10.1016/j.tig.2010.02.005; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Mishra PK, 2021, MOL BIOL CELL, V32, P74, DOI 10.1091/mbc.E20-06-0379; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Molina O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13334; Nakamura KI, 2008, EMBO J, V27, P3036, DOI 10.1038/emboj.2008.215; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Niikura Y, 2015, DEV CELL, V32, P589, DOI 10.1016/j.devcel.2015.01.024; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Ortega P, 2021, ELIFE, V10, DOI 10.7554/eLife.69881; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ouyang J, 2021, NATURE, V594, P283, DOI 10.1038/s41586-021-03538-8; Padilla-Nash HM, 2001, GENE CHROMOSOME CANC, V30, P349, DOI 10.1002/gcc.1101; Read LR, 2004, NUCLEIC ACIDS RES, V32, P1184, DOI 10.1093/nar/gkh280; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; van Sluis M, 2015, GENE DEV, V29, P1151, DOI 10.1101/gad.260703.115; Vydzhak O, 2020, J MOL BIOL, V432, P4287, DOI 10.1016/j.jmb.2020.05.011; Wang Y, 2014, GENOMICS, V103, P222, DOI 10.1016/j.ygeno.2014.02.002; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Zhou J, 2021, NAT CANCER, V2, P598, DOI 10.1038/s43018-021-00203-x	51	14	14	3	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 23	2021	600	7890					748	+		10.1038/s41586-021-04200-z	http://dx.doi.org/10.1038/s41586-021-04200-z		DEC 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XT2KA	34853474	Green Published			2022-12-28	WOS:000724666000002
J	Seeberg, KA; Borgeraas, H; Hofso, D				Seeberg, K. A.; Borgeraas, H.; Hofso, D.			Summary for Patients: Do Gastric Bypass and Sleeve Gastrectomy Help Reduce Liver Fat Content and Scarring in Patients With Type 2 Diabetes?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material; Early Access																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.												10.7326/P21-0012	http://dx.doi.org/10.7326/P21-0012		NOV 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN0FB	34843384				2022-12-28	WOS:000729189800001
J	Beltrame, JF; Tavella, R; Jones, D; Zeitz, C				Beltrame, John F.; Tavella, Rosanna; Jones, Dione; Zeitz, Chris			Management of ischaemia with non-obstructive coronary arteries (INOCA)	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONVERTING ENZYME-INHIBITION; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; ENHANCED EXTERNAL COUNTERPULSATION; CALCIUM-CHANNEL BLOCKER; EXERCISE-INDUCED ANGINA; ST-SEGMENT DEPRESSION; CHEST-PAIN; VARIANT ANGINA; ENDOTHELIAL FUNCTION	Up to half of patients undergoing elective coronary angiography for the investigation of chest pain do not present with evidence of obstructive coronary artery disease. These patients are often discharged with a diagnosis of non-cardiac chest pain, yet many could have an ischaemic basis for their symptoms. This type of ischaemic chest pain in the absence of obstructive coronary artery disease is referred to as INOCA (ischaemia with non-obstructive coronary arteries). This comprehensive review of INOCA management looks at why these patients require treatment, who requires treatment based on diagnostic evaluation, what clinical treatment targets should be considered, how to treat patients using a personalised medicine approach, when to initiate treatment, and where future research is progressing.	[Beltrame, John F.; Tavella, Rosanna; Jones, Dione; Zeitz, Chris] Univ Adelaide, Adelaide Med Sch, Queen Elizabeth Hosp Campus, Adelaide, SA, Australia; [Beltrame, John F.; Tavella, Rosanna; Jones, Dione; Zeitz, Chris] SA Hlth, Dept Cardiol, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia; [Beltrame, John F.; Tavella, Rosanna; Zeitz, Chris] Queen Elizabeth Hosp, Basil Hetzel Inst Translat Hlth Res, Adelaide, SA, Australia	University of Adelaide	Beltrame, JF (corresponding author), Univ Adelaide, Adelaide Med Sch, Queen Elizabeth Hosp Campus, Adelaide, SA, Australia.; Beltrame, JF (corresponding author), SA Hlth, Dept Cardiol, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia.; Beltrame, JF (corresponding author), Queen Elizabeth Hosp, Basil Hetzel Inst Translat Hlth Res, Adelaide, SA, Australia.	john.beltrame@adelaide.edu.au						Acikel Sadik, 2010, Am J Emerg Med, V28, DOI 10.1016/j.ajem.2009.05.021; Ahmed B, 2017, CARDIOVASC REVASCULA, V18, P431, DOI 10.1016/j.carrev.2017.04.012; Arnold SV, 2016, CIRC-CARDIOVASC QUAL, V9, P554, DOI 10.1161/CIRCOUTCOMES.116.002781; Arrighi JA, 2000, LANCET, V356, P310, DOI 10.1016/S0140-6736(00)02510-1; Asbury EA, 2004, EUR HEART J, V25, P1695, DOI 10.1016/j.ehj.2004.07.035; Asbury EA, 2008, MENOPAUSE, V15, P454, DOI 10.1097/gme.0b013e31815982eb; ASCHERMANN M, 1990, AM J CARDIOL, V65, pJ46, DOI 10.1016/0002-9149(90)91312-T; BASS C, 1983, BRIT MED J, V287, P1505, DOI 10.1136/bmj.287.6404.1505; Bassi S, 2005, INT J CARDIOL, V99, P485, DOI 10.1016/j.ijcard.2003.11.057; Baumeister Timo-Benjamin, 2016, Drug Saf Case Rep, V3, P10; Bavry AA, 2014, AM HEART J, V167, P826, DOI 10.1016/j.ahj.2014.01.017; Beltrame JF, 2005, EUR HEART J, V26, P946, DOI 10.1093/eurheartj/ehi242; Beltrame JF, 2004, J AM COLL CARDIOL, V44, P57, DOI 10.1016/j.jacc.2004.03.055; Beltrame JF, 2002, CARDIOLOGY, V97, P197, DOI 10.1159/000063121; Beltrame JF, 2003, HARRISONS ADV CARDIO, V1st, P294; Beltrame JF, 2017, EUR HEART J, V38, P2565, DOI 10.1093/eurheartj/ehv351; Beltrame JF, 2016, CIRC J, V80, P289, DOI 10.1253/circj.CJ-15-1202; Beltrame JF, 2012, CIRC J, V76, P818, DOI 10.1253/circj.CJ-12-0205; Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295; Beltrame JF, 2009, HEART LUNG CIRC, V18, P19, DOI 10.1016/j.hlc.2008.11.002; Botker HE, 1998, AM J CARDIOL, V82, P1352, DOI 10.1016/S0002-9149(98)00640-7; Bove KB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240722; BUGIARDINI R, 1993, AM J CARDIOL, V72, P343, DOI 10.1016/0002-9149(93)90683-4; CANNON RO, 1988, AM J CARDIOL, V61, P1338, DOI 10.1016/0002-9149(88)91180-0; CANNON RO, 1990, AM J CARDIOL, V66, P37, DOI 10.1016/0002-9149(90)90732-G; CANNON RO, 1994, NEW ENGL J MED, V330, P1411, DOI 10.1056/NEJM199405193302003; CANNON RO, 1985, AM J CARDIOL, V56, P242, DOI 10.1016/0002-9149(85)90842-2; CHAHINE RA, 1993, J AM COLL CARDIOL, V21, P1365, DOI 10.1016/0735-1097(93)90310-W; CHAUHAN A, 1993, BRIT HEART J, V69, P516; Chen Jack P, 2007, J Invasive Cardiol, V19, pE89; Chen JW, 2002, AM J CARDIOL, V90, P974, DOI 10.1016/S0002-9149(02)02664-4; Chen JW, 1997, AM J CARDIOL, V80, P32; Chevalier P, 1998, J AM COLL CARDIOL, V31, P57, DOI 10.1016/S0735-1097(97)00442-7; COLQUHOUN DM, 1991, BRIT HEART J, V65, P234; de Vries J, 2007, EUR J PAIN, V11, P360, DOI 10.1016/j.ejpain.2006.04.002; Denardo SJ, 2011, CLIN CARDIOL, V34, P483, DOI 10.1002/clc.20935; Di Fiore DP, 2013, INT J EVID-BASED HEA, V11, P56, DOI 10.1111/1744-1609.12002; ELIASSON T, 1993, CORONARY ARTERY DIS, V4, P819; Eriksson BE, 2000, J AM COLL CARDIOL, V36, P1619, DOI 10.1016/S0735-1097(00)00931-1; Fabian E, 2004, AM J CARDIOL, V94, P652, DOI 10.1016/j.amjcard.2004.05.035; Feizi Aram, 2012, Iran J Nurs Midwifery Res, V17, P547; Ford TJ, 2020, JACC-CARDIOVASC INTE, V13, P1847, DOI 10.1016/j.jcin.2020.05.052; Ford TJ, 2020, JACC-CARDIOVASC INTE, V13, P33, DOI 10.1016/j.jcin.2019.11.001; Ford TJ, 2018, J AM COLL CARDIOL, V72, P2841, DOI 10.1016/j.jacc.2018.09.006; Giannini F, 2018, JACC-CARDIOVASC INTE, V11, P784, DOI 10.1016/j.jcin.2018.01.251; Giannini F, 2017, JACC-CARDIOVASC INTE, V10, P1901, DOI 10.1016/j.jcin.2017.06.062; Goldsmith YB, 2008, J CLIN ONCOL, V26, P3802, DOI 10.1200/JCO.2008.17.1637; Handberg EM, 2021, AM HEART J, V237, P90, DOI 10.1016/j.ahj.2021.03.011; Heberden W., 1772, MED T COLL PHYSICIAN, V2, P59; Henry TD, 2018, EUR HEART J, V39, P2208, DOI 10.1093/eurheartj/ehx764; HEUPLER FA, 1979, AM J CARDIOL, V44, P798, DOI 10.1016/0002-9149(79)90200-5; Higuma T, 2010, J CARDIOL, V56, P354, DOI 10.1016/j.jjcc.2010.07.010; HUCKELL VF, 1981, BRIT HEART J, V45, P649; Inaba Y, 2010, J NUCL CARDIOL, V17, P646, DOI 10.1007/s12350-010-9226-2; Janjua M, 2009, HEART, V95, P656, DOI 10.1136/hrt.2008.161646; Jespersen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093170; Jessurun G, 2003, EUR J PAIN, V7, P507, DOI 10.1016/S1090-3801(03)00022-3; KASKI JC, 1994, J AM COLL CARDIOL, V23, P652, DOI 10.1016/0735-1097(94)90750-1; KATON W, 1988, AM J MED, V84, P1, DOI 10.1016/0002-9343(88)90001-0; Kawano H, 2001, J AM COLL CARDIOL, V37, P735, DOI 10.1016/S0735-1097(00)01187-6; Kayikcioglu M, 2003, EUR HEART J, V24, P1999, DOI 10.1016/S0195-668X(03)00478-0; KEMP HG, 1973, AM J CARDIOL, V32, P375, DOI 10.1016/S0002-9149(73)80150-X; Kim SR, 2019, CLIN CARDIOL, V42, P899, DOI 10.1002/clc.23239; KISHIDA H, 1987, CLIN PHARMACOL THER, V42, P166, DOI 10.1038/clpt.1987.127; Kissel Christine K, 2018, Curr Treat Options Cardiovasc Med, V20, P78, DOI 10.1007/s11936-018-0667-2; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Kook H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239039; Kronhaus KD, 2009, INT J CARDIOL, V135, P256, DOI 10.1016/j.ijcard.2008.03.022; Kunadian V, 2020, EUR HEART J, V41, P3504, DOI 10.1093/eurheartj/ehaa503; LABLANCHE JM, 1992, J CARDIOVASC PHARM, V20, pS82, DOI 10.1097/00005344-199206203-00014; LANZA GA, 1994, CIRCULATION, V90, P2695, DOI 10.1161/01.CIR.90.6.2695; Lanza GA, 1999, AM J CARDIOL, V84, P854, DOI 10.1016/S0002-9149(99)00450-6; Lee BK, 2015, CIRCULATION, V131, P1054, DOI 10.1161/CIRCULATIONAHA.114.012636; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; Lim TK, 2018, CARDIOVASC THER, V36, DOI 10.1111/1755-5922.12311; Luo CF, 2012, CARDIOLOGY, V122, P260, DOI 10.1159/000339876; Ma YG, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0135-8; Maseri A, 2001, AM J MED, V111, P326, DOI 10.1016/S0002-9343(01)00930-5; Maseri A., 1995, ISCHEMIC HEART DIS R, P559; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; McGillion M, 2008, BRIT MED J, V336, P338, DOI 10.1136/bmj.39465.522569.80; Mehta PK, 2011, JACC-CARDIOVASC IMAG, V4, P514, DOI 10.1016/j.jcmg.2011.03.007; Meisel SR, 2002, AM J CARDIOL, V89, P1114, DOI 10.1016/S0002-9149(02)02283-X; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Merz CNB, 2016, EUR HEART J, V37, P1504, DOI 10.1093/eurheartj/ehv647; Merz CNB, 2010, AM HEART J, V159, P987, DOI 10.1016/j.ahj.2010.03.024; Meune C, 2003, RESUSCITATION, V58, P145, DOI 10.1016/S0300-9572(03)00149-7; Michelsen MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196962; Mohri M, 2003, J AM COLL CARDIOL, V41, P15, DOI 10.1016/S0735-1097(02)02632-3; Mohri M, 1998, LANCET, V351, P1165, DOI 10.1016/S0140-6736(97)07329-7; Mongiardo R, 1996, AM J CARDIOL, V78, P84, DOI 10.1016/S0002-9149(96)00230-5; Morikawa Y, 2013, CORONARY ARTERY DIS, V24, P177, DOI 10.1097/MCA.0b013e32835cbef5; Morita S, 2014, CORONARY ARTERY DIS, V25, P671, DOI 10.1097/MCA.0000000000000144; Motz W, 1996, HYPERTENSION, V27, P1031, DOI 10.1161/01.HYP.27.5.1031; Nalbantgil, 1999, Int J Angiol, V8, P40, DOI 10.1007/s005479900137; Oikawa Y, 2010, J CARDIOL, V55, P238, DOI 10.1016/j.jjcc.2009.11.005; Ong P, 2018, INT J CARDIOL, V250, P16, DOI 10.1016/j.ijcard.2017.08.068; Ong P, 2015, CIRC J, V79, P1431, DOI 10.1253/circj.CJ-15-0520; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; OPHERK D, 1981, CIRCULATION, V63, P817, DOI 10.1161/01.CIR.63.4.817; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pauly DF, 2011, AM HEART J, V162, P678, DOI 10.1016/j.ahj.2011.07.011; PHANEUF DC, 1980, CATHETER CARDIO DIAG, V6, P413, DOI 10.1002/ccd.1810060410; Porto I, 2010, NAT REV CLIN ONCOL, V7, P476, DOI 10.1038/nrclinonc.2010.67; PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8; Radico F, 2018, EUR HEART J, V39, P2135, DOI 10.1093/eurheartj/ehy185; Rai B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051137; Rambarat CA, 2019, INT J CARDIOL, V276, P8, DOI 10.1016/j.ijcard.2018.09.081; ROBERTSON RM, 1982, CIRCULATION, V65, P281, DOI 10.1161/01.CIR.65.2.281; Rosen SD, 1999, J CARDIOVASC PHARM, V34, P554, DOI 10.1097/00005344-199910000-00012; Rumsfeld JS, 2002, CIRCULATION, V106, P5, DOI 10.1161/01.CIR.0000020805.31531.48; Russo G, 2013, CARDIOVASC DRUG THER, V27, P229, DOI 10.1007/s10557-013-6439-z; Rutledge T, 2001, J AM COLL CARDIOL, V37, P780, DOI 10.1016/S0735-1097(00)01163-3; Safdar B, 2020, EUR HEART J-ACUTE CA, V9, P5, DOI 10.1177/2048872618764418; Santoro F, 2012, INT J CARDIOL, V161, pE29, DOI 10.1016/j.ijcard.2012.03.156; Sato K, 2019, INT J CARDIOL, V291, P13, DOI 10.1016/j.ijcard.2019.02.038; Sen N, 2009, ANADOLU KARDIYOL DER, V9, P371; Sgueglia GA, 2007, HEART, V93, P591, DOI 10.1136/hrt.2006.102194; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990; Sheikh AR, 2015, CIRCULATION, V132, pE242, DOI 10.1161/CIRCULATIONAHA.115.017254; SHIMIZU H, 1993, JPN CIRC J, V57, P175, DOI 10.1253/jcj.57.175; Shimizu M, 2007, INT J CARDIOL, V114, P188, DOI 10.1016/j.ijcard.2006.01.026; Shimokawa H, 2021, EUR HEART J, V42, P4592, DOI 10.1093/eurheartj/ehab282; Shimokawa H, 2014, EUR HEART J, V35, P3180, DOI 10.1093/eurheartj/ehu427; Shin ES, 2014, HEART, V100, P1531, DOI 10.1136/heartjnl-2014-305986; Sidi A, 2008, J CLIN ANESTH, V20, P64, DOI 10.1016/j.jclinane.2007.02.016; Song JK, 2000, J AM COLL CARDIOL, V35, P1850, DOI 10.1016/S0735-1097(00)00646-X; Spertus JA, 2008, CIRCULATION, V118, P2103, DOI 10.1161/CIRCULATIONAHA.107.747568; Szot W, 2015, ANN AGR ENV MED, V22, P390, DOI 10.5604/12321966.1152100; Takagi Y, 2013, J AM COLL CARDIOL, V62, P1144, DOI 10.1016/j.jacc.2013.07.018; Takahashi J, 2015, EUR HEART J, V36, P228, DOI 10.1093/eurheartj/ehu313; Tavella R, 2016, EUR HEART J-QUAL CAR, V2, P117, DOI 10.1093/ehjqcco/qcv034; Topal E, 2006, J ELECTROCARDIOL, V39, P211, DOI 10.1016/j.jelectrocard.2005.08.011; Tyni-Lenne Raija, 2002, Physiother Res Int, V7, P35, DOI 10.1002/pri.239; Verheye S, 2015, NEW ENGL J MED, V372, P519, DOI 10.1056/NEJMoa1402556; de Carvalho EEV, 2015, J NUCL CARDIOL, V22, P130, DOI 10.1007/s12350-014-9949-6; Villano A, 2013, AM J CARDIOL, V112, P8, DOI 10.1016/j.amjcard.2013.02.045; Yamabe H, 1995, CARDIOVASC DRUG THER, V9, P755, DOI 10.1007/BF00879868; YASUE H, 1988, CIRCULATION, V78, P1, DOI 10.1161/01.CIR.78.1.1; Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049; YEUNG AC, 1991, NEW ENGL J MED, V325, P1551, DOI 10.1056/NEJM199111283252205; Yildirim AB, 2010, CARDIOL J, V17, P512; Yoshida K, 1999, INT J CARDIOL, V70, P155, DOI 10.1016/S0167-5273(99)00079-0; Yoshida K, 2008, J CARDIOL, V52, P49, DOI 10.1016/j.jjcc.2008.04.002; Zhang XL, 2014, CORONARY ARTERY DIS, V25, P40, DOI 10.1097/MCA.0000000000000054	145	8	8	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								e060602	10.1136/bmj-2021-060602	http://dx.doi.org/10.1136/bmj-2021-060602			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836873	Bronze			2022-12-28	WOS:000727787900012
J	Karp, AT; Faith, JT; Marlon, JR; Staver, AC				Karp, Allison T.; Faith, J. Tyler; Marlon, Jennifer R.; Staver, A. Carla			Global response of fire activity to late Quaternary grazer extinctions	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; MEGAFAUNAL EXTINCTION; PLANT-COMMUNITIES; LATE PLEISTOCENE; CLIMATE-CHANGE; NORTH; VEGETATION; REGIMES; IMPACT; RECONSTRUCTIONS	Fire activity varies substantially at global scales because of the influence of climate, but at broad spatiotemporal scales, the possible effects of herbivory on fire activity are unknown. Here, we used late Quaternary large-bodied herbivore extinctions as a global exclusion experiment to examine the responses of grassy ecosystem paleofire activity (through charcoal proxies) to continental differences in extinction severity. Grassy ecosystem fire activity increased in response to herbivore extinction, with larger increases on continents that suffered the largest losses of grazers; browser declines had no such effect. These shifts suggest that herbivory can have Earth system-scale effects on fire and that herbivore impacts should be explicitly considered when predicting changes in past and future global fire activity.	[Karp, Allison T.; Staver, A. Carla] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Faith, J. Tyler] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA; [Faith, J. Tyler] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Faith, J. Tyler] Univ Witwatersrand, Origins Ctr, Johannesburg, South Africa; [Marlon, Jennifer R.] Yale Univ, Sch Environm, New Haven, CT USA; [Staver, A. Carla] Yale Univ, Yale Inst Biospher Studies, New Haven, CT USA	Yale University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Witwatersrand; Yale University; Yale University	Karp, AT (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	allison.karp@yale.edu		Faith, J. Tyler/0000-0002-1101-7161; Karp, Allison/0000-0001-9764-749X	US National Science Foundation (NSF) [MSB-1802453]; NSF Dynamics of Coupled Natural and Human Systems program [1826666]	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Dynamics of Coupled Natural and Human Systems program	A.C.S. and A.T.K. were supported by funding from US National Science Foundation (NSF) grant MSB-1802453, and J.T.F. was supported by funding from NSF Dynamics of Coupled Natural and Human Systems program (1826666).	Abraham JO, 2019, ECOL EVOL, V9, P7047, DOI 10.1002/ece3.5270; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; Andermann T, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2313; Archibald S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9ead; Archibald S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0309; Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Barnosky AD, 2016, P NATL ACAD SCI USA, V113, P856, DOI 10.1073/pnas.1505295112; Barnosky AD, 2010, QUATERN INT, V217, P10, DOI 10.1016/j.quaint.2009.11.017; Blarquez O, 2014, COMPUT GEOSCI-UK, V72, P255, DOI 10.1016/j.cageo.2014.07.020; Boulanger MT, 2014, QUATERNARY SCI REV, V85, P35, DOI 10.1016/j.quascirev.2013.11.024; Broughton JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07897-1; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; Charles GK, 2017, ECOL APPL, V27, P143, DOI 10.1002/eap.1422; Cocker SL, 2021, CAN J EARTH SCI, V58, P1059, DOI 10.1139/cjes-2020-0164; Commerford J. L., 2013, American Journal of Plant Sciences, V4, P1; Cordova CE, 2019, QUATERNARY RES, V92, P497, DOI 10.1017/qua.2019.17; Daniau AL, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004249; Daniau AL, 2013, P NATL ACAD SCI USA, V110, P5069, DOI 10.1073/pnas.1214292110; De Deckker P, 2021, AUST J EARTH SCI, V68, P928, DOI 10.1080/08120099.2021.1896578; dos Santos RAL, 2013, NAT GEOSCI, V6, P627, DOI [10.1038/ngeo1856, 10.1038/NGEO1856]; Enquist BJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14369-y; Faith JT, 2014, EARTH-SCI REV, V128, P105, DOI 10.1016/j.earscirev.2013.10.009; Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106; Faurby S, 2018, ECOLOGY, V99, P2626, DOI 10.1002/ecy.2443; Forbes ES, 2019, FUNCT ECOL, V33, P1597, DOI 10.1111/1365-2435.13376; Gill JL, 2014, NEW PHYTOL, V201, P1163, DOI 10.1111/nph.12576; Gill JL, 2012, QUATERNARY SCI REV, V34, P66, DOI 10.1016/j.quascirev.2011.12.008; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Hempson GP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17348-4; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Hermanowski B, 2015, VEG HIST ARCHAEOBOT, V24, P279, DOI 10.1007/s00334-014-0472-0; Hermanowski B, 2012, QUATERNARY RES, V77, P138, DOI 10.1016/j.yqres.2011.10.009; Higuera PE, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103135118; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Jia SH, 2018, P NATL ACAD SCI USA, V115, P6237, DOI 10.1073/pnas.1707984115; Johnson CN, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0443; Johnson CN, 2016, AUST J BOT, V64, P643, DOI 10.1071/BT16138; Kershaw AP, 2007, J QUATERNARY SCI, V22, P481, DOI 10.1002/jqs.1127; Kimuyu DM, 2014, ECOL APPL, V24, P741, DOI 10.1890/13-1135.1; KINGDON J, 2013, MAMMALS AFRICA; Klein R.G., 1984, P553; Koerner SE, 2018, NAT ECOL EVOL, V2, P1925, DOI 10.1038/s41559-018-0696-y; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Levavasseur G, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044019; Leys BA, 2018, ECOL EVOL, V8, P8831, DOI 10.1002/ece3.4394; Lundgren EJ, 2021, SCI DATA, V8, DOI 10.1038/s41597-020-00788-5; Lundgren EJ, 2020, P NATL ACAD SCI USA, V117, P7871, DOI 10.1073/pnas.1915769117; Marlon JR, 2009, P NATL ACAD SCI USA, V106, P2519, DOI 10.1073/pnas.0808212106; Marlon J, 2006, HOLOCENE, V16, P1059, DOI 10.1177/0959683606069396; Marlon JR, 2016, BIOGEOSCIENCES, V13, P3225, DOI 10.5194/bg-13-3225-2016; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; Meltzer DJ, 2015, ANNU REV ANTHROPOL, V44, P33, DOI 10.1146/annurev-anthro-102214-013854; Moss PT, 2017, J QUATERNARY SCI, V32, P704, DOI 10.1002/jqs.2977; Nelson DM, 2016, QUATERNARY SCI REV, V139, P67, DOI 10.1016/j.quascirev.2016.03.006; Nelson DM, 2012, GLOBAL CHANGE BIOL, V18, P3160, DOI 10.1111/j.1365-2486.2012.02766.x; Pachzelt A, 2015, GLOBAL ECOL BIOGEOGR, V24, P991, DOI 10.1111/geb.12313; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Power MJ, 2010, PALAEOGEOGR PALAEOCL, V291, P52, DOI 10.1016/j.palaeo.2009.09.014; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Robinson GS, 2005, ECOL MONOGR, V75, P295, DOI 10.1890/03-4064; Rowan J, 2019, ECOL STUD-ANAL SYNTH, V239, P61, DOI 10.1007/978-3-030-25865-8_3; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Saltre F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13277-0; Saltre F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10511; Schowanek SD, 2021, GLOBAL ECOL BIOGEOGR, V30, P896, DOI 10.1111/geb.13264; SCOTT L, 1983, S AFR J SCI, V79, P266; SCOTT L, 1989, PALAEOGEOGR PALAEOCL, V70, P345, DOI 10.1016/0031-0182(89)90112-0; Shi N, 1998, VEG HIST ARCHAEOBOT, V7, P127, DOI 10.1007/BF01374001; Staver AC, 2021, J ECOL, V109, P2804, DOI 10.1111/1365-2745.13685; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; Stuart AJ, 2015, GEOL J, V50, P338, DOI 10.1002/gj.2633; Urban MA, 2015, ECOLOGY, V96, P642, DOI 10.1890/14-0209.1; Vachula RS, 2018, HOLOCENE, V28, P173, DOI 10.1177/0959683617715624; van der Kaars S, 2000, PALAEOGEOGR PALAEOCL, V155, P135, DOI 10.1016/S0031-0182(99)00098-X; van der Kaars S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14142; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Wang SC, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0989; Wilson KM, 2020, QUATERNARY SCI REV, V248, DOI 10.1016/j.quascirev.2020.106601; Wroe S, 2013, P NATL ACAD SCI USA, V110, P8777, DOI 10.1073/pnas.1302698110	84	5	6	8	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1145	+		10.1126/science.abj1580	http://dx.doi.org/10.1126/science.abj1580			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822271				2022-12-28	WOS:000725668600049
J	Wise, J				Wise, Jacqui			Headlines play down the gravity of covid-19 in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Donnelly L., 2021, TELEGRAPH; Ely J, 2021, MAIL ONLINE; Smith C, 2022, NAT MED, V28, P185, DOI 10.1038/s41591-021-01578-1	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2826	10.1136/bmj.n2826	http://dx.doi.org/10.1136/bmj.n2826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824090	Bronze			2022-12-28	WOS:000744251500006
J	Hung, KL; Yost, KE; Xie, LQ; Shi, QM; Helmsauer, K; Luebeck, J; Schopflin, R; Lange, JT; Gonzalez, RC; Weiser, NE; Chen, CE; Valieva, ME; Wong, ITL; Wu, SH; Dehkordi, SR; Duffy, CV; Kraft, K; Tang, J; Belk, JA; Rose, JC; Corces, MR; Granja, JM; Li, R; Rajkumar, U; Friedlein, J; Bagchi, A; Satpathy, AT; Tjian, R; Mundlos, S; Bafna, V; Henssen, AG; Mischel, PS; Liu, Z; Chang, HWY				Hung, King L.; Yost, Kathryn E.; Xie, Liangqi; Shi, Quanming; Helmsauer, Konstantin; Luebeck, Jens; Schopflin, Robert; Lange, Joshua T.; Chamorro Gonzalez, Rocio; Weiser, Natasha E.; Chen, Celine; Valieva, Maria E.; Wong, Ivy Tsz-Lo; Wu, Sihan; Dehkordi, Siavash R.; Duffy, Connor V.; Kraft, Katerina; Tang, Jun; Belk, Julia A.; Rose, John C.; Corces, M. Ryan; Granja, Jeffrey M.; Li, Rui; Rajkumar, Utkrisht; Friedlein, Jordan; Bagchi, Anindya; Satpathy, Ansuman T.; Tjian, Robert; Mundlos, Stefan; Bafna, Vineet; Henssen, Anton G.; Mischel, Paul S.; Liu, Zhe; Chang, Howard Y.			ecDNA hubs drive cooperative intermolecular oncogene expression	NATURE			English	Article							HOMOGENEOUSLY STAINING REGIONS; DOUBLE MINUTE CHROMOSOMES; CIRCULAR DNA; SELECTIVE-INHIBITION; SENSITIVE ANALYSIS; READ ALIGNMENT; C-MYC; NEUROBLASTOMA; PROTEIN; GENOME	Extrachromosomal DNA (ecDNA) is prevalent in human cancers and mediates high expression of oncogenes through gene amplification and altered gene regulation(1). Gene induction typically involves cis-regulatory elements that contact and activate genes on the same chromosome(2,3). Here we show that ecDNA hubs-clusters of around 10-100 ecDNAs within the nucleus-enable intermolecular enhancer-gene interactions to promote oncogene overexpression. ecDNAs that encode multiple distinct oncogenes form hubs in diverse cancer cell types and primary tumours. Each ecDNA is more likely to transcribe the oncogene when spatially clustered with additional ecDNAs. ecDNA hubs are tethered by the bromodomain and extraterminal domain (BET) protein BRD4 in a MYC-amplified colorectal cancer cell line. The BET inhibitor JQ1 disperses ecDNA hubs and preferentially inhibits ecDNA-derived-oncogene transcription. The BRD4-bound PVT1 promoter is ectopically fused to MYC and duplicated in ecDNA, receiving promiscuous enhancer input to drive potent expression of MYC. Furthermore, the PVT1 promoter on an exogenous episome suffices to mediate gene activation in trans by ecDNA hubs in a JQ1-sensitive manner. Systematic silencing of ecDNA enhancers by CRISPR interference reveals intermolecular enhancer-gene activation among multiple oncogene loci that are amplified on distinct ecDNAs. Thus, protein-tethered ecDNA hubs enable intermolecular transcriptional regulation and may serve as units of oncogene function and cooperative evolution and as potential targets for cancer therapy.	[Hung, King L.; Yost, Kathryn E.; Shi, Quanming; Duffy, Connor V.; Kraft, Katerina; Rose, John C.; Corces, M. Ryan; Granja, Jeffrey M.; Li, Rui; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Sch Med, Stanford, CA USA; [Xie, Liangqi; Liu, Zhe] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Xie, Liangqi; Tjian, Robert] Univ Calif Berkeley, Dept Mol & Cell Biol, Li Ka Shing Ctr Biomed & Hlth Sci, CIRM Ctr Excellence, Berkeley, CA USA; [Xie, Liangqi; Tjian, Robert] Howard Hughes Med Inst, Berkeley, CA USA; [Helmsauer, Konstantin] Charite Univ Med Berlin, Dept Pediat Oncol & Hematol, Berlin, Germany; [Luebeck, Jens; Henssen, Anton G.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, San Diego, CA 92103 USA; [Luebeck, Jens; Rajkumar, Utkrisht; Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA USA; [Schopflin, Robert; Mundlos, Stefan] Max Planck Inst Mol Genet, Dev & Dis Res Grp, Berlin, Germany; [Schopflin, Robert] Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany; [Schopflin, Robert] Max Planck Inst Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Lange, Joshua T.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA USA; [Lange, Joshua T.; Wong, Ivy Tsz-Lo] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Lange, Joshua T.; Weiser, Natasha E.; Wong, Ivy Tsz-Lo; Belk, Julia A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wu, Sihan] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Belk, Julia A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Friedlein, Jordan; Bagchi, Anindya] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Program, La Jolla, CA USA; [Mundlos, Stefan] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Henssen, Anton G.] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr ECRC, Berlin, Germany; [Henssen, Anton G.] Charite Univ Med Berlin, Berlin, Germany; [Henssen, Anton G.] German Canc Consortium DKTK, Partner Site Berlin, Heidelberg, Germany; [Henssen, Anton G.] German Canc Res Ctr, Heidelberg, Germany; [Henssen, Anton G.] Berlin Inst Hlth, Berlin, Germany; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of California System; University of California San Diego; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; Sanford Burnham Prebys Medical Discovery Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Berlin Institute of Health; Howard Hughes Medical Institute; Stanford University	Chang, HWY (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Sch Med, Stanford, CA USA.; Chang, HWY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu	; Hung, King/V-4605-2017	Lange, Joshua/0000-0002-4246-6058; Belk, Julia/0000-0003-4724-6158; Luebeck, Jens/0000-0003-4391-979X; Rose, John/0000-0003-1810-4337; Henssen, Anton/0000-0003-1534-778X; Chamorro Gonzalez, Rocio/0000-0002-5653-7259; Wu, Sihan/0000-0001-8329-7492; Xie, Liangqi/0000-0002-6546-9622; Hung, King/0000-0002-3662-4662; Helmsauer, Konstantin/0000-0003-0773-4114; Mischel, Paul/0000-0002-4560-2211; Weiser, Natasha/0000-0001-9971-2961; Mundlos, Stefan/0000-0002-9788-3166	NIH [R35-CA209919, RM1-HG007735, S10OD018220, 1S10OD021763]; Stanford Graduate Fellowship; National Science Foundation [NSF DGE-1656518]; NCI [NIH F99CA253729]; NINDS [NS047101]; Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) [398299703]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [949172]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft (DFG; German Research Foundation)(German Research Foundation (DFG)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC))	We thank members of the Chang, Liu, Mischel, and Bafna laboratories for discussions; R. Zermeno, M. Weglarz and L. Nichols at the Stanford Shared FACS Facility for assistance with cell sorting experiments; X. Ji, D. Wagh and J. Coller at the Stanford Functional Genomics Facility for assistance with high-throughput sequencing; and A. Pang of Bionano Genomics for assistance with optical mapping. H.Y.C. was supported by NIH R35-CA209919 and RM1-HG007735; K.L.H. was supported by a Stanford Graduate Fellowship; and K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518), a Stanford Graduate Fellowship and a NCI Predoctoral to Postdoctoral Fellow Transition Award (NIH F99CA253729). Cell sorting for this project was done on instruments in the Stanford Shared FACS Facility. Sequencing was performed by the Stanford Functional Genomics Facility (supported by NIH grants S10OD018220 and 1S10OD021763). Microscopy was performed on instruments in the UCSD Microscopy Core (supported by NINDS NS047101). A.G.H. is supported by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) (398299703) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 949172). Z.L. is a Janelia Group Leader, and H.Y.C. and R.T. are Investigators of the Howard Hughes Medical Institute.	Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Bailey C, 2020, ANN ONCOL, V31, P884, DOI 10.1016/j.annonc.2020.03.303; BALABANMALENBAUM G, 1977, SCIENCE, V198, P739, DOI 10.1126/science.71759; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Bhattacharyya S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11950-y; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Boeva V, 2017, NAT GENET, V49, P1408, DOI 10.1038/ng.3921; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; COX D, 1965, LANCET, V2, P55; Dehkordi SR, 2021, PATTERNS, V2, DOI 10.1016/j.patter.2021.100248; Deshpande V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08200-y; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flynn RA, 2021, CELL, V184, P2394, DOI 10.1016/j.cell.2021.03.012; Fulco CP, 2019, NAT GENET, V51, P1664, DOI 10.1038/s41588-019-0538-0; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gogolin S, 2013, CELL CYCLE, V12, P1091, DOI 10.4161/cc.24091; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Grimm JB, 2020, NAT METHODS, V17, P815, DOI 10.1038/s41592-020-0909-6; Haas BJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1842-9; Hadi K, 2020, CELL, V183, P197, DOI 10.1016/j.cell.2020.08.006; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; HAMKALO BA, 1985, P NATL ACAD SCI USA, V82, P1126, DOI 10.1073/pnas.82.4.1126; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Helmsauer K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19452-y; Henssen A, 2016, CLIN CANCER RES, V22, P2470, DOI 10.1158/1078-0432.CCR-15-1449; Itoh N, 1998, J CELL SCI, V111, P3275; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kim H, 2020, NAT GENET, V52, P891, DOI 10.1038/s41588-020-0678-2; Kitajima K, 2001, BIOCHEM BIOPH RES CO, V288, P1182, DOI 10.1006/bbrc.2001.5892; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Koche RP, 2020, NAT GENET, V52, P29, DOI 10.1038/s41588-019-0547-z; Kumar P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba2489; L'Abbate A, 2014, NUCLEIC ACIDS RES, V42, P9131, DOI 10.1093/nar/gku590; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luebeck J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18099-z; Marrano P, 2017, GENE CHROMOSOME CANC, V56, P28, DOI 10.1002/gcc.22398; MAURER BJ, 1987, NATURE, V327, P434, DOI 10.1038/327434a0; Mirkin EV, 2014, J MOL BIOL, V426, P550, DOI 10.1016/j.jmb.2013.11.001; Morton AR, 2019, CELL, V179, P1330, DOI 10.1016/j.cell.2019.10.039; Mumbach MR, 2019, NAT METHODS, V16, P489, DOI 10.1038/s41592-019-0407-x; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Normanno D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8357; Oobatake Y, 2020, GENE CHROMOSOME CANC, V59, P133, DOI 10.1002/gcc.22810; Overhauser J, 1992, Methods Mol Biol, V12, P129, DOI 10.1385/0-89603-229-9:129; Park J, 2016, ONCOTARGET, V7, P28670, DOI 10.18632/oncotarget.8764; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; QUINN LA, 1979, CANCER RES, V39, P4914; Rajkumar U, 2019, ISCIENCE, V21, P428, DOI 10.1016/j.isci.2019.10.035; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ren CY, 2018, P NATL ACAD SCI USA, V115, P7949, DOI 10.1073/pnas.1720000115; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHWAB M, 1986, MOL CELL BIOL, V6, P2752, DOI 10.1128/MCB.6.7.2752; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; STAHL F, 1992, MOL CELL BIOL, V12, P1179, DOI 10.1128/MCB.12.3.1179; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tolomeo D, 2021, GENE, V779, DOI 10.1016/j.gene.2021.145497; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; VANDERBLIEK AM, 1988, NUCLEIC ACIDS RES, V16, P4841, DOI 10.1093/nar/16.11.4841; VANDEVANTER DR, 1990, J NATL CANCER I, V82, P1815, DOI 10.1093/jnci/82.23.1815; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Verhaak RGW, 2019, NAT REV CANCER, V19, P283, DOI 10.1038/s41568-019-0128-6; Vicario R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129876; Vidal E, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky064; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villamon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053740; WAHL GM, 1989, CANCER RES, V49, P1333; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu SH, 2019, NATURE, V575, P699, DOI 10.1038/s41586-019-1763-5; Xie LQ, 2020, NAT METHODS, V17, P430, DOI 10.1038/s41592-020-0775-2; Xue KS, 2016, ELIFE, V5, DOI 10.7554/eLife.13974; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng H, 2019, NAT REV MOL CELL BIO, V20, P535, DOI 10.1038/s41580-019-0132-4; Zhu YF, 2021, CANCER CELL, V39, P694, DOI 10.1016/j.ccell.2021.03.006	93	44	44	12	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 23	2021	600	7890					731	+		10.1038/s41586-021-04116-8	http://dx.doi.org/10.1038/s41586-021-04116-8		NOV 2021	41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XT2KA	34819668	Green Submitted, Green Accepted			2022-12-28	WOS:000722128900004
J	Robinson, F				Robinson, Francesca			Cradle to grave general practice: the family doctor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The GP partner and trainer talks to Francesca Robinson about his commitment to his patients and training the next generation											0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2811	10.1136/bmj.n2811	http://dx.doi.org/10.1136/bmj.n2811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815220	Bronze			2022-12-28	WOS:000722577100006
J	Slomski, A				Slomski, Anita			Virtual Care Mitigates Pain and Drug Errors After Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2001	2001						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9XP	34812864				2022-12-28	WOS:000755138500004
J	Nolan, T				Nolan, Tom			Tom Nolan's research reviews-19 November 2021	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Matta J, 2022, JAMA INTERN MED, V182, P19, DOI 10.1001/jamainternmed.2021.6454; Pfeffer MA, 2021, NEW ENGL J MED, V385, P1845, DOI 10.1056/NEJMoa2104508; Santomauro DF, 2021, LANCET, V398, P1700, DOI 10.1016/S0140-6736(21)02143-7; Vaccarino V, 2021, JAMA-J AM MED ASSOC, V326, P1818, DOI 10.1001/jama.2021.17649; Walter EB, 2022, NEW ENGL J MED, V386, P35, DOI 10.1056/NEJMoa2116298	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2852	10.1136/bmj.n2852	http://dx.doi.org/10.1136/bmj.n2852			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799351	Bronze			2022-12-28	WOS:000723212300001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Refugee doctors join NHS through innovative scheme	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Edwards N, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l4144; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2534; NHS England, 2020, ADD FUNDS SUPP WINT	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2020	375								n2993	10.1136/bmj.n2993	http://dx.doi.org/10.1136/bmj.n2993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN0EQ	34872903	Bronze			2022-12-28	WOS:000729188700001
J	Maksimovic, N; Eilbott, DH; Cookmeyer, T; Wan, FH; Rusz, J; Nagarajan, V; Haley, SC; Maniv, E; Gong, A; Faubel, S; Hayes, IM; Bangura, A; Singleton, J; Palmstrom, JC; Winter, L; McDonald, R; Jang, S; Ai, P; Lin, Y; Ciocys, S; Gobbo, J; Werman, Y; Oppeneer, PM; Altman, E; Lanzara, A; Analytis, JG				Maksimovic, Nikola; Eilbott, Daniel H.; Cookmeyer, Tessa; Wan, Fanghui; Rusz, Jan; Nagarajan, Vikram; Haley, Shannon C.; Maniv, Eran; Gong, Amanda; Faubel, Stefano; Hayes, Ian M.; Bangura, Ali; Singleton, John; Palmstrom, Johanna C.; Winter, Laurel; McDonald, Ross; Jang, Sooyoung; Ai, Ping; Lin, Yi; Ciocys, Samuel; Gobbo, Jacob; Werman, Yochai; Oppeneer, Peter M.; Altman, Ehud; Lanzara, Alessandra; Analytis, James G.			Evidence for a delocalization quantum phase transition without symmetry breaking in CeCoIn5	SCIENCE			English	Article							HEAVY-FERMION SUPERCONDUCTIVITY	The study of quantum phase transitions that are not clearly associated with broken symmetry is a major effort in condensed matter physics, particularly in regard to the problem of high-temperature superconductivity, for which such transitions are thought to underlie the mechanism of superconductivity itself. Here we argue that the putative quantum critical point in the prototypical unconventional superconductor CeCoIn5 is characterized by the delocalization of electrons in a transition that connects two Fermi surfaces of different volumes, with no apparent broken symmetry. Drawing on established theory of f-electron metals, we discuss an interpretation for such a transition that involves the fractionalization of spin and charge, a model that effectively describes the anomalous transport behavior we measured for the Hall effect.	[Maksimovic, Nikola; Eilbott, Daniel H.; Cookmeyer, Tessa; Wan, Fanghui; Nagarajan, Vikram; Haley, Shannon C.; Maniv, Eran; Gong, Amanda; Faubel, Stefano; Hayes, Ian M.; Jang, Sooyoung; Ciocys, Samuel; Gobbo, Jacob; Werman, Yochai; Altman, Ehud; Lanzara, Alessandra; Analytis, James G.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Maksimovic, Nikola; Eilbott, Daniel H.; Cookmeyer, Tessa; Wan, Fanghui; Nagarajan, Vikram; Haley, Shannon C.; Maniv, Eran; Gong, Amanda; Faubel, Stefano; Hayes, Ian M.; Jang, Sooyoung; Ai, Ping; Lin, Yi; Ciocys, Samuel; Gobbo, Jacob; Werman, Yochai; Altman, Ehud; Lanzara, Alessandra; Analytis, James G.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Rusz, Jan; Oppeneer, Peter M.] Uppsala Univ, Dept Phys & Astron, Box 516, S-75120 Uppsala, Sweden; [Bangura, Ali] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Singleton, John; Palmstrom, Johanna C.; Winter, Laurel; McDonald, Ross] Natl High Magnet Field Lab, Los Alamos, NM 97545 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Uppsala University; State University System of Florida; Florida State University	Maksimovic, N; Analytis, JG (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Maksimovic, N; Analytis, JG (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.	nikola_maksimovic@berkeley.edu; analytis@berkeley.edu	; Rusz, Jan/A-3324-2008	Altman, Ehud/0000-0003-4068-8287; Eilbott, Daniel/0000-0002-3933-9541; Cookmeyer, Tessa/0000-0001-6264-7908; Maniv, Eran/0000-0001-6602-1208; Gong, Amanda/0000-0003-3078-606X; Rusz, Jan/0000-0002-0074-1349	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05-CH11231, KC2202]; National Science Foundation Graduate Research Fellowship grant [DGE-1752814]; Gordon and Betty Moore Foundations EPiQS Initiative [GBMF9067]; Swedish Research Council (VR); K. and A. Wallenberg Foundation [2015.0060]; National Science Foundation [DMR1644779]; state of Florida	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship grant; Gordon and Betty Moore Foundations EPiQS Initiative; Swedish Research Council (VR)(Swedish Research Council); K. and A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Science Foundation(National Science Foundation (NSF)); state of Florida	This work was supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division under contract DE-AC02-05-CH11231 within the Quantum Materials program (KC2202). V.N., T.C., and D.H.E. are supported by National Science Foundation Graduate Research Fellowship grant DGE-1752814. This work was partially supported by the Gordon and Betty Moore Foundations EPiQS Initiative through grant GBMF9067. P.M.O. and J.R. are supported by the Swedish Research Council (VR) and K. and A. Wallenberg Foundation award 2015.0060. DFT calculations were performed using resources of Swedish National Infrastructure for Computing (SNIC) at the NSC center (cluster Tetralith). Pulsed-field and dilution fridge experiments were conducted at the National High Magnetic Field Laboratory facilities in Tallahassee, Florida, and Los Alamos, New Mexico, respectively, which are supported by National Science Foundation Cooperative Agreement DMR1644779 and the state of Florida.	[Anonymous], **DATA OBJECT**, DOI 10.17605/OSF.IO/DFM7X; Badoux S, 2016, NATURE, V531, P210, DOI 10.1038/nature16983; Banerjee A, 2018, NPJ QUANTUM MATER, V3, DOI 10.1038/s41535-018-0079-2; Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257001; Blaha P, 2020, J CHEM PHYS, V152, DOI 10.1063/1.5143061; Chen K, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.045134; Chen QY, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.235148; Chen QY, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.035117; Chen QY, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.045107; Curro NJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.180514; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Elgazzar S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214510; Fujimori S, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/15/153002; Gauthier N, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.125111; Gegenwart P, 1998, PHYS REV LETT, V81, P1501, DOI 10.1103/PhysRevLett.81.1501; Gofryk K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186402; IOFFE LB, 1989, PHYS REV B, V39, P8988, DOI 10.1103/PhysRevB.39.8988; Jang S, 2020, P NATL ACAD SCI USA, V117, P23467, DOI 10.1073/pnas.2001778117; Kohori Y., 2001, Physical Review B (Condensed Matter and Materials Physics), V64, p134526/1, DOI 10.1103/PhysRevB.64.134526; Kohori Y, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.134526; Koitzsch A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155128; Kunes J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205111; Lederer S, 2017, P NATL ACAD SCI USA, V114, P4905, DOI 10.1073/pnas.1620651114; Maksimovic N., 2021, CE11, V5; Nakajima Y, 2007, PHYSICA C, V460, P680, DOI 10.1016/j.physc.2007.03.082; Nakajima Y., PHYS C, V5, P0; Paglione J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246405; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; Pham LD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.056404; Pippard A. B., 2009, MAGNETORESISTANCE ME; Rourke PMC, 2012, COMPUT PHYS COMMUN, V183, P324, DOI 10.1016/j.cpc.2011.10.015; Sakai H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.121105; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Senthil T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214511; Settai R, 2001, J PHYS-CONDENS MAT, V13, pL627, DOI 10.1088/0953-8984/13/27/103; Si QM, 2010, SCIENCE, V329, P1161, DOI 10.1126/science.1191195; Sidorov VA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157004; Singh S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057001; Stock C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087001; Tokiwa Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.107003; Varma CM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155113; Zhou BB, 2013, NAT PHYS, V9, P474, DOI [10.1038/nphys2672, 10.1038/NPHYS2672]	46	7	7	11	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					76	+	eaaz4566	10.1126/science.aaz4566	http://dx.doi.org/10.1126/science.aaz4566			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34855511	Green Submitted, Green Published			2022-12-28	WOS:000740261400043
J	Hargreaves, D; Mates, E; Menon, P; Alderman, H; Devakumar, D; Fawzi, W; Greenfield, G; Hammoudeh, W; He, SS; Lahiri, A; Liu, Z; Nguyen, PH; Sethi, V; Wang, HJ; Neufeld, LM; Patton, GC				Hargreaves, Dougal; Mates, Emily; Menon, Purnima; Alderman, Harold; Devakumar, Delan; Fawzi, Wafai; Greenfield, Geva; Hammoudeh, Weeam; He, Shanshan; Lahiri, Anwesha; Liu, Zheng; Phuong Hong Nguyen; Sethi, Vani; Wang, Haijun; Neufeld, Lynnette M.; Patton, George C.			Strategies and interventions for healthy adolescent growth, nutrition, and development	LANCET			English	Article							OBESITY PREVENTION; FOOD SECURITY; OVERWEIGHT; EDUCATION; CHILDREN; AGRICULTURE; TECHNOLOGY; CHILDHOOD; PROGRAMS	Adolescence is a pivotal point in the life course, characterised by transformative physical, cognitive, and emotional growth, an openness to change, and a drive to reshape the social environment. It offers unique opportunities to adopt changes in diet and physical activity that can persist into later life. Yet pre-existing nutritional problems, including micronutrient deficiencies, food insecurity, and poor-quality diets, persist at the same time as adolescents face the rapid emergence of an obesity epidemic. Adolescent growth and nutrition has been largely overlooked in intervention and policy research. Most intervention studies have emphasised micronutrient supplementation, with few taking into account the multiple drivers of adolescent diets. This Series paper highlights that effective interventions and policies will need to cut across sectors; be supported by multifaceted and multilevel policy; and extend across education, health, food systems, social protection, and digital media. Better data standardisation and systems will be essential in coordinating and monitoring these responses. In a context of shifts in planetary ecosystems and commercial drivers, resilient food systems will need to both ensure access to healthy and affordable foods and provide the infrastructure and incentives for continuing physical activity. Intergenerational partnerships with young people will be essential in bringing about transformative change and ensuring that food policies reflect their needs and aspirations.	[Hargreaves, Dougal] Imperial Coll London, Mohn Ctr Childrens Hlth & Wellbeing, London W2 1NY, England; [Mates, Emily] Emergency Nutr Network, Oxford, England; [Menon, Purnima; Phuong Hong Nguyen] Int Food Policy Res Inst, New Delhi, India; [Alderman, Harold] Int Food Policy Res Inst, Washington, DC 20036 USA; [Devakumar, Delan] UCL, Inst Global Hlth, London, England; [Fawzi, Wafai] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Fawzi, Wafai] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Fawzi, Wafai] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Greenfield, Geva] Imperial Coll London, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London, England; [Hammoudeh, Weeam] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, West Bank, Israel; [He, Shanshan] Youth Nework Lancet Standing Commiss Adolescent H, Beijing, Peoples R China; [Lahiri, Anwesha] Inst Econ Growth, New Delhi, India; [Sethi, Vani] UNICEF India, New Delhi, India; [Liu, Zheng; Wang, Haijun] Peking Univ, Sch Publ Hlth, Maternal & Child Hlth, Beijing, Peoples R China; [Neufeld, Lynnette M.] Global Alliance Improved Nutr, Geneva, Switzerland; [Patton, George C.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Imperial College London; CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Birzeit University; Peking University; Murdoch Children's Research Institute; University of Melbourne	Hargreaves, D (corresponding author), Imperial Coll London, Mohn Ctr Childrens Hlth & Wellbeing, London W2 1NY, England.	d.hargreaves@imperial.ac.uk		Mates, Emily/0000-0002-0042-3017; Lahiri, Anwesha/0000-0002-4112-4929	Fondation Botnar; Wellcome Trust; National Institute for Health Research (NIHR) through the National School for Public Health Research Programme; Applied Research Collaboration North West London; Bill & Melinda Gates Foundation; National Key R&D Programme of China [2016YFC1300204]; National Natural Science Foundation of China [81903343]; Ireland's Department for Foreign Affairs	Fondation Botnar; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) through the National School for Public Health Research Programme; Applied Research Collaboration North West London; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Key R&D Programme of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ireland's Department for Foreign Affairs	This work received funding support from Fondation Botnar and the Wellcome Trust. Neither organisation played any role in writing the manuscript or the decision to submit for publication. We would also like to acknowledge support from the following: the National Institute for Health Research (NIHR) through the National School for Public Health Research Programme and the Applied Research Collaboration North West London (DH); the Bill & Melinda Gates Foundation (PHN, PM, HA); the National Key R&D Programme of China (2016YFC1300204) and the National Natural Science Foundation of China (81903343; ZL, HW); and Ireland's Department for Foreign Affairs (EM). The Comprehensive National Nutrition Survey (CNNS) 2016-18 was conducted under the leadership of the Ministry of Health and Family Welfare (MoHFW), Government of India and Technical Advisory Committee designated by the MoHFW, in collaboration with UNICEF and the Population Council. The CNNS was funded through a generous grant from Aditya Mittal, president of ArcelorMittal, and Megha Mittal, Managing Director of ESCADA. The views expressed in this publication are those of the authors and not necessarily those of any funding bodies or institutions mentioned above.	American Psychology Association, 2020, IMP FOOD ADV CHILDH; Andretti B, 2021, PREV MED, V146, DOI 10.1016/j.ypmed.2021.106456; [Anonymous], 2011, BRIGHT FUTURES NUTR; Azzopardi PS, 2019, LANCET, V393, P1101, DOI 10.1016/S0140-6736(18)32427-9; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Braverman MT, 2004, AM J PUBLIC HEALTH, V94, P1230, DOI 10.2105/AJPH.94.7.1230; Bryan CJ, 2016, P NATL ACAD SCI USA, V113, P10830, DOI 10.1073/pnas.1604586113; Bundy DA., 2018, CHILD ADOLESCENT HLT; Carducci B, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzaa098; Chen JL, 2014, ADOLESC HEALTH MED T, V5, P159, DOI 10.2147/AHMT.S39969; Chong A, 2016, AM ECON J-APPL ECON, V8, P222, DOI 10.1257/app.20140494; Cordeiro LS, 2012, J NUTR, V142, P1741, DOI 10.3945/jn.111.155994; Debar LL, 2012, PEDIATRICS, V129, pE611, DOI 10.1542/peds.2011-0863; DENNISON CM, 1995, J HUM NUTR DIET, V8, P9, DOI 10.1111/j.1365-277X.1995.tb00292.x; Dickin KL, 2014, J ACAD NUTR DIET, V114, P945, DOI 10.1016/j.jand.2013.09.029; Drake LJ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.530176; Dush JL, 2020, PUBLIC HEALTH NURS, V37, P327, DOI 10.1111/phn.12708; Feng L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184704; Fernandez-Gaxiola AC, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009218.pub3; Garrett J, 2014, 1 POSHAN INT FOOD PO; Gillespie S, 2019, FOOD POLICY, V82, P3, DOI 10.1016/j.foodpol.2018.10.012; Godin K, 2015, CLIN OBES, V5, P103, DOI 10.1111/cob.12099; Hawkes C., 2017, WHAT CAN BE LEARNED; Headey DD, 2019, J NUTR, V149, P2020, DOI 10.1093/jn/nxz158; Holmboe-Ottesen G, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.18891; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Jacob CM, 2021, INT J BEHAV NUTR PHY, V18, DOI 10.1186/s12966-020-01065-9; Keats EC, 2021, LANCET CHILD ADOLESC, V5, P367, DOI 10.1016/S2352-4642(20)30274-1; Kenney EL, 2020, HEALTH AFFAIR, V39, P1122, DOI 10.1377/hlthaff.2020.00133; Kornet-van der Aa DA, 2017, OBES REV, V18, P581, DOI 10.1111/obr.12519; Lapierre MA, 2017, PEDIATRICS, V140, pS152, DOI 10.1542/peds.2016-1758V; Lassi ZS, 2017, ANN NY ACAD SCI, V1393, P34, DOI 10.1111/nyas.13335; Lavelle F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040870; Liu Z, 2022, JAMA PEDIATR, V176, DOI 10.1001/jamapediatrics.2021.4375; Liu Z, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0848-8; Liu Z, 2019, CHILD OBES, V15, P105, DOI 10.1089/chi.2018.0251; Lofton S, 2016, J SCH NURS, V32, P32, DOI 10.1177/1059840515605508; Lohman BJ, 2018, J PEDIATR-US, V202, P115, DOI 10.1016/j.jpeds.2018.05.052; Masipa TS, 2017, JAMBA-J DISASTER RIS, V9, DOI 10.4102/jamba.v9i1.411; Michaud-Letourneau I, 2017, FOOD POLICY, V70, P84, DOI 10.1016/j.foodpol.2017.07.001; Ministry of Health and Family Welfare G. O. I. UNICEF PopulationCouncil, 2019, COMPR NAT NUTR SURV; Mitchell TB, 2016, HEALTH PSYCHOL, V35, P704, DOI 10.1037/hea0000381; Moores CJ, 2018, OBES REV, V19, P698, DOI 10.1111/obr.12660; Muth ND, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0282; Neufeld LM, 2022, LANCET, V399, P185, DOI 10.1016/S0140-6736(21)01687-1; Neufeld LM, 2019, ANN NY ACAD SCI, V1450, P172, DOI 10.1111/nyas.14139; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Norris SA, 2022, LANCET, V399, P172, DOI 10.1016/S0140-6736(21)01590-7; Olfert MD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010147; Ottley PG, 2018, CHILD OBES, V14, pS12, DOI 10.1089/chi.2018.0020; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Pell D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n254; Perez-Ferrer C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6330-8; Petry N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110693; Plummer ML, 2017, GLOBAL ACCELERATED A; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; Powell LM, 2020, ECON HUM BIOL, V37, DOI 10.1016/j.ehb.2020.100856; Pozuelo JR, 2020, LANCET CHILD ADOLESC, V4, P177, DOI 10.1016/S2352-4642(19)30432-8; Quinn EL, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170377; Rappaport AI, 2021, J CLIN PATHOL, V74, P657, DOI 10.1136/jclinpath-2020-206717; Rivera RL, 2016, J NUTR, V146, P2375, DOI 10.3945/jn.116.231373; Rowe F, 2010, HEALTH EDUC, V110, P197, DOI 10.1108/09654281011038868; Rudolf M, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12529; Ruel MT, 2018, GLOB FOOD SECUR-AGR, V17, P128, DOI 10.1016/j.gfs.2018.01.002; Ruotsalainen H, 2015, J ADV NURS, V71, P2461, DOI 10.1111/jan.12696; Russell SJ, 2019, OBES REV, V20, P554, DOI 10.1111/obr.12812; Sadler Richard C, 2016, Can J Public Health, V107, P5346, DOI 10.17269/cjph.107.5346; Samuels L., 2015, GET HLTH STAY HLTH; Scarborough P, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003025; Schoonover H., 2006, FOOD THOUGHT US FARM; Sethi V, 2019, COMPREHENSIVE NATL N, V1; Shekar M., 2017, INVESTMENT FRAMEWORK; Sheldon T, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2534; Slater J, 2013, INT J CONSUM STUD, V37, DOI 10.1111/ijcs.12042; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Taillie LS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003015; The World Bank, AD OUT SCH LOW SEC; Thomason DL, 2016, J PEDIATR HEALTH CAR, V30, P569, DOI 10.1016/j.pedhc.2015.11.016; Thow AM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020268; UNICEF DSD and SASSA, 2012, S AFR CHILD SUPP GRA; Vallabhan MK, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0733; Van Hook J, 2018, J HEALTH SOC BEHAV, V59, P391, DOI 10.1177/0022146518788869; Verguet S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.587046; Webb P, 2016, FOOD NUTR BULL, V37, pS170, DOI 10.1177/0379572116674856; WHO, 2019, WHO WELC IND ACT AL; Wickham CA, 2018, APPETITE, V125, P333, DOI 10.1016/j.appet.2018.02.001; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; World Bank, 2018, STATE SOCIAL SAFETY; World Health Organization, E LIB EVIDENCE NUTR; Zhou S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8257-0	90	17	17	49	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					198	210		10.1016/S0140-6736(21)01593-2	http://dx.doi.org/10.1016/S0140-6736(21)01593-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34856192	Green Submitted			2022-12-28	WOS:000740652500025
J	Lim, XX; Shu, B; Zhang, SJ; Tan, AWK; Ng, TS; Lim, XN; Chew, VSY; Shi, J; Screaton, GR; Lok, SM; Anand, GS				Lim, Xin-Xiang; Shu, Bo; Zhang, Shuijun; Tan, Aaron W. K.; Ng, Thiam-Seng; Lim, Xin-Ni; Chew, Valerie S. -Y.; Shi, Jian; Screaton, Gavin R.; Lok, Shee-Mei; Anand, Ganesh S.			Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics	CELL			English	Article							EXCHANGE MASS-SPECTROMETRY; CRYO-EM; HYDROGEN-EXCHANGE; PROTEIN; IDENTIFICATION; TEMPERATURE; MOSQUITO; BINDING; POTENT	The human monoclonal antibody (HmAb) C10 potently cross-neutralizes Zika virus (ZIKV) and dengue virus. Analysis of antibody fragment (Fab) C10 interactions with ZIKV and dengue virus serotype 2 (DENV2) particles by cryoelectron microscopy (cryo-EM) and amide hydrogen/deuterium exchange mass spectrometry (HDXMS) shows that Fab C10 binding decreases overall ZIKV particle dynamics, whereas with DENV2, the same Fab causes increased dynamics. Testing of different Fab C10:DENV2 E protein molar ratios revealed that, at higher Fab ratios, especially at saturated concentrations, the Fab enhanced viral dynamics (detected by HDXMS), and observation under cryo-EM showed increased numbers of distorted particles. Our results suggest that Fab C10 stabilizes ZIKV but that with DENV2 particles, high Fab C10 occupancy promotes E protein dimer conformational changes leading to overall increased particle dynamics and distortion of the viral surface. This is the first instance of a broadly neutralizing antibody eliciting virus-specific increases in whole virus particle dynamics.	[Lim, Xin-Xiang; Lok, Shee-Mei; Anand, Ganesh S.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Shu, Bo; Zhang, Shuijun; Tan, Aaron W. K.; Ng, Thiam-Seng; Lim, Xin-Ni; Chew, Valerie S. -Y.; Lok, Shee-Mei] Duke Natl Univ, Singapore Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Screaton, Gavin R.] Univ Oxford, Div Med Sci, Oxford OX3 9DU, England; [Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Ctr Bioimaging Sci, 14 Sci Dr 4, Singapore 117557, Singapore; [Anand, Ganesh S.] Penn State Univ, Huck Inst Life Sci, Dept Chem, 104 Chem Bldg, University Pk, PA 16802 USA; [Zhang, Shuijun] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Peoples R China	National University of Singapore; University of Oxford; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanjing Agricultural University	Lok, SM; Anand, GS (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Lok, SM (corresponding author), Duke Natl Univ, Singapore Med Sch, 8 Coll Rd, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Ctr Bioimaging Sci, 14 Sci Dr 4, Singapore 117557, Singapore.; Anand, GS (corresponding author), Penn State Univ, Huck Inst Life Sci, Dept Chem, 104 Chem Bldg, University Pk, PA 16802 USA.	sheemeilok@duke-nus.edu.sg; gsa5089@psu.edu		Tan, Aaron/0000-0002-4046-7380; Screaton, Gavin/0000-0002-3549-4309; Lim, Xin-Ni/0000-0001-8117-3613	NRF [NRF2017NRF-CRP001-027]; MOE Tier 3 grant [MOE2012-T3-1-008]; Pennsylvania State University (PSU) [IO 120000001317]; National Research Foundation investigatorship award [NRF-NRFI2016-01]; National Research Foundation competitive research project grant [NRF2016NRF-CRP001-063]; Duke-NUS Signature Research Program - Ministry of Health, Singapore	NRF; MOE Tier 3 grant; Pennsylvania State University (PSU); National Research Foundation investigatorship award; National Research Foundation competitive research project grant; Duke-NUS Signature Research Program - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore)	We thank Victor Kostyuchenko and Guntur Fibriansah for technical support. This work was supported by the NRF (NRF2017NRF-CRP001-027) and a MOE Tier 3 grant (MOE2012-T3-1-008) (to G.S.A. and S.-M.L.), startup funding from The Pennsylvania State University (PSU) (IO 120000001317) (to G.S.A.), a National Research Foundation investigatorship award (NRF-NRFI2016-01), a National Research Foundation competitive research project grant (NRF2016NRF-CRP001-063), and the Duke-NUS Signature Research Program funded by the Ministry of Health, Singapore (to S.-M.L.) We thank Felix Rey for the F(ab') 2 antibody and discussions. We also thank Theresa Buckley, Sean Braet, and Varun Venkatakrishnan (Department of Chemistry, PSU) for helpful discussions.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004; Ilca SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9843; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Lim XX, 2017, STRUCTURE, V25, P1391, DOI 10.1016/j.str.2017.07.007; Lim XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14339; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma A, 2021, CELL, V184, P6052, DOI 10.1016/j.cell.2021.11.010; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	33	3	3	5	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6067	+		10.1016/j.cell.2021.11.009	http://dx.doi.org/10.1016/j.cell.2021.11.009		DEC 2021	28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YJ0DU	34852238	Green Submitted, Bronze			2022-12-28	WOS:000744210600001
J	Yang, JM; Chi, WY; Liang, J; Takayanagi, S; Iglesias, PA; Huang, CH				Yang, Jr-Ming; Chi, Wei-Yu; Liang, Jessica; Takayanagi, Saki; Iglesias, Pablo A.; Huang, Chuan-Hsiang			Deciphering cell signaling networks with massively multiplexed biosensor barcoding	CELL			English	Article							INFRARED FLUORESCENT PROTEINS; FRET BIOSENSOR; MONOMERIC RED; ACTIVATION; AMPK; RAS; INHIBITION; DYNAMICS; ORANGE; IMAGE	Genetically encoded fluorescent biosensors are powerful tools for monitoring biochemical activities in live cells, but their multiplexing capacity is limited by the available spectral space. We overcome this problem by developing a set of barcoding proteins that can generate over 100 barcodes and are spectrally separable from commonly used biosensors. Mixtures of barcoded cells expressing different biosensors are simultaneously imaged and analyzed by deep learning models to achieve massively multiplexed tracking of signaling events. Importantly, different biosensors in cell mixtures show highly coordinated activities, thus facilitating the delineation of their temporal relationship. Simultaneous tracking of multiple biosensors in the receptor tyrosine kinase signaling network reveals distinct mechanisms of effector adaptation, cell autonomous and non-autonomous effects of KRAS mutations, as well as complex interactions in the network. Biosensor barcoding presents a scalable method to expand multiplexing capabilities for deciphering the complexity of signaling networks and their interactions between cells.	[Yang, Jr-Ming; Chi, Wei-Yu; Huang, Chuan-Hsiang] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Liang, Jessica] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Takayanagi, Saki] Johns Hopkins Sch Med, XDBio Grad Program, Baltimore, MD 21205 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Whiting Sch Engn, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Yang, JM; Huang, CH (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	jyang38@jhmi.edu; chuang29@jhmi.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X; , Jessica/0000-0002-3426-3234; Takayanagi, Saki/0000-0002-0657-8562; Yang, Jr-Ming/0000-0002-6296-8987; Huang, Chuan-Hsiang/0000-0001-9993-8004	NIH [S10OD016374, S10OD023548, K22CA212060, R01GM136711]; Cervical Cancer SPORE [P50CA098252]; W.W. Smith Charitable Trust [C1901]; Sol Goldman Pancreatic Cancer Research Center	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cervical Cancer SPORE; W.W. Smith Charitable Trust; Sol Goldman Pancreatic Cancer Research Center	We would like to thank Hoku West-Foyle and Takanari Inoue for helpful discussions, as well as Michiyuki Matsuda for plasmids of PicchuEV, Prin-BRAF, PrinCRAF, EV-RSK, EV-ROCK, and EV-S6K. Zeiss LSM 780 and 880 confocal microscopes were purchased with NIH grants S10OD016374 and S10OD023548, respectively. This work was supported by NIH (K22CA212060 and R01GM136711 to C.-H.H.), Cervical Cancer SPORE P50CA098252 (Career Development Award to J.-M.Y., Pilot Project Award to C.-H.H.), the W.W. Smith Charitable Trust (C1901 to C.-H.H.), and the Sol Goldman Pancreatic Cancer Research Center (to C.-H.H.).	Abadi M., 2016, TENSORFLOW LARGE SCA; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Bengio Y., 2010, P 13 INT C ART INT S, P249; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Chapnick DA, 2019, METHODS MOL BIOL, V1978, P343, DOI 10.1007/978-1-4939-9236-2_21; CHATILA T, 1989, J IMMUNOL, V143, P1283; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; Chernov KG, 2017, CHEM REV, V117, P6423, DOI 10.1021/acs.chemrev.6b00700; Chollet F., 2018, ASTROPHYSICS SOURCE; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; De Simone A, 2021, NATURE, V590, P129, DOI 10.1038/s41586-020-03085-8; Elzi DJ, 2001, AM J PHYSIOL-CELL PH, V281, pC350; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Fritz RD, 2015, DEV CELL, V35, P78, DOI 10.1016/j.devcel.2015.09.002; Fujita Y, 2014, FEBS J, V281, P3177, DOI 10.1111/febs.12852; Fukushima S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224121; Gelens L, 2014, MOL BIOL CELL, V25, P3486, DOI 10.1091/mbc.E14-08-1306; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Greenwald EC, 2018, CHEM REV, V118, P11707, DOI 10.1021/acs.chemrev.8b00333; Guzeloglu A, 2004, BIOL REPROD, V71, P170, DOI 10.1095/biolreprod.103.025411; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hinton G., 2012, NEURAL NETWORKS MACH, V264, P1; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Hoeller O, 2014, DEV CELL, V28, P607, DOI 10.1016/j.devcel.2014.03.009; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Iglesias PA, 2014, IET SYST BIOL, V8, P268, DOI 10.1049/iet-syb.2014.0026; Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115; King DB, 2015, ACS SYM SER, V1214, P1; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Konagaya Y, 2017, CELL REP, V21, P2628, DOI 10.1016/j.celrep.2017.10.113; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Kuchenov D, 2016, CELL CHEM BIOL, V23, P1550, DOI 10.1016/j.chembiol.2016.11.008; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lambert TJ, 2019, NAT METHODS, V16, P277, DOI 10.1038/s41592-019-0352-8; Li CJ, 2017, CELL STRUCT FUNCT, V42, P1, DOI 10.1247/csf.16016; Linghu CY, 2020, CELL, V183, P1682, DOI 10.1016/j.cell.2020.10.035; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Marston DJ, 2020, NAT CHEM BIOL, V16, P826, DOI 10.1038/s41589-020-0542-9; Martin K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21901; Mehta S, 2018, NAT CELL BIOL, V20, P1215, DOI 10.1038/s41556-018-0200-6; Mehta S, 2014, ELIFE, V3, DOI 10.7554/eLife.03765; Meus MA, 2017, J CELL PHYSIOL, V232, P1717, DOI 10.1002/jcp.25496; Micutkova L, 2012, INT J CANCER, V130, P1544, DOI 10.1002/ijc.26149; Miyamoto T, 2015, CELL REP, V11, P657, DOI 10.1016/j.celrep.2015.03.057; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Pargett M, 2017, METHODS MOL BIOL, V1636, P35, DOI 10.1007/978-1-4939-7154-1_3; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Rao JN, 2001, AM J PHYSIOL-CELL PH, V280, pC993, DOI 10.1152/ajpcell.2001.280.4.C993; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sample V, 2015, MOL BIOL CELL, V26, P1935, DOI 10.1091/mbc.E14-02-0764; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Shen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171257; Shindo Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10485; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Terai K, 2006, EMBO J, V25, P3556, DOI 10.1038/sj.emboj.7601241; Terai K, 2019, CELL STRUCT FUNCT, V44, P153, DOI 10.1247/csf.18035; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Tu YH, 2018, ANNU REV CONDEN MA P, V9, P183, DOI 10.1146/annurev-conmatphys-033117-054046; van Haastert PJM, 2017, MOL BIOL CELL, V28, P922, DOI 10.1091/mbc.E16-10-0733; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212; Xiang X, 2011, CELL MOL BIOENG, V4, P670, DOI 10.1007/s12195-011-0211-x; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Yang JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07150-9; Zhan HW, 2020, DEV CELL, V54, P608, DOI 10.1016/j.devcel.2020.08.001; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhou X, 2015, CELL REP, V10, P1767, DOI 10.1016/j.celrep.2015.02.031	86	9	9	5	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6193	+		10.1016/j.cell.2021.11.005	http://dx.doi.org/10.1016/j.cell.2021.11.005		DEC 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FF	34838160	Green Accepted, hybrid			2022-12-28	WOS:000730753900004
J	Silberner, J				Silberner, Joanne			The US opened up access to health records-how do patients use them?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												joanne.silberner@gmail.com						[Anonymous], 2020, ONC DATA BRIEF NO57; Bell SK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5867; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Gantzer HE, 2021, ANN INTERN MED, V174, P115, DOI 10.7326/M20-6632; Parker Pope T, 2021, NEW YORK TIMES; Twachtman G, 2020, MEDSCAPE	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2021	375								n2789	10.1136/bmj.n2789	http://dx.doi.org/10.1136/bmj.n2789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1KZ	34880048				2022-12-28	WOS:000740890600003
J	Slomski, A				Slomski, Anita			Preterm Delivery Is a Long-term Hypertension Risk Factor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2120	2120						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874433				2022-12-28	WOS:000730077500003
J	Al-Matar, SH; Sairam, C; Roussel, L; Langelier, MJ; Vinh, DC				Al-Matar, Shahad H.; Sairam, Charith; Roussel, Lucie; Langelier, Melanie J.; Vinh, Donald C.			Fever, abdominal pain, serositis, arthralgia, hearing loss, proteinuria, and a family history: Muckle Wells syndrome	LANCET			English	Editorial Material									[Al-Matar, Shahad H.; Sairam, Charith; Roussel, Lucie; Langelier, Melanie J.; Vinh, Donald C.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada	McGill University	Vinh, DC (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada.	donald.vinh@mcgill.ca							0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2021	398	10316					2101	2101						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XJ1NQ	34863351				2022-12-28	WOS:000726564200023
J	Montasser, ME; Van Hout, CV; Miloscio, L; Howard, AD; Rosenberg, A; Callaway, M; Shen, B; Li, N; Locke, AE; Verweij, N; De, T; Ferreira, MA; Lotta, LA; Baras, A; Daly, TJ; Hartford, SA; Lin, W; Mao, Y; Ye, B; White, D; Gong, G; Perry, JA; Ryan, KA; Fang, Q; Tzoneva, G; Pefanis, E; Hunt, C; Tang, Y; Lee, L; Sztalryd-Woodle, C; Mitchell, BD; Healy, M; Streeten, EA; Taylor, SI; O'Connell, JR; Economides, AN; Della Gatta, G; Shuldiner, AR				Montasser, May E.; Van Hout, Cristopher V.; Miloscio, Lawrence; Howard, Alicia D.; Rosenberg, Avraham; Callaway, Myrasol; Shen, Biao; Li, Ning; Locke, Adam E.; Verweij, Niek; De, Tanima; Ferreira, Manuel A.; Lotta, Luca A.; Baras, Aris; Daly, Thomas J.; Hartford, Suzanne A.; Lin, Wei; Mao, Yuan; Ye, Bin; White, Derek; Gong, Guochun; Perry, James A.; Ryan, Kathleen A.; Fang, Qing; Tzoneva, Gannie; Pefanis, Evangelos; Hunt, Charleen; Tang, Yajun; Lee, Lynn; Sztalryd-Woodle, Carole; Mitchell, Braxton D.; Healy, Matthew; Streeten, Elizabeth A.; Taylor, Simeon, I; O'Connell, Jeffrey R.; Economides, Aris N.; Della Gatta, Giusy; Shuldiner, Alan R.		Regeneron Genetics Ctr Collaborati	Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen	SCIENCE			English	Article							LOW-DENSITY-LIPOPROTEIN; CONGENITAL DISORDER; INSULIN-RESISTANCE; N-GLYCOSYLATION; NULL MUTATION; LOW-FREQUENCY; GENOME-WIDE; ASSOCIATION; CHOLESTEROL; DISEASE	Increased blood levels of low-density lipoprotein cholesterol (LDL-C) and fibrinogen are independent risk factors for cardiovascular disease. We identified associations between an Amish-enriched missense variant (p.Asn352Ser) in a functional domain of beta-1,4-galactosyltransferase 1 (B4GALT1) and 13.9 milligrams per deciliter lower LDL-C (P = 4.1 x 10(-19)) and 29 milligrams per deciliter lower plasma fibrinogen (P = 1.3 x 10(-5)). B4GALT1 gene-based analysis in 544,955 subjects showed an association with decreased coronary artery disease (odds ratio = 0.64, P = 0.006). The mutant protein had 50% lower galactosyltransferase activity compared with the wild-type protein. N-linked glycan profiling of human serum found serine 352 allele to be associated with decreased galactosylation and sialylation of apolipoprotein B100, fibrinogen, immunoglobulin G, and transferrin. B4galt1 (353)Ser knock-in mice showed decreases in LDL-C and fibrinogen. Our findings suggest that targeted modulation of protein galactosylation may represent a therapeutic approach to decreasing cardiovascular disease.	[Montasser, May E.; Howard, Alicia D.; Perry, James A.; Ryan, Kathleen A.; Sztalryd-Woodle, Carole; Mitchell, Braxton D.; Streeten, Elizabeth A.; Taylor, Simeon, I; O'Connell, Jeffrey R.] Univ Maryland, Dept Med, Div Endocrinol Diabet & Nutr, Sch Med, Baltimore, MD 21201 USA; [Montasser, May E.; Howard, Alicia D.; Perry, James A.; Ryan, Kathleen A.; Sztalryd-Woodle, Carole; Mitchell, Braxton D.; Streeten, Elizabeth A.; Taylor, Simeon, I; O'Connell, Jeffrey R.] Univ Maryland, Dept Med, Program Personalized & Genom Med, Sch Med, Baltimore, MD 21201 USA; [Van Hout, Cristopher V.; Miloscio, Lawrence; Locke, Adam E.; Verweij, Niek; De, Tanima; Ferreira, Manuel A.; Lotta, Luca A.; Baras, Aris; Ye, Bin; Tzoneva, Gannie; Economides, Aris N.; Della Gatta, Giusy; Shuldiner, Alan R.] Regeneron Genet Ctr LLC, Tarrytown, NY 10591 USA; [Van Hout, Cristopher V.] Univ Nacl Autonoma Mexico, Lab Int Invest Genoma Humano, Campus Juriquilla, Queretaro 76230, Queretaro, Mexico; [Howard, Alicia D.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Rosenberg, Avraham; Callaway, Myrasol; Shen, Biao; Li, Ning; Daly, Thomas J.; Hartford, Suzanne A.; Lin, Wei; Mao, Yuan; White, Derek; Gong, Guochun; Fang, Qing; Pefanis, Evangelos; Hunt, Charleen; Tang, Yajun; Lee, Lynn; Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Sztalryd-Woodle, Carole] US Dept Vet Affairs, Washington, DC 20420 USA; [Mitchell, Braxton D.] VA Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Healy, Matthew] Enveda Biosci, Boulder, CO 80301 USA; [Streeten, Elizabeth A.] Univ Maryland, Dept Pediat, Div Genet, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Universidad Nacional Autonoma de Mexico; US Food & Drug Administration (FDA); Regeneron; US Department of Veterans Affairs; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore	Montasser, ME (corresponding author), Univ Maryland, Dept Med, Div Endocrinol Diabet & Nutr, Sch Med, Baltimore, MD 21201 USA.; Montasser, ME (corresponding author), Univ Maryland, Dept Med, Program Personalized & Genom Med, Sch Med, Baltimore, MD 21201 USA.	mmontass@som.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Van Hout, Cristopher V./AAQ-3494-2021	Van Hout, Cristopher V./0000-0001-9689-5344; Verweij, Niek/0000-0002-4303-7685; Locke, Adam/0000-0001-6227-198X; Healy, Matthew/0000-0001-6439-5038; Shen, Biao/0000-0001-5791-1583	NIH [U01HL137181, U01HL072515, R01AG18728, R01HL121007, HHSN268201500014C, 3R01HL-11762602S1, 3R01HL-120393-02S1, P30DK072488]; American Heart Association [17GRNT33661168]; Regeneron Pharmaceuticals, Inc.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Regeneron Pharmaceuticals, Inc.(Regeneron)	This work was supported in part by NIH grants U01HL137181, U01HL072515, R01AG18728, R01HL121007, HHSN268201500014C, 3R01HL-11762602S1, 3R01HL-120393-02S1, and P30DK072488 and by American Heart Association grant 17GRNT33661168 and Regeneron Pharmaceuticals, Inc.	Adamzik M, 1999, INVEST RADIOL, V34, P767, DOI 10.1097/00004424-199912000-00006; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Albert JS, 2014, NEW ENGL J MED, V370, P2307, DOI 10.1056/NEJMoa1315496; Arden Erik, 2016, J Biol Methods, V3; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Barata L, 2019, HEPATOL COMMUN, V3, P894, DOI 10.1002/hep4.1353; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; BOWIE A, 1993, ATHEROSCLEROSIS, V102, P63, DOI 10.1016/0021-9150(93)90084-8; Budoff MJ, 2006, ACAD RADIOL, V13, P166, DOI 10.1016/j.acra.2005.09.090; Cheng CM, 2015, CANCER CELL, V28, P569, DOI 10.1016/j.ccell.2015.09.021; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Daley E, 2010, J BONE MINER RES, V25, P247, DOI 10.1359/jbmr.090720; de Vries PS, 2016, HUM MOL GENET, V25, P358, DOI 10.1093/hmg/ddv454; FILIPOVIC I, 1979, EUR J BIOCHEM, V93, P51, DOI 10.1111/j.1432-1033.1979.tb12793.x; FILIPOVIC I, 1989, J BIOL CHEM, V264, P8815; Guillard M, 2011, J PEDIATR-US, V159, P1041, DOI 10.1016/j.jpeds.2011.08.007; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Harrus D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205571; Helander A, 2003, CLIN CHEM, V49, P1881, DOI 10.1373/clinchem.2003.023341; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Hoffmann TJ, 2018, NAT GENET, V50, P401, DOI 10.1038/s41588-018-0064-5; Horenstein RB, 2013, ARTERIOSCL THROM VAS, V33, P413, DOI 10.1161/ATVBAHA.112.245480; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Illumina, INFINIUMTM GLOB SCRE; Iourin O, 1996, GLYCOCONJUGATE J, V13, P1031, DOI 10.1007/BF01053199; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kotani N, 2001, BIOCHEM J, V357, P827, DOI 10.1042/0264-6021:3570827; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lauc G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003225; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li QX, 1997, DEV BIOL, V181, P257, DOI 10.1006/dbio.1996.8444; Liu D, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1616-2; Mbatchou J, 2021, NAT GENET, V53, P1097, DOI 10.1038/s41588-021-00870-7; Meade TW, 1997, J CLIN PATHOL, V50, P13, DOI 10.1136/jcp.50.1.13; Menni C, 2018, CIRC RES, V122, P1555, DOI 10.1161/CIRCRESAHA.117.312174; Minster RL, 2016, NAT GENET, V48, P1049, DOI 10.1038/ng.3620; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Montasser ME, 2018, CIRCULATION, V138, P1343, DOI 10.1161/CIRCULATIONAHA.118.034016; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Nioi P, 2016, NEW ENGL J MED, V374, P2131, DOI 10.1056/NEJMoa1508419; O Connell R., 2021, MIXED MODEL ANAL PED; O'Connell J. R., 2021, MIXED MODEL ANAL PED; Perez-Cerda C, 2017, J PEDIATR-US, V183, P170, DOI 10.1016/j.jpeds.2016.12.060; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Preston RJS, 2013, BLOOD, V121, P3801, DOI 10.1182/blood-2012-10-415000; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shen HQ, 2010, ARCH INTERN MED, V170, P1850, DOI 10.1001/archinternmed.2010.384; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Staretz-Chacham O, 2020, CLIN GENET, V97, P920, DOI 10.1111/cge.13735; Su S, 2008, ATHEROSCLEROSIS, V200, P213, DOI 10.1016/j.atherosclerosis.2007.12.009; Sul JH, 2011, J COMPUT BIOL, V18, P1611, DOI 10.1089/cmb.2011.0161; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; University of Maryland School of Medicine, 2021, AM RES PROGR; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van den Boogert MAW, 2020, J INHERIT METAB DIS, V43, P611, DOI 10.1002/jimd.12200; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Vilar R, 2020, HAEMATOLOGICA, V105, P284, DOI 10.3324/haematol.2019.236901; Ward-Caviness CK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216222; WELTY FK, 1995, CIRCULATION, V92, P2036, DOI 10.1161/01.CIR.92.8.2036; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yamamoto M, 2006, HYPERTENS RES, V29, P227, DOI 10.1291/hypres.29.227; Yerges-Armstrong Laura M, 2016, J Gerontol A Biol Sci Med Sci, V71, P1295, DOI 10.1093/gerona/glv212; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	74	3	3	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1221	+		10.1126/science.abe0348	http://dx.doi.org/10.1126/science.abe0348			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855475				2022-12-28	WOS:000728578700052
J	Ortiz-Ramirez, C; Guillotin, B; Xu, X; Rahni, R; Zhang, S; Yan, Z; Araujo, PCD; Demesa-Arevalo, E; Lee, L; Van Eck, J; Gingeras, TR; Jackson, D; Gallagher, KL; Birnbaum, KD				Ortiz-Ramirez, Carlos; Guillotin, Bruno; Xu, Xiaosa; Rahni, Ramin; Zhang, Sanqiang; Yan, Zhe; Araujo, Poliana Coqueiro Dias; Demesa-Arevalo, Edgar; Lee, Laura; Van Eck, Joyce; Gingeras, Thomas R.; Jackson, David; Gallagher, Kimberly L.; Birnbaum, Kenneth D.			Ground tissue circuitry regulates organ complexity in maize and Setaria	SCIENCE			English	Article							KRANZ ANATOMY; ROOT; ARABIDOPSIS; MOVEMENT; GENE; TOLERANCE; MECHANISM; SYSTEM; PLAYS; SHR	Most plant roots have multiple cortex layers that make up the bulk of the organ and play key roles in physiology, such as flood tolerance and symbiosis. However, little is known about the formation of cortical layers outside of the highly reduced anatomy of Arabidopsis. Here, we used single-cell RNA sequencing to rapidly generate a cell-resolution map of the maize root, revealing an alternative configuration of the tissue formative transcription factor SHORT-ROOT (SHR) adjacent to an expanded cortex. We show that maize SHR protein is hypermobile, moving at least eight cell layers into the cortex. Higher-order SHR mutants in both maize and Setaria have reduced numbers of cortical layers, showing that the SHR pathway controls expansion of cortical tissue to elaborate anatomical complexity.	[Ortiz-Ramirez, Carlos; Guillotin, Bruno; Rahni, Ramin; Zhang, Sanqiang; Araujo, Poliana Coqueiro Dias; Lee, Laura; Birnbaum, Kenneth D.] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA; [Ortiz-Ramirez, Carlos] CINVESTAV Irapuato, UGA Lab Nacl Genom Biodiversidad, Guanajuato 36821, Mexico; [Xu, Xiaosa; Demesa-Arevalo, Edgar; Gingeras, Thomas R.; Jackson, David] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Yan, Zhe; Gallagher, Kimberly L.] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Van Eck, Joyce] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Van Eck, Joyce] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY 14853 USA; [Yan, Zhe] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Germplasm Utilizat MOA, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Araujo, Poliana Coqueiro Dias] Univ Fed Rural Semi Arido, Dept Agron & Forest Sci, Mossoro, RN, Brazil	New York University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Cold Spring Harbor Laboratory; University of Pennsylvania; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Universidade Federal Rural do Semi-Arido (UFERSA)	Birnbaum, KD (corresponding author), NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA.	ken.birnbaum@nyu.edu	Ortiz-Ramirez, Carlos/AAG-3118-2019	Xu, Xiaosa/0000-0002-3452-6751; Coqueiro Dias Araujo, Poliana/0000-0002-5744-2251; Demesa-Arevalo, Edgar/0000-0002-2793-5928; Lee, Laura/0000-0002-2821-7469; Van Eck, Joyce/0000-0002-8005-365X; Ortiz-Ramirez, Carlos/0000-0002-5166-1955; Yan, Zhe/0000-0003-0369-6245; Zhang, Sanqiang/0000-0002-1984-1120	NSF [IOS-1934388, IOS 1445025, IOS-1930101, PGRP-23020]; NIH [R35GM136362]; Human Frontier Science Program Organization [LT -000972/2018]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Organization(Human Frontier Science Program)	K.D.B and D.J. are supported by NSF grant IOS-1934388. K.D.B, D.J., and T.R.G. were supported by NSF grant IOS 1445025. K.D.B. is funded by NIH grant R35GM136362. D.J. is funded by NSF IOS-1930101. K.L.G. is funded by NSF PGRP-23020. B.G. is funded by the Human Frontier Science Program Organization grant: LT -000972/2018.	BENFEY PN, 1993, DEVELOPMENT, V119, P57; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chang YM, 2012, PLANT PHYSIOL, V160, P165, DOI 10.1104/pp.112.203810; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Crawford KM, 2000, CURR BIOL, V10, P1032, DOI 10.1016/S0960-9822(00)00657-6; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; DOLAN L, 1993, DEVELOPMENT, V119, P71; Dong WT, 2021, NATURE, V589, P586, DOI 10.1038/s41586-020-3016-z; Efroni I, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0580-x; Esau K., 1977, Anatomy of seed plants.; Gunawardena AHLAN, 2001, PLANTA, V212, P205, DOI 10.1007/s004250000381; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hughes TE, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.177543; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kaldorf M, 1999, J PLANT PHYSIOL, V154, P718, DOI 10.1016/S0176-1617(99)80250-8; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Liu F, 2018, PLANT CELL PHYSIOL, V59, P1683, DOI 10.1093/pcp/pcy094; Marand AP, 2021, CELL, V184, P3041, DOI 10.1016/j.cell.2021.04.014; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Opitz N, 2016, J EXP BOT, V67, P1095, DOI 10.1093/jxb/erv453; Ortiz-Ramirez Carlos, 2018, Curr Protoc Plant Biol, V3, pe20072, DOI 10.1002/cppb.20072; SENN A, 1980, Z PFLANZENPHYSIOL, V100, P299, DOI 10.1016/S0044-328X(80)80234-0; Slewinski TL, 2014, MOL PLANT, V7, P1388, DOI 10.1093/mp/ssu036; Slewinski TL, 2012, PLANT CELL PHYSIOL, V53, P2030, DOI 10.1093/pcp/pcs147; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Wu S, 2014, P NATL ACAD SCI USA, V111, P16184, DOI 10.1073/pnas.1407371111; Xiao TT, 2019, PLANT CELL, V31, P1751, DOI 10.1105/tpc.19.00008; Xu XS, 2021, DEV CELL, V56, P557, DOI 10.1016/j.devcel.2020.12.015; Zhu JM, 2010, PLANT CELL ENVIRON, V33, P740, DOI 10.1111/j.1365-3040.2009.02099.x	30	10	10	20	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1247	1252		10.1126/science.abj2327	http://dx.doi.org/10.1126/science.abj2327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855479	Green Accepted			2022-12-28	WOS:000728578700056
J	Mayer, T; Venkatesh, A; Berwick, DM				Mayer, Thom; Venkatesh, Arjun; Berwick, Donald M.			Criterion-Based Measurements of Patient Experience in Health Care Eliminating Winners and Losers to Create a New Moral Ethos	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint argues for a change in the assessment of patient experience in health care, moving from norm-based scores and rankings to a criterion-based system with transparent reporting of results.	[Mayer, Thom] Natl Football League Players Assoc, Washington, DC USA; [Mayer, Thom] Duke Univ, Sch Med, Durham, NC USA; [Venkatesh, Arjun] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Venkatesh, Arjun] Yale New Haven Hlth Serv Corp, Ctr Outcomes Res & Evaluat CORE, New Haven, CT USA; [Berwick, Donald M.] Inst Healthcare Improvement, Boston, MA USA	Duke University; Yale University; Institute for Healthcare Improvement	Mayer, T (corresponding author), Natl Football League Players Assoc, 2728 Teton Pines Dr, Wilson, WY 83014 USA.; Mayer, T (corresponding author), Duke Univ, Sch Med, 2728 Teton Pines Dr, Wilson, WY 83014 USA.							American Association of Medical Colleges, CURR REP GRAD SYST U; [Anonymous], 2021, HCAHPS STAR RAT TECH; Bae JA, 2020, JAMA-J AM MED ASSOC, V324, P839, DOI 10.1001/jama.2020.11165; Berwick D M, 1995, Qual Manag Health Care, V4, P27; Berwick DM, 2016, JAMA-J AM MED ASSOC, V315, P1329, DOI 10.1001/jama.2016.1509; Kohn A., 2019, NEW YORK TIMES; Muller JZ., 2018, TYRANNY METRICS, P4; Reichheld F., 2011, ULTIMATE QUESTION 2; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752; West CP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9385	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2021	326	24					2471	2472		10.1001/jama.2021.21771	http://dx.doi.org/10.1001/jama.2021.21771		DEC 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC6FM	34854868				2022-12-28	WOS:000725722000002
J	Tanne, JH				Tanne, Janice Hopkins			US Supreme Court seems likely to accept Mississippi law that would limit abortion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Nash E., 2021, 26 STATES ARE CERTAI; Hopkins J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2176	2	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2987	10.1136/bmj.n2987	http://dx.doi.org/10.1136/bmj.n2987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857508				2022-12-28	WOS:000732779300012
J	Limb, M				Limb, Matthew			St John Ambulance volunteers prepare to boost capacity in ambulance trusts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2590; Rimmer A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4680; UK Parliament, 2020, HANS NATL HLTH SERV, V684	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								n2974	10.1136/bmj.n2974	http://dx.doi.org/10.1136/bmj.n2974			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34852993				2022-12-28	WOS:000726688600001
J	Mi, X; Ippoliti, M; Quintana, C; Greene, A; Chen, ZJ; Gross, J; Arute, F; Arya, K; Atalaya, J; Babbush, R; Bardin, JC; Basso, J; Bengtsson, A; Bilmes, A; Bourassa, A; Brill, L; Broughton, M; Buckley, BB; Buell, DA; Burkett, B; Bushnell, N; Chiaro, B; Collins, R; Courtney, W; Debroy, D; Demura, S; Derk, AR; Dunsworth, A; Eppens, D; Erickson, C; Farhi, E; Fowler, AG; Foxen, B; Gidney, C; Giustina, M; Harrigan, MP; Harrington, SD; Hilton, J; Ho, A; Hong, S; Huang, T; Huff, A; Huggins, WJ; Ioffe, LB; Isakov, SV; Iveland, J; Jeffrey, E; Jiang, Z; Jones, C; Kafri, D; Khattar, T; Kim, S; Kitaev, A; Klimov, PV; Korotkov, AN; Kostritsa, F; Landhuis, D; Laptev, P; Lee, J; Lee, K; Locharla, A; Lucero, E; Martin, O; McClean, JR; McCourt, T; McEwen, M; Miao, KC; Mohseni, M; Montazeri, S; Mruczkiewicz, W; Naaman, O; Neeley, M; Neill, C; Newman, M; Niu, MY; O'Brien, TE; Opremcak, A; Ostby, E; Pato, B; Petukhov, A; Rubin, NC; Sank, D; Satzinger, KJ; Shvarts, V; Su, Y; Strain, D; Szalay, M; Trevithick, MD; Villalonga, B; White, T; Yao, ZJ; Yeh, P; Yoo, JW; Zalcman, A; Neven, H; Boixo, S; Smelyanskiy, V; Megrant, A; Kelly, J; Chen, Y; Sondhi, SL; Moessner, R; Kechedzhi, K; Khemani, V; Roushan, P				Mi, Xiao; Ippoliti, Matteo; Quintana, Chris; Greene, Ami; Chen, Zijun; Gross, Jonathan; Arute, Frank; Arya, Kunal; Atalaya, Juan; Babbush, Ryan; Bardin, Joseph C.; Basso, Joao; Bengtsson, Andreas; Bilmes, Alexander; Bourassa, Alexandre; Brill, Leon; Broughton, Michael; Buckley, Bob B.; Buell, David A.; Burkett, Brian; Bushnell, Nicholas; Chiaro, Benjamin; Collins, Roberto; Courtney, William; Debroy, Dripto; Demura, Sean; Derk, Alan R.; Dunsworth, Andrew; Eppens, Daniel; Erickson, Catherine; Farhi, Edward; Fowler, Austin G.; Foxen, Brooks; Gidney, Craig; Giustina, Marissa; Harrigan, Matthew P.; Harrington, Sean D.; Hilton, Jeremy; Ho, Alan; Hong, Sabrina; Huang, Trent; Huff, Ashley; Huggins, William J.; Ioffe, L. B.; Isakov, Sergei, V; Iveland, Justin; Jeffrey, Evan; Jiang, Zhang; Jones, Cody; Kafri, Dvir; Khattar, Tanuj; Kim, Seon; Kitaev, Alexei; Klimov, Paul, V; Korotkov, Alexander N.; Kostritsa, Fedor; Landhuis, David; Laptev, Pavel; Lee, Joonho; Lee, Kenny; Locharla, Aditya; Lucero, Erik; Martin, Orion; McClean, Jarrod R.; McCourt, Trevor; McEwen, Matt; Miao, Kevin C.; Mohseni, Masoud; Montazeri, Shirin; Mruczkiewicz, Wojciech; Naaman, Ofer; Neeley, Matthew; Neill, Charles; Newman, Michael; Niu, Murphy Yuezhen; O'Brien, Thomas E.; Opremcak, Alex; Ostby, Eric; Pato, Balint; Petukhov, Andre; Rubin, Nicholas C.; Sank, Daniel; Satzinger, Kevin J.; Shvarts, Vladimir; Su, Yuan; Strain, Doug; Szalay, Marco; Trevithick, Matthew D.; Villalonga, Benjamin; White, Theodore; Yao, Z. Jamie; Yeh, Ping; Yoo, Juhwan; Zalcman, Adam; Neven, Hartmut; Boixo, Sergio; Smelyanskiy, Vadim; Megrant, Anthony; Kelly, Julian; Chen, Yu; Sondhi, S. L.; Moessner, Roderich; Kechedzhi, Kostyantyn; Khemani, Vedika; Roushan, Pedram			Time-crystalline eigenstate order on a quantum processor	NATURE			English	Article								Quantum many-body systems display rich phase structure in their low-temperature equilibrium states(1). However, much of nature is not in thermal equilibrium. Remarkably, it was recently predicted that out-of-equilibrium systems can exhibit novel dynamical phases(2-8) that may otherwise be forbidden by equilibrium thermodynamics, a paradigmatic example being the discrete time crystal (DTC)(7,9-15). Concretely, dynamical phases can be defined in periodically driven many-body-localized (MBL) systems via the concept of eigenstate order(7,16,17). In eigenstate-ordered MBL phases, the entire many-body spectrum exhibits quantum correlations and long-range order, with characteristic signatures in late-time dynamics from all initial states. It is, however, challenging to experimentally distinguish such stable phases from transient phenomena, or from regimes in which the dynamics of a few select states can mask typical behaviour. Here we implement tunable controlled-phase (CPHASE) gates on an array of superconducting qubits to experimentally observe an MBL-DTC and demonstrate its characteristic spatiotemporal response for generic initial states(7,9,10). Our work employs a time-reversal protocol to quantify the impact of external decoherence, and leverages quantum typicality to circumvent the exponential cost of densely sampling the eigenspectrum. Furthermore, we locate the phase transition out of the DTC with an experimental finite-size analysis. These results establish a scalable approach to studying non-equilibrium phases of matter on quantum processors.	[Mi, Xiao; Quintana, Chris; Greene, Ami; Chen, Zijun; Gross, Jonathan; Arute, Frank; Arya, Kunal; Atalaya, Juan; Babbush, Ryan; Bardin, Joseph C.; Basso, Joao; Bengtsson, Andreas; Bilmes, Alexander; Bourassa, Alexandre; Brill, Leon; Broughton, Michael; Buckley, Bob B.; Buell, David A.; Burkett, Brian; Bushnell, Nicholas; Chiaro, Benjamin; Collins, Roberto; Courtney, William; Debroy, Dripto; Demura, Sean; Derk, Alan R.; Dunsworth, Andrew; Eppens, Daniel; Erickson, Catherine; Farhi, Edward; Fowler, Austin G.; Foxen, Brooks; Gidney, Craig; Giustina, Marissa; Harrigan, Matthew P.; Harrington, Sean D.; Hilton, Jeremy; Ho, Alan; Hong, Sabrina; Huang, Trent; Huff, Ashley; Huggins, William J.; Ioffe, L. B.; Isakov, Sergei, V; Iveland, Justin; Jeffrey, Evan; Jiang, Zhang; Jones, Cody; Kafri, Dvir; Khattar, Tanuj; Kim, Seon; Kitaev, Alexei; Klimov, Paul, V; Korotkov, Alexander N.; Kostritsa, Fedor; Landhuis, David; Laptev, Pavel; Lee, Joonho; Lee, Kenny; Locharla, Aditya; Lucero, Erik; Martin, Orion; McClean, Jarrod R.; McCourt, Trevor; McEwen, Matt; Miao, Kevin C.; Mohseni, Masoud; Montazeri, Shirin; Mruczkiewicz, Wojciech; Naaman, Ofer; Neeley, Matthew; Neill, Charles; Newman, Michael; Niu, Murphy Yuezhen; O'Brien, Thomas E.; Opremcak, Alex; Ostby, Eric; Pato, Balint; Petukhov, Andre; Rubin, Nicholas C.; Sank, Daniel; Satzinger, Kevin J.; Shvarts, Vladimir; Su, Yuan; Strain, Doug; Szalay, Marco; Trevithick, Matthew D.; Villalonga, Benjamin; White, Theodore; Yao, Z. Jamie; Yeh, Ping; Yoo, Juhwan; Zalcman, Adam; Neven, Hartmut; Boixo, Sergio; Smelyanskiy, Vadim; Megrant, Anthony; Kelly, Julian; Chen, Yu; Kechedzhi, Kostyantyn; Roushan, Pedram] Google Res, Mountain View, CA 94043 USA; [Ippoliti, Matteo; Khemani, Vedika] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Bardin, Joseph C.] Univ Massachusetts, Dept Elect & Comp Engn, Amherst, MA 01003 USA; [Bourassa, Alexandre] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Korotkov, Alexander N.] Univ Calif Riverside, Dept Elect & Comp Engn, Riverside, CA 92521 USA; [Lee, Joonho] Columbia Univ, Dept Chem, New York, NY 10027 USA; [McEwen, Matt] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Sondhi, S. L.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Sondhi, S. L.] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford, England; [Moessner, Roderich] Max Planck Inst Phys Komplexer Syst, Dresden, Germany	Google Incorporated; Stanford University; University of Massachusetts System; University of Massachusetts Amherst; University of Chicago; University of California System; University of California Riverside; Columbia University; University of California System; University of California Santa Barbara; Princeton University; University of Oxford; Max Planck Society	Roushan, P (corresponding author), Google Res, Mountain View, CA 94043 USA.; Khemani, V (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	vkhemani@stanford.edu; pedramr@googre.com	Su, Yuan/GYA-2675-2022		Defense Advanced Research Projects Agency via the DRINQS programme; Google Research Award: Quantum Hardware For Scientific Research In Physics; Sloan Foundation through a Sloan Research Fellowship; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF8686]; Deutsche Forschungsgemeinschaft [SFB 1143, 247310070, EXC 2147, 390858490]; Leverhulme International Professorship	Defense Advanced Research Projects Agency via the DRINQS programme; Google Research Award: Quantum Hardware For Scientific Research In Physics; Sloan Foundation through a Sloan Research Fellowship(Alfred P. Sloan Foundation); Gordon and Betty Moore Foundation's EPiQS Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leverhulme International Professorship	This work was supported in part by the Defense Advanced Research Projects Agency via the DRINQS programme (M.I., V.K., R.M. and S.L.S.), by a Google Research Award: Quantum Hardware For Scientific Research In Physics (V.K. and M.I.), and by the Sloan Foundation through a Sloan Research Fellowship (V.K.) The views, opinions and/or findings expressed are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the US Government. M.I. was funded in part by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF8686. This work was partly supported by the Deutsche Forschungsgemeinschaft under grant SFB 1143 (project-id 247310070), the cluster of excellence ct.qmat (EXC 2147, project-id 390858490) and a Leverhulme International Professorship (S.L.S.).	Abanin DA, 2021, ANN PHYS-NEW YORK, V427, DOI 10.1016/j.aop.2021.168415; Abanin DA, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.021001; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Bordia P, 2017, NAT PHYS, V13, P460, DOI [10.1038/NPHYS4020, 10.1038/nphys4020]; Bukov M, 2015, ADV PHYS, V64, P139, DOI 10.1080/00018732.2015.1055918; EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; Else DV, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011026; Else DV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.090402; Faraday M., 1831, PHILOS T R SOC LONDO, VA52, P299, DOI [DOI 10.1098/RSTL.1831.0018, 10.1098/rstl.1831.0018]; Goldstein S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.050403; Harper F, 2020, ANNU REV CONDEN MA P, V11, P345, DOI 10.1146/annurev-conmatphys-031218-013721; Ho WW, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.010602; Ho WW, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.094302; Huse DA, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014206; Ippoliti M, 2021, PRX QUANTUM, V2, DOI 10.1103/PRXQuantum.2.030346; Khemani V, 2019, PREPRINT; Khemani V, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.250401; Kjall JA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.107204; Lazarides A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.030402; Luitz DJ, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021046; Mi X, 2021, SCIENCE, V374, P1479, DOI 10.1126/science.abg5029; Mori T, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aabcdf; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Pal A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174411; Pal S, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.180602; Pekker D, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011052; Po HC, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041070; Ponte P, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.140401; Popescu S, 2006, NAT PHYS, V2, P754, DOI 10.1038/nphys444; Randall J, 2021, SCIENCE, V374, P1474, DOI 10.1126/science.abk0603; Richter J, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.230501; Rovny J, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.180603; Rudner MS, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031005; Sacha K, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aa8b38; Titum P, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021013; von Keyserlingk CW, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.085112; Wen X. G., 2007, QUANTUM FIELD THEORY; Wilczek F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160401; Yates D. J., 2021, LONG LIVED PI EDGE M	45	35	35	19	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					531	+		10.1038/s41586-021-04257-w	http://dx.doi.org/10.1038/s41586-021-04257-w		NOV 2021	7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34847568	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000744785600001
J	Wilkinson, E				Wilkinson, Emma			Reaching net zero carbon emissions in health systems	LANCET			English	Editorial Material								14 countries have now pledged to develop a carbon-neutral health system. The question now is: how will they do it? Emma Wilkinson reports.											0	2	2	3	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					1953	1954		10.1016/S0140-6736(21)02642-8	http://dx.doi.org/10.1016/S0140-6736(21)02642-8		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XD7PT	34800426				2022-12-28	WOS:000722897200011
J	Richterman, A; Richard-Greenblatt, M; Whitaker, K				Richterman, Aaron; Richard-Greenblatt, Melissa; Whitaker, Kathryn			Back Pain, Fever, and Cough in a 46-Year-Old Man Pott disease (tuberculous spondylitis)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								A 46-year-old man with a history of travel to India had 3 months of upper back pain and 2 weeks of dry cough and subjective fevers that did not improve with empirical azithromycin. Chest CT showed a dense consolidation in the left lower lobe; MRI showed a paraspinal mass with extensive contrast enhancement in the lower thoracic vertebral bodies and relative sparing of the disks. What is the diagnosis and what would you do next?	[Richterman, Aaron; Whitaker, Kathryn] Univ Penn, Div Infect Dis, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Richard-Greenblatt, Melissa] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Whitaker, K (corresponding author), Univ Penn, Div Infect Dis, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Kathryn.Whitaker@pennmedicine.upenn.edu		Richterman, Aaron/0000-0001-7920-7191				Batirel A, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.013; Ferrer MF, 2012, INT ORTHOP, V36, P221, DOI 10.1007/s00264-011-1414-4; Griffiths DL, 1999, INT ORTHOP, V23, P73; Johansen IS, 2015, CLIN INFECT DIS, V61, P554, DOI 10.1093/cid/civ326; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; Pertuiset E, 1999, MEDICINE, V78, P309, DOI 10.1097/00005792-199909000-00003; Shikhare SN, 2011, SEMIN MUSCULOSKEL R, V15, P446, DOI 10.1055/s-0031-1293491; Trecarichi EM, 2012, EUR REV MED PHARMACO, V16, P58	9	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2070	2071		10.1001/jama.2021.17584	http://dx.doi.org/10.1001/jama.2021.17584			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812888				2022-12-28	WOS:000724001500027
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: E-consultations are increasing the GP workload	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2867	10.1136/bmj.n2867	http://dx.doi.org/10.1136/bmj.n2867			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815221	Bronze			2022-12-28	WOS:000722577100008
J	Saul, H; Gursul, D				Saul, Helen; Gursul, Deniz			Group programmes for weight loss may be more effective than one-to-one sessions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz] NIHR Ctr Engagement & Disseminat, Twickenham, England		Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						National Institute for Health and Care Excellence, 2014, 2014 NICE CLIN GUID	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2021	375								n2771	10.1136/bmj.n2771	http://dx.doi.org/10.1136/bmj.n2771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3LL	34810160				2022-12-28	WOS:000730089900008
J	Schummers, L; Darling, EK; Dunn, S; McGrail, K; Gayowsky, A; Law, MR; Laba, TL; Kaczorowski, J; Norman, WV				Schummers, Laura; Darling, Elizabeth K.; Dunn, Sheila; McGrail, Kimberlyn; Gayowsky, Anastasia; Law, Michael R.; Laba, Tracey-Lea; Kaczorowski, Janusz; Norman, Wendy V.			Abortion Safety and Use with Normally Prescribed Mifepristone in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERRUPTED TIME-SERIES; MEDICAL ABORTION; UNITED-STATES; REGRESSION; PREGNANCY	Abortion Outcomes with Unrestricted Mifepristone Using population-based administrative data from Ontario, investigators found that after mifepristone became available with a normal prescription, the abortion rate remained relatively stable, the proportion of abortions provided by medication increased rapidly, and adverse events and complications remained stable, as compared with the period when mifepristone was unavailable. Background In the United States, mifepristone is available for medical abortion (for use with misoprostol) only with Risk Evaluation and Mitigation Strategy (REMS) restrictions, despite an absence of evidence to support such restrictions. Mifepristone has been available in Canada with a normal prescription since November 2017. Methods Using population-based administrative data from Ontario, Canada, we examined abortion use, safety, and effectiveness using an interrupted time-series analysis comparing trends in incidence before mifepristone was available (January 2012 through December 2016) with trends after its availability without restrictions (November 7, 2017, through March 15, 2020). Results A total of 195,183 abortions were performed before mifepristone was available and 84,032 after its availability without restrictions. After the availability of mifepristone with a normal prescription, the abortion rate continued to decline, although more slowly than was expected on the basis of trends before mifepristone had been available (adjusted risk difference in time-series analysis, 1.2 per 1000 female residents between 15 and 49 years of age; 95% confidence interval [CI], 1.1 to 1.4), whereas the percentage of abortions provided as medical procedures increased from 2.2% to 31.4% (adjusted risk difference, 28.8 percentage points; 95% CI, 28.0 to 29.7). There were no material changes between the period before mifepristone was available and the nonrestricted period in the incidence of severe adverse events (0.03% vs. 0.04%; adjusted risk difference, 0.01 percentage points; 95% CI, -0.06 to 0.03), complications (0.74% vs. 0.69%; adjusted risk difference, 0.06 percentage points; 95% CI, -0.07 to 0.18), or ectopic pregnancy detected after abortion (0.15% vs. 0.22%; adjusted risk difference, -0.03 percentage points; 95% CI, -0.19 to 0.09). There was a small increase in ongoing intrauterine pregnancy continuing to delivery (adjusted risk difference, 0.08%; 95% CI, 0.04 to 0.10). Conclusions After mifepristone became available as a normal prescription, the abortion rate remained relatively stable, the proportion of abortions provided by medication increased rapidly, and adverse events and complications remained stable, as compared with the period when mifepristone was unavailable. (Funded by the Canadian Institutes of Health Research and the Women's Health Research Institute.)	[Schummers, Laura; Norman, Wendy V.] Univ British Columbia, Dept Family Practice, 5950 Univ Blvd, Vancouver, BC V6T 1Z3, Canada; [McGrail, Kimberlyn; Law, Michael R.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Schummers, Laura; Darling, Elizabeth K.; Gayowsky, Anastasia] McMaster Univ, ICES, Hamilton, ON, Canada; [Darling, Elizabeth K.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Dunn, Sheila] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Dunn, Sheila] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Kaczorowski, Janusz] Univ Montreal, Dept Family & Emergency Med, Montreal, PQ, Canada; [Laba, Tracey-Lea] Univ Technol, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia; [Norman, Wendy V.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Publ Hlth Environm & Soc, London, England	University of British Columbia; University of British Columbia; McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; Universite de Montreal; University of Technology Sydney; University of London; London School of Hygiene & Tropical Medicine	Norman, WV (corresponding author), Univ British Columbia, Dept Family Practice, 5950 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	wendy.norman@ubc.ca	Norman, Wendy V./D-6796-2015; Laba, Tracey-Lea/H-8908-2013	Norman, Wendy V./0000-0003-4340-7882; Schummers, Laura/0000-0003-3536-0498; Laba, Tracey-Lea/0000-0002-5182-9092	Canadian Institutes of Health Research [PJT-168964]; Women's Health Research Institute of the Provincial Health Services Authority of British Columbia; Government of Ontario Ministry of Health; Ministry of Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women's Health Research Institute of the Provincial Health Services Authority of British Columbia; Government of Ontario Ministry of Health; Ministry of Long-Term Care	Supported by a grant (PJT-168964) from the Canadian Institutes of Health Research and by a grant from the Women's Health Research Institute of the Provincial Health Services Authority of British Columbia.; We thank staff members at ICES, which is supported by the Government of Ontario Ministry of Health and the Ministry of Long-Term Care, for their assistance with data management; staff members at IQVIA Solutions Canada for use of their Drug Information File; and our fellow members of the Canadian Contraception and Abortion Research Team for their contributions to the study.	Aiken ARA, 2021, BJOG-INT J OBSTET GY, V128, P1464, DOI 10.1111/1471-0528.16668; American College of Obstetricians and Gynecologists, 2018, IMPROVING ACCESS MIF; Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Baird B, 2015, REPROD HEALTH MATTER, V23, P169, DOI 10.1016/j.rhm.2015.10.002; Berard V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112401; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Brown BP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.24610; Chong ER, 2021, CONTRACEPTION, V104, P43, DOI 10.1016/j.contraception.2021.03.019; Cleland K, 2013, OBSTET GYNECOL, V121, P166, DOI [http://10.1097/AOG.0b013e3182755763, 10.1097/AOG.0b013e3182755763]; Comm Practice Bulletins Gyneco, 2020, OBSTET GYNECOL, V136, pE31, DOI 10.1097/AOG.0000000000004082; Costescu D, 2018, J OBSTET GYNAECOL CA, V40, P750, DOI 10.1016/j.jogc.2017.12.010; Costescu D, 2016, J OBSTET GYNAECOL CA, V38, P366, DOI 10.1016/j.jogc.2016.01.002; Devane C, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0520-8; FERRIS LE, 1995, CAN MED ASSOC J, V152, P1801; Gambir K, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003934; Gissler M, 2012, BJOG-INT J OBSTET GY, V119, P324, DOI 10.1111/j.1471-0528.2011.03189.x; Grant K., 2017, GLOBE MAIL; Grimes DA, 2006, AM J OBSTET GYNECOL, V194, P92, DOI 10.1016/j.ajog.2005.06.070; Guilbert ER, 2016, CAN FAM PHYSICIAN, V62, pE201; Gynuity Health Projects, 2017, MAP MIFEPRISTONE APP; Hategeka C, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003567; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Health Canada, 2015, REGULATORY DECISION; Health Canada, 2017, MIFEGYMISO HLTH CANA; ICES, MISSION VISION VALUE; Jatlaoui TC, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6625a1; Jones HE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186487; Kulier R, 2011, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002855.PUB3; Kulier R, 2011, CONTRACEPTION, V83, P30, DOI 10.1016/j.contraception.2010.06.014; Matheson FI, 2017, 2011 ONTARIO MARGINA; Munro S, 2020, ANN FAM MED, V18, P413, DOI 10.1370/afm.2562; Nelson BK, 1998, ACAD EMERG MED, V5, P739, DOI 10.1111/j.1553-2712.1998.tb02493.x; Raymond EG, 2017, NEW ENGL J MED, V376, P790, DOI 10.1056/NEJMsb1612526; Saeed S, 2018, INT J PUBLIC HEALTH, V63, P547, DOI 10.1007/s00038-018-1091-9; Samiedaluie S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1485-4; Turner SL, 2021, RES SYNTH METHODS, V12, P106, DOI 10.1002/jrsm.1435; United Nations High Commissioner for Human Rights, 2020, INFORM SERIES SEXUAL; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; World Health Organization, 2021, WOMEN REPROD AGE 15	39	5	5	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					57	67		10.1056/NEJMsa2109779	http://dx.doi.org/10.1056/NEJMsa2109779		DEC 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC1QX	34879191	Bronze, Green Accepted			2022-12-28	WOS:000728089600001
J	Fawzy, AM; Lip, GYH				Fawzy, Ameenathul M.; Lip, Gregory Y. H.			In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fawzy, Ameenathul M.; Lip, Gregory Y. H.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England	Liverpool Heart & Chest Hospital	Fawzy, AM (corresponding author), Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England.							Kim HS, 2020, LANCET, V396, P1079, DOI 10.1016/S0140-6736(20)31791-8	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC	2021	174	12					JC138	JC138		10.7326/ACPJ202112210-138	http://dx.doi.org/10.7326/ACPJ202112210-138		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0OD	34871060				2022-12-28	WOS:000729197600001
J	Zhang, Y; Quigley, A; Wang, QY; MacIntyre, CR				Zhang, Yi; Quigley, Ashley; Wang, Quanyi; MacIntyre, C. Raina			Non-pharmaceutical interventions during the roll out of covid-19 vaccines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSMISSION		[Zhang, Yi; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing Res Ctr Prevent Med, Beijing 100013, Peoples R China; [Quigley, Ashley; MacIntyre, C. Raina] Univ New South Wales, Kirby Inst, Biosecur Program, Kensington, NSW 2052, Australia	University of New South Wales Sydney; Kirby Institute	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing Res Ctr Prevent Med, Beijing 100013, Peoples R China.	bjcdcxm@126.com		WANG, QUANYI/0000-0001-9552-2503				Abo SMC, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040761; Anderson RM, 2020, LANCET, V396, P1614, DOI 10.1016/S0140-6736(20)32318-7; Baraniuk C, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1960; Bo YC, 2021, INT J INFECT DIS, V102, P247, DOI 10.1016/j.ijid.2020.10.066; Brooks JT, 2021, JAMA-J AM MED ASSOC, V325, P998, DOI 10.1001/jama.2021.1505; Brown CM, 2021, MMWR-MORBID MORTAL W, V70, P1059, DOI 10.15585/mmwr.mm7031e2; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Flaskerud JH, 2020, ISSUES MENT HEALTH N, V41, P846, DOI 10.1080/01612840.2020.1779883; Fricke LM, 2021, J INFECTION, V82, P1, DOI 10.1016/j.jinf.2020.11.039; Hannah R, 2020, OUR WORLD DATA; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Liu Y, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab124; MacIntyre CR, 2022, VACCINE, V40, P2506, DOI 10.1016/j.vaccine.2021.04.042; MacIntyre CR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012330; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n432; Nakamoto I, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/22321; Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315; Sandmann FG, 2021, LANCET INFECT DIS, V21, P962, DOI 10.1016/S1473-3099(21)00079-7; Vanden Driessche K, 2021, LANCET RESP MED, V9, P340, DOI 10.1016/S2213-2600(21)00020-5; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794; World Health Organization, 2020, HOM COTT MASK DEAF H; Yang J, 2021, NAT HUM BEHAV, V5, P1009, DOI 10.1038/s41562-021-01155-z	25	9	10	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2314	10.1136/bmj.n2314	http://dx.doi.org/10.1136/bmj.n2314			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34853011	Green Published, hybrid			2022-12-28	WOS:000732779300014
J	Dyer, C				Dyer, Clare			Voluntary erasure of Northern Ireland neurologist being investigated for poor diagnosis to be challenged	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2958	10.1136/bmj.n2958	http://dx.doi.org/10.1136/bmj.n2958			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH5YO	34848486				2022-12-28	WOS:000725509900005
J	Varshney, N				Varshney, Natasha			Recycling in the NHS-where does the buck stop?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], Waste in the NHS-Key Facts; [Anonymous], PLASTIC PRODUCTS PAC	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2948	10.1136/bmj.n2948	http://dx.doi.org/10.1136/bmj.n2948			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34845006	Bronze			2022-12-28	WOS:000740896100014
J	Wise, J				Wise, Jacqui			Sixty seconds on ... trust in scientists	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, WELLCOME GLOBAL MONI; Murugesu J., NEW SCI, V2021	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								n2942	10.1136/bmj.n2942	http://dx.doi.org/10.1136/bmj.n2942			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34845058				2022-12-28	WOS:000740896100010
J	Jaffe, S				Jaffe, Susan			Therarlos founder counters fraud charges in federal trial	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 27	2021	398	10315					1952	1952						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XD7PT	34838165				2022-12-28	WOS:000722897200010
J	Alderton, G; Scanlon, ST				Alderton, Gemma; Scanlon, Seth Thomas			INFLAMMATION An expanding view	SCIENCE			English	Editorial Material																			0	0	0	12	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1068	1069		10.1126/science.abn1721	http://dx.doi.org/10.1126/science.abn1721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822288				2022-12-28	WOS:000725668600035
J	Dixit, A				Dixit, Avika			Too tired to stay	SCIENCE			English	Editorial Material									[Dixit, Avika] Moderna Therapeut, Clin Dev, Cambridge, MA 02139 USA		Dixit, A (corresponding author), Moderna Therapeut, Clin Dev, Cambridge, MA 02139 USA.	SciCareerEditor@aaas.org							0	0	0	5	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1166	1166						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34843400				2022-12-28	WOS:000725668600053
J	Edgell, C				Edgell, Caitlin			Open access for human-and planetary-health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edgell, Caitlin] Oxford PharmaGenesis, Oxford, England		Edgell, C (corresponding author), Oxford PharmaGenesis, Oxford, England.							[Anonymous], 2019, BBC NEWS 0501; [Anonymous], 2018, GLOB WARM 1 5 IPCC; [Anonymous], 2019, BUS LEAD DECL CLIM E; [Anonymous], 2016, STAT DAT SHAR PUBL H; [Anonymous], 2019, U BRIST DECL CLIM EM; [Anonymous], 2020, SHAR RES DAT FIND RE; Atwoli L, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1734; Finley K., 2020, WIRED; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2913	10.1136/bmj.n2913	http://dx.doi.org/10.1136/bmj.n2913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836928	Bronze			2022-12-28	WOS:000727787900008
J	Limb, M				Limb, Matthew			Ministers and national leaders are failing to model compassionate treatment of staff, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2430; Rimmer A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2594	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2930	10.1136/bmj.n2930	http://dx.doi.org/10.1136/bmj.n2930			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836879				2022-12-28	WOS:000727787900015
J	Wu, YC; Han, XF; Su, YJ; Glidewell, M; Daniels, JS; Liu, JM; Sengupta, T; Rey-Suarez, I; Fischer, R; Patel, A; Combs, C; Sun, JH; Wu, XF; Christensen, R; Smith, C; Bao, LY; Sun, YL; Duncan, LH; Chen, JJ; Pommier, Y; Shi, YB; Murphy, E; Roy, S; Upadhyaya, A; Colon-Ramos, D; La Riviere, P; Shroff, H				Wu, Yicong; Han, Xiaofei; Su, Yijun; Glidewell, Melissa; Daniels, Jonathan S.; Liu, Jiamin; Sengupta, Titas; Rey-Suarez, Ivan; Fischer, Robert; Patel, Akshay; Combs, Christian; Sun, Junhui; Wu, Xufeng; Christensen, Ryan; Smith, Corey; Bao, Lingyu; Sun, Yilun; Duncan, Leighton H.; Chen, Jiji; Pommier, Yves; Shi, Yun-Bo; Murphy, Elizabeth; Roy, Sougata; Upadhyaya, Arpita; Colon-Ramos, Daniel; La Riviere, Patrick; Shroff, Hari			Multiview confocal super-resolution microscopy	NATURE			English	Article							LIGHT-SHEET MICROSCOPY; PLANE ILLUMINATION MICROSCOPY; WIDE-FIELD; RESOLUTION; EMBRYOS; SYSTEM	Confocal microscopy(1) remains a major workhorse in biomedical optical microscopy owing to its reliability and flexibility in imaging various samples, but suffers from substantial point spread function anisotropy, diffraction-limited resolution, depth-dependent degradation in scattering samples and volumetric bleaching(2). Here we address these problems, enhancing confocal microscopy performance from the sub-micrometre to millimetre spatial scale and the millisecond to hour temporal scale, improving both lateral and axial resolution more than twofold while simultaneously reducing phototoxicity. We achieve these gains using an integrated, four-pronged approach: (1) developing compact line scanners that enable sensitive, rapid, diffraction-limited imaging over large areas; (2) combining line-scanning with multiview imaging, developing reconstruction algorithms that improve resolution isotropy and recover signal otherwise lost to scattering; (3) adapting techniques from structured illumination microscopy, achieving super-resolution imaging in densely labelled, thick samples; (4) synergizing deep learning with these advances, further improving imaging speed, resolution and duration. We demonstrate these capabilities on more than 20 distinct fixed and live samples, including protein distributions in single cells; nuclei and developing neurons in Caenorhabditis elegans embryos, larvae and adults; myoblasts in imaginal disks of Drosophila wings; and mouse renal, oesophageal, cardiac and brain tissues.	[Wu, Yicong; Han, Xiaofei; Su, Yijun; Christensen, Ryan; Shroff, Hari] Natl Inst Biomed Imaging & Bioengn, Lab High Resolut Opt Imaging, NIH, Bethesda, MD 20892 USA; [Han, Xiaofei] Tsinghua Univ, Dept Automat, Beijing, Peoples R China; [Su, Yijun] Leica Microsyst, Buffalo Grove, IL USA; [Su, Yijun] SVision, Bellevue, WA USA; [Glidewell, Melissa; Daniels, Jonathan S.] Appl Sci Instrumentat, Eugene, OR USA; [Liu, Jiamin; Chen, Jiji; Shroff, Hari] NIH, Adv Imaging & Microscopy Resource, Bldg 10, Bethesda, MD 20892 USA; [Sengupta, Titas; Duncan, Leighton H.; Colon-Ramos, Daniel] Yale Univ, Dept Neurosci, Sch Med, New Haven, CT USA; [Sengupta, Titas; Duncan, Leighton H.; Colon-Ramos, Daniel] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Rey-Suarez, Ivan; Upadhyaya, Arpita] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Fischer, Robert] NHLBI, Cell & Dev Biol Ctr, Bldg 10, Bethesda, MD 20892 USA; [Patel, Akshay; Roy, Sougata] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Combs, Christian; Wu, Xufeng] NHLBI, Light Microscopy Facil, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sun, Junhui; Murphy, Elizabeth] NHLBI, Lab Cardiac Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Smith, Corey; La Riviere, Patrick] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Bao, Lingyu; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, Bethesda, MD USA; [Sun, Yilun; Pommier, Yves] NIH, Lab Mol Pharmacol, Dev Therapeut Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Upadhyaya, Arpita] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Colon-Ramos, Daniel; La Riviere, Patrick; Shroff, Hari] Marine Biol Lab, Woods Hole, MA 02543 USA; [Colon-Ramos, Daniel] Univ Puerto Rico, Inst Neurobiol, Recinto Ciencias Med, San Juan, PR 00901 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Tsinghua University; National Institutes of Health (NIH) - USA; Yale University; Yale University; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; Marine Biological Laboratory - Woods Hole; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Wu, YC (corresponding author), Natl Inst Biomed Imaging & Bioengn, Lab High Resolut Opt Imaging, NIH, Bethesda, MD 20892 USA.	yicong.wu@nih.gov		Fischer, Robert/0000-0003-0650-2696; Patel, Akshay/0000-0001-6176-2496; Sun, Yilun/0000-0002-6249-2704; Wu, Yicong/0000-0002-8819-7527; Shi, Yun-Bo/0000-0002-6330-0639	NIH; Chinese Scholar Council; National Institute of Biomedical Imaging and Bioengineering; National Institute of Heart, Lung, and Blood; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute within the National Institutes of Health; National Institute of General Medical Sciences of the NIH [R25GM109439]; NIBIB [T32 EB002103]; Center for Cancer Research, the Intramural Program of the National Cancer Institute, NIH [Z01-BC 006150]; Gordon and Betty Moore Foundation; NIH [R01 GM131054, R35GM124878]; Whitman and Fellows programme at MBL; Office of Data Science Strategy, NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholar Council; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Heart, Lung, and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute within the National Institutes of Health; National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Center for Cancer Research, the Intramural Program of the National Cancer Institute, NIH; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitman and Fellows programme at MBL; Office of Data Science Strategy, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Liu and F. Zhang from the NHLBI Transgenic Core for making the TOMM20-mNeonGreen transgenic mouse line; E.Jorgensen, C. Frokjaer-Jensen and M. Rich for sharing the EG6994 C. elegans strain; L. Samelson for the gift of the Jurkat T cells; G.Patterson for the H2B-GFP plasmid; J. Hammer for the F-tractin-tdTomato plasmid; N.Koonce and L.Shao for sharing images of larvae imaged with spinning-disk microscopy and iSIM; SVision LLC for maintaining and updating the 3D RCAN GitHub site; X.Li for assistance with imaging samples on the OMX 3D SIM; E.Tyler and A.Hoofring (NIH Medical Arts) for help with figure preparation; R.Leapman, H. Eden, S.Parekh and M.Guo for feedback on the manuscript; Q.Dai for supporting X.H.'s visit to H.S.'s lab; and C.Waterman for supporting R.F's participation in this project. We thank the Research Center for Minority Institutions programme, the Marine Biological Laboratories (MBL) and the Instituto de Neurobiologia de la Universidad de Puerto Rico for providing meeting and brainstorming platforms. H.S., P.L.R. and D.C.-R. acknowledge the Whitman and Fellows programme at MBL for providing funding and space for discussions valuable to this work. Research in the D.C.-R. lab was supported by NIH was supported by an international exchange fellowship from the Chinese Scholar Council. This research was supported by the intramural research programmes of the National Institute of Biomedical Imaging and Bioengineering; National Institute of Heart, Lung, and Blood; Eunice Kennedy Shriver National Institute of Child Health and Human Development; and the National Cancer Institute within the National Institutes of Health. C.S. acknowledges funding from the National Institute of General Medical Sciences of the NIH under award number R25GM109439 (project title: University of Chicago Initiative for Maximizing Student Development (IMSD)) and NIBIB under grant number T32 EB002103. Y.P. and Y. Sun are supported by the Center for Cancer Research, the Intramural Program of the National Cancer Institute, NIH (Z01-BC 006150). This research is funded in part by the Gordon and Betty Moore Foundation. A.U. acknowledges support from NIH R01 GM131054. S.R. acknowledges support from NIH R35GM124878. This work utilized the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov), and we also thank the Office of Data Science Strategy, NIH, for providing a seed grant enabling us to train deep-learning models using cloud-based computational resources. The NIH and its staff do not recommend or endorse any company, product or service.	Armenti ST, 2014, DEVELOPMENT, V141, P4640, DOI 10.1242/dev.115048; Barth R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2196; Baumgart E, 2012, OPT EXPRESS, V20, P21805, DOI 10.1364/OE.20.021805; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chen JJ, 2021, NAT METHODS, V18, P678, DOI 10.1038/s41592-021-01155-x; Descloux A, 2019, NAT METHODS, V16, P918, DOI 10.1038/s41592-019-0515-7; Duncan LH, 2019, JOVE-J VIS EXP, DOI 10.3791/59533; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Gambarotto D, 2019, NAT METHODS, V16, P71, DOI 10.1038/s41592-018-0238-1; Guo M, 2020, NAT BIOTECHNOL, V38, P1337, DOI 10.1038/s41587-020-0560-x; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Han XF, 2021, LAB CHIP, V21, P1549, DOI 10.1039/d0lc01233e; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/TPAMI.2018.2844175, 10.1109/ICCV.2017.322]; Ji N, 2017, NAT METHODS, V14, P374, DOI 10.1038/nmeth.4218; Kosmach A, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109846; Kruger JR, 2020, BIOMED OPT EXPRESS, V11, P3139, DOI 10.1364/BOE.391787; Kumar A, 2016, BIOL BULL-US, V231, P26, DOI 10.1086/689589; Kumar A, 2014, NAT PROTOC, V9, P2555, DOI 10.1038/nprot.2014.172; Laissue PP, 2017, NAT METHODS, V14, P657, DOI 10.1038/nmeth.4344; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Liu TL, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1392; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Royer LA, 2016, NAT BIOTECHNOL, V34, P1267, DOI 10.1038/nbt.3708; Shroff H., 2019, US patent, Patent No. [10,247,930, 10247930]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tabara H, 1996, NUCLEIC ACIDS RES, V24, P2119, DOI 10.1093/nar/24.11.2119; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Wang HD, 2019, NAT METHODS, V16, P103, DOI 10.1038/s41592-018-0239-0; Weigert M, 2018, NAT METHODS, V15, P1090, DOI 10.1038/s41592-018-0216-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YC, 2018, NAT METHODS, V15, P1011, DOI 10.1038/s41592-018-0211-z; Wu YC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01250-8; Wu YC, 2016, OPTICA, V3, P897, DOI 10.1364/OPTICA.3.000897; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; York AG, 2013, NAT METHODS, V10, P1122, DOI [10.1038/NMETH.2687, 10.1038/nmeth.2687]; Zheng W, 2017, NAT METHODS, V14, P869, DOI [10.1038/NMETH.4337, 10.1038/nmeth.4337]	41	14	14	28	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					279	+		10.1038/s41586-021-04110-0	http://dx.doi.org/10.1038/s41586-021-04110-0		NOV 2021	34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34837071	Green Accepted			2022-12-28	WOS:000722839100004
J	Extance, A				Extance, Andy			mRNA vaccines: hope beneath the hype	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								mRNA vaccines have proven themselves as the most effective covid-19 vaccines, and their makers are now seeking to help conditions from cancer to HIV. Andy Extance investigates their promise and limitations				aextance@virginmedia.com						Feldman RA, 2019, VACCINE, V37, P3326, DOI 10.1016/j.vaccine.2019.04.074; [Anonymous], CHEM ENG NEWS; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Dolgin E, 2021, NAT REV DRUG DISCOV, V20, P801, DOI 10.1038/d41573-021-00176-7; Dolgin E, 2021, NATURE, V597, P318, DOI 10.1038/d41586-021-02483-w; Feinmann J, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2375; HIV.gov, MOD OTH VACC HIV VAC; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kose N, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw6647; Langreth R, BLOOMBERG; Moderna, MOD THER REL MRNA 01; Moderna, MOD OTH VACC CMV VAC; Moderna, PROGR DET; Parsons L., 2021, PFIZER BIONTECH SAY; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sewell HF, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4838; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; World Health Organization, 2021, WHO SUPP S AFR CONS; World Health Organization, PANDEMIC INFLUENZA V	19	7	7	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2744	10.1136/bmj.n2744	http://dx.doi.org/10.1136/bmj.n2744			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819269	Bronze			2022-12-28	WOS:000740893700001
J	Eichenfield, DZ; Sprague, J; Eichenfield, LF				Eichenfield, Dawn Z.; Sprague, Jessica; Eichenfield, Lawrence F.			Management of Acne Vulgaris	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INFLAMMATORY-BOWEL-DISEASE; ORAL TETRACYCLINE-CLASS; EVIDENCE-BASED RECOMMENDATIONS; BENZOYL PEROXIDE; DOUBLE-BLIND; ADAPALENE GEL; SPIRONOLACTONE USE; TOPICAL RETINOIDS; ANDROGEN EXCESS; PARALLEL-GROUP	ImportanceAcne vulgaris is an inflammatory disease of the pilosebaceous unit of the skin that primarily involves the face and trunk and affects approximately 9% of the population worldwide (approximately 85% of individuals aged 12-24 years, and approximately 50% of patients aged 20-29 years). Acne vulgaris can cause permanent physical scarring, negatively affect quality of life and self-image, and has been associated with increased rates of anxiety, depression, and suicidal ideation. ObservationsAcne vulgaris is classified based on patient age, lesion morphology (comedonal, inflammatory, mixed, nodulocystic), distribution (location on face, trunk, or both), and severity (extent, presence or absence of scarring, postinflammatory erythema, or hyperpigmentation). Although most acne does not require specific medical evaluation, medical workup is sometimes warranted. Topical therapies such as retinoids (eg, tretinoin, adapalene), benzoyl peroxide, azelaic acid, and/or combinations of topical agents are first-line treatments. When prescribed as a single therapy in a randomized trial of 207 patients, treatment with tretinoin 0.025% gel reduced acne lesion counts at 12 weeks by 63% compared with baseline. Combinations of topical agents with systemic agents (oral antibiotics such as doxycycline and minocycline, hormonal therapies such as combination oral contraception [COC] or spironolactone, or isotretinoin) are recommended for more severe disease. In a meta-analysis of 32 randomized clinical trials, COC was associated with reductions in inflammatory lesions by 62%, placebo was associated with a 26% reduction, and oral antibiotics were associated with a 58% reduction at 6-month follow-up. Isotretinoin is approved by the US Food and Drug Administration for treating severe recalcitrant nodular acne but is often used to treat resistant or persistent moderate to severe acne, as well as acne that produces scarring or significant psychosocial distress. Conclusions and RelevanceAcne vulgaris affects approximately 9% of the population worldwide and approximately 85% of those aged 12 to 24 years. First-line therapies are topical retinoids, benzoyl peroxide, azelaic acid, or combinations of topicals. For more severe disease, oral antibiotics such as doxycycline or minocycline, hormonal therapies such as combination oral conceptive agents or spironolactone, or isotretinoin are most effective. This review summarizes the characteristics of comedonal, inflammatory, and nodulocystic acne and describes current methods of treatment.	[Eichenfield, Dawn Z.; Sprague, Jessica; Eichenfield, Lawrence F.] Univ Calif San Diego, Sch Med, Dept Dermatol, La Jolla, CA 92123 USA; [Eichenfield, Dawn Z.; Sprague, Jessica; Eichenfield, Lawrence F.] Rady Childrens Hosp, Div Pediat & Adolescent Dermatol, San Diego, CA 92123 USA; [Eichenfield, Lawrence F.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92123 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Eichenfield, LF (corresponding author), Univ Calif San Diego, 3020 Childrens Way,Mail Code 5092, San Diego, CA 92123 USA.; Eichenfield, LF (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,Mail Code 5092, San Diego, CA 92123 USA.	leichenfield@rchsd.org						Agnew Tamara, 2016, J Clin Aesthet Dermatol, V9, P40; Arora MK, 2011, CLIN BIOCHEM, V44, P1035, DOI 10.1016/j.clinbiochem.2011.06.984; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Baldwin Hilary, 2020, J Clin Aesthet Dermatol, V13, P26; Barbaric J, 2018, BRIT J DERMATOL, V178, P61, DOI 10.1111/bjd.15495; Barbieri JS, 2021, BRIT J DERMATOL, V185, P476, DOI 10.1111/bjd.20499; Barbieri JS, 2021, JAMA DERMATOL, V157, P296, DOI 10.1001/jamadermatol.2020.5468; Barbieri JS, 2021, J AM ACAD DERMATOL, V84, P228, DOI 10.1016/j.jaad.2020.07.041; Barbieri JS, 2020, J AM ACAD DERMATOL, V82, P72, DOI 10.1016/j.jaad.2019.06.025; Barbieri JS, 2018, J DRUGS DERMATOL, V17, P632; Barbieri JS, 2017, J AM ACAD DERMATOL, V77, P456, DOI 10.1016/j.jaad.2017.04.016; Barbieri JS, 2016, J AM ACAD DERMATOL, V75, P1142, DOI 10.1016/j.jaad.2016.06.057; Barker RA, 2020, AM J CLIN DERMATOL, V21, P303, DOI 10.1007/s40257-020-00511-5; Baughn E, 2014, J AM ACAD DERMATOL, V71, P450, DOI 10.1016/j.jaad.2014.03.051; Bertolani MB, 2021, DERMATOL THER, V34, DOI 10.1111/dth.14724; Bhate K, 2014, CLIN EXP DERMATOL, V39, P273, DOI 10.1111/ced.12270; Bhate K, 2013, BRIT J DERMATOL, V168, P474, DOI 10.1111/bjd.12149; Biggar RJ, 2013, CANCER EPIDEMIOL, V37, P870, DOI 10.1016/j.canep.2013.10.004; BJELLERUP M, 1987, PHOTODERMATOLOGY, V4, P281; Blasiak RC, 2013, JAMA DERMATOL, V149, P1392, DOI 10.1001/jamadermatol.2013.6746; Bowe WP, 2010, J AM ACAD DERMATOL, V63, P124, DOI 10.1016/j.jaad.2009.07.043; Brown J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000194.pub2; Callender Valerie D, 2014, J Clin Aesthet Dermatol, V7, P19; Chandrashekhar BS, 2015, J CLIN DIAGN RES, V9, pWC4, DOI 10.7860/JCDR/2015/10663.5469; Cooper AJ, 1998, MED J AUSTRALIA, V169, P259, DOI 10.5694/j.1326-5377.1998.tb140250.x; Dai R, 2018, J EUR ACAD DERMATOL, V32, P2244, DOI 10.1111/jdv.15204; Draelos ZD, 2007, J AM ACAD DERMATOL, V56, P439, DOI 10.1016/j.jaad.2006.10.005; Dreno B, 2018, AM J CLIN DERMATOL, V19, P275, DOI 10.1007/s40257-018-0352-y; Droitcourt C, 2019, INT J EPIDEMIOL, V48, P1623, DOI 10.1093/ije/dyz093; Eichenfield LF, 2013, PEDIATRICS, V131, pS163, DOI 10.1542/peds.2013-0490B; Eichenfield LF, 2010, J DRUGS DERMATOL, V9, P1395; Eichenfield LF, 2010, PEDIATRICS, V125, pE1316, DOI 10.1542/peds.2009-3447; Etminan M, 2013, JAMA DERMATOL, V149, P216, DOI 10.1001/jamadermatol.2013.1344; Fallah H, 2021, INT J DERMATOL, V60, P451, DOI 10.1111/ijd.15089; Gabbard RD, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050756; Garg V, 2021, J AM ACAD DERMATOL, V84, P1348, DOI 10.1016/j.jaad.2020.12.071; Gold LS, 2019, J AM ACAD DERMATOL, V80, P168, DOI 10.1016/j.jaad.2018.08.020; Gold LS, 2016, AM J CLIN DERMATOL, V17, P293, DOI 10.1007/s40257-016-0178-4; Goshtasebi A, 2019, CLIN ENDOCRINOL, V90, P517, DOI 10.1111/cen.13932; Goulden V, 1997, BRIT J DERMATOL, V136, P66, DOI 10.1111/j.1365-2133.1997.tb08748.x; Greywal T, 2017, J AM ACAD DERMATOL, V77, P109, DOI 10.1016/j.jaad.2016.11.028; Grosshans E, 1998, BRIT J DERMATOL, V139, P26; Gupta Aditya K, 2004, J Drugs Dermatol, V3, P427; Guzman A K, 2018, Int J Womens Dermatol, V4, P174, DOI 10.1016/j.ijwd.2018.03.006; Halvorsen JA, 2011, J INVEST DERMATOL, V131, P363, DOI 10.1038/jid.2010.264; Handler MZ, 2016, DERMATOL SURG, V42, P573, DOI 10.1097/DSS.0000000000000715; Hansen TJ, 2016, J AM ACAD DERMATOL, V75, P323, DOI 10.1016/j.jaad.2016.03.019; Hebert A, 2020, JAMA DERMATOL, V156, P621, DOI 10.1001/jamadermatol.2020.0465; HEGEMANN L, 1994, BRIT J DERMATOL, V130, P569, DOI 10.1111/j.1365-2133.1994.tb13101.x; Hodgkiss-Harlow CJ, 2011, J AM ACAD DERMATOL, V65, P517, DOI 10.1016/j.jaad.2010.06.040; Iijima S, 2019, J CUTAN IMMUNOL ALL, V2, P108, DOI 10.1002/cia2.12069; JICK SS, 1993, LANCET, V341, P1181, DOI 10.1016/0140-6736(93)91004-6; Kadayifci A, 2004, DIS ESOPHAGUS, V17, P168, DOI 10.1111/j.1442-2050.2004.00384.x; Kann L, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6506a1; Kazandjieva J, 2017, CLIN DERMATOL, V35, P156, DOI 10.1016/j.clindermatol.2016.10.007; Kolli SS, 2019, AM J CLIN DERMATOL, V20, P345, DOI 10.1007/s40257-019-00423-z; Kose O, 2008, PEDIATR DERMATOL, V25, P383, DOI 10.1111/j.1525-1470.2008.00688.x; Krakowski AC, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2008.00667.x; Kumar S., 2019, IP INDIAN J CLIN EXP, V5, P306, DOI [10.18231/j.ijced.2019.064, DOI 10.18231/J.IJCED.2019.064]; Layton AM, 2021, BRIT J DERMATOL, V184, P219, DOI 10.1111/bjd.19477; Lazic Mosler E., 2018, COCHRANE DB SYST REV, V2018, DOI [10.1002/14651858.CD012263.pub2, DOI 10.1002/14651858.CD012263.PUB2]; Lee SY, 2016, EUR J GASTROEN HEPAT, V28, P210, DOI [10.1097/MEG.0000000000000496, 10.1111/jgh.12079]; LEVINE RM, 1983, ARCH DERMATOL, V119, P480, DOI 10.1001/archderm.119.6.480; Leyden James J, 2011, J Clin Aesthet Dermatol, V4, P40; Leyden JJ, 2008, CUTIS, V82, P417; Leyden JJ, 1996, J DERMATOL TREAT, V7, P223, DOI 10.3109/09546639609089553; Liszewski W, 2019, J AM ACAD DERMATOL, V80, P1147, DOI 10.1016/j.jaad.2018.10.023; Mackenzie IS, 2017, BRIT J CLIN PHARMACO, V83, P653, DOI 10.1111/bcp.13152; Margolis DJ, 2010, AM J GASTROENTEROL, V105, P2610, DOI 10.1038/ajg.2010.303; Nor NHM, 2013, J DERMATOL TREAT, V24, P377, DOI 10.3109/09546634.2012.699179; O'Neill AM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0558-5; Opel D, 2017, BRIT J DERMATOL, V177, P960, DOI 10.1111/bjd.15207; Pariser David M, 2019, J Clin Aesthet Dermatol, V12, pE53; Patel M, 2010, J DRUGS DERMATOL, V9, P655; Penso L, 2020, JAMA DERMATOL, V156, P854, DOI 10.1001/jamadermatol.2020.1602; Piette WW, 2008, ARCH DERMATOL, V144, P1564, DOI 10.1001/archdermatol.2008.518; Plovanich M, 2015, JAMA DERMATOL, V151, P941, DOI 10.1001/jamadermatol.2015.34; Poulin Y, 2011, BRIT J DERMATOL, V164, P1376, DOI 10.1111/j.1365-2133.2011.10344.x; Pugashetti R, 2013, DERMATOL THER, V26, P302, DOI 10.1111/dth.12077; Rademaker M, 2016, INT J DERMATOL, V55, P518, DOI 10.1111/ijd.12942; Rademaker M, 2010, AUSTRALAS J DERMATOL, V51, P248, DOI 10.1111/j.1440-0960.2010.00657.x; Raoof TJ, 2020, J AM ACAD DERMATOL, V82, P832, DOI 10.1016/j.jaad.2019.05.078; Schmidt TH, 2016, JAMA DERMATOL, V152, P391, DOI 10.1001/jamadermatol.2015.4498; Schulte BC, 2015, J DRUGS DERMATOL, V14, P964; Singer S, 2019, JAMA DERMATOL, V155, P1162, DOI 10.1001/jamadermatol.2019.1416; Sladden MJ, 2007, ARCH DERMATOL, V143, P1187, DOI 10.1001/archderm.143.9.1187; Smith RN, 2007, AM J CLIN NUTR, V86, P107, DOI 10.1093/ajcn/86.1.107; Stotland M, 2009, AM J CLIN DERMATOL, V10, P221, DOI 10.2165/00128071-200910040-00002; Stringer T, 2018, J DERMATOL TREAT, V29, P688, DOI 10.1080/09546634.2018.1442552; Stuart B, 2021, BRIT J DERMATOL, V185, P512, DOI 10.1111/bjd.20080; Tan A U, 2018, Int J Womens Dermatol, V4, P56, DOI 10.1016/j.ijwd.2017.10.006; Tan JKL, 2015, BRIT J DERMATOL, V172, P3, DOI 10.1111/bjd.13462; Tan J, 2019, J AM ACAD DERMATOL, V80, P1691, DOI 10.1016/j.jaad.2019.02.044; Tan J, 2018, EUR J DERMATOL, V28, P502, DOI 10.1684/ejd.2018.3367; Tan J, 2016, J CUTAN MED SURG, V20, P13, DOI 10.1177/1203475415595776; Tang XQ, 2020, J COSMET DERMATOL-US, V19, P10, DOI 10.1111/jocd.13197; Thiboutot D, 2006, J AM ACAD DERMATOL, V54, P242, DOI 10.1016/j.jaad.2004.10.879; Thiboutot DM, 2006, ARCH DERMATOL, V142, P597, DOI 10.1001/archderm.142.5.597; Trifu V, 2011, BRIT J DERMATOL, V165, P177, DOI 10.1111/j.1365-2133.2011.10332.x; VEXIAU P, 1990, J INVEST DERMATOL, V94, P279, DOI 10.1111/1523-1747.ep12874121; Voutilainen R, 2015, J STEROID BIOCHEM, V145, P226, DOI 10.1016/j.jsbmb.2014.06.004; Yentzer BA, 2010, CUTIS, V86, P103; Yin NC, 2014, AM J CLIN DERMATOL, V15, P7, DOI 10.1007/s40257-013-0049-1; Zaenglein AL, 2006, PEDIATRICS, V118, P1188, DOI 10.1542/peds.2005-2022; Zaenglein AL, 2018, NEW ENGL J MED, V379, P1343, DOI 10.1056/NEJMcp1702493; Zaenglein AL, 2016, J AM ACAD DERMATOL, V74, P945, DOI 10.1016/j.jaad.2015.12.037; Zaenglein AL, 2013, J DRUGS DERMATOL, V12, P619; Zane LT, 2006, ARCH DERMATOL, V142, P1016, DOI 10.1001/archderm.142.8.1016; Zasada M, 2019, POSTEP DERM ALERGOL, V36, P392, DOI 10.5114/ada.2019.87443; Zhanel G, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01297-18; Zimmerman Y, 2014, HUM REPROD UPDATE, V20, P76, DOI 10.1093/humupd/dmt038	111	18	18	13	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2055	2067		10.1001/jama.2021.17633	http://dx.doi.org/10.1001/jama.2021.17633			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812859				2022-12-28	WOS:000724001500025
J	Kumar, D; Ferreira, VH; Hall, VG; Hu, Q; Samson, R; Ku, T; Ierullo, M; Majchrzak-Kita, B; Tomlinson, G; Gingras, AC; Humar, A				Kumar, Deepali; Ferreira, Victor H.; Hall, Victoria G.; Hu, Queenie; Samson, Reuben; Ku, Terrance; Ierullo, Matthew; Majchrzak-Kita, Beata; Tomlinson, George; Gingras, Anne-Claude; Humar, Atul			Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine Secondary Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article								Background: COVID-19 is more severe in transplant recipients. Variants of concern have supplanted wild-type virus. In transplant recipients, data are limited on 2-dose or 3-dose vaccine immunogenicity against variant viruses. Objective: To assess neutralizing antibody responses against SARS-CoV-2 variants in transplant recipients after 2 and 3 vaccine doses. Design: Secondary analysis of a randomized, double-blind, controlled trial of a third dose of mRNA-1273 vaccine versus placebo. (ClinicalTrials.gov: NCT04885907). Setting: Single-center transplant program. Patients: Organ transplant recipients. Intervention: Third dose of mRNA-1273 vaccine versus placebo. Measurements: Sera were analyzed for neutralization against wild-type virus and the Alpha, Beta, and Delta variants using a surrogate virus neutralization assay and a spike-pseudotyped lentivirus assay. Results: A total of 117 transplant recipients were analyzed (60 in the mRNA-1273 group and 57 in the placebo group). Sera were obtained before and 4 to 6 weeks after the third dose. After 2 doses, the proportion of patients with positive neutralization for all 3 variants was small compared with wild-type virus. After the third dose of mRNA-1273 vaccine, the proportion with a positive neutralization response versus placebo was improved for all 3 variants as measured by both assays. Based on the pseudovirus neutralization assay against the Delta variant, 33 of 60 (55%) patients were positive in the mRNA-1273 group versus 10 of 57 (18%) in the placebo group (difference, 37 [95% CI, 19 to 53] percentage points). The differences were 36 (CI, 17 to 51) percentage points for the Alpha variant and 31 (CI, 15 to 46) percentage points for the Beta variant. In the mRNA-1273 group, lower neutralization values were observed for variants compared with wild-type virus, especially the Beta variant. Limitations: There is no clear correlate of protection for neutralizing antibody. This was a secondary analysis. Conclusion: In organ transplant recipients, a third dose of mRNA vaccine increases neutralizing antibody response against SARS-CoV-2 variants compared with placebo. Primary funding source: Ajmera Transplant Centre.	[Kumar, Deepali; Ferreira, Victor H.; Hall, Victoria G.; Ku, Terrance; Ierullo, Matthew; Majchrzak-Kita, Beata; Tomlinson, George; Humar, Atul] Univ Hlth Network, PMB 11-175,585 Univ Ave, Toronto, ON M5G 2N2, Canada; [Hu, Queenie; Samson, Reuben; Gingras, Anne-Claude] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Sinai Hlth, Toronto, ON, Canada; [Samson, Reuben; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Kumar, D (corresponding author), Univ Hlth Network, PMB 11-175,585 Univ Ave, Toronto, ON M5G 2N2, Canada.	deepali.kumar@uhn.ca; atul.humar@uhn.ca	Ferreira, Victor H/AAY-8861-2021; Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Ferreira, Victor H/0000-0002-1472-9711; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Ierullo, Matthew/0000-0001-9638-873X; Hu, Queenie/0000-0003-4272-5053	Ajmera Transplant Centre, University Health Network, the University of Toronto; University Health Network Foundation	Ajmera Transplant Centre, University Health Network, the University of Toronto; University Health Network Foundation	By the Ajmera Transplant Centre, University Health Network, the University of Toronto, and the University Health Network Foundation.	Abe KT, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142362; Bates TA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25479-6; Benotmane I, 2021, JAMA-J AM MED ASSOC, V326, P1063, DOI 10.1001/jama.2021.12339; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489; Callaway E, 2021, NATURE, V595, P17, DOI 10.1038/d41586-021-01696-3; Del Bello A, 2022, AM J TRANSPLANT, V22, P322, DOI 10.1111/ajt.16775; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Hall VG, 2021, NEW ENGL J MED, V385, P1244, DOI 10.1056/NEJMc2111462; Hall VG, 2021, AM J TRANSPLANT, V21, P3980, DOI 10.1111/ajt.16766; Heinz FX, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00369-6; Kamar N, 2021, NEW ENGL J MED, V385, P661, DOI 10.1056/NEJMc2108861; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Medeiros-Ribeiro AC, 2021, NAT MED, V27, P1744, DOI 10.1038/s41591-021-01469-5; Peled Y, 2022, J HEART LUNG TRANSPL, V41, P148, DOI 10.1016/j.healun.2021.08.010; Qin CX, 2021, TRANSPLANTATION, V105, pE265, DOI 10.1097/TP.0000000000003907; Steensels D, 2021, JAMA-J AM MED ASSOC, V326, P1533, DOI 10.1001/jama.2021.15125; Stumpf J, 2021, LANCET REG HEALTH-EU, V9, DOI 10.1016/j.lanepe.2021.100178; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; Taylor SC, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02438-20; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Zeng C, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.143213	24	24	24	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					226	+		10.7326/M21-3480	http://dx.doi.org/10.7326/M21-3480		NOV 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	34807716	Green Published			2022-12-28	WOS:000729198400001
J	Whitehead, DC; Mehrotra, A				Whitehead, David C.; Mehrotra, Ateev			The Growing Phenomenon of "Virtual-First" Primary Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Whitehead, David C.] Mass Gen Brigham, Boston, MA USA; [Mehrotra, Ateev] Harvard Med Sch, Boston, MA USA	Harvard University; Harvard Medical School	Mehrotra, A (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Whitehead, David/GPS-5249-2022	Whitehead, David/0000-0002-3132-5292				Connolly C., 2021, NEJM CATAL INNOV CAR, DOI [10.1056/CAT.21.0031, DOI 10.1056/CAT.21.0031]; Grandchamp C, 2011, HEALTH ECON, V20, P1257, DOI 10.1002/hec.1668; Landi H., 2020, FIERCE HEALTHCARE; Livingston S, 2021, BUSINESS INSIDER; MDLive, 2020, MDLIVE LAUNCH VIRT P; Toppenberg MD, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05564-0; UnitedHealth Group, 2021, UNITEDHEALTHCARE LAU	7	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2021	326	23					2365	2366		10.1001/jama.2021.21169	http://dx.doi.org/10.1001/jama.2021.21169		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC5RI	34807253				2022-12-28	WOS:000722720200001
J	Long, LY; Wei, J; Lim, SA; Raynor, JL; Shi, H; Connelly, JP; Wang, H; Guy, C; Xie, BE; Chapman, NM; Fu, GT; Wang, YY; Huang, HL; Su, W; Saravia, J; Risch, I; Wang, YD; Li, YX; Niu, MM; Dhungana, Y; Anil, KC; Zhou, PP; Vogel, P; Yu, JY; Pruett-Miller, SM; Peng, JM; Chi, HB				Long, Lingyun; Wei, Jun; Lim, Seon Ah; Raynor, Jana L.; Shi, Hao; Connelly, Jon P.; Wang, Hong; Guy, Cliff; Xie, Boer; Chapman, Nicole M.; Fu, Guotong; Wang, Yanyan; Huang, Hongling; Su, Wei; Saravia, Jordy; Risch, Isabel; Wang, Yong-Dong; Li, Yuxin; Niu, Mingming; Dhungana, Yogesh; Anil, K. C.; Zhou, Peipei; Vogel, Peter; Yu, Jiyang; Pruett-Miller, Shondra M.; Peng, Junmin; Chi, Hongbo			CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity	NATURE			English	Article							QUIESCENCE; NETWORK; MICE; UBIQUITINATION; IDENTIFICATION; PROTEINS; MTORC1; BRAIN; EXIT	Nutrients are emerging regulators of adaptive immunity(1). Selective nutrients interplay with immunological signals to activate mechanistic target of rapamycin complex 1 (mTORC1), a key driver of cell metabolism(2-4), but how these environmental signals are integrated for immune regulation remains unclear. Here we use genome-wide CRISPR screening combined with protein-protein interaction networks to identify regulatory modules that mediate immune receptor- and nutrient-dependent signalling to mTORC1 in mouse regulatory T (T-reg) cells. SEC31A is identified to promote mTORC1 activation by interacting with the GATOR2 component SEC13 to protect it from SKP1-dependent proteasomal degradation. Accordingly, loss of SEC31A impairs T cell priming and T-reg suppressive function in mice. In addition, the SWI/SNF complex restricts expression of the amino acid sensor CASTOR1, thereby enhancing mTORC1 activation. Moreover, we reveal that the CCDC101-associated SAGA complex is a potent inhibitor of mTORC1, which limits the expression of glucose and amino acid transporters and maintains T cell quiescence in vivo. Specific deletion of Ccdc101 in mouse T-reg cells results in uncontrolled inflammation but improved antitumour immunity. Collectively, our results establish epigenetic and post-translational mechanisms that underpin how nutrient transporters, sensors and transducers interplay with immune signals for three-tiered regulation of mTORC1 activity and identify their pivotal roles in licensing T cell immunity and immune tolerance.	[Long, Lingyun; Wei, Jun; Lim, Seon Ah; Raynor, Jana L.; Shi, Hao; Guy, Cliff; Chapman, Nicole M.; Fu, Guotong; Wang, Yanyan; Huang, Hongling; Su, Wei; Saravia, Jordy; Risch, Isabel; Dhungana, Yogesh; Anil, K. C.; Zhou, Peipei; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Connelly, Jon P.; Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Hong; Xie, Boer; Li, Yuxin; Niu, Mingming; Peng, Junmin] St Jude Childrens Res Hosp, Ctr Prote & Metabol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yu, Jiyang] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	li, Yu/HCI-9086-2022; SU, WEI/GPC-6511-2022; Chi, Hongbo/M-9397-2018; Fu, Guotong/ABG-3381-2021; Peng, Junmin/N-2614-2018; Li, yuxin/GSD-1668-2022; SHI, HAO/ABE-4662-2020	SU, WEI/0000-0003-4165-8776; Chi, Hongbo/0000-0002-9997-2496; Peng, Junmin/0000-0003-0472-7648; SHI, HAO/0000-0002-2796-629X; Fu, Guotong/0000-0002-2673-9378; Wang, Hong/0000-0002-6215-6348; Wei, Jun/0000-0002-6769-847X	ALSAC; US National Institutes of Health [R01AG053987, AI105887, AI131703, AI140761, AI150241, AI150514, CA250533, CA253188]	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge M. Hendren and S. Rankin for animal colony management; J. Wen for help with phenotypic studies; C. Li and S. Zhou for technical and scientific insights; G. Neale and S. Olsen for assistance with sequencing; the St. Jude Immunology FACS core facility for cell sorting; and the St. Jude Communications and Science/Medical Content Outreach for artwork. This work was supported by ALSAC and by US National Institutes of Health grants R01AG053987 (to J.P.) and AI105887, AI131703, AI140761, AI150241, AI150514, CA250533 and CA253188 (to H.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bai B, 2020, NEURON, V105, P975, DOI 10.1016/j.neuron.2019.12.015; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cortez JT, 2020, NATURE, V582, P416, DOI 10.1038/s41586-020-2246-4; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu GT, 2021, NATURE, V595, P724, DOI 10.1038/s41586-021-03692-z; Huang HL, 2020, IMMUNOL REV, V295, P15, DOI 10.1111/imr.12845; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Li YX, 2016, J PROTEOME RES, V15, P2309, DOI 10.1021/acs.jproteome.6b00344; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lim SA, 2021, NATURE, V591, P306, DOI 10.1038/s41586-021-03235-6; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Loo CS, 2020, IMMUNITY, V53, P143, DOI 10.1016/j.immuni.2020.06.011; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi H, 2019, IMMUNITY, V51, P1012, DOI 10.1016/j.immuni.2019.10.001; Shi H, 2018, IMMUNITY, V49, P899, DOI 10.1016/j.immuni.2018.10.010; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Stewart E, 2018, CANCER CELL, V34, P411, DOI 10.1016/j.ccell.2018.07.012; Su W, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.022; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597; WANG H, 2019, NAT COMMUN, V10; Wang H, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00384-6; Wang XS, 2014, MOL CELL PROTEOMICS, V13, P3663, DOI 10.1074/mcp.O114.039586; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yu JY, 2016, BIOINFORMATICS, V32, P260, DOI 10.1093/bioinformatics/btv556; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; ZHENG GX, 2017, NATURE, V0008; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67	58	10	10	12	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					308	+		10.1038/s41586-021-04109-7	http://dx.doi.org/10.1038/s41586-021-04109-7		NOV 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XL6FG	34795452	Green Accepted			2022-12-28	WOS:000720301500001
J	Andreeva, L; David, L; Rawson, S; Shen, C; Pasricha, T; Pelegrin, P; Wu, H				Andreeva, Liudmila; David, Liron; Rawson, Shaun; Shen, Chen; Pasricha, Teerithveen; Pelegrin, Pablo; Wu, Hao			NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation	CELL			English	Article							CRYO-EM STRUCTURE; COLD AUTOINFLAMMATORY SYNDROME; BEAM-INDUCED MOTION; BAYESIAN-APPROACH; INFLAMMASOME; MECHANISM; NEK7; PHOSPHORYLATION; BINDING; DOMAIN	The NACHT-, leucine-rich-repeat- (LRR), and pyrin domain-containing protein 3 (NLRP3) is emerging to be a critical intracellular inflammasome sensor of membrane integrity and a highly important clinical target against chronic inflammation. Here, we report that an endogenous, stimulus-responsive form of full-length mouse NLRP3 is a 12- to 16-mer double-ring cage held together by LRR-LRR interactions with the pyrin domains shielded within the assembly to avoid premature activation. Surprisingly, this NLRP3 form is predominantly membrane localized, which is consistent with previously noted localization of NLRP3 at various membrane organelles. Structure-guided mutagenesis reveals that trans-Golgi network dispersion into vesicles, an early event observed for many NLRP3-activating stimuli, requires the double-ring cages of NLRP3. Double-ring-defective NLRP3 mutants abolish inflammasome punctum formation, caspase-1 processing, and cell death. Thus, our data uncover a physiological NLRP3 oligomer on the membrane that is poised to sense diverse signals to induce inflammasome activation.	[Andreeva, Liudmila; David, Liron; Rawson, Shaun; Shen, Chen; Pasricha, Teerithveen; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Andreeva, Liudmila; David, Liron; Shen, Chen; Pasricha, Teerithveen; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Rawson, Shaun] Harvard Cryo EM Ctr Struct Biol, Boston, MA 02115 USA; [Pasricha, Teerithveen] Northeastern Univ, Boston, MA 02115 USA; [Pelegrin, Pablo] Univ Murcia, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Murcia, Spain	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Northeastern University; University of Murcia	Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	wu@crystal.harvard.edu	Pelegrin, Pablo/M-2007-2014	Pelegrin, Pablo/0000-0002-9688-1804; Rawson, Shaun/0000-0002-2973-2630; Andreeva, Liudmila/0000-0003-3421-7438	National Institutes of Health [HD087988, AI124491]; CancerResearch Institute Irvington Postdoctoral Fellowship; Damon Runyon Fellowship Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CancerResearch Institute Irvington Postdoctoral Fellowship; Damon Runyon Fellowship Award	We thank Dr. Maria Ericsson at the HMSEMfacility for training and support; Drs. Sarah Sterling and Richard Walsh at the Harvard Cryo-EM Center for Structural Biology for cryo-EM training, help with data collection, and valuable advice; Dr. Janette Myers at the Pacific Northwest Center for Cryo-EM at Oregon Health & Science University; Dr. Kyounghwan Lee at the University of Massachusetts Cryo-EM Core for screening and preliminary dataset collection; and the SBGrid teamfor software support and computational resources. Wealso thank Dr. Ross Tomaino and Taplin Biological Mass Spectrometry Facility for protein analysis, Grigoriy Losyev at the BWH Human Immunology Center Flow Core and Ronald Mathieu at ONC-HSCI Flow Cytometry Research Facility for cell sorting, Harry Leung at BCH/PCMM Microscopy Core for training and advice, and Paula Montero Llopis at the Microscopy Resources on the North Quad (MicRoN) core atHarvardMedical School formicroscope use. WT andNLRP3~/~ iBMDMs were kindgifts fromDr. KatherineFitzgerald atUniversityofMassachusettsMedical School, plasmid pLenti-CMVie-IRES-BlastR (Addgene plasmid #119863) was a gift from Dr. Ghassan Mouneimne, pLV-eGFP (Addgene plasmid #36083) was a gift fromDr. Pantelis Tsoulfas, and lentivirus packaging plasmids pMD2.G (Addgene plasmid #12259) and psPAX2 (Addgene plasmid #12260) were gifts from Dr. Didier Trono. The graphical abstract was created with Biorender.com. This work was supported by National Institutes of Health (HD087988 and AI124491 toH.W.), the CancerResearch Institute Irvington Postdoctoral Fellowship (to C.S.), and the DamonRunyon FellowshipAward (to L.A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Collison J, 2019, NAT REV RHEUMATOL, V15, P190, DOI 10.1038/s41584-019-0194-x; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Daussy CF, 2021, J VIROL, V95, DOI 10.1128/JVI.00826-20; David L, 2018, P NATL ACAD SCI USA, V115, P1499, DOI 10.1073/pnas.1721967115; DeLano W.L, PYMOL MOL GRAPHICS S; Dorstyn L, 2018, CELL DEATH DIFFER, V25, P1194, DOI 10.1038/s41418-017-0025-z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Guo CS, 2018, IMMUNITY, V49, P842, DOI 10.1016/j.immuni.2018.08.021; Hafner-Bratkovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07573-4; Hamarsheh S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01444; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hochheiser I.V., 2007, CRYO EM STRUCTURE NL, V2021; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kalantari P, 2014, CELL REP, V6, P196, DOI 10.1016/j.celrep.2013.12.014; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Klaholz BP, 2019, ACTA CRYSTALLOGR D, V75, P878, DOI 10.1107/S2059798319013391; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15986; Liu Y, 2020, NEUROSCI LETT, V736, DOI 10.1016/j.neulet.2020.135279; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Magupalli VG, 2020, SCIENCE, V369, P1448, DOI 10.1126/science.aas8995; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matyszewski M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23045-8; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Niu TT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26142-w; Oroz J, 2016, J BIOL CHEM, V291, P19487, DOI 10.1074/jbc.M116.741082; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rahman T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01828; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sanchez-Garcia R., 2020, DEEPEMHANCER DEEP LE, V2012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmacke NA, 2019, 799320 BIORXIV, DOI [10.1101/799320, DOI 10.1101/799320]; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shen C, 2019, P NATL ACAD SCI USA, V116, P2052, DOI 10.1073/pnas.1817221116; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Tapia-Abellan A., SCI ADV, V7; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang JZ, 2019, SCIENCE, V364, P44, DOI 10.1126/science.aav5870; Wang LF, 2021, J ALLERGY CLIN IMMUN, V147, P2021, DOI 10.1016/j.jaci.2021.04.018; Wang Z, 2018, ARTERIOSCL THROM VAS, V38, P2765, DOI 10.1161/ATVBAHA.118.311916; Yaron JR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.277; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou MY, 2015, GENE DEV, V29, P2349, DOI 10.1101/gad.272278.115; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	76	30	31	12	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2021	184	26					6299	+		10.1016/j.cell.2021.11.011	http://dx.doi.org/10.1016/j.cell.2021.11.011		DEC 2021	37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XW1KQ	34861190	Bronze, Green Accepted			2022-12-28	WOS:000735387500001
J	Gadde, KM; Allison, DB				Gadde, Kishore M.; Allison, David B.			Long-acting amylin analogue for weight reduction	LANCET			English	Editorial Material							SEMAGLUTIDE 2.4 MG; PRAMLINTIDE; OBESITY; ADULTS		[Gadde, Kishore M.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Allison, David B.] Indiana Univ, Sch Publ Hlth Bloomington, Bloomington, IN USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Indiana University System; Indiana University Bloomington	Gadde, KM (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	kishore.gadde@pbrc.edu						Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Aronne L, 2007, J CLIN ENDOCR METAB, V92, P2977, DOI 10.1210/jc.2006-2003; Davies M, 2021, LANCET, V397, P971, DOI 10.1016/S0140-6736(21)00213-0; Enebo LB, 2021, LANCET, V397, P1736, DOI 10.1016/S0140-6736(21)00845-X; Gadde KM, 2018, J AM COLL CARDIOL, V71, P69, DOI 10.1016/j.jacc.2017.11.011; George BJ, 2018, PSYCHOL METHODS, V23, P337, DOI 10.1037/met0000138; Lau DCW, 2021, LANCET, V398, P2160, DOI 10.1016/S0140-6736(21)01751-7; Rubino D, 2021, JAMA-J AM MED ASSOC, V325, P1414, DOI 10.1001/jama.2021.3224; Smith SR, 2008, DIABETES CARE, V31, P1816, DOI 10.2337/dc08-0029; TUKEY JW, 1954, J AM STAT ASSOC, V49, P706, DOI 10.2307/2281535; U.S. Food and Drug Administration, 2021, E9 R1 STAT PRINC CLI; Wadden TA, 2021, JAMA-J AM MED ASSOC, V325, P1403, DOI 10.1001/jama.2021.1831; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2021	398	10317					2132	2134		10.1016/S0140-6736(21)01999-1	http://dx.doi.org/10.1016/S0140-6736(21)01999-1		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XN4HM	34798059				2022-12-28	WOS:000729467800003
J	Lebwohl, MG; Gold, LS; Strober, B; Papp, KA; Armstrong, AW; Bagel, J; Kircik, L; Ehst, B; Hong, HCH; Soung, J; Fromowitz, J; Guenthner, S; Piscitelli, SC; Rubenstein, DS; Brown, PM; Tallman, AM; Bissonnette, R				Lebwohl, Mark G.; Stein Gold, Linda; Strober, Bruce; Papp, Kim A.; Armstrong, April W.; Bagel, Jerry; Kircik, Leon; Ehst, Benjamin; Hong, H. Chih-ho; Soung, Jennifer; Fromowitz, Jeff; Guenthner, Scott; Piscitelli, Stephen C.; Rubenstein, David S.; Brown, Philip M.; Tallman, Anna M.; Bissonnette, Robert			Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SATISFACTION; ADHERENCE; MILD	BACKGROUND Tapinarof cream is a topical aryl hydrocarbon receptor-modulating agent under investigation for the treatment of psoriasis. Tapinarof modulates the expression of interleukin-17 and the skin-barrier proteins filaggrin and loricrin. METHODS We conducted two identical phase 3 randomized trials of tapinarof in patients with mild-to-severe plaque psoriasis. Adults with a baseline Physician's Global Assessment (PGA) score of 2 (mild) to 4 (severe) (on a scale from 0 to 4, with higher scores indicating more severe psoriasis) and a percent of total body-surface area affected of 3 to 20% were randomly assigned in a 2:1 ratio to use tapinarof 1% cream or vehicle cream once daily for 12 weeks. The primary end point, PGA response, was a PGA score of 0 (clear) or 1 (almost clear) and a decrease from baseline of at least 2 points at week 12. Secondary efficacy end points at week 12 were a reduction of at least 75% in the Psoriasis Area and Severity Index (PASI) score, a PGA score of 0 or 1, the mean change from baseline in the percent of body-surface area affected, and a reduction of at least 90% in the PASI score. Patient-reported outcomes were the mean changes from baseline to week 12 in the proportion of patients who had a decrease of at least 4 points in the Peak Pruritus Numeric Rating Scale (PP-NRS) score (range, 0 [no itch] to 10 [worst imaginable itch]), the PP-NRS total score, the Dermatology Life Quality Index total score, and the Psoriasis Symptom Diary score. Results In trials 1 and 2, a total of 692 and 674 patients, respectively, were screened, with 510 and 515 patients being enrolled. A PGA response occurred in 35.4% of the patients in the tapinarof group and in 6.0% of those in the vehicle group in trial 1 and in 40.2% and 6.3%, respectively, in trial 2 (P<0.001 for both comparisons). RESULTS for secondary end points and patient-reported outcomes were generally in the same direction as those for the primary end point. Adverse events with tapinarof cream included folliculitis, nasopharyngitis, contact dermatitis, headache, upper respiratory tract infection, and pruritus. CONCLUSIONS Tapinarof 1% cream once daily was superior to vehicle control in reducing the severity of plaque psoriasis over a period of 12 weeks but was associated with local adverse events and headache. Larger and longer trials are needed to evaluate the efficacy and safety of tapinarof cream as compared with existing treatments for psoriasis.	[Lebwohl, Mark G.; Kircik, Leon] Icahn Sch Med Mt Sinai, 5 E 98th St,5th Fl, New York, NY 10029 USA; [Stein Gold, Linda] Henry Ford Hlth Syst, Detroit, MI USA; Yale Univ, New Haven, CT USA; [Strober, Bruce] Cent Connecticut Dermatol Res, Cromwell, CT USA; [Papp, Kim A.] Prob Med Res, Waterloo, ON, Canada; [Hong, H. Chih-ho] Univ British Columbia, Vancouver, BC, Canada; Prob Med Res, Waterloo, ON, Canada; Innovaderm Res, Montreal, PQ, Canada; [Armstrong, April W.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Soung, Jennifer] Southern Calif Dermatol, Santa Ana, CA USA; [Bagel, Jerry] Psoriasis Treatment Ctr Cent New Jersey, E Windsor, NJ USA; [Kircik, Leon] Skin Sci, Louisville, KY USA; [Ehst, Benjamin] Oregon Med Res Ctr, Portland, OR USA; [Fromowitz, Jeff] Dermatol Boca, Boca Raton, FL USA; [Guenthner, Scott] Indiana Clin Trials Ctr, Plainfield, IN USA; [Piscitelli, Stephen C.; Rubenstein, David S.; Brown, Philip M.; Tallman, Anna M.] Dermavant Sci, Morrisville, NC USA	Icahn School of Medicine at Mount Sinai; Henry Ford Health System; Henry Ford Hospital; Yale University; University of British Columbia; Innovaderm Research Inc.; University of Southern California	Lebwohl, MG (corresponding author), Icahn Sch Med Mt Sinai, 5 E 98th St,5th Fl, New York, NY 10029 USA.	mark.lebwohl@mssm.edu			Dermavant Sciences	Dermavant Sciences	Supported by Dermavant Sciences.	Belinchon I, 2016, PATIENT PREFER ADHER, V10, P2357, DOI 10.2147/PPA.S117006; Bissonnette R, 2012, J EUR ACAD DERMATOL, V26, P1516, DOI 10.1111/j.1468-3083.2011.04332.x; Bissonnette R, 2021, J AM ACAD DERMATOL, V85, pE39, DOI 10.1016/j.jaad.2021.03.006; Bissonnette R, 2021, J AM ACAD DERMATOL, V84, P1059, DOI 10.1016/j.jaad.2020.10.085; Elmets CA, 2021, J AM ACAD DERMATOL, V84, P432, DOI 10.1016/j.jaad.2020.07.087; Furue M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215424; Gold LFS, 2016, SEMIN CUTAN MED SURG, V35, pS36, DOI 10.12788/j.sder.2016.006; Gold LS, 2021, J AM ACAD DERMATOL, V84, P624, DOI 10.1016/j.jaad.2020.04.181; Menter A, 2019, J AM ACAD DERMATOL, V80, P1029, DOI 10.1016/j.jaad.2018.11.057; Paller AS, 2021, J AM ACAD DERMATOL, V84, P632, DOI 10.1016/j.jaad.2020.05.135; Parisi R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1590; Peppers J, 2019, J AM ACAD DERMATOL, V80, P89, DOI 10.1016/j.jaad.2018.06.047; Puig L, 2013, ACTAS DERMO-SIFILOGR, V104, P488, DOI 10.1016/j.ad.2012.12.005; Robbins K, 2019, J AM ACAD DERMATOL, V80, P714, DOI 10.1016/j.jaad.2018.10.037; Smith S, 2020, J INVEST DERMATOL, V140, pS81; Smith SH, 2017, J INVEST DERMATOL, V137, P2110, DOI 10.1016/j.jid.2017.05.004; Wheeler MA, 2017, J BIOL CHEM, V292, P12383, DOI 10.1074/jbc.R116.767723	17	16	16	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2219	2229		10.1056/NEJMoa2103629	http://dx.doi.org/10.1056/NEJMoa2103629			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XL4CS	34879448	Bronze			2022-12-28	WOS:000728093600011
J	Shen, LL; Tang, KL; Wang, WD; Wang, C; Wu, HJ; Mao, ZY; An, SY; Chang, SH; Kuang, TY; Shen, JR; Han, GY; Zhang, X				Shen, Liangliang; Tang, Kailu; Wang, Wenda; Wang, Chen; Wu, Hangjun; Mao, Zhiyuan; An, Shaoya; Chang, Shenghai; Kuang, Tingyun; Shen, Jian-Ren; Han, Guangye; Zhang, Xing			Architecture of the chloroplast PSI-NDH supercomplex in Hordeum vulgare	NATURE			English	Article							CYCLIC ELECTRON FLOW; NAD(P)H DEHYDROGENASE COMPLEX; PHOTOSYSTEM-I; PROTEIN; TRANSPORT; SUBUNITS; TOBACCO; PHOTOSYNTHESIS; PSBQ; PGR5	The chloroplast NADH dehydrogenase-like (NDH) complex is composed of at least 29 subunits and has an important role in mediating photosystem I (PSI) cyclic electron transport (CET)(1-3). The NDH complex associates with PSI to form the PSI-NDH supercomplex and fulfil its function. Here, we report cryo-electron microscopy structures of a PSI-NDH supercomplex from barley (Hordeum vulgare). The structures reveal that PSI-NDH is composed of two copies of the PSI-light-harvesting complex I (LHCI) subcomplex and one NDH complex. Two monomeric LHCI proteins, Lhca5 and Lhca6, mediate the binding of two PSI complexes to NDH. Ten plant chloroplast-specific NDH subunits are presented and their exact positions as well as their interactions with other subunits in NDH are elucidated. In all, this study provides a structural basis for further investigations on the functions and regulation of PSI-NDH-dependent CET.	[Shen, Liangliang; Wang, Wenda; Mao, Zhiyuan; Kuang, Tingyun; Shen, Jian-Ren; Han, Guangye] Chinese Acad Sci, Photosynth Res Ctr, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China; [Shen, Liangliang; Mao, Zhiyuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Kailu; Wang, Chen; An, Shaoya; Zhang, Xing] Zhejiang Univ, Dept Biophys, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China; [Tang, Kailu; Wang, Chen; An, Shaoya; Zhang, Xing] Zhejiang Univ, Dept Pathol, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China; [Wu, Hangjun; An, Shaoya; Chang, Shenghai; Zhang, Xing] Zhejiang Univ, Ctr Cryo Electron Microscopy, Sch Med, Hangzhou, Peoples R China; [Shen, Jian-Ren] Okayama Univ, Inst Interdisciplinary Sci, Okayama, Japan; [Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Zhang, Xing] Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; Zhejiang University; Zhejiang University; Okayama University; Okayama University; Zhejiang University	Shen, JR; Han, GY (corresponding author), Chinese Acad Sci, Photosynth Res Ctr, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China.; Zhang, X (corresponding author), Zhejiang Univ, Dept Biophys, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China.; Zhang, X (corresponding author), Zhejiang Univ, Dept Pathol, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China.; Zhang, X (corresponding author), Zhejiang Univ, Ctr Cryo Electron Microscopy, Sch Med, Hangzhou, Peoples R China.; Shen, JR (corresponding author), Okayama Univ, Inst Interdisciplinary Sci, Okayama, Japan.; Shen, JR (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.; Zhang, X (corresponding author), Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China.	shen@cc.okayama-u.ac.jp; hanguangye@ibcas.ac.cn; xzhang1999@zju.edu.cn	wang, chen/GWM-9481-2022	Wang, Wenda/0000-0002-1842-8633; Shen, Jian-Ren/0000-0003-4471-8797; Shen, Liangliang/0000-0003-0868-3283	National Key R&D Program of China [2020YFA0907600, 2018YFA0507700, 2017YFA0503700, 2017YFA0504803, 2019YFA0906300, 2021YFA1300403]; Strategic Priority Research Program of CAS [XDA26050402, XDB17000000]; Key Research Program of Frontier Sciences of CAS [QYZDY-SSW-SMC003]; Youth Innovation Promotion Association of CAS [2020081]; CAS Interdisciplinary Innovation Team [JCTD-2020-06]; CAS Project for Young Scientists in Basic Research [YSBR-004]; Fundamental Research Funds for the Central Universities [2018XZZX001-13]; JSPS KAKENHI [JP17H06434]	National Key R&D Program of China; Strategic Priority Research Program of CAS; Key Research Program of Frontier Sciences of CAS; Youth Innovation Promotion Association of CAS; CAS Interdisciplinary Innovation Team; CAS Project for Young Scientists in Basic Research; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Ma from the Protein Facility (School of Medicine, Zhejiang University) for providing the platform for sample purification, X. Meng in the Center of Biomedical Analysis (Tsinghua University) for protein mass spectrometry analysis and W. Tang from the Institute of Botany (CAS) for instrumental support in sample preparation. The project was funded by the National Key R&D Program of China (2020YFA0907600, 2018YFA0507700, 2017YFA0503700, 2017YFA0504803, 2019YFA0906300, 2021YFA1300403), the Strategic Priority Research Program of CAS (XDA26050402, XDB17000000), the Key Research Program of Frontier Sciences of CAS (QYZDY-SSW-SMC003), the Youth Innovation Promotion Association of CAS (2020081), the CAS Interdisciplinary Innovation Team (JCTD-2020-06), the CAS Project for Young Scientists in Basic Research (YSBR-004), the Fundamental Research Funds for the Central Universities (2018XZZX001-13) and JSPS KAKENHI (JP17H06434).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Ishikawa N, 2008, PLANT CELL PHYSIOL, V49, P1066, DOI 10.1093/pcp/pcn083; Johnson GN, 2011, BBA-BIOENERGETICS, V1807, P906, DOI 10.1016/j.bbabio.2011.05.008; Kato Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24065-0; Kato Y, 2018, PLANT PHYSIOL, V176, P1728, DOI 10.1104/pp.17.01120; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; Kouril R, 2014, PLANT J, V77, P568, DOI 10.1111/tpj.12402; Laughlin TG, 2019, NATURE, V566, P411, DOI 10.1038/s41586-019-0921-0; Manaresi E, 1999, J VIROL METHODS, V81, P91, DOI 10.1016/S0166-0934(99)00066-X; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; Miyake C, 2010, PLANT CELL PHYSIOL, V51, P1951, DOI 10.1093/pcp/pcq173; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Otani T, 2018, PLANT J, V94, P122, DOI 10.1111/tpj.13846; Otani T, 2017, PLANT CELL PHYSIOL, V58, P851, DOI 10.1093/pcp/pcx009; Pan XW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14456-0; Pan XW, 2018, SCIENCE, V360, P1109, DOI 10.1126/science.aat1156; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Peng LW, 2011, PLANT PHYSIOL, V155, P1629, DOI 10.1104/pp.110.171264; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Peng LW, 2008, J BIOL CHEM, V283, P34873, DOI 10.1074/jbc.M803207200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Quiles MJ, 1996, PLANT CELL PHYSIOL, V37, P1134, DOI 10.1093/oxfordjournals.pcp.a029064; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2020, ADV BOT RES, V96, P177, DOI 10.1016/bs.abr.2020.07.005; Shikanai T, 2016, BBA-BIOENERGETICS, V1857, P1015, DOI 10.1016/j.bbabio.2015.10.013; Shikanai T, 2014, CURR OPIN BIOTECH, V26, P25, DOI 10.1016/j.copbio.2013.08.012; Shimizu H, 2008, PLANT CELL PHYSIOL, V49, P835, DOI 10.1093/pcp/pcn058; Sirpio S, 2009, FEBS LETT, V583, P2355, DOI 10.1016/j.febslet.2009.06.031; Sirpio S, 2009, J BIOL CHEM, V284, P905, DOI 10.1074/jbc.M805404200; Suorsa M, 2010, PLANT CELL PHYSIOL, V51, P877, DOI 10.1093/pcp/pcq070; Takabayashi A, 2009, PLANT J, V57, P207, DOI 10.1111/j.1365-313X.2008.03680.x; Wang J, 2021, J INTEGR PLANT BIOL, V63, P1367, DOI 10.1111/jipb.13095; Yabuta S, 2010, PLANT CELL PHYSIOL, V51, P866, DOI 10.1093/pcp/pcq060; Yamamoto H, 2021, PLANT CELL PHYSIOL, V62, P1131, DOI 10.1093/pcp/pcaa143; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Yamori W, 2016, ANNU REV PLANT BIOL, V67, P81, DOI 10.1146/annurev-arplant-043015-112002; Zhang CL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14732-z; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	52	12	13	30	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					649	+		10.1038/s41586-021-04277-6	http://dx.doi.org/10.1038/s41586-021-04277-6		DEC 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34879391				2022-12-28	WOS:000741978500001
J	Albritton, J; Ortiz, A; Wines, R; Booth, G; DiBello, M; Brown, S; Gartlehner, G; Crotty, K				Albritton, Jordan; Ortiz, Alexa; Wines, Roberta; Booth, Graham; DiBello, Michael; Brown, Stephen; Gartlehner, Gerald; Crotty, Karen			Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment A Rapid Review	ANNALS OF INTERNAL MEDICINE			English	Review							TELE-HEALTH-CARE; HEART-FAILURE; PATIENT SATISFACTION; RANDOMIZED-TRIAL; NON-INFERIORITY; SEVERE COPD; TELEMEDICINE; TELEHEALTH; MANAGEMENT; OUTCOMES	Background: Video teleconferencing (VTC) as a substitute for in-person health care or as an adjunct to usual care has increased in recent years. Purpose: To assess the benefits and harms of VTC visits for disease prevention, diagnosis, and treatment and to develop an evidence map describing gaps in the evidence. Data Sources: Systematically searched PubMed, EMBASE, Web of Science, and the Cochrane Library from 1 January 2013 to 3 March 2021. Study Selection: Two investigators independently screened the literature and identified 38 randomized controlled trials (RCTs) meeting inclusion criteria. Data Extraction: Data abstraction by a single investigator was confirmed by a second investigator; 2 investigators independently rated risk of bias. Data Synthesis: Results from 20 RCTs rated low risk of bias or some concerns of bias show that the use of VTC for the treatment and management of specific diseases produces largely similar outcomes when used to replace or augment usual care. Nine of 12 studies where VTC was intended to replace usual care and 5 of 8 studies where VTC was intended to augment usual care found similar effects between the intervention and control groups. The remaining 6 included studies (3 intended to replace usual care and 3 intended to augment usual care) found 1 or more primary outcomes that favored the VTC group over the usual care group. Studies comparing VTC with usual care that did not involve in-person care were more likely to favor the VTC group. No studies evaluated the use of VTC for diagnosis or prevention of disease. Studies that reported harms found no differences between the intervention and control groups; however, many studies did not report harms. No studies evaluated the effect of VTC on health equity or disparities. Limitations: Studies that focused on mental health, substance use disorders, maternal care, and weight management were excluded. Included studies were limited to RCTs with sample sizes of 50 patients or greater. Component analyses were not conducted in the studies. Conclusion: Replacing or augmenting aspects of usual care with VTC generally results in similar clinical effectiveness, health care use, patient satisfaction, and quality of life as usual care for areas studied. However, included trials were limited to a handful of disease categories, with patients seeking care for a limited set of purposes.	[Albritton, Jordan; Ortiz, Alexa; Wines, Roberta; Booth, Graham; Brown, Stephen; Crotty, Karen] RTI Int, 3040 East Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA; [DiBello, Michael] Insight Policy Res, Hyde Pk, MA USA; [Gartlehner, Gerald] Danube Univ Krems, Krems An Der Donau, Austria	Research Triangle Institute; Danube University Krems	Albritton, J (corresponding author), RTI Int, 3040 East Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.	jalbritton@rti.org; kcrotty@rti.org		Brown, Stephen/0000-0002-2337-9717; Albritton, Jordan/0000-0002-8539-5720; Gartlehner, Gerald/0000-0001-5531-3678; Booth, Graham/0000-0001-8167-707X; Ortiz, Alexa/0000-0002-8121-1250; Wines, Roberta/0000-0002-3168-0163; Crotty, Karen/0000-0002-5633-5040	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By PCORI.	Amwell, VIRT CAR HYBR CAR CO; Augestad KM, 2020, BRIT J SURG, V107, P509, DOI 10.1002/bjs.11491; Beck CA, 2017, NEUROLOGY, V89, P1152, DOI 10.1212/WNL.0000000000004357; Bennell KL, 2017, ANN INTERN MED, V166, P453, DOI 10.7326/M16-1714; Buchanan AH, 2015, J GENET COUNS, V24, P961, DOI 10.1007/s10897-015-9836-6; Buvik A, 2019, J MED INTERNET RES, V21, DOI 10.2196/11330; Buvik A, 2019, J TELEMED TELECARE, V25, P451, DOI 10.1177/1357633X18783921; Buvik A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1717-7; Comin-Colet J, 2016, J TELEMED TELECARE, V22, P282, DOI 10.1177/1357633X15600583; Cremades M, 2020, AM J SURG, V219, P882, DOI 10.1016/j.amjsurg.2020.03.023; Duke Danny C, 2016, J Diabetes Sci Technol, V10, P816, DOI 10.1177/1932296816642577; Fatehi F, 2015, DIABETES TECHNOL THE, V17, P717, DOI 10.1089/dia.2014.0416; Gandolfi M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7962826; Garritty C, 2021, J CLIN EPIDEMIOL, V130, P13, DOI 10.1016/j.jclinepi.2020.10.007; Goedeke J, 2019, J PEDIATR SURG, V54, P200, DOI 10.1016/j.jpedsurg.2018.10.014; Grand View Research, 2020, US VIRT VIS MARK SIZ; Gunasekeran DV, 2020, J MED INTERNET RES, V22, DOI 10.2196/17417; Halterman JS, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2017.4938; Hansen CR, 2017, EUR J ENDOCRINOL, V176, P727, DOI 10.1530/EJE-16-0811; Harkey K, 2021, JAMA SURG, V156, P221, DOI 10.1001/jamasurg.2020.6265; Harris MA, 2015, DIABETES CARE, V38, P1427, DOI 10.2337/dc14-2469; Herbert MS, 2017, J PAIN, V18, P200, DOI 10.1016/j.jpain.2016.10.014; Hwang R, 2017, J PHYSIOTHER, V63, P101, DOI 10.1016/j.jphys.2017.02.017; Isetta V, 2015, THORAX, V70, P1054, DOI 10.1136/thoraxjnl-2015-207032; Ishani A, 2016, AM J KIDNEY DIS, V68, P41, DOI 10.1053/j.ajkd.2016.01.018; Jeong JY, 2018, TELEMED E-HEALTH, V24, P604, DOI 10.1089/tmj.2017.0203; Koonin LM, 2020, MMWR-MORBID MORTAL W, V69, P1595, DOI 10.15585/mmwr.mm6943a3; Lindsay JA, 2021, J RURAL HEALTH, V37, P242, DOI 10.1111/jrh.12480; Lugo VM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224069; Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072; McLean S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071238; Muller KI, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5221; Muller KI, 2017, EUR J NEUROL, V24, P807, DOI 10.1111/ene.13294; Muller KI, 2017, CEPHALALGIA, V37, P855, DOI 10.1177/0333102416654885; Muller KI, 2017, NEUROLOGY, V89, P153, DOI 10.1212/WNL.0000000000004085; Noel K, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-1094-5; Nouryan CN, 2019, TELEMED E-HEALTH, V25, P447, DOI 10.1089/tmj.2018.0099; Ora HP, 2020, CLIN REHABIL, V34, P369, DOI 10.1177/0269215519896616; Orlandoni P, 2016, GERIATR GERONTOL INT, V16, P762, DOI 10.1111/ggi.12551; Page MJ, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003583; Perry TT, 2018, ANN ALLERG ASTHMA IM, V120, P401, DOI 10.1016/j.anai.2018.02.013; Ray KN, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2491; Ringbaek T, 2015, INT J CHRONIC OBSTR, V10, P1801, DOI 10.2147/COPD.S85596; Robinson J, 2020, NEJM CATAL INNOV CAR, V1, DOI [10.1056/CAT.20.0399, DOI 10.1056/CAT.20.0399]; Rodriguez JA, 2021, AM J MANAG CARE, V27, P21, DOI 10.37765/ajmc.2021.88573; Silva M, 2019, J PEDIATR ORTHOP B, V28, P542, DOI 10.1097/BPB.0000000000000576; Sood A, 2018, J TELEMED TELECARE, V24, P385, DOI 10.1177/1357633X17704346; Sorknaes AD, 2013, J TELEMED TELECARE, V19, P466, DOI 10.1177/1357633X13512067; Stephenson R, 2020, AIDS BEHAV, V24, P1517, DOI 10.1007/s10461-019-02741-z; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Taylor-Gjevre R, 2018, MUSCULOSKELET CARE, V16, P90, DOI 10.1002/msc.1215; Tupper OD, 2018, INT J CHRONIC OBSTR, V13, P2657, DOI 10.2147/COPD.S164121; von Sengbusch S, 2020, PEDIATR DIABETES, V21, P1502, DOI 10.1111/pedi.13133; Walle T, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000912; Wilkinson JR, 2016, NEUROL-CLIN PRACT, V6, P241, DOI 10.1212/CPJ.0000000000000252	55	5	5	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					256	+		10.7326/M21-3511	http://dx.doi.org/10.7326/M21-3511		DEC 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	34871056				2022-12-28	WOS:000729194400001
J	Logan, PA; Horne, JC; Gladman, JRF; Gordon, AL; Sach, T; Clark, A; Robinson, K; Armstrong, S; Stirling, S; Leighton, P; Darby, J; Allen, F; Irvine, L; Wilson, ECF; Fox, C; Conroy, S; Mountain, G; McCartney, K; Godfrey, M; Sims, E				Logan, Pip A.; Horne, Jane C.; Gladman, John R. F.; Gordon, Adam L.; Sach, Tracey; Clark, Allan; Robinson, Katie; Armstrong, Sarah; Stirling, Sue; Leighton, Paul; Darby, Janet; Allen, Fran; Irvine, Lisa; Wilson, Ed C. F.; Fox, Chris; Conroy, Simon; Mountain, Gail; McCartney, Karen; Godfrey, Maureen; Sims, Erika			Multifactorial falls prevention programme compared with usual care in UK care homes for older people: multicentre cluster randomised controlled trial with economic evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To determine the clinical and cost effectiveness of a multifactorial fall prevention programme compared with usual care in long term care homes. DESIGN Multicentre, parallel, cluster randomised controlled trial. SETTING Long term care homes in the UK, registered to care for older people or those with dementia. PARTICIPANTS 1657 consenting residents and 84 care homes. 39 were randomised to the intervention group and 45 were randomised to usual care. INTERVENTIONS Guide to Action for Care Homes (GtACH): a multifactorial fall prevention programme or usual care. MAIN OUTCOME MEASURES Primary outcome measure was fall rate at 91-180 days after randomisation. The economic evaluation measured health related quality of life using quality adjusted life years (QALYs) derived from the five domain five level version of the EuroQoL index (EQ-5D5L) or proxy version (EQ-5D-5L-P) and the Dementia Quality of Life utility measure (DEMQOL-U), which were self-completed by competent residents and by a care home staff member proxy (DEMQOL-P-U) for all residents (in case the ability to complete changed during the study) until 12 months after randomisation. Secondary outcome measures were falls at 1-90, 181-270, and 271-360 days after randomisation, Barthel index score, and the Physical Activity Measure Residential Care Homes (PAM-RC) score at 91, 180, 270, and 360 days after randomisation. RESULTS Mean age of residents was 85 years. 32% were men. GtACH training was delivered to 1051/1480 staff (71%). Primary outcome data were available for 630 participants in the GtACH group and 712 in the usual care group. The unadjusted incidence rate ratio for falls between 91 and 180 days was 0.57 (95% confidence interval 0.45 to 0.71, P(0.001) in favour of the GtACH programme (GtACH: six falls/1000 residents v usual care: 10 falls/1000). Barthel activities of daily living indices and PAM-RC scores were similar between groups at all time points. The incremental cost was 108 pound (95% confidence interval-271.06 pound to 487.58), incremental QALYs gained for EQ-5D-5L-P was 0.024 (95% confidence interval 0.004 to 0.044) and for DEMQOL-P-U was 0.005 (-0.019 to 0.03). The incremental costs per EQ-5D-5L-P and DEMQOL-P-U based QALY were 4544 pound and 20 pound 889, respectively. CONCLUSIONS The GtACH programme was associated with a reduction in fall rate and cost effectiveness, without a decrease in activity or increase in dependency.	[Logan, Pip A.; Horne, Jane C.; Gladman, John R. F.; Gordon, Adam L.; Robinson, Katie; Armstrong, Sarah; Leighton, Paul; Darby, Janet; Allen, Fran; McCartney, Karen] Univ Nottingham, Queens Med Ctr, Sch Med, Nottingham NG7 2UH, England; [Logan, Pip A.] Nottingham CityCare Partnership, Nottingham, England; [Logan, Pip A.; Gladman, John R. F.; Gordon, Adam L.] NIHR Appl Res Collaborat East Midlands, Nottingham, England; [Logan, Pip A.; Gladman, John R. F.; Gordon, Adam L.] NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Gladman, John R. F.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Gordon, Adam L.] Univ Hosp Derby & Burton NHS Fdn Trust, Derby, England; [Sach, Tracey; Clark, Allan; Stirling, Sue; Wilson, Ed C. F.; Sims, Erika] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Irvine, Lisa] Univ Hertfordshire, Hatfield, Herts, England; [Fox, Chris] Univ Exeter, Exeter Med Sch, Exeter, Devon, England; [Conroy, Simon] UCL, London, England; [Mountain, Gail] Univ Bradford, Bradford, W Yorkshire, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of East Anglia; University of Hertfordshire; University of Exeter; University of London; University College London; University of Bradford	Logan, PA (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Med, Nottingham NG7 2UH, England.; Logan, PA (corresponding author), Nottingham CityCare Partnership, Nottingham, England.; Logan, PA (corresponding author), NIHR Appl Res Collaborat East Midlands, Nottingham, England.; Logan, PA (corresponding author), NIHR Nottingham Biomed Res Ctr, Nottingham, England.	pip.logan@nottingham.ac.uk	; Gordon, Adam/C-3934-2018	Leighton, Paul/0000-0001-5208-0274; Mountain, Gail/0000-0002-5417-7691; Sach, Tracey/0000-0002-8098-9220; Logan, Philippa/0000-0002-6657-2381; Conroy, Simon/0000-0002-4306-6064; Irvine, Lisa/0000-0003-1936-3584; Gordon, Adam/0000-0003-1676-9853	National Institute for Health Research (NIHR) HTA programme [13/115/29]; NIHR Applied Research Collaboration-East Midlands (ARC-EM); NIHR Nottingham Biomedical Research Centre	National Institute for Health Research (NIHR) HTA programme(National Institute for Health Research (NIHR)); NIHR Applied Research Collaboration-East Midlands (ARC-EM); NIHR Nottingham Biomedical Research Centre	This study was funded by the National Institute for Health Research (NIHR) HTA programme (ref 13/115/29) . PAL, JCH, JRFG, and ALG are funded in part by the NIHR Applied Research Collaboration-East Midlands (ARC-EM) . PAL, JRFG, and ALG are funded in part by theY NIHR Nottingham Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NIHR, NHS, or Department of Health and Social Care.	Achterberg WP, 2020, AGE AGEING, V49, P3, DOI 10.1093/ageing/afz145; Armstrong K., 2019, E MIDLANDS RES AGEIN, V24; Bunn F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030987; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Chadborn NH, 2021, EUR GERIATR MED, V12, P17, DOI 10.1007/s41999-020-00389-w; Corp S, STATA MP 16; Devi R, 2021, AGE AGEING, V50, P1371, DOI 10.1093/ageing/afab007; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Gordon AL, 2014, AGE AGEING, V43, P97, DOI 10.1093/ageing/aft077; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Inspectorate. TC, 2016, MAN FALLS FRACT CAR; Involve, 2019, UK STAND PUBL INV RE; Laing W, 2017, CARE HOMES OLDER PEO; Luff R, 2015, QUAL AGEING OLDER AD, V16, P186, DOI 10.1108/QAOA-06-2015-0027; Martin A, 2019, VALUE HEALTH, V22, P1417, DOI 10.1016/j.jval.2019.07.002; Meads DM, 2020, APPL HEALTH ECON HEA, V18, P237, DOI 10.1007/s40258-019-00531-1; Mulhern B, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17050; NICE,, 2013, FALLS OLD PEOPL ASS; Oliver D, 2007, REV CLIN GERONTOL, V17, P75, DOI 10.1017/S0959259808002451; Public Health England, FALLS APPL ALL OUR H; R Development Core Team, 2009, R LANG ENV STAT COMP; Robertson Kate, 2012, Br J Community Nurs, V17, P206; Robinson K, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00925-z; RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225; Smith SC, 2007, PSYCHOL MED, V37, P737, DOI 10.1017/S0033291706009469; Spilsbury K, 2011, INT J NURS STUD, V48, P732, DOI 10.1016/j.ijnurstu.2011.02.014; Staniszewska S, 2017, Res Involv Engagem, V3, P13, DOI 10.1186/s40900-017-0062-2; Usman A, 2019, AGE AGEING, V48, P407, DOI 10.1093/ageing/afy191; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Wade D T, 1988, Int Disabil Stud, V10, P64; Walker GM, 2016, CLIN REHABIL, V30, P972, DOI 10.1177/0269215515604672; Walston JD, 2017, OXFORD TXB GERIATRIC; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whitney J, 2013, AGE AGEING, V42, P754, DOI 10.1093/ageing/aft130; Whitney J, 2012, ARCH GERONTOL GERIAT, V55, P690, DOI 10.1016/j.archger.2012.05.010	35	12	12	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2021	375								e066991	10.1136/bmj-2021-066991	http://dx.doi.org/10.1136/bmj-2021-066991			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP4DA	34876412	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000730815800009
J	[Anonymous]				[Anonymous]			Current Comment (Reprinted from JAMA, vol 77, pg 1823, 1921)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2217	2217		10.1001/jama.2020.18254	http://dx.doi.org/10.1001/jama.2020.18254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874430				2022-12-28	WOS:000730077500036
J	Saul, H; Gursul, D				Saul, Helen; Gursul, Deniz			Strategies to reduce fractures in older people are not effective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz] NIHR Ctr Engagement & Disseminat, Twickenham, England		Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						Age UK, 2019, STAYING STEAD; British Geriatric Society, COMPREHENSIVE GERIAT; National Falls Prevention Coordination Group (NFPCG) and Public Health England, FALLS FRACT CONS STA; National Institute for Health and Care Excellence, GUID CG161 FALLS OLD	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2021	375								n2929	10.1136/bmj.n2929	http://dx.doi.org/10.1136/bmj.n2929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP4CS	34872913				2022-12-28	WOS:000730815000001
J	May, H; Sarig, R; Pokhojaev, A; Fornai, C; Martinon-Torres, M; de Castro, JMB; Weber, GW; Zaidner, Y; Hershkovitz, I				May, Hila; Sarig, Rachel; Pokhojaev, Ariel; Fornai, Cinzia; Martinon-Torres, Maria; Bermudez de Castro, Jose Maria; Weber, Gerhard W.; Zaidner, Yossi; Hershkovitz, Israel			Response to Comment on "A Middle Pleistocene Homo from Nesher Ramla, Israel"	SCIENCE			English	Editorial Material								Marom and Rak claim, on the basis of a few mandibular features, that the Nesher Ramla (NR) Homo is a Neanderthal. Their comments lack substance and contribute little to the debate surrounding the evolution of Middle Pleistocene Homo. Limitations and preconceptions in their study prevented them from achieving resolution beyond a dichotomous interpretation of the NR as either a Neanderthal or a modern human.	[May, Hila; Pokhojaev, Ariel; Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [May, Hila; Sarig, Rachel; Pokhojaev, Ariel; Hershkovitz, Israel] Tel Aviv Univ, Den David Ctr Human Evolut & Biohist Res, Shmunis Family Anthropol Inst, Tel Aviv, Israel; [Sarig, Rachel; Pokhojaev, Ariel] Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, Tel Aviv, Israel; [Fornai, Cinzia] Vienna Sch Interdisciplinary Dent, Klosterneuburg, Austria; [Fornai, Cinzia; Weber, Gerhard W.] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Fornai, Cinzia] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Martinon-Torres, Maria; Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Martinon-Torres, Maria; Bermudez de Castro, Jose Maria] UCL, Dept Anthropol, London, England; [Weber, Gerhard W.] Univ Vienna, Core Facil Microcomputed Tomog, Vienna, Austria; [Weber, Gerhard W.] Univ Vienna, Human Evolut & Archaeol Sci, Vienna, Austria; [Zaidner, Yossi] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University of Vienna; University of Zurich; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; University of Vienna; University of Vienna; Hebrew University of Jerusalem	May, H; Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel.; May, H; Sarig, R; Hershkovitz, I (corresponding author), Tel Aviv Univ, Den David Ctr Human Evolut & Biohist Res, Shmunis Family Anthropol Inst, Tel Aviv, Israel.; Sarig, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, Tel Aviv, Israel.	mayhila@tauex.tau.ac.il; sarigrac@tauex.tau.ac.il; anatom2@tauex.tau.ac.il	Weber, Gerhard W/F-2583-2010; Hershkovitz, Israel/ABH-4511-2020	Weber, Gerhard W/0000-0002-8542-6259; Hershkovitz, Israel/0000-0001-5841-6090; Pokhojaev, Ariel/0000-0002-6356-7552; Zaidner, Yossi/0000-0002-4247-4824; Martinon-Torres, Maria/0000-0002-2750-4554; Sarig, Rachel/0000-0002-9323-5014; May, Hila/0000-0002-5256-2369; Fornai, Cinzia/0000-0002-0911-0164				de Castro JMB, 2015, AM J PHYS ANTHROPOL, V156, P102, DOI 10.1002/ajpa.22631; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Hershkovitz I, 2021, SCIENCE, V372, P1424, DOI 10.1126/science.abh3169; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Hershkovitz I, 2016, QUATERN INT, V398, P148, DOI 10.1016/j.quaint.2015.08.059; Hershkovitz I, 2015, NATURE, V520, P216, DOI 10.1038/nature14134; Howell FC, 1999, J ANTHROPOL RES, V55, P191, DOI 10.1086/jar.55.2.3631209; de Castro JMB, 2019, QUATERNARY SCI REV, V217, P45, DOI 10.1016/j.quascirev.2018.04.003; Marom A, 2021, SCIENCE, V374, DOI 10.1126/science.abl4336; Martinon-Torres M, 2019, J HUM EVOL, V127, P93, DOI 10.1016/j.jhevol.2018.12.001; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Sella-Tunis T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24293-3; Vialet A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189714; Xing S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20432-y	15	1	1	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572							eabl5789	10.1126/science.abl5789	http://dx.doi.org/10.1126/science.abl5789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855476				2022-12-28	WOS:000728578700002
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: GPs need extra staff and capacity to deliver accelerated booster programme, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								n2982	10.1136/bmj.n2982	http://dx.doi.org/10.1136/bmj.n2982			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34857586	Bronze			2022-12-28	WOS:000732779300001
J	Feinmann, J				Feinmann, Jane			What happened to our national emergency stockpiles?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								When the pandemic began, many nations' emergency stockpiles came into the spotlight-and were found wanting. Twenty months later, JaneFeinmann asks what happened, and if procurement has got any better				jane@janefeinmann.com						Anderson M, 2021, LANCET REG HEALTH-EU, V9, DOI 10.1016/j.lanepe.2021.100203; [Anonymous], 2020, CHANNEL 4 NEWS 0507; [Anonymous], 2021, NATL STRATEGY COVID; [Anonymous], 2020, WRITTEN EVIDENCE SUB; [Anonymous], 2019, CNA 0919; Casalicchio E., 2021, POLITICO PAVIA; European Commission, 2020, COVID 19 COMM CREAT; European Commission, CRIS MAN SOL; Feuer W., 2020, CNBC; Frieden J, 2021, MEDPAGE TODAY; Grierson J., 2021, GUARDIAN 1108; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1072; Illing S, 2020, VOX 0415; Johanniter International, UPD RESCEU MED STOCK; Kim E.Tammy., 2020, NEW YORK TIMES; Lawrence, 2020, GUARDIAN        0412; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2602; National Audit Office, 2020, SUPPL PERS PROT EQ P; Palmer D., 2020, POLITICO; PPE Portrait Project, 2021, HUM COR CAR; Public Health England, 2014, PAND INFL STRAT FRAM; Roberts M., 2020, BBC 0930; Sullivan O, 2020, E ANGLIAN DAILY 1113; Trendall S., 2019, GOVT ROLL OUT 5M PAN; Willyard C., 2021, NATURE; Wong B., 2020, S CHINA MORNING POST; World Health Organization, 2020, PRIOR MED DEV LIST C	27	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2849	10.1136/bmj.n2849	http://dx.doi.org/10.1136/bmj.n2849			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH5YO	34848399	Bronze			2022-12-28	WOS:000725509900004
J	McCann, S				McCann, Sophie			The UK government's migration policy plans will only cause more suffering and death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McCann, Sophie] MSF, Geneva, Switzerland	Doctors Without Borders	McCann, S (corresponding author), MSF, Geneva, Switzerland.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2962	10.1136/bmj.n2962	http://dx.doi.org/10.1136/bmj.n2962			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH5YO	34848393	Green Published, hybrid			2022-12-28	WOS:000725509900007
J	Ankuda, CK; Morrison, RS; Aldridge, MD				Ankuda, Claire K.; Morrison, R. Sean; Aldridge, Melissa D.			The 2021 Medicare Advantage Hospice Carve-In	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ankuda, Claire K.; Morrison, R. Sean; Aldridge, Melissa D.] Icahn Sch Med Mt Sinai, Brookdale Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Morrison, R. Sean; Aldridge, Melissa D.] James J Peters Bronx VA Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai	Ankuda, CK (corresponding author), Icahn Sch Med Mt Sinai, Brookdale Dept Geriatr & Palliat Med, New York, NY 10029 USA.	claire.ankuda@mssm.edu		Ankuda, Claire/0000-0003-1371-8524				Aldridge MD, 2021, JAMA INTERN MED, V181, P1114, DOI 10.1001/jamainternmed.2020.6300; Ankuda CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20345; Center for Health Equity Research and Promotion US Department of Veterans Affairs, BER FAM SURV INP; Centers for Medicare & Medicaid Services, MED ADV VAL BAS INS; Government Accountability Office, MED ADV BEN DIS FEE; Hunt LJ, 2021, J AM GERIATR SOC, V69, P1457, DOI 10.1111/jgs.17107; Medpac, 2020, REP C MED PAYM POL; Rahman M, 2015, HEALTH AFFAIR, V34, P1675, DOI 10.1377/hlthaff.2015.0272; Shrank WH, 2020, JAMA-J AM MED ASSOC, V324, P35, DOI 10.1001/jama.2020.8459; Teno JM., 2021, JAMA HLTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.2269	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2021	326	23					2367	2368		10.1001/jama.2021.21161	http://dx.doi.org/10.1001/jama.2021.21161		NOV 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC5RI	34842906	Green Accepted			2022-12-28	WOS:000725789800002
J	Tan, MMJ; Neill, R; Haldane, V; Jung, AS; De Foo, C; Tan, SM; Shrestha, P; Verma, M; Bonk, M; Abdalla, SM; Legido-Quigley, H				Tan, Melisa Mei Jin; Neill, Rachel; Haldane, Victoria; Jung, Anne-Sophie; De Foo, Chuan; Tan, See Mieng; Shrestha, Pami; Verma, Monica; Bonk, Mathias; Abdalla, Salma M.; Legido-Quigley, Helena			Assessing the role of qualitative factors in pandemic responses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tan, Melisa Mei Jin; De Foo, Chuan; Tan, See Mieng; Shrestha, Pami; Verma, Monica; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Neill, Rachel] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Haldane, Victoria] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jung, Anne-Sophie; Legido-Quigley, Helena] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Abdalla, Salma M.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Bonk, Mathias] Berlin Inst Global Hlth, Berlin, Germany	National University of Singapore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; Boston University	Tan, MMJ (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	melisatan@nus.edu.sg	Foo, Chuan De/AAJ-9844-2021	Foo, Chuan De/0000-0001-7254-4881; Neill, Rachel/0000-0002-1110-5479; Jung, Anne-Sophie/0000-0001-7039-7830	WHO; Singapore's National Medical Research Council [NMRC/CG/C026/2017_NUHS]	WHO(World Health Organization); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	This collection of articles was proposed by The Independent Panel for Pandemic Preparedness and Response. Open access fees were funded by WHO and Singapore's National Medical Research Council (NMRC/CG/C026/2017_NUHS). The BMJ commissioned, peer reviewed, edited, and made the decision to publish these articles. Kamran Abbasi was the lead editor for The BMJ.	Abbey EJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239398; African Union, 2020, EUR UN SUPP AFR COVI; [Anonymous], 2021, BBC NEWS 0711; Association of Southeast Asian Nations, 2020, ASEAN HLTH SECT EFF; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Baum F, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n91; Bump JB, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n73; Centre for Disease Control,,, 2021, AFR CDC WAS CRUC RES; Davis KE, 2012, LAW SOC REV, V46, P71, DOI 10.1111/j.1540-5893.2012.00473.x; Delegation of the European Union to ASEAN,, 2021, EU ASEAN LAUNCH SE A; DST Root CA X3 Expiration, 2021, Q REP EUR EL MARK; Elbe Stefan, 2005, INT RELAT, V19, P403, DOI DOI 10.1177/0047117805058532; European Commission,, 2020, HUM AID 64 MILL MOST; European Commission,, 2020, COR GLOB RESP EU HUM; Farr C., 2020, CNBC 0721; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9; Ingram A, 2013, ANTIPODE, V45, P436, DOI 10.1111/j.1467-8330.2012.01008.x; Joseph J, 2010, ALTERNATIVES, V35, P29, DOI 10.1177/030437541003500102; Karliner J, 2019, HLTH CARE HARM ARUP; KCAA, 2021, APPR COVID 19 PCR TE; Kings J., 2020, DEVPOLICY BLOG 0508; Lai L., 2020, STRAITS TIMES 1113; Marten R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n243; Ministry of Employment and Labor,, GOV LAUNCH ADD EC RE; Ministry of Health & Medical Services, COV 19 TESTS; Ministry of Public Health,, 2020, JOINT INTR REV PUBL; Ministry of Public Health,, 2020, ORD 230 020 CREAT CO; National Emergency System, 2020, SIT REP COR COVID 19; National Health Service, 2020, DEL NET ZER NAT HLTH; National Healthcare Security Administration,, 2020, PER CAP MED COST PAT; New Zealand Government, 2021, GET TEST COVID 19; New Zealand Government,, MORTG HOL BUS FIN SU; Nienaber M., 2021, REUTERS 0426; Nilsson M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n127; Obulutsa G., 2021, AFRICANEWS 0128; OECD,, 2020, BEST COMM MIGR INT C; Ong Aihwa, 2005, GLOBAL ASSEMBLAGES T; Organisation for Economic Co-operation and Development, 2021, COVID 19 SPEND HELP; Peru News Agency, 2020, ANDINA 1007; Ramchandani R, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-067488; Ravi SJ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003648; Razavi A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002477; Reuters Staff, 2021, REUTERS 0131; Rizan C, 2021, J ROY SOC MED, V114, P250, DOI 10.1177/01410768211001583; Saute R, 2020, COVID 19 MOZAMBIQUE; Soh G., STRAITS TIMES 0924, V2021; Stowell D, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004545; Tangcharoensathien V, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n83; Tomson G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n59; Uruguay Presidency,, 2021, GOV MEAS ADDR HLTH E; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2021, COVID 19 SOL RESP FU; WHO, 2021, SOL CLIN TRIAL COVID; Wieler L. H., 2021, EMERGING COVID 19 SU	57	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2021	375								e067512	10.1136/bmj-2021-067512	http://dx.doi.org/10.1136/bmj-2021-067512			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1NC	34840137	Green Published, hybrid			2022-12-28	WOS:000740896100022
J	Baez-Ortega, A				Baez-Ortega, Adrian			As cancer grows old	SCIENCE			English	Editorial Material									[Baez-Ortega, Adrian] Wellcome Sanger Inst, Hinxton CB10 1SA, England; [Baez-Ortega, Adrian] Univ Cambridge, Magdalene Coll, Cambridge CB3 0AG, England	Wellcome Trust Sanger Institute; University of Cambridge	Baez-Ortega, A (corresponding author), Wellcome Sanger Inst, Hinxton CB10 1SA, England.; Baez-Ortega, A (corresponding author), Univ Cambridge, Magdalene Coll, Cambridge CB3 0AG, England.	ab2324@cam.ac.uk						Baez-Ortega A., 2020, THESIS U CAMBRIDGE; Baez-Ortega A, 2019, SCIENCE, V365, P464, DOI 10.1126/science.aau9923; Metzger MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005904; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Strakova A, 2015, CURR OPIN GENET DEV, V30, P49, DOI 10.1016/j.gde.2015.03.005	5	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1066	1066		10.1126/science.abm8137	http://dx.doi.org/10.1126/science.abm8137			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822272				2022-12-28	WOS:000725668600032
J	Dyer, C				Dyer, Clare			Showjumper sues mother's GP for inadequate advice that led to her spina bifida	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, EWHC 3506 QB	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375													1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YZ2MB	34836877				2022-12-28	WOS:000755314300001
J	Kickbusch, I; Holzscheiter, A				Kickbusch, Ilona; Holzscheiter, Anna			Can geopolitics derail the pandemic treaty?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								During the pandemic, the world has experienced how the geopolitics of global health have immediate, ruthless repercussions for the lives and livelihoods of billions, say Ilona Kickbusch and Anna Holzscheiter. The challenge of a pandemic treaty negotiation process is to be responsive to these interconnected levels of geopolitics	[Kickbusch, Ilona] Grad Inst Int & Dev Studies, Geneva, Switzerland; [Holzscheiter, Anna] Tech Univ Dresden, Dresden, Germany	Technische Universitat Dresden	Holzscheiter, A (corresponding author), Tech Univ Dresden, Dresden, Germany.	anna.holzscheiter@tu-dresden.de			Global Health Centre, Graduate Institute, Geneva	Global Health Centre, Graduate Institute, Geneva	This article is part of a collection of articles on a global pandemic treaty. The collection was proposed by the Global Health Centre at the Graduate Institute. The BMJ edited and made the decisions to publish the articles. Article handling and open access fees are funded by a research project at the Global Health Centre, Graduate Institute, Geneva. Kamran Abbasi and Juliet Dobson are the editors for The BMJ.	[Anonymous], GLOBAL COVID 19 SUMM; [Anonymous], 2021, XINHUANET; Barabantseva E, 2021, GEOPOLITICS, V26, P343, DOI 10.1080/14650045.2019.1636558; Blom IM, 2021, LANCET GLOB HEALTH, V9, pE1361, DOI 10.1016/S2214-109X(21)00307-7; Charbonnier P, ECOLOGICAL REALPOLIT; Gostin LO, 2021, JAMA-J AM MED ASSOC, V326, P1257, DOI 10.1001/jama.2021.16104; Government of Norway, 2021, 100 DAY PROP REV DES; Macaes B, NEW TECHNOLOGICAL OR; Olatunbosun-Alakija A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2848; Ramakrishnan N, 2021, WIRE; Ramakrishnan N., 2021, PEOPLES DISPATC 1119; Svet Lustig V, 2021, HLTH POLICY WATCH; Tomlinson C., 2021, NEW FRAME 0416; World Health Organization, 2021, PROP MOD ENG REL STA	14	3	3	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								e069129	10.1136/bmj-2021-069129	http://dx.doi.org/10.1136/bmj-2021-069129			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836885	Green Published, hybrid			2022-12-28	WOS:000727787900003
J	Medzhitov, R				Medzhitov, Ruslan			The spectrum of inflammatory responses	SCIENCE			English	Review							HOMEOSTASIS; CELLS; MECHANISMS; IMMUNITY; DEFENSE; DISEASE; RESOLUTION; TOLERANCE; HALLMARKS; HEALTH	Inflammation is an integral part of animal biology. It provides critical protection from adverse environmental factors by enforcing the defense of homeostasis and the functional and structural integrity of tissues and organs. Recent advances have uncovered a broad range of biological processes that involve inflammatory control, calling for a renewed framework of inflammation beyond its classical roles in defense from infection and injury. In this Review, new perspectives on inflammation biology are discussed and new research directions are suggested to address the fundamental gaps in our current understanding.	[Medzhitov, Ruslan] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Yale Univ, Howard Hughes Med Inst, Sch Med, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA.; Medzhitov, R (corresponding author), Yale Univ, Howard Hughes Med Inst, Sch Med, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute; Blavatnik Family Foundation; Food Allergy Science Initiative; National Institutes of Health [AI144152-01]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Blavatnik Family Foundation; Food Allergy Science Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Howard Hughes Medical Institute, the Blavatnik Family Foundation, the Food Allergy Science Initiative, and the National Institutes of Health (grant AI144152-01).	Akdis CA, 2021, NAT REV IMMUNOL, V21, P739, DOI 10.1038/s41577-021-00538-7; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Ayres JS, 2020, CELL, V181, P250, DOI 10.1016/j.cell.2020.03.036; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Besedovsky L, 2019, PHYSIOL REV, V99, P1325, DOI 10.1152/physrev.00010.2018; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Cimino I, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106868118; Colaco HG, 2016, FEBS J, V283, P2448, DOI 10.1111/febs.13730; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Florsheim EB, 2021, CELL, V184, P1440, DOI 10.1016/j.cell.2020.12.007; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Henderson NC, 2020, NATURE, V587, P555, DOI 10.1038/s41586-020-2938-9; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Howe HF, 1988, ECOLOGICAL RELATIONS; Iason G, 2005, P NUTR SOC, V64, P123, DOI 10.1079/PNS2004415; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kearney CJ, 2017, MOL CELL, V65, P965, DOI 10.1016/j.molcel.2017.02.024; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meizlish ML, 2021, ANNU REV IMMUNOL, V39, P557, DOI 10.1146/annurev-immunol-061020-053734; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pagan AJ, 2018, ANNU REV IMMUNOL, V36, P639, DOI 10.1146/annurev-immunol-032712-100022; Peters A, 2021, CELL, V184, P1455, DOI 10.1016/j.cell.2021.01.043; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Qing H, 2020, CELL, V182, P1660, DOI 10.1016/j.cell.2020.08.044; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571	53	34	34	27	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1070	1075		10.1126/science.abi5200	http://dx.doi.org/10.1126/science.abi5200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822279				2022-12-28	WOS:000725668600036
J	Liu, Y; Liu, JY; Plante, KS; Plante, JA; Xie, XP; Zhang, XW; Ku, ZQ; An, ZQ; Scharton, D; Schindewolf, C; Widen, SG; Menachery, VD; Shi, PY; Weaver, SC				Liu, Yang; Liu, Jianying; Plante, Kenneth S.; Plante, Jessica A.; Xie, Xuping; Zhang, Xianwen; Ku, Zhiqiang; An, Zhiqiang; Scharton, Dionna; Schindewolf, Craig; Widen, Steven G.; Menachery, Vineet D.; Shi, Pei-Yong; Weaver, Scott C.			The N501Y spike substitution enhances SARS-CoV-2 infection and transmission	NATURE			English	Article							B.1.1.7; FITNESS; LINEAGE	The B.1.1.7 variant (also known as Alpha) of SARS-CoV-2, the cause of the COVID-19 pandemic, emerged in the UK in the summer of 2020. The prevalence of this variant increased rapidly owing to an increase in infection and/or transmission efficiency(1). The Alpha variant contains 19 nonsynonymous mutations across its viral genome, including 8 substitutions or deletions in the spike protein that interacts with cellular receptors to mediate infection and tropism. Here, using a reverse genetics approach, we show that of the 8 individual spike protein substitutions, only N501Y resulted in consistent fitness gains for replication in the upper airway in a hamster model as well as in primary human airway epithelial cells. The N501Y substitution recapitulated the enhanced viral transmission phenotype of the eight mutations in the Alpha spike protein, suggesting that it is a major determinant of the increased transmission of the Alpha variant. Mechanistically, the N501Y substitution increased the affinity of the viral spike protein for cellular receptors. As suggested by its convergent evolution in Brazil, South Africa and elsewhere(2,3), our results indicate that N501Y substitution is an adaptive spike mutation of major concern.	[Liu, Yang; Xie, Xuping; Zhang, Xianwen; Widen, Steven G.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Liu, Yang; Liu, Jianying; Plante, Kenneth S.; Plante, Jessica A.; Scharton, Dionna; Schindewolf, Craig; Menachery, Vineet D.; Shi, Pei-Yong; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Liu, Jianying; Plante, Kenneth S.; Plante, Jessica A.; Scharton, Dionna; Weaver, Scott C.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA; [Liu, Jianying; Plante, Kenneth S.; Plante, Jessica A.; Scharton, Dionna; Schindewolf, Craig; Menachery, Vineet D.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ku, Zhiqiang; An, Zhiqiang] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston	Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	peshi@utmb.edu; sweaver@utmb.edu	Plante, Jessica/GRS-0172-2022; zhang, xian/GYA-0290-2022	Plante, Jessica/0000-0002-4768-7458; An, Zhiqiang/0000-0001-9309-2335; Plante, Kenneth/0000-0002-7485-3167; Ku, Zhiqiang/0000-0001-8347-0013	NIA of the NIH [AI153602, AG049042, R24AI120942]; NIAID of the NIH [AI153602, AG049042, R24AI120942]; University of Texas System; Welch Foundation [AU-0042-20030616]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP150551, RP190561]; NIH [AI134907, UL1TR001439]; Sealy & Smith foundation; Kleberg foundation; John S. Dunn foundation; Amon G. Carter foundation; Gilson Longenbaugh foundation; Summerfield Robert foundation; James W. McLaughlin Fellowship Fund	NIA of the NIH; NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas System; Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas (CPRIT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy & Smith foundation; Kleberg foundation; John S. Dunn foundation; Amon G. Carter foundation; Gilson Longenbaugh foundation; Summerfield Robert foundation; James W. McLaughlin Fellowship Fund	This research was supported by grants from the NIA and NIAID of the NIH (AI153602 and AG049042 to V.D.M., and R24AI120942 to S.C.W.); a STARs award provided by the University of Texas System to V.D.M.; a Welch Foundation grant AU-0042-20030616; and Cancer Prevention and Research Institute of Texas (CPRIT) grants RP150551 and RP190561 to Z.A. P.-Y.S. was supported by NIH grant AI134907 and UL1TR001439, and by awards from the Sealy & Smith, Kleberg, John S. Dunn, Amon G. Carter, Gilson Longenbaugh and Summerfield Robert foundations. J.L. was supported by a James W. McLaughlin Fellowship Fund.	Andersen C., 2019, CATSEYES CREATE CATS; Bergren NA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008102; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Claro IM, 2021, EMERG INFECT DIS, V27, P970, DOI 10.3201/eid2703.210038; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Frampton D, 2021, LANCET INFECT DIS, V21, P1246, DOI 10.1016/S1473-3099(21)00170-5; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Gribble J, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009226; Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Ku Z., 2021, NAT COMMUN, V12, DOI [10.1038/s41467-020-20789-7, DOI 10.1038/s41467-020-20789-7]; Larsen B.B., 2020, IDENTIFICATION NOVEL; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Liu JY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20747-3; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Meng B, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109292; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Thorne Lucy G, 2021, bioRxiv, DOI 10.1101/2021.06.06.446826; Touret F, 2021, MBIO, V12, DOI 10.1128/mBio.00850-21; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wiser MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126210; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	33	81	83	9	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					294	+		10.1038/s41586-021-04245-0	http://dx.doi.org/10.1038/s41586-021-04245-0		NOV 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW6UU	34818667	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000741978100001
J	Sheldon, T				Sheldon, Tony			Covid-19: Austria enters lockdown as cases surge across Europe	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Our World in Data, 2021, COR COVID 19 CAS	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2021	375								n2861	10.1136/bmj.n2861	http://dx.doi.org/10.1136/bmj.n2861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE2GM	34799343	Bronze			2022-12-28	WOS:000723212300006
J	White, C				White, Charlotte			Our worst fears about the impact of Universal Credit cut are coming true	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[White, Charlotte] Earlsfield Foodbank South West London, London, England		White, C (corresponding author), Earlsfield Foodbank South West London, London, England.							Goodwin S., 2021, BMJ OPINION	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2021	375								n2846	10.1136/bmj.n2846	http://dx.doi.org/10.1136/bmj.n2846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9RR	34794951	Bronze			2022-12-28	WOS:000727793600005
J	Zhang, F; Park, SY; Yao, CL; Lu, HP; Dunfield, SP; Xiao, CX; Ulicna, S; Zhao, XM; Du Hill, L; Chen, XH; Wang, XM; Mundt, LE; Stone, KH; Schelhas, LT; Teeter, G; Parkin, S; Ratcliff, EL; Loo, YL; Berry, JJ; Beard, MC; Yan, YF; Larson, BW; Zhu, K				Zhang, Fei; Park, So Yeon; Yao, Canglang; Lu, Haipeng; Dunfield, Sean P.; Xiao, Chuanxiao; Ulicna, Sona; Zhao, Xiaoming; Du Hill, Linze; Chen, Xihan; Wang, Xiaoming; Mundt, Laura E.; Stone, Kevin H.; Schelhas, Laura T.; Teeter, Glenn; Parkin, Sean; Ratcliff, Erin L.; Loo, Yueh-Lin; Berry, Joseph J.; Beard, Matthew C.; Yan, Yanfa; Larson, Bryon W.; Zhu, Kai			Metastable Dion-Jacobson 2D structure enables efficient and stable perovskite solar cells	SCIENCE			English	Article							PERFORMANCE; STABILITY	The performance of three-dimensional (3D) organic-inorganic halide perovskite solar cells (PSCs) can be enhanced through surface treatment with 2D layered perovskites that have efficient charge transport. We maximized hole transport across the layers of a metastable Dion-Jacobson (DJ) 2D perovskite that tuned the orientational arrangements of asymmetric bulky organic molecules. The reduced energy barrier for hole transport increased out-of-plane transport rates by a factor of 4 to 5, and the power conversion efficiency (PCE) for the 2D PSC was 4.9%. With the metastable DJ 2D surface layer, the PCE of three common 3D PSCs was enhanced by approximately 12 to 16% and could reach approximately 24.7%. For a triple-cation-mixed-halide PSC, 90% of the initial PCE was retained after 1000 hours of 1-sun operation at similar to 40 degrees C in nitrogen.	[Zhang, Fei; Park, So Yeon; Lu, Haipeng; Chen, Xihan; Schelhas, Laura T.; Beard, Matthew C.; Larson, Bryon W.; Zhu, Kai] Natl Renewable Energy Lab, Chem & Nanosci Ctr, Golden, CO 80401 USA; [Yao, Canglang; Wang, Xiaoming; Yan, Yanfa] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Yao, Canglang; Wang, Xiaoming; Yan, Yanfa] Univ Toledo, Wright Ctr Photovolta Innovat & Commercializat, Toledo, OH 43606 USA; [Dunfield, Sean P.; Xiao, Chuanxiao; Teeter, Glenn; Berry, Joseph J.] Natl Renewable Energy Lab, Mat Sci Ctr, Golden, CO 80401 USA; [Dunfield, Sean P.; Berry, Joseph J.] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Dunfield, Sean P.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Ulicna, Sona; Mundt, Laura E.; Stone, Kevin H.; Schelhas, Laura T.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Zhao, Xiaoming; Loo, Yueh-Lin] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Du Hill, Linze; Ratcliff, Erin L.] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ 85721 USA; [Parkin, Sean] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Ratcliff, Erin L.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Ratcliff, Erin L.] Univ Arizona, Dept Mat Sci & Engn, Tucson, AZ 85721 USA; [Berry, Joseph J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Princeton University; University of Arizona; University of Kentucky; University of Arizona; University of Arizona; University of Colorado System; University of Colorado Boulder	Zhang, F; Larson, BW; Zhu, K (corresponding author), Natl Renewable Energy Lab, Chem & Nanosci Ctr, Golden, CO 80401 USA.	fei.zhang@nrel.gov; bryon.larson@nrel.gov; kai.zhu@nrel.gov	ZHANG, FEI/L-3977-2019; Zhu, Kai/AAF-1940-2019; Lu, Haipeng/AAJ-7397-2021; Chen, Xihan/M-9210-2016	ZHANG, FEI/0000-0002-3774-9520; Lu, Haipeng/0000-0003-0252-3086; Chen, Xihan/0000-0001-7907-2549; Dunfield, Sean/0000-0002-2855-4457; Yan, Yanfa/0000-0003-3977-5789	US Department of Energy [DE-AC36-08GO28308]; Alliance for Sustainable Energy; (TRMC) from the Center for Hybrid Organic-Inorganic Semiconductors for Energy - Office of Basic Energy Sciences, Office of Science within the US Department of Energy; National Center for Photovoltaics [DE-FOA-0002064, DEEE0008790]; US Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Office of Naval Research [N00014-20-1-2440]; National Science Foundation [CMMI-1824674]; Princeton Center for Complex Materials; National Science Foundation (NSF)-MRSEC program [DMR1420541]; US Department of Energy's Office of Energy Efficiency and Renewable Energy and located at the National Renewable Energy Laboratory [DE-AC02-05CH11231]	US Department of Energy(United States Department of Energy (DOE)); Alliance for Sustainable Energy; (TRMC) from the Center for Hybrid Organic-Inorganic Semiconductors for Energy - Office of Basic Energy Sciences, Office of Science within the US Department of Energy(United States Department of Energy (DOE)); National Center for Photovoltaics; US Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Princeton Center for Complex Materials; National Science Foundation (NSF)-MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); US Department of Energy's Office of Energy Efficiency and Renewable Energy and located at the National Renewable Energy Laboratory(United States Department of Energy (DOE))	The work was partially supported by the US Department of Energy under contract DE-AC36-08GO28308 with Alliance for Sustainable Energy, the manager and operator of the National Renewable Energy Laboratory. The authors acknowledge the support on 2D structure design, first-principle calculations, synthesis of PDAI2 and DMePDAI2, single-crystal synthesis and analysis, and optoelectronic characterizations (such as TRPL and TRMC) from the Center for Hybrid Organic-Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center funded by the Office of Basic Energy Sciences, Office of Science within the US Department of Energy. The authors also acknowledge the support on device fabrication and characterization and general thin-film perovskite characterizations from the De-Risking Halide Perovskite Solar Cells program of the National Center for Photovoltaics, and the support on SnO2 ETL synthesis along with the corresponding device fabrication and characterization from DE-FOA-0002064 and award DEEE0008790, funded by the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. L.D.H. and E.L.R. acknowledge funding support on UPS characterization and analysis from the Office of Naval Research under award N00014-20-1-2440. X.Z. and Y.-L.L. acknowledge support on SCLC characterization and analysis from the National Science Foundation, under grant CMMI-1824674, and funding from the Princeton Center for Complex Materials, a National Science Foundation (NSF)-MRSEC program (DMR1420541). The DFT calculations were performed by using computational resources sponsored by the US Department of Energy's Office of Energy Efficiency and Renewable Energy and located at the National Renewable Energy Laboratory and resources of the National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility located at Lawrence Berkeley National Laboratory, operated under contract DE-AC02-05CH11231. The views expressed in the article do not necessarily represent the views of the US Department of Energy or the US government.	Ahmad S, 2019, JOULE, V3, P794, DOI 10.1016/j.joule.2018.11.026; Anaraki EH, 2016, ENERG ENVIRON SCI, V9, P3128, DOI 10.1039/c6ee02390h; Ashiotis G, 2015, J APPL CRYSTALLOGR, V48, P510, DOI 10.1107/S1600576715004306; Bi DQ, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.142, 10.1038/nenergy.2016.142]; Corradi AB, 1999, INORG CHEM, V38, P716, DOI 10.1021/ic980893k; Even J, 2013, J PHYS CHEM LETT, V4, P2999, DOI 10.1021/jz401532q; Gangadharan DT, 2019, ENERG ENVIRON SCI, V12, P2860, DOI 10.1039/c9ee01591d; Gao Y, 2019, NAT CHEM, V11, P1151, DOI 10.1038/s41557-019-0354-2; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Guidon M, 2010, J CHEM THEORY COMPUT, V6, P2348, DOI 10.1021/ct1002225; Hou Y, 2020, SCIENCE, V367, P1135, DOI 10.1126/science.aaz3691; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Jang YW, 2021, NAT ENERGY, V6, P63, DOI 10.1038/s41560-020-00749-7; Jiang XQ, 2020, NANO ENERGY, V75, DOI 10.1016/j.nanoen.2020.104892; Jung EH, 2019, NATURE, V567, P511, DOI 10.1038/s41586-019-1036-3; Khenkin MV, 2020, NAT ENERGY, V5, P35, DOI 10.1038/s41560-019-0529-5; Krukau AV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2404663; Li XT, 2021, CHEM REV, V121, P2230, DOI 10.1021/acs.chemrev.0c01006; Li X, 2015, NAT CHEM, V7, P703, DOI [10.1038/nchem.2324, 10.1038/NCHEM.2324]; Liang CW, 2020, ENERG ENVIRON SCI, V13, P86, DOI 10.1039/c9ee02388g; Liang LS, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.202000197; Lv YP, 2020, J MATER CHEM A, V8, P10283, DOI 10.1039/d0ta02437f; Ma CQ, 2018, ADV MATER, V30, DOI 10.1002/adma.201800710; Mao LL, 2018, J AM CHEM SOC, V140, P3775, DOI 10.1021/jacs.8b00542; McGott DL, 2021, JOULE, V5, P1057, DOI 10.1016/j.joule.2021.03.015; Miessler G.L., 2014, INORG CHEM, V5th ed.; Miessler G.L., 2014, INORG CHEM, V5; Min H, 2019, SCIENCE, V366, P749, DOI 10.1126/science.aay7044; National Renewable Energy Laboratory, 2020, BEST RES CELL EFFICI; Passarelli JV, 2018, J AM CHEM SOC, V140, P7313, DOI 10.1021/jacs.8b03659; Perkins CL, 2006, J VAC SCI TECHNOL A, V24, P497, DOI 10.1116/1.2194929; Shi EZ, 2020, NATURE, V580, P614, DOI 10.1038/s41586-020-2219-7; Silver S, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903900; Tao SX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14435-4; Wang K, 2018, ACS NANO, V12, P4919, DOI 10.1021/acsnano.8b01999; Xiao CX, 2017, ACS APPL MATER INTER, V9, P38373, DOI 10.1021/acsami.7b08582; Xue JJ, 2021, SCIENCE, V371, P636, DOI 10.1126/science.abd4860; Yu TL, 2014, DALTON T, V43, P13115, DOI 10.1039/c4dt01181c; Zhang F, 2021, CHEM-US, V7, P774, DOI 10.1016/j.chempr.2020.12.023; Zhang F, 2020, ENERG ENVIRON SCI, V13, P1154, DOI 10.1039/c9ee03757h; Zhang F, 2019, J AM CHEM SOC, V141, P5972, DOI 10.1021/jacs.9b00972; Zhang F, 2017, ADV MATER, V29, DOI 10.1002/adma.201606806; Zhao WD, 2020, J MATER CHEM A, V8, P9919, DOI 10.1039/d0ta02706e; Zheng XP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.102; Zhu HW, 2021, J AM CHEM SOC, V143, P3231, DOI 10.1021/jacs.0c12802	46	54	54	160	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					71	+	eabj2637	10.1126/science.abj2637	http://dx.doi.org/10.1126/science.abj2637			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34822309				2022-12-28	WOS:000740261400042
J	Watts, G				Watts, Geoff			Tom Hemming Karlsen: hepatologist with a public health message	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					18	18		10.1016/S0140-6736(21)02746-X	http://dx.doi.org/10.1016/S0140-6736(21)02746-X		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YA3YW	34863356				2022-12-28	WOS:000738273800010
J	Tsukahara, T; Brann, DH; Pashkovski, SL; Guitchounts, G; Bozza, T; Datta, SR				Tsukahara, Tatsuya; Brann, David H.; Pashkovski, Stan L.; Guitchounts, Grigori; Bozza, Thomas; Datta, Sandeep Robert			A transcriptional rheostat couples past activity to future sensory responses	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; NARIS OCCLUSION ALTERS; ODORANT RECEPTORS; OLFACTORY-BULB; CELL-TYPES; COMPENSATORY PLASTICITY; CORTICAL ADAPTATION; HOMEOSTATIC CONTROL; GENE-EXPRESSION; NEURAL ACTIVITY	Animals traversing different environments encounter both stable background stimuli and novel cues, which are thought to be detected by primary sensory neurons and then distinguished by downstream brain circuits. Here, we show that each of the 1,000 olfactory sensory neuron (OSN) subtypes in the mouse harbors a distinct transcriptome whose content is precisely determined by interactions between its odorant receptor and the environment. This transcriptional variation is systematically organized to support sensory adaptation: expression levels of more than 70 genes relevant to transforming odors into spikes continuously vary across OSN subtypes, dynamically adjust to new environments over hours, and accurately predict acute OSN-specific odor responses. The sensory periphery therefore separates salient signals from predictable background via a transcriptional rheostat whose moment-to-moment state reflects the past and constrains the future; these findings suggest a general model in which structured transcriptional variation within a cell type reflects individual experience.	[Tsukahara, Tatsuya; Brann, David H.; Pashkovski, Stan L.; Guitchounts, Grigori; Datta, Sandeep Robert] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Harvard University; Harvard Medical School; Northwestern University	Datta, SR (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	srdatta@hms.harvard.edu		Datta, Sandeep/0000-0002-8068-3862; Guitchounts, Grigori/0000-0003-0142-0149; Tsukahara, Tatsuya/0000-0002-6928-8562	NIH [R011DC016222, U19 NS112953, F31DC019017]; Simons Collaboration on the Global Brain; Brain Research Foundation; Tan Yang Center at Harvard Medical School; Japan Society for the Promotion of Science; Louis Perry Jones Fund; Tan Yang Center; NSF Graduate Research Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Collaboration on the Global Brain; Brain Research Foundation; Tan Yang Center at Harvard Medical School; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Louis Perry Jones Fund; Tan Yang Center; NSF Graduate Research Fellowship(National Science Foundation (NSF))	We thank John McGann and Matthew Grubb for technical advice on naris occlusion; Venkatesh Murthy, Dima Rinberg, and Catherine Dulac for mice; and Kelsey Tyssowski, Vanessa Ruta, Rachel Wilson, Bernardo Sabatini, David Ginty, Michael Greenberg, Piali Sengupta, and the Datta lab for useful comments on the manuscript. We thank Neha Bhagat for laboratory assistance and Janet Wallace for administrative assistance. We thank the Bauer Core Facility at Harvard University for sequencing and the Flow Cytometry Core at Beth Israel Deaconess Medical Center. Portions of this research were conducted on the O2 High Performance Compute Cluster at Harvard Medical School. Illustrations were created in part with BioRender.com and Vecteezy. com. S.R.D. is supported by NIH grants R011DC016222 and U19 NS112953 and by grants from the Simons Collaboration on the Global Brain, the Brain Research Foundation, and the Tan Yang Center at Harvard Medical School. T.T. is supported by postdoctoral fellowships from the Japan Society for the Promotion of Science, the Louis Perry Jones Fund, and the Tan Yang Center. D.H.B. is supported by an NSF Graduate Research Fellowship and by NIH grant F31DC019017.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Arneodo EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03837-1; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barber CN, 2015, J NEUROPHYSIOL, V114, P2023, DOI 10.1152/jn.00076.2015; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Benda J, 2021, CURR BIOL, V31, pR110, DOI 10.1016/j.cub.2020.11.054; Best AR, 2005, J NEUROSCI, V25, P2513, DOI 10.1523/JNEUROSCI.5298-04.2005; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Brann DH, 2020, ANNU REV NEUROSCI, V43, P277, DOI 10.1146/annurev-neuro-102119-103452; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Cadiou H, 2014, J NEUROSCI, V34, P4857, DOI 10.1523/JNEUROSCI.0688-13.2014; Cho CE, 2016, ELIFE, V5, DOI [10.7554/elife.14000, 10.7554/eLife.14000]; Chong E, 2020, SCIENCE, V368, P1329, DOI 10.1126/science.aba2357; Chu MW, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0287-17.2017; Cleland TA, 2005, CHEM SENSES, V30, P801, DOI 10.1093/chemse/bji072; Coppola DM, 2012, J MOL NEUROSCI, V47, P604, DOI 10.1007/s12031-011-9690-4; Coppola DM, 2006, HISTOL HISTOPATHOL, V21, P487, DOI 10.14670/HH-21.487; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; de March CA, 2020, MOL CELL NEUROSCI, V104, DOI 10.1016/j.mcn.2020.103469; Dey S, 2015, CELL, V161, P1334, DOI 10.1016/j.cell.2015.04.052; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fischl AM, 2014, CHEM SENSES, V39, P439, DOI 10.1093/chemse/bju015; Fitzwater E, 2021, CHEM SENSES, V46, DOI 10.1093/chemse/bjaa071; Fletcher RB, 2017, CELL STEM CELL, V20, P817, DOI 10.1016/j.stem.2017.04.003; Galliano E, 2021, J NEUROSCI, V41, P2135, DOI 10.1523/JNEUROSCI.1606-20.2020; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gouwens NW, 2020, CELL, V183, P935, DOI 10.1016/j.cell.2020.09.057; Grabska-Barwinska A, 2017, NAT NEUROSCI, V20, P98, DOI 10.1038/nn.4444; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; HOPFIELD JJ, 1991, P NATL ACAD SCI USA, V88, P6462, DOI 10.1073/pnas.88.15.6462; Hu XS, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0103-19.2019; Ibarra-Soria X, 2017, ELIFE, V6, DOI 10.7554/eLife.21476; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Jiang Y, 2015, NAT NEUROSCI, V18, P1446, DOI 10.1038/nn.4104; Juang BT, 2013, CELL, V154, P1010, DOI 10.1016/j.cell.2013.08.006; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; Kass MD, 2016, CHEM SENSES, V41, P123, DOI 10.1093/chemse/bjv065; Kass MD, 2013, CHEM SENSES, V38, P77, DOI 10.1093/chemse/bjs081; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Kim DW, 2019, CELL, V179, P713, DOI 10.1016/j.cell.2019.09.020; Kim EJ, 2020, NEURON, V107, P274, DOI 10.1016/j.neuron.2020.04.018; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kostal L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000053; Kotliar D, 2019, ELIFE, V8, DOI 10.7554/eLife.43803; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lecoq J, 2009, J NEUROSCI, V29, P3067, DOI 10.1523/JNEUROSCI.6187-08.2009; Li A, 2014, J NEUROSCI, V34, P16058, DOI 10.1523/JNEUROSCI.3382-14.2014; Li HJ, 2017, CELL, V171, P1206, DOI 10.1016/j.cell.2017.10.019; Litwin-Kumar A, 2017, NEURON, V93, P1153, DOI 10.1016/j.neuron.2017.01.030; Ma LM, 2014, SCIENCE, V344, P194, DOI 10.1126/science.1248805; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Martelli C, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.684742; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; McNamara AM, 2008, LEARN MEMORY, V15, P117, DOI 10.1101/lm.785608; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Monahan K, 2017, ELIFE, V6, DOI 10.7554/elife.28620.001; Monahan K, 2015, ANNU REV CELL DEV BI, V31, P721, DOI 10.1146/annurev-cellbio-100814-125308; MOORE PA, 1994, CHEM SENSES, V19, P71, DOI 10.1093/chemse/19.1.71; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Ng R, 2019, NEURON, V104, P947, DOI 10.1016/j.neuron.2019.08.041; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; Oberland S, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2075.00366, 10.3389/fncel.2015.00366]; Pachitariu M., 2017, BIORXIV, DOI DOI 10.1101/061507; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Parrilla M, 2016, J COMP NEUROL, V524, P2713, DOI 10.1002/cne.24051; Pashkovski SL, 2020, NATURE, V583, P253, DOI 10.1038/s41586-020-2451-1; Repicky SE, 2009, J NEUROCHEM, V109, P193, DOI 10.1111/j.1471-4159.2009.05925.x; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Scala F, 2021, NATURE, V598, P144, DOI 10.1038/s41586-020-2907-3; Schaffer ES, 2018, NEURON, V98, P736, DOI 10.1016/j.neuron.2018.04.004; Scholz P, 2016, CHEM SENSES, V41, P313, DOI 10.1093/chemse/bjw003; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; SULLIVAN SL, 1995, CURR OPIN GENET DEV, V5, P516, DOI 10.1016/0959-437X(95)90057-N; Tan LZ, 2018, CHEM SENSES, V43, P427, DOI 10.1093/chemse/bjy030; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tes x ileanu T., 2019, ELIFE, V8, P308; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Turrigiano GG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0258; Tyssowski KM, 2019, CURR OPIN NEUROBIOL, V59, P87, DOI 10.1016/j.conb.2019.05.001; Vihani A, 2020, ELIFE, V9, DOI 10.7554/eLife.54501; von der Weid B, 2015, NAT NEUROSCI, V18, P1455, DOI 10.1038/nn.4100; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Waggener CT, 2007, NEUROSCI LETT, V427, P112, DOI 10.1016/j.neulet.2007.09.013; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Wang Q, 2017, CHEM SENSES, V42, P611, DOI 10.1093/chemse/bjx028; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Weber AI, 2019, ANNU REV VIS SCI, V5, P427, DOI 10.1146/annurev-vision-091718-014818; Weinreb C, 2018, BIOINFORMATICS, V34, P1246, DOI 10.1093/bioinformatics/btx792; Williams AH, 2018, NEURON, V98, P1099, DOI 10.1016/j.neuron.2018.05.015; Wilson CD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01432-4; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Wilson DA, 2009, NEUROBIOL LEARN MEM, V92, P199, DOI 10.1016/j.nlm.2008.07.010; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Wu YM, 2018, NEURON, V100, P1066, DOI 10.1016/j.neuron.2018.09.051; Xavier AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25507; Yadon CA, 2005, LEARN MEMORY, V12, P601, DOI 10.1101/lm.41405; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zhang JJ, 2012, MOL CELL NEUROSCI, V51, P79, DOI 10.1016/j.mcn.2012.08.006; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zwicker D, 2016, P NATL ACAD SCI USA, V113, P5570, DOI 10.1073/pnas.1600357113	122	7	7	4	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2021	184	26					6326	+		10.1016/j.cell.2021.11.022	http://dx.doi.org/10.1016/j.cell.2021.11.022		DEC 2021	51	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	XW1NB	34879231	hybrid, Green Accepted			2022-12-28	WOS:000735393800001
J	Driver, BE; Semler, MW; Self, WH; Ginde, AA; Trent, SA; Gandotra, S; Smith, LM; Page, DB; Vonderhaar, DJ; West, JR; Joffe, AM; Mitchell, SH; Doerschug, KC; Hughes, CG; High, K; Landsperger, JS; Jackson, KE; Howell, MP; Robison, SW; Gaillard, JP; Whitson, MR; Barnes, CM; Latimer, AJ; Koppurapu, VS; Alvis, BD; Russell, DW; Gibbs, KW; Wang, L; Lindsell, CJ; Janz, DR; Rice, TW; Prekker, ME; Casey, JD				Driver, Brian E.; Semler, Matthew W.; Self, Wesley H.; Ginde, Adit A.; Trent, Stacy A.; Gandotra, Sheetal; Smith, Lane M.; Page, David B.; Vonderhaar, Derek J.; West, Jason R.; Joffe, Aaron M.; Mitchell, Steven H.; Doerschug, Kevin C.; Hughes, Christopher G.; High, Kevin; Landsperger, Janna S.; Jackson, Karen E.; Howell, Michelle P.; Robison, Sarah W.; Gaillard, John P.; Whitson, Micah R.; Barnes, Christopher M.; Latimer, Andrew J.; Koppurapu, Vikas S.; Alvis, Bret D.; Russell, Derek W.; Gibbs, Kevin W.; Wang, Li; Lindsell, Christopher J.; Janz, David R.; Rice, Todd W.; Prekker, Matthew E.; Casey, Jonathan D.		Bougie Investigators Pragmatic	Effect of Use of a Bougie vs Endotracheal Tube With Stylet on Successful Intubation on the First Attempt Among Critically Ill Patients Undergoing Tracheal Intubation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUM ELASTIC BOUGIE; DIFFICULT AIRWAY MANAGEMENT; VIDEO LARYNGOSCOPY; PROSPECTIVE-VALIDATION; C-MAC; GUIDELINES	IMPORTANCE For critically ill adults undergoing emergency tracheal intubation, failure to intubate the trachea on the first attempt occurs in up to 20% of cases and is associated with severe hypoxemia and cardiac arrest. Whether using a tracheal tube introducer ("bougie") increases the likelihood of successful intubation compared with using an endotracheal tube with stylet remains uncertain. OBJECTIVE To determine the effect of use of a bougie vs an endotracheal tube with stylet on successful intubation on the first attempt. DESIGN, SETTING, AND PARTICIPANTS The Bougie or Stylet in Patients Undergoing Intubation Emergently (BOUGIE) trial was a multicenter, randomized clinical trial among 1102 critically ill adults undergoing tracheal intubation in 7 emergency departments and 8 intensive care units in the US between April 29, 2019, and February 14, 2021; the date of final follow-up was March 14, 2021. INTERVENTIONS Patients were randomly assigned to use of a bougie (n = 556) or use of an endotracheal tube with stylet (n = 546). MAIN OUTCOMES AND MEASURES The primary outcome was successful intubation on the first attempt. The secondary outcome was the incidence of severe hypoxemia, defined as a peripheral oxygen saturation less than 80%. RESULTS Among 1106 patients randomized. 1102 (99.6%) completed the trial and were included in the primary analysis (median age, 58 years; 41.0% women). Successful intubation on the first attempt occurred in 447 patients (80.4%) in the bougie group and 453 patients (83.0%) in the stylet group (absolute risk difference, -2.6 percentage points [95% CI, -7.3 to 2.2]; P = .27). A total of 58 patients (11.0%) in the bougie group experienced severe hypoxemia, compared with 46 patients (8.8%) in the stylet group (absolute risk difference, 2.2 percentage points [95% CI. -1.6 to 6.0]). Esophageal intubation occurred in 4 patients (0.7%) in the bougie group and 5 patients (0.9%) in the stylet group, pneumothorax was present after intubation in 14 patients (2.5%) in the bougie group and 15 patients (2.7%) in the stylet group, and injury to oral, glottic, or thoracic structures occurred in 0 patients in the bougie group and 3 patients (0.5%) in the stylet group. CONCLUSIONS AND RELEVANCE Among critically ill adults undergoing tracheal intubation, use of a bougie did not significantly increase the incidence of successful intubation on the first attempt compared with use of an endotracheal tube with stylet.	[Driver, Brian E.; Prekker, Matthew E.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Semler, Matthew W.; Landsperger, Janna S.; Jackson, Karen E.; Rice, Todd W.; Casey, Jonathan D.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Self, Wesley H.; High, Kevin] Vanderbilt Univ, Med Ctr, Dept Emergency Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Self, Wesley H.] Vanderbilt Inst Clin & Translat Sci, Nashville, TN USA; [Ginde, Adit A.; Trent, Stacy A.; Howell, Michelle P.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Trent, Stacy A.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA; [Gandotra, Sheetal; Page, David B.; Robison, Sarah W.; Whitson, Micah R.; Russell, Derek W.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Smith, Lane M.; Gaillard, John P.] Wake Forest Baptist Hlth, Dept Emergency Med, Winston Salem, NC USA; [Page, David B.; Whitson, Micah R.] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, AL USA; [Vonderhaar, Derek J.] Ochsner Hlth Syst, Dept Pulm & Crit Care Med, New Orleans, LA USA; [Vonderhaar, Derek J.] Louisiana State Univ, Sch Med, Sect Emergency Med, New Orleans, LA USA; [West, Jason R.] Lincoln Med Ctr, Dept Emergency Med, Bronx, NY USA; [Joffe, Aaron M.; Barnes, Christopher M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Mitchell, Steven H.; Latimer, Andrew J.] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Doerschug, Kevin C.; Koppurapu, Vikas S.] Univ Iowa, Dept Internal Med, Iowa City, IA USA; [Hughes, Christopher G.; Alvis, Bret D.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Russell, Derek W.] Birmingham Vet Affairs Med Ctr, Pulm Sect, Birmingham, AL USA; [Gibbs, Kevin W.] Wake Forest Sch Med, Sect Pulm Crit Care Allergy & Immunol Dis, Winston Salem, NC 27101 USA; [Wang, Li; Lindsell, Christopher J.] Vanderbilt Univ, Med Ctr, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Janz, David R.] Univ Med Ctr New Orleans, New Orleans, LA USA; [Janz, David R.] Louisiana State Univ, Sch Med, Sect Pulm Crit Care Med & Allergy Immunol, New Orleans, LA USA; [Prekker, Matthew E.] Hennepin Cty Med Ctr, Div Pulm & Crit Care Med, Minneapolis, MN 55415 USA	Hennepin County Medical Center; Vanderbilt University; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center; University of Alabama System; University of Alabama Birmingham; Ochsner Health System; Louisiana State University System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Iowa; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Wake Forest University; Vanderbilt University; Louisiana State University System; Hennepin County Medical Center	Driver, BE (corresponding author), 701 Pk Ave S, Minneapolis, MN 55415 USA.	Brian.Driver@hcmed.org	Casey, Jonathan/AAG-1211-2020; Russell, Derek W./X-7040-2019	Casey, Jonathan/0000-0002-0977-290X; Russell, Derek W./0000-0002-2716-1344; Gibbs, Kevin/0000-0002-5272-2289; Gandotra, Sheetal/0000-0002-5475-9704	NHLBI [K23HL143053]; NIH/NHLBI [T32HL105346-07]; NIH [K12HL133117, K23HL153584, UL1 TR000445]; NCATS/NIH [UL1 TR000445]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr Semler was supported in part by the NHLBI (K23HL143053). Dr Russell was supported in part by the NIH/NHLBI (T32HL105346-07). Dr Rice was supported in part by the NIH (UL1 RR024975). Dr Casey was supported in part by the NIH (K12HL133117 and K23HL153584). Data collection used the Research Electronic Data Capture (REDCap) tool developed and maintained with Vanderbilt Institute for Clinical and Translational Research grant support (UL1 TR000445 from NCATS/NIH).	Alkhouri H, 2017, EMERG MED AUSTRALAS, V29, P499, DOI 10.1111/1742-6723.12815; Amathieu R, 2011, ANESTHESIOLOGY, V114, P25, DOI 10.1097/ALN.0b013e318201c44f; Angerman S, 2018, ANAESTHESIA, V73, P348, DOI 10.1111/anae.14182; Benumof JL, 2021, NEW ENGL J MED, V384, P1836, DOI 10.1056/NEJMra1916801; Buis ML, 2016, RESUSCITATION, V99, P63, DOI 10.1016/j.resuscitation.2015.11.005; Casey JD, 2019, NEW ENGL J MED, V380, P811, DOI 10.1056/NEJMoa1812405; Combes X, 2011, ANESTHESIOLOGY, V114, P105, DOI 10.1097/ALN.0b013e318201c42e; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Driver B, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047790; Driver B, 2017, ANN EMERG MED, V70, P473, DOI 10.1016/j.annemergmed.2017.04.033; Driver BE, 2020, ACAD EMERG MED, V27, P1362, DOI 10.1111/acem.14041; Driver BE, 2018, JAMA-J AM MED ASSOC, V319, P2179, DOI 10.1001/jama.2018.6496; Driver BE, 2016, ACAD EMERG MED, V23, P433, DOI 10.1111/acem.12933; Fletcher GCL, 2002, BRIT J ANAESTH, V88, P418, DOI 10.1093/bja/88.3.418; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Gataure PS, 1996, ANAESTHESIA, V51, P935, DOI 10.1111/j.1365-2044.1996.tb14961.x; Higgs A, 2018, BRIT J ANAESTH, V120, P323, DOI 10.1016/j.bja.2017.10.021; Janz DR, 2016, CRIT CARE MED, V44, P1980, DOI 10.1097/CCM.0000000000001841; KIDD JF, 1988, ANAESTHESIA, V43, P437, DOI 10.1111/j.1365-2044.1988.tb06625.x; Latimer AJ, 2021, ANN EMERG MED, V77, P296, DOI 10.1016/j.annemergmed.2020.10.016; Latto IP, 2002, ANAESTHESIA, V57, P379, DOI 10.1046/j.1365-2044.2002.02411.x; Marson BA, 2014, ANAESTHESIA, V69, P219, DOI 10.1111/anae.12534; Mosier JM, 2020, AM J RESP CRIT CARE, V201, P775, DOI 10.1164/rccm.201908-1636CI; Natt B, 2021, CURR ANESTHESIOL REP, V11, P116, DOI 10.1007/s40140-021-00448-3; Noguchi T, 2003, CAN J ANAESTH, V50, P712, DOI 10.1007/BF03018715; NOLAN JP, 1993, ANAESTHESIA, V48, P630, DOI 10.1111/j.1365-2044.1993.tb07133.x; NOLAN JP, 1992, ANAESTHESIA, V47, P878, DOI 10.1111/j.1365-2044.1992.tb03154.x; Pfuntner AWL, 2013, HEALTHCARE COST UTIL; Prekker M., BOUGIE STYLET PATIEN; Russotto V, 2021, JAMA-J AM MED ASSOC, V325, P1164, DOI 10.1001/jama.2021.1727; Sakles JC, 2014, WEST J EMERG MED, V15, P930, DOI 10.5811/westjem.2014.9.23691	31	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2021	326	24					2488	2497		10.1001/jama.2021.22002	http://dx.doi.org/10.1001/jama.2021.22002		DEC 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC6FM	34879143	Green Published, Bronze			2022-12-28	WOS:000728824300001
J	Voelker, R				Voelker, Rebecca			Asbestos Wasn't Found in Cosmetics Containing Talc	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2121	2121						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874438				2022-12-28	WOS:000730077500008
J	Dyer, C				Dyer, Clare			Radiologist who breached conditions on his practice is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n708	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2021	375								n3018	10.1136/bmj.n3018	http://dx.doi.org/10.1136/bmj.n3018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YZ2PG	34872922	Bronze			2022-12-28	WOS:000755322600001
J	Zhang, B; Ma, L				Zhang, Bin; Ma, Lin			Transverse Nasal Creases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhang, Bin; Ma, Lin] Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China	Capital Medical University	Zhang, B (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China.	bch_maleen@aliyun.com		, Bin/0000-0002-2970-746X					0	0	1	26	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					2281	2281		10.1056/NEJMicm2111716	http://dx.doi.org/10.1056/NEJMicm2111716		DEC 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XL4CS	34874630				2022-12-28	WOS:000726232400001
J	Marom, A; Rak, Y				Marom, Assaf; Rak, Yoel			Comment on "A Middle Pleistocene Homo from Nesher Ramla, Israel"	SCIENCE			English	Editorial Material								Hershkovitz et al. (Reports, 25 June 2021, p. 1424) conclude that the Nesher Ramla (NR) fossils represent a distinctive Homo paleodeme that played a role as a source population for Neanderthals. However, the highly diagnostic features of the Neanderthal mandible- clearly displayed by the NR fossils-are largely overlooked. Our analyses indicate that the NR fossils represent simply a Neanderthal.	[Marom, Assaf] Technion Israel Inst Technol, Rappaport Fac Med, Dept Anat, Haifa, Israel; [Rak, Yoel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Rak, Yoel] Arizona State Univ, Inst Human Origins, Tempe, AZ USA; [Rak, Yoel] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Marom, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Anat, Haifa, Israel.	assafma@technion.ac.il		Marom, Assaf/0000-0003-0537-4661				Gibbons A., SCIENCE, V372, DOI [10.1126/science.abk1535 (2021), DOI 10.1126/SCIENCE.ABK1535(2021)]; Hershkovitz I, 2021, SCIENCE, V372, P1424, DOI 10.1126/science.abh3169; Hitchens C, 2007, GOD IS NOT GREAT REL, P150; Hovers E, 2009, LITHIC ASSEMBLAGES Q; Jones N, 2021, NATURE, V595, P20, DOI 10.1038/d41586-021-01738-w; McCown T, 1939, STONE AGE MOUNT CARM, V2; Rak Y, 2002, AM J PHYS ANTHROPOL, V119, P199, DOI 10.1002/ajpa.10131	7	3	3	2	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572							eabl4336	10.1126/science.abl4336	http://dx.doi.org/10.1126/science.abl4336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1EO	34855484				2022-12-28	WOS:000728578700001
J	Phimister, EG				Phimister, Elizabeth G.			Predicting Proteome-Scale Protein Structure with Artificial Intelligence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Burley, Stephen K./0000-0002-2487-9713				Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Castellano GM, 2019, J THORAC ONCOL, V14, P1982, DOI 10.1016/j.jtho.2019.06.015; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Staquicini DI, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2105739118; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Westbrook JD, 2019, STRUCTURE, V27, P211, DOI 10.1016/j.str.2018.11.007	6	5	5	4	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2021	385	23					2191	2194		10.1056/NEJMcibr2113027	http://dx.doi.org/10.1056/NEJMcibr2113027			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YE4VC	34874637				2022-12-28	WOS:000741124300018
J	Beder, D; Ashton, P; Mishra, V				Beder, Daniel; Ashton, Pamela; Mishra, Vibhash			Overactive bladder in women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-INCONTINENCE; MIRABEGRON; SYMPTOMS; EFFICACY		[Beder, Daniel; Mishra, Vibhash] Royal Free Hosp, Dept Urol, London NW3 2QG, England; [Ashton, Pamela] Clapham Family Practice, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Beder, D (corresponding author), Royal Free Hosp, Dept Urol, London NW3 2QG, England.	d.beder@nhs.net						Abrams P, 2015, EUR UROL, V67, P577, DOI 10.1016/j.eururo.2014.02.012; BAUS, UR INP OUTP CHART BL; Bryant Charmaine M, 2002, Br J Nurs, V11, P560; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Chapple CR, 2017, EUR UROL, V72, P389, DOI 10.1016/j.eururo.2017.01.037; D'Ancona C, 2019, NEUROUROL URODYNAM, V38, P433, DOI 10.1002/nau.23897; Drake MJ, 2016, EUR UROL, V70, P136, DOI 10.1016/j.eururo.2016.02.030; Elstad EA, 2010, J ADV NURS, V66, P2460, DOI 10.1111/j.1365-2648.2010.05422.x; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Funada S, COCHRANE DB SYST REV, V2020; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Hashim H, 2008, BJU INT, V102, P62, DOI 10.1111/j.1464-410X.2008.07463.x; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Herschorn S, 2017, BJU INT, V120, P562, DOI 10.1111/bju.13882; Herschorn S, 2013, UROLOGY, V82, P313, DOI 10.1016/j.urology.2013.02.077; Irwin DE, 2006, BJU INT, V97, P96, DOI 10.1111/j.1464-410X.2005.05889.x; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Kujubu DA, 2008, NAT CLIN PRACT NEPHR, V4, P426, DOI 10.1038/ncpneph0856; Nambiar AK, 2018, EUR UROL, V73, P596, DOI 10.1016/j.eururo.2017.12.031; National Institute for Health and Care Excellence, 2013, MIR TREAT SYMPT OV B; National Institute for Health and Care Excellence, 2019, CKS INC UR WOM INTR; National Institute for Health and Care Excellence, 2019, UR INC PELV ORG PROL; Stewart Kate, 2002, J Am Pharm Assoc (Wash), V42, P469, DOI 10.1331/108658002763316905; Subak LL, 2009, J UROLOGY, V182, pS2, DOI 10.1016/j.juro.2009.08.071; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375; Szabo SM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026391; Szabo SM, 2018, ADV THER, V35, P1831, DOI 10.1007/s12325-018-0796-8; Wein AJ, 1999, INT J FERTIL WOMEN M, V44, P56; Wyman JF, 2009, INT J CLIN PRACT, V63, P1177, DOI 10.1111/j.1742-1241.2009.02078.x	30	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2021	375								e063526	10.1136/bmj-2020-063526	http://dx.doi.org/10.1136/bmj-2020-063526			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ3JK	34853012				2022-12-28	WOS:000726688600014
J	Agirman, G; Yu, KB; Hsiao, EY				Agirman, Gulistan; Yu, Kristie B.; Hsiao, Elaine Y.			Signaling inflammation across the gut-brain axis	SCIENCE			English	Review							INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; MICROGLIA; ABNORMALITIES; ASTROCYTES; HISTAMINE; PROMOTE	The brain and gastrointestinal tract are critical sensory organs responsible for detecting, relaying, integrating, and responding to signals derived from the internal and external environment. At the interface of this sensory function, immune cells in the intestines and brain consistently survey environmental factors, eliciting responses that inform on the physiological state of the body. Recent research reveals that cross-talk along the gut-brain axis regulates inflammatory nociception, inflammatory responses, and immune homeostasis. Here, we discuss molecular and cellular mechanisms involved in the signaling of inflammation across the gut-brain axis. We further highlight interactions between the gut and the brain in inflammation-associated diseases.	[Agirman, Gulistan; Yu, Kristie B.; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Agirman, G (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	agirman@g.ucla.edu		Yu, Kristie/0000-0001-6735-3968; Agirman, Gulistan/0000-0003-3379-9632	National Institute of Neurological Disorders and Stroke [R01NS115537]; UCLA Whitcome Training Fellowship; New York Stem Cell Foundation	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCLA Whitcome Training Fellowship; New York Stem Cell Foundation	G.A. is supported by funding from the National Institute of Neurological Disorders and Stroke (R01NS115537). K.B.Y. is supported by funding from the UCLA Whitcome Training Fellowship. E.Y.H. is a New York Stem Cell Foundation-Robertson Investigator and supported in part by the New York Stem Cell Foundation.	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Benakis C, 2020, CURR OPIN NEUROBIOL, V61, P1, DOI 10.1016/j.conb.2019.11.009; Bluthe RM, 1996, NEUROREPORT, V7, P2823, DOI 10.1097/00001756-199611040-00083; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Campos-Acuna J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00239; Challis C, 2020, NAT NEUROSCI, V23, P327, DOI 10.1038/s41593-020-0589-7; Constantinescu CS, 2005, J NEUROCHEM, V95, P331, DOI 10.1111/j.1471-4159.2005.03368.x; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; de Lima KA, 2020, ANNU REV IMMUNOL, V38, P597, DOI 10.1146/annurev-immunol-102319-103410; Deczkowska A, 2018, NAT NEUROSCI, V21, P779, DOI 10.1038/s41593-018-0145-x; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Fitzpatrick Z, 2020, NATURE, V587, P472, DOI 10.1038/s41586-020-2886-4; Giovannoni F, 2020, TRENDS IMMUNOL, V41, P805, DOI 10.1016/j.it.2020.07.007; Golomb SM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108438; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Heiss CN, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109163; Houser MC, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01240-4; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huh JR, 2020, NAT REV IMMUNOL, V20, P217, DOI 10.1038/s41577-019-0247-z; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Jacobson A, 2021, MUCOSAL IMMUNOL, V14, P555, DOI 10.1038/s41385-020-00368-1; Jiang NM, 2018, TRENDS MOL MED, V24, P794, DOI 10.1016/j.molmed.2018.06.008; Kadowaki A, 2020, TRENDS NEUROSCI, V43, P622, DOI 10.1016/j.tins.2020.06.002; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Mayo L, 2016, BRAIN, V139, P1939, DOI 10.1093/brain/aww113; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Parker A, 2020, GUT MICROBES, V11, P135, DOI 10.1080/19490976.2019.1638722; Payne SC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00418; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Rao S, 2017, CELL, V168, P503, DOI 10.1016/j.cell.2017.01.006; Reed DE, 2003, J PHYSIOL-LONDON, V547, P531, DOI 10.1113/jphysiol.2002.032011; Rojas OL, 2019, CELL, V176, P610, DOI 10.1016/j.cell.2018.11.035; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sanmarco LM, 2021, NATURE, V590, P473, DOI 10.1038/s41586-020-03116-4; Scott SA, 2020, P NATL ACAD SCI USA, V117, P19376, DOI 10.1073/pnas.2000047117; Sgritta M, 2019, NEURON, V101, P246, DOI 10.1016/j.neuron.2018.11.018; SHANAHAN F, 1985, J IMMUNOL, V135, P1331; Shi XD, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.150052; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Spadoni I, 2015, SCIENCE, V350, P830, DOI 10.1126/science.aad0135; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; TAMURA K, 1992, DIGEST DIS SCI, V37, P1084, DOI 10.1007/BF01300291; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; White JP, 2018, CELL, V175, P1198, DOI 10.1016/j.cell.2018.08.069; Xu CL, 2020, IMMUNITY, V53, P417, DOI 10.1016/j.immuni.2020.06.025; Xu HP, 2019, IMMUNITY, V51, P696, DOI 10.1016/j.immuni.2019.09.004; Xu KY, 2021, GUT, V70, P1486, DOI 10.1136/gutjnl-2020-323263; Yam MF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082164; Yan YQ, 2021, IMMUNITY, V54, P499, DOI 10.1016/j.immuni.2021.02.002; Zhao JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42286-8	65	38	38	74	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1087	1092		10.1126/science.abi6087	http://dx.doi.org/10.1126/science.abi6087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822299				2022-12-28	WOS:000725668600039
J	Lado, JL				Lado, Jose L.			Putting a twist on spintronics	SCIENCE			English	Editorial Material							SUPERCONDUCTIVITY		[Lado, Jose L.] Aalto Univ, Dept Appl Phys, Espoo 00076, Finland	Aalto University	Lado, JL (corresponding author), Aalto Univ, Dept Appl Phys, Espoo 00076, Finland.	jose.lado@aalto.fi		Lado, Jose/0000-0002-9916-1589				Andrei EY, 2021, NAT REV MATER, V6, P201, DOI 10.1038/s41578-021-00284-1; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gibertini M, 2019, NAT NANOTECHNOL, V14, P408, DOI 10.1038/s41565-019-0438-6; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; Kezilebieke S, 2020, NATURE, V588, P424, DOI 10.1038/s41586-020-2989-y; Klein DR, 2018, SCIENCE, V360, P1218, DOI 10.1126/science.aar3617; Park JM, 2021, NATURE, V590, DOI 10.1038/s41586-021-03192-0; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Seyler KL, 2018, NANO LETT, V18, P3823, DOI 10.1021/acs.nanolett.8b01105; Sivadas N, 2018, NANO LETT, V18, P7658, DOI 10.1021/acs.nanolett.8b03321; Song TC, 2021, SCIENCE, V374, P1140, DOI 10.1126/science.abj7478; Song TC, 2018, SCIENCE, V360, P1214, DOI 10.1126/science.aar4851; Ubrig N, 2020, 2D MATER, V7, DOI 10.1088/2053-1583/ab4c64	14	0	0	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1048	1049		10.1126/science.abm0091	http://dx.doi.org/10.1126/science.abm0091			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822287				2022-12-28	WOS:000725668600017
J	Le Gal, G; Kovacs, MJ; Bertoletti, L; Couturaud, F; Dennie, C; Hirsch, AM; Huisman, MV; Klok, FA; Kraaijpoel, N; Mallick, R; Pecarskie, A; Pena, E; Phillips, P; Pichon, I; Ramsay, T; Righini, M; Rodger, MA; Roy, PM; Sanchez, O; Schmidt, J; Schulman, S; Shivakumar, S; Trinh-Duc, A; Verdet, R; Vinsonneau, U; Wells, P; Wu, C; Yeo, E; Carrier, M				Le Gal, Gregoire; Kovacs, Michael J.; Bertoletti, Laurent; Couturaud, Francis; Dennie, Carole; Hirsch, Andrew M.; Huisman, Menno, V; Klok, Frederikus A.; Kraaijpoel, Noemie; Mallick, Ranjeeta; Pecarskie, Amanda; Pena, Elena; Phillips, Penny; Pichon, Isabelle; Ramsay, Tim; Righini, Marc; Rodger, Marc A.; Roy, Pierre-Marie; Sanchez, Olivier; Schmidt, Jeannot; Schulman, Sam; Shivakumar, Sudeep; Trinh-Duc, Albert; Verdet, Rachel; Vinsonneau, Ulric; Wells, Philip; Wu, Cynthia; Yeo, Erik; Carrier, Marc		SSPE Investigators	Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation A Multicenter Prospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							COMPRESSION ULTRASONOGRAPHY; DIAGNOSIS; ANGIOGRAPHY; CANCER; RATES	Background: The incidence of pulmonary embolism has been increasing, but its case-fatality rate is decreasing, suggesting a lesser severity of illness. The clinical importance of patients with pulmonary embolism isolated to the subsegmental vessels is unknown. Objective: To determine the rate of recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation. Design: Multicenter prospective cohort study. (ClinicalTrials. gov: NCT01455818) Setting: Eighteen sites between February 2011 and February 2021. Patients: Patients with isolated subsegmental pulmonary embolism. Intervention: At diagnosis, patients underwent bilateral lower-extremity venous ultrasonography, which was repeated 1 week later if results were negative. Patients without deep venous thrombosis did not receive anticoagulant therapy. Measurements: The primary outcome was recurrent venous thromboembolism during the 90-day follow-up period. Results: Recruitment was stopped prematurely because the predefined stopping rule was met after 292 of a projected 300 patients were enrolled. Of the 266 patients included in the primary analysis, the primary outcome occurred in 8 patients, for a cumulative incidence of 3.1% (95% CI, 1.6% to 6.1%) over the 90-day follow-up. The incidence of recurrent venous thromboembolism was 2.1% (CI, 0.8% to 5.5%) and 5.7% (CI, 2.2% to 14.4%) over the 90-day follow-up in patients with single and multiple isolated subsegmental pulmonary embolism, respectively. No patients had a fatal recurrent pulmonary embolism. Limitation: The study was restricted to patients with low-risk subsegmental pulmonary embolism. Conclusion: Overall, patients with subsegmental pulmonary embolism who did not have proximal deep venous thrombosis had a higher-than-expected rate of recurrent venous thromboembolism.	[Le Gal, Gregoire; Couturaud, Francis] Ctr Hosp Reg & Univ Brest, Ctr Invest Clin, Brest, France; [Le Gal, Gregoire; Pecarskie, Amanda; Phillips, Penny; Rodger, Marc A.; Wells, Philip] Univ Ottawa, Ottawa Hosp, Dept Med, Res Inst, Ottawa, ON, Canada; [Kovacs, Michael J.] Western Univ, Schulich Sch Med & Dent, Dept Med, Div Hematol, London, ON, Canada; [Bertoletti, Laurent] CHU St Etienne, Serv Med Vasc & Therapeut, Hop Nord, INSERM,SAINBIOSE,U1059,Dysfonct Vasc & Hemostase, F-42055 St Etienne, France; [Bertoletti, Laurent] Univ Jean Monnet, C1C1408, F-42055 St Etienne, France; [Bertoletti, Laurent] Reseau Francais F CRIN INNOVTE, St Etienne, France; [Couturaud, Francis] Univ Brest, Med Vasc & Pneumol, Hop Cavale Blanche,Reseau Francais CRIN INNOVTE, EA3878 GETBO,Dept Med Interne,CHRU Brest, Brest, France; [Dennie, Carole; Pena, Elena] Univ Ottawa, Ottawa Hosp, Dept Radiol, Res Inst, Ottawa, ON, Canada; [Hirsch, Andrew M.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada; [Huisman, Menno, V; Klok, Frederikus A.] Leiden Univ, Dept Med Thrombosis & Hemostasis, Med Ctr, Dutch Thrombosis Network, Leiden, Netherlands; [Kraaijpoel, Noemie] Univ Amsterdam, Dept Vasc Med, Amsterdam UMC, Amsterdam, Netherlands; [Mallick, Ranjeeta] Ottawa Hosp, Ottawa Methods Ctr, Res Inst, Ottawa, ON, Canada; [Pichon, Isabelle] Hop Instruct Armees, Serv Rech Clin, Brest, France; [Ramsay, Tim] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Righini, Marc] Univ Geneva, Geneva Univ Hosp, Div Angiol & Hemostasis, Geneva, Switzerland; [Righini, Marc] Univ Geneva, Fac Med, Geneva, Switzerland; [Rodger, Marc A.] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada; [Roy, Pierre-Marie] Univ Angers, Ctr Hosp Univ Angers, Dept Med Urgence, MITOVASC,Equipe CarMe,Reseau Francais CRIN INNOVT, Angers, France; [Sanchez, Olivier] Univ Paris, Hop Europeen Georges Pompidou,Reseau Francais F C, AP HP,INSERM UMR S 1140 Innovat Therapies Hemosta, Serv Pneumol & Soins Intensifs,Ctr Univ Paris, Paris, France; [Schmidt, Jeannot] Ctr Hosp Univ Gabriel Montpied, Dept Med Urgence, Reseau Francais CRIN INNOVTE, Clermont Ferrand, France; [Schulman, Sam] McMaster Univ, Dept Med, Thrombosis & Atherosclerosis Res Inst, Moscow, ON, Canada; [Schulman, Sam] IM Sechenov First Moscow State Med Univ, Dept Obstet & Gynecol, Moscow, Russia; [Shivakumar, Sudeep] Dalhousie Univ, Dept Med, Nova Scotia Hlth, Halifax, NS, Canada; [Trinh-Duc, Albert] Ctr Hosp Agen Nerac, Agen, Lot & Garonne, France; [Verdet, Rachel] Ctr Hosp Reg Univ Brest, Direct Rech & Innovat, Brest, France; [Vinsonneau, Ulric] Clermont Tonnerre Hosp Mil Training, Dept Cardiol, Brest, France; [Wu, Cynthia] Univ Alberta Hosp, Dept Med, Edmonton, AB, Canada; [Yeo, Erik] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Ottawa; Ottawa Hospital Research Institute; Western University (University of Western Ontario); CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest; Universite de Bretagne Occidentale; University of Ottawa; Ottawa Hospital Research Institute; McGill University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; University of Ottawa; Ottawa Hospital Research Institute; Val-de-Grace Hospital; University of Ottawa; Ottawa Hospital Research Institute; University of Geneva; University of Geneva; McGill University; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; McMaster University; Sechenov First Moscow State Medical University; Dalhousie University; CHU Brest; University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Carrier, M (corresponding author), Ottawa Hosp, Gen Campus,501 Smyth Rd,Box 201a, Ottawa, ON K1H 8L6, Canada.	mcarrier@toh.ca	Klok, Erik/U-4870-2019; Roy, Pierre-Marie/AAA-7737-2022; Danguy des Déserts, Marc/AAE-3237-2019	Klok, Erik/0000-0001-9961-0754; Danguy des Déserts, Marc/0000-0002-0185-9955; BERTOLETTI, Laurent/0000-0001-8214-3010; de Moreuil, Claire/0000-0003-1142-0978; van Es, Nick/0000-0001-5256-6346	Brest University Hospital; Geneva University Hospital; Heart and Stroke Foundation of Canada; French Ministry of Health Programme Hospitalier de Recherche Clinique; Canadian Institutes of Health Research [CDT-142654]; Ottawa Hospital Research Institute; Leiden University Medical Center	Brest University Hospital; Geneva University Hospital; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); French Ministry of Health Programme Hospitalier de Recherche Clinique; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Hospital Research Institute; Leiden University Medical Center	This work was sponsored by Brest University Hospital, the Ottawa Hospital Research Institute, Leiden University Medical Center, and Geneva University Hospital, with funding from the Heart and Stroke Foundation of Canada and the French Ministry of Health Programme Hospitalier de Recherche Clinique. Drs. Carrier, Le Gal, Shivakumar, Rodger, Hirsch, Wells, Schulman, Yeo, Wu, and Kovacs are investigators in the CanVECTOR Network, which receives grant funding from the Canadian Institutes of Health Research (funding reference: CDT-142654).	Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Auer RC, 2009, J AM COLL SURGEONS, V208, P871, DOI 10.1016/j.jamcollsurg.2008.12.030; Bariteau A, 2018, ACAD EMERG MED, V25, P828, DOI 10.1111/acem.13399; Baumgartner C, 2021, RES PRACT THROMB HAE, V5, P14, DOI 10.1002/rth2.12464; Bikdeli B, 2019, JAMA-J AM MED ASSOC, V322, P574, DOI 10.1001/jama.2019.8594; Carrier M, 2012, J THROMB HAEMOST, V10, P1486, DOI 10.1111/j.1538-7836.2012.04804.x; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Carrier M, 2017, HEMATOL-AM SOC HEMAT, P237, DOI 10.1182/asheducation-2017.1.237; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; den Exter PL, 2020, RES PRACT THROMB HAE, V4, P1251, DOI 10.1002/rth2.12422; Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Khan F, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4363; Le Gal G, 2006, J THROMB HAEMOST, V4, P724, DOI 10.1111/j.1538-7836.2006.01819.x; Pena E, 2012, J THROMB HAEMOST, V10, P496, DOI 10.1111/j.1538-7836.2011.04612.x; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 2002, THROMB HAEMOSTASIS, V88, P402; Rodrigues JD, 2016, J THROMB HAEMOST, V14, P1765, DOI 10.1111/jth.13407; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178	20	10	10	2	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					29	+		10.7326/M21-2981	http://dx.doi.org/10.7326/M21-2981		NOV 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34807722				2022-12-28	WOS:000729199300001
J	Slomski, A				Slomski, Anita			Intensive Blood Pressure Control Lowers Cardiovascular Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2001	2001		10.1001/jama.2021.20472	http://dx.doi.org/10.1001/jama.2021.20472			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812865				2022-12-28	WOS:000724001500047
J	Jabagi, MJ; Botton, J; Bertrand, M; Weill, A; Farrington, P; Zureik, M; Dray-Spira, R				Jabagi, Marie Joelle; Botton, Jeremie; Bertrand, Marion; Weill, Alain; Farrington, Paddy; Zureik, Mahmoud; Dray-Spira, Rosemary			Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jabagi, Marie Joelle; Botton, Jeremie; Bertrand, Marion; Weill, Alain; Zureik, Mahmoud; Dray-Spira, Rosemary] French Natl Agcy Medicines & Hlth Prod Safety, French Natl Hlth Insurance, EPI PHARE, St Denis, France; [Farrington, Paddy] Open Univ, Sch Math & Stat, Milton Keynes, Bucks, England	Open University - UK	Jabagi, MJ (corresponding author), EPI PHARE, 143-147 Blvd Anatole France, F-93285 St Denis, France.	marie-joelle.jabagi@ansm.sante.fr		Weill, Alain/0000-0001-8687-9092; Farrington, Conor Patrick/0000-0002-7148-2612; Botton, Jeremie/0000-0002-4814-6370; Dray-Spira, Rosemary/0000-0001-7646-3667				Barda N, 2021, NEW ENGL J MED, V385, P1078, DOI 10.1056/NEJMoa2110475; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Klein NP, 2021, JAMA-J AM MED ASSOC, V326, P1390, DOI 10.1001/jama.2021.15072; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577	4	39	39	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					80	+		10.1001/jama.2021.21699	http://dx.doi.org/10.1001/jama.2021.21699		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34807248	Bronze, Green Published			2022-12-28	WOS:000722720200002
J	Callaway, E				Callaway, Ewen			BEYOND OMICRON: WHAT'S NEXT FOR SARS-COV-2 EVOLUTION	NATURE			English	Editorial Material																		Bedford T, 2021, PREPRINT, DOI [10.1101/2021.09.11.459844, DOI 10.1101/2021.09.11.459844]; Eguia RT, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009453; Liu Y, 2021, PREPRINT, DOI [10.1101/2021.08.12.456173, DOI 10.1101/2021.08.12.456173]; Peacock T. P, 2021, PREPRINT, DOI [10.1101/2021.05.28.446163(2021, DOI 10.1101/2021.05.28.446163(2021]; Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020	5	64	65	10	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 9	2021	600	7888					204	207						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XL0PT	34876665				2022-12-28	WOS:000727856300013
J	Lolic, M; Araojo, R; Okeke, M; Woodcock, J				Lolic, Milena; Araojo, Richardae; Okeke, Melvyn; Woodcock, Janet			Racial and Ethnic Representation in US Clinical Trials of New Drugs and Biologics, 2015-2019	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lolic, Milena; Araojo, Richardae; Woodcock, Janet] US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA; [Okeke, Melvyn] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Lolic, M (corresponding author), US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	milena.lolic@fda.hhs.gov						[Anonymous], 2018, SCI AM; Geller SE, 2011, J WOMENS HEALTH, V20, P315, DOI 10.1089/jwh.2010.2469; Rottas M, 2021, CONTEMP CLIN TRIALS, V106, DOI 10.1016/j.cct.2021.106421; United States Census Bureau, NAT POP CHAR 2010 20; US Food and Drug Administration, 2016, COLL RAC ETHN DAT CL; US Food and Drug administration, 2015 2019 DRUG TRIAL	6	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2021	326	21					2201	2203		10.1001/jama.2021.16680	http://dx.doi.org/10.1001/jama.2021.16680			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XO3GR	34874429	Bronze, Green Published			2022-12-28	WOS:000730077500024
J	Vidal, SJ; Bekerman, E; Hansen, D; Lu, B; Wang, K; Mwangi, J; Rowe, W; Campigotto, F; Zheng, J; Kato, D; Chandrashekar, A; Barrett, J; Patel, S; Wan, HH; Anioke, T; Mercado, NB; Nkolola, JP; Ferguson, MJ; Rinaldi, WJ; Callebaut, C; Blair, W; Cihlar, T; Geleziunas, R; Yant, SR; Barouch, DH				Vidal, Samuel J.; Bekerman, Elena; Hansen, Derek; Lu, Bing; Wang, Kelly; Mwangi, Judy; Rowe, William; Campigotto, Federico; Zheng, Jim; Kato, Darryl; Chandrashekar, Abishek; Barrett, Julia; Patel, Shivani; Wan, Huahua; Anioke, Tochi; Mercado, Noe B.; Nkolola, Joseph P.; Ferguson, Melissa J.; Rinaldi, William J.; Callebaut, Christian; Blair, Wade; Cihlar, Tomas; Geleziunas, Romas; Yant, Stephen R.; Barouch, Dan H.			Long-acting capsid inhibitor protects macaques from repeat SHIV challenges	NATURE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; BIOANALYSIS; INFECTION; MEN	Because no currently available vaccine can prevent HIV infection, pre-exposure prophylaxis (PrEP) with antiretrovirals (ARVs) is an important tool for combating the HIV pandemic(1,2). Long-acting ARVs promise to build on the success of current PrEP strategies, which must be taken daily, by reducing the frequency of administration(3). GS-CA1 is a small-molecule HIV capsid inhibitor with picomolar antiviral potency against a broad array of HIV strains, including variants resistant to existing ARVs, and has shown long-acting therapeutic potential in a mouse model of HIV infection(4). Here we show that a single subcutaneous administration of GS-CA1 provides long-term protection against repeated rectal simian-human immunodeficiency virus (SHIV) challenges in rhesus macaques. Whereas all control animals became infected after 15 weekly challenges, a single 300 mg kg(-1) dose of GS-CA1 provided per-exposure infection risk reduction of 97% for 24 weeks. Pharmacokinetic analysis showed a correlation between GS-CA1 plasma concentration and protection from SHIV challenges. GS-CA1 levels greater than twice the rhesus plasma protein-adjusted 95% effective concentration conferred 100% protection in this model. These proof-of-concept data support the development of capsid inhibitors as a novel long-acting PrEP strategy in humans.	[Vidal, Samuel J.; Chandrashekar, Abishek; Barrett, Julia; Patel, Shivani; Wan, Huahua; Anioke, Tochi; Mercado, Noe B.; Nkolola, Joseph P.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Vidal, Samuel J.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Vidal, Samuel J.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Bekerman, Elena; Hansen, Derek; Lu, Bing; Wang, Kelly; Mwangi, Judy; Rowe, William; Campigotto, Federico; Zheng, Jim; Kato, Darryl; Callebaut, Christian; Blair, Wade; Cihlar, Tomas; Geleziunas, Romas; Yant, Stephen R.] Gilead Sci, Foster City, CA 94404 USA; [Ferguson, Melissa J.; Rinaldi, William J.] Alpha Genesis Inc, Yemassee, SC USA; [Barouch, Dan H.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Gilead Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Yant, SR (corresponding author), Gilead Sci, Foster City, CA 94404 USA.; Barouch, DH (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.	stephen.yant@gilead.com; dbarouch@bidmc.harvard.edu	Chandrashekar, Abishek/P-2610-2019	Chandrashekar, Abishek/0000-0001-7821-5552	Gilead Sciences	Gilead Sciences(Gilead Sciences)	We thank E. Bondzie, O. Sanborn, D. Sellers and K. Verrington for assistance with rhesus specimen processing and S. Suthram for assistance with statistical analysis. The study was funded by Gilead Sciences.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Begley R.L.J., 2020, AIDS 2020 23 INT AID; Carnes SK, 2018, CURR OPIN HIV AIDS, V13, P359, DOI 10.1097/COH.0000000000000472; Coelho LE, 2019, LANCET HIV, V6, pE788, DOI 10.1016/S2352-3018(19)30238-3; Daar E., 2020, C RETR OPP INF VIRT; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2018, LANCET HIV, V5, pE629, DOI 10.1016/S2352-3018(18)30215-7; Landovitz RJ, 2021, NEW ENGL J MED, V385, P595, DOI 10.1056/NEJMoa2101016; Link JO, 2020, NATURE, V584, P614, DOI 10.1038/s41586-020-2443-1; Margot N., 2020, 2020 HIV DRUG THER G; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Marzinke M. A., J INFECT DIS, DOI [10.1093/infdis/jiab152(2021, DOI 10.1093/INFDIS/JIAB152(2021]; Ramanathan R, 2011, J MASS SPECTROM, V46, P595, DOI 10.1002/jms.1921; Sturm RM, 2016, BIOANALYSIS, V8, P1709, DOI 10.4155/bio-2016-0079; Sullivan P, 2018, 22 INT AIDS C AMST N; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; WHO, 2013, CONSOLIDATED GUIDELI; Yant SR, 2019, NAT MED, V25, P1377, DOI 10.1038/s41591-019-0560-x	23	5	5	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					612	+		10.1038/s41586-021-04279-4	http://dx.doi.org/10.1038/s41586-021-04279-4		DEC 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34875675	hybrid, Green Published			2022-12-28	WOS:000741978300002
J	Long, MC; Stephens, BB; McKain, K; Sweeney, C; Keeling, RF; Kort, EA; Morgan, EJ; Bent, JD; Chandra, N; Chevallier, F; Commane, R; Daube, BC; Krummel, PB; Loh, Z; Luijkx, IT; Munro, D; Patra, P; Peters, W; Ramonet, M; Rodenbeck, C; Stavert, A; Tans, P; Wofsy, SC				Long, Matthew C.; Stephens, Britton B.; McKain, Kathryn; Sweeney, Colm; Keeling, Ralph F.; Kort, Eric A.; Morgan, Eric J.; Bent, Jonathan D.; Chandra, Naveen; Chevallier, Frederic; Commane, Roisin; Daube, Bruce C.; Krummel, Paul B.; Loh, Zoe; Luijkx, Ingrid T.; Munro, David; Patra, Prabir; Peters, Wouter; Ramonet, Michel; Rodenbeck, Christian; Stavert, Ann; Tans, Pieter; Wofsy, Steven C.			Strong Southern Ocean carbon uptake evident in airborne observations	SCIENCE			English	Article							ATMOSPHERIC CO2; TIME-SERIES; SURFACE; VARIABILITY; EXCHANGE; MODEL; TRENDS; FLUXES; PCO(2); HISTORY	The Southern Ocean plays an important role in determining atmospheric carbon dioxide (CO2), yet estimates of air-sea CO2 flux for the region diverge widely. In this study, we constrained Southern Ocean air-sea CO2 exchange by relating fluxes to horizontal and vertical CO2 gradients in atmospheric transport models and applying atmospheric observations of these gradients to estimate fluxes. Aircraft-based measurements of the vertical atmospheric CO2 gradient provide robust flux constraints. We found an annual mean flux of -0.53 +/- 0.23 petagrams of carbon per year (net uptake) south of 45 degrees S during the period 2009-2018. This is consistent with the mean of atmospheric inversion estimates and surface-ocean partial pressure of CO2 (P-CO2)-based products, but our data indicate stronger annual mean uptake than suggested by recent interpretations of profiling float observations.	[Long, Matthew C.; Stephens, Britton B.; Bent, Jonathan D.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [McKain, Kathryn; Munro, David] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [McKain, Kathryn; Sweeney, Colm; Munro, David; Tans, Pieter] NOAA, Global Monitoring Lab, Boulder, CO USA; [Keeling, Ralph F.; Morgan, Eric J.; Bent, Jonathan D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kort, Eric A.] Univ Michigan, Dept Climate & Space Sci & Engn, Ann Arbor, MI 48109 USA; [Chandra, Naveen] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Chevallier, Frederic; Ramonet, Michel] CEA CNRS UVSQ, Lab Sci Climat & Environm, IPSL LSCE, UMR8212 91191, Gif Sur Yvette, France; [Commane, Roisin] Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisades, NY USA; [Daube, Bruce C.; Wofsy, Steven C.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Krummel, Paul B.; Loh, Zoe; Stavert, Ann] CSIRO Oceans & Atmosphere, Climate Sci Ctr, Aspendale, Vic, Australia; [Luijkx, Ingrid T.; Peters, Wouter] Wageningen Univ, Dept Meteorol & Air Qual, Environm Sci Grp, Wageningen, Netherlands; [Patra, Prabir] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Peters, Wouter] Univ Groningen, Ctr Isotope Res, Groningen, Netherlands; [Rodenbeck, Christian] Max Planck Inst Biogeochem, Jena, Germany; [Wofsy, Steven C.] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Bent, Jonathan D.] Picarro Inc, Santa Clara, CA USA; [Chandra, Naveen] JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan	National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Michigan System; University of Michigan; National Institute for Environmental Studies - Japan; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Columbia University; Harvard University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Wageningen University & Research; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Groningen; Max Planck Society; Harvard University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Long, MC (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	mclong@ucar.edu	Loh, Zoe/AAD-5268-2021; Krummel, Paul B/A-4293-2013; Peters, Wouter/B-8305-2008; Kort, Eric A/F-9942-2012; Stavert, Ann R/M-1080-2018; McKain, Kathryn/AAG-9135-2019; Sweeney, Colm/AAE-9291-2019; Commane, Roisin/O-3497-2019	Loh, Zoe/0000-0001-6424-1098; Krummel, Paul B/0000-0002-4884-3678; Peters, Wouter/0000-0001-8166-2070; Kort, Eric A/0000-0003-4940-7541; McKain, Kathryn/0000-0002-8323-5758; Commane, Roisin/0000-0003-1373-1550; Bent, Jonathan/0000-0002-1972-3044; Long, Matthew/0000-0003-1273-2957; Sweeney, Colm/0000-0002-4517-0797; Stavert, Ann/0000-0002-4857-2134; Chandra, Naveen/0000-0002-5357-7757	National Center for Atmospheric Research - NSF [1852977];  [NSF-PLR-1502301];  [NSF-ATM-0628388];  [NSF-ATM-0628519];  [NSF-ATM-0628575];  [NSF-PLR-1501993];  [NSF-PLR-1501292];  [NSF-PLR-1501997];  [NSF-AGS-1547626];  [NSF-AGS-1547797];  [NSF-AGS-1623745];  [NSF-AGS-1623748];  [NASA-NNX17AE74G];  [NASA-NNX15AJ23G];  [NASA-NNX16AL92A];  [NOAA-NA15OAR4320071]	National Center for Atmospheric Research - NSF(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This material is based on work supported by the National Center for Atmospheric Research, which is a major facility sponsored by the NSF under Cooperative Agreement No. 1852977. Computing resources were provided by the Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory (CISL). Data were collected using NSF's Lower Atmosphere Observing Facilities, which are managed and operated by NCAR's Earth Observing Laboratory. Additional sources of funding include NSF-PLR-1502301, NSF-ATM-0628388, NSF-ATM-0628519, NSF-ATM-0628575, NSF-PLR-1501993, NSF-PLR-1501292, NSF-PLR-1501997, NSF-AGS-1547626, NSF-AGS-1547797, NSF-AGS-1623745, NSF-AGS-1623748, NASA-NNX17AE74G, NASA-NNX15AJ23G, NASA-NNX16AL92A, and NOAA-NA15OAR4320071.	Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Basu S, 2018, ATMOS CHEM PHYS, V18, P7189, DOI 10.5194/acp-18-7189-2018; Bourgeois I, 2020, ATMOS CHEM PHYS, V20, P10611, DOI 10.5194/acp-20-10611-2020; Brunke EG, 2004, ATMOS ENVIRON, V38, P5693, DOI 10.1016/j.atmosenv.2004.04.024; Bushinsky SM, 2019, GLOBAL BIOGEOCHEM CY, V33, P1370, DOI 10.1029/2019GB006176; Canadell J. G., 2021, CLIMATE CHANGE 2021; Chevallier F, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006390; Chevallier F, 2013, GEOSCI MODEL DEV, V6, P783, DOI 10.5194/gmd-6-783-2013; Chevallier F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013887; Crippa M., 2019, EDGAR v5.0 Global Greenhouse Gas Emissions; Crotwell A., 2020, 20 WMO IAEA CARB DIO; Crotwell A.M., 2020, 20 WMO IAEA M CARB D; Crowell S, 2019, ATMOS CHEM PHYS, V19, P9797, DOI 10.5194/acp-19-9797-2019; Daube BC, 2002, J ATMOS OCEAN TECH, V19, P1532, DOI 10.1175/1520-0426(2002)019<1532:AHPFRA>2.0.CO;2; Denning AS, 1996, TELLUS B, V48, P543, DOI 10.1034/j.1600-0889.1996.t01-1-00010.x; DENNING AS, 1995, NATURE, V376, P240, DOI 10.1038/376240a0; DeVries T, 2014, GLOBAL BIOGEOCHEM CY, V28, P631, DOI 10.1002/2013GB004739; Diskin GS, 2002, P SOC PHOTO-OPT INS, V4817, P196, DOI 10.1117/12.453736; Dlugokencky E.J., ATMOSPHERIC SULFUR H, DOI [10.15138/p646-pa37 (2021, DOI 10.15138/P646-PA37(2021]; Dlugokencky E. J., 2021, ATMOSPHERIC SULFUR H; Enting IG, 2000, GEOPH MONOG SERIES, V114, P19; Fay AR, 2018, BIOGEOSCIENCES, V15, P3841, DOI 10.5194/bg-15-3841-2018; Francey RJ, 2019, ATMOS CHEM PHYS, V19, P14741, DOI 10.5194/acp-19-14741-2019; Gaubert B, 2019, BIOGEOSCIENCES, V16, P117, DOI 10.5194/bg-16-117-2019; Geller LS, 1997, GEOPHYS RES LETT, V24, P675, DOI 10.1029/97GL00523; Gray AR, 2018, GEOPHYS RES LETT, V45, P9049, DOI 10.1029/2018GL078013; Gruber N, 2019, ANNU REV MAR SCI, V11, P159, DOI 10.1146/annurev-marine-121916-063407; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Jacobson A. R., 2020, CARBONTRACKER CT2019; Jiang CL, 2014, J CLIMATE, V27, P76, DOI 10.1175/JCLI-D-12-00571.1; Jin YM, 2021, ATMOS CHEM PHYS, V21, P217, DOI 10.5194/acp-21-217-2021; Johnson KS, 2017, J GEOPHYS RES-OCEANS, V122, P6416, DOI 10.1002/2017JC012838; Karion A, 2013, ATMOS MEAS TECH, V6, P511, DOI 10.5194/amt-6-511-2013; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Landschutzer P, 2013, BIOGEOSCIENCES, V10, P7793, DOI 10.5194/bg-10-7793-2013; Landschutzer P, 2016, GLOBAL BIOGEOCHEM CY, V30, P1396, DOI 10.1002/2015GB005359; Landschutzer P., 2019, NCEI ACCESSION 01913, DOI [10.25921/9hsn-xq82, DOI 10.25921/9HSNXQ82]; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Law RM, 2010, TELLUS B, V62, P810, DOI 10.1111/j.1600-0889.2010.00470.x; Lenton A, 2013, BIOGEOSCIENCES, V10, P4037, DOI 10.5194/bg-10-4037-2013; Long M. C., UCAR/NCAR-DASH Repository (2021), DOI 10.5065/fepv-0z52; Long M. C., [Southern Ocean Air-Sea Carbon Fluxes from Aircraft Observations: Modeling Datasets, version 1.0, UCAR/NCAR-DASH Repository (2021)], DOI 10.5065/fepv-0z52; Long M. C., 2021, SO OCEAN AIR SEA CAR, DOI [10.5065/6vnv-1x08, DOI 10.5065/6VNV-1X08]; Masarie KA, 2001, J GEOPHYS RES-ATMOS, V106, P20445, DOI 10.1029/2000JD000023; McKinley GA, 2016, NATURE, V530, P469, DOI 10.1038/nature16958; Munro DR, 2015, GEOPHYS RES LETT, V42, P7623, DOI 10.1002/2015GL065194; Munro DR, 2015, DEEP-SEA RES PT II, V114, P49, DOI 10.1016/j.dsr2.2014.12.014; Olsen A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020583; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; Patra PK, 2018, SOLA, V14, P91, DOI 10.2151/sola.2018-016; Peters W, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006157; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Peylin P, 2013, BIOGEOSCIENCES, V10, P6699, DOI 10.5194/bg-10-6699-2013; PROFFITT MH, 1983, REV SCI INSTRUM, V54, P1719, DOI 10.1063/1.1137316; Ramonet M, 1996, TELLUS B, V48, P502, DOI 10.1034/j.1600-0889.1996.t01-2-00008.x; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Rodenbeck C, 2005, TECHNICAL REPORTS 6; Rodenbeck C, 2014, BIOGEOSCIENCES, V11, P4599, DOI 10.5194/bg-11-4599-2014; Saeki T, 2017, GEOSCI LETT, V4, DOI 10.1186/s40562-017-0074-7; Santoni GW, 2014, ATMOS MEAS TECH, V7, P1509, DOI 10.5194/amt-7-1509-2014; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; Schuh AE, 2019, GLOBAL BIOGEOCHEM CY, V33, P484, DOI 10.1029/2018GB006086; Schuldt K. N., MULTILABORATORY COMP; Schuldt K.N., 2020, MULTILABORATORY COMP; Stavert AR, 2019, ATMOS MEAS TECH, V12, P1103, DOI 10.5194/amt-12-1103-2019; Stephens B., 2017, ORCAS MERGE PRODUCTS, DOI [10.5065/D6SB445X, DOI 10.5065/D6SB445X]; Stephens BB, 2013, BIOGEOSCIENCES, V10, P2683, DOI 10.5194/bg-10-2683-2013; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Stephens BB, 2021, ATMOS MEAS TECH, V14, P2543, DOI 10.5194/amt-14-2543-2021; Stephens BB, 2018, B AM METEOROL SOC, V99, P381, DOI 10.1175/BAMS-D-16-0206.1; Sweeney C, 2015, J GEOPHYS RES-ATMOS, V120, P5155, DOI 10.1002/2014JD022591; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Trenberth KE, 2005, J CLIMATE, V18, P864, DOI 10.1175/JCLI-3299.1; Turnbull JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024213; UCAR/NCAR-Earth Observing Laboratory, 2005, NSF NCAR GV HIAP AIR, DOI [10.5065/D6DR2SJP, DOI 10.5065/D6DR2SJP]; van der Laan-Luijkx IT, 2017, GEOSCI MODEL DEV, V10, P2785, DOI 10.5194/gmd-10-2785-2017; Wahlen M., 2001, EXCHANGES ATMOSPHERI; Wanninkhof R, 2014, LIMNOL OCEANOGR-METH, V12, P351, DOI 10.4319/lom.2014.12.351; Williams NL, 2017, GLOBAL BIOGEOCHEM CY, V31, P591, DOI 10.1002/2016GB005541; Wofsy S., 2021, ATOM MERGED ATMOSPHE, DOI [10.3334/ORNLDAAC/1925, DOI 10.3334/ORNLDAAC/1925]; Wofsy S., 2017, HIPPO MEDUSA Flask Sample Trace Gas and Isotope Data, version 1.0, DOI 10.3334/CDIAC/HIPPO_014; Wofsy S., 2017, HIPPO MEDUSA FLASK S; Wofsy S., 2017, HIPPO NOAA Flask Sample GHG, Halocarbon, and Hydrocarbon Data, version 1.0, UCAR/NCAR-Earth Observing Laboratory; Wofsy SC, 2011, PHILOS T R SOC A, V369, P2073, DOI 10.1098/rsta.2010.0313; Wofsy S. C., 2012, HIPPO NOAA FLASK SAM, DOI [10.3334/CDIAC/hippo_013, DOI 10.3334/CDIAC/HIPPO_013]; Wofsy S. C., 2012, HIPPO MERGED 10 2 ME, DOI [10.3334/CDIAC/hippo_010, DOI 10.3334/CDIAC/HIPPO_010, 10.3334/CDIAC/HIPPO_010]; Wofsy S. C., UCAR/NCAR-Earth Observing Laboratory; Wofsy S.C., 2021, ATOM MERGED ATMOSPHE; Zondlo MA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014445	90	10	10	10	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1275	+		10.1126/science.abi4355	http://dx.doi.org/10.1126/science.abi4355			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855495	Green Published			2022-12-28	WOS:000728578700062
J	Mahase, E				Mahase, Elisabeth			Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, LANCET, DOI [10.1016/, DOI 10.1016/]	1	8	8	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2021	375								n3011	10.1136/bmj.n3011	http://dx.doi.org/10.1136/bmj.n3011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN7XE	34862175	Bronze			2022-12-28	WOS:000729712200025
J	Tanne, JH				Tanne, Janice Hopkins			Covid 19: Omicron is a cause for concern, not panic, says US president	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, REMARKS PRESIDENT BI; Johns Hopkins University corona virus resource center, SEARCH COV 19 VAR; Kimball S., 2021, CNBC NEW YORK 1129; Walensky R., 2021, CDC EXPANDS COVID 19; World Health Organization, 2021, UPD OM	5	3	3	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2021	375								n2956	10.1136/bmj.n2956	http://dx.doi.org/10.1136/bmj.n2956			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH5YO	34848487	Bronze			2022-12-28	WOS:000725509900011
J	Romanauska, A				Romanauska, Anete			Seeing fat inside the nucleus	SCIENCE			English	Editorial Material							METABOLISM; MEMBRANE; LIPIDS		[Romanauska, Anete] Max Perutz Labs Vienna, A-1300 Vienna, Austria		Romanauska, A (corresponding author), Max Perutz Labs Vienna, A-1300 Vienna, Austria.	anete.romanauska@univie.ac.at						Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Muro E, 2014, MOL BIOL CELL, V25, P1819, DOI 10.1091/mbc.E13-09-0516; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Romanauska A, 2021, DEV CELL, V56, P2562, DOI 10.1016/j.devcel.2021.07.018; Romanauska A, 2018, CELL, V174, P700, DOI 10.1016/j.cell.2018.05.047; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Ungricht R, 2017, NAT REV MOL CELL BIO, V18, P229, DOI 10.1038/nrm.2016.153; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333	13	0	0	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI					10.1126/science.abm8139	http://dx.doi.org/10.1126/science.abm8139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8HK	34822281				2022-12-28	WOS:000725668600034
J	Silver, A				Silver, Andrew			Could rural China's healthcare deal with covid-19?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												aesilver360@gmail.com						McDonald J., AP NEWS, V2021; Nelson L, 2021, CHINAS HEALTHCARE SY; Silver A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2756; Tan Xiaodong, 2017, Value Health Reg Issues, V12, P112, DOI 10.1016/j.vhri.2017.04.001; Wang L, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0486-6; Zhang J, 2018, J HOSP MANAGEMENT HL, V2, P22	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								n2759	10.1136/bmj.n2759	http://dx.doi.org/10.1136/bmj.n2759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ0TK	34824132	Bronze			2022-12-28	WOS:000744251500005
J	Iacobucci, G				Iacobucci, Gareth			Give people choice of treatment options for depression, says NICE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2021, DEPR AD GUID DRAFT C; Office for National Statistics, 2021, COR DEPR AD	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2021	375								n2877	10.1136/bmj.n2877	http://dx.doi.org/10.1136/bmj.n2877			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XD2YX	34815264				2022-12-28	WOS:000722577100002
J	Kuehn, BM				Kuehn, Bridget M.			COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2002	2002						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812857	Bronze			2022-12-28	WOS:000724001500048
J	Lehman, CD; Topol, EJ				Lehman, Constance D.; Topol, Eric J.			Readiness for mammography and artificial intelligence	LANCET			English	Editorial Material									[Lehman, Constance D.] Harvard Med Sch, Mass Gen Brigham, Radiol, Boston, MA 02114 USA; [Topol, Eric J.] Scripps Res Jolla, Scripps Res Translat Inst, La Jolla, CA USA	Harvard University; Harvard Medical School	Lehman, CD (corresponding author), Harvard Med Sch, Mass Gen Brigham, Radiol, Boston, MA 02114 USA.	clehman@mgh.harvard.edu		Topol, Eric/0000-0002-1478-4729					0	2	2	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2021	398	10314					1867	1867						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XA8TI	34801097				2022-12-28	WOS:000720912600015
J	Kallesh, A; Kumar, VS				Kallesh, Anil; Kumar, Vikram S.			Congenital Langerhans-Cell Histiocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kallesh, Anil] Sarji Hosp, Shivamogga, India; [Kumar, Vikram S.] Subbaiah Inst Med Sci & Res Ctr, Shivamogga, India		Kumar, VS (corresponding author), Subbaiah Inst Med Sci & Res Ctr, Shivamogga, India.	vikramskumar@yahoo.co.in							0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2021	385	24					E86	E86		10.1056/NEJMicm2112460	http://dx.doi.org/10.1056/NEJMicm2112460			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XL4CS	34879451				2022-12-28	WOS:000728093600004
J	Xiao, YH; Lidsky, PV; Shirogane, Y; Aviner, R; Wu, CT; Li, WY; Zheng, WH; Talbot, D; Catching, A; Doitsh, G; Su, WH; Gekko, CE; Nayak, A; Ernst, JD; Brodsky, L; Brodsky, E; Rousseau, E; Capponi, S; Bianco, S; Nakamura, R; Jackson, PK; Frydman, J; Andino, R				Xiao, Yinghong; Lidsky, Peter, V; Shirogane, Yuta; Aviner, Ranen; Wu, Chien-Ting; Li, Weiyi; Zheng, Weihao; Talbot, Dale; Catching, Adam; Doitsh, Gilad; Su, Weiheng; Gekko, Colby E.; Nayak, Arabinda; Ernst, Joel D.; Brodsky, Leonid; Brodsky, Elia; Rousseau, Elsa; Capponi, Sara; Bianco, Simone; Nakamura, Robert; Jackson, Peter K.; Frydman, Judith; Andino, Raul			A defective viral genome strategy elicits broad protective immunity against respiratory viruses	CELL			English	Article							HUMAN POLIOVIRUS RECEPTOR; INTERFERING PARTICLES; I INTERFERON; STRUCTURAL PROTEIN; TRANSGENIC MICE; IFN-GAMMA; RNA; GENE; SARS-COV-2; SYSTEM	RNA viruses generate defective viral genomes (DVGs) that can interfere with replication of the parental wild type virus. To examine their therapeutic potential, we created a DVG by deleting the capsid-coding region of poliovirus. Strikingly, intraperitoneal or intranasal administration of this genome, which we termed eTIP1, elicits an antiviral response, inhibits replication, and protects mice from several RNA viruses, including enteroviruses, influenza, and SARS-CoV-2. While eTIP1 replication following intranasal administration is limited to the nasal cavity, its antiviral action extends non-cell-autonomously to the lungs. eTIP1 broad-spectrum antiviral effects are mediated by both local and distal type I interferon responses. Importantly, while a single eTIP1 dose protects animals from SARS-CoV-2 infection, it also stimulates production of SARS-CoV-2 neutralizing antibodies that afford long-lasting protection from SARS-CoV-2 reinfection. Thus, eTIP1 is a safe and effective broad-spectrum antiviral generating short-and long-term protection against SARSCoV-2 and other respiratory infections in animal models.	[Xiao, Yinghong; Lidsky, Peter, V; Shirogane, Yuta; Aviner, Ranen; Li, Weiyi; Talbot, Dale; Catching, Adam; Doitsh, Gilad; Su, Weiheng; Gekko, Colby E.; Nayak, Arabinda; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Shirogane, Yuta] Kyushu Univ, Fac Med, Dept Virol, Fukuoka, Japan; [Aviner, Ranen; Nayak, Arabinda; Frydman, Judith] Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA; [Wu, Chien-Ting; Jackson, Peter K.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Zheng, Weihao; Ernst, Joel D.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA; [Talbot, Dale; Nakamura, Robert] Aleph Therapeut Inc, Stanford, CA 94305 USA; [Su, Weiheng] Jilin Univ, Sch Life Sci, Changchun, Peoples R China; [Brodsky, Leonid] Univ Haifa, Tauber Bioinformat Res Ctr, IL-31905 Haifa, Israel; [Brodsky, Leonid] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31905 Haifa, Israel; [Brodsky, Elia] Pine Biotech Inc, New Orleans, LA 70112 USA; [Rousseau, Elsa; Capponi, Sara; Bianco, Simone] IBM Almaden Res Ctr, AI & Cognit Software, Funct Genom & Cellular Engn, San Jose, CA 95120 USA	University of California System; University of California San Francisco; Kyushu University; Stanford University; Stanford University; University of California System; University of California San Francisco; Jilin University; University of Haifa; University of Haifa; International Business Machines (IBM)	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	raul.andino@ucsf.edu	; Aviner, Ranen/AAE-6533-2019	Shirogane, Yuta/0000-0002-4284-0310; Xiao, Yinghong/0000-0002-6850-6521; Aviner, Ranen/0000-0002-2476-6487; Zheng, Weihao/0000-0002-8038-1207; Brodsky, Elia/0000-0003-3068-416X; Jackson, Peter/0000-0002-1742-2539; Lidsky, Peter/0000-0001-8976-6800; , judith/0000-0003-2302-6943	DARPA [HR0011-17-2-0027]; NIH [R41AI157129]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Dr. Miguel Garcia-Knight for sharing SARS-CoV-2 Delta variant that he isolated in the context of clinical studies conducted in San Francisco; Drs. Luis Sigal, Eric Dang, Hiten Madhani and members of Andino lab for critical discussions and comments for manuscript prepara-tion; and Gary Howard for editorial support. This work was supported by the DARPA INTERCEPT program managed by James Gimlett and adminis-tered through DARPA Cooperative Agreement (grant no. HR0011-17-2-0027) and NIH R41AI157129. We thank the UCSF Center for Advanced Tech-nology core for the Illumina HiSeq4000 for RNA-seq and Gladstone Histol-ogy and Light Microscopy Core for the mouse tissue samples processing and H&E staining.	Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Andino R., 2019, BIORXIV, DOI [10.1101/519751, DOI 10.1101/519751]; Ascough S, 2019, AM J RESP CRIT CARE, V200, P481, DOI 10.1164/rccm.201810-1921OC; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Bessiere P, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009427; Bohrer AC, 2021, J EXP MED, V218, DOI 10.1084/jem.20210469; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Burrill Cecily P, 2013, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15h02s29; Burrill Cecily P, 2013, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15h01s29; Canedo-Marroquin G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.569760; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen C, 2021, BIORXIV PREPRINT, DOI [10. 1101/2021.03.22.436481, DOI 10.1101/2021.03.22.436481, 10.1101/2021.03.22.436481]; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; CHUMAKOV KM, 1991, P NATL ACAD SCI USA, V88, P199, DOI 10.1073/pnas.88.1.199; Chumakov K, 2020, SCIENCE, V368, P1187, DOI 10.1126/science.abc4262; Cohen Cheryl, 2021, medRxiv, DOI 10.1101/2021.07.20.21260855; Collier DA, 2021, NATURE, V596, P417, DOI 10.1038/s41586-021-03739-1; Crotty S, 2002, MICROBES INFECT, V4, P1301, DOI 10.1016/S1286-4579(02)00008-4; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Darif D, 2021, MICROB PATHOGENESIS, V153, DOI 10.1016/j.micpath.2021.104799; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Deng XD, 2021, CELL, V184, P3426, DOI 10.1016/j.cell.2021.04.025; Dimmock NJ, 2015, VIRUSES-BASEL, V7, P3768, DOI 10.3390/v7072796; Dimmock NJ, 2014, J VIROL, V88, P5217, DOI 10.1128/JVI.03193-13; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Domingo E, 2002, VIRUS RES, V82, P39; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Easton AJ, 2011, VACCINE, V29, P2777, DOI 10.1016/j.vaccine.2011.01.102; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Findlay JS, 2015, FUTURE VIROL, V10, P547, DOI 10.2217/FVL.15.5; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fitzpatrick JM, 2020, J NEUROIMMUNOL, V343, DOI 10.1016/j.jneuroim.2020.577217; Furio L, 2009, J INVEST DERMATOL, V129, P1963, DOI 10.1038/jid.2009.21; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Genoyer E, 2019, ANNU REV VIROL, V6, P547, DOI 10.1146/annurev-virology-092818-015652; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goff PH, 2012, J VIROL, V86, P10852, DOI 10.1128/JVI.01298-12; Goncalves BC, 2021, FUND CLIN PHARMACOL, V35, P305, DOI 10.1111/fcp.12609; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Guo Kejun, 2021, bioRxiv, DOI 10.1101/2021.03.20.436257; Gupta V, 2021, CLIN INFECT DIS, V73, pE2823, DOI 10.1093/cid/ciaa1451; Hoagland DA, 2021, IMMUNITY, V54, P557, DOI 10.1016/j.immuni.2021.01.017; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Huang QR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21037-2; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Jangra S, 2021, ANGEW CHEM INT EDIT, V60, P9467, DOI 10.1002/anie.202015362; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Kang L, 2021, CELL, V184, P4392, DOI 10.1016/j.cell.2021.07.007; Kikkert M, 2020, J INNATE IMMUN, V12, P4, DOI 10.1159/000503030; Kim KH, 1998, ADV EXP MED BIOL, V440, P347; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; Kluger, 2021, RES SQUARE; Konopka-Anstadt JL, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0176-7; Konz JO, 2021, VACCINE-X, V8, DOI 10.1016/j.jvacx.2021.100102; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Levi LI, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009110; Li D, 2016, FASEB J, V30, P1757, DOI 10.1096/fj.15-281410; Li D, 2016, CELL CYCLE, V15, P850, DOI 10.1080/15384101.2016.1151584; Lundstrom K, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050109; Lutrick K, 2021, JMIR RES PROTOC, V10, DOI 10.2196/28925; MCCLURE MA, 1980, VIROLOGY, V100, P408, DOI 10.1016/0042-6822(80)90532-2; Meganck RM, 2021, NAT MED, V27, P401, DOI 10.1038/s41591-021-01282-0; Meyerholz DK, 2020, METHODS MOL BIOL, V2099, P205, DOI 10.1007/978-1-0716-0211-9_16; Murillo-Zamora E, 2021, PUBLIC HEALTH, V193, P113, DOI 10.1016/j.puhe.2021.01.021; Nagata N, 2004, VIROLOGY, V321, P87, DOI 10.1016/j.virol.2003.12.008; Narayanan K, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P373; Nelemans T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100961; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Palese P, 2012, JAIDS-J ACQ IMM DEF, V59, P53, DOI 10.1097/01.qai.0000413747.69761.5b; Peersen OB, 2017, VIRUS RES, V234, P4, DOI 10.1016/j.virusres.2017.01.026; PERRAULT J, 1979, P NATL ACAD SCI USA, V76, P6191, DOI 10.1073/pnas.76.12.6191; Perrault J, 1981, Curr Top Microbiol Immunol, V93, P151; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2010, ADV VIRUS RES, V77, P85, DOI 10.1016/S0065-3527(10)77004-4; Preissner KT, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.619221; Que YF, 2022, INT REV IMMUNOL, V41, P217, DOI 10.1080/08830185.2021.1884248; RAHIM MMA, 2020, J VIROL, V94; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Rathnasinghe Raveen, 2021, bioRxiv, DOI 10.1101/2021.04.28.441797; Rezelj VV, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22341-7; Samarasinghe AE, 2014, IMMUNOL CELL BIOL, V92, P449, DOI 10.1038/icb.2013.113; Scheideler M, 2020, CHEM PHYS LIPIDS, V226, DOI 10.1016/j.chemphyslip.2019.104837; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SEMLER BL, 1978, P NATL ACAD SCI USA, V75, P4704, DOI 10.1073/pnas.75.10.4704; SHIROGANE Y, 2021, BIORXIV, DOI DOI 10.1101/2021.01.11.426198; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tse LV, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00658; Van Damme P, 2019, LANCET, V394, P148, DOI 10.1016/S0140-6736(19)31279-6; Vignuzzi M, 2019, NAT MICROBIOL, V4, P1075, DOI 10.1038/s41564-019-0465-y; Wang C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15001-9; White KM, 2021, SCIENCE, V371, P926, DOI 10.1126/science.abf4058; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; World Health Organization, 2020, WHO; Xiao YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00354-5; Yeh MT, 2020, CELL HOST MICROBE, V27, P736, DOI 10.1016/j.chom.2020.04.003; Yuan S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.659419; Zhang J, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100099; Zhang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01634-18; Zhou Bin, 2020, bioRxiv, DOI 10.1101/2020.10.27.357558; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	107	8	8	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2021	184	25					6037	+		10.1016/j.cell.2021.11.023	http://dx.doi.org/10.1016/j.cell.2021.11.023		DEC 2021	30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XP3FJ	34852237	Bronze, Green Published			2022-12-28	WOS:000730754300007
J	Semeghini, G; Levine, H; Keesling, A; Ebadi, S; Wang, TT; Bluvstein, D; Verresen, R; Pichler, H; Kalinowski, M; Samajdar, R; Omran, A; Sachdev, S; Vishwanath, A; Greiner, M; Vuletic, V; Lukin, MD				Semeghini, G.; Levine, H.; Keesling, A.; Ebadi, S.; Wang, T. T.; Bluvstein, D.; Verresen, R.; Pichler, H.; Kalinowski, M.; Samajdar, R.; Omran, A.; Sachdev, S.; Vishwanath, A.; Greiner, M.; Vuletic, V.; Lukin, M. D.			Probing topological spin liquids on a programmable quantum simulator	SCIENCE			English	Article							LATTICE GAUGE-THEORIES; KAGOME-LATTICE; GROUND-STATES; ANTIFERROMAGNETS; SYSTEMS; ANYONS; PHASES; MATTER	Quantum spin liquids, exotic phases of matter with topological order, have been a major focus in physics for the past several decades. Such phases feature long-range quantum entanglement that can potentially be exploited to realize robust quantum computation. We used a 219-atom programmable quantum simulator to probe quantum spin liquid states. In our approach, arrays of atoms were placed on the links of a kagome lattice, and evolution under Rydberg blockade created frustrated quantum states with no local order. The onset of a quantum spin liquid phase of the paradigmatic toric code type was detected by using topological string operators that provide direct signatures of topological order and quantum correlations. Our observations enable the controlled experimental exploration of topological matter and protected quantum information processing.	[Semeghini, G.; Levine, H.; Keesling, A.; Ebadi, S.; Wang, T. T.; Bluvstein, D.; Verresen, R.; Kalinowski, M.; Samajdar, R.; Omran, A.; Sachdev, S.; Vishwanath, A.; Greiner, M.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Keesling, A.; Omran, A.] QuEra Comp, Boston, MA 02135 USA; [Pichler, H.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Pichler, H.] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria; [Sachdev, S.] Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA; [Vuletic, V.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Vuletic, V.] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Harvard University; University of Innsbruck; Austrian Academy of Sciences; Institute for Advanced Study - USA; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Vishwanath, A; Greiner, M; Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Vuletic, V (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Vuletic, V (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	avishwanath@g.harvard.edu; greiner@physics.harvard.edu; vuletic@mit.edu; lukin@physics.harvard.edu	Omran, Ahmed/AHH-4541-2022; Pichler, Hannes/AAC-9665-2022; Semeghini, Giulia/H-6683-2018	Omran, Ahmed/0000-0002-2253-0278; Pichler, Hannes/0000-0003-2144-536X; Samajdar, Rhine/0000-0001-5171-7798; Verresen, Ruben/0000-0002-0385-7363; Semeghini, Giulia/0000-0001-9071-2279; Ebadi, Sepehr/0000-0003-4146-3637; Bluvstein, Dolev/0000-0002-9934-9530	Center for Ultracold Atoms; National Science Foundation; U.S. Department of Energy [DE-SC0021013, DE-SC0019030]; Army Research Office MURI; DARPA ONISQ program; QuEra Computing; Amazon Web Services; Max Planck/Harvard Research Center for Quantum Optics fellowship; National Defense Science and Engineering Graduate (NDSEG) fellowship; Gordon College; NSF Graduate Research Fellowship Program [DGE1745303]; Fannie and John Hertz Foundation; Harvard Quantum Initiative Postdoctoral Fellowship in Science and Engineering; Simons Collaboration on Ultra-Quantum Matter (Simons Foundation) [651440]; FAS Division of Science Research Computing Group at Harvard University; U.S. Department of Energy (LBNL QSA Center)	Center for Ultracold Atoms; National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Army Research Office MURI(MURI); DARPA ONISQ program; QuEra Computing; Amazon Web Services; Max Planck/Harvard Research Center for Quantum Optics fellowship; National Defense Science and Engineering Graduate (NDSEG) fellowship; Gordon College; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Fannie and John Hertz Foundation; Harvard Quantum Initiative Postdoctoral Fellowship in Science and Engineering; Simons Collaboration on Ultra-Quantum Matter (Simons Foundation); FAS Division of Science Research Computing Group at Harvard University; U.S. Department of Energy (LBNL QSA Center)(United States Department of Energy (DOE))	We acknowledge financial support from the Center for Ultracold Atoms, the National Science Foundation, the U.S. Department of Energy (DE-SC0021013 and LBNL QSA Center), the Army Research Office MURI, the DARPA ONISQ program, QuEra Computing, and Amazon Web Services. We further acknowledge support from the Max Planck/Harvard Research Center for Quantum Optics fellowship (to G.S.), the National Defense Science and Engineering Graduate (NDSEG) fellowship (to H.L.), Gordon College (to T.T.W,), the NSF Graduate Research Fellowship Program (grant DGE1745303) and The Fannie and John Hertz Foundation (to D.B.), the Harvard Quantum Initiative Postdoctoral Fellowship in Science and Engineering (to R.V.), the Simons Collaboration on Ultra-Quantum Matter (Simons Foundation grant 651440 to R.V., A.V., and S.S.). R.S. and S.S. were supported by the U.S. Department of Energy under grant DE-SC0019030. The DMRG simulations were performed by using the Tensor Network Python (TeNPy) package developed by J. Hauschild and F. Pollmann (36) and were run on the FASRC Cannon and Odyssey clusters supported by the FAS Division of Science Research Computing Group at Harvard University.	Andersen CK, 2020, NAT PHYS, V16, P875, DOI 10.1038/s41567-020-0920-y; Banuls MC, 2020, EUR PHYS J D, V74, DOI 10.1140/epjd/e2020-100571-8; BRICMONT J, 1983, PHYS LETT B, V122, P73, DOI 10.1016/0370-2693(83)91171-1; Celi A, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021057; Cong I, 2019, NAT PHYS, V15, P1273, DOI 10.1038/s41567-019-0648-8; de Leseleuc S, 2019, SCIENCE, V365, P775, DOI 10.1126/science.aav9105; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; Dziarmaga J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.245701; Ebadi S, 2021, NATURE, V595, P227, DOI 10.1038/s41586-021-03582-4; FREDENHAGEN K, 1983, COMMUN MATH PHYS, V92, P81, DOI 10.1007/BF01206315; Fu MX, 2015, SCIENCE, V350, P655, DOI 10.1126/science.aab2120; Glaetzle AW, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041037; Gregor K, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025009; Gross C, 2017, SCIENCE, V357, P995, DOI 10.1126/science.aal3837; Halperin B. I., 2020, FRACTIONAL QUANTUM H, DOI DOI 10.1142/1175; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Hastings MB, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045141; Hauschild J., 2018, SCIPOST PHYS LECT NO, V005, DOI [10.21468/SciPostPhysLectNotes.5, DOI 10.21468/SCIPOSTPHYSLECTNOTES.5]; Hermele M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135301; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Misguich G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137202; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Ozawa T, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.015006; Polkovnikov A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161201; READ N, 1991, PHYS REV LETT, V66, P1773, DOI 10.1103/PhysRevLett.66.1773; Rispoli M, 2019, NATURE, V573, P385, DOI 10.1038/s41586-019-1527-2; ROKHSAR DS, 1988, PHYS REV LETT, V61, P2376, DOI 10.1103/PhysRevLett.61.2376; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Sachdev S, 2019, REP PROG PHYS, V82, DOI 10.1088/1361-6633/aae110; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Samajdar R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015785118; Satzinger KJ, 2021, SCIENCE, V374, P1237, DOI 10.1126/science.abi8378; Savary L, 2017, REP PROG PHYS, V80, DOI 10.1088/0034-4885/80/1/016502; Scholl P, 2021, NATURE, V595, P233, DOI 10.1038/s41586-021-03585-1; Semeghini G., 2021, **DATA OBJECT**, DOI [10.7910/DVN/BDCTRX, DOI 10.7910/DVN/BDCTRX]; Song C, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.030502; Stoudenmire EM, 2012, ANNU REV CONDEN MA P, V3, P111, DOI 10.1146/annurev-conmatphys-020911-125018; SUTHERLAND B, 1988, PHYS REV B, V37, P3786, DOI 10.1103/PhysRevB.37.3786; Tagliacozzo L, 2013, ANN PHYS-NEW YORK, V330, P160, DOI 10.1016/j.aop.2012.11.009; Turner CJ, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.155134; Verresen R., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.5553679, DOI 10.5281/ZENODO.5553679]; Verresen R, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.031005; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Wen XG, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.041004; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; Yao NY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185302; Zaletel MP, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165112; Zhou SY, 2021, PHYS REV B, V104, DOI 10.1103/PhysRevB.104.L081107; Zurek WH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.105701	55	74	74	18	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2021	374	6572					1242	+		10.1126/science.abi8794	http://dx.doi.org/10.1126/science.abi8794			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1EO	34855494	Green Submitted			2022-12-28	WOS:000728578700055
J	Kagawa, H; Javali, A; Khoei, HH; Sommer, TM; Sestini, G; Novatchkova, M; Reimer, YSO; Castel, G; Bruneau, A; Maenhoudt, N; Lammers, J; Loubersac, S; Freour, T; Vankelecom, H; David, L; Rivron, N				Kagawa, Harunobu; Javali, Alok; Khoei, Heidar Heidari; Sommer, Theresa Maria; Sestini, Giovanni; Novatchkova, Maria; Reimer, Yvonne Scholte Op; Castel, Gael; Bruneau, Alexandre; Maenhoudt, Nina; Lammers, Jenna; Loubersac, Sophie; Freour, Thomas; Vankelecom, Hugo; David, Laurent; Rivron, Nicolas			Human blastoids model blastocyst development and implantation	NATURE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN ENDOMETRIUM; EMBRYO MODELS; LONG-TERM; NAIVE; TROPHOBLAST; MOUSE; EXPRESSION; PATHWAY	One week after fertilization, human embryos implant into the uterus. This event requires the embryo to form a blastocyst consisting of a sphere encircling a cavity lodging the embryo proper. Stem cells can form a blastocyst model that we called a blastoid(1). Here we show that naive human pluripotent stem cells cultured in PXGL medium(2) and triply inhibited for the Hippo, TGF-beta and ERK pathways efficiently (with more than 70% efficiency) form blastoids generating blastocyst-stage analogues of the three founding lineages (more than 97% trophectoderm, epiblast and primitive endoderm) according to the sequence and timing of blastocyst development. Blastoids spontaneously form the first axis, and we observe that the epiblast induces the local maturation of the polar trophectoderm, thereby endowing blastoids with the capacity to directionally attach to hormonally stimulated endometrial cells, as during implantation. Thus, we propose that such a human blastoid is a faithful, scalable and ethical model for investigating human implantation and development(3,4).	[Kagawa, Harunobu; Javali, Alok; Khoei, Heidar Heidari; Sommer, Theresa Maria; Sestini, Giovanni; Novatchkova, Maria; Reimer, Yvonne Scholte Op; Rivron, Nicolas] Austrian Acad Sci IMBA, Vienna BioCtr VBC, Inst Mol Biotechnol, Vienna, Austria; [Novatchkova, Maria] Vienna Bioctr, Inst Mol Pathol IMP, Vienna, Austria; [Castel, Gael; Bruneau, Alexandre; Lammers, Jenna; Loubersac, Sophie; Freour, Thomas; David, Laurent] Univ Nantes, Ctr Rech Transplantat & Immunol, CHU Nantes, INSERM,ITUN,UMR 1064, Nantes, France; [Maenhoudt, Nina; Vankelecom, Hugo] Univ Leuven, KU Leuven, Dept Dev & Regenerat, Unit Stem Cell Res,Cluster Stem Cell & Dev Biol, Leuven, Belgium; [Lammers, Jenna; Loubersac, Sophie; Freour, Thomas] CHU Nantes, Serv Biol Reprod, Nantes, France; [David, Laurent] Univ Nantes, CHU Nantes, SFR Sante, INSERM,CNRS,FED 4203,INSERM UMS 016,CNRS UMS 3556, Nantes, France	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; KU Leuven; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Rivron, N (corresponding author), Austrian Acad Sci IMBA, Vienna BioCtr VBC, Inst Mol Biotechnol, Vienna, Austria.	nicolas.rivron@imba.oeaw.ac.at		Sestini, Giovanni/0000-0002-6643-7585; Scholte op Reimer, Yvonne/0000-0002-1656-9221; Castel, Gael/0000-0002-7563-1179; Bruneau, Alexandre/0000-0002-3135-4309; Freour, Thomas/0000-0002-7243-7709; Kagawa, Harunobu/0000-0003-0436-3805; Vankelecom, Hugo/0000-0002-2251-7284; Maenhoudt, Nina/0000-0002-5523-3819; Javali, Alok/0000-0002-8769-0272	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [101002317]; Austrian Science Fund (FWF) [M3131-B]; ANR 'BOOSTIVF'	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ANR 'BOOSTIVF'(French National Research Agency (ANR))	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC-Co grant agreement no.101002317 `BLASTOID: a discovery platform for early human embryogenesis'). H.H.K. is supported by the Austrian Science Fund (FWF), Lise Meitner Programme M3131-B. This project has also received funding from the ANR `BOOSTIVF'. L.D. thanks the iPSCDTC and MicroPICell core facilities. We thank Y. Takashima for sharing the H9 and H9-GFP cell lines; A. Smith, P. Andrews and G. Guo for sharing the HNES1, Shef6, niPSC 16.2b and cR-NCRM2 cell lines; H. Baharvand for sharing the endometrial organoids; K. Woltjen for sharing the PB-TAC-ERP2 and pCAG-PBase plasmids; K. Guan for sharing pQCXIH-Myc-YAP, pQCXIH-Myc-YAP-5SA, pQCXIH-Myc-YAP-S94A plasmids; J. M. Brickman for sharing the RNA isolated from PrE differentiated cells and nEND cells; S. Srinivas for sharing the single-cell RNA-seq data of peri-gastrulation embryo; A. Bykov and L. Cochella for technical assistance for SMARTSeq2 library preparation; and the NGS, Biooptic and Stem Cell facility at IMBA for critical assistance.	Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Boretto M, 2017, DEVELOPMENT, V144, P1775, DOI 10.1242/dev.148478; Castel G, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108419; Clark AT, 2021, STEM CELL REP, V16, P1416, DOI 10.1016/j.stemcr.2021.05.008; Dumortier JG, 2019, SCIENCE, V365, P465, DOI 10.1126/science.aaw7709; Fan Y, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00316-8; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gerri C, 2020, NATURE, V587, P443, DOI 10.1038/s41586-020-2759-x; Gregory PW, 1929, SCIENCE, V69, P226, DOI 10.1126/science.69.1782.226-a; Guo G, 2021, CELL STEM CELL, V28, P1040, DOI 10.1016/j.stem.2021.02.025; Guo G, 2017, DEVELOPMENT, V144, P2748, DOI 10.1242/dev.146811; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; HARDY K, 1989, DEVELOPMENT, V107, P597; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Io S, 2021, CELL STEM CELL, V28, P1023, DOI 10.1016/j.stem.2021.03.013; Jeschke U, 2009, J HISTOCHEM CYTOCHEM, V57, P871, DOI 10.1369/jhc.2009.952085; Kim SI, 2016, METHODS MOL BIOL, V1357, P111, DOI 10.1007/7651_2015_251; Kimmelman J, 2016, LANCET, V387, P1979, DOI 10.1016/S0140-6736(16)30390-7; Linneberg-Agerholm M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.180620; Liu XD, 2021, NATURE, V591, P627, DOI 10.1038/s41586-021-03372-y; Ma HX, 2019, SCIENCE, V366, P836, DOI 10.1126/science.aax7890; Matsuo M, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz005; Meistermann D, 2021, CELL STEM CELL, V28, P1625, DOI 10.1016/j.stem.2021.04.027; Messmer T, 2019, CELL REP, V26, P815, DOI 10.1016/j.celrep.2018.12.099; Mischler A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100386; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rivron N, 2018, NATURE, V564, P183, DOI 10.1038/d41586-018-07663-9; Rivron NC, 2018, NATURE, V557, P106, DOI 10.1038/s41586-018-0051-0; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Rossant J, 2016, CURR TOP DEV BIOL, V117, P275, DOI 10.1016/bs.ctdb.2015.11.015; Sozen B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25853-4; Stirparo GG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158501; Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Tyser RCV, 2021, NATURE, V600, P285, DOI 10.1038/s41586-021-04158-y; Vrij EJ, 2016, LAB CHIP, V16, P734, DOI 10.1039/c5lc01499a; Wang WX, 2020, NAT MED, V26, P1644, DOI 10.1038/s41591-020-1040-z; Xiang LF, 2020, NATURE, V577, P537, DOI 10.1038/s41586-019-1875-y; Yanagida A, 2021, CELL STEM CELL, V28, P1016, DOI 10.1016/j.stem.2021.04.031; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu LQ, 2021, NATURE, V591, P620, DOI 10.1038/s41586-021-03356-y; Zhang Y, 2021, BIOINFORMATICS, V37, P2025, DOI 10.1093/bioinformatics/btab036; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao C., REPROGRAMMED IBLASTO, DOI [10.1101/2021.05.07.442980(2021, DOI 10.1101/2021.05.07.442980(2021]; Zhou F, 2019, NATURE, V572, P660, DOI 10.1038/s41586-019-1500-0	47	61	61	17	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					600	+		10.1038/s41586-021-04267-8	http://dx.doi.org/10.1038/s41586-021-04267-8		DEC 2021	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34856602	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000741978400001
J	Tu, HW; Hu, KQ; Zhang, M; Zhuang, YL; Song, T				Tu, Hongwei; Hu, Keqi; Zhang, Meng; Zhuang, Yali; Song, Tie			Effectiveness of 14 day quarantine strategy: Chinese experience of prevention and control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COVID-19		[Tu, Hongwei; Zhang, Meng; Zhuang, Yali; Song, Tie] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Peoples R China; [Hu, Keqi] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	Song, T (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Peoples R China.	tsong@cdcp.org.cn			Key Research and Development Program of Guangdong Province [2019B111103001]; National Natural Science Foundation of China [82041030]	Key Research and Development Program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Key Research and Development Program of Guangdong Province (2019B111103001) and the National Natural Science Foundation of China (82041030) for financial support.	Arora P, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00502-w; Ashcroft P, 2021, ELIFE, V10, DOI 10.7554/eLife.63704; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Brown RCH, 2021, LANCET INFECT DIS, V21, pE58, DOI 10.1016/S1473-3099(20)30766-0; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Clifford S, 2020, STRATEGIES REDUCE RI, DOI [10.1101/2020.07.24.20161281, DOI 10.1101/2020.07.24.20161281]; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMc2107808, 10.1056/NEJMoa2105000]; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Homma Y, 2021, J INFECTION, V83, pE15, DOI 10.1016/j.jinf.2021.06.011; Hu SX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21710-6; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Leung K, 2021, LANCET PUBLIC HEALTH, V6, pE674, DOI 10.1016/S2468-2667(21)00167-5; Li B., 2021, EPIDEMIOLOGY, DOI [10.1101/2021.07.07.21260122v2, DOI 10.1101/2021.07.07.21260122, 10.1101/2021.07.07.21260122]; Liu Zhuoming, 2021, bioRxiv, DOI 10.1101/2020.11.06.372037; Lu J, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102960; Meyerowitz EA, 2021, ANN INTERN MED, V174, P69, DOI 10.7326/M20-5008; Oran DP, 2021, ANN INTERN MED, V174, P655, DOI 10.7326/M20-6976; Russell TW, 2021, LANCET PUBLIC HEALTH, V6, pE12, DOI 10.1016/S2468-2667(20)30263-2; World Health Organization, 2020, CONS QUAR CONT COVID; Xin H, 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciab501, DOI 10.1093/CID/CIAB501]; Zhang M, 2021, CHINA CDC WEEKLY, V3, P584, DOI 10.46234/ccdcw2021.148; Zhou Bin, 2020, bioRxiv, DOI 10.1101/2020.10.27.357558	22	8	8	6	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2021	375								e066121	10.1136/bmj-2021-066121	http://dx.doi.org/10.1136/bmj-2021-066121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS2XZ	34852996	hybrid, Green Published			2022-12-28	WOS:000732779300015
J	Casanova, JL; Abel, L				Casanova, Jean-Laurent; Abel, Laurent			Mechanisms of viral inflammation and disease in humans	SCIENCE			English	Review							SIMPLEX-VIRUS ENCEPHALITIS; GENETIC DISSECTION; INTRINSIC IMMUNITY; TLR3 DEFICIENCY; INBORN-ERRORS; INTERFERON; INFECTION; PATIENT; IMMUNOLOGY; INFLUENZA	Disease and accompanying inflammation are uncommon outcomes of viral infection in humans. Clinical inflammation occurs if steady-state cell-intrinsic and leukocytic immunity to viruses fails. Inflammation attests to the attempts of newly recruited and activated leukocytes to resolve infection in the blood or tissues. In the confusing battle between a myriad of viruses and cells, studies of human genetics can separate the root cause of inflammation and disease from its consequences. Single-gene inborn errors of cell-intrinsic or leukocytic immunity underlying diverse infections in the skin, brain, or lungs can help to clarify the human determinants of viral disease. The genetic elucidation of immunological deficits in a single patient with a specific vulnerability profile can reveal mechanisms of inflammation and disease that may be triggered by other causes, inherited or otherwise, in other patients. This human genetic dissection of viral infections is giving rise to a new biology and a new medicine.	[Casanova, Jean-Laurent; Abel, Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA; [Casanova, Jean-Laurent; Abel, Laurent] Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM U1163, Paris, France; [Casanova, Jean-Laurent; Abel, Laurent] Univ Paris, Imagine Inst, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Rockefeller University	Casanova, JL (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA.; Casanova, JL (corresponding author), Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis, INSERM U1163, Paris, France.; Casanova, JL (corresponding author), Univ Paris, Imagine Inst, Paris, France.; Casanova, JL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	casanova@rockefeller.edu		Casanova, Jean-Laurent/0000-0002-7782-4169	Howard Hughes Medical Institute; Rockefeller University; St. Giles Foundation; National Institutes of Health (NIH) [R01AI088364]; National Center for Advancing Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program [UL1 TR001866]; Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]; Yale High Performance Computing Center [S10OD018521]; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; French National Research Agency (ANR) under the "Investments for the Future" program [ANR-10-IAHU-01]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French Foundation for Medical Research (FRM) [EQU201903007798]; FRM; ANR GENCOVID project; ANRS-COV05 project; ANR AABIFNCOV project [ANR-20-CO11-0001]; Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Institut National de la Sante et de la Recherche Medicale (INSERM); REACTing-INSERM; University of Paris; ANR GENVIR project [ANR-20-CE93-003]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rockefeller University; St. Giles Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Yale High Performance Computing Center; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; French National Research Agency (ANR) under the "Investments for the Future" program(French National Research Agency (ANR)); Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); FRM(Fondation pour la Recherche Medicale); ANR GENCOVID project(French National Research Agency (ANR)); ANRS-COV05 project; ANR AABIFNCOV project(French National Research Agency (ANR)); Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); REACTing-INSERM; University of Paris; ANR GENVIR project(French National Research Agency (ANR))	The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute; the Rockefeller University; the St. Giles Foundation; the National Institutes of Health (NIH) (R01AI088364); the National Center for Advancing Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program (UL1 TR001866); a Fast Grant from Emergent Ventures; Mercatus Center at George Mason University; the Yale Center for Mendelian Genomics and the GSP Coordinating Center funded by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and U24HG008956); the Yale High Performance Computing Center (S10OD018521); the Fisher Center for Alzheimer's Research Foundation; the Meyer Foundation; the French National Research Agency (ANR) under the "Investments for the Future" program (ANR-10-IAHU-01); the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID); the French Foundation for Medical Research (FRM) (EQU201903007798); the FRM and ANR GENCOVID project; the ANRS-COV05, ANR GENVIR (ANR-20-CE93-003) and ANR AABIFNCOV (ANR-20-CO11-0001) projects; the Square Foundation; Grandir-Fonds de solidarite pour l'enfance; the SCOR Corporate Foundation for Science; Institut National de la Sante et de la Recherche Medicale (INSERM); REACTing-INSERM; and the University of Paris.	Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Asgari S, 2017, P NATL ACAD SCI USA, V114, P8342, DOI 10.1073/pnas.1704259114; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20202486; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bastard P, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139980; Beziat V, 2021, CELL, V184, P3812, DOI 10.1016/j.cell.2021.06.004; Beziat V, 2020, HUM GENET, V139, P919, DOI 10.1007/s00439-020-02183-x; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bruzzese A, 2020, CANCERS, V12, DOI 10.3390/cancers12102962; Casanova J. L., ANNU REV PATHOL-MECH, V16, P23; Casanova JL, 2020, HUM GENET, V139, P681, DOI 10.1007/s00439-020-02184-w; Casanova JL, 2018, SEMIN IMMUNOL, V36, P1, DOI 10.1016/j.smim.2017.12.008; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Casanova JL, 2013, COLD SH Q B, V78, P157, DOI 10.1101/sqb.2013.78.019968; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chen J, 2021, J EXP MED, V218, DOI 10.1084/jem.20211349; Chen YK, 2021, SCIENCE, V373, P918, DOI 10.1126/science.abg5953; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Jong SJ, 2018, J EXP MED, V215, P2289, DOI 10.1084/jem.20170308; DUBOS RJ, 1955, SCI AM, V192, P31, DOI 10.1038/scientificamerican0555-31; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Gao DX, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI134529; Gaudet RG, 2021, SCIENCE, V373, DOI 10.1126/science.abf8113; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Haller O, 2018, ANNU REV VIROL, V5, P33, DOI 10.1146/annurev-virology-092917-043525; Hernandez N, 2018, J EXP MED, V215, P2567, DOI 10.1084/jem.20180628; Heusinkveld LE, 2019, J CLIN IMMUNOL, V39, P532, DOI 10.1007/s10875-019-00665-w; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Ku CL, 2020, HUM GENET, V139, P783, DOI 10.1007/s00439-020-02180-0; Lafaille FG, 2019, NAT MED, V25, P1873, DOI 10.1038/s41591-019-0672-3; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Lamborn IT, 2017, J EXP MED, V214, P1949, DOI 10.1084/jem.20161759; Lim HK, 2019, J EXP MED, V216, P2038, DOI 10.1084/jem.20181621; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.20211211; McLaren PJ, 2021, NAT REV GENET, V22, P645, DOI 10.1038/s41576-021-00378-0; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7; Nathan C, 2021, SCIENCE, V373, P276, DOI 10.1126/science.abj5637; Notarangelo LD, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb1662; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; ORTH G, 1978, P NATL ACAD SCI USA, V75, P1537, DOI 10.1073/pnas.75.3.1537; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Paludan SR, 2021, NAT REV IMMUNOL, V21, P137, DOI 10.1038/s41577-020-0391-5; POZZETTO B, 1984, J INFECT DIS, V150, P707, DOI 10.1093/infdis/150.5.707; Pulendran B, 2020, SCIENCE, V369, P1582, DOI 10.1126/science.aay4014; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Sologuren I, 2018, J CLIN IMMUNOL, V38, P513, DOI 10.1007/s10875-018-0512-0; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; van der Wijst MGP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh2624; Vidal SM, 2008, ANNU REV IMMUNOL, V26, P81, DOI 10.1146/annurev.immunol.26.021607.090304; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang Q, 2020, MED-CAMBRIDGE, V1, P14, DOI 10.1016/j.medj.2020.12.001; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang SY, 2019, CURR OPIN IMMUNOL, V59, P88, DOI 10.1016/j.coi.2019.03.008; Zhang SY, 2018, CELL, V172, P952, DOI 10.1016/j.cell.2018.02.019; Zhang SY, 2015, J EXP MED, V212, P1342, DOI 10.1084/jem.2129insight4; Zimmer B, 2018, P NATL ACAD SCI USA, V115, pE8775, DOI 10.1073/pnas.1809853115	68	26	25	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2021	374	6571			SI		1080	1086		10.1126/science.abj7965	http://dx.doi.org/10.1126/science.abj7965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8HK	34822298	Green Accepted			2022-12-28	WOS:000725668600038
J	Van de Vyver, J; Leite, AC; Alwan, NA				Van de Vyver, Julie; Leite, Ana C.; Alwan, Nisreen A.			Navigating the social identity of long covid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		[Van de Vyver, Julie; Leite, Ana C.] Univ Durham, Durham, England; [Alwan, Nisreen A.] Univ Southampton, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	Durham University; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Van de Vyver, J (corresponding author), Univ Durham, Durham, England.		Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463				Abrams D, 2015, PEACE CONFL, V21, P28, DOI 10.1037/pac0000084; [Anonymous], PREVALENCE ONGOING S; Ballering A., EPIDEMIOL COMMUNITY, V75, P603, DOI [10.1136/jech-2021-216643, DOI 10.1136/JECH-2021-216643]; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Cruwys T, 2015, SOC PSYCHOL PERS SCI, V6, P65, DOI 10.1177/1948550614543309; FitzGerald C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0179-8; Greenaway KH, 2015, J PERS SOC PSYCHOL, V109, P53, DOI 10.1037/pspi0000019; Haslam C, 2016, J AFFECT DISORDERS, V194, P188, DOI 10.1016/j.jad.2016.01.010; Jetten J, 2017, EUR J SOC PSYCHOL, V47, P789, DOI 10.1002/ejsp.2333; Junker NM, 2019, BRIT J SOC PSYCHOL, V58, P991, DOI 10.1111/bjso.12308; Pantelic Marija., BMJ OPINION; van Dick R., 2002, EUR J WORK ORGAN PSY, V11, P129, DOI [10.1080/13594320143000889, DOI 10.1080/13594320143000889]	12	5	5	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2021	375								n2933	10.1136/bmj.n2933	http://dx.doi.org/10.1136/bmj.n2933			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9PM	34836878	Green Accepted, Bronze			2022-12-28	WOS:000727787900007
J	Sun, SZ; Weinberger, KR; Nori-Sarma, A; Spangler, KR; Sun, YT; Dominici, F; Wellenius, GA				Sun, Shengzhi; Weinberger, Kate R.; Nori-Sarma, Amruta; Spangler, Keith R.; Sun, Yuantong; Dominici, Francesca; Wellenius, Gregory A.			Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITAL ADMISSIONS; AIR-POLLUTION; HIGH-TEMPERATURES; EXTREME-HEAT; MORTALITY; ASSOCIATION; MORBIDITY; SERIES; EXPOSURE; CLIMATE	OBJECTIVE To quantify the association between ambient heat and visits to the emergency department (ED) for any cause and for cause specific conditions in the conterminous United States among adults with health insurance. DESIGN Time stratified case crossover analyses with distributed lag non-linear models. SETTING US nationwide administrative healthcare claims database. PARTICIPANTS All commercial and Medicare Advantage beneficiaries (74.2 million) aged 18 years and older between May and September 2010 to 2019. MAIN OUTCOME MEASURES Daily rates of ED visits for any cause, heat related illness, renal disease, cardiovascular disease, respiratory disease, and mental disorders based on discharge diagnosis codes. RESULTS 21 996 670 ED visits were recorded among adults with health insurance living in 2939 US counties. Days of extreme heat-defined as the 95th centile of the local warm season (May through September) temperature distribution (at 34.4 degrees C v 14.9 degrees C national average level)-were associated with a 7.8% (95% confidence interval 7.3% to 8.2%) excess relative risk of ED visits for any cause, 66.3% (60.2% to 72.7%) for heat related illness, 30.4% (23.4% to 37.8%) for renal disease, and 7.9% (5.2% to 10.7%) for mental disorders. Days of extreme heat were associated with an excess absolute risk of ED visits for heat related illness of 24.3 (95% confidence interval 22.9 to 25.7) per 100 000 people at risk per day. Heat was not associated with a higher risk of ED visits for cardiovascular or respiratory diseases. Associations were more pronounced among men and in counties in the north east of the US or with a continental climate. CONCLUSIONS Among both younger and older adults, days of extreme heat are associated with a higher risk of ED visits for any cause, heat related illness, renal disease, and mental disorders. These results suggest that the adverse health effects of extreme heat are not limited to older adults and carry important implications for the health of adults across the age spectrum.	[Sun, Shengzhi; Nori-Sarma, Amruta; Spangler, Keith R.; Sun, Yuantong; Wellenius, Gregory A.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Sun, Shengzhi; Wellenius, Gregory A.] OptumLabs, Eden Prairie, MN 55346 USA; [Weinberger, Kate R.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Dominici, Francesca] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Boston University; Optum; University of British Columbia; Harvard University; Harvard T.H. Chan School of Public Health	Sun, SZ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA.; Sun, SZ (corresponding author), OptumLabs, Eden Prairie, MN 55346 USA.	szsun@bu.edu; wellenius@bu.edu	Sun, Shengzhi/G-2015-2018	Sun, Shengzhi/0000-0002-3708-1225	US National Institutes of Health/National Institute of Environmental Health Sciences [R01-ES029950, F32-ES027742]; Wellcome Trust [216033-Z-19-Z]	US National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome Trust)	This study is supported by grants R01-ES029950 (SS, ANS, KRS, YS, FD, GAW) and F32-ES027742 (KRW) from the US National Institutes of Health/National Institute of Environmental Health Sciences, and grant 216033-Z-19-Z from the Wellcome Trust (SS, ANS, KRS, GAW) . The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Anderson GB, 2013, AM J RESP CRIT CARE, V187, P1098, DOI 10.1164/rccm.201211-1969OC; [Anonymous], 2020, OPTUMLABS OPTUMLABS; Bai L, 2014, SCI TOTAL ENVIRON, V490, P838, DOI 10.1016/j.scitotenv.2014.05.024; Bassil KL, 2010, INT J ENV RES PUB HE, V7, P991, DOI 10.3390/ijerph7030991; Bobb JF, 2014, JAMA-J AM MED ASSOC, V312, P2659, DOI 10.1001/jama.2014.15715; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Di Q, 2017, JAMA-J AM MED ASSOC, V318, P2446, DOI 10.1001/jama.2017.17923; Phung D, 2017, ENVIRON POLLUT, V220, P597, DOI 10.1016/j.envpol.2016.10.008; Phung D, 2016, ENVIRON POLLUT, V208, P33, DOI 10.1016/j.envpol.2015.06.004; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Gronlund CJ, 2016, CLIMATIC CHANGE, V136, P631, DOI 10.1007/s10584-016-1638-9; Gronlund CJ, 2014, ENVIRON HEALTH PERSP, V122, P1187, DOI 10.1289/ehp.1206132; Hopp S, 2018, PREV MED, V110, P81, DOI 10.1016/j.ypmed.2018.02.001; Jay O, 2021, LANCET, V398, P709, DOI 10.1016/S0140-6736(21)01209-5; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Kingsley SL, 2016, ENVIRON HEALTH PERSP, V124, P460, DOI 10.1289/ehp.1408826; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Li MM, 2015, INT J ENV RES PUB HE, V12, P5256, DOI 10.3390/ijerph120505256; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; Lippmann SJ, 2013, ENVIRON RES, V124, P35, DOI 10.1016/j.envres.2013.03.009; Liu JW, 2021, ENVIRON INT, V153, DOI 10.1016/j.envint.2021.106533; Lohmus M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071515; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McTavish RK, 2018, AM J KIDNEY DIS, V71, P200, DOI 10.1053/j.ajkd.2017.07.011; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; National Weather Service,, WEATH REL FAT INJ ST; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Ogbomo AS, 2017, INT J BIOMETEOROL, V61, P833, DOI 10.1007/s00484-016-1261-5; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Sarofim M.C., 2016, TEMPERATURE RELATED; Schaffer A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-3; Shindell D, 2020, GEOHEALTH, V4, DOI 10.1029/2019GH000234; Spangler KR, 2019, J EXPO SCI ENV EPID, V29, P777, DOI 10.1038/s41370-018-0105-2; Sun SZ, 2019, ENVIRON INT, V126, P7, DOI 10.1016/j.envint.2019.02.023; USGCRP,, IMP RISKS AD US 4 NA, VII2018; van Loenhout JAF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5021-1; Wang Y, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0167-3; Wang Y, 2020, ENVIRON INT, V136, DOI 10.1016/j.envint.2020.105486; Wei YG, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6258; Weinberger KR, 2020, ENVIRON EPIDEMIOL, V4, DOI 10.1097/EE9.0000000000000096; Wondmagegn BY, 2021, SCI TOTAL ENVIRON, V781, DOI 10.1016/j.scitotenv.2021.146815; Xu RB, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002950; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zhang K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-11; Zhao Q, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/ehp3889, 10.1289/EHP3889]; Zhao Q, 2017, ENVIRON POLLUT, V224, P310, DOI 10.1016/j.envpol.2017.02.010	52	12	12	7	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2021	375								e065653	10.1136/bmj-2021-065653	http://dx.doi.org/10.1136/bmj-2021-065653			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XE5JI	34819309	hybrid, Green Published			2022-12-28	WOS:000723423400003
J	Boer, CG; Hatzikotoulas, K; Southam, L; Stefansdottir, L; Zhang, YF; de Almeida, RC; Wu, TT; Zheng, J; Hartley, A; Teder-Laving, M; Skogholt, AH; Terao, C; Zengini, E; Alexiadis, G; Barysenka, A; Bjornsdottir, G; Gabrielsen, ME; Gilly, A; Ingvarsson, T; Johnsen, MB; Jonsson, H; Kloppenburg, M; Luetge, A; Lund, SH; Magi, R; Mangino, M; Nelissen, RRGHH; Shivakumar, M; Steinberg, J; Takuwa, H; Thomas, LF; Tuerlings, M; Babis, GC; Cheung, JPY; Kang, JH; Kraft, P; Lietman, SA; Samartzis, D; Slagboom, PE; Stefansson, K; Thorsteinsdottir, U; Tobias, JH; Uitterlinden, AG; Winsvold, B; Zwart, JA; Smith, GD; Sham, PC; Thorleifsson, G; Gaunt, TR; Morris, AP; Valdes, AM; Tsezou, A; Cheah, KSE; Ikegawa, S; Hveem, K; Esko, T; Wilkinson, JM; Lee, MTM; van Meurs, JBJ; Styrkarsdottir, U; Zeggini, E				Boer, Cindy G.; Hatzikotoulas, Konstantinos; Southam, Lorraine; Stefansdottir, Lilja; Zhang, Yanfei; de Almeida, Rodrigo Coutinho; Wu, Tian T.; Zheng, Jie; Hartley, April; Teder-Laving, Maris; Skogholt, Anne Heidi; Terao, Chikashi; Zengini, Eleni; Alexiadis, George; Barysenka, Andrei; Bjornsdottir, Gyda; Gabrielsen, Maiken E.; Gilly, Arthur; Ingvarsson, Thorvaldur; Johnsen, Marianne B.; Jonsson, Helgi; Kloppenburg, Margreet; Luetge, Almut; Lund, Sigrun H.; Magi, Reedik; Mangino, Massimo; Nelissen, Rob R. G. H. H.; Shivakumar, Manu; Steinberg, Julia; Takuwa, Hiroshi; Thomas, Laurent F.; Tuerlings, Margo; Babis, George C.; Cheung, Jason Pui Yin; Kang, Jae Hee; Kraft, Peter; Lietman, Steven A.; Samartzis, Dino; Slagboom, P. Eline; Stefansson, Kari; Thorsteinsdottir, Unnur; Tobias, Jonathan H.; Uitterlinden, Andre G.; Winsvold, Bendik; Zwart, John-Anker; Smith, George Davey; Sham, Pak Chung; Thorleifsson, Gudmar; Gaunt, Tom R.; Morris, Andrew P.; Valdes, Ana M.; Tsezou, Aspasia; Cheah, Kathryn S. E.; Ikegawa, Shiro; Hveem, Kristian; Esko, Tonu; Wilkinson, J. Mark; Lee, Ming Ta Michael; van Meurs, Joyce B. J.; Styrkarsdottir, Unnur; Zeggini, Eleftheria		ArcOGEN Consortium Hunt All	Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations (vol 184, pg 4784, 2021)	CELL			English	Correction												eleftheria.zeggini@helmholtz-muenchen.de	Winsvold, Bendik/ABF-7839-2021; Lund, Sigrún Helga/AAG-6042-2019; Kraft, Peter/GQH-8448-2022; Hveem, Kristian/AFV-4683-2022	Winsvold, Bendik/0000-0003-4171-8919; Lund, Sigrún Helga/0000-0002-3806-2296; Shivakumar, Manu/0000-0003-4733-7375				Boer CG, 2021, CELL, V184, P4784, DOI 10.1016/j.cell.2021.07.038	1	7	7	4	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2021	184	24					6003	6005		10.1016/j.cell.2021.11.003	http://dx.doi.org/10.1016/j.cell.2021.11.003		NOV 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	XC9ER	34822786	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000722314300005
J	Oliver, D				Oliver, David			David Oliver: Dismissing unwell people to argue for pandemic freedoms is abhorrent and unrealistic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Andrasfay T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014746118; Donnelly L., 2021, TELEGRAPH; Ely J, 2021, MAIL ONLINE; Harmans L, 2021, NED TIJDSCHR GENEES, V165, pC4844; Office for National Statistics, COR COVID 19 LAT INS; Spiegelhalter D, 2021, GUARDIAN 0724; Suleman M., 2021, UNEQUAL PANDEMIC FAI; USIP, 2021, SPECIAL REPORT	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2844	10.1136/bmj.n2844	http://dx.doi.org/10.1136/bmj.n2844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819299	Bronze			2022-12-28	WOS:000740893700002
J	Wise, J				Wise, Jacqui			NICE recommends progesterone to prevent early miscarriage	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], ECTOPIC PREGNANCY MI; Coomarasamy A, 2019, NEW ENGL J MED, V380, P1815, DOI 10.1056/NEJMoa1813730	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2021	375								n2896	10.1136/bmj.n2896	http://dx.doi.org/10.1136/bmj.n2896			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE1ME	34819313				2022-12-28	WOS:000740893700010
J	Zettler, PJ; Adashi, EY; Cohen, IG				Zettler, Patricia J.; Adashi, Eli Y.; Cohen, I. Glenn			A Divisive Ruling on Devices - Genus Medical Technologies v. FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zettler, Patricia J.] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Zettler, Patricia J.] Ohio State Univ, Moritz Coll Law, Drug Enforcement & Policy Ctr, Columbus, OH 43210 USA; [Adashi, Eli Y.] Brown Univ, Dept Med Sci, Providence, RI USA; [Cohen, I. Glenn] Harvard Univ, Harvard Law Sch, Cambridge, MA 02138 USA; [Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA	James Cancer Hospital & Solove Research Institute; Ohio State University; Ohio State University; Brown University; Harvard University; Harvard University	Zettler, PJ (corresponding author), Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA.; Zettler, PJ (corresponding author), Ohio State Univ, Moritz Coll Law, Drug Enforcement & Policy Ctr, Columbus, OH 43210 USA.			Adashi, Eli/0000-0001-7730-1192				Anonymous, 2021, FED REGISTER, V86, P43553; Marks P, 2018, NEW ENGL J MED, V378, P954, DOI 10.1056/NEJMsr1715626	2	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2021	385	26					2409	2411		10.1056/NEJMp2117295	http://dx.doi.org/10.1056/NEJMp2117295		NOV 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XS4FC	34818475				2022-12-28	WOS:000721972500001
J	Rubin, R				Rubin, Rita			Compounded Drug Guidance for Hospital and Health System Pharmacies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2021	326	20					2003	2003		10.1001/jama.2021.20539	http://dx.doi.org/10.1001/jama.2021.20539			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF3VI	34812883				2022-12-28	WOS:000724001500050
J	Tanne, JH				Tanne, Janice Hopkins			Covid 19: US government committee hears how social media spreads misinformation	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, HEARING COMBATING CO; Dyer O, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3589	2	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2021	375								n2834	10.1136/bmj.n2834	http://dx.doi.org/10.1136/bmj.n2834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9RR	34794972	Bronze			2022-12-28	WOS:000727793600002
